Citrus Sinensis ID: 020981

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------32
Protein Sequence
METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR
Secondary Structure (PSIPRED)
cccccccEEEEEEccccccccccHHHHcccccccccccHHHHHHHHHHHHccHHHHHHHHcccccccccccccccHHHHHHHcccHHHHHHHHHcccccccccccccccccHHHccccHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccEEEEEEccEEEEEEEEcccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccEEEcccccEEEccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEHHHHHHHccHHHHHHHHHccccccccccccccHHHHHHHHccHHHHHHHHHHcccccccccccccHHHHHHHHccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHcccccccccccccccccccHHHHHHHHccccHccccccccccEEEcccEEEEEEEcccccccccccHHHHHHHHHHHHHHccccHHEEEEEEEcccccEEEEccccccEHHHHHcccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEcHHHcEEEccccccccccccccEccccEEEccc
Coil and Loop (DISEMBL)
metkvpvrttllkqsslapdreRKEAElngldddgeeikpEFRLMFLANERDVEGIKELLDSgidvnfrdidNRTALHVAACQGFTEVVSLLLErgadvdpkdrwgstplgdaiyYKNHEVIKLLEKhgakplmapmhvkharevpeyeidpheldftnsveiTKGTFILAFWRGIQVAVKKLgeevisdddRVRAFRDELALLQKIRHPNVVQFLGavtqsspmmivteylpkgDLRAFLKrkgalkpstAVRFALDIARgmnylhenkpvpiihrdlepsnilrddsgnlkvadfgvsklltvkedrpltcqdtscr
Flexible Loop (DISEMBL)
metkvpvrttllkqsslapdrerkeaelngldddgeeiKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLergadvdpkdrwgstplgdaiYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLgeevisdddrVRAFRDELAllqkirhpnvVQFLgavtqsspmMIVTEYLPKGDLRAFLKrkgalkpstAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGvsklltvkedrpltcqdtscr
Low Complexity Region (SEG)
METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR
Disordered region (IsUnstruct)
****************************************EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV**************
Disordered Region (DISOPRED)
******V*******************************KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL**AIYYKNHEVIKLLEK***************REVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEE******RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV**************
Disordered Region (DISEMBL)
METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR
Disordered Region (DISPRO)
*****PVRT***KQSSLAPDRERKEA*****DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG*****A**HVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	319	2.2.26 [Sep-21-2011]
Q5UQG7	1651	Putative serine/threonine	N/A	no	0.545	0.105	0.375	5e-26
Q05609	821	Serine/threonine-protein	no	no	0.423	0.164	0.464	3e-25
Q54H46	642	Probable serine/threonine	yes	no	0.514	0.255	0.385	4e-25
Q54H45	690	Probable serine/threonine	no	no	0.514	0.237	0.396	6e-25
Q9FPR3	933	Serine/threonine-protein	no	no	0.429	0.146	0.442	8e-25
P18160	2410	Dual specificity protein	no	no	0.479	0.063	0.418	3e-24
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.401	0.077	0.396	9e-24
Q54N73	691	Seven transmembrane domai	no	no	0.401	0.185	0.453	7e-23
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.429	0.084	0.378	3e-22
Q86AE1	527	Probable serine/threonine	no	no	0.510	0.309	0.393	3e-22

>sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1

 Score =  118 bits (296), Expect = 5e-26,   Method: Composition-based stats.
 Identities = 68/181 (37%), Positives = 101/181 (55%), Gaps = 7/181 (3%)

Query: 141 HAREVPEYEIDPHELDFTNSV-EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
           H R   E+E+D HELDF  S+     G    A W+G +VAVKKL    I+ D   R F+ 
Sbjct: 779 HQRVEDEWEVDFHELDFMESLGSGGSGEVFKAMWKGTEVAVKKLVNSNITKDAE-RNFKQ 837

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFAL 257
           E+  +  +RHPNVV F+ A T+   M IV E++  G L   L  +    + P   +R A 
Sbjct: 838 EIHRMTSLRHPNVVLFMAASTRPPNMCIVMEFMSLGSLYDLLGNELVTEIPPVLRIRIAY 897

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
             A+GM++LH +    I+HRDL+  N+L D   N+KV+DFG++K+    + +  T +D+ 
Sbjct: 898 QAAKGMHFLHSSD---IVHRDLKSLNLLLDSKWNVKVSDFGLTKIKDNNKGKSSTKEDSV 954

Query: 318 C 318
           C
Sbjct: 955 C 955

Acanthamoeba polyphaga (taxid: 5757)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  116 bits (290), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 65/140 (46%), Positives = 87/140 (62%), Gaps = 5/140 (3%)

Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           GT   A W G  VAVK L E+    + RV  F  E+A+++++RHPN+V F+GAVTQ   +
Sbjct: 563 GTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 621

Query: 226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            IVTEYL +G L   L + GA   L     +  A D+A+GMNYLH   P PI+HRDL+  
Sbjct: 622 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRDLKSP 680

Query: 283 NILRDDSGNLKVADFGVSKL 302
           N+L D    +KV DFG+S+L
Sbjct: 681 NLLVDKKYTVKVCDFGLSRL 700

Acts as a negative regulator in the ethylene response pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  115 bits (288), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/174 (38%), Positives = 105/174 (60%), Gaps = 10/174 (5%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           +ID H++     V I KG +    L  WRG QVAVKKL    I +++ ++ F  E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 424

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
            +RHPNV+QFLG+      + I TEY+P+G L + L  +   L+ S  ++  +D A+G+ 
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           YLH + PV I+HRDL+  N+L D++  +KVADFG+S +   ++   +T   T C
Sbjct: 485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC 535

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  115 bits (287), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 69/174 (39%), Positives = 103/174 (59%), Gaps = 10/174 (5%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           +ID  ++     V I KG F    L  WRG QVAVKKL    I +++ ++ F  E+ L++
Sbjct: 385 DIDTQQIKI--GVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 441

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
            +RHPNV+QFLG+   S  + I TEY+P+G L + L   K  +  S   R  +D A+G+ 
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           YLH + PV I+HRDL+  N+L D++  +KVADFG+S +   ++   +T   T C
Sbjct: 502 YLHGSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC 552

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  114 bits (286), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 62/140 (44%), Positives = 90/140 (64%), Gaps = 3/140 (2%)

Query: 164 TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
           + G    A W G +VAVKK  ++  S    +  FR E+ +++++RHPNVV FLGAVT+  
Sbjct: 679 SYGEVYHADWHGTEVAVKKFLDQDFSGA-ALAEFRSEVRIMRRLRHPNVVFFLGAVTRPP 737

Query: 224 PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            + IVTE+LP+G L   L R K  +     ++ ALD+A GMN LH + P  I+HRDL+  
Sbjct: 738 NLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPT-IVHRDLKTP 796

Query: 283 NILRDDSGNLKVADFGVSKL 302
           N+L D++ N+KV DFG+S+L
Sbjct: 797 NLLVDNNWNVKVGDFGLSRL 816

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3

 Score =  112 bits (281), Expect = 3e-24,   Method: Composition-based stats.
 Identities = 74/177 (41%), Positives = 97/177 (54%), Gaps = 24/177 (13%)

Query: 147  EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
            EYEID +EL+F  +  I KG F      +WR   VA+K +  +       +  F++E+ +
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164

Query: 204  LQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALD 258
            L K+RHPNVVQFLGA T        IVTE++  G LR FL     L    P   ++ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224

Query: 259  IARGMNYLHENKPVPIIHRDLEPSNILRD---DSGN----------LKVADFGVSKL 302
            IA+GMNYLH   P PI+HRDL   NIL D   D  N           K++DFG+S+L
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRL 2280

Essential for spore differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  111 bits (277), Expect = 9e-24,   Method: Composition-based stats.
 Identities = 52/131 (39%), Positives = 90/131 (68%), Gaps = 3/131 (2%)

Query: 173  WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
            W+ + VA+KK  ++ I D++ +   R+E+A L+K+ HPN++  +GA  +   + IVTEY+
Sbjct: 1418 WKNVDVAIKKFIKQKI-DENHLLGIREEIAFLKKLHHPNIITMVGASLKKPNICIVTEYM 1476

Query: 233  PKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
             KG+LR  ++     L+    ++  ++IA+G++YLH   P PIIHRD++PSNIL D++ N
Sbjct: 1477 AKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHSFDP-PIIHRDIKPSNILIDENWN 1535

Query: 292  LKVADFGVSKL 302
            +K+ADFG +++
Sbjct: 1536 VKIADFGFARI 1546

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54N73|7TMK1_DICDI Seven transmembrane domain-containing tyrosine-protein kinase 1 OS=Dictyostelium discoideum GN=7tmk1 PE=3 SV=1

 Score =  108 bits (269), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 64/141 (45%), Positives = 84/141 (59%), Gaps = 13/141 (9%)

Query: 171 AFWRGIQVAVKKLGEEVISDDDRVR---AFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           A W+G  VAVK L      + D  +    F  E+A+L  +RHPNV+QFLG  ++++   I
Sbjct: 380 AVWKGAVVAVKILHRNSFRNTDGNKEENVFLKEVAILSILRHPNVLQFLGVCSETNLNGI 439

Query: 228 VTEYLPKGDL------RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           VTEY+  G L      R FL ++    P  A   A+ IARGM YLH+ KP PI+HRDL  
Sbjct: 440 VTEYMGGGSLDRLLTDRYFLIKQ---NPILAWNMAISIARGMFYLHDWKPNPILHRDLST 496

Query: 282 SNILRDDSGNL-KVADFGVSK 301
            NIL D+S  + KVADFG+SK
Sbjct: 497 KNILLDESLTIAKVADFGLSK 517

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  106 bits (264), Expect = 3e-22,   Method: Composition-based stats.
 Identities = 59/156 (37%), Positives = 97/156 (62%), Gaps = 19/156 (12%)

Query: 162  EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
            +I  G++ + F   W+G+ VAVKK  ++ +S+  ++  FR E+A L +++H N+V F+GA
Sbjct: 1369 QIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSET-QLLEFRAEMAFLSELKHSNIVTFIGA 1427

Query: 219  VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI------ARGMNYLHENKPV 272
              +   + IVTEY+  G+LR  LK      P   + FA  +      A G++YLH + P+
Sbjct: 1428 CIKKPNICIVTEYMRMGNLRDVLK-----NPDIKITFANKLKLLYGAAMGIDYLHSSNPM 1482

Query: 273  PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
             I+HRD++P+NIL D+  N+K+ADFG ++   +KED
Sbjct: 1483 -IVHRDIKPANILVDEHFNVKIADFGFAR---IKED 1514

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86AE1|Y9853_DICDI Probable serine/threonine-protein kinase DDB_G0271538 OS=Dictyostelium discoideum GN=DDB_G0271538 PE=3 SV=1

 Score =  106 bits (264), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/178 (39%), Positives = 98/178 (55%), Gaps = 15/178 (8%)

Query: 147 EYEIDPHELDFTN---SVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E E D   LD+++    VEI +G+F     A + G  VAVK+L   V  D D  +    E
Sbjct: 20  EDENDFSSLDYSDLFMDVEIGRGSFGQVQKASYFGTDVAVKQLSTLVSIDPDYFKFMLRE 79

Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR--FALD 258
           + +L+ +RHPN+VQ++GA       MIVTEY+  GDL  F+K +G    S  +R   ALD
Sbjct: 80  IKILKGMRHPNIVQYIGACCHEGRYMIVTEYIKGGDLHQFIKARGVSNISWTLRMKLALD 139

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGN----LKVADFGVSKLLTVKEDRPLT 312
           IA   +YLH  K   +I RDL+  NIL D+ G+     KV DFG +++   K+   LT
Sbjct: 140 IASAFSYLHSKK---VIFRDLKAKNILVDEIGDGLYRAKVIDFGFARIFDGKDTNNLT 194

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	319
255562560	466	protein kinase, putative [Ricinus commun	0.996	0.682	0.8	1e-147
356555470	456	PREDICTED: probable serine/threonine-pro	0.990	0.692	0.799	1e-146
449459316	458	PREDICTED: serine/threonine-protein kina	0.971	0.676	0.817	1e-145
356549162	455	PREDICTED: probable serine/threonine-pro	0.990	0.694	0.789	1e-144
225443668	462	PREDICTED: dual specificity protein kina	1.0	0.690	0.780	1e-142
224076914	423	predicted protein [Populus trichocarpa]	0.962	0.725	0.794	1e-141
255558750	401	Serine/threonine-protein kinase HT1, put	0.974	0.775	0.765	1e-132
356499380	454	PREDICTED: dual specificity protein kina	0.968	0.680	0.750	1e-132
356553484	453	PREDICTED: serine/threonine-protein kina	0.978	0.688	0.734	1e-130
449433589	460	PREDICTED: probable serine/threonine-pro	0.984	0.682	0.744	1e-129

>gi|255562560|ref|XP_002522286.1| protein kinase, putative [Ricinus communis] gi|223538539|gb|EEF40144.1| protein kinase, putative [Ricinus communis]

 Score =  526 bits (1354), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 264/330 (80%), Positives = 288/330 (87%), Gaps = 12/330 (3%)

Query: 1   METKVPVRTTLLKQSSLAPDRERKEAELNG-------LDDDGEE----IKPEFRLMFLAN 49
           ME K  VR TL KQSSLAP+R R+E   N        + +D EE    I P  RLM+  +
Sbjct: 1   MEGKSSVRFTLGKQSSLAPERSREEDVSNDQEEGSEDMSNDPEEELEDIHPGVRLMYSCH 60

Query: 50  ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
           E D++GI+ELLDSGIDVNFRDIDNRTALH+AACQG+T+VV+LLL  GA+ DPKDRWGSTP
Sbjct: 61  EGDLDGIRELLDSGIDVNFRDIDNRTALHLAACQGYTDVVALLLNNGAETDPKDRWGSTP 120

Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFI 169
           L DAIYYKNH+VIKLLEK GAKPLMAPMHV HAREVPEYEI+PHELDFTNSVEITKGTF 
Sbjct: 121 LADAIYYKNHDVIKLLEKRGAKPLMAPMHVNHAREVPEYEINPHELDFTNSVEITKGTFH 180

Query: 170 LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           LA WRGIQVAVKKLGE+VISD+D+VRAF DELALLQKIRHPNVVQFLGAVTQSSPMMIVT
Sbjct: 181 LASWRGIQVAVKKLGEDVISDEDKVRAFSDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 240

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           EYL KGDLRAFLK+KGAL+P TAVRF LDIARG+NYLHENKP PIIHRDLEPSNILRDDS
Sbjct: 241 EYLHKGDLRAFLKKKGALRPGTAVRFGLDIARGLNYLHENKP-PIIHRDLEPSNILRDDS 299

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           G+LKVADFGVSKLLTVKED+PLTCQDTSCR
Sbjct: 300 GHLKVADFGVSKLLTVKEDKPLTCQDTSCR 329

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356555470|ref|XP_003546054.1| PREDICTED: probable serine/threonine-protein kinase drkB-like [Glycine max]

 Score =  525 bits (1353), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 255/319 (79%), Positives = 284/319 (89%), Gaps = 3/319 (0%)

Query: 1   METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
           ME+K P R TL KQSSLAP+R  KEAEL     DGE +    RLM+ A E DV+GI+E L
Sbjct: 1   MESKNPARFTLGKQSSLAPERHNKEAELQ---KDGEAVDQGVRLMYSAFEGDVDGIREAL 57

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           +SG+ VN++DIDNRTALHVAAC+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58  ESGVSVNYKDIDNRTALHVAACEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117

Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
           VIKLLEKHGAKPLMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF  A WRG +VAV
Sbjct: 118 VIKLLEKHGAKPLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCSALWRGTKVAV 177

Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
           KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237

Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           +KRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 MKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297

Query: 301 KLLTVKEDRPLTCQDTSCR 319
           KLL VKED+PLTCQDTSCR
Sbjct: 298 KLLAVKEDKPLTCQDTSCR 316

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449459316|ref|XP_004147392.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus]

 Score =  520 bits (1338), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 256/313 (81%), Positives = 278/313 (88%), Gaps = 3/313 (0%)

Query: 7   VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV 66
           VR  L KQSS+APDR+ +EAEL    +DGEEI P  RLM+LANE D+EGIKELLDSGIDV
Sbjct: 11  VRFLLGKQSSMAPDRQPEEAELA---EDGEEIDPGVRLMYLANEGDLEGIKELLDSGIDV 67

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
           NF DIDNRTALH+AACQG  E+V LLL RGA++DPKDRWGSTPL DAI+YKNHEVIKLLE
Sbjct: 68  NFHDIDNRTALHIAACQGCNEIVDLLLRRGAEIDPKDRWGSTPLADAIFYKNHEVIKLLE 127

Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEE 186
           K GAK LMAPMHVKHAREVPEYEIDP E DFTNSV +TKGTF LA WRGIQVAVK+L E+
Sbjct: 128 KRGAKHLMAPMHVKHAREVPEYEIDPKEFDFTNSVNLTKGTFHLASWRGIQVAVKELPED 187

Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
           VIS++D+V AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL   L +KG 
Sbjct: 188 VISEEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCQLLHKKGP 247

Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
           LKP  AV+FALDIARGMNYLHENKP PIIHRDLEPSNILRDD+GNLKVADFGVSKLLTVK
Sbjct: 248 LKPIVAVKFALDIARGMNYLHENKPAPIIHRDLEPSNILRDDTGNLKVADFGVSKLLTVK 307

Query: 307 EDRPLTCQDTSCR 319
           ED+PLTCQDT+CR
Sbjct: 308 EDKPLTCQDTACR 320

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356549162|ref|XP_003542966.1| PREDICTED: probable serine/threonine-protein kinase drkA-like [Glycine max]

 Score =  516 bits (1328), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 252/319 (78%), Positives = 281/319 (88%), Gaps = 3/319 (0%)

Query: 1   METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
           ME+K P R TL KQSSLAP+R  KEAEL    +DGE +    RLM+ A E DV+GI E L
Sbjct: 1   MESKNPARFTLGKQSSLAPERHNKEAELQ---NDGEVVDQGVRLMYSAFEGDVDGICEAL 57

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           + G+ VN++DIDNRTALHVA C+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58  EFGVSVNYKDIDNRTALHVAVCEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117

Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
           VIKLLEKHGAK LMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF +A WRG +VAV
Sbjct: 118 VIKLLEKHGAKLLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCIALWRGTEVAV 177

Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
           KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237

Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           LKRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 LKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297

Query: 301 KLLTVKEDRPLTCQDTSCR 319
           KLL VKED+PLTC DTSCR
Sbjct: 298 KLLAVKEDKPLTCHDTSCR 316

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225443668|ref|XP_002263226.1| PREDICTED: dual specificity protein kinase shkB [Vitis vinifera] gi|297740576|emb|CBI30758.3| unnamed protein product [Vitis vinifera]

 Score =  510 bits (1313), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 252/323 (78%), Positives = 284/323 (87%), Gaps = 4/323 (1%)

Query: 1   METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
           +E+K  VR TL KQSSLAP+R R EA   G   D E I P  RLM+LANE D+EG++ELL
Sbjct: 3   VESKTAVRFTLGKQSSLAPERARDEALTEGEQGDVEGIDPRVRLMYLANEGDLEGLRELL 62

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           DSG+DVNFRDIDNRTALHVAACQGF++VV  LL+ GA++D +DRWGSTPL DAI+YKNH+
Sbjct: 63  DSGMDVNFRDIDNRTALHVAACQGFSDVVEFLLKNGAEIDLEDRWGSTPLADAIHYKNHD 122

Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
           VIKLLEKHGA+ LMAPMHV +AREVPEYEIDP ELDFTNSV+ITKGT+ +A WRGIQVAV
Sbjct: 123 VIKLLEKHGAQHLMAPMHVNNAREVPEYEIDPKELDFTNSVDITKGTYRIASWRGIQVAV 182

Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
           K+LG+EVI D+D+V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL AF
Sbjct: 183 KRLGDEVIIDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLHAF 242

Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           LKRKGALK +TAV+FALDIARGMNYLHE++P  IIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 243 LKRKGALKTATAVKFALDIARGMNYLHEHRPEAIIHRDLEPSNILRDDSGHLKVADFGVS 302

Query: 301 KLL----TVKEDRPLTCQDTSCR 319
           KLL    TVKED PL CQ+TSCR
Sbjct: 303 KLLKVANTVKEDYPLICQETSCR 325

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076914|ref|XP_002305047.1| predicted protein [Populus trichocarpa] gi|222848011|gb|EEE85558.1| predicted protein [Populus trichocarpa]

 Score =  505 bits (1301), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 248/312 (79%), Positives = 280/312 (89%), Gaps = 5/312 (1%)

Query: 8   RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN 67
           R TL KQSSLAP+R+R+E+++   D DG  + P  RLM+LANE ++EGIKEL++S +DVN
Sbjct: 1   RFTLGKQSSLAPERDREESDV---DMDG--VDPGVRLMYLANEGNLEGIKELVNSDVDVN 55

Query: 68  FRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
           FRDID RTALH+A+CQG T+VV LLL+ GA++DPKDRWGSTPL DAI+YKNH+VIKLLEK
Sbjct: 56  FRDIDGRTALHIASCQGLTQVVDLLLDHGAEIDPKDRWGSTPLADAIFYKNHDVIKLLEK 115

Query: 128 HGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEV 187
            GAKPLMAPMHVKHAREVPEYEI+P ELDFTNSVE+TKGTF +A WRGIQVAVKKLGEEV
Sbjct: 116 RGAKPLMAPMHVKHAREVPEYEINPDELDFTNSVELTKGTFCVALWRGIQVAVKKLGEEV 175

Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
           +SD+D+VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE+LPKGD  AFLKRKGAL
Sbjct: 176 LSDEDKVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEFLPKGDFCAFLKRKGAL 235

Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           KP  AVR ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG+LKVADFG+SKLLTVKE
Sbjct: 236 KPIAAVRLALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGHLKVADFGISKLLTVKE 295

Query: 308 DRPLTCQDTSCR 319
           ++PL   D S R
Sbjct: 296 EKPLISLDNSWR 307

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558750|ref|XP_002520399.1| Serine/threonine-protein kinase HT1, putative [Ricinus communis] gi|223540446|gb|EEF42015.1| Serine/threonine-protein kinase HT1, putative [Ricinus communis]

 Score =  478 bits (1231), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 245/320 (76%), Positives = 274/320 (85%), Gaps = 9/320 (2%)

Query: 5   VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKE-LLDSG 63
            P R TL KQSSL P+R+R E E    +  G  I P  RLM+LA+E D++GI E LL+SG
Sbjct: 18  TPARFTLGKQSSLKPERDRHEEEEEEEEVAG--IDPRVRLMYLASEGDIDGINEVLLESG 75

Query: 64  IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
            DVNF+DID RTALHVAACQG T+V+ LLL+RGA++DPKDRWGSTPL DAIYYKNH+VIK
Sbjct: 76  TDVNFKDIDGRTALHVAACQGLTDVLQLLLDRGAEIDPKDRWGSTPLADAIYYKNHDVIK 135

Query: 124 LLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKL 183
           LLE HGAKP +APMHV++AREVPEYEIDP+ELDF+NSV+ITKGTF  A WRGIQVAVK L
Sbjct: 136 LLEIHGAKPPIAPMHVQNAREVPEYEIDPNELDFSNSVDITKGTFRSASWRGIQVAVKTL 195

Query: 184 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
           GEEV +D+D+V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL A+LK 
Sbjct: 196 GEEVFTDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCAYLKL 255

Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           KGALKP  AV+FALDIARGMNYLHE+KP  IIHRDLEPSNILRDDSG+LKVADFGVSKLL
Sbjct: 256 KGALKPRVAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKLL 315

Query: 304 ----TVKEDRPLTCQDTSCR 319
               TVKEDRP  CQDTS R
Sbjct: 316 KVTKTVKEDRP--CQDTSWR 333

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356499380|ref|XP_003518519.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max]

 Score =  478 bits (1229), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 241/321 (75%), Positives = 271/321 (84%), Gaps = 12/321 (3%)

Query: 4   KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDS 62
           K+  R +L +QSSLAP+R        G   D  E + P  RLM+LANE D +GIKELLD+
Sbjct: 5   KLQPRFSLGRQSSLAPER-------GGCGGDASEALDPAVRLMYLANEGDSDGIKELLDA 57

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G DVNF DID RTALHVAACQG T+VV LLL RGADVDP+DRWGSTPL DA+YYKNH+V+
Sbjct: 58  GSDVNFTDIDGRTALHVAACQGRTDVVGLLLRRGADVDPQDRWGSTPLVDAMYYKNHDVV 117

Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
           KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRG QVAVK 
Sbjct: 118 KLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGTQVAVKT 177

Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           LGEE+ +DDD+V+AF DEL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDLRA+LK
Sbjct: 178 LGEELFTDDDKVKAFHDELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLRAYLK 237

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           RKGALKP TAV+FALDIARGMNYLHE+KP  IIHRDLEPSNILRDDSG+LKVADFGVSKL
Sbjct: 238 RKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKL 297

Query: 303 L----TVKEDRPLTCQDTSCR 319
           L    TVKED+P+T  DTS R
Sbjct: 298 LKVAKTVKEDKPVTSLDTSWR 318

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356553484|ref|XP_003545086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max]

 Score =  469 bits (1208), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 238/324 (73%), Positives = 270/324 (83%), Gaps = 12/324 (3%)

Query: 1   METK-VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKEL 59
           METK +  R +L +QSSLAP+R        G  D  E + P  RLM+LANE D +GIKEL
Sbjct: 1   METKKLHPRFSLGRQSSLAPERA-------GAGDSSEALDPAVRLMYLANEGDSDGIKEL 53

Query: 60  LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           LD+G +VNF DID RT+LHVAACQG T+VV LLL RGA VDP+DRWGSTPL DA+YYKNH
Sbjct: 54  LDAGSNVNFTDIDGRTSLHVAACQGRTDVVDLLLRRGAHVDPQDRWGSTPLVDAMYYKNH 113

Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
           +V+KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRGIQVA
Sbjct: 114 QVVKLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGIQVA 173

Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
           VK LGEE+ +DDD+V+AF  EL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDL A
Sbjct: 174 VKTLGEELFTDDDKVKAFHYELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLGA 233

Query: 240 FLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
           +LKRKGALKP TAV+FALDIARGMNYLHE+KP  IIHRDLEPSNILRDDSG+LKVADFGV
Sbjct: 234 YLKRKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGV 293

Query: 300 SKLL----TVKEDRPLTCQDTSCR 319
           SKLL     VKED+P+   DTS R
Sbjct: 294 SKLLKVAKMVKEDKPVASLDTSWR 317

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449433589|ref|XP_004134580.1| PREDICTED: probable serine/threonine-protein kinase drkD-like [Cucumis sativus]

 Score =  466 bits (1200), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 236/317 (74%), Positives = 266/317 (83%), Gaps = 3/317 (0%)

Query: 6   PVRTTLLKQSSLAPDRERKEAELNGL---DDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
           PV+  L KQSSLAPD +    +L  L       E I    RLM+LANE D+EGI E+LDS
Sbjct: 4   PVKFKLGKQSSLAPDGDVHLEDLEELVKQHQTEEGIDSRVRLMYLANEGDLEGINEVLDS 63

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G+DVNFRDIDNRTALH+AACQGF +VV+LLLERGA+VD KDRWGSTPL DAI+YKNH+VI
Sbjct: 64  GVDVNFRDIDNRTALHIAACQGFADVVALLLERGAEVDSKDRWGSTPLRDAIHYKNHDVI 123

Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
           KLLEKHGAKP +APM VK+AREVP+YEIDP ELDFTNSV ITKGTF  A WRG +VAVK+
Sbjct: 124 KLLEKHGAKPPVAPMLVKNAREVPDYEIDPKELDFTNSVNITKGTFRRASWRGTEVAVKE 183

Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           LGE++ +D+++VRAFRDELALLQKIRHPNVVQFLGAVTQS PMMIVTEYLPKGDL A L 
Sbjct: 184 LGEDLFTDEEKVRAFRDELALLQKIRHPNVVQFLGAVTQSWPMMIVTEYLPKGDLGALLS 243

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           RK  +K  + VR ALDIARGMNYLHENKP PIIHR+LEPSNILRDDSG+LKVADFGVSKL
Sbjct: 244 RKREIKTMSVVRLALDIARGMNYLHENKPAPIIHRNLEPSNILRDDSGHLKVADFGVSKL 303

Query: 303 LTVKEDRPLTCQDTSCR 319
           LTVKED+  TC +TS R
Sbjct: 304 LTVKEDKFSTCSETSRR 320

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	319
TAIR|locus:2117129	459	AT4G18950 [Arabidopsis thalian	0.978	0.679	0.742	1.1e-121
TAIR|locus:2098999	471	AT3G58760 [Arabidopsis thalian	1.0	0.677	0.682	7.6e-112
TAIR|locus:2044034	479	AT2G43850 [Arabidopsis thalian	0.943	0.628	0.524	3.8e-78
TAIR|locus:2045258	476	AT2G31800 [Arabidopsis thalian	0.946	0.634	0.504	3.9e-76
TAIR|locus:2080517	477	AT3G59830 [Arabidopsis thalian	0.946	0.633	0.516	6.5e-74
TAIR|locus:2014849	438	VIK "VH1-interacting kinase" [	0.811	0.591	0.483	2.5e-58
WB|WBGene00016030	850	C24A1.3 [Caenorhabditis elegan	0.514	0.192	0.367	1.7e-26
TAIR|locus:2144613	821	CTR1 "CONSTITUTIVE TRIPLE RESP	0.423	0.164	0.464	2.3e-26
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.617	0.360	0.377	3e-26
DICTYBASE|DDB_G0289791	642	drkA "DRK subfamily protein ki	0.514	0.255	0.385	7.4e-26

TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)]

 Score = 1197 (426.4 bits), Expect = 1.1e-121, P = 1.1e-121
 Identities = 233/314 (74%), Positives = 268/314 (85%)

Query:     8 RTTLLKQSSLAPDR--ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
             R T+ +QSS+AP++  E        + +DGEEI    RLM+LANE D+EGIKEL+DSGID
Sbjct:     9 RFTIGRQSSMAPEKIPEPSVHSEEEVFEDGEEIDGGVRLMYLANEGDIEGIKELIDSGID 68

Query:    66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
              N+RDID+RTALHVAACQG  +VV LLL+R A+VDPKDRWGSTP  DAI+YKN +VIK+L
Sbjct:    69 ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPKDRWGSTPFADAIFYKNIDVIKIL 128

Query:   126 EKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGE 185
             E HGAK  MAPMHVK AREVPEYEI+P ELDFT S EITKGT+ +A WRGIQVAVKKL +
Sbjct:   129 EIHGAKHPMAPMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRGIQVAVKKLDD 188

Query:   186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
             EV+SDDD+VR F DELALLQ++RHPN+VQFLGAVTQS+PMMIVTEYLP+GDLR  LKRKG
Sbjct:   189 EVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKG 248

Query:   246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
              LKP+TAVR+ALDIARGM+YLHE K  PIIHRDLEPSNILRDDSG+LKVADFGVSKL+TV
Sbjct:   249 QLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNILRDDSGHLKVADFGVSKLVTV 308

Query:   306 KEDRPLTCQDTSCR 319
             KED+P TCQD SCR
Sbjct:   309 KEDKPFTCQDISCR 322

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)]

 Score = 1104 (393.7 bits), Expect = 7.6e-112, P = 7.6e-112
 Identities = 226/331 (68%), Positives = 261/331 (78%)

Query:     1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIK-------PEFRLMFLANERDV 53
             ++ K P R  L +QSSLAP+       L   +DD            P  RLM+LANE D+
Sbjct:     3 IKPKSPARFKLGRQSSLAPESRTPIDTLTEDEDDDLAAAATAGIGDPTIRLMYLANEGDI 62

Query:    54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
             +GI ++LDSG +V++RDID RTALHVAACQG T+VV LLL RGA VD KDRWGSTPL DA
Sbjct:    63 DGINKMLDSGTNVDYRDIDARTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADA 122

Query:   114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW 173
             +YYKNH+VIKLLEKHGAKP +APMHV   +EVPEYEI P ELDF+NSV+I+KGTF  A W
Sbjct:   123 VYYKNHDVIKLLEKHGAKPTIAPMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASW 182

Query:   174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
             RGI VAVK  GEE+ +D+D+V AFRDELALLQKIRHPNVVQFLGAVTQS+PMMIVTEYLP
Sbjct:   183 RGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 242

Query:   234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
             KGDLR +L RKG L P+ AV+FAL+IARGMNYLHE+KP  IIH DLEP NILRDDSG+LK
Sbjct:   243 KGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHLK 302

Query:   294 VADFGVSKLL----TVKEDRPL-TCQDTSCR 319
             VADFGVSKLL    TVK+DRP+ TC D+S R
Sbjct:   303 VADFGVSKLLVVKKTVKKDRPVVTCLDSSWR 333

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)]

 Score = 786 (281.7 bits), Expect = 3.8e-78, P = 3.8e-78
 Identities = 163/311 (52%), Positives = 214/311 (68%)

Query:     7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPE-----FRLMFLANERDVEGIKELLD 61
             +R +  +QSSL P R   ++  +  DD+     PE      +L+F+A++ DV GI+ELLD
Sbjct:    42 MRFSFGRQSSLDPIRRSPDSSKS--DDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLD 99

Query:    62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
              GIDVN  D+D RTALH+AAC+G   VV  LL R A++D +DRWGST   DA YY N +V
Sbjct:   100 EGIDVNSIDLDGRTALHIAACEGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDV 159

Query:   122 IKLLEKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQV 178
               LL+  GAK P     PM V + REVPEYE++P E+    S  I+KG + +A W G +V
Sbjct:   160 YNLLKARGAKVPKTRKTPMTVSNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRV 219

Query:   179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
             +VK L ++  SD +R+ AFR EL LL+K+RHPNV+QF+GAVTQ+ PMMIV EY PKGDL 
Sbjct:   220 SVKILDKDSYSDPERINAFRHELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLS 279

Query:   239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
              +L++KG L PS A+RFALDIARGMNYLHE KP PIIH DL+P NIL D  G LK++ FG
Sbjct:   280 VYLQKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFG 339

Query:   299 VSKLLTVKEDR 309
             + +L  + +D+
Sbjct:   340 MIRLSKISQDK 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)]

 Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
 Identities = 155/307 (50%), Positives = 209/307 (68%)

Query:     7 VRTTLLKQSSLAPDRERKEAELNGLD-DDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
             +R +  +QSSL P R   +   NG      + +    +L+F+A   DVEG+++LLD GID
Sbjct:    42 MRFSFGRQSSLDPIRRSPDGS-NGPQLAVPDNLDATMQLLFVACRGDVEGVQDLLDEGID 100

Query:    66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
             VN  D+D RTALH+AAC+G  +VV LLL R A++D +DRWGST   DA YY N +V  +L
Sbjct:   101 VNSIDLDGRTALHIAACEGHVDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFNIL 160

Query:   126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
             +  GAK P     PM V + REVPEYE++P EL    +  I+KG + +A W G +V+VK 
Sbjct:   161 KARGAKVPKTKRTPMVVANPREVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSVKI 220

Query:   183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
             L +++  D D + AF+ EL L +K+RHPNVVQF+GAVTQ+ PMMIV+EY PKGDL ++L+
Sbjct:   221 LDKDLYKDSDTINAFKHELTLFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQ 280

Query:   243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
             +KG L P+  +RFALDIARGMNYLHE KP P+IH DL+P NI+ D  G+LKVA FG+   
Sbjct:   281 KKGRLSPAKVLRFALDIARGMNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGLISF 340

Query:   303 LTVKEDR 309
               +  D+
Sbjct:   341 AKLSSDK 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)]

 Score = 746 (267.7 bits), Expect = 6.5e-74, P = 6.5e-74
 Identities = 158/306 (51%), Positives = 206/306 (67%)

Query:     7 VRTTLLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
             +R +  +QSSL P R   E+          E +    +L+F+A++ DV G++ELL+ GID
Sbjct:    42 MRFSFGRQSSLDPIRRSPESLSCEPHMSVPENLDSTMQLLFMASKGDVNGVEELLNEGID 101

Query:    66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
             VN  D+D RTALH+A+C+G  +VV +LL R A++D +DRWGST   DA YY N EV  LL
Sbjct:   102 VNSIDLDGRTALHIASCEGHYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVYNLL 161

Query:   126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
             +  GAK P     PM V + +EVPEYE++P EL       I+KGT+ +A W G +V+VK 
Sbjct:   162 KARGAKAPKTRKTPMTVGNPKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVSVKI 221

Query:   183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
               ++  SD +RV AF +EL LL K RHPN+VQF+GAVTQ+ PMMIV E  PKGDL  +L+
Sbjct:   222 FDKDSYSDPERVNAFTNELTLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQ 281

Query:   243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
             +KG L PS A+RFALDIARGMNYLHE KP PIIH +L P NIL D  G LK++ FG+ KL
Sbjct:   282 KKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGLIKL 341

Query:   303 LTVKED 308
               + ED
Sbjct:   342 SKIGED 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 599 (215.9 bits), Expect = 2.5e-58, P = 2.5e-58
 Identities = 135/279 (48%), Positives = 187/279 (67%)

Query:    44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
             +++ A++ D   +++LL+     V+ RD D RT LHVA+  G+ +VV  LLE GADV+ +
Sbjct:    41 ILWHAHQNDAAAVRKLLEEDPTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQ 100

Query:   103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH--AREVP-------EYEIDPH 153
             DRW +TPL DA   +  ++I+LL+ HG   L    +  H   + VP       ++EI+P 
Sbjct:   101 DRWKNTPLADAEGARKQKMIELLKSHGG--LSYGQNGSHFEPKPVPPPIPKKCDWEIEPA 158

Query:   154 ELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRV-RAFRDELALLQKIRH 209
             ELDF+N+  I KG+F   + A+WRG  VAVK++    +SDD  V + FR E+ LL K+RH
Sbjct:   159 ELDFSNAAMIGKGSFGEIVKAYWRGTPVAVKRILPS-LSDDRLVIQDFRHEVDLLVKLRH 217

Query:   210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
             PN+VQFLGAVT+  P+M++TEYL  GDL  +LK KG L P+TAV FALDIARGM YLH N
Sbjct:   218 PNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLH-N 276

Query:   270 KPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVK 306
             +P  IIHRDL+P N+L  +S   +LKV DFG+SKL+ V+
Sbjct:   277 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 315

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009734 "auxin mediated signaling pathway" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0005829 "cytosol" evidence=RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

WB|WBGene00016030 C24A1.3 [Caenorhabditis elegans (taxid:6239)]

 Score = 245 (91.3 bits), Expect = 1.7e-26, Sum P(2) = 1.7e-26
 Identities = 64/174 (36%), Positives = 93/174 (53%)

Query:   154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
             E++F  S  I  G+F   +   +RG  VAVK+                 E+++L ++ HP
Sbjct:   515 EIEFQES--IGSGSFGKVYKGTYRGKLVAVKRYRAMAFGCKSETDMLCREVSILSRLAHP 572

Query:   211 NVVQFLG-AVTQSSPMMIVTEYLPKGDL--RAFLKRKG--ALKPSTAVRFALDIARGMNY 265
             NVV F+G ++   S   I+TE++  G L  R   +RK    + P+  +R +LD+ARGM Y
Sbjct:   573 NVVAFVGTSLDDPSQFAIITEFVENGSLFRRENGERKNYRVMDPAFRLRISLDVARGMRY 632

Query:   266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
             LHE+   P+IHRDL   NIL    G   VADFG S+ +  +ED  LT Q  + R
Sbjct:   633 LHESAAKPVIHRDLNSHNILIHADGRSVVADFGESRFVCQREDENLTKQPGNLR 686

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0043652 "engulfment of apoptotic cell" evidence=IMP

TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 295 (108.9 bits), Expect = 2.3e-26, Sum P(2) = 2.3e-26
 Identities = 65/140 (46%), Positives = 87/140 (62%)

Query:   166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
             GT   A W G  VAVK L E+    + RV  F  E+A+++++RHPN+V F+GAVTQ   +
Sbjct:   563 GTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 621

Query:   226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
              IVTEYL +G L   L + GA   L     +  A D+A+GMNYLH   P PI+HRDL+  
Sbjct:   622 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRDLKSP 680

Query:   283 NILRDDSGNLKVADFGVSKL 302
             N+L D    +KV DFG+S+L
Sbjct:   681 NLLVDKKYTVKVCDFGLSRL 700

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009744 "response to sucrose stimulus" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0010105 "negative regulation of ethylene mediated signaling pathway" evidence=TAS

GO:0010182 "sugar mediated signaling pathway" evidence=TAS

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009686 "gibberellin biosynthetic process" evidence=IMP

GO:0048510 "regulation of timing of transition from vegetative to reproductive phase" evidence=IMP

GO:2000035 "regulation of stem cell division" evidence=IMP

GO:2000069 "regulation of post-embryonic root development" evidence=IMP

GO:0071281 "cellular response to iron ion" evidence=IEP

GO:0009750 "response to fructose stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 302 (111.4 bits), Expect = 3.0e-26, P = 3.0e-26
 Identities = 85/225 (37%), Positives = 133/225 (59%)

Query:    98 DVDPKDRWGSTP---LGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHARE-VPE-YEI 150
             DV   D W       L DA+   + E++KL ++ G+K        H K + E +P   EI
Sbjct:   215 DVFVVDGWSQEETDGLRDAL---SKEILKLKDQPGSKQKSISFFEHDKSSNELIPACIEI 271

Query:   151 -----DPHELDFTN-SVE--ITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFR 198
                  D  E+D T   +E  +  G++     RG     +VA+K L  + ++++  +R F 
Sbjct:   272 PTDGTDEWEIDVTQLKIEKKVASGSYG-DLHRGTYCSQEVAIKFLKPDRVNNE-MLREFS 329

Query:   199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
              E+ +++K+RH NVVQFLGA T+S  + IVTE++ +G +  FL K+K A K  T ++ AL
Sbjct:   330 QEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVAL 389

Query:   258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
             D+A+GM+YLH+N    IIHRDL+ +N+L D+ G +KVADFGV+++
Sbjct:   390 DVAKGMSYLHQNN---IIHRDLKTANLLMDEHGLVKVADFGVARV 431

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 287 (106.1 bits), Expect = 7.4e-26, Sum P(2) = 7.4e-26
 Identities = 67/174 (38%), Positives = 105/174 (60%)

Query:   149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
             +ID H++     V I KG +    L  WRG QVAVKKL    I+++  ++ F  E+ L++
Sbjct:   368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENI-LKEFHREINLMK 424

Query:   206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMN 264
              +RHPNV+QFLG+      + I TEY+P+G L + L  +   L+ S  ++  +D A+G+ 
Sbjct:   425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484

Query:   265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
             YLH + PV I+HRDL+  N+L D++  +KVADFG+S +   ++   +T   T C
Sbjct:   485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC 535

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.IV.2537.1 hypothetical protein (423 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	319
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-40
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-38
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-38
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-30
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-29
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-27
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-26
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-23
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	9e-23
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-20
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	4e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-15
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	3e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-13
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	1e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-12
PTZ00322	664	PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct	2e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-12
PHA02874	434	PHA02874, PHA02874, ankyrin repeat protein; Provis	8e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-11
PHA02874	434	PHA02874, PHA02874, ankyrin repeat protein; Provis	2e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-09
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	2e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-09
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	2e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-09
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	4e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-09
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	7e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	1e-08
PLN03192	823	PLN03192, PLN03192, Voltage-dependent potassium ch	1e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-08
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	2e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-08
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	5e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
pfam00023	33	pfam00023, Ank, Ankyrin repeat	5e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-07
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	2e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-07
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-07
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-07
pfam13857	56	pfam13857, Ank_5, Ankyrin repeats (many copies)	5e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-07
PLN03192	823	PLN03192, PLN03192, Voltage-dependent potassium ch	7e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-07
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	1e-06
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-06
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	3e-06
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	3e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-06
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-05
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	2e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-05
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	4e-05
pfam13606	30	pfam13606, Ank_3, Ankyrin repeat	4e-05
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	6e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-05
smart00248	30	smart00248, ANK, ankyrin repeats	6e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-05
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	9e-05
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	9e-05
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-04
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	5e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-04
PHA02946	446	PHA02946, PHA02946, ankyin-like protein; Provision	9e-04
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	0.001
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.001
TIGR00870	743	TIGR00870, trp, transient-receptor-potential calci	0.001
PHA02798	489	PHA02798, PHA02798, ankyrin-like protein; Provisio	0.001
PHA02736	154	PHA02736, PHA02736, Viral ankyrin protein; Provisi	0.001
PHA02716	764	PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provi	0.001
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.001
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	0.002
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	0.003
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  151 bits (383), Expect = 4e-44
 Identities = 52/136 (38%), Positives = 80/136 (58%), Gaps = 6/136 (4%)

Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
            + ++VAVK L E+  + + ++  F  E  +++K+ HPNVV+ LG  T+  P+ IV EY+
Sbjct: 26  KKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYM 83

Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
             GDL ++L K +  L  S  + FAL IARGM YL        IHRDL   N L  ++  
Sbjct: 84  EGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLV 140

Query: 292 LKVADFGVSKLLTVKE 307
           +K++DFG+S+ L   +
Sbjct: 141 VKISDFGLSRDLYDDD 156

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  149 bits (378), Expect = 2e-43
 Identities = 53/156 (33%), Positives = 86/156 (55%), Gaps = 15/156 (9%)

Query: 162 EITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
           ++ +G F        +G       +VAVK L E   + ++    F +E ++++K+ HPN+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLSHPNI 63

Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKP 271
           V+ LG  TQ  P+ IVTEY+P GDL  FL++ G  L     ++ AL IA+GM YL     
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122

Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
              +HRDL   N L  ++  +K++DFG+S+ +   +
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  149 bits (378), Expect = 3e-43
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 13/150 (8%)

Query: 166 GTFILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           G       +G      ++VAVK L E+  + + ++  F  E  +++K+ HPN+V+ LG  
Sbjct: 13  GEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIVKLLGVC 70

Query: 220 TQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           T+  P+MIV EY+P GDL  +L+  R   L  S  + FAL IARGM YL        IHR
Sbjct: 71  TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHR 127

Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           DL   N L  ++  +K++DFG+S+ L   +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDD 157

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  141 bits (357), Expect = 3e-40
 Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 14/156 (8%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ KG       +  +VAVK L E+  + ++  + F  E  +++K+ HPNVV+ LG  T+
Sbjct: 10  EVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE 67

Query: 222 SSPMMIVTEYLPKGDLRAFLKR---------KGALKPSTAVRFALDIARGMNYLHENKPV 272
             P+ +V EY+  GDL  +L++         K  L     + FA+ IA+GM YL   K  
Sbjct: 68  EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-- 125

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
             +HRDL   N L  +   +K++DFG+S+ +   + 
Sbjct: 126 -FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  136 bits (344), Expect = 2e-38
 Identities = 57/155 (36%), Positives = 83/155 (53%), Gaps = 9/155 (5%)

Query: 157 FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +    ++  G+F     A  +  G  VAVK L +          A R E+ +L+++ HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59

Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP 271
           +V+ + A      + +V EY   GDL  +L R G L    A + AL I RG+ YLH N  
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG- 118

Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
             IIHRDL+P NIL D++G +K+ADFG++K L   
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLKS 151

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  134 bits (341), Expect = 7e-38
 Identities = 49/148 (33%), Positives = 80/148 (54%), Gaps = 10/148 (6%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           ++ +G+F    LA  +  G  VA+K + ++ I  D        E+ +L+K++HPN+V+  
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNIVRLY 63

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                   + +V EY   GDL   LK++G L    A  +   I   + YLH      I+H
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLT 304
           RDL+P NIL D+ G++K+ADFG+++ L 
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLD 148

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  132 bits (334), Expect = 2e-37
 Identities = 56/161 (34%), Positives = 82/161 (50%), Gaps = 12/161 (7%)

Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
           + +G F    LA  +  G +VA+K +  +       +     E+ +L+K+ HPN+V+  G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                + + +V EY   G L+  LK     L     +R  L I  G+ YLH N    IIH
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115

Query: 277 RDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
           RDL+P NIL   D+G +K+ADFG+SKLLT  +    T   T
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  124 bits (314), Expect = 6e-34
 Identities = 43/128 (33%), Positives = 69/128 (53%), Gaps = 6/128 (4%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM--IVTEYLPKG 235
           +AVK + E     ++ + A   E+ +L  ++HPN+V++ G+          I  EY+  G
Sbjct: 28  MAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
            L + LK+ G L      ++   I  G+ YLH N    I+HRD++ +NIL D  G +K+A
Sbjct: 87  SLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLA 143

Query: 296 DFGVSKLL 303
           DFG +K L
Sbjct: 144 DFGCAKRL 151

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 2e-30
 Identities = 61/166 (36%), Positives = 94/166 (56%), Gaps = 14/166 (8%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
           + I+  EL    +  I KG F   +L  +RG +VAVK L ++  +     +AF  E +++
Sbjct: 1   WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVKCLKDDSTA----AQAFLAEASVM 54

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARG 262
             +RHPN+VQ LG V Q +P+ IVTEY+ KG L  +L+ +G   +  +  + FALD+  G
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           M YL E      +HRDL   N+L  +    KV+DFG++K  +  +D
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 5e-29
 Identities = 61/157 (38%), Positives = 84/157 (53%), Gaps = 14/157 (8%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    E+  G F    L  WRG I VA+K + E  +S+DD    F +E  ++ 
Sbjct: 1   IDPSELTFLK--ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMM 54

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HPN+VQ  G  T+  P+ IVTEY+  G L  +L+ RKG L     +    D+   M 
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           YL  N     IHRDL   N L  +   +KV+DFG+++
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  106 bits (267), Expect = 3e-27
 Identities = 58/157 (36%), Positives = 85/157 (54%), Gaps = 14/157 (8%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           I+P EL F    E+  G F    L  WR  I+VA+K + E  +S++D    F +E  ++ 
Sbjct: 1   INPSELTFMK--ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMM 54

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G  TQ  P+ IVTE++  G L  +L+ R+G L     +    D+  GM 
Sbjct: 55  KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           YL  N     IHRDL   N L   +G +KV+DFG+++
Sbjct: 115 YLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (265), Expect = 6e-27
 Identities = 48/131 (36%), Positives = 77/131 (58%), Gaps = 5/131 (3%)

Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           G ++AVK++  +  S + +  V A   E+ LL+ ++H  +VQ+ G +     + I  EY+
Sbjct: 27  GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G ++  LK  GAL  +   ++   I  G+ YLH N    I+HRD++ +NILRD +GN+
Sbjct: 87  PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV 143

Query: 293 KVADFGVSKLL 303
           K+ DFG SK L
Sbjct: 144 KLGDFGASKRL 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 6e-26
 Identities = 51/143 (35%), Positives = 79/143 (55%), Gaps = 15/143 (10%)

Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
           G  VA+KK+     EE I       A R E++LL++++HPN+V+ L  +     + +V E
Sbjct: 24  GEIVALKKIRLDNEEEGIP----STALR-EISLLKELKHPNIVKLLDVIHTERKLYLVFE 78

Query: 231 YLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           Y    DL+ +L KR G L P+        + RG+ Y H ++   I+HRDL+P NIL +  
Sbjct: 79  YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRD 134

Query: 290 GNLKVADFGVSKLLTVKEDRPLT 312
           G LK+ADFG+++   +   R  T
Sbjct: 135 GVLKLADFGLARAFGIP-LRTYT 156

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  102 bits (256), Expect = 1e-25
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 12/160 (7%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
            F    +I KG F     A  +  G +VA+K +  E     +++     E+ +L+K +HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHEN 269
           N+V++ G+  +   + IV E+   G L+  LK     L  S       ++ +G+ YLH N
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
               IIHRD++ +NIL    G +K+ DFG+S  L+  + R
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR 154

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 2e-25
 Identities = 55/149 (36%), Positives = 75/149 (50%), Gaps = 15/149 (10%)

Query: 162 EITKGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
           E+  GT     W G  +VAVK L    +S      AF  E  +++K+RH  +VQ     +
Sbjct: 21  EVWMGT-----WNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
           +  P+ IVTEY+ KG L  FLK      L+    V  A  IA GM YL        IHRD
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRD 128

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           L   NIL  ++   K+ADFG+++L+   E
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDE 157

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  100 bits (251), Expect = 7e-25
 Identities = 48/138 (34%), Positives = 76/138 (55%), Gaps = 11/138 (7%)

Query: 171 AFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
             W+   + VAVK L E+ +     V  F  E A++++I+HPN+VQ LG  T+  P  I+
Sbjct: 25  GVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80

Query: 229 TEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
           TE++  G+L  +L+   +  +     +  A  I+  M YL +      IHRDL   N L 
Sbjct: 81  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLV 137

Query: 287 DDSGNLKVADFGVSKLLT 304
            ++  +KVADFG+S+L+T
Sbjct: 138 GENHLVKVADFGLSRLMT 155

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.4 bits (248), Expect = 2e-24
 Identities = 44/125 (35%), Positives = 71/125 (56%), Gaps = 5/125 (4%)

Query: 179 AVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           AVK   L ++  +  + V+    E+ALL K++HPN+VQ+LG   +   + I  E +P G 
Sbjct: 29  AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L   LK+ G+        +   I  G+ YLH+      +HRD++ +NIL D +G +K+AD
Sbjct: 89  LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLAD 145

Query: 297 FGVSK 301
           FG++K
Sbjct: 146 FGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 99.2 bits (248), Expect = 2e-24
 Identities = 48/167 (28%), Positives = 88/167 (52%), Gaps = 11/167 (6%)

Query: 156 DFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
           ++     I +G F    ++G+       VA+K++  E I ++  +++   E+ LL+ ++H
Sbjct: 1   NYQLGDLIGRGAFG-VVYKGLNLETGDFVAIKQISLEKIKEEA-LKSIMQEIDLLKNLKH 58

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           PN+V+++G++  S  + I+ EY   G LR  +K+ G    S    +   + +G+ YLHE 
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
               +IHRD++ +NIL    G +K+ADFGV+  L        +   T
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 2e-24
 Identities = 48/128 (37%), Positives = 70/128 (54%), Gaps = 6/128 (4%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             +VAVK     +  D  R   F  E  +L++  HPN+V+ +G   Q  P+ IV E +P 
Sbjct: 19  NTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76

Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G L  FL++K   L     ++ +LD A GM YL E+K    IHRDL   N L  ++  LK
Sbjct: 77  GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ESKNC--IHRDLAARNCLVGENNVLK 133

Query: 294 VADFGVSK 301
           ++DFG+S+
Sbjct: 134 ISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 99.1 bits (247), Expect = 3e-24
 Identities = 53/135 (39%), Positives = 80/135 (59%), Gaps = 9/135 (6%)

Query: 175 GIQVAVKK--LGEEVISDDDRVRAFRD----ELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
           G  +AVK+  L     S  DR R+  D    E+ALL++++H N+VQ+LG+   +  + I 
Sbjct: 25  GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            EY+P G + A L   GA + +    F   I +G+NYLH      IIHRD++ +NIL D+
Sbjct: 85  LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDN 141

Query: 289 SGNLKVADFGVSKLL 303
            G +K++DFG+SK L
Sbjct: 142 KGGIKISDFGISKKL 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.1 bits (244), Expect = 5e-24
 Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 16/160 (10%)

Query: 150 IDPHELDFTNSVEITKGTFILAFWRGI-----QVAVKKLGEEVISDDDRVRAFRDELALL 204
           I P EL      EI  G F L  W G      +VA+K + E  +S++D    F +E  ++
Sbjct: 1   IHPSELTL--VQEIGSGQFGLV-WLGYWLEKRKVAIKTIREGAMSEED----FIEEAQVM 53

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
            K+ HP +VQ  G  T+ SP+ +V E++  G L  +L+ ++G     T +   LD+  GM
Sbjct: 54  MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113

Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            YL  +    +IHRDL   N L  ++  +KV+DFG+++ +
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV 150

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 7e-24
 Identities = 55/148 (37%), Positives = 77/148 (52%), Gaps = 6/148 (4%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G   L   + I VA+K L +   SD  R   F  E +++ +  HPN+++  G VT+
Sbjct: 19  EVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQR-LDFLTEASIMGQFDHPNIIRLEGVVTK 76

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MI+TEY+  G L  FL+   G       V     IA GM YL E   V   HRDL 
Sbjct: 77  SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV---HRDLA 133

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKED 308
             NIL + +   KV+DFG+S+ L   E 
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEA 161

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.2 bits (245), Expect = 7e-24
 Identities = 47/141 (33%), Positives = 76/141 (53%), Gaps = 16/141 (11%)

Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIV 228
           G QVAVK L     E+  SD      F  E+ +L+ + H N+V++ G   +     + ++
Sbjct: 33  GEQVAVKSLNHSGEEQHRSD------FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86

Query: 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
            EYLP G LR +L+R +  +     + F+  I +GM+YL   +    IHRDL   NIL +
Sbjct: 87  MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVE 143

Query: 288 DSGNLKVADFGVSKLLTVKED 308
               +K++DFG++K+L   +D
Sbjct: 144 SEDLVKISDFGLAKVLPEDKD 164

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.1 bits (240), Expect = 4e-23
 Identities = 47/132 (35%), Positives = 71/132 (53%), Gaps = 4/132 (3%)

Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
             G   A+KK+   V  D++  +    EL  L+    P VV+  GA  +   + IV EY+
Sbjct: 24  PTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
             G L   LK+ G +        A  I +G++YLH  +   IIHRD++PSN+L +  G +
Sbjct: 82  DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEV 139

Query: 293 KVADFGVSKLLT 304
           K+ADFG+SK+L 
Sbjct: 140 KIADFGISKVLE 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 95.7 bits (238), Expect = 4e-23
 Identities = 58/157 (36%), Positives = 83/157 (52%), Gaps = 14/157 (8%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP +L F    E+  G F       WRG   VA+K + E  +S+D+    F +E  ++ 
Sbjct: 1   IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
           K+ H  +VQ  G  T+  P+ IVTEY+  G L  +L+  G   +PS  +    D+  GM 
Sbjct: 55  KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA 114

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           YL   +    IHRDL   N L DD G +KV+DFG+S+
Sbjct: 115 YLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 95.3 bits (237), Expect = 7e-23
 Identities = 40/117 (34%), Positives = 71/117 (60%), Gaps = 4/117 (3%)

Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS 250
           ++ V A R E+ L+ ++ HP++++ LGA  + S   +  E++  G +   L + GA K +
Sbjct: 44  EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA 103

Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVK 306
             + +   + RG++YLHEN+   IIHRD++ +N+L D +G  L++ADFG +  L  K
Sbjct: 104 VIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 91.3 bits (227), Expect = 9e-23
 Identities = 48/104 (46%), Positives = 64/104 (61%), Gaps = 5/104 (4%)

Query: 29  NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
           N  D+DG        L   A+   +E +K LL++G DVN +D D RT LH+AA  G  E+
Sbjct: 1   NARDEDGRTP-----LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEI 55

Query: 89  VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           V LLLE+GADV+ +D+ G+TPL  A    N +V+KLL KHGA  
Sbjct: 56  VKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADV 99

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 89.6 bits (223), Expect = 1e-22
 Identities = 42/89 (47%), Positives = 54/89 (60%), Gaps = 2/89 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   ++E +K LL+ G DVN  D    TALH+AA  G  E+V LLLE GADV+ KD
Sbjct: 1   LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLLLEHGADVNAKD 58

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + G+T L  A    N E++KLL +HGA  
Sbjct: 59  KDGNTALHLAARNGNLEIVKLLLEHGADI 87

Length = 91

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.4 bits (235), Expect = 1e-22
 Identities = 53/165 (32%), Positives = 87/165 (52%), Gaps = 19/165 (11%)

Query: 152 PHELDFTNSVEITKGTFILAF---WRG-IQVAVKKLGEEVISDDDRVRA--FRDELALLQ 205
           P E +FT   ++  G F   +   W+  ++VA+K     ++  DD ++   F+ E+  L+
Sbjct: 4   PRE-EFTLERKLGSGYFGEVWEGLWKNRVRVAIK-----ILKSDDLLKQQDFQKEVQALK 57

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGM 263
           ++RH +++      +   P+ I+TE + KG L AFL+      L  ++ +  A  +A GM
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117

Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            YL E      IHRDL   NIL  +    KVADFG+++L+  KED
Sbjct: 118 AYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI--KED 157

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 96.3 bits (238), Expect = 2e-22
 Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 10/156 (6%)

Query: 156 DFTNSVEITKGTFILAF--WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NV 212
            +    ++ +G+F   +       VA+K L +++ S    V  F  E+ +L  + HP N+
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFALDIARGMNYLHEN 269
           V+          + +V EY+  G L   LK   RKG L  S A+     I   + YLH  
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 270 KPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLT 304
               IIHRD++P NIL D  G  +K+ DFG++KLL 
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 92.9 bits (232), Expect = 4e-22
 Identities = 40/134 (29%), Positives = 71/134 (52%), Gaps = 8/134 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G    +K++    +S+ +R  A   E+ +L+K+ HPN++++  +  +   + IV EY   
Sbjct: 25  GKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83

Query: 235 GDLRAFLKRKGALKPSTAVRFALD----IARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           GDL   +K++            LD    +   + YLH  K   I+HRD++P NI    +G
Sbjct: 84  GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNG 140

Query: 291 NLKVADFGVSKLLT 304
            +K+ DFG+SK+L+
Sbjct: 141 LVKLGDFGISKVLS 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 92.8 bits (231), Expect = 4e-22
 Identities = 51/137 (37%), Positives = 69/137 (50%), Gaps = 12/137 (8%)

Query: 176 IQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           I VAVK L  + +SD  DD    F  E A++  + H N+++  G V    P+M+VTE  P
Sbjct: 24  IPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78

Query: 234 KGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
            G L   L+    G    ST   +A+ IA GM YL   +    IHRDL   NIL      
Sbjct: 79  LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDK 135

Query: 292 LKVADFGVSKLLTVKED 308
           +K+ DFG+ + L   ED
Sbjct: 136 VKIGDFGLMRALPQNED 152

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 1e-21
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 6/156 (3%)

Query: 153 HELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
            EL   N   + KG +++   + ++VAVK L +E I+   +   F  E +++ ++ HP +
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58

Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
           V+ +G V +  P+M+V E  P G L  +LK++  +  S     A  +A GM YL     V
Sbjct: 59  VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
              HRDL   N+L  +    K++DFG+S+ L    D
Sbjct: 118 ---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.2 bits (226), Expect = 1e-21
 Identities = 56/144 (38%), Positives = 80/144 (55%), Gaps = 10/144 (6%)

Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
           N  E+ KGT          VAVK   E+ +  + +++ F  E  +L++  HPN+V+ +G 
Sbjct: 7   NFGEVFKGTL----KDKTPVAVKTCKED-LPQELKIK-FLSEARILKQYDHPNIVKLIGV 60

Query: 219 VTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
            TQ  P+ IV E +P GD  +FL K+K  LK    V+FALD A GM YL        IHR
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N L  ++  LK++DFG+S+
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.0 bits (227), Expect = 2e-21
 Identities = 44/131 (33%), Positives = 69/131 (52%), Gaps = 3/131 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ I     V     E  +L +I HP +V+   A      + +V EY P G+L 
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L ++G      A  +A +I   + YLH      II+RDL+P NIL D  G++K+ DFG
Sbjct: 82  SHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFG 138

Query: 299 VSKLLTVKEDR 309
           ++K L+ +  R
Sbjct: 139 LAKELSSEGSR 149

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 90.8 bits (225), Expect = 2e-21
 Identities = 55/152 (36%), Positives = 84/152 (55%), Gaps = 14/152 (9%)

Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA- 218
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG  
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
           V +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           RDL   N+L  +    KV+DFG++K  +  +D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.9 bits (226), Expect = 3e-21
 Identities = 38/143 (26%), Positives = 75/143 (52%), Gaps = 7/143 (4%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           ++ +G ++      I VAVK       +       F  E  ++++  HP++V+ +G +T+
Sbjct: 21  DVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78

Query: 222 SSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           + P+ IV E  P G+LR++L   K +L  ++ + ++  ++  + YL   + V   HRD+ 
Sbjct: 79  N-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV---HRDIA 134

Query: 281 PSNILRDDSGNLKVADFGVSKLL 303
             N+L      +K+ DFG+S+ L
Sbjct: 135 ARNVLVSSPDCVKLGDFGLSRYL 157

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.1 bits (227), Expect = 3e-21
 Identities = 47/142 (33%), Positives = 74/142 (52%), Gaps = 16/142 (11%)

Query: 178 VAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEY 231
           VA+KK    +  ++++    + A R E+ LLQK+RHPN+V+    VT      + +V EY
Sbjct: 27  VALKK----IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81

Query: 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           +   DL   L         S    +   +  G+ YLH N    I+HRD++ SNIL ++ G
Sbjct: 82  MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDG 137

Query: 291 NLKVADFGVSKLLTVKEDRPLT 312
            LK+ADFG+++  T +     T
Sbjct: 138 VLKLADFGLARPYTKRNSADYT 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 90.4 bits (225), Expect = 4e-21
 Identities = 44/124 (35%), Positives = 68/124 (54%), Gaps = 3/124 (2%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
            A+K + +  +   ++V     E  +L + + P VV+   +      + +V EYLP GDL
Sbjct: 21  YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
            + L+  G+L    A  +  +I   + YLH N    IIHRDL+P NIL D +G+LK+ DF
Sbjct: 81  ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDF 137

Query: 298 GVSK 301
           G+SK
Sbjct: 138 GLSK 141

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 89.8 bits (223), Expect = 6e-21
 Identities = 49/143 (34%), Positives = 71/143 (49%), Gaps = 16/143 (11%)

Query: 173 WRGI-----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           W G+      VAVK L    +   D    F  E  +++K+RHP ++Q     T   P+ I
Sbjct: 23  WEGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78

Query: 228 VTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           VTE +  G L  +L+     ALK    +  A  +A GM YL        IHRDL   N+L
Sbjct: 79  VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVL 135

Query: 286 RDDSGNLKVADFGVSKLLTVKED 308
             ++   KVADFG+++++  KED
Sbjct: 136 VGENNICKVADFGLARVI--KED 156

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 89.3 bits (222), Expect = 9e-21
 Identities = 41/127 (32%), Positives = 66/127 (51%), Gaps = 8/127 (6%)

Query: 179 AVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           AVK   E  I D+D   ++   DE+ +L+ ++HPN+V++ G       + I  EY   G 
Sbjct: 29  AVK---EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L   L+    L       + L +  G+ YLH +    I+HRD++P+NI  D +G +K+ D
Sbjct: 86  LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGD 142

Query: 297 FGVSKLL 303
           FG +  L
Sbjct: 143 FGCAVKL 149

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 42/140 (30%), Positives = 74/140 (52%), Gaps = 15/140 (10%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              +VA+K + E   S  +R   F +E +++++    +VV+ LG V+   P ++V E + 
Sbjct: 35  PETRVAIKTVNENA-SMRER-IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92

Query: 234 KGDLRAFLKRK-------GALKPSTAVRF---ALDIARGMNYLHENKPVPIIHRDLEPSN 283
           KGDL+++L+ +         L P T  +F   A +IA GM YL   K    +HRDL   N
Sbjct: 93  KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARN 149

Query: 284 ILRDDSGNLKVADFGVSKLL 303
            +  +   +K+ DFG+++ +
Sbjct: 150 CMVAEDLTVKIGDFGMTRDI 169

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 88.6 bits (219), Expect = 2e-20
 Identities = 45/112 (40%), Positives = 67/112 (59%), Gaps = 5/112 (4%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALKPST 251
           V A   E+ LL+ ++H  +VQ+ G +   +   + I  EY+P G ++  LK  GAL  S 
Sbjct: 48  VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
             ++   I  GM+YLH N    I+HRD++ +NILRD +GN+K+ DFG SK L
Sbjct: 108 TRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 44/135 (32%), Positives = 70/135 (51%), Gaps = 4/135 (2%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK  E    +D +  A R E+ +L+++RH N+V    A  +   + +V EY+ +  L
Sbjct: 29  VAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
                  G L P     +   + + + Y H +    IIHRD++P NIL  +SG LK+ DF
Sbjct: 88  ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDF 144

Query: 298 GVSKLLTVKEDRPLT 312
           G ++ L  +   PLT
Sbjct: 145 GFARALRARPASPLT 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 46/137 (33%), Positives = 66/137 (48%), Gaps = 18/137 (13%)

Query: 177 QVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
            VAVK L  +     D  R  F  E+ +L ++  PN+ + LG  T   P+ ++ EY+  G
Sbjct: 48  LVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104

Query: 236 DLRAFLKR-----------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           DL  FL++             +L  ST +  A  IA GM YL     V   HRDL   N 
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNC 161

Query: 285 LRDDSGNLKVADFGVSK 301
           L   +  +K+ADFG+S+
Sbjct: 162 LVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 88.2 bits (219), Expect = 3e-20
 Identities = 44/134 (32%), Positives = 76/134 (56%), Gaps = 7/134 (5%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L EE  +     +   DE  ++  + HP+VV+ LG +  SS + ++T+ +P G
Sbjct: 37  IPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLG 93

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GM+YL E +   ++HRDL   N+L     ++K+
Sbjct: 94  CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKI 150

Query: 295 ADFGVSKLLTVKED 308
            DFG++KLL V E 
Sbjct: 151 TDFGLAKLLDVDEK 164

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 87.7 bits (217), Expect = 3e-20
 Identities = 49/131 (37%), Positives = 76/131 (58%), Gaps = 11/131 (8%)

Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           + G +VAVK      I  D   +AF +E A++ K+ H N+V+ LG +  +  + IV E +
Sbjct: 27  YTGQKVAVK-----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80

Query: 233 PKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            KG+L  FL+ +G    S    ++F+LD+A GM YL   K   ++HRDL   NIL  + G
Sbjct: 81  SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDG 137

Query: 291 NLKVADFGVSK 301
             KV+DFG+++
Sbjct: 138 VAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 84.0 bits (208), Expect = 4e-20
 Identities = 39/82 (47%), Positives = 50/82 (60%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    +E +K LL+ G DVN RD D  T LH+AA  G  +VV LLL+ GADV+ +D
Sbjct: 44  LHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARD 103

Query: 104 RWGSTPLGDAIYYKNHEVIKLL 125
           + G TPL  A    + EV+KLL
Sbjct: 104 KDGRTPLHLAAKNGHLEVVKLL 125

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 87.9 bits (218), Expect = 4e-20
 Identities = 48/145 (33%), Positives = 68/145 (46%), Gaps = 25/145 (17%)

Query: 176 IQVAVKKLGE--EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
             VA+K L E  E     +    FR E  L+  ++HPN+V  LG  T+  P  ++ EYL 
Sbjct: 36  TSVAIKTLKENAEPKVQQE----FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91

Query: 234 KGDLRAFLKR----------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
            GDL  FL R                K +L  S  +  A+ IA GM YL  +     +HR
Sbjct: 92  HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148

Query: 278 DLEPSNILRDDSGNLKVADFGVSKL 302
           DL   N L  +   +K++DFG+S+ 
Sbjct: 149 DLAARNCLVGEGLTVKISDFGLSRD 173

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.4 bits (217), Expect = 4e-20
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 3/126 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + ++   +   VR   +E  +LQ++ HP +V    +      M +V + L  GDLR
Sbjct: 29  AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L +K          +  +I   + YLH      IIHRD++P NIL D+ G++ + DF 
Sbjct: 89  YHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN 145

Query: 299 VSKLLT 304
           ++  +T
Sbjct: 146 IATKVT 151

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 87.1 bits (216), Expect = 6e-20
 Identities = 41/130 (31%), Positives = 71/130 (54%), Gaps = 8/130 (6%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K++    +S  +R  A  +E+ +L  + HPN++ +  A    + + IV EY P GDL 
Sbjct: 29  ALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS 87

Query: 239 AFLKRKGALK---PSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
             + ++   +   P   + R  + + RG+  LHE K   I+HRDL+ +NIL   +  +K+
Sbjct: 88  KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKI 144

Query: 295 ADFGVSKLLT 304
            D G+SK+L 
Sbjct: 145 GDLGISKVLK 154

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (215), Expect = 6e-20
 Identities = 44/110 (40%), Positives = 67/110 (60%), Gaps = 5/110 (4%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           V A   E+ LL+ +RH  +VQ+ G +   +   + I  EY+P G ++  LK  GAL  + 
Sbjct: 48  VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV 107

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
             R+   I +G++YLH N    I+HRD++ +NILRD +GN+K+ DFG SK
Sbjct: 108 TRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.9 bits (215), Expect = 8e-20
 Identities = 56/150 (37%), Positives = 81/150 (54%), Gaps = 9/150 (6%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R I VA+K L  +    + + R F  E +++ +  HPN++   G VT+
Sbjct: 19  EVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L AFL++  G       V     IA GM YL +   +  +HRDL 
Sbjct: 77  SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 133

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVL---EDDP 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.5 bits (215), Expect = 1e-19
 Identities = 53/145 (36%), Positives = 80/145 (55%), Gaps = 12/145 (8%)

Query: 175 GIQVAVKK--LGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
           G  VA+KK  LGE   + D  +   A R E+ LLQ+++HPN++  L      S + +V E
Sbjct: 25  GRIVAIKKIKLGERKEAKDGINFT-ALR-EIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82

Query: 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           ++   DL   +K K   L P+    + L   RG+ YLH N    I+HRDL+P+N+L    
Sbjct: 83  FME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASD 138

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQ 314
           G LK+ADFG+++      +R +T Q
Sbjct: 139 GVLKLADFGLAR-SFGSPNRKMTHQ 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 85.7 bits (212), Expect = 2e-19
 Identities = 52/163 (31%), Positives = 92/163 (56%), Gaps = 18/163 (11%)

Query: 153 HELDFTNS---VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
           +E ++  +   V + KGT+ + +        +++A+K++ E    D   V+   +E+AL 
Sbjct: 3   YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALH 59

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKP--STAVRFALDIAR 261
             ++H N+VQ+LG+ +++    I  E +P G L A L+ K G LK    T + +   I  
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLL 303
           G+ YLH+N+   I+HRD++  N+L +  SG +K++DFG SK L
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.7 bits (212), Expect = 2e-19
 Identities = 51/143 (35%), Positives = 78/143 (54%), Gaps = 6/143 (4%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G   L   R I VA+K L  +    + + R F  E +++ +  HPN++   G VT+
Sbjct: 19  EVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MI+TE++  G L +FL++  G       V     IA GM YL E   +  +HRDL 
Sbjct: 77  SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLA 133

Query: 281 PSNILRDDSGNLKVADFGVSKLL 303
             NIL + +   KV+DFG+S+ L
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 85.9 bits (213), Expect = 2e-19
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 22/143 (15%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             VAVK L ++    D  +     E+ +++ I +H N++  LG  TQ  P+ +V EY   
Sbjct: 43  STVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100

Query: 235 GDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
           G+LR FL+ +                  L     V FA  +ARGM +L   K    IHRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRD 157

Query: 279 LEPSNILRDDSGNLKVADFGVSK 301
           L   N+L  +   +K+ADFG+++
Sbjct: 158 LAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 40/136 (29%), Positives = 73/136 (53%), Gaps = 7/136 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK+     S+     A R E+ LL+++ HPN+++ L        + +V E++   DL
Sbjct: 27  VAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDL 84

Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              +K +    P + ++ +   + +G+ + H +    I+HRDL+P N+L +  G LK+AD
Sbjct: 85  YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLAD 141

Query: 297 FGVSKLLTVKEDRPLT 312
           FG+++       RP T
Sbjct: 142 FGLARSFGSPV-RPYT 156

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 85.1 bits (210), Expect = 3e-19
 Identities = 47/133 (35%), Positives = 73/133 (54%), Gaps = 7/133 (5%)

Query: 175 GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTE 230
           G ++AVK++    E       V A   E+ LL+ + H  +VQ+ G +       + I  E
Sbjct: 27  GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86

Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           ++P G ++  LK  GAL  +   ++   I  G++YLH N    I+HRD++ +NILRD  G
Sbjct: 87  HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVG 143

Query: 291 NLKVADFGVSKLL 303
           N+K+ DFG SK L
Sbjct: 144 NVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.4 bits (211), Expect = 3e-19
 Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 31/166 (18%)

Query: 162 EITKGT-FILAFWRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           ++ K T F L    G   VAVK L E   +    +R    E  LL+++ HP+V++  GA 
Sbjct: 15  KVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72

Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPS------------------------TAVRF 255
           +Q  P++++ EY   G LR+FL+    + PS                          + F
Sbjct: 73  SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           A  I+RGM YL E K   ++HRDL   N+L  +   +K++DFG+S+
Sbjct: 133 AWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 85.1 bits (211), Expect = 3e-19
 Identities = 41/106 (38%), Positives = 58/106 (54%), Gaps = 3/106 (2%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           EL +L K   P +V F GA   +  + I  EY+  G L   LK  +G +      + A+ 
Sbjct: 49  ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           + +G+ YLHE     IIHRD++PSNIL +  G +K+ DFGVS  L 
Sbjct: 109 VLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.0 bits (211), Expect = 4e-19
 Identities = 47/142 (33%), Positives = 76/142 (53%), Gaps = 6/142 (4%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
            G  VA+KK+    +      +A R E+  LQ  +HP VV+ L      S  ++V EY+P
Sbjct: 24  TGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82

Query: 234 KGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
             DL   L+  +  L  +    +   + +G+ Y+H N    I+HRDL+P+N+L    G L
Sbjct: 83  -SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVL 138

Query: 293 KVADFGVSKLLTVKEDRPLTCQ 314
           K+ADFG+++L + +E R  + Q
Sbjct: 139 KIADFGLARLFSEEEPRLYSHQ 160

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 84.2 bits (208), Expect = 8e-19
 Identities = 49/139 (35%), Positives = 71/139 (51%), Gaps = 16/139 (11%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 228
             +VAVK L  ++ S  D +  F  E A +++  HPNV++ +G   +S         M++
Sbjct: 27  FQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85

Query: 229 TEYLPKGDLRAFL--KRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             ++  GDL  FL   R G     L   T VRF +DIA GM YL        IHRDL   
Sbjct: 86  LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAAR 142

Query: 283 NILRDDSGNLKVADFGVSK 301
           N + +++  + VADFG+SK
Sbjct: 143 NCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 40/110 (36%), Positives = 60/110 (54%), Gaps = 3/110 (2%)

Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           D V+A R E+  L+ + H N+VQ+LG  T    + I  EY+P G + + L+  G  +   
Sbjct: 50  DMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
              F   +  G+ YLH      I+HRDL+  N+L D  G  K++DFG+SK
Sbjct: 110 VRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.1 bits (203), Expect = 4e-18
 Identities = 48/140 (34%), Positives = 66/140 (47%), Gaps = 19/140 (13%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
             VAVK L E   + +D  + F  E  LL   +H N+V+F G  T+  P ++V EY+  G
Sbjct: 36  ELVAVKTLKE--TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93

Query: 236 DLRAFLKR--------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           DL  FL+                G L  S  ++ A+ IA GM YL     V   HRDL  
Sbjct: 94  DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLAT 150

Query: 282 SNILRDDSGNLKVADFGVSK 301
            N L      +K+ DFG+S+
Sbjct: 151 RNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 5e-18
 Identities = 46/133 (34%), Positives = 71/133 (53%), Gaps = 17/133 (12%)

Query: 178 VAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K     VI     D     + E+++L++ RHPN+V + G+  +   + IV EY   G
Sbjct: 31  VAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85

Query: 236 DLRAFLKR-KGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
            L+   +  +G L     +   R  L   +G+ YLHE      IHRD++ +NIL  + G+
Sbjct: 86  SLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG---KIHRDIKGANILLTEDGD 139

Query: 292 LKVADFGVSKLLT 304
           +K+ADFGVS  LT
Sbjct: 140 VKLADFGVSAQLT 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.4 bits (201), Expect = 7e-18
 Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 10/133 (7%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+K L +  +S +    AF  E  L+++++HP +V+    VTQ  P+ I+TEY+  G 
Sbjct: 32  KVAIKSLKQGSMSPE----AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGS 86

Query: 237 LRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK      L  +  +  A  IA GM ++        IHRDL  +NIL  ++   K+
Sbjct: 87  LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKI 143

Query: 295 ADFGVSKLLTVKE 307
           ADFG+++L+   E
Sbjct: 144 ADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 81.7 bits (202), Expect = 7e-18
 Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 9/107 (8%)

Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           EL + +  + P +V++ GA     SS + I  EY   G L +  K+          +   
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108

Query: 258 DIA----RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            IA    +G++YLH  K   IIHRD++PSNIL    G +K+ DFGVS
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS 152

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 81.8 bits (202), Expect = 8e-18
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 27/146 (18%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L EE  +  D    F+ E AL+ +  HPN+V+ LG      PM ++ EY+  GDL
Sbjct: 38  VAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95

Query: 238 RAFLKRKGALKPSTAVR----------------------FALDIARGMNYLHENKPVPII 275
             FL+ +      +                          A  +A GM YL E K    +
Sbjct: 96  NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FV 152

Query: 276 HRDLEPSNILRDDSGNLKVADFGVSK 301
           HRDL   N L  ++  +K+ADFG+S+
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 47/130 (36%), Positives = 73/130 (56%), Gaps = 11/130 (8%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---PMMIVTEYLPK 234
           VAVKKL     S  + +R F  E+ +L+ ++H N+V++ G V  S+    + +V EYLP 
Sbjct: 36  VAVKKLQH---STAEHLRDFEREIEILKSLQHDNIVKYKG-VCYSAGRRNLRLVMEYLPY 91

Query: 235 GDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G LR +L K +  L     + +A  I +GM YL   +    +HRDL   NIL +    +K
Sbjct: 92  GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK 148

Query: 294 VADFGVSKLL 303
           + DFG++K+L
Sbjct: 149 IGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.1 bits (197), Expect = 2e-17
 Identities = 49/141 (34%), Positives = 78/141 (55%), Gaps = 12/141 (8%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK L    +S    V+AF +E  L++ ++H  +V+    VT+  P+ I+TEY+ KG 
Sbjct: 32  KVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87

Query: 237 LRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK    G +     + F+  IA GM Y+        IHRDL  +N+L  +S   K+
Sbjct: 88  LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKI 144

Query: 295 ADFGVSKLLTVKEDRPLTCQD 315
           ADFG+++++   ED   T ++
Sbjct: 145 ADFGLARVI---EDNEYTARE 162

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 79.7 bits (196), Expect = 2e-17
 Identities = 56/149 (37%), Positives = 80/149 (53%), Gaps = 16/149 (10%)

Query: 162 EITKGTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
           E+  GT     W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L AV 
Sbjct: 21  EVWMGT-----WNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-LYAVV 70

Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
              P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  +HRD
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           L  +NIL  ++   KVADFG+++L+   E
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 15/136 (11%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  E  S+ D    F  E  ++ K  H N+V+ +G   +  P  I+ E +  G
Sbjct: 37  LQVAVKTL-PESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGG 94

Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A D+A+G  YL EN     IHRD+   N L   
Sbjct: 95  DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTC 151

Query: 289 SGN---LKVADFGVSK 301
            G     K+ADFG+++
Sbjct: 152 KGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 53/146 (36%), Positives = 79/146 (54%), Gaps = 11/146 (7%)

Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSS 223
           GT I +  + I  AVK L    I+D + V  F  E  +++   HPNV+  LG    ++ S
Sbjct: 14  GTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71

Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEP 281
           P+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL  
Sbjct: 72  PL-VVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAA 126

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKE 307
            N + D+S  +KVADFG+++ +  KE
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKE 152

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 3e-17
 Identities = 43/128 (33%), Positives = 76/128 (59%), Gaps = 11/128 (8%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+KK+  E  ++D+ V   A R E++LL+++ HPN+V+ L  V   + + +V E+L   
Sbjct: 27  VALKKIRLE--TEDEGVPSTAIR-EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL- 82

Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           DL+ ++       L P     +   + +G+ Y H ++   ++HRDL+P N+L D  G LK
Sbjct: 83  DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALK 139

Query: 294 VADFGVSK 301
           +ADFG+++
Sbjct: 140 LADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 13/154 (8%)

Query: 157 FTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           FT    I KG+F   + + I       VA+K +  E    +D +   + E+  L + R P
Sbjct: 3   FTLLECIGKGSFGEVY-KAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSP 59

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            + ++ G+  + S + I+ EY   G     LK  G L  +       ++  G+ YLHE  
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEG 118

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
               IHRD++ +NIL  + G++K+ADFGVS  LT
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLT 149

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 44/138 (31%), Positives = 62/138 (44%), Gaps = 7/138 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL-GAVTQSSPMMIVTEYLP 233
           G +VA+K L  +   ++ +   FR E AL  ++ HPN+V  L         +  V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
              LR  L   GAL      R  L +   +   H      I+HRDL+P NI+        
Sbjct: 63  GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRP 119

Query: 291 NLKVADFGVSKLLTVKED 308
           + KV DFG+  LL    D
Sbjct: 120 HAKVLDFGIGTLLPGVRD 137

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.5 bits (193), Expect = 7e-17
 Identities = 56/145 (38%), Positives = 78/145 (53%), Gaps = 11/145 (7%)

Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   +  W G  +VAVK L    +S +    +F +E  +++K+RH  +VQ L AV    P
Sbjct: 20  GEVWMGTWNGNTKVAVKTLKPGTMSPE----SFLEEAQIMKKLRHDKLVQ-LYAVVSEEP 74

Query: 225 MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + IVTEY+ KG L  FLK     ALK    V  A  +A GM Y+     +  IHRDL  +
Sbjct: 75  IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 131

Query: 283 NILRDDSGNLKVADFGVSKLLTVKE 307
           NIL  D    K+ADFG+++L+   E
Sbjct: 132 NILVGDGLVCKIADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.7 bits (194), Expect = 8e-17
 Identities = 36/105 (34%), Positives = 69/105 (65%), Gaps = 7/105 (6%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFA 256
           E++L+++++H N+V+    +   + +M+V EY+ K DL+ ++     +GAL P+T   F 
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
             + +G+ + HEN+   ++HRDL+P N+L +  G LK+ADFG+++
Sbjct: 107 YQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.1 bits (192), Expect = 9e-17
 Identities = 48/126 (38%), Positives = 70/126 (55%), Gaps = 8/126 (6%)

Query: 178 VAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           VAVK   E +  D   ++A F  E  +L++  HPN+V+ +G  TQ  P+ IV E +  GD
Sbjct: 23  VAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79

Query: 237 LRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
              FL+ +G  LK    ++   + A GM YL E+K    IHRDL   N L  +   LK++
Sbjct: 80  FLTFLRTEGPRLKVKELIQMVENAAAGMEYL-ESKHC--IHRDLAARNCLVTEKNVLKIS 136

Query: 296 DFGVSK 301
           DFG+S+
Sbjct: 137 DFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.7 bits (195), Expect = 9e-17
 Identities = 42/126 (33%), Positives = 67/126 (53%), Gaps = 3/126 (2%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
            A+K L +  I    +V    +E  +LQ IRHP +V   G+    S + +V EY+P G+L
Sbjct: 29  YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
            + L++ G      A  +A  +   + YLH      I++RDL+P N+L D  G +K+ DF
Sbjct: 89  FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF 145

Query: 298 GVSKLL 303
           G +K +
Sbjct: 146 GFAKRV 151

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVT 229
           ++VAVK +  ++ +  + +  F  E A ++   HPNV++ +G   ++S +      M++ 
Sbjct: 28  LKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL 86

Query: 230 EYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
            ++  GDL +FL   R G     L   T ++F +DIA GM YL        IHRDL   N
Sbjct: 87  PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARN 143

Query: 284 ILRDDSGNLKVADFGVSK 301
            +  +   + VADFG+SK
Sbjct: 144 CMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 17/142 (11%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V         F  E+ ++ ++++PN+++ LG      P+ ++TEY+ 
Sbjct: 43  QPVLVAVKMLRADVTKTARN--DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100

Query: 234 KGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
            GDL  FL ++             ++  +  +  A+ IA GM YL     +  +HRDL  
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157

Query: 282 SNILRDDSGNLKVADFGVSKLL 303
            N L  +   +K+ADFG+S+ L
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNL 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 77.6 bits (191), Expect = 2e-16
 Identities = 38/133 (28%), Positives = 74/133 (55%), Gaps = 6/133 (4%)

Query: 174 RGIQVAVKKLG---EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
           +G  +AVK++      V++ +      ++E+ LL+ ++H N+VQ+LG     + + I  E
Sbjct: 23  QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82

Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           ++P G + + L R G L      ++   I  G+ YLH N    ++HRD++ +N++   +G
Sbjct: 83  FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNG 139

Query: 291 NLKVADFGVSKLL 303
            +K+ DFG ++ L
Sbjct: 140 IIKLIDFGCARRL 152

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 13/133 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VA+K +   V  D   +     E+++L++   P +V++ G+  +++ + IV EY   
Sbjct: 28  GQVVAIKVV--PVEEDLQEII---KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82

Query: 235 GDLRAFLKRKGALKPSTAVRFAL---DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           G +   +K     K  T    A       +G+ YLH NK    IHRD++  NIL ++ G 
Sbjct: 83  GSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQ 137

Query: 292 LKVADFGVSKLLT 304
            K+ADFGVS  LT
Sbjct: 138 AKLADFGVSGQLT 150

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 49/140 (35%), Positives = 72/140 (51%), Gaps = 21/140 (15%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A  K+ +E  S++D  R F  EL +L K+  HPN++  LGA      + I  EY P G+L
Sbjct: 32  AAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90

Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL++   L+   A                ++FA D+A GM YL E +    IHRDL  
Sbjct: 91  LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAA 147

Query: 282 SNILRDDSGNLKVADFGVSK 301
            N+L  ++   K+ADFG+S+
Sbjct: 148 RNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 77.3 bits (190), Expect = 2e-16
 Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 9/157 (5%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G   +   + + VA+K L +   ++  R   F  E +++ +  H N+++  G VT+
Sbjct: 20  EVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQFSHHNIIRLEGVVTK 77

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P MI+TEY+  G L  +L+   G       V     IA GM YL +   +  +HRDL 
Sbjct: 78  FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLA 134

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
             NIL + +   KV+DFG+S++L   ED P     TS
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTS 168

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 45/145 (31%), Positives = 80/145 (55%), Gaps = 15/145 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYL 232
           G QVAVK L  E  S  + +   + E+ +L+ + H N+V++ G  T+   + + ++ E+L
Sbjct: 33  GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 233 PKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G L+ +L R K  +     +++A+ I +GM+YL   +    +HRDL   N+L +    
Sbjct: 91  PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147

Query: 292 LKVADFGVSKLL-------TVKEDR 309
           +K+ DFG++K +       TVK+D 
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDL 172

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.4 bits (188), Expect = 3e-16
 Identities = 41/132 (31%), Positives = 77/132 (58%), Gaps = 7/132 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           V +K++  E ++ D+R+ A ++E  +L+ + HPN++++     +   +MIV EY P G L
Sbjct: 28  VIIKQIPVEQMTKDERLAA-QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86

Query: 238 RAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKV 294
             +++++    L   T + F + I   ++++H      I+HRDL+  NIL D     +K+
Sbjct: 87  AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKI 143

Query: 295 ADFGVSKLLTVK 306
            DFG+SK+L+ K
Sbjct: 144 GDFGISKILSSK 155

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 30/115 (26%), Positives = 60/115 (52%), Gaps = 10/115 (8%)

Query: 199 DELALLQKIRHPNVVQFLG--AVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTA 252
            E+ +L++++HPN+V++        +  + IV EY   GDL   +++    +  ++    
Sbjct: 48  SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107

Query: 253 VRFALDIARGMNYLH---ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
            R    +   +   H   +     ++HRDL+P+NI  D + N+K+ DFG++K+L 
Sbjct: 108 WRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILG 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.4 bits (188), Expect = 4e-16
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)

Query: 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF    +I KG+F + F           A+K++    ++  +R  A  DE  +L K+   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
            ++++  +      + IV EY   GDL   LK  R   L      RF + I  G+ +LH 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            K   I+HRD++  N+  D   N+K+ D GV+KLL
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 5e-16
 Identities = 44/149 (29%), Positives = 80/149 (53%), Gaps = 12/149 (8%)

Query: 163 ITKGTFILAFWRGIQVAVKK-LGEEVI---SDDDRVRAFRDELALLQKIRH---PNVVQF 215
           I +G +  A +RG  V   + +  ++I   + DD V   + E+ALL ++R    PN+ ++
Sbjct: 9   IGRGAY-GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
            G+  +   + I+ EY   G +R  L + G +          ++   + Y+H+   V +I
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK---VGVI 123

Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           HRD++ +NIL  ++GN+K+ DFGV+ LL 
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLN 152

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.8 bits (190), Expect = 7e-16
 Identities = 49/141 (34%), Positives = 71/141 (50%), Gaps = 10/141 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VA+KK+        D  R  R E+ LL+ +RH N++  L  +   SP       IVT
Sbjct: 25  GRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           E +   DL   +K    L       F   I RG+ YLH      +IHRDL+PSNIL + +
Sbjct: 84  ELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSN 139

Query: 290 GNLKVADFGVSKLLTVKEDRP 310
            +LK+ DFG+++ +   ED  
Sbjct: 140 CDLKICDFGLARGVDPDEDEK 160

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 75.7 bits (187), Expect = 8e-16
 Identities = 37/131 (28%), Positives = 66/131 (50%), Gaps = 4/131 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
             + A+K L +  +  + +V+    ++  L +   HP +++          +  V EY P
Sbjct: 26  NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G+L  ++++ G+L       +A +I   + YLH      IIHRDL+P NIL D   ++K
Sbjct: 86  NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK 142

Query: 294 VADFGVSKLLT 304
           + DFG +K+L 
Sbjct: 143 ITDFGTAKVLD 153

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.2 bits (187), Expect = 8e-16
 Identities = 50/143 (34%), Positives = 75/143 (52%), Gaps = 22/143 (15%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           +  A+K++ E    DD R   F  EL +L K+  HPN++  LGA      + +  EY P 
Sbjct: 35  MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92

Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
           G+L  FL++   L+  P+ A+               FA D+ARGM+YL + +    IHRD
Sbjct: 93  GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 149

Query: 279 LEPSNILRDDSGNLKVADFGVSK 301
           L   NIL  ++   K+ADFG+S+
Sbjct: 150 LAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 49/139 (35%), Positives = 75/139 (53%), Gaps = 9/139 (6%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPK 234
            VA+KK+  +   D   + + R E+ LL  +RHPN+V+    V       + +V EY  +
Sbjct: 34  IVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92

Query: 235 GDLRAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            DL + L         + V+   L + RG+ YLHEN    IIHRDL+ SN+L  D G LK
Sbjct: 93  -DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLK 148

Query: 294 VADFGVSKLLTVKEDRPLT 312
           +ADFG+++   +   +P+T
Sbjct: 149 IADFGLARTYGLP-AKPMT 166

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.7 bits (183), Expect = 2e-15
 Identities = 50/140 (35%), Positives = 71/140 (50%), Gaps = 21/140 (15%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A  K  +E  S DD  R F  EL +L K+  HPN++  LGA      + +  EY P G+L
Sbjct: 25  AAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 83

Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL++   L+   A                + FA D+ARGM+YL + +    IHRDL  
Sbjct: 84  LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAA 140

Query: 282 SNILRDDSGNLKVADFGVSK 301
            NIL  ++   K+ADFG+S+
Sbjct: 141 RNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 47/139 (33%), Positives = 73/139 (52%), Gaps = 14/139 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
           G  VA+KK+      D   + A R E+ +L+K++HPNVV  +    +           + 
Sbjct: 33  GRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91

Query: 227 IVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +VT Y+   DL   L+     L  S    + L +  G+NYLHEN    I+HRD++ +NIL
Sbjct: 92  MVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANIL 147

Query: 286 RDDSGNLKVADFGVSKLLT 304
            D+ G LK+ADFG+++   
Sbjct: 148 IDNQGILKIADFGLARPYD 166

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 40/124 (32%), Positives = 65/124 (52%), Gaps = 3/124 (2%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K++ + ++   + VR    E  +L   +   +V+ L A      + +  EY+P GD 
Sbjct: 29  VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
           R  L   G L    A  +  ++   ++ LHE   +  IHRDL+P N L D SG++K+ DF
Sbjct: 89  RTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDF 145

Query: 298 GVSK 301
           G+SK
Sbjct: 146 GLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 50/156 (32%), Positives = 91/156 (58%), Gaps = 17/156 (10%)

Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIR 208
           D+T   +I +GT+ + +       G  VA+KK+  E  S+++ V   A R E++LL++++
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIR-EISLLKELQ 57

Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFAL-DIARGMNY 265
           HPN+V     + Q S + ++ E+L   DL+ +L    KG    +  V+  L  I +G+ +
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            H  +   ++HRDL+P N+L D+ G +K+ADFG+++
Sbjct: 117 CHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 38/127 (29%), Positives = 72/127 (56%), Gaps = 10/127 (7%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K++  +   DD+ V   A R E+ LL++++H N+V+    +     + +V EY  + 
Sbjct: 28  VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ- 83

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL+ +     G + P     F   + +G+ + H +    ++HRDL+P N+L + +G LK+
Sbjct: 84  DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKL 140

Query: 295 ADFGVSK 301
           ADFG+++
Sbjct: 141 ADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 69.6 bits (171), Expect = 3e-15
 Identities = 30/60 (50%), Positives = 39/60 (65%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   ++E +K LL+ G DVN +D D  TALH+AA  G  E+V LLLE GAD++ KD
Sbjct: 32  LHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEHGADINLKD 91

Length = 91

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 43/139 (30%), Positives = 77/139 (55%), Gaps = 19/139 (13%)

Query: 178 VAVKKLGEEVISDDDRVRAF--RDELALLQKIR---HPNVVQFLG-----AVTQSSPMMI 227
           VA+KK+   V   ++ +     R E+ALL+++    HPN+V+ L         +   + +
Sbjct: 27  VALKKV--RVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83

Query: 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           V E++ + DL  +L +  K  L P T       + RG+++LH ++   I+HRDL+P NIL
Sbjct: 84  VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNIL 139

Query: 286 RDDSGNLKVADFGVSKLLT 304
               G +K+ADFG++++ +
Sbjct: 140 VTSDGQVKIADFGLARIYS 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 44/124 (35%), Positives = 64/124 (51%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++VI  DD V     E  +L    +HP + Q          +  V EY+  GDL
Sbjct: 24  AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R G      A  +A +I  G+ +LHE     II+RDL+  N+L D  G++K+ADF
Sbjct: 84  MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADF 140

Query: 298 GVSK 301
           G+ K
Sbjct: 141 GMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 34/136 (25%), Positives = 66/136 (48%), Gaps = 8/136 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+KK    +           +E+ +++  +HPN+V +  +      + +V EY+  
Sbjct: 44  GKEVAIKK----MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99

Query: 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G L   + +    +          ++ +G+ YLH      +IHRD++  NIL    G++K
Sbjct: 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVK 156

Query: 294 VADFGVSKLLTVKEDR 309
           +ADFG +  LT ++ +
Sbjct: 157 LADFGFAAQLTKEKSK 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 43/129 (33%), Positives = 66/129 (51%), Gaps = 8/129 (6%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +      A   EL ++  +  H N+V  LGA T   P++++TEY   
Sbjct: 66  MKVAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123

Query: 235 GDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL  FL+RK    L     + F+  +A+GM +L        IHRDL   N+L      +
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIV 180

Query: 293 KVADFGVSK 301
           K+ DFG+++
Sbjct: 181 KICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.0 bits (182), Expect = 4e-15
 Identities = 37/104 (35%), Positives = 57/104 (54%), Gaps = 2/104 (1%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +  +   + ++ +
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            RG+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 8e-15
 Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 10/158 (6%)

Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
           DP EL FT    I KG+F    ++GI    K++    I D    +D +   + E+ +L +
Sbjct: 1   DPEEL-FTKLERIGKGSF-GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
              P + ++ G+  + + + I+ EYL  G     LK  G L+ +       +I +G++YL
Sbjct: 59  CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYL 117

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           H  +    IHRD++ +N+L  + G++K+ADFGV+  LT
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT 152

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.6 bits (178), Expect = 8e-15
 Identities = 41/144 (28%), Positives = 78/144 (54%), Gaps = 6/144 (4%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G Q  +K++    +S  +R  + R E+A+L  ++HPN+VQ+  +  ++  + IV +Y   
Sbjct: 25  GKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83

Query: 235 GDLRAFL-KRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL   +  ++G L P   +  + + I   + ++H+ K   I+HRD++  NI     G +
Sbjct: 84  GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTI 140

Query: 293 KVADFGVSKLLTVKEDRPLTCQDT 316
           K+ DFG++++L    +   TC  T
Sbjct: 141 KLGDFGIARVLNSTVELARTCIGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 53/145 (36%), Positives = 75/145 (51%), Gaps = 11/145 (7%)

Query: 166 GTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   +  W G  +VA+K L    +  +    AF  E  +++K+RH  +V  L AV    P
Sbjct: 20  GEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRHDKLVP-LYAVVSEEP 74

Query: 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + IVTE++ KG L  FLK      LK    V  A  IA GM Y+     +  IHRDL  +
Sbjct: 75  IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAA 131

Query: 283 NILRDDSGNLKVADFGVSKLLTVKE 307
           NIL  D+   K+ADFG+++L+   E
Sbjct: 132 NILVGDNLVCKIADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 22/141 (15%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K L +  I++  +   F+ E +L+ ++ HPN+V  LG VTQ  P+ ++ EYL +GDL
Sbjct: 37  VAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94

Query: 238 RAFL-----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             FL                   K +L     +  A+ IA GM YL  +     +H+DL 
Sbjct: 95  HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLA 151

Query: 281 PSNILRDDSGNLKVADFGVSK 301
             NIL  +  ++K++D G+S+
Sbjct: 152 ARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 44/137 (32%), Positives = 70/137 (51%), Gaps = 16/137 (11%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E+  ++ +    F  E+ ++ +++ PN+++ L     S P+ ++TEY+  GDL
Sbjct: 49  VAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 238 RAFLKRKGALKP-----------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
             FL R    +            ST +  A  IA GM YL     +  +HRDL   N L 
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163

Query: 287 DDSGNLKVADFGVSKLL 303
             +  +K+ADFG+S+ L
Sbjct: 164 GKNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 9/153 (5%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 215
            I+KG F    LA  R  G   A+K L +  +   ++V   + E A++      P V + 
Sbjct: 3   PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
             +      + +V EYL  GD  + +K  G L    A ++  ++  G+  LH+     II
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119

Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           HRD++P N+L D +G+LK+ DFG+S+     + 
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 43/123 (34%), Positives = 71/123 (57%), Gaps = 9/123 (7%)

Query: 193 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252
           +V+A RD LAL    + P +V    ++  ++ + +V EYL  GD+++ L   G      A
Sbjct: 50  QVQAERDALAL---SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA 106

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           V++  ++A  ++YLH +    IIHRDL+P N+L  + G++K+ DFG+SK   V  +R L 
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK---VTLNRELN 160

Query: 313 CQD 315
             D
Sbjct: 161 MMD 163

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 37/114 (32%), Positives = 65/114 (57%), Gaps = 6/114 (5%)

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           +E  +L+++ HP +++          + ++ EY+P G+L ++L+  G    ST + +A +
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           I   + YLH  +   I++RDL+P NIL D  G++K+ DFG +K L    DR  T
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWT 157

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 10/158 (6%)

Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
           DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L +
Sbjct: 1   DPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
              P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++YL
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYL 117

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           H  K    IHRD++ +N+L  + G +K+ADFGV+  LT
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT 152

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 71.5 bits (175), Expect = 2e-14
 Identities = 38/109 (34%), Positives = 64/109 (58%), Gaps = 5/109 (4%)

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPS-TAVRF 255
           R E  LL K++HPN+V F  +      + IV EY   GDL   +K ++G L P  T +++
Sbjct: 46  RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
            + +  G+ ++HE +   ++HRD++  NI    +G +K+ DFG ++LLT
Sbjct: 106 FVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 22/145 (15%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           + + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 43  KPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100

Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157

Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 71.2 bits (174), Expect = 3e-14
 Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 14/160 (8%)

Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALL 204
           DP EL FT    I KG+F   F +GI       VA+K +  E    +D +   + E+ +L
Sbjct: 1   DPEEL-FTKLERIGKGSFGEVF-KGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVL 56

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
            +   P V ++ G+  + + + I+ EYL  G     L R G            +I +G++
Sbjct: 57  SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLD 115

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           YLH  K    IHRD++ +N+L  + G++K+ADFGV+  LT
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT 152

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 42/130 (32%), Positives = 69/130 (53%), Gaps = 7/130 (5%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA-VTQSSPMMIVTEYL 232
            G  VA+KK+ +   +     R +R EL LL+ +RH N++      ++    +  VTE L
Sbjct: 34  TGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
              DL   L     L+      F   I RG+ Y+H      ++HRDL+PSNIL +++ +L
Sbjct: 93  GT-DLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDL 147

Query: 293 KVADFGVSKL 302
           K+ DFG++++
Sbjct: 148 KICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 22/143 (15%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  K
Sbjct: 48  VTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105

Query: 235 GDLRAFLKRKGALK----------PSTAVRF------ALDIARGMNYLHENKPVPIIHRD 278
           G+LR +L+ +              P   + F         +ARGM YL   K    IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRD 162

Query: 279 LEPSNILRDDSGNLKVADFGVSK 301
           L   N+L  ++  +K+ADFG+++
Sbjct: 163 LAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              +VA+K++  E       V   R E+  + +  HPNVV++  +      + +V  YL 
Sbjct: 25  NNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82

Query: 234 KGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            G L   +K     G L  +       ++ +G+ YLH N     IHRD++  NIL  + G
Sbjct: 83  GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDG 139

Query: 291 NLKVADFGVSKLL 303
           ++K+ADFGVS  L
Sbjct: 140 SVKIADFGVSASL 152

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 38/107 (35%), Positives = 64/107 (59%), Gaps = 5/107 (4%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
           E++LL+ ++H N+V     +     + +V EYL   DL+ +L   G L     V+ F   
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           + RG++Y H+ K   I+HRDL+P N+L ++ G LK+ADFG+++  +V
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 46/133 (34%), Positives = 67/133 (50%), Gaps = 14/133 (10%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           V VK L +    D++    FR EL + +K+ H NVV+ LG   ++ P  ++ EY   GDL
Sbjct: 38  VLVKALQK--TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95

Query: 238 RAFL----KRKGALKP---STAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           + FL     +   LKP   ST  + AL   IA GM++L   +    +HRDL   N L   
Sbjct: 96  KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSS 152

Query: 289 SGNLKVADFGVSK 301
              +KV+   +SK
Sbjct: 153 QREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.2 bits (172), Expect = 6e-14
 Identities = 41/161 (25%), Positives = 85/161 (52%), Gaps = 14/161 (8%)

Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRH 209
           +F    +I KG F + +       G  VA+KK+   E++    R    + E+ LL+++ H
Sbjct: 3   NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAV-RFALDIARGMNY 265
           PNV+++L +  +++ + IV E    GDL   +K   ++  L P   + ++ + +   + +
Sbjct: 62  PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
           +H  +   I+HRD++P+N+    +G +K+ D G+ +  + K
Sbjct: 122 MHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 70.4 bits (172), Expect = 6e-14
 Identities = 47/139 (33%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------SPMMIV 228
           ++VAVK + +  I     +  F  E   +++  HPNV++ +G   Q+       SP++I+
Sbjct: 27  LKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85

Query: 229 TEYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             ++  GDL +FL   R G     L     V+F  DIA GM YL        IHRDL   
Sbjct: 86  P-FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAAR 141

Query: 283 NILRDDSGNLKVADFGVSK 301
           N + +++ N+ VADFG+SK
Sbjct: 142 NCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.0 bits (174), Expect = 6e-14
 Identities = 38/118 (32%), Positives = 63/118 (53%), Gaps = 15/118 (12%)

Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
           +D   R    E+ +L+ + HPNVV+       +  + ++ E++  G L        A + 
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THIADEQ 168

Query: 250 STAVRFALDIAR----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
             A     D+AR    G+ YLH      I+HRD++PSN+L + + N+K+ADFGVS++L
Sbjct: 169 FLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL 218

Length = 353

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 47/145 (32%), Positives = 74/145 (51%), Gaps = 22/145 (15%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 49  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106

Query: 233 PKGDLRAFL--KRKGALK----PSTA----------VRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L  +R   ++    P+            V  A  +ARGM YL   K    IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIH 163

Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 14/136 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
           G +VA+KKL     S     R +R EL LL+ + H NV+  L   T +S +       +V
Sbjct: 40  GRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           T  L   DL   +K +  L     ++F +  I RG+ Y+H      IIHRDL+PSNI  +
Sbjct: 99  TH-LMGADLNNIVKCQ-KLSDDH-IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVN 152

Query: 288 DSGNLKVADFGVSKLL 303
           +   LK+ DFG+++  
Sbjct: 153 EDCELKILDFGLARHT 168

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 22/145 (15%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           + + VAVK L +   + D  +     E+ L++ I +H N++  LG  TQ  P+ ++ EY 
Sbjct: 43  QTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100

Query: 233 PKGDLRAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIH 276
            KG+LR FL+ +    P                   V  A  +ARGM YL   +    IH
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIH 157

Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 7/107 (6%)

Query: 31  LDDDGEEIKPE---FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHV---AACQG 84
            +D+  +I  E   +  +  A+   VE ++ LL +G DVNFR    +T LH+    + + 
Sbjct: 2   EEDESVDIIMEAALYDYLLNASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEK 61

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE-VIKLLEKHGA 130
             ++V LLLE GADV+  +R G TPL   +Y      VIKLL K GA
Sbjct: 62  VKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGA 108

Length = 471

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 2/101 (1%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL ++ + R P +V F GA    + + +  E++  G L    K+ G +      + A+ +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
             G+ YL+      I+HRD++PSNIL +  G +K+ DFGVS
Sbjct: 113 VEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 46/133 (34%), Positives = 75/133 (56%), Gaps = 10/133 (7%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK +    +S    V AF  E  +++ ++H  +V+ L AV    P+ I+TE++ KG 
Sbjct: 32  KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 86

Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK  +G+ +P    + F+  IA GM ++ +      IHRDL  +NIL   S   K+
Sbjct: 87  LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 143

Query: 295 ADFGVSKLLTVKE 307
           ADFG+++++   E
Sbjct: 144 ADFGLARVIEDNE 156

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 11/140 (7%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              +V VK+L     +  D    F  E+   +++ HPNV+Q LG   +S P ++V E+ P
Sbjct: 21  SKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78

Query: 234 KGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            GDL+ +L+          +     R A ++A G+ +LH+      IH DL   N     
Sbjct: 79  LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTA 135

Query: 289 SGNLKVADFGVSKLLTVKED 308
             ++K+ D+G++ L    ED
Sbjct: 136 DLSVKIGDYGLA-LEQYPED 154

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 42/128 (32%), Positives = 67/128 (52%), Gaps = 8/128 (6%)

Query: 178 VAVKKLGEEVISDDDRVR--AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+KK  E    DD  V+  A R E+ +L+++RH N+V  +    +   + +V E++   
Sbjct: 29  VAIKKFLES--EDDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
            L    K    L  S   ++   I RG+ + H +    IIHRD++P NIL   SG +K+ 
Sbjct: 86  VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLC 142

Query: 296 DFGVSKLL 303
           DFG ++ L
Sbjct: 143 DFGFARTL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 20/155 (12%)

Query: 162 EITKGTF--ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
           E+ +GT   IL    G I+VAVK L +     D   + F  E  L+    HPN+V+ LG 
Sbjct: 10  EVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGV 67

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------VRFALDIARGMNYLHENKP 271
              + P  I+ E +  GDL ++L+     +           +   LD+A+G  YL +   
Sbjct: 68  CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH- 126

Query: 272 VPIIHRDLEPSNILRDDSGN-----LKVADFGVSK 301
              IHRDL   N L  + G      +K+ DFG+++
Sbjct: 127 --FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 19/139 (13%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VAVK L +   + D+  + F  E  LL  ++H ++V+F G   +  P+++V EY+  G
Sbjct: 36  ILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92

Query: 236 DLRAFLKRKGA-------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           DL  FL+  G              L  S  +  A  IA GM YL        +HRDL   
Sbjct: 93  DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 149

Query: 283 NILRDDSGNLKVADFGVSK 301
           N L  ++  +K+ DFG+S+
Sbjct: 150 NCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 21/138 (15%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K L ++   +      F+ E  +  +++HPN+V  LG VT+  P+ ++  Y    DL
Sbjct: 38  VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95

Query: 238 RAFL----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL                  K  L+P+  V     IA GM +L  +    ++H+DL  
Sbjct: 96  HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152

Query: 282 SNILRDDSGNLKVADFGV 299
            N+L  D  N+K++D G+
Sbjct: 153 RNVLVFDKLNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.6 bits (167), Expect = 3e-13
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 3/106 (2%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E +LL+ ++H N+V     +     + +V EY+     +   K  G L P     F   +
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL 112

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
            RG++Y+H+     I+HRDL+P N+L  D+G LK+ADFG+++  +V
Sbjct: 113 LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 5/103 (4%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E +LL+ ++H N+V     +     + +V EYL   DL+ ++    G L       F   
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           + RG+ Y H+ +   ++HRDL+P N+L  + G LK+ADFG+++
Sbjct: 112 LLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 53/154 (34%), Positives = 79/154 (51%), Gaps = 13/154 (8%)

Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
           DF   + + KG+F   +LA  +G     A+K L ++VI  DD V     E   LAL  K 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK- 59

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
             P + Q          +  V EY+  GDL   +++ G  K   AV +A +IA G+ +LH
Sbjct: 60  -PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 II+RDL+  N++ D  G++K+ADFG+ K
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 37/183 (20%)

Query: 144 EVPEYEID-PHEL---DFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
           EV   E+  P +L    F  +V   KG       R + VAVK L  +  ++ +    F  
Sbjct: 20  EVHLCEVVNPQDLPTLQFPFNVR--KG-------RPLLVAVKILRPD--ANKNARNDFLK 68

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------- 245
           E+ +L +++ PN+++ LG      P+ ++TEY+  GDL  FL                  
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
                A+  S+ +  AL IA GM YL     +  +HRDL   N L  ++  +K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 301 KLL 303
           + L
Sbjct: 186 RNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.0 bits (166), Expect = 4e-13
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 6/138 (4%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G   L   R + VA+  L     SD  R R F  E   L +  H N+V+  G +T+
Sbjct: 20  ELCRGCLKLPSKRELPVAIHTL-RAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITR 77

Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
            + MMIVTEY+  G L +FL++ +G L     +     +A GM YL E   +  +H+ L 
Sbjct: 78  GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLA 134

Query: 281 PSNILRDDSGNLKVADFG 298
              +L +     K++ F 
Sbjct: 135 AHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 37/103 (35%), Positives = 61/103 (59%), Gaps = 5/103 (4%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
           E++LL+ ++H N+V     +     + +V EYL K DL+ +L   G       V+ F   
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           + RG+NY H  K   ++HRDL+P N+L ++ G LK+ADFG+++
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 38/107 (35%), Positives = 63/107 (58%), Gaps = 5/107 (4%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
           E++LL+ ++H N+V     V     + +V EYL K DL+ ++   G +     V+ F   
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           I RG+ Y H  K   ++HRDL+P N+L ++ G LK+ADFG+++  +V
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 67.7 bits (165), Expect = 5e-13
 Identities = 40/132 (30%), Positives = 69/132 (52%), Gaps = 13/132 (9%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           I VA+K      I D    + F+   D +  +  + H  +V+ LG    +S + +VT+  
Sbjct: 37  IPVAIK-----TIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLS 90

Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G L   + + + +L P   + + + IA+GM YL E++   ++HR+L   NIL      
Sbjct: 91  PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSI 147

Query: 292 LKVADFGVSKLL 303
           +++ADFGV+ LL
Sbjct: 148 VQIADFGVADLL 159

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 41/130 (31%), Positives = 62/130 (47%), Gaps = 17/130 (13%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   +++   R E  +L     P +V+   +      + +V EY+P GDL 
Sbjct: 30  AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM 89

Query: 239 AFLKRKGALKPSTAVRF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
             L RK      TA RF       ALD    + +         IHRD++P NIL D  G+
Sbjct: 90  NLLIRKDVFPEETA-RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGH 139

Query: 292 LKVADFGVSK 301
           +K+ADFG+ K
Sbjct: 140 IKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 51/154 (33%), Positives = 79/154 (51%), Gaps = 13/154 (8%)

Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
           DF   + + KG+F   +LA  +G     A+K L ++V+  DD V     E   LAL  K 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK- 59

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
             P + Q          +  V EY+  GDL   +++ G  K   AV +A +I+ G+ +LH
Sbjct: 60  -PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 II+RDL+  N++ D  G++K+ADFG+ K
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 67.2 bits (164), Expect = 8e-13
 Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 8/129 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIVTEYL 232
           G  VAVK L  E          ++ E+ +L+ + H N+V++ G  ++     + ++ EY+
Sbjct: 33  GEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G LR +L +   L  +  + FA  I  GM YLH       IHRDL   N+L D+   +
Sbjct: 91  PLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146

Query: 293 KVADFGVSK 301
           K+ DFG++K
Sbjct: 147 KIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 8e-13
 Identities = 47/152 (30%), Positives = 69/152 (45%), Gaps = 18/152 (11%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP------MMIVTE 230
           VA+K +       +D     ++E  +L+K   HPN+  F GA  + +P      + +V E
Sbjct: 34  VAIKIMD----IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89

Query: 231 YLPKG---DL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
               G   DL +   K+   LK         +  RG+ YLHENK   +IHRD++  NIL 
Sbjct: 90  LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILL 146

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
             +  +K+ DFGVS  L     R  T   T  
Sbjct: 147 TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.4 bits (165), Expect = 9e-13
 Identities = 42/126 (33%), Positives = 61/126 (48%), Gaps = 7/126 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           A+K L +  I   D V +   E  + +     RHP +V           +  V EY   G
Sbjct: 28  AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           DL   +      +P  AV +A  +  G+ YLHENK   I++RDL+  N+L D  G +K+A
Sbjct: 88  DLMMHIHTDVFSEPR-AVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIA 143

Query: 296 DFGVSK 301
           DFG+ K
Sbjct: 144 DFGLCK 149

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 48/141 (34%), Positives = 74/141 (52%), Gaps = 11/141 (7%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           QV VK+L       +     F +E    + ++H N++Q LG  T+ +P ++V E+ P GD
Sbjct: 24  QVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81

Query: 237 LRAFLK--RKGAL---KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L+ +L+  RK  L    P+T  R A +IA G+ +LH+N     IH DL   N L      
Sbjct: 82  LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLT 138

Query: 292 LKVADFGVSKLLTVKEDRPLT 312
           +K+ D+G+S     KED  +T
Sbjct: 139 VKIGDYGLSH-NKYKEDYYVT 158

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 35/129 (27%), Positives = 61/129 (47%), Gaps = 3/129 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + +  I +  +      E  +L++  HP +V+          + ++ EY   G+L 
Sbjct: 22  ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L+ +G     TA  +   +     YLH      II+RDL+P N+L D +G +K+ DFG
Sbjct: 82  TILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFG 138

Query: 299 VSKLLTVKE 307
            +K L   +
Sbjct: 139 FAKKLKSGQ 147

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 37/133 (27%), Positives = 75/133 (56%), Gaps = 7/133 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VA+KK+  +  ++     A R E++LL+++ HPN+V+ L  +   + + +V E+L +
Sbjct: 25  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 83

Query: 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            DL+ F+       +       +   + +G+ + H ++   ++HRDL+P N+L +  G +
Sbjct: 84  -DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAI 139

Query: 293 KVADFGVSKLLTV 305
           K+ADFG+++   V
Sbjct: 140 KLADFGLARAFGV 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 37/121 (30%), Positives = 62/121 (51%), Gaps = 10/121 (8%)

Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KG 245
           I  ++ +  F  E+ +L + +HPN+V    A    + + I+ E+   G L + +    +G
Sbjct: 40  IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG 99

Query: 246 ALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
             +P      R  L+    +N+LH +K   +IHRDL+  NIL    G++K+ADFGVS   
Sbjct: 100 LTEPQIRYVCRQMLE---ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153

Query: 304 T 304
            
Sbjct: 154 K 154

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 37/128 (28%), Positives = 65/128 (50%), Gaps = 4/128 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + + V+   + V  F +E  +L     P + Q   A      + +V EY P GDL 
Sbjct: 30  AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89

Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
           + L R          +F L ++   ++ +H+   +  +HRD++P N+L D +G++K+ADF
Sbjct: 90  SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADF 146

Query: 298 GVSKLLTV 305
           G +  LT 
Sbjct: 147 GSAARLTA 154

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 39/124 (31%), Positives = 68/124 (54%), Gaps = 6/124 (4%)

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL-KPSTAV 253
           A + E+ LL K++HPN+V F  +  ++  + IV EY   GDL   + R +G L      +
Sbjct: 45  ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104

Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLT 312
            + + I+ G+ ++H+ K   I+HRD++  NI    +G + K+ DFG+++ L    +   T
Sbjct: 105 SWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161

Query: 313 CQDT 316
           C  T
Sbjct: 162 CVGT 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 39/139 (28%), Positives = 69/139 (49%), Gaps = 6/139 (4%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
            G   A+K L +  I    +V+    E ++L ++ HP +V  + +    + +  + E++ 
Sbjct: 42  TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G+L   L++ G      A  +  ++     YLH      II+RDL+P N+L D+ G++K
Sbjct: 102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158

Query: 294 VADFGVSKLLTVKEDRPLT 312
           V DFG +K +    DR  T
Sbjct: 159 VTDFGFAKKVP---DRTFT 174

Length = 329

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 40/133 (30%), Positives = 74/133 (55%), Gaps = 7/133 (5%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 37  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 93

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL E +   ++HRDL   N+L     ++K+
Sbjct: 94  CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKI 150

Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL   E
Sbjct: 151 TDFGLAKLLGADE 163

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 40/138 (28%), Positives = 77/138 (55%), Gaps = 21/138 (15%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+K + E   S  +R+  F +E +++++    +VV+ LG V+Q  P +++ E + +GD
Sbjct: 38  RVAIKTVNEAA-SMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 95

Query: 237 LRAFLKRKGALKPSTA-------------VRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+ NK    +HRDL   N
Sbjct: 96  LKSYLR---SLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARN 149

Query: 284 ILRDDSGNLKVADFGVSK 301
            +  +   +K+ DFG+++
Sbjct: 150 CMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 7/137 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-IVTEYLP 233
           G Q  +KKL     S  +R +A   E  LL +++HPN+V +  +      ++ IV  +  
Sbjct: 25  GKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83

Query: 234 KGDLRAFLK-RKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
            GDL   LK +KG L P +  V + + IA  + YLHE     I+HRDL+  N+    +  
Sbjct: 84  GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNI 140

Query: 292 LKVADFGVSKLLTVKED 308
           +KV D G++++L  + D
Sbjct: 141 IKVGDLGIARVLENQCD 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 37/82 (45%), Positives = 45/82 (54%)

Query: 47  LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
           LA   D  G + LL  G D N RD D RT LH+A   G  +VV +LLE GAD    D+ G
Sbjct: 89  LAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDG 148

Query: 107 STPLGDAIYYKNHEVIKLLEKH 128
            TPL  A      EV++LL +H
Sbjct: 149 KTPLELAEENGFREVVQLLSRH 170

Length = 664

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 113 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 13/151 (8%)

Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAF---RDELALLQKIRHPNVVQFL 216
           KG+F   +LA  +G     A+K L ++V+ +DD V      R  LAL  +  HP +    
Sbjct: 5   KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFLTHLF 62

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                   +  V EYL  GDL   ++  G    + A  +A +I  G+ +LH+     II+
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIY 119

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           RDL+  N+L D  G++K+ADFG+ K     E
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 65.3 bits (160), Expect = 4e-12
 Identities = 42/124 (33%), Positives = 70/124 (56%), Gaps = 8/124 (6%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKG 235
           VA+KKL  E   +   + + R E+ +L K++HPN+V     V  S+   + +V EY+ + 
Sbjct: 33  VALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EH 90

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL++ ++  K     S      L +  G+ +LH+N    I+HRDL+ SN+L ++ G LK+
Sbjct: 91  DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKI 147

Query: 295 ADFG 298
            DFG
Sbjct: 148 CDFG 151

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 35/104 (33%), Positives = 60/104 (57%), Gaps = 3/104 (2%)

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           + E  +L+ ++HP +V  + A      + ++ EYL  G+L   L+R+G     TA  +  
Sbjct: 48  KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           +I+  + +LH+     II+RDL+P NIL D  G++K+ DFG+ K
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK 148

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 64.3 bits (156), Expect = 6e-12
 Identities = 32/107 (29%), Positives = 58/107 (54%), Gaps = 3/107 (2%)

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           + E+ +++  +H N+V + G+  +   + I  E+   G L+      G L  S     + 
Sbjct: 54  QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR 113

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           +  +G+ YLH       +HRD++ +NIL  D+G++K+ADFGVS  +T
Sbjct: 114 ETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQIT 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.8 bits (158), Expect = 6e-12
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 11/149 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  +AVK++   V S + + R   D    ++ +  P  V F GA+ +   + I  E +  
Sbjct: 26  GTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VMD 83

Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
             L  F K+   KG   P   + + A+ I + + YLH    V  IHRD++PSN+L + +G
Sbjct: 84  TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNG 141

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +K+ DFG+S  L    D      D  C+
Sbjct: 142 QVKLCDFGISGYLV---DSVAKTIDAGCK 167

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.1 bits (158), Expect = 7e-12
 Identities = 39/124 (31%), Positives = 68/124 (54%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 24  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 84  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 140

Query: 298 GVSK 301
           G+ K
Sbjct: 141 GMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 64.0 bits (156), Expect = 7e-12
 Identities = 39/142 (27%), Positives = 72/142 (50%), Gaps = 6/142 (4%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
            V  K++    +S+ +R R   +E+ +L  ++HPN++ +       + ++I  EY   G 
Sbjct: 27  LVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85

Query: 237 L-RAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L    +++KG L     V + L  I   ++Y+H+     I+HRD++  NI    +G +K+
Sbjct: 86  LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142

Query: 295 ADFGVSKLLTVKEDRPLTCQDT 316
            DFG+SK+L  +     T   T
Sbjct: 143 GDFGISKILGSEYSMAETVVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 44/140 (31%), Positives = 66/140 (47%), Gaps = 22/140 (15%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L +  ++     + F+ E  LL  ++H ++V+F G      P+++V EY+  GDL
Sbjct: 38  VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94

Query: 238 RAFLK----------------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL+                 KG L  S  +  A  IA GM YL        +HRDL  
Sbjct: 95  NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLAT 151

Query: 282 SNILRDDSGNLKVADFGVSK 301
            N L   +  +K+ DFG+S+
Sbjct: 152 RNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 33/77 (42%), Positives = 48/77 (62%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           + IK +LD GIDVN +D + +T LH A  +G  E + +L E GADV+ +D  G  P+  A
Sbjct: 105 DMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIA 164

Query: 114 IYYKNHEVIKLLEKHGA 130
           I +   ++IKLL + GA
Sbjct: 165 IKHNFFDIIKLLLEKGA 181

Length = 434

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 64.1 bits (157), Expect = 9e-12
 Identities = 45/156 (28%), Positives = 84/156 (53%), Gaps = 17/156 (10%)

Query: 164 TKGTFILAFWR--GIQVAVKKLGEEVISDDD--RVRAFRDELALLQKI-RHPNVVQFLGA 218
           T G+  LA  +  G  VA+KK+ ++  S ++   +R    E+  L+K+  HPN+V+    
Sbjct: 11  TFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIVKLKEV 66

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIH 276
             ++  +  V EY+ +G+L   +K RKG     + +R  +  I +G+ ++H++      H
Sbjct: 67  FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFH 122

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           RDL+P N+L      +K+ADFG+++   ++   P T
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYT 156

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 46/139 (33%), Positives = 67/139 (48%), Gaps = 21/139 (15%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   S+  R + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL
Sbjct: 38  VAVKALKE--ASESAR-QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL 94

Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             FL+                 G L     +  A  IA GM YL     +  +HRDL   
Sbjct: 95  NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATR 151

Query: 283 NILRDDSGNLKVADFGVSK 301
           N L      +K+ DFG+S+
Sbjct: 152 NCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++ I      +    E   LL+ ++HP +V    +   +  +  V +Y+  G+L
Sbjct: 24  AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L+R+ +     A  +A +IA  + YLH      II+RDL+P NIL D  G++ + DF
Sbjct: 84  FFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDF 140

Query: 298 GVSK 301
           G+ K
Sbjct: 141 GLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 8/138 (5%)

Query: 30  GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
           G+D + ++ + +  L +   + D+E IK L + G DVN  D +    +H+A    F +++
Sbjct: 114 GIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDII 173

Query: 90  SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA------KPLMAPMH--VKH 141
            LLLE+GA  + KD  G +PL +A  Y ++  IKLL  HG       K    P+H  + H
Sbjct: 174 KLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIH 233

Query: 142 AREVPEYEIDPHELDFTN 159
            R   E  I+   ++  +
Sbjct: 234 NRSAIELLINNASINDQD 251

Length = 434

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 42/124 (33%), Positives = 71/124 (57%), Gaps = 6/124 (4%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 28  AMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 86

Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
             L  K  +     V+F L ++A  +++LH    + II+RDL+P NIL D+ G++K+ DF
Sbjct: 87  TRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDF 142

Query: 298 GVSK 301
           G+SK
Sbjct: 143 GLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 13/135 (9%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           VAVK     ++ +D+   A +DEL     ++Q++ +P +V+ +G + ++   M+V E   
Sbjct: 25  VAVK-----ILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAE 78

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G L  FL++   +           ++ GM YL E      +HRDL   N+L       K
Sbjct: 79  LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAK 135

Query: 294 VADFGVSKLLTVKED 308
           ++DFG+SK L   E+
Sbjct: 136 ISDFGLSKALGADEN 150

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 40/152 (26%), Positives = 81/152 (53%), Gaps = 16/152 (10%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGA 218
           E+ + T +L    G+ VA+KK+    I D    +A  D   E+ LL+++ HPNV+++  +
Sbjct: 17  EVYRATCLL---DGVPVALKKVQ---IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70

Query: 219 VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 274
             + + + IV E    GDL    + F K+K  +   T  ++ + +   + ++H  +   +
Sbjct: 71  FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---V 127

Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
           +HRD++P+N+    +G +K+ D G+ +  + K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 36/132 (27%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI---VTEY 231
           G +VA+KK+           R  R EL +L+  +H N++     +           V   
Sbjct: 30  GKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L + DL   +     L       F   + RG+ Y+H      +IHRDL+PSN+L ++   
Sbjct: 89  LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCE 145

Query: 292 LKVADFGVSKLL 303
           L++ DFG+++ L
Sbjct: 146 LRIGDFGMARGL 157

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 7/129 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G+ +A+K++  E+  D+ +      EL +L K   P +V F GA      + +  EY+  
Sbjct: 26  GVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83

Query: 235 GDLRAFLKRKGAL--KPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           G L        A    P   +R     + +G+ +L E     IIHRD++P+N+L + +G 
Sbjct: 84  GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQ 141

Query: 292 LKVADFGVS 300
           +K+ DFGVS
Sbjct: 142 VKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 9/152 (5%)

Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF   + + KG+F   +LA  +G     A+K L ++V+  DD V     E  +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
             +  L +  Q+   +  V EY+  GDL   +++ G  K   AV +A +IA G+ +LH  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
               II+RDL+  N++ D  G++K+ADFG+ K
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 4/102 (3%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL ++ +I+H N++  +    +   + +V + +   DL+  + RK  L  S      L I
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
             G+N LH+      +HRDL P+NI  +  G  K+ADFG+++
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.8 bits (152), Expect = 3e-11
 Identities = 42/133 (31%), Positives = 72/133 (54%), Gaps = 7/133 (5%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      +    F DE  ++  + HP++V+ LG V  S  + +VT+ +P G
Sbjct: 37  IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 93

Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  ++ + K  +     + + + IA+GM YL E +   ++HRDL   N+L     ++K+
Sbjct: 94  CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 150

Query: 295 ADFGVSKLLTVKE 307
            DFG+++LL   E
Sbjct: 151 TDFGLARLLEGDE 163

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 36/130 (27%), Positives = 67/130 (51%), Gaps = 5/130 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ +   ++V+    E  +L  + HP +     +    + + +V +Y P G+L 
Sbjct: 30  ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89

Query: 239 AFL-KRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
             L ++ G        RF A ++   + YLH      I++RDL+P NIL  +SG++ ++D
Sbjct: 90  RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSD 146

Query: 297 FGVSKLLTVK 306
           F +SK   V+
Sbjct: 147 FDLSKQSDVE 156

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E +LL+ ++H N+V     +     +  V EY+   DL  ++ +  G L P     F   
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ 111

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           + RG+ Y+H      I+HRDL+P N+L    G LK+ADFG+++
Sbjct: 112 LLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 9/159 (5%)

Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L F++  EI  G+F  + F R ++    VA+KK+       +++ +    E+  LQ
Sbjct: 12  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           K+RHPN +Q+ G   +     +V EY            K  L+            +G+ Y
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH +    +IHRD++  NIL  + G +K+ DFG + ++ 
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 6/144 (4%)

Query: 166 GTFILAFWRGIQ---VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           G  ILA ++      VA+K+  +  I    +V     E  +L  I HP  V   G+    
Sbjct: 44  GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103

Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           S + +V E++  G+   FL+R           +A  I     YL   + + I++RDL+P 
Sbjct: 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPE 160

Query: 283 NILRDDSGNLKVADFGVSKLLTVK 306
           N+L D  G +K+ DFG +K++  +
Sbjct: 161 NLLLDKDGFIKMTDFGFAKVVDTR 184

Length = 340

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 40/136 (29%), Positives = 72/136 (52%), Gaps = 15/136 (11%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
            +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  G
Sbjct: 37  TRVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94

Query: 236 DLRAFLK--------RKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           DL+++L+          G   P+    ++ A +IA GM YL+  K    +HRDL   N +
Sbjct: 95  DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151

Query: 286 RDDSGNLKVADFGVSK 301
                 +K+ DFG+++
Sbjct: 152 VAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 2/104 (1%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK    +      + ++ +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            RG+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 33/114 (28%), Positives = 62/114 (54%), Gaps = 15/114 (13%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKGDLRAFLK-----RKGALKPSTA 252
           E+ALL++++H NVV  +    + +   +  + +Y  + DL   +K     ++ ++ PS  
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKL 302
                 I  G++YLH N    ++HRDL+P+NIL      + G +K+ D G+++L
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.6 bits (149), Expect = 6e-11
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 7/133 (5%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      ++     DE  ++  +  P V + LG +  +S + +VT+ +P G
Sbjct: 37  IPVAIKVLRENTSPKANK--EILDEAYVMAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYG 93

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GM+YL E   V ++HRDL   N+L     ++K+
Sbjct: 94  CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKI 150

Query: 295 ADFGVSKLLTVKE 307
            DFG+++LL + E
Sbjct: 151 TDFGLARLLDIDE 163

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 12/150 (8%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEY-- 231
           G  +AVK++      D+   +    +L ++ +    P +V+F GA+ +     I  E   
Sbjct: 29  GTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86

Query: 232 --LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
             L K     +   K  +      + A+   + +NYL E   + IIHRD++PSNIL D +
Sbjct: 87  ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRN 144

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           GN+K+ DFG+S  L    D     +D  CR
Sbjct: 145 GNIKLCDFGISGQL---VDSIAKTRDAGCR 171

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.1 bits (148), Expect = 7e-11
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 12/153 (7%)

Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           EL   N   + KG + +   + I VA+K  K   E    D+ +R    E  ++ ++ +P 
Sbjct: 2   ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMR----EAEIMHQLDNPY 56

Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENK 270
           +V+ +G V ++  +M+V E    G L  FL  +K  +  S  V     ++ GM YL    
Sbjct: 57  IVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
               +HRDL   N+L  +    K++DFG+SK L
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 9/162 (5%)

Query: 148 YEIDPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELA 202
           ++ DP +L FT+  EI  G+F  + F R ++    VA+KK+       +++ +    E+ 
Sbjct: 19  FKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
            LQ+I+HPN +++ G   +     +V EY            K  L+            +G
Sbjct: 78  FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           + YLH +    +IHRD++  NIL  + G +K+ADFG + + +
Sbjct: 138 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 61.2 bits (148), Expect = 9e-11
 Identities = 29/111 (26%), Positives = 63/111 (56%), Gaps = 7/111 (6%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
           E+ LL+++ HPNV+++L +  + + + IV E    GDL    + F K+K  +   T  ++
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
            + +   + ++H  +   ++HRD++P+N+    +G +K+ D G+ +  + K
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 10/132 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----MMIVT 229
           G +VA+KK+ +      D  R  R E+ LL+ +RHP++V+    +   S      + +V 
Sbjct: 25  GEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           E L + DL   +K    L P     F   + R + Y+H      + HRDL+P NIL +  
Sbjct: 84  E-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANAD 139

Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 140 CKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 3/123 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   G+L 
Sbjct: 24  AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L R+       A  +  +I   + YLH      +++RDL+  N++ D  G++K+ DFG
Sbjct: 84  FHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFG 140

Query: 299 VSK 301
           + K
Sbjct: 141 LCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 35/129 (27%), Positives = 60/129 (46%), Gaps = 20/129 (15%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVR-- 254
           E  LL  + H N++  L    +   P  ++  Y+  G+L+ FL+  R G      A+   
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 255 ----FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK--------L 302
                A+ IA GM+YLH+     +IH+D+   N + D+   +K+ D  +S+         
Sbjct: 118 QLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174

Query: 303 LTVKEDRPL 311
           L   E+RP+
Sbjct: 175 LGDNENRPV 183

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 7/109 (6%)

Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 254
           +    EL +L K   P ++ F GA    + + I TE++  G L  +      +      R
Sbjct: 44  KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGR 99

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            A+ + +G+ YL   K   I+HRD++PSN+L +  G +K+ DFGVS  L
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 13/147 (8%)

Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQ 214
           I KG+F   +LA  +  G   AVK L ++ I    + + + A R+   LL+ ++HP +V 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVG 60

Query: 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 274
              +   +  +  V +Y+  G+L   L+R+       A  +A ++A  + YLH    + I
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNI 117

Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSK 301
           I+RDL+P NIL D  G++ + DFG+ K
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 4/111 (3%)

Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKP 249
           ++ +  +  E+ +L    HPN+V+ L A    + + I+ E+   G + A  L+ +  L  
Sbjct: 43  EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE 102

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
                        +NYLHENK   IIHRDL+  NIL    G++K+ADFGVS
Sbjct: 103 PQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 8/142 (5%)

Query: 165 KGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP +     A 
Sbjct: 5   KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 64

Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
                +  V EY   G+L   L R+       A  +  +I   + YLH      +++RD+
Sbjct: 65  QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 121

Query: 280 EPSNILRDDSGNLKVADFGVSK 301
           +  N++ D  G++K+ DFG+ K
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 9/145 (6%)

Query: 163 ITKGTF---ILAFWRGIQV--AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFL 216
           I KG+F   +LA  +  +   AVK L ++ I      +    E   LL+ ++HP +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            +   +  +  V +Y+  G+L   L+R+       A  +A +IA  + YLH    + I++
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVY 119

Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL+P NIL D  G++ + DFG+ K
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 38/160 (23%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VA+KK+  +   +   + A R E+ +L+++ H N+V             IVT+   K
Sbjct: 32  GELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNL---------KEIVTD---K 78

Query: 235 GDLRAFLKRKGA--------------LKPSTAVRFALD--------IARGMNYLHENKPV 272
            D   F K KGA              L  S  V F+ D        +  G+NY H+    
Sbjct: 79  QDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN-- 136

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
             +HRD++ SNIL ++ G +K+ADFG+++L   +E RP T
Sbjct: 137 -FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 21/142 (14%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRH-PNVVQFLGA--VTQSSP---MMIVT 229
           VA+KK   E   D++ +   A R E++LLQ +     +V+ L    V + +    + +V 
Sbjct: 29  VALKKTRLE--MDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85

Query: 230 EYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           EYL   DL+ F+   G      L   T   F   + +G+ + H++    ++HRDL+P N+
Sbjct: 86  EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNL 141

Query: 285 LRDDSGN-LKVADFGVSKLLTV 305
           L D     LK+AD G+ +  ++
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSI 163

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 38/124 (30%), Positives = 68/124 (54%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E++ DD+ +   + E  +  Q   +P +V        +S + +V EY+  GDL
Sbjct: 24  AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  +A +I   +N+LHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 84  MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDY 140

Query: 298 GVSK 301
           G+ K
Sbjct: 141 GMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 13/145 (8%)

Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFL 216
           KG+F   +LA  +G     A+K L ++VI  DD V     E   LAL  K  HP +    
Sbjct: 5   KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTALH 62

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                   +  V EY+  GDL   ++R        +  +A ++   + +LH +    +I+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIY 119

Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL+  NIL D  G+ K+ADFG+ K
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 19/162 (11%)

Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L FT+  EI  G+F  + F R ++    VA+KK+       +++ +    E+  LQ
Sbjct: 12  DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYL--PKGDLRAFLKRKGALKPSTAVRFA---LDIA 260
           ++RHPN +++ G   +     +V EY      D+    K     KP   V  A       
Sbjct: 71  QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAICHGAL 125

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           +G+ YLH ++    IHRD++  NIL  + G +K+ADFG + L
Sbjct: 126 QGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 3/127 (2%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +L+  RHP +     +      +  V EY+  
Sbjct: 20  GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+          +  +I   ++YLH  K   I++RDL+  N++ D  G++K+
Sbjct: 80  GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKI 136

Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 137 TDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 4/140 (2%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           +G   AVK L ++V+  DD V     E  +L     +P +            +  V E+L
Sbjct: 19  KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
             GDL   ++ KG      A  +A +I  G+ +LH      II+RDL+  N++ D  G++
Sbjct: 79  NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHI 135

Query: 293 KVADFGVSKLLTVKEDRPLT 312
           K+ADFG+ K     ++R  T
Sbjct: 136 KIADFGMCKENVFGDNRAST 155

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 36/124 (29%), Positives = 67/124 (54%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +      HP +V         S +  V E++  GDL
Sbjct: 24  AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +N+LHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 84  MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 140

Query: 298 GVSK 301
           G+ K
Sbjct: 141 GMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 45/146 (30%), Positives = 70/146 (47%), Gaps = 16/146 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
           G +VA+KK+     +     R FR EL +L   +H NV   L A+    P        + 
Sbjct: 25  GKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNV---LSALDILQPPHIDPFEEIY 80

Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
           +VTE L + DL   +     L       F   I RG+ YLH      I+HRD++P N+L 
Sbjct: 81  VVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLV 136

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLT 312
           + +  LK+ DFG++++    E + +T
Sbjct: 137 NSNCVLKICDFGLARVEEPDESKHMT 162

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 39/123 (31%), Positives = 60/123 (48%), Gaps = 2/123 (1%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   G+L 
Sbjct: 24  AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L R+       A  +  +I   ++YLH  K V  ++RDL+  N++ D  G++K+ DFG
Sbjct: 84  FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFG 141

Query: 299 VSK 301
           + K
Sbjct: 142 LCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 3/113 (2%)

Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           D     + E+ ++++ +H N+V + G+      + I  EY   G L+      G L    
Sbjct: 48  DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ 107

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 +  +G+ YLH       +HRD++ +NIL  D+G++K+ADFGV+  +T
Sbjct: 108 IAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKIT 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 10/134 (7%)

Query: 178 VAVKKLGEEVISDDD---RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           VA+KK  E   S+DD   +  A R E+ +L++++HPN+V  +    +   + +V EY   
Sbjct: 29  VAIKKFVE---SEDDPVIKKIALR-EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
             L    K    +      +      + +N+ H++     IHRD++P NIL    G +K+
Sbjct: 85  TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKL 141

Query: 295 ADFGVSKLLTVKED 308
            DFG +++LT   D
Sbjct: 142 CDFGFARILTGPGD 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 11/110 (10%)

Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
           L+   HPNVV+     T S     + + +V E++ + DL  +L +  +  +   T     
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 116

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
             + RG+++LH ++   ++HRDL+P NIL   SG +K+ADFG++++ + +
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 163

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 40/124 (32%), Positives = 62/124 (50%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++VI  DD V     E  +L   R HP + Q          +  V E++  GDL
Sbjct: 24  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              +++      + A  +A +I   + +LH+     II+RDL+  N+L D  G+ K+ADF
Sbjct: 84  MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 140

Query: 298 GVSK 301
           G+ K
Sbjct: 141 GMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 58.8 bits (142), Expect = 5e-10
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 10/109 (9%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
           E  LL K+ HP +V+F  +  +     I+TEY    DL             L  +    +
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLL 303
            + +  G++Y+H+ +   I+HRDL+  NI L+++   LK+ DFGVS+LL
Sbjct: 112 FIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL--LKIGDFGVSRLL 155

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 44/133 (33%), Positives = 70/133 (52%), Gaps = 12/133 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 42  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            +L   DL   +K +        V+F +  I RG+ Y+H      IIHRDL+PSN+  ++
Sbjct: 101 THLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155

Query: 289 SGNLKVADFGVSK 301
              LK+ DFG+++
Sbjct: 156 DCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 36/113 (31%), Positives = 58/113 (51%), Gaps = 6/113 (5%)

Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGAL 247
            ++ +  +  E+ +L    HP +V+ LGA      + I+ E+ P G + A +    +G  
Sbjct: 49  SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT 108

Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           +P   V     +   + YLH  K   IIHRDL+  N+L    G++K+ADFGVS
Sbjct: 109 EPQIQV-ICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 30/141 (21%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM---------IV 228
           VA+KK+  E   +   + A R E+ +LQ ++H NVV  L  + ++             +V
Sbjct: 40  VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN-LIEICRTKATPYNRYKGSFYLV 97

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIAR-------GMNYLHENKPVPIIHRDLE 280
            E+    DL   L  K        V+F L +I +       G+ Y+H NK   I+HRD++
Sbjct: 98  FEFCEH-DLAGLLSNK-------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMK 146

Query: 281 PSNILRDDSGNLKVADFGVSK 301
            +NIL    G LK+ADFG+++
Sbjct: 147 AANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 40/142 (28%), Positives = 78/142 (54%), Gaps = 23/142 (16%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF--------------LGAVTQS 222
           +VAVKK+   V++D   V+    E+ +++++ H N+V+               +G++T+ 
Sbjct: 32  RVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88

Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + + IV EY+ + DL   L+ +G L    A  F   + RG+ Y+H      ++HRDL+P+
Sbjct: 89  NSVYIVQEYM-ETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143

Query: 283 NIL-RDDSGNLKVADFGVSKLL 303
           N+    +   LK+ DFG+++++
Sbjct: 144 NVFINTEDLVLKIGDFGLARIV 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 44/132 (33%), Positives = 75/132 (56%), Gaps = 13/132 (9%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM---IVTEYLP 233
           VA+KK+ +   +  D  R FR E+  LQ++  HPN+V+ L  V ++       +V EY+ 
Sbjct: 35  VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYM- 91

Query: 234 KGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           + DL A + R   L+     R+ +  + + + Y+H      +IHRDL+PSNIL +    +
Sbjct: 92  ETDLHAVI-RANILED-VHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRV 146

Query: 293 KVADFGVSKLLT 304
           K+ADFG+++ L+
Sbjct: 147 KLADFGLARSLS 158

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 31/124 (25%), Positives = 62/124 (50%), Gaps = 7/124 (5%)

Query: 183 LGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYL---PKGDLR 238
            G++    D  +     E+ ++ +++RHPN+V++     ++  + IV + +   P G+  
Sbjct: 41  FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF 100

Query: 239 AFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
             LK K        +    + +   + YLH+ K   I+HRDL P+NI+  +   + + DF
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158

Query: 298 GVSK 301
           G++K
Sbjct: 159 GLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 3/124 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+KK+ ++ +   ++++    E  +L    +P VV    +      + +V EY+  GD  
Sbjct: 30  AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             LK  GAL    A  +  +    + YLH      I+HRDL+P N+L    G++K+ DFG
Sbjct: 90  TLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG 146

Query: 299 VSKL 302
           +SK+
Sbjct: 147 LSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 15/108 (13%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE-VVSLLLERGADVDPK 102
            +  ++E+  + ++ LL++G DVN  +    T LH+      T  V+ LL++ GADV+ K
Sbjct: 54  YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAK 113

Query: 103 DRWGSTPL-----GDAIYYKNHEVIKLLEKHGAKP------LMAPMHV 139
           D+ G TPL     G  I  K   VI+LL + GA         M P+ V
Sbjct: 114 DKVGRTPLHVYLSGFNINPK---VIRLLLRKGADVNALDLYGMTPLAV 158

Length = 471

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 40/137 (29%), Positives = 68/137 (49%), Gaps = 10/137 (7%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-----QSSPMMIVTEY 231
           +VA+KK+     +  D  R  R E+ LL+ + H NV+     +        + + IV E 
Sbjct: 32  KVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE- 89

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   DL   ++    L       F   + RG+ Y+H      ++HRDL+PSN+L + + +
Sbjct: 90  LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCD 146

Query: 292 LKVADFGVSKLLTVKED 308
           LK+ DFG+++  + K D
Sbjct: 147 LKICDFGLARTTSEKGD 163

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 45/143 (31%), Positives = 67/143 (46%), Gaps = 9/143 (6%)

Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGA 218
           KG+F    LA  +G     A+K L ++V+  DD V     E  +L     HP +      
Sbjct: 5   KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
                 +  V EYL  GDL   ++         A  +A +I  G+ +LH      I++RD
Sbjct: 65  FQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRD 121

Query: 279 LEPSNILRDDSGNLKVADFGVSK 301
           L+  NIL D  G++K+ADFG+ K
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 37/126 (29%), Positives = 69/126 (54%), Gaps = 8/126 (6%)

Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           AVK L ++++    +   + A R+   LL+ ++HP +V    +   +  +  V +++  G
Sbjct: 24  AVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           +L   L+R+ +     A  +A +IA  + YLH    + I++RDL+P NIL D  G++ + 
Sbjct: 82  ELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLT 138

Query: 296 DFGVSK 301
           DFG+ K
Sbjct: 139 DFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 9/156 (5%)

Query: 148 YEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAFRDELA 202
           Y+ DP E+ F    EI  G+F   ++         VAVKK+       +++ +    E+ 
Sbjct: 15  YKDDPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
            LQ+++HPN +++ G   +     +V EY            K  L+            +G
Sbjct: 74  FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + YLH +    +IHRD++  NIL  + G +K+ADFG
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 18/95 (18%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAA--CQGFTEVVSLLLERGADVDPKDR--------- 104
           ++ LLD+G +VN ++ D    LH+     +   +++ LL+++G D++ K+R         
Sbjct: 124 VEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRVNYLLSYGV 183

Query: 105 -------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
                  +G TPL  A+Y  N E +K L   GA P
Sbjct: 184 PINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANP 218

Length = 422

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 42/144 (29%), Positives = 73/144 (50%), Gaps = 20/144 (13%)

Query: 174 RGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVTQSS-----P 224
            G++VA+KK     IS  +      R  R E+ +L++ +H N++  L  +   S      
Sbjct: 29  TGVKVAIKK-----ISPFEHQTFCQRTLR-EIKILRRFKHENIIGILDIIRPPSFESFND 82

Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + IV E +   DL   +K +  L       F   I RG+ Y+H      ++HRDL+PSN+
Sbjct: 83  VYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNL 137

Query: 285 LRDDSGNLKVADFGVSKLLTVKED 308
           L + + +LK+ DFG++++   + D
Sbjct: 138 LLNTNCDLKICDFGLARIADPEHD 161

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 36/113 (31%), Positives = 63/113 (55%), Gaps = 14/113 (12%)

Query: 200 ELALLQKIR---HPNVVQFLGAVT-----QSSPMMIVTEYLPKGDLRAFLKRKGA--LKP 249
           E+ALL+++    HPN+V+ +         + + + +V E++ + DLR +L +     L  
Sbjct: 49  EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA 107

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++
Sbjct: 108 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 13/134 (9%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L +    +D    + LL  G +VN  D  N + LH A       +V +LLE GA  D +D
Sbjct: 172 LHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARD 231

Query: 104 RWGSTPLGDAI-YYKNHEVIKLLEKHG----AKPL---MAPMHVKHARE-----VPEYEI 150
           + G+TPL  ++ Y K+++++KLL +HG    AK     +  +H     E     + EY  
Sbjct: 232 KCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSSIKSERKLKLLLEYGA 291

Query: 151 DPHELDFTNSVEIT 164
           D + L+      ++
Sbjct: 292 DINSLNSYKLTPLS 305

Length = 477

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 43/129 (33%), Positives = 72/129 (55%), Gaps = 12/129 (9%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +A+KK+  E   +D+ V   A R E++LL++++H N+V+    V     + +V EYL   
Sbjct: 30  IALKKIRLE--QEDEGVPSTAIR-EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL- 85

Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-L 292
           DL+  +      A  P     +   I RG+ Y H ++   ++HRDL+P N+L D   N L
Sbjct: 86  DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNAL 142

Query: 293 KVADFGVSK 301
           K+ADFG+++
Sbjct: 143 KLADFGLAR 151

Length = 294

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 13/153 (8%)

Query: 151 DPHELDFTNSVEI---TKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP      N V+I   + G   +A  +  G QVAVKK+    +    R     +E+ +++
Sbjct: 16  DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMR 71

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
             +HPN+V+   +      + +V E+L  G L   +      +   A    L + + +++
Sbjct: 72  DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSF 130

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           LH      +IHRD++  +IL    G +K++DFG
Sbjct: 131 LHAQG---VIHRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 39/143 (27%), Positives = 61/143 (42%), Gaps = 30/143 (20%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
           VRA RD LA   +  +P VV+   +    + + ++ EYLP GD+   L +K         
Sbjct: 48  VRAERDILA---EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET- 103

Query: 254 RF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL--- 303
           RF       A+D    + Y         IHRD++P N+L D  G++K++DFG+   L   
Sbjct: 104 RFYIAETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154

Query: 304 -------TVKEDRPLTCQDTSCR 319
                   +    P    D   +
Sbjct: 155 HRTEFYRILSHALPSNFLDFISK 177

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 35/126 (27%), Positives = 64/126 (50%), Gaps = 6/126 (4%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           A+K L ++ I     V     E  +L +      P +V    +    S + +VT+Y+  G
Sbjct: 22  AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG 81

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           +L   L+++G      A  +  ++   + +LH+     I++RDL+P NIL D +G++ + 
Sbjct: 82  ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALC 138

Query: 296 DFGVSK 301
           DFG+SK
Sbjct: 139 DFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 27/75 (36%), Positives = 40/75 (53%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +  LL  G+ +N +D+   T LH A      E V  LL+ GA+ +  +++G TPL  AI 
Sbjct: 175 VNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAIL 234

Query: 116 YKNHEVIKLLEKHGA 130
             N E+ KLL  +G 
Sbjct: 235 NNNKEIFKLLLNNGP 249

Length = 422

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 6/106 (5%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
           V+A RD LA   +  +  VV+   +      +  V +Y+P GD+ + L R G  +   A 
Sbjct: 48  VKAERDILA---EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR 104

Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
            +  ++   +  +H+   +  IHRD++P NIL D  G++K+ DFG+
Sbjct: 105 FYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 8/103 (7%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFLKRKGALKPSTAVRFAL 257
           E  +L+ I HP+++Q  G  T +    ++   LP  K DL  +L  K  +     +    
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            + R + YLHEN+   IIHRD++  NI  +  G++ + DFG +
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 3/70 (4%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L  +  +  D   A   EL +L  + +H N+V  LGA T   P++++TEY   
Sbjct: 69  LRVAVKML--KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126

Query: 235 GDLRAFLKRK 244
           GDL  FL++K
Sbjct: 127 GDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 19/141 (13%)

Query: 175 GIQVAVKKLGEEVISD-DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-----PMMI 227
           G   AVK L  + ISD D+ + A   E  +LQ +  HPNVV+F G   ++       + +
Sbjct: 47  GSLAAVKIL--DPISDVDEEIEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101

Query: 228 VTEYLPKGD----LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           V E    G     ++  L     L  +           G+ +LH N+   IIHRD++ +N
Sbjct: 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNN 158

Query: 284 ILRDDSGNLKVADFGVSKLLT 304
           IL    G +K+ DFGVS  LT
Sbjct: 159 ILLTTEGGVKLVDFGVSAQLT 179

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 54.4 bits (130), Expect = 1e-08
 Identities = 32/77 (41%), Positives = 42/77 (54%), Gaps = 3/77 (3%)

Query: 56  IKELLDSGI--DVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
            K LL++G   DVN   D D  T LH AA  G  ++V LLLE GAD + ++ +G T L  
Sbjct: 127 AKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDP 186

Query: 113 AIYYKNHEVIKLLEKHG 129
           A      E++KLL   G
Sbjct: 187 AAKNGRIELVKLLLDKG 203

Length = 235

>gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 2/96 (2%)

Query: 32  DDDGEEIKP--EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
           D+ GE   P     L+ +A+  +   ++ELL + +D +  D   RT LH+AA +G+ + V
Sbjct: 515 DNGGEHDDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCV 574

Query: 90  SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
            +LL+   +V  +D  G+T L +AI  K+H++ ++L
Sbjct: 575 LVLLKHACNVHIRDANGNTALWNAISAKHHKIFRIL 610

Length = 823

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 33/138 (23%), Positives = 69/138 (50%), Gaps = 7/138 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K++    +    +     +E+ ++++ +HPN+V +L +      + +V EYL  
Sbjct: 44  GQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +  +  +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 101 GSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156

Query: 295 ADFGVSKLLTVKEDRPLT 312
            DFG    +T ++ +  T
Sbjct: 157 TDFGFCAQITPEQSKRST 174

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 20/156 (12%)

Query: 163 ITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
           I KGT+     +L    G + AVK L + +   D+ + A  + L  L    HPNVV+F G
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSD--HPNVVKFYG 82

Query: 218 A-----VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
                 V     + +V E    G +    + FLKR   ++         +   G+ +LH 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142

Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           NK    IHRD++ +NIL    G +K+ DFGVS  LT
Sbjct: 143 NK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 32/131 (24%), Positives = 67/131 (51%), Gaps = 4/131 (3%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK  +   +++ +    R EL +L+ ++  N+V+   A  +   + +V EY+ K  L
Sbjct: 29  VAIKKFKDSEENEEVKETTLR-ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
               +    + P     +   + + +++ H+N    I+HRD++P N+L   +  LK+ DF
Sbjct: 88  ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDF 144

Query: 298 GVSKLLTVKED 308
           G ++ L+   +
Sbjct: 145 GFARNLSEGSN 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 1e-08
 Identities = 28/97 (28%), Positives = 55/97 (56%), Gaps = 7/97 (7%)

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV----RFALDIARG 262
           ++HPN++Q LG   ++ P ++V EY   GDL+++L ++   + ++ +    R A +IA G
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
           + ++H++     +H DL   N        +KV D+G+
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFL-KRKGALKPSTAVRFA 256
           E  LLQ + HP+V++    +   +   +V   LP    DL  +L KR   L    A+   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
             I  G+ YLH  +   IIHRD++  NI  +D   + + D G ++
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 38/142 (26%), Positives = 70/142 (49%), Gaps = 14/142 (9%)

Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
           ++G  V   +L    + D   D     + E+ +L+K   H N+  + GA  + +P     
Sbjct: 23  YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82

Query: 225 -MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
            + +V E+   G +   +K  +   LK         +I RG+++LH++K   +IHRD++ 
Sbjct: 83  QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKG 139

Query: 282 SNILRDDSGNLKVADFGVSKLL 303
            N+L  ++  +K+ DFGVS  L
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQL 161

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 31/83 (37%), Positives = 46/83 (55%), Gaps = 7/83 (8%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFT-----EVVSLLLERGADVDPKDRWGSTPL 110
           +K LLD+G D+N    +N T LH  +   +      E+V LLLE GA+V+  D  G TPL
Sbjct: 51  VKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPL 110

Query: 111 GDAIYYK--NHEVIKLLEKHGAK 131
             AI  K  ++ +++ L  +GA 
Sbjct: 111 LYAISKKSNSYSIVEYLLDNGAN 133

Length = 422

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 4/96 (4%)

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE 268
           P +V+  G     S + I  E L    L   LKR +G +      +  + I + ++YL E
Sbjct: 74  PYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132

Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
              V  IHRD++PSNIL D SGN+K+ DFG+S  L 
Sbjct: 133 KHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLV 166

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 10/132 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY--- 231
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T    +    ++   
Sbjct: 40  GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98

Query: 232 LP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +P    DL   +K +  L           + +G+ Y+H      IIHRDL+P N+  ++ 
Sbjct: 99  MPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNED 154

Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 155 CELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 30/115 (26%), Positives = 62/115 (53%), Gaps = 7/115 (6%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFAL 257
           E  +L+K+  P +V    A    + + +V   +  GDL+  +   G   L+    + ++ 
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
            I  G+ +LH    + I++RD++P N+L DD GN +++D G++  + +K+ + +T
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTIT 152

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.0 bits (129), Expect = 3e-08
 Identities = 31/135 (22%), Positives = 69/135 (51%), Gaps = 7/135 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K++    +    +     +E+ +++++++PN+V FL +      + +V EYL  
Sbjct: 44  GQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +  +       +  + + +LH N+   +IHRD++  N+L    G++K+
Sbjct: 101 GSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156

Query: 295 ADFGVSKLLTVKEDR 309
            DFG    +T ++ +
Sbjct: 157 TDFGFCAQITPEQSK 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 42/142 (29%), Positives = 71/142 (50%), Gaps = 14/142 (9%)

Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
           ++G  V   +L    + D  +D     + E+ +L+K   H N+  + GA  + SP     
Sbjct: 33  YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92

Query: 225 -MMIVTEYLPKGDLRAFLKR-KG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
            + +V E+   G +   +K  KG ALK         +I RG+ +LH +K   +IHRD++ 
Sbjct: 93  QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKG 149

Query: 282 SNILRDDSGNLKVADFGVSKLL 303
            N+L  ++  +K+ DFGVS  L
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQL 171

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 41/130 (31%), Positives = 64/130 (49%), Gaps = 10/130 (7%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY----- 231
           +VAVKKL     S     R +R EL LL+ ++H NV+  L   T ++ +    E      
Sbjct: 42  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   DL   +K +  L           + RG+ Y+H      IIHRDL+PSN+  ++   
Sbjct: 101 LMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCE 156

Query: 292 LKVADFGVSK 301
           L++ DFG+++
Sbjct: 157 LRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 6/103 (5%)

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF- 255
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       P    +F 
Sbjct: 90  FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFY 147

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             ++   ++ +H    + +IHRD++P N+L D  G+LK+ADFG
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 50.5 bits (121), Expect = 5e-08
 Identities = 25/50 (50%), Positives = 30/50 (60%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
           L   A   +++ +K LL  G DVN RD D RT LH+AA  G  EVV LLL
Sbjct: 77  LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 37/128 (28%), Positives = 64/128 (50%), Gaps = 5/128 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A KKL ++ I          +E  +L+K+    VV    A      + +V   +  
Sbjct: 25  GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84

Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL+  +   G    +   AV +A +I  G+  LH+ +   I++RDL+P NIL DD G++
Sbjct: 85  GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHI 141

Query: 293 KVADFGVS 300
           +++D G++
Sbjct: 142 RISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat

 Score = 47.9 bits (115), Expect = 5e-08
 Identities = 19/33 (57%), Positives = 23/33 (69%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104
           D  T LH+AA  G  EVV LLLE GADV+ +D+
Sbjct: 1   DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 44/137 (32%), Positives = 64/137 (46%), Gaps = 21/137 (15%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           GI VAVKKL     +     RA+R EL LL+ + H N++  L   T   P   + E+   
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKSLEEF--- 98

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 284
            D+   ++   A      +   LD  R          G+ +LH      IIHRDL+PSNI
Sbjct: 99  QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 154

Query: 285 LRDDSGNLKVADFGVSK 301
           +      LK+ DFG+++
Sbjct: 155 VVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 37/107 (34%), Positives = 51/107 (47%), Gaps = 14/107 (13%)

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       K A   + 
Sbjct: 90  FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
            V  ALD    M +         IHRD++P N+L D SG+LK+ADFG
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 52.5 bits (126), Expect = 7e-08
 Identities = 33/124 (26%), Positives = 64/124 (51%), Gaps = 5/124 (4%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A KKL ++ +      +   +E  +L+K+    +V    A      + +V   +  GDL+
Sbjct: 22  ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81

Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
             +   G      + A+ +A  I  G+ +LH+ +   I++RDL+P N+L DD GN++++D
Sbjct: 82  YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISD 138

Query: 297 FGVS 300
            G++
Sbjct: 139 LGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 7/119 (5%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E  +L ++  P +V    +      + +V  ++  G+L   L+R+G    S A  +  ++
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
              +  LH+     +I+RDL+P NIL D  G++ + DFG+ KL    +D+     +T C
Sbjct: 103 LCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK----TNTFC 154

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 6/107 (5%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
           V+A RD LA   +   P VV    +   +  + ++ E+LP GDL   L +          
Sbjct: 48  VKAERDVLA---ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR 104

Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            +  +    +  +H+   +  IHRD++P NIL D  G++K++DFG+S
Sbjct: 105 FYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 5/128 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A KKL ++ I          +E  +L+K+    VV    A      + +V   +  
Sbjct: 25  GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84

Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL+  +   G        AV +A +I  G+  LH  +   I++RDL+P NIL DD G++
Sbjct: 85  GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHI 141

Query: 293 KVADFGVS 300
           +++D G++
Sbjct: 142 RISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 44/128 (34%), Positives = 61/128 (47%), Gaps = 4/128 (3%)

Query: 8   RTTLLKQSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLA-NERDVEGIKELLDSGI 64
           + T L  +S AP   R   +L   G D + + IK E  L  +A N  D E I+ L+  G 
Sbjct: 273 KNTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGA 332

Query: 65  DVNFRDIDNRTALHVAAC-QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           DVN  D    T LH A+      ++V  LLE GA+V+ +D    TP+  A    N  +I 
Sbjct: 333 DVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIIN 392

Query: 124 LLEKHGAK 131
            L  +GA 
Sbjct: 393 TLLDYGAD 400

Length = 682

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 51.3 bits (122), Expect = 2e-07
 Identities = 31/135 (22%), Positives = 68/135 (50%), Gaps = 7/135 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 44  GQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + +++LH N+   +IHRD++  NIL    G++K+
Sbjct: 101 GSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156

Query: 295 ADFGVSKLLTVKEDR 309
            DFG    +T ++ +
Sbjct: 157 TDFGFCAQITPEQSK 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 31/121 (25%), Positives = 62/121 (51%), Gaps = 3/121 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  + + ++V   R E  +L +     VV+   +      + ++ E+LP GD+ 
Sbjct: 30  AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L +K  L       +  +    ++ +H+   +  IHRD++P N+L D  G++K++DFG
Sbjct: 90  TLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFG 146

Query: 299 V 299
           +
Sbjct: 147 L 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 31/121 (25%), Positives = 62/121 (51%), Gaps = 3/121 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  + + ++V   R E  +L +     VV+   +      + ++ E+LP GD+ 
Sbjct: 30  AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMM 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L +K  L       +  +    ++ +H+   +  IHRD++P N+L D  G++K++DFG
Sbjct: 90  TLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFG 146

Query: 299 V 299
           +
Sbjct: 147 L 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 31/121 (25%), Positives = 62/121 (51%), Gaps = 3/121 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ + + ++V   + E  +L +  +  VV+   +      +  V +Y+P GD+ 
Sbjct: 30  AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L R        A  +  ++   +  +H+   +  IHRD++P NIL D  G++K+ DFG
Sbjct: 90  SLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFG 146

Query: 299 V 299
           +
Sbjct: 147 L 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 32/121 (26%), Positives = 62/121 (51%), Gaps = 3/121 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ +   ++V   + E  +L +  +  VV+   +      +  V +Y+P GD+ 
Sbjct: 30  AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L R G      A  +  ++   +  +H+   +  IHRD++P NIL D  G++K+ DFG
Sbjct: 90  SLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG 146

Query: 299 V 299
           +
Sbjct: 147 L 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 5/128 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A K+L ++ I          +E  +L+K+    VV    A      + +V   +  
Sbjct: 25  GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84

Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL+  +   G    +   A+ +A +I  G+  LH       ++RDL+P NIL DD G++
Sbjct: 85  GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHI 141

Query: 293 KVADFGVS 300
           +++D G++
Sbjct: 142 RISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 42/134 (31%), Positives = 69/134 (51%), Gaps = 15/134 (11%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 228
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T +          +V
Sbjct: 40  GEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             Y+ + DL+   K  G       V++ +  +  G+ Y+H      IIHRDL+P N+  +
Sbjct: 99  MPYM-QTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151

Query: 288 DSGNLKVADFGVSK 301
           +   LK+ DFG+++
Sbjct: 152 EDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 46.5 bits (111), Expect = 2e-07
 Identities = 26/53 (49%), Positives = 32/53 (60%)

Query: 73  NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
            RTALH AA  G  E+V  LLE+G D++  D  G+T L  A    N EV+KLL
Sbjct: 1   GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLL 53

Length = 54

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 30/142 (21%)

Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229
              VA+KK+     +++++     RA R EL LL+  R H N+            M IV 
Sbjct: 27  EETVAIKKITNVFSKKILAK----RALR-ELKLLRHFRGHKNITCLYD-------MDIVF 74

Query: 230 ----------EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
                     E L + DL   ++    L  +    F   I  G+ Y+H      ++HRDL
Sbjct: 75  PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDL 131

Query: 280 EPSNILRDDSGNLKVADFGVSK 301
           +P N+L +    LK+ DFG+++
Sbjct: 132 KPGNLLVNADCELKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 46.1 bits (110), Expect = 3e-07
 Identities = 23/50 (46%), Positives = 30/50 (60%)

Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
          L   A    +E +K LL+ G+D+N  D D  TALH+AA  G  EV+ LLL
Sbjct: 5  LHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54

Length = 54

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 31/123 (25%), Positives = 60/123 (48%), Gaps = 14/123 (11%)

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
           AF +  +L+ ++ H ++V+  G V      ++V EY+  G L  FL R+     S   + 
Sbjct: 47  AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKN-NVSLHWKL 104

Query: 256 --ALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGN---LKVADFGVSKLLTVK 306
             A  +A  ++YL + K   ++H ++   NIL      + G    +K++D G+   +  +
Sbjct: 105 DVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161

Query: 307 EDR 309
           E+R
Sbjct: 162 EER 164

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 43/139 (30%), Positives = 62/139 (44%), Gaps = 23/139 (16%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232
            G  VA+KKL     +     RA+R EL L++ + H N++  L   T Q S       YL
Sbjct: 40  TGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPS 282
               + A L           ++  LD  R          G+ +LH      IIHRDL+PS
Sbjct: 99  VMELMDANL--------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147

Query: 283 NILRDDSGNLKVADFGVSK 301
           NI+      LK+ DFG+++
Sbjct: 148 NIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 30/111 (27%), Positives = 57/111 (51%), Gaps = 4/111 (3%)

Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           R E  +L+ +R  P +V    A    + + ++ +Y+  G+L   L ++     S    + 
Sbjct: 52  RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
            +I   +++LH+     II+RD++  NIL D  G++ + DFG+SK    +E
Sbjct: 112 AEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 7/124 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G QVAVKK+    +    R     +E+ +++   H NVV    +      + +V E+L  
Sbjct: 47  GKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +      +   A    L + R ++YLH      +IHRD++  +IL    G +K+
Sbjct: 104 GALTDIVTHTRMNEEQIAT-VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159

Query: 295 ADFG 298
           +DFG
Sbjct: 160 SDFG 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 49.4 bits (117), Expect = 5e-07
 Identities = 39/97 (40%), Positives = 55/97 (56%), Gaps = 8/97 (8%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-----CQGFTEVVSLLLERGAD 98
           L   A++ D + +K LL SG DVN +D D  T LH+AA      +G  EV  LLLE GAD
Sbjct: 77  LHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGAD 136

Query: 99  VDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           +D  +     G+TPL  A    + ++++LL + GA P
Sbjct: 137 LDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADP 173

Length = 235

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 29/123 (23%), Positives = 60/123 (48%), Gaps = 8/123 (6%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVKK+  +     + ++  + E+   ++++HPN++ ++ +    S + +V+  +  G  
Sbjct: 28  VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86

Query: 238 RAFLKR--KGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
              LK      L P  A+ F L D+   ++Y+H       IHR ++ S+IL    G + +
Sbjct: 87  EDLLKTHFPEGL-PELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVL 142

Query: 295 ADF 297
           +  
Sbjct: 143 SGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies)

 Score = 45.8 bits (109), Expect = 5e-07
 Identities = 20/47 (42%), Positives = 28/47 (59%)

Query: 64  IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           ID+N  D +  T LH+AA  G  E+V  LL+ G D++ +D  G T L
Sbjct: 7   IDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53

Length = 56

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 49.7 bits (118), Expect = 6e-07
 Identities = 30/135 (22%), Positives = 67/135 (49%), Gaps = 7/135 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 45  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157

Query: 295 ADFGVSKLLTVKEDR 309
            DFG    +T ++ +
Sbjct: 158 TDFGFCAQITPEQSK 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 32/126 (25%), Positives = 59/126 (46%), Gaps = 7/126 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A KKL ++ +           E  +L K+    +V    A    + + +V   +  GDLR
Sbjct: 22  ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81

Query: 239 AFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
             +    +         A  +   I  G+ +LH+ +   II+RDL+P N+L D+ GN+++
Sbjct: 82  YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRI 138

Query: 295 ADFGVS 300
           +D G++
Sbjct: 139 SDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 23/57 (40%), Positives = 32/57 (56%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
           L   A   D+  +KELL  G++V+  D    TAL VA  +   ++V LL+  GADVD
Sbjct: 626 LCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVD 682

Length = 823

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 14/94 (14%)

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMN 264
             +VQ   A      + +V EY+P GDL   +       K A   +  V  ALD    M 
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           +         IHRD++P N+L D SG+LK+ADFG
Sbjct: 163 F---------IHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 23/82 (28%), Positives = 42/82 (51%)

Query: 51  RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           + ++ +K L+  G D +  + D  + LH+A   G  + + LL++  A +D +D  G TPL
Sbjct: 113 KKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPL 172

Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
             A+   +  + K+L   GA  
Sbjct: 173 IIAMAKGDIAICKMLLDSGANI 194

Length = 413

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 1/80 (1%)

Query: 52  DVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           + E  K LL  G D+N +D     TALH A       +  LLL  GA+V+  D+  ++PL
Sbjct: 146 EAEITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPL 205

Query: 111 GDAIYYKNHEVIKLLEKHGA 130
             A+ + N  ++ +L ++GA
Sbjct: 206 HHAVKHYNKPIVHILLENGA 225

Length = 477

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 17/191 (8%)

Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELD-------FTNSVEITKGTFILAFWRG 175
           +  EK+ A   + P   K   ++PE E  P   +        T  V     T      RG
Sbjct: 32  EAFEKYCAD--LDPEAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRG 89

Query: 176 IQVAVKKLGEEVISDDDRVRAF-RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
                K + + V+ +D+R  A+ R EL  L    H  +V+          ++++ EY   
Sbjct: 90  SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149

Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           GDL    +  LK     +          I   ++ +H  K   ++HRDL+ +NI    +G
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTG 206

Query: 291 NLKVADFGVSK 301
            +K+ DFG SK
Sbjct: 207 IIKLGDFGFSK 217

Length = 478

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 6/112 (5%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           E+ +L+ I H  ++  + A    S + M++ +Y  K DL  ++ R G L    A+     
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDRSGPLPLEQAITIQRR 193

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
           +   + YLH      IIHRD++  NI  D+  N  + DFG +  L    D P
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242

Length = 392

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 5/128 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A KKL ++ I          +E  +L+K+    VV    A      + +V   +  
Sbjct: 25  GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84

Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL+  +   G        A+ +A ++  G+  L   +   I++RDL+P NIL DD G++
Sbjct: 85  GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHI 141

Query: 293 KVADFGVS 300
           +++D G++
Sbjct: 142 RISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 47.5 bits (112), Expect = 3e-06
 Identities = 34/98 (34%), Positives = 45/98 (45%), Gaps = 5/98 (5%)

Query: 40  PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
             +  + L     +  +   L     +  RD+D R  LH AA +G  ++V LLL  GADV
Sbjct: 40  NLYLELALLPAASLSELLLKLIVDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGADV 99

Query: 100 DPKDRWGSTPLGDAIYYKN-----HEVIKLLEKHGAKP 132
           + KD  G TPL  A    N      EV KLL + GA  
Sbjct: 100 NAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADL 137

Length = 235

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 40/104 (38%), Positives = 55/104 (52%), Gaps = 5/104 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANER---DVEGIKE-LLDSGIDVNFRDIDNRTALHV 79
           KEA ++G D   ++I      M L  ER   D   I E LL+ G DVN +DI   T +H 
Sbjct: 126 KEA-ISGNDIHYDKINESIEYMKLIKERIQQDELLIAEMLLEGGADVNAKDIYCITPIHY 184

Query: 80  AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           AA +G  ++V+LLL  GADV+       + L  A+  KN + IK
Sbjct: 185 AAERGNAKMVNLLLSYGADVNIIALDDLSVLECAVDSKNIDTIK 228

Length = 682

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.8 bits (113), Expect = 3e-06
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKSLEEF---QDV 97

Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 98  YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 153

Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 154 SDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 32/118 (27%), Positives = 57/118 (48%), Gaps = 6/118 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  V V+    E  +++  ++A ++E+ L    RHPN++      T  S + +++ ++  
Sbjct: 25  GTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83

Query: 235 GDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           G   + LK       S A+         RG+NYLH+N     IHR+++ S+IL    G
Sbjct: 84  GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDG 138

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 34/125 (27%), Positives = 63/125 (50%), Gaps = 11/125 (8%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--MMIVTEYLPK 234
            A+K + ++     ++V   R E+  L+++  HPN+++ +  +       + +V E L  
Sbjct: 27  YAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMD 83

Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            +L   +K RK  L       +   + + ++++H N    I HRD++P NIL  D   LK
Sbjct: 84  MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILK 139

Query: 294 VADFG 298
           +ADFG
Sbjct: 140 LADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 40/135 (29%), Positives = 63/135 (46%), Gaps = 21/135 (15%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
            VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QD 103

Query: 237 LRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILR 286
           +   ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+ 
Sbjct: 104 VYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVV 159

Query: 287 DDSGNLKVADFGVSK 301
                LK+ DFG+++
Sbjct: 160 KSDCTLKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.7 bits (111), Expect = 6e-06
 Identities = 37/168 (22%), Positives = 78/168 (46%), Gaps = 19/168 (11%)

Query: 150 IDPHELDFTNSVEITKGT--FILAFWRGI----QVAVKKLGEEVISDDDRVRAFRDELAL 203
           I+  ++D   SV I +     I   ++GI    +V ++   +        +    +E+  
Sbjct: 15  IESDDIDKYTSVLIKENDQNSI---YKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKN 71

Query: 204 LQKIRHPNVVQFLG---AVTQSSP-MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           L++I   N+++  G    +    P + ++ EY  +G LR  L ++  L   T +  A+D 
Sbjct: 72  LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDC 131

Query: 260 ARGMNYLHE--NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
            +G+  L++  NKP    +++L   + L  ++  LK+   G+ K+L+ 
Sbjct: 132 CKGLYNLYKYTNKP----YKNLTSVSFLVTENYKLKIICHGLEKILSS 175

Length = 283

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 46.2 bits (109), Expect = 9e-06
 Identities = 38/119 (31%), Positives = 63/119 (52%), Gaps = 19/119 (15%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
           E+ALL++++HPNV+         S   + ++ +Y  + DL   +K   A K        P
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106

Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLL 303
            + V+  L  I  G++YLH N    ++HRDL+P+NIL      + G +K+AD G ++L 
Sbjct: 107 RSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 2/79 (2%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTE--VVSLLLERGADVDPKDRWGSTPLGDA 113
           ++EL+ +G D    D+   T LH  A     +  +V  LL  G  ++ ++R+G TPL  A
Sbjct: 205 VRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYA 264

Query: 114 IYYKNHEVIKLLEKHGAKP 132
             + N    + L   GA  
Sbjct: 265 AVFNNPRACRRLIALGADI 283

Length = 471

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 25/94 (26%), Positives = 50/94 (53%), Gaps = 4/94 (4%)

Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
           +PN ++   +VT     +++ +Y+  GDL   LK++G L  +   +    +   +N LH+
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 269 NKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSK 301
           +    IIH D++  N+L D +   + + D+G+ K
Sbjct: 128 HN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 28/163 (17%)

Query: 150 IDPHELDFTNSVEITKGTFIL-------AFWR--------------GIQVAVKKLGEEVI 188
           +DP +L + ++ E+ +   +L       AF R               ++VAVK L     
Sbjct: 21  VDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR 80

Query: 189 SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
           S + +  A   EL ++  +  H N+V  LGA T+  P+ I+TEY   GDL  +L R    
Sbjct: 81  SSEKQ--ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR---- 134

Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
              T +++ LD  R    L      P+  R    S     D G
Sbjct: 135 NKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG 177

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 30/105 (28%), Positives = 57/105 (54%), Gaps = 4/105 (3%)

Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           R E  +L+ IR  P +V    A    + + ++ +Y+  G+L   L ++   K      ++
Sbjct: 52  RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            +I   + +LH+   + II+RD++  NIL D +G++ + DFG+SK
Sbjct: 112 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 22/66 (33%), Positives = 42/66 (63%), Gaps = 3/66 (4%)

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           GDL   L + G    +    +A +I  G+ ++H N+ V  ++RDL+P+NIL D+ G++++
Sbjct: 82  GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NRFV--VYRDLKPANILLDEHGHVRI 138

Query: 295 ADFGVS 300
           +D G++
Sbjct: 139 SDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 13/99 (13%)

Query: 44  LMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ--GFTEVVSLLLERG 96
           L +L+N         E +K LL+ G +VN  D +  T L  A  +      +V  LL+ G
Sbjct: 72  LHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNG 131

Query: 97  ADVDPKDRWGSTPLGDAIY----YKNHEVIKLLEKHGAK 131
           A+V+ K+  G   L   +Y      + +++KLL   G  
Sbjct: 132 ANVNIKNSDGENLL--HLYLESNKIDLKILKLLIDKGVD 168

Length = 422

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 26/103 (25%), Positives = 52/103 (50%), Gaps = 3/103 (2%)

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           R  L+L+     P +V    A      +  + + +  GDL   L + G         +A 
Sbjct: 45  RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT 104

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           +I  G+ ++H      +++RDL+P+NIL D+ G+++++D G++
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 29/103 (28%), Positives = 53/103 (51%), Gaps = 4/103 (3%)

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           FR+E  +L    +  +     A    + + +V +Y   GDL   L +     P    RF 
Sbjct: 48  FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107

Query: 257 L-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           L ++   ++ +H+   +  +HRD++P NIL D +G++++ADFG
Sbjct: 108 LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 4/69 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-PMMIVTEYLPKG 235
           VAVK L E   + + +  A   EL +L  I  H NVV  LGA T+   P+M++ EY   G
Sbjct: 40  VAVKMLKEGATASEYK--ALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFG 97

Query: 236 DLRAFLKRK 244
           +L  +L+ K
Sbjct: 98  NLSNYLRSK 106

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 19/119 (15%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
           E+ALL++++HPNV+         +   + ++ +Y  + DL   +K   A K        P
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106

Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLL 303
              V+  L  I  G++YLH N    ++HRDL+P+NIL      + G +K+AD G ++L 
Sbjct: 107 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 20/61 (32%), Positives = 29/61 (47%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
           LL +GI +N R+   +T LH AA          L+  GAD++     G+TPL   +   N
Sbjct: 243 LLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTPLSLMVRNNN 302

Query: 119 H 119
            
Sbjct: 303 G 303

Length = 471

>gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat

 Score = 39.5 bits (93), Expect = 4e-05
 Identities = 16/29 (55%), Positives = 20/29 (68%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVD 100
           D  T LH+AA  G  E+V LLLE GAD++
Sbjct: 1   DGNTPLHLAARNGNLELVKLLLEHGADIN 29

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 32/85 (37%), Positives = 42/85 (49%), Gaps = 5/85 (5%)

Query: 51  RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA---DVDPKDRWGS 107
           RD E IK L+  G   + +  D  + LH A  +G  + V  LL+ G    DV  KD  G 
Sbjct: 46  RDSEAIKLLMKHGAIPDVKYPDIESELHDAVEEGDVKAVEELLDLGKFADDVFYKD--GM 103

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
           TPL  A   K  +++KLL   GA P
Sbjct: 104 TPLHLATILKKLDIMKLLIARGADP 128

Length = 413

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 3/68 (4%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           VAVK L       +    A   EL +L  +  H N+V  LGA T   P +++TEY   GD
Sbjct: 68  VAVKMLKPSAHLTERE--ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125

Query: 237 LRAFLKRK 244
           L  FL+RK
Sbjct: 126 LLNFLRRK 133

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|197603 smart00248, ANK, ankyrin repeats

 Score = 39.1 bits (92), Expect = 6e-05
 Identities = 17/29 (58%), Positives = 22/29 (75%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVD 100
           D RT LH+AA  G  EVV LLL++GAD++
Sbjct: 1   DGRTPLHLAAENGNLEVVKLLLDKGADIN 29

Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 6e-05
 Identities = 23/73 (31%), Positives = 42/73 (57%), Gaps = 4/73 (5%)

Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +V +Y   GDL   L +     P    RF L ++   ++ +H+   +  +HRD++P N+L
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVL 134

Query: 286 RDDSGNLKVADFG 298
            D +G++++ADFG
Sbjct: 135 LDKNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 28/114 (24%), Positives = 61/114 (53%), Gaps = 5/114 (4%)

Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           R E  +L+ +R  P +V    A    + + ++ +Y+  G++   L ++          ++
Sbjct: 52  RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDR 309
            +I   + +LH+   + I++RD++  NIL D  G++ + DFG+SK  L+ +++R
Sbjct: 112 GEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)

Query: 151 DPHELDFTNSVEITKG-TFILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP  L   N ++I +G T I+   R    G QVAVK +    +    R     +E+ +++
Sbjct: 18  DPRSL-LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 73

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
             +H NVV+   +      + ++ E+L  G L   + +   L           + + + Y
Sbjct: 74  DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCY 132

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           LH      +IHRD++  +IL    G +K++DFG
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFG 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 11/106 (10%)

Query: 49  NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WG 106
           N R+VE  K +L +    N + ID       +       E+  LLL  GAD++ KDR  G
Sbjct: 110 NNRNVEIFKIILTNRYK-NIQTIDLVYIDKKSKDDIIEAEITKLLLSYGADINMKDRHKG 168

Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKPLM------APMH--VKHARE 144
           +T L  A   K+  + +LL  +GA   +      +P+H  VKH  +
Sbjct: 169 NTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNK 214

Length = 477

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 50  ERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
           E DV+ ++ELLD G    DV ++D    T LH+A      +++ LL+ RGAD D  +   
Sbjct: 78  EGDVKAVEELLDLGKFADDVFYKD--GMTPLHLATILKKLDIMKLLIARGADPDIPNTDK 135

Query: 107 STPLGDAIYYKNHEVIKLLEKHGA 130
            +PL  A+   + + I+LL  H A
Sbjct: 136 FSPLHLAVMMGDIKGIELLIDHKA 159

Length = 413

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 28/73 (38%), Positives = 37/73 (50%), Gaps = 1/73 (1%)

Query: 39  KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-CQGFTEVVSLLLERGA 97
           K +  L+      D+E    L D+G  VN  D    T LH A+     + +V  LLERGA
Sbjct: 239 KNDLSLLKAIRNEDLETSLLLYDAGFSVNSIDDCKNTPLHHASQAPSLSRLVPKLLERGA 298

Query: 98  DVDPKDRWGSTPL 110
           DV+ K+  G TPL
Sbjct: 299 DVNAKNIKGETPL 311

Length = 682

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 4/69 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E   + + +  A   EL +L  I  H NVV  LGA T+ + P+M++ E+   G
Sbjct: 40  VAVKMLKEGATASEHK--ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97

Query: 236 DLRAFLKRK 244
           +L  FL+ K
Sbjct: 98  NLSNFLRAK 106

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 27/69 (39%), Positives = 37/69 (53%), Gaps = 4/69 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 40  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 97

Query: 236 DLRAFLKRK 244
           +L  +L+ K
Sbjct: 98  NLSNYLRSK 106

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 32/124 (25%), Positives = 58/124 (46%), Gaps = 7/124 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VAVKK+    +    R     +E+ +++  +H NVV+   +      + +V E+L  
Sbjct: 45  GKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +      +   A    L + + ++ LH      +IHRD++  +IL    G +K+
Sbjct: 102 GALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157

Query: 295 ADFG 298
           +DFG
Sbjct: 158 SDFG 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 3/69 (4%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     S + +  A   EL ++  +  H N+V  LGA T+S P+ I+TEY   
Sbjct: 68  MKVAVKMLKPTARSSEKQ--ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFY 125

Query: 235 GDLRAFLKR 243
           GDL  +L +
Sbjct: 126 GDLVNYLHK 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 23/75 (30%), Positives = 42/75 (56%), Gaps = 4/75 (5%)

Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSN 283
           + +V +Y   GDL   L +     P    RF + ++   ++ +H+   V   HRD++P N
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV---HRDIKPDN 132

Query: 284 ILRDDSGNLKVADFG 298
           +L D +G++++ADFG
Sbjct: 133 VLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 3/47 (6%)

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           ++  +ARGM +L   K    IHRDL   NIL  ++  +K+ DFG+++
Sbjct: 178 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 7/79 (8%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAA---CQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
           +K L+D G +VN ++ D  T LH A    C+   +V+ +LL+ GADV+  +     PL  
Sbjct: 425 VKTLIDRGANVNSKNKDLSTPLHYACKKNCK--LDVIEMLLDNGADVNAINIQNQYPLLI 482

Query: 113 AIYYKNHEVIKLLEKHGAK 131
           A+ Y  H ++ +L  +GA+
Sbjct: 483 ALEY--HGIVNILLHYGAE 499

Length = 682

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 3/47 (6%)

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           ++  +ARGM +L   K    IHRDL   NIL  ++  +K+ DFG+++
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 39.8 bits (93), Expect = 8e-04
 Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 3/89 (3%)

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           PN+V     +     + +V ++   G L + + +   +      R+A ++   ++ LH  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFG 298
               I+ RDL P+NIL DD G++++  F 
Sbjct: 105 G---IVCRDLNPNNILLDDRGHIQLTYFS 130

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165256 PHA02946, PHA02946, ankyin-like protein; Provisional

 Score = 40.4 bits (94), Expect = 9e-04
 Identities = 34/89 (38%), Positives = 46/89 (51%), Gaps = 13/89 (14%)

Query: 49  NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
           +ER VE   ELL  G   N  D D    LH+A+      +V++LL  GAD +  D+   T
Sbjct: 51  DERFVE---ELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKT 107

Query: 109 PLGDAIYY---KNHEVIK---LLEKHGAK 131
           PL    YY    + EVI+   LL ++GAK
Sbjct: 108 PL----YYLSGTDDEVIERINLLVQYGAK 132

Length = 446

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 4/79 (5%)

Query: 52  DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           D + +K LL+ G+DVN +  I   TALH +        + LLLE GAD++  + +  TPL
Sbjct: 247 DYDILKLLLEHGVDVNAKSYILGLTALHSSIKS--ERKLKLLLEYGADINSLNSYKLTPL 304

Query: 111 GDAIY-YKNHEVIKLLEKH 128
             A+  Y    + ++L  +
Sbjct: 305 SSAVKQYLCINIGRILISN 323

Length = 477

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 7/96 (7%)

Query: 50  ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
           +R+ + +  LL+ G +VN RD  ++T +H AA +    +++ LL+ GAD++   +   T 
Sbjct: 352 DRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTA 411

Query: 110 LGDAIYYKN-HEVIKLLEKHGA------KPLMAPMH 138
           L  A+   N +  +K L   GA      K L  P+H
Sbjct: 412 LHFALCGTNPYMSVKTLIDRGANVNSKNKDLSTPLH 447

Length = 682

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 17/47 (36%), Positives = 29/47 (61%), Gaps = 3/47 (6%)

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           ++  +A+GM +L   K    IHRDL   NIL  ++  +K+ DFG+++
Sbjct: 184 YSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 26/83 (31%), Positives = 38/83 (45%), Gaps = 19/83 (22%)

Query: 68  FRDIDNRTALHVAA-CQGFTEVVSLLLERGADVDPK---DRWGSTPLGDAIYY------- 116
              I   TALH+AA  Q + E+V LLLERGA V  +   D +  +   D+ Y+       
Sbjct: 126 TPGI---TALHLAAHRQNY-EIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLNA 181

Query: 117 ----KNHEVIKLLEKHGAKPLMA 135
                +  ++ LL +  A  L A
Sbjct: 182 AACLGSPSIVALLSEDPADILTA 204

The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743

>gnl|CDD|222931 PHA02798, PHA02798, ankyrin-like protein; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 23/84 (27%), Positives = 44/84 (52%), Gaps = 8/84 (9%)

Query: 56  IKELLDSGIDVNFRDIDNRTAL-----HVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           +K  ++ G +VN  D +  T L     ++   +   ++V +L+E GAD++ K+  G TPL
Sbjct: 54  VKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPL 113

Query: 111 GDAI---YYKNHEVIKLLEKHGAK 131
              +   Y  N E++  + ++GA 
Sbjct: 114 YCLLSNGYINNLEILLFMIENGAD 137

Length = 489

>gnl|CDD|165103 PHA02736, PHA02736, Viral ankyrin protein; Provisional

 Score = 38.3 bits (89), Expect = 0.001
 Identities = 19/58 (32%), Positives = 34/58 (58%), Gaps = 4/58 (6%)

Query: 72  DNRTALHVAACQGFT---EVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLL 125
             +  +H+ +        E + LL+E GAD++ K+R +G+TPL  A+Y +N+E+   L
Sbjct: 54  HGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWL 111

Length = 154

>gnl|CDD|165089 PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provisional

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 4/95 (4%)

Query: 20  DRERKEAELNGLDDDGEEIKPEFRLMF--LANERDVEGIKELLDSGIDVNFRDIDNRTAL 77
           + E     +  LD +  +  P     +  LA   D+  +   L  G+ ++++D   RT L
Sbjct: 262 NPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCL 321

Query: 78  HVAACQGF--TEVVSLLLERGADVDPKDRWGSTPL 110
           H    +    T+++ LL E G D++  D  G+T L
Sbjct: 322 HQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVL 356

Length = 764

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 24/140 (17%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-----QFLGAVTQSSP---MMIV 228
           +VA+KK    V+ D    +    EL +++ + H N++      +     ++     + +V
Sbjct: 93  KVAIKK----VLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145

Query: 229 TEYLPKGDLRAFLK---RKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
            E++P+  +  ++K   R     P   V+ ++  + R + Y+H      I HRDL+P N+
Sbjct: 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNL 201

Query: 285 LRD-DSGNLKVADFGVSKLL 303
           L D ++  LK+ DFG +K L
Sbjct: 202 LIDPNTHTLKLCDFGSAKNL 221

Length = 440

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 9/90 (10%)

Query: 225 MMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           + +V +Y   GDLR  +K +       +   A    + +   ++++H      +IHRD++
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170

Query: 281 PSNILRDDSGNLKVADFGVSKLL--TVKED 308
            +NIL   +G +K+ DFG SK+   TV +D
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDD 200

Length = 496

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 17/61 (27%), Positives = 25/61 (40%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L +     + E +K LLD G + N  +    T LH+A      E+  LLL  G  +    
Sbjct: 196 LHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAILNNNKEIFKLLLNNGPSIKTII 255

Query: 104 R 104
            
Sbjct: 256 E 256

Length = 422

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 34/143 (23%), Positives = 62/143 (43%), Gaps = 14/143 (9%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+KK+ E++  +    + F  E  +   + HP +V      +   P+     Y+    
Sbjct: 29  RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88

Query: 237 LRAFLKR-------KGALKPSTAVRFALDI----ARGMNYLHENKPVPIIHRDLEPSNIL 285
           L++ LK           L   T+V   L I       + Y+H      ++HRDL+P NIL
Sbjct: 89  LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNIL 145

Query: 286 RDDSGNLKVADFGVSKLLTVKED 308
               G + + D+G +    ++E+
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEE 168

Length = 932

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	319
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.98
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.97
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.97
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.96
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.96
KOG0198	313	consensus MEKK and related serine/threonine protei	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.96
KOG0589	426	consensus Serine/threonine protein kinase [General	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.95
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.95
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.95
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
KOG0586	596	consensus Serine/threonine protein kinase [General	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.95
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.95
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.94
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.93
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.93
KOG0584	632	consensus Serine/threonine protein kinase [General	99.93
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.93
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.93
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.93
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.93
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.93
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.93
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.93
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.93
PHA02988	283	hypothetical protein; Provisional	99.93
PHA03212	391	serine/threonine kinase US3; Provisional	99.93
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.93
PTZ00267	478	NIMA-related protein kinase; Provisional	99.93
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.93
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.93
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.93
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.92
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.92
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.92
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.92
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.92
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.92
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.92
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.92
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.92
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.92
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.92
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.92
PTZ00283	496	serine/threonine protein kinase; Provisional	99.91
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.91
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.91
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.91
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.91
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.91
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.91
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.91
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.91
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.91
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.91
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.91
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.91
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.91
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.91
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.91
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.91
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.9
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.9
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.9
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.9
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.9
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.9
PTZ00036	440	glycogen synthase kinase; Provisional	99.9
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.9
PHA03207	392	serine/threonine kinase US3; Provisional	99.9
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.9
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.9
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.9
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.9
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.9
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.9
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.9
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.9
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.9
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.9
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.9
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.9
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.9
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.9
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.9
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.9
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.9
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.9
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.9
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.9
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.9
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.9
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.9
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.9
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.9
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.9
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.9
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.9
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.9
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.9
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.9
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.9
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.9
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.9
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.9
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.9
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.9
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.9
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.9
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.9
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.9
PHA03211	461	serine/threonine kinase US3; Provisional	99.9
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.9
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.9
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.9
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.9
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.89
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.89
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.89
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.89
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.89
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.89
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.89
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.89
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.89
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.89
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.89
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.89
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.89
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.89
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.89
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.89
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.89
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.89
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.89
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.89
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.89
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.89
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.89
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.89
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.89
PHA03209	357	serine/threonine kinase US3; Provisional	99.89
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.89
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.89
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.89
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.89
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.89
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.89
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.89
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.89
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.89
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.89
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.89
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.89
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.89
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.89
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.89
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.89
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.89
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.89
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.89
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.89
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.89
PHA03210	501	serine/threonine kinase US3; Provisional	99.89
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.89
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.89
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.89
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.89
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.89
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.89
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.89
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.89
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.89
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.89
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.89
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.88
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.88
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.88
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.88
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.88
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.88
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.88
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.88
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.88
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.88
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.88
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.88
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.88
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.88
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.88
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.88
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.88
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.88
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.88
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.88
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.88
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.88
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.88
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.88
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.88
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.88
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.88
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.88
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.88
KOG3653	534	consensus Transforming growth factor beta/activin	99.88
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.88
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.88
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.88
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.88
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.88
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.88
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.88
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.88
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.88
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.88
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.88
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.88
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.88
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.88
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.88
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.88
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.88
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.88
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.88
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.87
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.87
PLN00009	294	cyclin-dependent kinase A; Provisional	99.87
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.87
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.87
PTZ00284	467	protein kinase; Provisional	99.87
KOG1152	772	consensus Signal transduction serine/threonine kin	99.87
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.87
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.87
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.87
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.87
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.87
PHA02743	166	Viral ankyrin protein; Provisional	99.87
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.87
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.87
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.87
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.87
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.87
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.87
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.87
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.87
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.87
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.87
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.87
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.87
PHA02791	284	ankyrin-like protein; Provisional	99.87
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.87
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.87
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.87
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.87
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.87
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.86
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.86
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.86
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.86
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.86
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.86
PHA02741	169	hypothetical protein; Provisional	99.86
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.86
PHA02791	284	ankyrin-like protein; Provisional	99.86
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.86
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.86
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.86
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.86
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.86
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.86
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.86
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.86
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.86
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.86
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.86
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.86
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.86
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.85
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.85
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.85
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.85
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.85
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.85
PHA02859	209	ankyrin repeat protein; Provisional	99.85
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.85
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.85
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.85
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.85
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.85
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.85
PHA02736	154	Viral ankyrin protein; Provisional	99.85
PHA02882	294	putative serine/threonine kinase; Provisional	99.85
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.85
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
PHA02878	477	ankyrin repeat protein; Provisional	99.85
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.84
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.84
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.84
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.84
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.84
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.84
PHA02859	209	ankyrin repeat protein; Provisional	99.84
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.84
KOG0508	615	consensus Ankyrin repeat protein [General function	99.84
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.84
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.84
PHA02875	413	ankyrin repeat protein; Provisional	99.83
PHA02878	477	ankyrin repeat protein; Provisional	99.83
PHA02875	413	ankyrin repeat protein; Provisional	99.83
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.83
PHA02884	300	ankyrin repeat protein; Provisional	99.83
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.83
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.82
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.82
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
PHA02795	437	ankyrin-like protein; Provisional	99.81
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.81
PHA02874	434	ankyrin repeat protein; Provisional	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.8
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.8
PHA02874	434	ankyrin repeat protein; Provisional	99.8
KOG0502	296	consensus Integral membrane ankyrin-repeat protein	99.8
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.8
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.8
PHA03100	480	ankyrin repeat protein; Provisional	99.8
PHA02946	446	ankyin-like protein; Provisional	99.8
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.79
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.79
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.79
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.79
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.79
PHA02741	169	hypothetical protein; Provisional	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
PHA03095	471	ankyrin-like protein; Provisional	99.78
KOG0510	929	consensus Ankyrin repeat protein [General function	99.78
PHA03095	471	ankyrin-like protein; Provisional	99.78
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.78
PHA02946	446	ankyin-like protein; Provisional	99.78
KOG0508	615	consensus Ankyrin repeat protein [General function	99.78
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.78
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.78
PHA02798	489	ankyrin-like protein; Provisional	99.77
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
PHA02876	682	ankyrin repeat protein; Provisional	99.77
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
PHA03100	480	ankyrin repeat protein; Provisional	99.77
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.77
PHA02798	489	ankyrin-like protein; Provisional	99.77
KOG0514	452	consensus Ankyrin repeat protein [General function	99.76
PHA02743	166	Viral ankyrin protein; Provisional	99.76
smart00090	237	RIO RIO-like kinase.	99.76
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
PHA02884	300	ankyrin repeat protein; Provisional	99.75
KOG0514	452	consensus Ankyrin repeat protein [General function	99.74
PHA02989	494	ankyrin repeat protein; Provisional	99.74
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.74
PHA02876	682	ankyrin repeat protein; Provisional	99.74
PHA02989	494	ankyrin repeat protein; Provisional	99.73
PHA02917	661	ankyrin-like protein; Provisional	99.73
KOG0502	296	consensus Integral membrane ankyrin-repeat protein	99.73
PHA02730	672	ankyrin-like protein; Provisional	99.73
PHA02917	661	ankyrin-like protein; Provisional	99.72
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
PHA02795	437	ankyrin-like protein; Provisional	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.72
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.7
PHA02730	672	ankyrin-like protein; Provisional	99.7
KOG0510	929	consensus Ankyrin repeat protein [General function	99.68
PF13857	56	Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A	99.68
PF13637	54	Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A	99.67
PHA02792	631	ankyrin-like protein; Provisional	99.67
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
KOG0505	527	consensus Myosin phosphatase, regulatory subunit [	99.67
KOG1710	396	consensus MYND Zn-finger and ankyrin repeat protei	99.67
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.65
COG0666	235	Arp FOG: Ankyrin repeat [General function predicti	99.65
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.65
PHA02736	154	Viral ankyrin protein; Provisional	99.65
cd00204	126	ANK ankyrin repeats; ankyrin repeats mediate prote	99.63
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.63
PTZ00322	664	6-phosphofructo-2-kinase/fructose-2,6-biphosphatas	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
PF13857	56	Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A	99.62
KOG0505	527	consensus Myosin phosphatase, regulatory subunit [	99.61
cd00204	126	ANK ankyrin repeats; ankyrin repeats mediate prote	99.6
PHA02792	631	ankyrin-like protein; Provisional	99.59
KOG0515	752	consensus p53-interacting protein 53BP/ASPP, conta	99.58
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.57
PTZ00322	664	6-phosphofructo-2-kinase/fructose-2,6-biphosphatas	99.57
TIGR00870	743	trp transient-receptor-potential calcium channel p	99.54
KOG0507	854	consensus CASK-interacting adaptor protein (caskin	99.53
KOG0507	854	consensus CASK-interacting adaptor protein (caskin	99.53

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-36  Score=257.22  Aligned_cols=159  Identities=33%  Similarity=0.606  Sum_probs=143.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|....+||.|+|+.||.     ++..||||.+.+... .+...+.+..|+.+|+.++|||||.+++++..++.+|+|||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            577777899999999984     578999999987754 45666788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC------CCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~DFgla~~~~  304 (319)
                      ||.||+|.+++++++.+++..++.|+.|++.||++||+++   ||||||||+||||+..      -.+||+|||+|+.+.
T Consensus        90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            9999999999999999999999999999999999999999   9999999999999864      458999999999998


Q ss_pred             cCCCCceeeccCCCC
Q 020981          305 VKEDRPLTCQDTSCR  319 (319)
Q Consensus       305 ~~~~~~~~~~~~~~~  319 (319)
                      ++ ...-+.+|||.|
T Consensus       167 ~~-~~a~tlcGSplY  180 (429)
T KOG0595|consen  167 PG-SMAETLCGSPLY  180 (429)
T ss_pred             ch-hHHHHhhCCccc
Confidence            55 555568899865

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=248.67  Aligned_cols=285  Identities=26%  Similarity=0.388  Sum_probs=229.6

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHH
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV   88 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~   88 (319)
                      +||||+|+.|+.....-+...|.-+|..+.-..||||+||..|+.++|+.|++..||||+.+..|+|||||||+.|.-.+
T Consensus        36 splhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqi  115 (448)
T KOG0195|consen   36 SPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQI  115 (448)
T ss_pred             chhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHH
Confidence            68999999999999999999999999999989999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccCC----------CCccccCCCccccc
Q 020981           89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE----------VPEYEIDPHELDFT  158 (319)
Q Consensus        89 v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~  158 (319)
                      .+-|+..||-+++.|++|.||+..|...-...+.+...++|..+...+-+...-..          .....++...+++.
T Consensus       116 aedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr~~gid~~~lnl~  195 (448)
T KOG0195|consen  116 AEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYTGIDVSSLNLI  195 (448)
T ss_pred             HHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccccccccCcchhhhhhh
Confidence            99999999999999999999998887666556666777778776654433221111          11112333333322


Q ss_pred             c-eeeeecceEEEEEEeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          159 N-SVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       159 ~-~~~ig~G~f~~v~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      . ..+.-.|..+...|.|..+++|++.-... +...-+.|..|..-++.+.||||+.+++.|.+...+.++..||+.|+|
T Consensus       196 tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            2 22334677888889999999999875433 233346788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          238 RAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       238 ~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      ...+++...  .+..++++|+.+++.|+.|||+..|+ |.---|.+..++||++.+.+|+
T Consensus       275 ynvlhe~t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhhee
Confidence            999998654  67789999999999999999998853 4444789999999999887764

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-34  Score=261.50  Aligned_cols=172  Identities=31%  Similarity=0.489  Sum_probs=160.5

Q ss_pred             CCCccccCCCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCccccccee
Q 020981          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (319)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~  218 (319)
                      .+|..-.+.....|.....+|+|+|..+|.     +|..||+|++.+..+..+...+.+.+|+++-+.++|||||+++++
T Consensus         7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~   86 (592)
T KOG0575|consen    7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF   86 (592)
T ss_pred             CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence            455555555557799999999999999984     689999999999888888888999999999999999999999999


Q ss_pred             EEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecC
Q 020981          219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (319)
Q Consensus       219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFg  298 (319)
                      |++.++.|+|+|+|..++|..+++.+++++|.+++.|++||+.||.|||+++   |+|||||..|+|++++.++||+|||
T Consensus        87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence            9999999999999999999999999899999999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCceeeccCCC
Q 020981          299 VSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       299 la~~~~~~~~~~~~~~~~~~  318 (319)
                      ||..+..++++..+.+|||-
T Consensus       164 LAt~le~~~Erk~TlCGTPN  183 (592)
T KOG0575|consen  164 LATQLEYDGERKKTLCGTPN  183 (592)
T ss_pred             eeeeecCcccccceecCCCc
Confidence            99999999999999999993

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-35  Score=249.04  Aligned_cols=162  Identities=33%  Similarity=0.472  Sum_probs=152.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|...+.||+|+||.|+.     +++.+|+|++++..+......+....|..+|..++||+||+++..|++..++|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            4788999999999999984     68899999999988887778889999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+.||.|...+.+++.+++..+..|+.+|+.||.|||+++   ||||||||+|||+|.+|+++|+|||||+..-..+..
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            99999999999999999999999999999999999999999   999999999999999999999999999988888778


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      ..+.+|||-|
T Consensus       182 t~tfcGT~eY  191 (357)
T KOG0598|consen  182 TRTFCGTPEY  191 (357)
T ss_pred             cccccCCccc
Confidence            8889999843

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-34  Score=245.48  Aligned_cols=160  Identities=27%  Similarity=0.387  Sum_probs=139.0

Q ss_pred             cccceeeeecceEEEEE-----EeceEeEEEEecccccCCHH----HHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      .|...+.+|.|+||.|.     .+|+.||||++++.......    .....++|+++|++++||+||+++++|......|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            46667889999999886     37899999999876543321    2233579999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC---CCEEEEecCccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLL  303 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DFgla~~~  303 (319)
                      +||||++||+|.+++..++.+.+..-..+++|++.|+.|||+.|   |+||||||+|||+..+   ..+||+|||+|+..
T Consensus       253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            99999999999999999999999999999999999999999999   9999999999999866   67999999999998


Q ss_pred             ccCCCCceeeccCCCC
Q 020981          304 TVKEDRPLTCQDTSCR  319 (319)
Q Consensus       304 ~~~~~~~~~~~~~~~~  319 (319)
                      .... ...+.+|||-|
T Consensus       330 g~~s-fm~TlCGTpsY  344 (475)
T KOG0615|consen  330 GEGS-FMKTLCGTPSY  344 (475)
T ss_pred             ccce-ehhhhcCCccc
Confidence            8554 44558889854

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-33  Score=229.53  Aligned_cols=159  Identities=30%  Similarity=0.506  Sum_probs=147.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|+....+|.|+||.|-.     +|..+|+|++.++......+.+...+|..+|+.+.||+++++++.+.+...+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            3688888999999998863     68899999999887777778888999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||++||.|.+++++.+++++..++.++.||+.||+|||+++   |++|||||+|||+|++|.+||+|||+|+.....   
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            99999999999999999999999999999999999999999   999999999999999999999999999987655   


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      ..+.+|||-|
T Consensus       198 T~TlCGTPeY  207 (355)
T KOG0616|consen  198 TWTLCGTPEY  207 (355)
T ss_pred             EEEecCCccc
Confidence            6778999943

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-33  Score=241.96  Aligned_cols=158  Identities=28%  Similarity=0.523  Sum_probs=145.7

Q ss_pred             cccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|...+.+|+|+||.|.     ..|+.||||.++++.+.+....-.+++|+++|+.++||||+.+|.+|...+++.||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            57777889999999886     3689999999999988888888889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |..+|.|.+++.+++.+++.+++.|++||.+|+.|+|+++   ++|||||.+|||+|.++++||+||||+-.|......-
T Consensus       134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence            9999999999999999999999999999999999999999   9999999999999999999999999999988775554


Q ss_pred             eeeccCC
Q 020981          311 LTCQDTS  317 (319)
Q Consensus       311 ~~~~~~~  317 (319)
                      + ++|+|
T Consensus       211 T-FCGSP  216 (668)
T KOG0611|consen  211 T-FCGSP  216 (668)
T ss_pred             H-hcCCc
Confidence            4 44444

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-32  Score=235.26  Aligned_cols=157  Identities=32%  Similarity=0.475  Sum_probs=141.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc-eEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~lv~  229 (319)
                      ++.....+|+|..|.|+.     +++.+|+|++...  .++...+++.+|+++++.++||+||.+||.|..... ++|+|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            566677899999998874     6889999999543  356667889999999999999999999999999985 99999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||++|||+++++..+++++.....++.++++||.|||. ++   ||||||||+|||++..|.+||||||.++.+...  
T Consensus       158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999999998999999999999999999999996 77   999999999999999999999999999988776  


Q ss_pred             CceeeccCCCC
Q 020981          309 RPLTCQDTSCR  319 (319)
Q Consensus       309 ~~~~~~~~~~~  319 (319)
                      ...+.+||..|
T Consensus       233 ~a~tfvGT~~Y  243 (364)
T KOG0581|consen  233 IANTFVGTSAY  243 (364)
T ss_pred             hcccccccccc
Confidence            66778888654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.2e-33  Score=233.42  Aligned_cols=164  Identities=27%  Similarity=0.475  Sum_probs=143.4

Q ss_pred             ccccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccce-eEEeCCc-eEE
Q 020981          155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MMI  227 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~-~~~~~~~-~~l  227 (319)
                      .+|...++||.|+||.||     ++|..+|.|.+.-.. .+....+....|+.+|++++|||||++++ .+..++. ++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            468888999999999888     478999999988443 34566678889999999999999999998 5555555 899


Q ss_pred             EEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCC-CeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPV-PIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      |||||.+|+|...++.    ++.+++..+++++.|++.||..+|++-|. .|+||||||.||+|+.+|.+||+||||+++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999864    34599999999999999999999993211 399999999999999999999999999999


Q ss_pred             cccCCCCceeeccCCCC
Q 020981          303 LTVKEDRPLTCQDTSCR  319 (319)
Q Consensus       303 ~~~~~~~~~~~~~~~~~  319 (319)
                      ++....-..+.+|||||
T Consensus       178 l~s~~tfA~S~VGTPyY  194 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYY  194 (375)
T ss_pred             hcchhHHHHhhcCCCcc
Confidence            99998888999999987

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.97  E-value=7e-32  Score=225.08  Aligned_cols=158  Identities=22%  Similarity=0.409  Sum_probs=137.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|+...++|+|+||+|+.     +|+.||||++... .+++.-.+-..+|+++|++++|||+|.++++|....++++|+|
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            366677899999999984     7999999998754 2345555667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ||+..-|.++-.....++...+..+..|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+|+.++.+.+.+
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            9987555554444455899999999999999999999999   9999999999999999999999999999999888888


Q ss_pred             eeeccCC
Q 020981          311 LTCQDTS  317 (319)
Q Consensus       311 ~~~~~~~  317 (319)
                      +..+.|.
T Consensus       159 TDYVATR  165 (396)
T KOG0593|consen  159 TDYVATR  165 (396)
T ss_pred             hhhhhhh
Confidence            7777665

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-31  Score=235.37  Aligned_cols=170  Identities=46%  Similarity=0.764  Sum_probs=143.1

Q ss_pred             CCCCccccCCCcccccceeeeecceEEEEE---EeceE-eEEEEecccccCCHHHHHHHHHHHHHHHhcCCCccccccee
Q 020981          143 REVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (319)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~ig~G~f~~v~---~~~~~-vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~  218 (319)
                      ...+.+.++...+.+.  ..+|.|+||.||   |.|.. ||+|.+......... .+.|.+|+.+|++++|||||+++|+
T Consensus        31 ~~~~~~~i~~~~l~~~--~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~  107 (362)
T KOG0192|consen   31 DELPEEEIDPDELPIE--EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGA  107 (362)
T ss_pred             ccccceecChHHhhhh--hhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            3345566665544433  349999999887   67888 999999876554444 7899999999999999999999999


Q ss_pred             EEeCC-ceEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEE
Q 020981          219 VTQSS-PMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKV  294 (319)
Q Consensus       219 ~~~~~-~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl  294 (319)
                      +.... ..++||||+++|+|.+++..  +..+++..+..|+.||+.||+|||++++  ||||||||+|||++.++ ++||
T Consensus       108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI  185 (362)
T KOG0192|consen  108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKI  185 (362)
T ss_pred             EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEE
Confidence            98887 79999999999999999987  5679999999999999999999999985  99999999999999998 9999


Q ss_pred             EecCcccccccCCCCceeeccCC
Q 020981          295 ADFGVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       295 ~DFgla~~~~~~~~~~~~~~~~~  317 (319)
                      +|||+++.............||+
T Consensus       186 ~DFGlsr~~~~~~~~~~~~~GT~  208 (362)
T KOG0192|consen  186 ADFGLSREKVISKTSMTSVAGTY  208 (362)
T ss_pred             CCCccceeeccccccccCCCCCc
Confidence            99999988776543333356665

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6e-31  Score=236.58  Aligned_cols=162  Identities=29%  Similarity=0.504  Sum_probs=143.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCH--HHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~  226 (319)
                      -.|.....+|+|+||.|+.     ++..||+|++.++.....  ...+.+.+|+.+++.++ ||||+++++++.....+|
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            3677888999999999874     578999998776422211  23456678999999999 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC-CCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DFgla~~~~~  305 (319)
                      +||||+.||+|.+++.+.+++++..+..+++|+++|++|||+++   |+||||||+|||++.+ +++||+|||++.....
T Consensus        97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            99999999999999999889999999999999999999999999   9999999999999999 9999999999999865


Q ss_pred             CCCCceeeccCCCC
Q 020981          306 KEDRPLTCQDTSCR  319 (319)
Q Consensus       306 ~~~~~~~~~~~~~~  319 (319)
                      ......+.+|||+|
T Consensus       174 ~~~~l~t~cGsp~Y  187 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAY  187 (370)
T ss_pred             CCCcccCCCCCccc
Confidence            55777889999965

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.3e-31  Score=235.50  Aligned_cols=152  Identities=28%  Similarity=0.496  Sum_probs=133.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI  227 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l  227 (319)
                      ..|...++||+|+||.||.     +|+.||+|+++.+..... ......+|+.+|+++.||||+++.+.....  ..+|+
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3688889999999999995     688999999987654333 234456799999999999999999988776  68999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+|||+. ||.-++...+ .|++.++..|++|++.||+|||.++   |+|||||.+|||||.+|.+||+|||||+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999965 9999888754 5999999999999999999999999   999999999999999999999999999999887


Q ss_pred             CCCce
Q 020981          307 EDRPL  311 (319)
Q Consensus       307 ~~~~~  311 (319)
                      ...++
T Consensus       272 ~~~~~  276 (560)
T KOG0600|consen  272 GSAPY  276 (560)
T ss_pred             CCccc
Confidence            76643

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=236.88  Aligned_cols=159  Identities=38%  Similarity=0.598  Sum_probs=138.2

Q ss_pred             CCCccccCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeE
Q 020981          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (319)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~  219 (319)
                      .++..++.....+|.....+|+|+||.||.    .|..||||.+.......   ..+|.+|+.++.+++|||+|+++|+|
T Consensus        64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            344456666667899999999999999984    45799999877543221   34599999999999999999999999


Q ss_pred             EeCCc-eEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEe
Q 020981          220 TQSSP-MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (319)
Q Consensus       220 ~~~~~-~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  296 (319)
                      .+.+. .+||+|||++|+|.+++....  .++|....+|+.+++.||+|||+..+.+||||||||+|||+|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            98884 999999999999999998654  789999999999999999999998877899999999999999999999999


Q ss_pred             cCccccccc
Q 020981          297 FGVSKLLTV  305 (319)
Q Consensus       297 Fgla~~~~~  305 (319)
                      ||+|+....
T Consensus       221 FGLa~~~~~  229 (361)
T KOG1187|consen  221 FGLAKLGPE  229 (361)
T ss_pred             ccCcccCCc
Confidence            999966554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=235.84  Aligned_cols=150  Identities=32%  Similarity=0.575  Sum_probs=139.4

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ..||.-.+.+|+|+|+.|+.     +++.||||++.+..+..+...+....|-..|.+| +||.|++||..|+++..+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            34777788999999999985     5789999999988777777777888999999999 69999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+||+++|+|.+++++.+.+++..++.|+.||+.||+|||++|   ||||||||+|||+|++|++||+|||.|+.+.+.
T Consensus       152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            9999999999999999999999999999999999999999999   999999999999999999999999999988653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=1.5e-30  Score=213.42  Aligned_cols=157  Identities=29%  Similarity=0.537  Sum_probs=135.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|...+.+|+|+|+.||.     +|+.||||+++.....+.-. ....+|+..|+.++|+||+.++++|.....+.+|+|
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            456677899999999985     68999999998764433222 345669999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+ .+|...++.+. .+++..+..|+.|+++||+|||++.   |+||||||.|+||+++|.+||+|||+|+.+.++...
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            995 69999998764 5899999999999999999999999   999999999999999999999999999999877665


Q ss_pred             ceeeccCC
Q 020981          310 PLTCQDTS  317 (319)
Q Consensus       310 ~~~~~~~~  317 (319)
                      ....+.|.
T Consensus       158 ~~~~V~TR  165 (318)
T KOG0659|consen  158 QTHQVVTR  165 (318)
T ss_pred             cccceeee
Confidence            55444444

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=2.7e-30  Score=230.38  Aligned_cols=148  Identities=30%  Similarity=0.439  Sum_probs=139.9

Q ss_pred             CcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ...+|.....||+|+||.|+.     +|..+|+|++++.......+....+.|-.+|....+|+||++|-.|++..++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            445899999999999999984     789999999999887788888999999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ||||++||++..+|.+.+.+++..++.|+.+++.|++.||+.|   +|||||||+|+|||..|++||+|||||.-+
T Consensus       219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999999999999999999999999999999999   999999999999999999999999999644

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.96  E-value=4.9e-30  Score=229.67  Aligned_cols=159  Identities=28%  Similarity=0.520  Sum_probs=146.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +.+.||+|.+.+.. ....+...+++|+++++.++||||+.++++|++..++|+|.|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            466677899999999995     56789999998754 345567789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |+.| +|..++...+.++++.++.++.|++.||.|||+.+   |+|||+||+|||++..|.+|+||||+|+.++.+....
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            9965 99999999999999999999999999999999999   9999999999999999999999999999999999999


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      ...-|||+|
T Consensus       158 tsikGtPlY  166 (808)
T KOG0597|consen  158 TSIKGTPLY  166 (808)
T ss_pred             eeccCcccc
Confidence            999999976

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-30  Score=229.42  Aligned_cols=157  Identities=24%  Similarity=0.449  Sum_probs=143.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|....+||+|+-|.||.     +++.||||.+.....   ...+.+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            577788999999988874     578999999876543   345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ||+||+|.+.+... .+++.++..+++++++||+|||.++   |+|||||.+|||++.+|.+||+|||+|..+.....++
T Consensus       351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            99999999988765 4899999999999999999999999   9999999999999999999999999999999999999


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      .+++||||+
T Consensus       427 ~TmVGTPYW  435 (550)
T KOG0578|consen  427 STMVGTPYW  435 (550)
T ss_pred             ccccCCCCc
Confidence            999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=227.22  Aligned_cols=155  Identities=25%  Similarity=0.435  Sum_probs=133.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCC-ceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS-PMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~-~~~lv  228 (319)
                      .|...+++|.|+||.|+.     .|..||||.++++.. +.++.-.+ +|+.-|++++ ||||+++.+++.+.. .+|+|
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nL-REvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNL-REVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHH-HHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            577788999999999985     578899999987754 34444444 5999999999 999999999998877 99999


Q ss_pred             EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |||| ..+|.++++.++ .+++..++.|+.||++||+|+|++|   +.|||+||+|||+.....+||+||||||.+... 
T Consensus        89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-  163 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK-  163 (538)
T ss_pred             HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC-
Confidence            9999 469999998764 5999999999999999999999999   999999999999999899999999999987655 


Q ss_pred             CCceeeccCC
Q 020981          308 DRPLTCQDTS  317 (319)
Q Consensus       308 ~~~~~~~~~~  317 (319)
                      .-++..++|.
T Consensus       164 pPYTeYVSTR  173 (538)
T KOG0661|consen  164 PPYTEYVSTR  173 (538)
T ss_pred             CCcchhhhcc
Confidence            2344566665

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.2e-29  Score=214.98  Aligned_cols=159  Identities=33%  Similarity=0.581  Sum_probs=136.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC--ceEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMI  227 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~l  227 (319)
                      .++.....+|+|+||.|+.     +|...|||.+....  ... .+.+.+|+.+|++++|||||+++|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            4577778899999999984     36799999987552  222 677899999999999999999999755444  6999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-CCCEEEEecCccccccc
Q 020981          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DFgla~~~~~  305 (319)
                      +|||+++|+|.+++.+.+ .+++..++++.+|+++||.|||+++   |+||||||+|||++. ++.+||+|||+++....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999877 7999999999999999999999999   999999999999999 79999999999998874


Q ss_pred             ---CCCCceeeccCCCC
Q 020981          306 ---KEDRPLTCQDTSCR  319 (319)
Q Consensus       306 ---~~~~~~~~~~~~~~  319 (319)
                         .........|||++
T Consensus       171 ~~~~~~~~~~~~Gtp~~  187 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNY  187 (313)
T ss_pred             ccccccccccccCCccc
Confidence               22334567888864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3e-29  Score=229.53  Aligned_cols=163  Identities=28%  Similarity=0.384  Sum_probs=148.0

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCce
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~  225 (319)
                      ....+|.....+|+|+||.|..     +++.+|||++++..+-..+..+....|-+++.... ||+++.++.+|++++++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            3445788899999999999975     57899999999998888888899999999999986 99999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+||||+.||++.. +...+.+++..+..|+..|+.||+|||+++   ||+||||.+|||+|.+|++||+|||+++..-.
T Consensus       445 ~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999999443 334467999999999999999999999999   99999999999999999999999999999888


Q ss_pred             CCCCceeeccCCC
Q 020981          306 KEDRPLTCQDTSC  318 (319)
Q Consensus       306 ~~~~~~~~~~~~~  318 (319)
                      ...+..+.+|||-
T Consensus       521 ~g~~TsTfCGTpe  533 (694)
T KOG0694|consen  521 QGDRTSTFCGTPE  533 (694)
T ss_pred             CCCccccccCChh
Confidence            8889999999993

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-28  Score=213.47  Aligned_cols=168  Identities=30%  Similarity=0.470  Sum_probs=144.8

Q ss_pred             ccccCCCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~  221 (319)
                      .........+|+....||.|.-..|+.     ++..||||++..+.....  ...+++|+..|+.++||||++++.+|..
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv   95 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVV   95 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence            344455566899999999998777763     578999999987765433  7889999999999999999999999999


Q ss_pred             CCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                      +..+|+||.||.+||+.++++..  ..+++..+..+.+++++||.|||++|   .||||||+.||||+.+|.+||+|||.
T Consensus        96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCcee
Confidence            99999999999999999999875  34899999999999999999999999   99999999999999999999999998


Q ss_pred             ccccccCCCCc----eeeccCCCC
Q 020981          300 SKLLTVKEDRP----LTCQDTSCR  319 (319)
Q Consensus       300 a~~~~~~~~~~----~~~~~~~~~  319 (319)
                      +..+-....+.    .+.+||||+
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~w  196 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCW  196 (516)
T ss_pred             eeeecccCceeeEeeccccCcccc
Confidence            77664443333    455999985

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.96  E-value=2.8e-29  Score=212.11  Aligned_cols=158  Identities=30%  Similarity=0.446  Sum_probs=133.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI  227 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l  227 (319)
                      .+|.....|++|+||.||.     ++..||+|+++.+.-....... -.+|+.+|.+++|||||.+-.+....  +.+|+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPIT-SLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcch-hHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            3677788999999999995     5789999999865432222222 35699999999999999998877543  57999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |||||+ -+|.+++.+-+ ++...++..++.|++.|++|||.+.   |+||||||+|+|++..|.+||+|||||+.|..+
T Consensus       155 VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            999996 59999998754 7999999999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCceeeccCC
Q 020981          307 EDRPLTCQDTS  317 (319)
Q Consensus       307 ~~~~~~~~~~~  317 (319)
                      ....+..+-|.
T Consensus       231 ~k~~T~lVVTL  241 (419)
T KOG0663|consen  231 LKPYTPLVVTL  241 (419)
T ss_pred             cccCcceEEEe
Confidence            66665555444

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=2.9e-29  Score=223.45  Aligned_cols=160  Identities=28%  Similarity=0.510  Sum_probs=144.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc-eEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~lv~  229 (319)
                      .|...+++|.|+||.++.     .+..+++|.+.......+.+ +..++|+.++++++|||||.+++.|..++. .+|||
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            567788999999998863     56789999998776655544 367789999999999999999999998887 99999


Q ss_pred             eecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      +||+||++.+.+++.+  .++++.+..|+.|++.|+.|||++.   |+|||||++|||+++++.+||.|||+|+.+.++.
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998754  4899999999999999999999988   9999999999999999999999999999999998


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                      +...+++|||+|
T Consensus       161 ~~a~tvvGTp~Y  172 (426)
T KOG0589|consen  161 SLASTVVGTPYY  172 (426)
T ss_pred             hhhheecCCCcc
Confidence            889999999986

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=9.5e-29  Score=211.55  Aligned_cols=157  Identities=29%  Similarity=0.499  Sum_probs=133.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCc-ccccceeEEeCC------
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSS------  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~------  223 (319)
                      .|...+++|+|+|+.||.     +|+.||+|+++.+... +..-....+|+.+++.++|+| |+.+++++.+.+      
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            466677899999999984     6889999999865432 112234567999999999999 999999998877      


Q ss_pred             ceEEEEeecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                      .+++|+||++ -+|..++....    .++...++.+++|++.||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            8999999995 69999998754    4777889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCceeeccCC
Q 020981          300 SKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       300 a~~~~~~~~~~~~~~~~~  317 (319)
                      |+.+.-+....+..++|-
T Consensus       167 Ara~~ip~~~yt~evvTl  184 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTL  184 (323)
T ss_pred             HHHhcCCcccccccEEEe
Confidence            998887766666555554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.6e-29  Score=226.16  Aligned_cols=158  Identities=28%  Similarity=0.435  Sum_probs=140.0

Q ss_pred             ccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |...+.+|.|+-|.|.     .+|+.+|||++.+..--.......+.+|+-+|+.+.|||++++|++|....++|+|+||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            5556678999999886     48999999999876433444456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCce
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~  311 (319)
                      +++|.|++++.+++++++.++.+|++||+.|+.|+|..+   |.||||||+|+|+|..+++||+|||+|..-.++ ...-
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-klLe  169 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KLLE  169 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC-cccc
Confidence            999999999999999999999999999999999999999   999999999999999999999999999875544 4555


Q ss_pred             eeccCCC
Q 020981          312 TCQDTSC  318 (319)
Q Consensus       312 ~~~~~~~  318 (319)
                      +.||+|-
T Consensus       170 TSCGSPH  176 (786)
T KOG0588|consen  170 TSCGSPH  176 (786)
T ss_pred             ccCCCcc
Confidence            6778773

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-28  Score=220.36  Aligned_cols=180  Identities=28%  Similarity=0.509  Sum_probs=152.6

Q ss_pred             HHHHHHHhhCCCCCCccccccccCCCCccccCCCcccccceeeeecceEEEEEEe------c---eEeEEEEecccccCC
Q 020981          120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWR------G---IQVAVKKLGEEVISD  190 (319)
Q Consensus       120 ~i~~~L~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~f~~v~~~------~---~~vAvK~l~~~~~~~  190 (319)
                      +++.+................+|-..+.|++..++..+.  .++|+|.||.|+..      +   ..||+|....+....
T Consensus       124 ~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~  201 (474)
T KOG0194|consen  124 ELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELT  201 (474)
T ss_pred             HHHHHHHhcccceeccceeecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeeccccccc
Confidence            344444443333334444567788888899998877776  79999999999841      1   238999988655456


Q ss_pred             HHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhC
Q 020981          191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHEN  269 (319)
Q Consensus       191 ~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH~~  269 (319)
                      ......+.+|.++|+.++|||||++||+...+.++++|||+|.||+|.+++++++. ++..+...++.+.+.||+|||++
T Consensus       202 ~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k  281 (474)
T KOG0194|consen  202 KEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK  281 (474)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC
Confidence            78889999999999999999999999999999999999999999999999998874 99999999999999999999999


Q ss_pred             CCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       270 ~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +   +|||||-++|+|++.++.+||+||||++.-.
T Consensus       282 ~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  282 N---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             C---CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            9   9999999999999999999999999988654

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.96  E-value=4.6e-29  Score=192.36  Aligned_cols=138  Identities=30%  Similarity=0.237  Sum_probs=128.4

Q ss_pred             cccccccccccCchhhhhhhh-hcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHc-CCCCcccCCCCCCHHHHHHHcC
Q 020981            7 VRTTLLKQSSLAPDRERKEAE-LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG   84 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~-ga~vn~~d~~g~tpLh~A~~~~   84 (319)
                      -|||||||++-++..+...+. ..+..+|.+|..|+||||+||..|+.++|+.|+.+ |+|+|+.+..|+||||||+..|
T Consensus        38 ~Rt~LHwa~S~g~~eiv~fLlsq~nv~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~  117 (226)
T KOG4412|consen   38 GRTPLHWACSFGHVEIVYFLLSQPNVKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKG  117 (226)
T ss_pred             CCceeeeeeecCchhHHHHHHhcCCCCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCC
Confidence            489999999999988888877 56888999999999999999999999999999998 9999999999999999999999


Q ss_pred             CHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccCC
Q 020981           85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE  144 (319)
Q Consensus        85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~  144 (319)
                      ..+++++|+++|+.++++|.+|+||+|-|+..|+.+++++|+..++....++....+|..
T Consensus       118 r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~TpL~  177 (226)
T KOG4412|consen  118 RLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTPLH  177 (226)
T ss_pred             hhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccHHH
Confidence            999999999999999999999999999999999999999999999888777766655543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9.8e-29  Score=221.00  Aligned_cols=151  Identities=38%  Similarity=0.666  Sum_probs=131.0

Q ss_pred             CCccccCCCcccccceeeeecceEEEEE---Eece-EeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEE
Q 020981          145 VPEYEIDPHELDFTNSVEITKGTFILAF---WRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (319)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~ig~G~f~~v~---~~~~-~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~  220 (319)
                      ...|+++...  +....+||.|-||.|+   |.+. +||+|.++....+.    +.|.+|+.+|++|+|++||++++++.
T Consensus       198 ~d~wei~r~~--l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~  271 (468)
T KOG0197|consen  198 RDPWEIPREE--LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCT  271 (468)
T ss_pred             cCCeeecHHH--HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEe
Confidence            3455555543  4455689999999886   6666 99999998654332    56779999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecC
Q 020981          221 QSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (319)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFg  298 (319)
                      .+.++|||||||+.|+|.++++.  ...+...+.+.|+.||++||+||++++   +|||||.++|||++++..+||+|||
T Consensus       272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccc
Confidence            98899999999999999999987  345889999999999999999999999   9999999999999999999999999


Q ss_pred             cccccc
Q 020981          299 VSKLLT  304 (319)
Q Consensus       299 la~~~~  304 (319)
                      ||+...
T Consensus       349 LAr~~~  354 (468)
T KOG0197|consen  349 LARLIG  354 (468)
T ss_pred             cccccC
Confidence            999443

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-29  Score=218.56  Aligned_cols=159  Identities=31%  Similarity=0.507  Sum_probs=128.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCH-----------HHHHHHHHHHHHHHhcCCCcccccceeE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD-----------DRVRAFRDELALLQKIRHPNVVQFLGAV  219 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~l~~~~  219 (319)
                      .|.....+|+|.||.|..     +++.||||++.+......           ...+...+|+.+|++|.|||||+|+++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            688889999999998864     588999999976432111           1235778999999999999999999998


Q ss_pred             Ee--CCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          220 TQ--SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       220 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      .+  .+++|+|+|||..|.+...-.....+++.+++.|+++++.||+|||.++   ||||||||+|+||+++|++||+||
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecc
Confidence            55  4689999999998877543222222889999999999999999999999   999999999999999999999999


Q ss_pred             CcccccccC-----CCCceeeccCC
Q 020981          298 GVSKLLTVK-----EDRPLTCQDTS  317 (319)
Q Consensus       298 gla~~~~~~-----~~~~~~~~~~~  317 (319)
                      |.+..+...     .......+|||
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTP  279 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTP  279 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCc
Confidence            999877322     22222356776

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=1.1e-27  Score=214.10  Aligned_cols=154  Identities=29%  Similarity=0.379  Sum_probs=134.5

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~  236 (319)
                      .||+|+||.||.     +|+.+|+|++.+...........+.+|+.+++.++||||+++++.+......|+||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            589999999884     578899999986554445556678889999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeeccC
Q 020981          237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT  316 (319)
Q Consensus       237 L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~  316 (319)
                      |.+++..++.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.............||
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            9999988888999999999999999999999999   9999999999999999999999999998754444444455666


Q ss_pred             CC
Q 020981          317 SC  318 (319)
Q Consensus       317 ~~  318 (319)
                      +.
T Consensus       159 ~~  160 (323)
T cd05571         159 PE  160 (323)
T ss_pred             cc
Confidence            63

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.7e-29  Score=201.88  Aligned_cols=158  Identities=29%  Similarity=0.468  Sum_probs=140.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|+....+|+|.||.||.     ++..||+|++.+..+.......++.+|+++.+.++||||+++|++|.++...|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            3677788899999999985     56789999998766555555577999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          230 EYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       230 e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||..+|++...+.  ....+++..+..|+.|++.|+.|+|.++   +|||||||+|+|++..+.+||+|||.+..-.  .
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~  176 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--S  176 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--C
Confidence            9999999999998  4566999999999999999999999999   9999999999999999999999999987654  4


Q ss_pred             CCceeeccCC
Q 020981          308 DRPLTCQDTS  317 (319)
Q Consensus       308 ~~~~~~~~~~  317 (319)
                      .+..+.+||.
T Consensus       177 ~kR~tlcgt~  186 (281)
T KOG0580|consen  177 NKRKTLCGTL  186 (281)
T ss_pred             CCceeeeccc
Confidence            5666777775

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.95  E-value=1.1e-27  Score=217.42  Aligned_cols=146  Identities=26%  Similarity=0.438  Sum_probs=132.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +++.+|+|++.+...........+.+|+.++..++||+|+++++.+.+...+|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            577788999999999984     478999999976544344555678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+++|+|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            9999999999998888999999999999999999999999   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2e-27  Score=215.80  Aligned_cols=146  Identities=27%  Similarity=0.472  Sum_probs=132.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||.|+||.||.     +++.||||++.............+.+|+.+++.++||||+++++.+......|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            577788999999999984     478999999976543344455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            9999999999998888999999999999999999999999   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=3.1e-27  Score=211.55  Aligned_cols=153  Identities=29%  Similarity=0.410  Sum_probs=133.2

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~  236 (319)
                      .||+|+||.||.     ++..+|+|++.+...........+.+|+.+++.++||||+++++.+......|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            589999999884     578999999987654445556778889999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeeccC
Q 020981          237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT  316 (319)
Q Consensus       237 L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~  316 (319)
                      |..++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.............||
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            9999988888999999999999999999999999   9999999999999999999999999998654433333344566


Q ss_pred             C
Q 020981          317 S  317 (319)
Q Consensus       317 ~  317 (319)
                      +
T Consensus       159 ~  159 (328)
T cd05593         159 P  159 (328)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.8e-27  Score=210.40  Aligned_cols=153  Identities=26%  Similarity=0.380  Sum_probs=132.8

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      ||+|+||.||.     ++..||+|.+.+...........+.+|+.+++.++||||+++++.+......|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            58899998884     4678999998765444455567788899999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeeccCC
Q 020981          238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       238 ~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~  317 (319)
                      .+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.............||+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence            999988888999999999999999999999999   99999999999999999999999999987554444444455665


Q ss_pred             C
Q 020981          318 C  318 (319)
Q Consensus       318 ~  318 (319)
                      .
T Consensus       158 ~  158 (312)
T cd05585         158 E  158 (312)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=2.6e-27  Score=211.67  Aligned_cols=153  Identities=29%  Similarity=0.393  Sum_probs=132.7

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~  236 (319)
                      .+|+|+||.||.     +|..||+|.+.............+.+|+.+++.++||||+++++.+......|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            589999999984     578999999986654444556677889999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeeccC
Q 020981          237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT  316 (319)
Q Consensus       237 L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~  316 (319)
                      |..++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.............||
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            9999988888999999999999999999999999   9999999999999999999999999998654433333334555


Q ss_pred             C
Q 020981          317 S  317 (319)
Q Consensus       317 ~  317 (319)
                      +
T Consensus       159 ~  159 (323)
T cd05595         159 P  159 (323)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.5e-27  Score=215.27  Aligned_cols=145  Identities=27%  Similarity=0.427  Sum_probs=130.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||.|+||.||.     +++.||+|++.+...........+.+|+.+++.++||||+++++.+......|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            567788999999999984     578899999876443344456778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999988888999999999999999999999999   999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.95  E-value=4e-27  Score=215.14  Aligned_cols=145  Identities=23%  Similarity=0.390  Sum_probs=131.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....||+|+||.||.     ++..+|+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            466788999999999985     467999999986554455566778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |+++|+|.+++.+.+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=2.2e-28  Score=201.63  Aligned_cols=160  Identities=26%  Similarity=0.434  Sum_probs=136.5

Q ss_pred             cccceeeeecceEEEEE-----EeceEeEEEEecccc-----cCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCc
Q 020981          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV-----ISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~-----~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  224 (319)
                      .|..++.+|.|..+.+.     .+|+.+|+|++..-.     .......+.-++|+++|+++ +||+|+++.++++++..
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            45667778888776553     478899999875321     11123345567899999998 59999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .++|+|.|+.|.|.+++.+.-.+++..++++++|++.|++|||.++   ||||||||+|||++++.++||+|||+|+.+.
T Consensus        98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence            9999999999999999999888999999999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCCCceeeccCCCC
Q 020981          305 VKEDRPLTCQDTSCR  319 (319)
Q Consensus       305 ~~~~~~~~~~~~~~~  319 (319)
                      +++ +....+|||.|
T Consensus       175 ~Ge-kLrelCGTPgY  188 (411)
T KOG0599|consen  175 PGE-KLRELCGTPGY  188 (411)
T ss_pred             Cch-hHHHhcCCCcc
Confidence            875 44557889854

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=207.08  Aligned_cols=160  Identities=30%  Similarity=0.396  Sum_probs=149.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.-.+.+|+|+||.|..     +++.+|+|+++++.+...++...-..|-++|+.++||++..+--.|+..+++|+|||
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe  248 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME  248 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence            566777899999998863     688999999999988888888888899999999999999999889999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |..||.|.-++.+.+.+++..++.+..+|+.||.|||+++   ||.||+|.+|+|+|++|++||+||||++.-.....+.
T Consensus       249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~  325 (516)
T KOG0690|consen  249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT  325 (516)
T ss_pred             EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccccccee
Confidence            9999999999998888999999999999999999999999   9999999999999999999999999999988888888


Q ss_pred             eeeccCCC
Q 020981          311 LTCQDTSC  318 (319)
Q Consensus       311 ~~~~~~~~  318 (319)
                      .+.+|||-
T Consensus       326 kTFCGTPE  333 (516)
T KOG0690|consen  326 KTFCGTPE  333 (516)
T ss_pred             ccccCChh
Confidence            99999993

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=3.5e-27  Score=211.31  Aligned_cols=148  Identities=27%  Similarity=0.461  Sum_probs=133.3

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||.|+||.||.     +++.+|+|.+...........+.+.+|+.+++.++||||+++++.+...+..|++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            3678888999999999884     47889999987654434445567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+.+++|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999987644

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=3.1e-27  Score=214.05  Aligned_cols=163  Identities=26%  Similarity=0.439  Sum_probs=143.8

Q ss_pred             CCCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       151 ~~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +...-.|.....||.|.|+.|..     ++..||||.+.+........ +.+.+|+.+|+.++|||||+++.+...+..+
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            34444677888999999998874     68899999998876554433 4488899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+||||+.+|.+.+++.+++++.+..+..++.|+.+|++|||+++   |+|||||++|||++.+.++||+|||++.++..
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999999999999999999999999999999999999   99999999999999999999999999999985


Q ss_pred             CCCCceeeccCCC
Q 020981          306 KEDRPLTCQDTSC  318 (319)
Q Consensus       306 ~~~~~~~~~~~~~  318 (319)
                      . ...-+.+|+|.
T Consensus       208 ~-~~lqt~cgspp  219 (596)
T KOG0586|consen  208 G-LMLQTFCGSPP  219 (596)
T ss_pred             c-ccccccCCCCC
Confidence            5 44455666664

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=6.3e-27  Score=210.44  Aligned_cols=159  Identities=27%  Similarity=0.419  Sum_probs=137.1

Q ss_pred             CcccccceeeeecceEEEEEEe------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          153 HELDFTNSVEITKGTFILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~~------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      ...+|.....+|.|+||.||..      +..+|+|.+.+...........+.+|+.+++.++||||+++++++......|
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3346888899999999988742      2579999987654444455667889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +||||+++|+|.+++..++.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999999998888999999999999999999999999   999999999999999999999999999876432


Q ss_pred             CCCceeeccCC
Q 020981          307 EDRPLTCQDTS  317 (319)
Q Consensus       307 ~~~~~~~~~~~  317 (319)
                         .....||+
T Consensus       185 ---~~~~~gt~  192 (340)
T PTZ00426        185 ---TYTLCGTP  192 (340)
T ss_pred             ---cceecCCh
Confidence               23345665

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=7.6e-27  Score=208.81  Aligned_cols=153  Identities=29%  Similarity=0.393  Sum_probs=131.8

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~  236 (319)
                      .+|+|+||.||.     ++..+|+|.+.+...........+..|+.+++.++||||+++++.+......|+||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            589999999984     578999999987654445556677889999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       237 L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      |..++...+.+++..+..++.|++.||.|||+ ++   |+||||||+|||++.++.+||+|||+++.............|
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            99999888889999999999999999999997 67   999999999999999999999999999865443333333455


Q ss_pred             CC
Q 020981          316 TS  317 (319)
Q Consensus       316 ~~  317 (319)
                      |+
T Consensus       159 t~  160 (325)
T cd05594         159 TP  160 (325)
T ss_pred             Cc
Confidence            55

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.6e-27  Score=207.63  Aligned_cols=147  Identities=27%  Similarity=0.485  Sum_probs=131.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.||.     +++.+|+|.+...........+.+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            467778999999998884     478899999875443333445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++...+.+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999998888999999999999999999999999   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=2.3e-27  Score=205.65  Aligned_cols=146  Identities=23%  Similarity=0.402  Sum_probs=134.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.+|.|..|.||.     ++..+|+|++.+............+.|.+||+.+.||+++.||..|.++...|++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            577788999999999985     347899999998877777777888899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ||+||+|..+++++  +.+++..++.|+.+++.||+|||-.|   ||.|||||+||||.++|++-|+||.|+....
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            99999999998865  45999999999999999999999999   9999999999999999999999999998763

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=5.9e-27  Score=213.66  Aligned_cols=145  Identities=24%  Similarity=0.404  Sum_probs=130.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +++.+|+|.+.+...........+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            577888999999999984     478999999875443333445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|..+
T Consensus        82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-27  Score=211.63  Aligned_cols=159  Identities=28%  Similarity=0.472  Sum_probs=143.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .|.....+|.|.||.++.     +|..+|+|.+.+...........+.+|+.+|+.+. ||||+.+++.|.+....++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            466678999999999984     58899999998876655555678899999999998 999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC----CCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DFgla~~~~~  305 (319)
                      |++.||.|.+.+... .+++..+..+++|++.++.|||+.+   ++||||||+|+|+...    +.+|++|||+|..+..
T Consensus       116 EL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999876 4999999999999999999999999   9999999999999733    4799999999999988


Q ss_pred             CCCCceeeccCCCC
Q 020981          306 KEDRPLTCQDTSCR  319 (319)
Q Consensus       306 ~~~~~~~~~~~~~~  319 (319)
                       +.+....+|||+|
T Consensus       192 -~~~~~~~~Gtp~y  204 (382)
T KOG0032|consen  192 -GERLHTIVGTPEY  204 (382)
T ss_pred             -CceEeeecCCccc
Confidence             6777889999976

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.4e-27  Score=210.45  Aligned_cols=147  Identities=31%  Similarity=0.504  Sum_probs=132.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.||.     +++.||+|++.+...........+.+|+.++..++||||+++++.+......|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            477788999999999884     468999999986544444455678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999998888999999999999999999999999   99999999999999999999999999986644

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=7.1e-27  Score=213.57  Aligned_cols=145  Identities=24%  Similarity=0.401  Sum_probs=130.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....||+|+||.||.     ++..+|+|.+.+...........+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            367788999999999985     467899999876544344556778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |+++|+|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=7.2e-27  Score=212.41  Aligned_cols=160  Identities=26%  Similarity=0.347  Sum_probs=136.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|+|+||.||.     +++.+|+|.+.+...........+.+|+.+++.++||||+++++.+..+...|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688888999999999984     46789999987543333444566888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC-
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~-  308 (319)
                      ||+++|+|.+++... .+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+..... 
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999999999998764 5889999999999999999999999   99999999999999999999999999987754332 


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      ...+..||+.
T Consensus       199 ~~~~~~gt~~  208 (370)
T cd05621         199 RCDTAVGTPD  208 (370)
T ss_pred             ecccCCCCcc
Confidence            2234566664

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.95  E-value=1e-27  Score=205.33  Aligned_cols=155  Identities=28%  Similarity=0.461  Sum_probs=126.0

Q ss_pred             CcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-----
Q 020981          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----  222 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----  222 (319)
                      ....|.....+|.|+||.||.     ++..+|||++-.+.-       .-.+|+.+|+.+.|||||++..+|...     
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            345677888999999999985     468999998754321       112699999999999999998887543     


Q ss_pred             CceEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC-CCEEEEec
Q 020981          223 SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADF  297 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DF  297 (319)
                      -+..+|||||+. +|..+++.    +..++...++.++.||++||.|||+.+   |.||||||+|+|+|.+ |.+|||||
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccC
Confidence            246789999975 99888874    467888999999999999999999999   9999999999999955 99999999


Q ss_pred             CcccccccCCCCceeeccCCC
Q 020981          298 GVSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       298 gla~~~~~~~~~~~~~~~~~~  318 (319)
                      |.|+.+..++..-.=.++-.|
T Consensus       171 GSAK~L~~~epniSYicSRyY  191 (364)
T KOG0658|consen  171 GSAKVLVKGEPNISYICSRYY  191 (364)
T ss_pred             CcceeeccCCCceeEEEeccc
Confidence            999999887655333333333

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.95  E-value=1e-26  Score=208.33  Aligned_cols=154  Identities=27%  Similarity=0.428  Sum_probs=133.3

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .||+|+||.||.     +++.||+|++.+...........+..|..+++.+ +||||+++++++.....+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            589999998874     4778999999876554555567788999999998 6999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            99999988888999999999999999999999999   999999999999999999999999999864443334444556


Q ss_pred             CCC
Q 020981          316 TSC  318 (319)
Q Consensus       316 ~~~  318 (319)
                      |+.
T Consensus       159 t~~  161 (329)
T cd05588         159 TPN  161 (329)
T ss_pred             Ccc
Confidence            653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=1.9e-26  Score=206.62  Aligned_cols=154  Identities=28%  Similarity=0.439  Sum_probs=132.6

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .+|+|+||.||.     +++.+|+|.+.+...........+.+|..++..+ +||||+++++++......|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            589999999874     4678999999876555555667788899988877 7999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|..++...+.+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.............|
T Consensus        82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            99999988888999999999999999999999999   999999999999999999999999999865443333344556


Q ss_pred             CCC
Q 020981          316 TSC  318 (319)
Q Consensus       316 ~~~  318 (319)
                      |+.
T Consensus       159 t~~  161 (329)
T cd05618         159 TPN  161 (329)
T ss_pred             Ccc
Confidence            653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.94  E-value=1.5e-26  Score=209.84  Aligned_cols=146  Identities=26%  Similarity=0.445  Sum_probs=131.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     ++..+|+|++.............+.+|..++..++||+|+++++.+.....+|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            467788999999999884     478999999976443344556778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+++|+|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=1.4e-26  Score=206.91  Aligned_cols=154  Identities=29%  Similarity=0.444  Sum_probs=131.2

Q ss_pred             eeeecceEEEEEE--------eceEeEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          161 VEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       161 ~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +.||+|+||.||.        .++.+|+|.+...... .......+.+|+.+++.++||||+++++.+..+...|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            4689999999884        4678999998754321 223345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCce
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~  311 (319)
                      +++++|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence            999999999988888899999999999999999999999   99999999999999999999999999986544444444


Q ss_pred             eeccCC
Q 020981          312 TCQDTS  317 (319)
Q Consensus       312 ~~~~~~  317 (319)
                      ...||+
T Consensus       159 ~~~gt~  164 (323)
T cd05584         159 TFCGTI  164 (323)
T ss_pred             ccCCCc
Confidence            455665

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.2e-26  Score=209.41  Aligned_cols=149  Identities=29%  Similarity=0.484  Sum_probs=134.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||.|+||.||.     +++.||+|++.+...........+..|+.++..++||||+++++.+......|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            477788999999999884     478999999986544444455778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++++|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            9999999999998888999999999999999999999999   9999999999999999999999999998776544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=2.1e-26  Score=205.13  Aligned_cols=154  Identities=30%  Similarity=0.443  Sum_probs=129.8

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .||+|+||.||.     ++..||+|.+...........+.+..|..++... +||||+++++.+......|+||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            589999999984     4678999999865443344445556677777654 7999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|..++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            99999988888999999999999999999999999   999999999999999999999999999876554444444566


Q ss_pred             CCC
Q 020981          316 TSC  318 (319)
Q Consensus       316 ~~~  318 (319)
                      |+.
T Consensus       159 t~~  161 (316)
T cd05592         159 TPD  161 (316)
T ss_pred             Ccc
Confidence            663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.9e-28  Score=230.08  Aligned_cols=164  Identities=26%  Similarity=0.332  Sum_probs=147.2

Q ss_pred             CcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ...+|...+.||+|+||.|..     +++.||+|++.+.-.........|+.|-.+|..-+.+-|+.+...|++..++|+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            344799999999999998763     578999999987554445566789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc-C
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV-K  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~-~  306 (319)
                      |||||+||+|..++.+..++++..++.|..+|+.||+-||+.|   +|||||||+|||||..|++||+|||.|-.+.. +
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            9999999999999999889999999999999999999999999   99999999999999999999999999988874 4


Q ss_pred             CCCceeeccCCCC
Q 020981          307 EDRPLTCQDTSCR  319 (319)
Q Consensus       307 ~~~~~~~~~~~~~  319 (319)
                      .-...+.+|||.|
T Consensus       230 ~V~s~~aVGTPDY  242 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDY  242 (1317)
T ss_pred             cEEeccccCCCCc
Confidence            5556788999954

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=3.4e-26  Score=204.54  Aligned_cols=159  Identities=31%  Similarity=0.417  Sum_probs=134.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-cccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....||.|+||.||.     +++.||+|++.+.........+.+..|..++..+.|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            466778999999999984     3568999999865444445566788899999999764 6888999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            99999999999988888999999999999999999999999   999999999999999999999999999765433333


Q ss_pred             ceeeccCC
Q 020981          310 PLTCQDTS  317 (319)
Q Consensus       310 ~~~~~~~~  317 (319)
                      .....||+
T Consensus       158 ~~~~~gt~  165 (324)
T cd05587         158 TRTFCGTP  165 (324)
T ss_pred             eeeecCCc
Confidence            34455665

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.94  E-value=3e-26  Score=208.43  Aligned_cols=162  Identities=26%  Similarity=0.343  Sum_probs=136.7

Q ss_pred             CcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ...+|.....+|+|+||.||.     +++.+|+|.+.+...........+.+|..+++.++||||+++++.+......|+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            345788899999999999884     467899999875433333445667889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||||+++|+|.+++... .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            99999999999998764 5889999999999999999999999   9999999999999999999999999998775433


Q ss_pred             C-CceeeccCCC
Q 020981          308 D-RPLTCQDTSC  318 (319)
Q Consensus       308 ~-~~~~~~~~~~  318 (319)
                      . ......||+.
T Consensus       197 ~~~~~~~~gt~~  208 (371)
T cd05622         197 MVRCDTAVGTPD  208 (371)
T ss_pred             cccccCcccCcc
Confidence            2 2234556663

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=2.3e-26  Score=205.30  Aligned_cols=153  Identities=27%  Similarity=0.384  Sum_probs=131.3

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .+|+|+||.||.     +++.+|+|.+.+...........+..|..++..+ +||||+++++++......|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            579999998884     3678999999865544445556677899998876 6999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|...+...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            99999988888999999999999999999999999   999999999999999999999999999875544444444556


Q ss_pred             CC
Q 020981          316 TS  317 (319)
Q Consensus       316 ~~  317 (319)
                      |+
T Consensus       159 t~  160 (321)
T cd05591         159 TP  160 (321)
T ss_pred             Cc
Confidence            65

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=2.3e-26  Score=205.21  Aligned_cols=153  Identities=29%  Similarity=0.420  Sum_probs=130.9

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .+|+|+||.||.     +++.||+|.+.+...........+..|..++..+ +||||+++++++......|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            589999999884     4678999998765443444556677888888877 5999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|.+++...+.+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            99999988888999999999999999999999999   999999999999999999999999999865444334444556


Q ss_pred             CC
Q 020981          316 TS  317 (319)
Q Consensus       316 ~~  317 (319)
                      |+
T Consensus       159 t~  160 (320)
T cd05590         159 TP  160 (320)
T ss_pred             Cc
Confidence            65

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-27  Score=200.71  Aligned_cols=145  Identities=30%  Similarity=0.512  Sum_probs=127.8

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-----CCceE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-----SSPMM  226 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----~~~~~  226 (319)
                      |.....+|.|+||+|+.     +|..||||++... +......+...+|+.+|+.++|+||+.+++++..     -+.+|
T Consensus        24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             ecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            44467899999998874     6899999999754 3455556677789999999999999999998865     24699


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +|+|+| +.+|...++.++.+++..+..++.|++.||.|+|+.+   ++||||||+|++++.+..+||+|||+|+.....
T Consensus       103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence            999999 6799999999888999999999999999999999999   999999999999999999999999999988653

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.7e-26  Score=204.22  Aligned_cols=148  Identities=24%  Similarity=0.374  Sum_probs=130.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +++.||+|++.+.........+.+.+|..++..++|+||+++++++......|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            567788999999998874     477999999875433344455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++|+|.+++.+ ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999976 456899999999999999999999999   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=5e-26  Score=203.95  Aligned_cols=148  Identities=28%  Similarity=0.445  Sum_probs=132.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     .++.+|+|.+.............+.+|+.+++.++||||+++++.+......|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            577788999999999984     578999999986554444556778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++|+|.+++.+. ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999876 67999999999999999999999999   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.94  E-value=3.4e-26  Score=208.11  Aligned_cols=160  Identities=26%  Similarity=0.336  Sum_probs=135.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     ++..+|+|.+.+...........+.+|+.+++.++||||+++++++......|+||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            3688888999999999884     47799999987543333444556788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC-
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~-  308 (319)
                      ||+++|+|.+++... .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+..... 
T Consensus       123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            999999999988764 5888999999999999999999999   99999999999999999999999999987654322 


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      ......||+.
T Consensus       199 ~~~~~~gt~~  208 (370)
T cd05596         199 RCDTAVGTPD  208 (370)
T ss_pred             cCCCCCCCcC
Confidence            2233456653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=3.9e-26  Score=204.35  Aligned_cols=154  Identities=27%  Similarity=0.427  Sum_probs=133.2

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .+|+|+||.||.     .++.+|+|++.+...........+.+|..++..+ +||+|+++++++.....+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            589999998874     4678999999876554555667788999999888 5999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|..++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            99999988888999999999999999999999999   999999999999999999999999999865444344444566


Q ss_pred             CCC
Q 020981          316 TSC  318 (319)
Q Consensus       316 ~~~  318 (319)
                      |+.
T Consensus       159 t~~  161 (327)
T cd05617         159 TPN  161 (327)
T ss_pred             Ccc
Confidence            653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=4.4e-26  Score=203.67  Aligned_cols=158  Identities=30%  Similarity=0.413  Sum_probs=133.5

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEe
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      |.....+|+|+||.||.     +++.||+|++.+.........+.+..|..++..+. |++|+++++++...+..|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            56678899999999984     47789999998654434445566778999998886 5778889999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.........
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999998654443333


Q ss_pred             eeeccCC
Q 020981          311 LTCQDTS  317 (319)
Q Consensus       311 ~~~~~~~  317 (319)
                      ....||+
T Consensus       159 ~~~~gt~  165 (323)
T cd05615         159 RTFCGTP  165 (323)
T ss_pred             cCccCCc
Confidence            3444555

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=4.8e-26  Score=203.44  Aligned_cols=159  Identities=30%  Similarity=0.400  Sum_probs=134.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....+|+|+||.||.     ++..+|+|.+.+...........+..|..++..+. |++|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            466778999999999984     45789999998654434444556677888888875 889999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            99999999999988888999999999999999999999999   999999999999999999999999999865444333


Q ss_pred             ceeeccCC
Q 020981          310 PLTCQDTS  317 (319)
Q Consensus       310 ~~~~~~~~  317 (319)
                      .....||+
T Consensus       158 ~~~~~gt~  165 (323)
T cd05616         158 TKTFCGTP  165 (323)
T ss_pred             cccCCCCh
Confidence            44455665

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=3.8e-26  Score=203.90  Aligned_cols=153  Identities=30%  Similarity=0.430  Sum_probs=127.3

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHH-HHHHhcCCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .||.|+||.||.     .+..+|+|++.+...........+..|. .+++.++||||+++++.+...+..|+||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            589999999884     4678999998765433333334444454 4678899999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|...+.....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.............|
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence            99999988778999999999999999999999999   999999999999999999999999999865444444444556


Q ss_pred             CC
Q 020981          316 TS  317 (319)
Q Consensus       316 ~~  317 (319)
                      |+
T Consensus       159 t~  160 (321)
T cd05603         159 TP  160 (321)
T ss_pred             Cc
Confidence            65

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=4.3e-26  Score=203.76  Aligned_cols=153  Identities=30%  Similarity=0.432  Sum_probs=126.8

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHH-HHHhcCCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .||+|+||.||.     +|+.||+|.+.+...........+..|.. +++.++||||+++++.+......|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            589999998874     57899999987654333333344444544 567899999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|..++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence            99999988888999999999999999999999999   999999999999999999999999999865444333334455


Q ss_pred             CC
Q 020981          316 TS  317 (319)
Q Consensus       316 ~~  317 (319)
                      |+
T Consensus       159 t~  160 (323)
T cd05575         159 TP  160 (323)
T ss_pred             Ch
Confidence            54

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=4.1e-26  Score=204.06  Aligned_cols=153  Identities=29%  Similarity=0.448  Sum_probs=127.8

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHH-HHHhcCCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .||.|+||.||.     +|+.+|+|++.+...........+..|.. +++.++||||+++++.+...+..|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            589999999884     47899999987654333333444555554 567789999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|..++.....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence            99999988888999999999999999999999999   999999999999999999999999999865444334444556


Q ss_pred             CC
Q 020981          316 TS  317 (319)
Q Consensus       316 ~~  317 (319)
                      |+
T Consensus       159 t~  160 (325)
T cd05604         159 TP  160 (325)
T ss_pred             Ch
Confidence            55

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=3.9e-26  Score=203.59  Aligned_cols=153  Identities=26%  Similarity=0.391  Sum_probs=131.3

Q ss_pred             eeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       161 ~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      +.+|+|+||.||.        .|..+|+|++...... ......+.+|+.++++++||||+++++.+......|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            4689999998873        4688999998764332 223345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCcee
Q 020981          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT  312 (319)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~  312 (319)
                      ++++|.+++.+...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence            99999999988888999999999999999999999999   999999999999999999999999999876655444444


Q ss_pred             eccCC
Q 020981          313 CQDTS  317 (319)
Q Consensus       313 ~~~~~  317 (319)
                      ..||+
T Consensus       158 ~~g~~  162 (318)
T cd05582         158 FCGTV  162 (318)
T ss_pred             ccCCh
Confidence            55555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.94  E-value=6.5e-26  Score=203.30  Aligned_cols=148  Identities=23%  Similarity=0.341  Sum_probs=130.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +++.+|+|.+.+...........+.+|..++..++|++|+++++.+...+..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            577788999999998874     467899999875433334445668889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++|+|.+++.+ ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999987 457899999999999999999999999   999999999999999999999999999876544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=7.5e-26  Score=202.96  Aligned_cols=159  Identities=23%  Similarity=0.372  Sum_probs=134.2

Q ss_pred             cccceeeeecceEEEEEE--------eceEeEEEEecccccC-CHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....||+|+||.||.        ++..+|+|++.+.... .....+.+..|+.+++.++ ||+|+++++.+.....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            366788999999999984        4678999998754322 2233456788999999995 99999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ++||||+++|+|.+++.++..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            999999999999999988888999999999999999999999999   99999999999999999999999999987644


Q ss_pred             CCC-CceeeccCC
Q 020981          306 KED-RPLTCQDTS  317 (319)
Q Consensus       306 ~~~-~~~~~~~~~  317 (319)
                      ... ......||+
T Consensus       158 ~~~~~~~~~~gt~  170 (332)
T cd05614         158 EEKERTYSFCGTI  170 (332)
T ss_pred             cCCCccccccCCc
Confidence            332 223345655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=6.4e-26  Score=202.04  Aligned_cols=154  Identities=30%  Similarity=0.441  Sum_probs=129.3

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .||+|+||.||.     +|..||+|.+.+...........+..|..++... +||+|+++++.+...+..|+||||+.+|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            589999998884     4678999999765432233445566788888765 7999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|..++.....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence            99999988888999999999999999999999999   999999999999999999999999999865443344444556


Q ss_pred             CCC
Q 020981          316 TSC  318 (319)
Q Consensus       316 ~~~  318 (319)
                      |+.
T Consensus       159 t~~  161 (316)
T cd05620         159 TPD  161 (316)
T ss_pred             CcC
Confidence            653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.94  E-value=1.1e-25  Score=197.68  Aligned_cols=146  Identities=25%  Similarity=0.385  Sum_probs=127.4

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....||+|+||.||.     ++..||+|.+.............+.+|+.+++.++|++++++++.+...+..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            55677899999999874     4789999998765443334445678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++|+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++..+..
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            9999999887643  35889999999999999999999999   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=7.5e-26  Score=202.40  Aligned_cols=153  Identities=29%  Similarity=0.416  Sum_probs=126.6

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHH-HHHHHhcCCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E-~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .||+|+||.||.     +++.+|+|++.+...........+..| ..+++.++||||+++++.+...+..|+||||++++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            589999998884     457899999876433222223334444 44567889999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence            99999988888999999999999999999999999   999999999999999999999999999876544444445566


Q ss_pred             CC
Q 020981          316 TS  317 (319)
Q Consensus       316 ~~  317 (319)
                      |+
T Consensus       159 t~  160 (325)
T cd05602         159 TP  160 (325)
T ss_pred             Cc
Confidence            66

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=6.6e-26  Score=198.49  Aligned_cols=152  Identities=25%  Similarity=0.370  Sum_probs=129.1

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      ||.|+||.||.     +++.+|+|.+...........+.+..|+.+++.++||||+++.+++......|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            58899998874     5789999998765444444456778899999999999999999999999999999999999999


Q ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceee
Q 020981          238 RAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC  313 (319)
Q Consensus       238 ~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~  313 (319)
                      ..++..    +..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++..+..........
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            888743    345899999999999999999999999   9999999999999999999999999998776554444444


Q ss_pred             ccCC
Q 020981          314 QDTS  317 (319)
Q Consensus       314 ~~~~  317 (319)
                      .||+
T Consensus       158 ~g~~  161 (280)
T cd05608         158 AGTP  161 (280)
T ss_pred             CCCc
Confidence            5555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=8.6e-26  Score=201.92  Aligned_cols=157  Identities=31%  Similarity=0.429  Sum_probs=130.1

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHH---HhcCCCcccccceeEEeCCceEEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL---QKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      |.....+|+|+||.||.     +++.||+|.+.+.........+.+.+|..++   +.++||||+++++++......|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            44567899999999884     4789999999765433344455677776665   456799999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||+++++|...+.. +.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence            999999999988765 46899999999999999999999999   99999999999999999999999999986544444


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                      ......|++
T Consensus       157 ~~~~~~g~~  165 (324)
T cd05589         157 RTSTFCGTP  165 (324)
T ss_pred             cccccccCc
Confidence            444455665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=9.1e-26  Score=202.24  Aligned_cols=152  Identities=28%  Similarity=0.400  Sum_probs=126.7

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc---CCCcccccceeEEeCCceEEEEeecCC
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      ||+|+||.||.     ++..||+|++.+...........+..|..++...   +||+|+++++.+......|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            58899999884     4789999998764433333344455567777665   699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeec
Q 020981          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (319)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~  314 (319)
                      |+|..++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.............
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            999999988888999999999999999999999999   99999999999999999999999999987544444344455


Q ss_pred             cCC
Q 020981          315 DTS  317 (319)
Q Consensus       315 ~~~  317 (319)
                      ||+
T Consensus       158 gt~  160 (330)
T cd05586         158 GTT  160 (330)
T ss_pred             CCc
Confidence            665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.93  E-value=1.3e-25  Score=200.01  Aligned_cols=153  Identities=29%  Similarity=0.430  Sum_probs=128.4

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .+|+|+||.||.     ++..||+|.+.............+..|..+++.. +||||+++++++......|+||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            589999999884     4678999999865433233345566678888764 8999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|.+++.....+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.............|
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            99999988778999999999999999999999999   999999999999999999999999999865444333444455


Q ss_pred             CC
Q 020981          316 TS  317 (319)
Q Consensus       316 ~~  317 (319)
                      |+
T Consensus       159 t~  160 (316)
T cd05619         159 TP  160 (316)
T ss_pred             Cc
Confidence            55

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.93  E-value=1.6e-25  Score=200.90  Aligned_cols=159  Identities=23%  Similarity=0.328  Sum_probs=133.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     .++.+|+|.+.+...........+.+|..++..++|++|+++++.+......|+|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            567788999999998874     367899999875433334445568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      |+++|+|.+++.+ ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+......
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999987 356899999999999999999999999   999999999999999999999999999866443222


Q ss_pred             -ceeeccCC
Q 020981          310 -PLTCQDTS  317 (319)
Q Consensus       310 -~~~~~~~~  317 (319)
                       .....||+
T Consensus       159 ~~~~~~gt~  167 (332)
T cd05623         159 QSSVAVGTP  167 (332)
T ss_pred             eecccccCc
Confidence             22345665

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=2.2e-26  Score=208.99  Aligned_cols=167  Identities=27%  Similarity=0.520  Sum_probs=142.7

Q ss_pred             cccCCCcccccceeeeecceEEEEEE-----eceEeEEEEeccc-ccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe
Q 020981          148 YEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEE-VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (319)
Q Consensus       148 ~~~~~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~  221 (319)
                      .+.++..........+|+|+|-.||.     +|..||.-.++.. ...++...+.|..|+++|+.|+||||+++|++|.+
T Consensus        33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            34555555555567899999999985     6788887765543 34566777899999999999999999999999987


Q ss_pred             CCc--eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecC
Q 020981          222 SSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG  298 (319)
Q Consensus       222 ~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFg  298 (319)
                      ...  +-+|+|.+..|+|..|+++.++++...++.|++||+.||.|||++.| ||||||||.+||||+ .-|.+||+|+|
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchh
Confidence            665  88999999999999999999999999999999999999999999986 699999999999998 66899999999


Q ss_pred             cccccccCCCCceeeccCC
Q 020981          299 VSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       299 la~~~~~~~~~~~~~~~~~  317 (319)
                      ||........+  .++|||
T Consensus       192 LAtl~r~s~ak--svIGTP  208 (632)
T KOG0584|consen  192 LATLLRKSHAK--SVIGTP  208 (632)
T ss_pred             HHHHhhccccc--eeccCc
Confidence            99987766443  388998

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.93  E-value=6.7e-26  Score=201.83  Aligned_cols=154  Identities=27%  Similarity=0.447  Sum_probs=135.0

Q ss_pred             eeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       160 ~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      .+.+|.|-||.||     .+|+.||||++.+-.+....+ ..+++|+.+|..+.||.||.+.--|++.+++++|||-+ .
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence            4578999999998     479999999999877765544 78999999999999999999999999999999999999 5


Q ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC---CCEEEEecCcccccccCCCC
Q 020981          235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       235 g~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DFgla~~~~~~~~~  309 (319)
                      |+..+.+-  +.+++++.....+..||+.||.|||-++   |+|.||||+|||+.+.   -.+||||||+|+++.....+
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            67777664  4578999999999999999999999999   9999999999999854   36999999999999887655


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      . +.+|||-|
T Consensus       724 r-sVVGTPAY  732 (888)
T KOG4236|consen  724 R-SVVGTPAY  732 (888)
T ss_pred             h-hhcCCccc
Confidence            5 48999954

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.93  E-value=1.4e-25  Score=199.93  Aligned_cols=153  Identities=32%  Similarity=0.454  Sum_probs=130.7

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .+|.|+||.||.     ++..+|+|.+.+...........+..|..++..+ +||||+++++++......|+||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            589999998874     4678999999865544445556777899999888 6999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeecc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~  315 (319)
                      +|..++.+.+.+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||+++.............|
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            99999988888999999999999999999999999   999999999999999999999999999765443333333445


Q ss_pred             CC
Q 020981          316 TS  317 (319)
Q Consensus       316 ~~  317 (319)
                      |+
T Consensus       159 ~~  160 (318)
T cd05570         159 TP  160 (318)
T ss_pred             Cc
Confidence            54

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.1e-27  Score=211.34  Aligned_cols=158  Identities=27%  Similarity=0.462  Sum_probs=139.5

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ..-|.....||.|+||.||.     +...||||+++-..-++.+..+.+..|+..|++++|||++.+-|+|..+...|+|
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            33567778899999999985     4678999999876666677778899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |||| -||-.+++.- ++++.+.++..|..+.+.||.|||+++   .||||||+.|||+++.|.+||+|||.|....+. 
T Consensus       105 MEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  105 MEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             HHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            9999 5688888863 457999999999999999999999999   999999999999999999999999999876554 


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                         .+++||||.
T Consensus       180 ---nsFvGTPyw  188 (948)
T KOG0577|consen  180 ---NSFVGTPYW  188 (948)
T ss_pred             ---hcccCCccc
Confidence               468999984

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-26  Score=179.72  Aligned_cols=147  Identities=27%  Similarity=0.531  Sum_probs=127.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|...++||+|+||.||.     ++..||+|.++.+.-+.. --....+|+.+++.++|.|||++++...++.++.+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            455667899999999985     567899999876542221 12345679999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||. .+|..++.+ ++.+....++.++.|++.||.|+|+++   ++|||+||+|++|+.+|.+|++|||+|+.+.-+-
T Consensus        82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            994 699999876 467899999999999999999999999   9999999999999999999999999999887654

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.1e-27  Score=204.87  Aligned_cols=160  Identities=29%  Similarity=0.476  Sum_probs=147.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ..|.....||+|+||.||.     +++.||+|++..+.  .....+.+++|+.++.+++++||.++|+.+..+..+|++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            4577778999999999985     67899999998654  3455678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      |||.||++.+.++....+.+..+..++++++.|+.|+|+++   .+|||||+.|||+..+|.+|++|||.+.+++....+
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999999999998877788999999999999999999999   999999999999999999999999999999999888


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      +.+++||||+
T Consensus       168 r~tfvGTPfw  177 (467)
T KOG0201|consen  168 RKTFVGTPFW  177 (467)
T ss_pred             cccccccccc
Confidence            8999999984

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=3e-25  Score=215.48  Aligned_cols=160  Identities=28%  Similarity=0.465  Sum_probs=139.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||.|+||.||.     .+..||+|++.............+..|+.+++.++||||+++++.+.....+|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            3677888999999999884     37899999997655555556677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+.+++|.+++...+.+++..++.|+.||+.||+|||.++   |+||||||+|||++.++.+||+|||+++.....+..
T Consensus        84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~  160 (669)
T cd05610          84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN  160 (669)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCCccc
Confidence            99999999999988778899999999999999999999998   999999999999999999999999999987655444


Q ss_pred             ceeeccCC
Q 020981          310 PLTCQDTS  317 (319)
Q Consensus       310 ~~~~~~~~  317 (319)
                      .....+||
T Consensus       161 ~~~~~~t~  168 (669)
T cd05610         161 MMDILTTP  168 (669)
T ss_pred             ccccccCc
Confidence            44444444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=208.14  Aligned_cols=148  Identities=34%  Similarity=0.632  Sum_probs=129.3

Q ss_pred             ccccCCCcccccceeeeecceEEEEE---EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  223 (319)
                      +|++...  ++.....||.|.||.||   |.| +||||++..... .++..+.|.+|+.++++-+|.||+-++|++....
T Consensus       386 ~WeIp~~--ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  386 EWEIPPE--EVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccCHH--Hhhccceeccccccceeeccccc-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            4555444  45566789999999998   445 899999987654 4568899999999999999999999999988776


Q ss_pred             ceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      . .||+.+|+|.+|..+++-. .+|.....+.|++|+++||.|||.++   |||||||..|||+.+++.+||+||||+..
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence            5 9999999999999999754 45888899999999999999999999   99999999999999999999999999864

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.93  E-value=2.1e-25  Score=197.54  Aligned_cols=157  Identities=27%  Similarity=0.479  Sum_probs=129.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|.|+||.||.     ++..+|+|++......  .....+.+|+.+++.++||||+++++++......++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            3678888999999999884     4788999998754321  12235667999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      ||+. ++|.+++... +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            9995 6888877654 56889999999999999999999999   99999999999999999999999999986544333


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                      ......||+
T Consensus       159 ~~~~~~~~~  167 (303)
T cd07869         159 TYSNEVVTL  167 (303)
T ss_pred             cCCCCcccC
Confidence            333334444

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.93  E-value=5.4e-27  Score=195.94  Aligned_cols=156  Identities=28%  Similarity=0.420  Sum_probs=142.1

Q ss_pred             cccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      -|+...++|+|+||.|+     .+|+.+|+|.+.-     +...+++..|+.+|.++..|++|++||.+.....+|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            36677899999999887     4799999999863     3456788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||..|+..+.+.. ++++++.++..+.+..+.||+|||-..   -+|||||+.|||++.+|.+||+|||.|-.++..-.+
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            9999999999975 467999999999999999999999987   799999999999999999999999999999998888


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      ..+..|||+.
T Consensus       186 RNTVIGTPFW  195 (502)
T KOG0574|consen  186 RNTVIGTPFW  195 (502)
T ss_pred             hCccccCccc
Confidence            8999999963

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=8.3e-26  Score=200.78  Aligned_cols=154  Identities=22%  Similarity=0.445  Sum_probs=134.8

Q ss_pred             ccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |+..+.+|+|-|.+|.     .+|..||||++.+-..+. -....+.+|+++|+.++|||||++|++..++.++|+|+|+
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            5566789999998875     489999999998765433 3446677799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCcccccccCCCC
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      -.+|+|.+|+-+. ..+.+..+.+|+.||+.|+.|+|+..   +|||||||+|+++. +-|.+||.|||++-.|.+++..
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL  175 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL  175 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence            9999999998665 45999999999999999999999998   99999999999876 5689999999999999988766


Q ss_pred             ceeec
Q 020981          310 PLTCQ  314 (319)
Q Consensus       310 ~~~~~  314 (319)
                      .++|.
T Consensus       176 ~TsCG  180 (864)
T KOG4717|consen  176 TTSCG  180 (864)
T ss_pred             hcccc
Confidence            66543

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.93  E-value=2.5e-26  Score=177.31  Aligned_cols=129  Identities=28%  Similarity=0.328  Sum_probs=122.3

Q ss_pred             cccccccccCchhhhhhhhhc-CCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            9 TTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      ||++-|++.+++...+.+.-. |.|+|..+..|.||||+||..|..+++++|++.||.|+.+|..|.||||.||..|+++
T Consensus        74 tPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklk  153 (226)
T KOG4412|consen   74 TPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLK  153 (226)
T ss_pred             chhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHhccchh
Confidence            799999999998888877766 9999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      ++++|+..|+.+|.+|+.|+||||.|...++.+...+|+++|++....+.
T Consensus       154 vie~Li~~~a~~n~qDk~G~TpL~~al~e~~~d~a~lLV~~gAd~~~edk  203 (226)
T KOG4412|consen  154 VIEYLISQGAPLNTQDKYGFTPLHHALAEGHPDVAVLLVRAGADTDREDK  203 (226)
T ss_pred             hHHHHHhcCCCCCcccccCccHHHHHHhccCchHHHHHHHhccceeeccc
Confidence            99999999999999999999999999888999999999999988765554

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.93  E-value=2.5e-27  Score=192.58  Aligned_cols=158  Identities=23%  Similarity=0.393  Sum_probs=136.0

Q ss_pred             cccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|...+.||+|.|+.|+     -+|+.+|+|.+....+... ..+.+.+|+++-+.++||||+++.+.+.+....|+|+|
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            46677889999999886     3789999999876655443 56789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC---CCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DFgla~~~~~~~  307 (319)
                      +|.|++|..-+..+..+++..+..+++||++||.|+|.++   |||||+||+|+++.+.   --+||+|||+|..+. +.
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g  166 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG  166 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence            9999999777766666889999999999999999999999   9999999999999743   348999999999988 44


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                      ..-.-.+|||-
T Consensus       167 ~~~~G~~GtP~  177 (355)
T KOG0033|consen  167 EAWHGFAGTPG  177 (355)
T ss_pred             cccccccCCCc
Confidence            45555677773

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.93  E-value=2.5e-25  Score=195.67  Aligned_cols=145  Identities=30%  Similarity=0.538  Sum_probs=125.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.||.     ++..||+|.+.....  ......+.+|+.+++.++||||+++++++......++|||
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            577788999999999984     478999999875432  1223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |++ ++|.+++...+ .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            996 59999887654 4788999999999999999999999   999999999999999999999999999865433

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PHA02988 hypothetical protein; Provisional

Probab=99.93  E-value=5.7e-25  Score=192.87  Aligned_cols=153  Identities=20%  Similarity=0.327  Sum_probs=129.6

Q ss_pred             cCCCcccccceeeeecceEEEEE---EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe----C
Q 020981          150 IDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S  222 (319)
Q Consensus       150 ~~~~~~~~~~~~~ig~G~f~~v~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~  222 (319)
                      ++....+......+++|+++.+|   ++|+.||+|.+...........+.+.+|+.++++++||||+++++++.+    .
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            33444444544578888887775   5789999999986544444446778899999999999999999999876    4


Q ss_pred             CceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      ...+++|||+++|+|.+++.+.+.+++.....++.|++.||.|||+. +   ++||||||+||++++++.+||+|||+++
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHh
Confidence            57899999999999999999888899999999999999999999985 6   8899999999999999999999999998


Q ss_pred             cccc
Q 020981          302 LLTV  305 (319)
Q Consensus       302 ~~~~  305 (319)
                      .+..
T Consensus       172 ~~~~  175 (283)
T PHA02988        172 ILSS  175 (283)
T ss_pred             hhcc
Confidence            7654

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=5.3e-25  Score=201.38  Aligned_cols=151  Identities=25%  Similarity=0.373  Sum_probs=129.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|...+.||.|+||.||.     +++.||+|....         ..+.+|+.+++.++||||+++++++......++++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            4688899999999999984     578899996432         34568999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC-CC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK-ED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~-~~  308 (319)
                      |++ +++|..++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+..... ..
T Consensus       163 e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        163 PRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             ecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            999 5799999988778999999999999999999999999   999999999999999999999999999764332 22


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      ......||+.
T Consensus       239 ~~~~~~gt~~  248 (391)
T PHA03212        239 KYYGWAGTIA  248 (391)
T ss_pred             ccccccCccC
Confidence            3334566663

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.93  E-value=8e-25  Score=193.85  Aligned_cols=145  Identities=32%  Similarity=0.560  Sum_probs=125.6

Q ss_pred             cccceeeeecceEEEEEEe---------------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccc
Q 020981          156 DFTNSVEITKGTFILAFWR---------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ  214 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~---------------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~  214 (319)
                      +|.....+|+|+||.||..                     +..||+|.+....  .......+.+|+.+++.++||||++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            5677789999999998742                     3469999987542  3445667889999999999999999


Q ss_pred             cceeEEeCCceEEEEeecCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 020981          215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------ALKPSTAVRFALDIARGMNYLHENKPVPII  275 (319)
Q Consensus       215 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~qi~~al~~lH~~~~~~iv  275 (319)
                      +++++...+..+++|||+++++|.+++....                   .+++..+..++.|++.||.|||+++   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999986532                   2566788899999999999999999   99


Q ss_pred             EcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          276 HRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       276 H~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||||||+|||++.++.+||+|||+++.+..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~  190 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYA  190 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceeccc
Confidence            999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=1.3e-24  Score=204.02  Aligned_cols=157  Identities=22%  Similarity=0.298  Sum_probs=131.9

Q ss_pred             cccceeeeecceEEEEEE-----e-ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~-~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .|.....+|+|++|.||.     + +..+|+|.+...   .......+.+|+.+++.++||||+++++.+...+..|+||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            478888999999998874     2 567888876432   3444567788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+++|+|.+++..    ..++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999988754    345889999999999999999999999   99999999999999999999999999998755


Q ss_pred             CCC--CceeeccCCC
Q 020981          306 KED--RPLTCQDTSC  318 (319)
Q Consensus       306 ~~~--~~~~~~~~~~  318 (319)
                      ...  .....+||+.
T Consensus       222 ~~~~~~~~~~~gt~~  236 (478)
T PTZ00267        222 SVSLDVASSFCGTPY  236 (478)
T ss_pred             ccccccccccCCCcc
Confidence            432  2234456664

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.93  E-value=1.5e-24  Score=194.38  Aligned_cols=147  Identities=30%  Similarity=0.449  Sum_probs=130.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|.|+||.||.     ++..+|+|.+....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            4688888999999999874     46789999987542  3445577899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+++  .|+||||||+|||++.++.+||+|||+++.+..
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999998888999999999999999999999863  299999999999999999999999999987643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.93  E-value=6.1e-25  Score=197.50  Aligned_cols=144  Identities=33%  Similarity=0.537  Sum_probs=122.7

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeC-C
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~  223 (319)
                      +|.....||.|+||.||..          +..||+|.+....  .......+.+|+.+++.+ +||||+++++++... .
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            5777889999999999752          3579999987432  234456788999999999 799999999987654 4


Q ss_pred             ceEEEEeecCCCCHHHHHHHc-----------------------------------------------------------
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK-----------------------------------------------------------  244 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~-----------------------------------------------------------  244 (319)
                      .++++|||+++|+|.+++...                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            689999999999999998753                                                           


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          245 ---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       245 ---~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                         .++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~  225 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  225 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccc
Confidence               23677888899999999999999999   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.1e-24  Score=191.22  Aligned_cols=146  Identities=27%  Similarity=0.395  Sum_probs=127.4

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |+....+|+|+||.||.     ++..||+|.+.............+.+|+.+++.++||||+++++.+..++..+++|||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            56678899999999874     4678999998765443333445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++..+..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999888653  35899999999999999999999999   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=1e-24  Score=195.84  Aligned_cols=143  Identities=28%  Similarity=0.514  Sum_probs=123.4

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-----ceE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PMM  226 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~~  226 (319)
                      |.....+|.|+||.||.     ++..||+|.+..... .......+.+|+.+++.++||||+++++++....     ..|
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            66778999999998874     578999999874322 2233456788999999999999999999875432     489


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +||||+ +++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            999999 5799999988888999999999999999999999999   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.92  E-value=2e-25  Score=205.22  Aligned_cols=156  Identities=28%  Similarity=0.416  Sum_probs=132.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC------c
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~  224 (319)
                      .|...+.+|+|+||.||.     +|+.||||..++..  .....+...+|+++|++++|||||+++++-....      .
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            355566899999999984     68999999988654  2334566788999999999999999998765433      5


Q ss_pred             eEEEEeecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec--CCC--CEEEEec
Q 020981          225 MMIVTEYLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSG--NLKVADF  297 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~DF  297 (319)
                      ..++||||.||||...+.+.   ..+++.++..+...++.||.|||+++   |+||||||.||++.  .+|  .-||+||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecc
Confidence            68999999999999999754   34999999999999999999999999   99999999999985  444  3699999


Q ss_pred             CcccccccCCCCceeeccCC
Q 020981          298 GVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       298 gla~~~~~~~~~~~~~~~~~  317 (319)
                      |.|+.+..+. ...+.+||+
T Consensus       169 G~Arel~d~s-~~~S~vGT~  187 (732)
T KOG4250|consen  169 GAARELDDNS-LFTSLVGTE  187 (732)
T ss_pred             cccccCCCCC-eeeeecCch
Confidence            9999988885 778889997

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.5e-25  Score=201.89  Aligned_cols=146  Identities=25%  Similarity=0.407  Sum_probs=133.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      -|...+-||-|+||.|..     +...||+|.+++...-..........|-.||..-.++-||+||..|++.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            466778899999998874     456799999988766566677778889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |++||++-++|-+.+.|++..++.|+.++.+|+++.|..|   +|||||||+|||||.+|++||+|||||.=+.
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence            9999999999999999999999999999999999999999   9999999999999999999999999997554

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.92  E-value=1.3e-24  Score=190.82  Aligned_cols=147  Identities=22%  Similarity=0.421  Sum_probs=126.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+|+.+|.     +++.+|+|++..... .....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            467788899999998874     467899999875432 22334667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |++++.+..+......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9988777655555556899999999999999999999999   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.92  E-value=2.5e-24  Score=193.23  Aligned_cols=146  Identities=32%  Similarity=0.502  Sum_probs=130.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|.|+||.||.     ++..+|+|.+....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            4678888999999999985     46789999887542  3445567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||++..+..
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999999888899999999999999999999975 5   99999999999999999999999999986643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.92  E-value=7.8e-25  Score=198.01  Aligned_cols=153  Identities=27%  Similarity=0.429  Sum_probs=127.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||.|+||.||.     +++.||+|++....  .......+.+|+.+++.++|+||+++++++.....+++|||
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            566777899999999984     47899999986432  33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |+++++|...    ...++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.......
T Consensus       153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            9999998653    23567778889999999999999999   9999999999999999999999999998765443322


Q ss_pred             eeeccCC
Q 020981          311 LTCQDTS  317 (319)
Q Consensus       311 ~~~~~~~  317 (319)
                      ....||+
T Consensus       226 ~~~~gt~  232 (353)
T PLN00034        226 NSSVGTI  232 (353)
T ss_pred             cccccCc
Confidence            3334554

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.92  E-value=2.6e-24  Score=209.50  Aligned_cols=145  Identities=22%  Similarity=0.361  Sum_probs=127.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     +++.||+|++.......+...+.+.+|+.+++.++||||+++++++...+..|++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            577788999999999985     478999999986554445556778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          231 YLPKGDLRAFLKRK-----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                      |++|++|.+++...           ..++...+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999998642           12455677889999999999999999   99999999999999999999999999


Q ss_pred             cccc
Q 020981          300 SKLL  303 (319)
Q Consensus       300 a~~~  303 (319)
                      ++..
T Consensus       160 Ak~i  163 (932)
T PRK13184        160 AIFK  163 (932)
T ss_pred             ceec
Confidence            9876

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.5e-26  Score=205.72  Aligned_cols=158  Identities=23%  Similarity=0.376  Sum_probs=140.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.+...+|.|+||.||.     ++...|.|++.   ..+.+..+.|.-|+++|..|.||+||++++.|..++.+|+..|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            466677899999999985     33445667664   2356778899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||.||....++-+- ..+++.++..+++|++.||.|||+++   |||||||+.|||++-+|.++|+|||.+......-.+
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            99999998887654 46999999999999999999999999   999999999999999999999999999988888888


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      ..++.||||.
T Consensus       187 RDsFIGTPYW  196 (1187)
T KOG0579|consen  187 RDSFIGTPYW  196 (1187)
T ss_pred             hccccCCccc
Confidence            8899999984

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=3.6e-24  Score=188.37  Aligned_cols=148  Identities=32%  Similarity=0.538  Sum_probs=132.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+|+.+|.     .++.+|+|.+.............+.+|+.++++++||||+++++.+......|++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            467778899999998873     478999999876544444556778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999988888999999999999999999999999   999999999999999999999999999876544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.92  E-value=2.9e-24  Score=195.68  Aligned_cols=146  Identities=28%  Similarity=0.461  Sum_probs=126.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-----ce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~  225 (319)
                      +|...+.||.|+||.||.     +++.||+|.+.... ......+.+.+|+.+++.++||||+++++++....     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            356778899999999884     57899999986532 23334567888999999999999999999998776     78


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+|+||+. ++|.+.+...+.+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++....
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            99999995 689998888788999999999999999999999999   99999999999999999999999999987654


Q ss_pred             C
Q 020981          306 K  306 (319)
Q Consensus       306 ~  306 (319)
                      .
T Consensus       156 ~  156 (372)
T cd07853         156 D  156 (372)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=6.8e-25  Score=184.69  Aligned_cols=139  Identities=24%  Similarity=0.409  Sum_probs=122.8

Q ss_pred             eeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEeecC
Q 020981          160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       160 ~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      .+.+|+|+|+.|.     .+|.+||||++.+..  .. ......+|++++..++ |+||++++++|+++..+|+|||-|.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gH-sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GH-SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--ch-HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            3468999998764     589999999998753  22 3355667999999996 9999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC---EEEEecCcccccc
Q 020981          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLT  304 (319)
Q Consensus       234 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DFgla~~~~  304 (319)
                      ||+|.+.+.++..+++.++.++.++|+.||.|||.+|   |.||||||+|||......   +|||||.|+.-+.
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence            9999999999999999999999999999999999999   999999999999976554   8999999887553

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.92  E-value=5.6e-24  Score=184.70  Aligned_cols=146  Identities=27%  Similarity=0.462  Sum_probs=129.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|.|+||.+|.     ++..+|+|++....   ......+.+|+.+++.++||||+++++.+......++||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            3688888999999998874     46789999986432   223456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+++++|.+++...+.+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..+...
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            99999999999988788999999999999999999999998   999999999999999999999999999876443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.92  E-value=5.1e-24  Score=186.26  Aligned_cols=141  Identities=26%  Similarity=0.410  Sum_probs=121.7

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      ||+|+||.||.     +|+.+|+|.+.............+..|+.+++.++||||+++++.+......|++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            58899998874     4789999998764443333344566799999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       238 ~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      .+++....  .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            98886543  4788888999999999999999999   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.92  E-value=3.2e-24  Score=195.50  Aligned_cols=145  Identities=33%  Similarity=0.510  Sum_probs=125.1

Q ss_pred             cccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCc
Q 020981          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  224 (319)
                      +|...+.||+|+||.||.          ++..||+|++....  .....+.+.+|+.+++.+ +||||+++++.+.....
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            567788999999999874          24589999987443  223446788899999999 79999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcC-----------------------------------------------------------
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG-----------------------------------------------------------  245 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  245 (319)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986532                                                           


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       246 ----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                                      .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.+..
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                            3677888899999999999999999   99999999999999999999999999986644

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.92  E-value=8.4e-24  Score=185.66  Aligned_cols=146  Identities=27%  Similarity=0.409  Sum_probs=127.3

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....||+|+||.+|.     +++.+|+|.+.............+.+|+.+++.++|++++++++.+...+..|++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            55667899999999874     5779999998765444444445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            9999999988654  34889999999999999999999999   99999999999999999999999999976544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-24  Score=204.13  Aligned_cols=149  Identities=25%  Similarity=0.486  Sum_probs=127.1

Q ss_pred             CcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCccccccee-EEe----
Q 020981          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGA-VTQ----  221 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~-~~~----  221 (319)
                      ....++..+.|.+|+|..||.     .|..+|+|++-.   .+....+..++|+++|+.|+ |+|||.+++. ...    
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            334677788999999999995     248999998753   35677889999999999997 9999999993 321    


Q ss_pred             --CCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          222 --SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       222 --~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                        .-.++|.||||.||+|-+++.++  ..|++.++++|+.|+++|+.+||...| ||||||||.+||||+.+|..|||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeCcc
Confidence              13578999999999999999853  459999999999999999999999985 6999999999999999999999999


Q ss_pred             Cccccccc
Q 020981          298 GVSKLLTV  305 (319)
Q Consensus       298 gla~~~~~  305 (319)
                      |.|..-..
T Consensus       191 GSatt~~~  198 (738)
T KOG1989|consen  191 GSATTKIL  198 (738)
T ss_pred             cccccccC
Confidence            99875433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.92  E-value=5.8e-25  Score=206.27  Aligned_cols=143  Identities=35%  Similarity=0.621  Sum_probs=127.3

Q ss_pred             cccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +....+++|+|.||.||.          ..+.||||.++...  +....++|++|++++..++|||||+++|+|..++++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            344456899999999984          35689999998653  455778999999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC
Q 020981          226 MIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      |+|+|||..|||.+||....              +++..+.+.++.||+.||+||-++.   +|||||..+|+||.+...
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999997431              2778899999999999999999999   999999999999999999


Q ss_pred             EEEEecCccccc
Q 020981          292 LKVADFGVSKLL  303 (319)
Q Consensus       292 ~kl~DFgla~~~  303 (319)
                      +||+||||+|.+
T Consensus       642 VKIsDfGLsRdi  653 (774)
T KOG1026|consen  642 VKISDFGLSRDI  653 (774)
T ss_pred             EEecccccchhh
Confidence            999999999865

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=8.5e-24  Score=198.85  Aligned_cols=163  Identities=22%  Similarity=0.297  Sum_probs=133.6

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC---
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---  223 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---  223 (319)
                      ....+|.....||+|+||.||.     +++.||+|.+..... .......+.+|+.++..++|+|++++...+....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3345788899999999999874     478999999876543 3445567888999999999999999887765332   


Q ss_pred             -----ceEEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEE
Q 020981          224 -----PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV  294 (319)
Q Consensus       224 -----~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl  294 (319)
                           .+++||||+++|+|.++++..    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 368999999999999998753    35889999999999999999999999   999999999999999999999


Q ss_pred             EecCcccccccCC--CCceeeccCCC
Q 020981          295 ADFGVSKLLTVKE--DRPLTCQDTSC  318 (319)
Q Consensus       295 ~DFgla~~~~~~~--~~~~~~~~~~~  318 (319)
                      +|||+++.+....  .......||+.
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~  210 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPY  210 (496)
T ss_pred             EecccCeeccccccccccccccCCcc
Confidence            9999998775432  22234556664

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.91  E-value=2.8e-24  Score=185.56  Aligned_cols=143  Identities=33%  Similarity=0.607  Sum_probs=126.4

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |...+.||+|+||.||.     .++.+|+|.+....... .......+|+.+++.++||||+++++++......+++||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence            45678899999999985     46789999998654322 2223345699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      +++++|.+++...+.+++..+..++.|++.||.+||+++   ++|+||||+||+++.++.++|+|||++..+
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            998899999997788999999999999999999999999   999999999999999999999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=9.1e-25  Score=189.60  Aligned_cols=162  Identities=31%  Similarity=0.399  Sum_probs=146.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .+|.-...+|+|+||.|..     +...+|||+++++.+...+..+.-..|-++|.... -|+++++..+|++-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            3677788999999999875     34679999999988766666666777888888885 67899999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||+.||+|--.+++-+++.+..+..|+.+|+.||-+||+++   ||.||||.+|||++.+|++||+|||+++.-.-+..
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCc
Confidence            999999999999999999999999999999999999999999   99999999999999999999999999998877777


Q ss_pred             CceeeccCCCC
Q 020981          309 RPLTCQDTSCR  319 (319)
Q Consensus       309 ~~~~~~~~~~~  319 (319)
                      ...+.+|||-|
T Consensus       506 TTkTFCGTPdY  516 (683)
T KOG0696|consen  506 TTKTFCGTPDY  516 (683)
T ss_pred             ceeeecCCCcc
Confidence            88889999954

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.91  E-value=7.6e-24  Score=183.82  Aligned_cols=147  Identities=24%  Similarity=0.496  Sum_probs=128.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.+|.|+|+.+|.     ++..+|+|.+.............+.+|+.+++.++|||++++++.+...+..++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            567788899999998873     578999998875444455566778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988853    234788999999999999999999999   99999999999999999999999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.91  E-value=1.2e-23  Score=184.64  Aligned_cols=146  Identities=25%  Similarity=0.376  Sum_probs=127.0

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|+||.+|.     +++.+|+|.+.............+.+|+.+++.++|++++.+++.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            45667899999999875     4778999998765444344445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+||++++++.+||+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            9999999888653  35899999999999999999999999   99999999999999999999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.91  E-value=3.4e-25  Score=198.88  Aligned_cols=154  Identities=37%  Similarity=0.523  Sum_probs=131.2

Q ss_pred             ccccCCCcccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  223 (319)
                      .|+++...  +....-+|.|+-|.||.   .+..||||+++.-          -..++.-|+.|+||||+.+.|+|....
T Consensus       118 ~WeiPFe~--IsELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP  185 (904)
T KOG4721|consen  118 LWEIPFEE--ISELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP  185 (904)
T ss_pred             hccCCHHH--hhhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence            45554432  22334578888888874   6889999988632          124788999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .+|||||||..|-|..+|+..+++++...+.|..+|+.||.|||.+.   |||||||.-||||..+..+||+|||-++.+
T Consensus       186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence            99999999999999999999999999999999999999999999999   999999999999999999999999999988


Q ss_pred             ccCCCCceeeccC
Q 020981          304 TVKEDRPLTCQDT  316 (319)
Q Consensus       304 ~~~~~~~~~~~~~  316 (319)
                      ... +...+++||
T Consensus       263 ~~~-STkMSFaGT  274 (904)
T KOG4721|consen  263 SDK-STKMSFAGT  274 (904)
T ss_pred             hhh-hhhhhhhhh
Confidence            776 444445555

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.91  E-value=1.4e-23  Score=182.32  Aligned_cols=144  Identities=28%  Similarity=0.430  Sum_probs=126.7

Q ss_pred             ccccceeeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      .+|.....+|+|+||.||.        .+..+|+|.+....  .......+.+|+..++.++||||+++++++..+...+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3577788899999999863        25689999987542  3344567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      +||||+++|+|.+++... ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+|++|||.+...
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            999999999999999764 46899999999999999999999999   999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.91  E-value=7.1e-24  Score=184.08  Aligned_cols=145  Identities=28%  Similarity=0.491  Sum_probs=129.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+|+.+|.     ++..+|+|.++...   ......+.+|+.+++.++||||+++++.+......|++||
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            577778899999998874     47899999986542   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998766433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.91  E-value=5.6e-24  Score=193.75  Aligned_cols=145  Identities=32%  Similarity=0.545  Sum_probs=125.2

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCc
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  224 (319)
                      +|...+.+|+|+||.||..          +..||+|.+....  .......+.+|+.+++.+ +|+||+++++.+.....
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            5777889999999988741          2479999987543  234456788999999999 79999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHc------------------------------------------------------------
Q 020981          225 MMIVTEYLPKGDLRAFLKRK------------------------------------------------------------  244 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~------------------------------------------------------------  244 (319)
                      .++||||+++|+|.+++...                                                            
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            99999999999999998642                                                            


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          245 ----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       245 ----------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                                .++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence                      13677888999999999999999999   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.91  E-value=6.7e-24  Score=188.38  Aligned_cols=145  Identities=30%  Similarity=0.526  Sum_probs=124.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.+|.|+||.||.     ++..+|+|.+......  .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            577888999999999985     4678999998754321  222356679999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |++ ++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....+
T Consensus        85 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          85 YLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            996 58888876543 4788999999999999999999999   999999999999999999999999999865443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.91  E-value=6.5e-24  Score=194.21  Aligned_cols=143  Identities=31%  Similarity=0.417  Sum_probs=124.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-C-----CcccccceeEEeCCc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H-----PNVVQFLGAVTQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~l~~~~~~~~~  224 (319)
                      .|...+.||+|+||.|..     +++.||||+++..    .....+-..|+.+|..++ |     -|+|+++++|..+++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            567789999999998863     6899999999853    344556677999999997 3     389999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC--CCEEEEecCcc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVS  300 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DFgla  300 (319)
                      +|||+|.+ ..+|.++++.++  .++...++.|+.||+.||.+||+.+   |||+||||+||||...  ..+||+|||.|
T Consensus       263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence            99999999 579999999875  4889999999999999999999999   9999999999999854  37999999999


Q ss_pred             cccccC
Q 020981          301 KLLTVK  306 (319)
Q Consensus       301 ~~~~~~  306 (319)
                      .+....
T Consensus       339 c~~~q~  344 (586)
T KOG0667|consen  339 CFESQR  344 (586)
T ss_pred             cccCCc
Confidence            876554

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-25  Score=198.47  Aligned_cols=160  Identities=25%  Similarity=0.349  Sum_probs=146.1

Q ss_pred             ccccceeeeecceEEEEE---EeceE--eEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAF---WRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~---~~~~~--vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .++.....+|.|+||.|-   ..++.  +|+|.+++..+.+..+.+.+..|-.+|..++.|+||++|..|.++.+.|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            356667789999999774   34444  8999999888888888888999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      |-|-||.++..+..++.+.+..++.++.-+++|++|||+++   ||.|||||+|++++.+|.+||.|||+|+.+..+ .+
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~K  575 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RK  575 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-Cc
Confidence            99999999999999999999999999999999999999999   999999999999999999999999999998877 67


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                      .++++|||-
T Consensus       576 TwTFcGTpE  584 (732)
T KOG0614|consen  576 TWTFCGTPE  584 (732)
T ss_pred             eeeecCCcc
Confidence            788999993

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=2.7e-23  Score=180.18  Aligned_cols=149  Identities=27%  Similarity=0.525  Sum_probs=130.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.+|.|+|+.+|.     +++.+|+|.++............+.+|+.++++++|++++++++.+...+..+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            567778899999998874     578999999875444445556788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999864    234789999999999999999999999   999999999999999999999999999876544


Q ss_pred             C
Q 020981          307 E  307 (319)
Q Consensus       307 ~  307 (319)
                      .
T Consensus       160 ~  160 (267)
T cd08224         160 T  160 (267)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-24  Score=194.95  Aligned_cols=145  Identities=33%  Similarity=0.567  Sum_probs=126.4

Q ss_pred             ccceeeeecceEEEEEE---e-ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          157 FTNSVEITKGTFILAFW---R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~---~-~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      ....++||+|.||.+..   . +..||||.++...  .......|..|+.+|.+|+||||++++|+|..++++++++|||
T Consensus       540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             eehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            44567899999997753   3 4899999998754  3455688999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          233 PKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       233 ~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++|+|.+|+.++..  .......+++.||++||+||.+.+   +||||+.+.|+|++.++++||+|||+++.+-.+
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence            99999999987632  345566789999999999999999   999999999999999999999999999965443

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.91  E-value=2.9e-23  Score=178.90  Aligned_cols=158  Identities=29%  Similarity=0.435  Sum_probs=133.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+++.+|.     .+..+++|.+...... ......+.+|+.+++.++|||++++++.+......|++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            356667899999988874     4688999998754333 3455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       231 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999999774  46889999999999999999999998   99999999999999999999999999987765443


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                      ......|++
T Consensus       157 ~~~~~~~~~  165 (256)
T cd08529         157 FANTIVGTP  165 (256)
T ss_pred             hhhccccCc
Confidence            333333433

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.91  E-value=2.4e-23  Score=179.59  Aligned_cols=147  Identities=24%  Similarity=0.446  Sum_probs=128.9

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |...+.+|.|+||.++.     ++..+++|.+...... ......+.+|+.++++++|+||+++++++......+++|||
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            66778899999996653     4788999998754433 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            9999999999765  45889999999999999999999999   9999999999999999999999999998775544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.8e-23  Score=179.76  Aligned_cols=146  Identities=34%  Similarity=0.621  Sum_probs=129.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .|.....+|.|+++.+|.     +++.+|+|.+......  .......+.+|+.+++.++||||+++++++..+...+++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            477788999999998874     4789999998654322  123346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+++.+.
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999988888999999999999999999999999   9999999999999999999999999997654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.91  E-value=3.6e-23  Score=183.65  Aligned_cols=144  Identities=32%  Similarity=0.505  Sum_probs=128.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.||.     ++..+|+|.+....  .......+.+|+++++.++||||+++++++..++..+++||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            577788999999998874     46788999886432  34445678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.+||+|||++....
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            99999999999888889999999999999999999997 46   9999999999999999999999999987654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.91  E-value=1.9e-23  Score=181.37  Aligned_cols=148  Identities=25%  Similarity=0.521  Sum_probs=128.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|++|.+|.     ++..+++|.+.............+.+|+.+++.++||||+++++++......+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            456677899999998873     578999998875444444555778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..+...
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999998864    345889999999999999999999999   999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=2.2e-23  Score=183.99  Aligned_cols=146  Identities=32%  Similarity=0.564  Sum_probs=127.5

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      |.....+|.|+++.+|.     +++.||+|.+......  .......+..|+.+++.++|+||+++++++......++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            55667899999998874     4679999998765433  1223455678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+ +++|.+++.... .+++..+..++.|+++||.|||+++   ++|+||||+||+++.++.+||+|||+++.....
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            999 899999998766 7999999999999999999999999   999999999999999999999999999877554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1e-24  Score=191.18  Aligned_cols=162  Identities=25%  Similarity=0.349  Sum_probs=142.7

Q ss_pred             CcccccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ....|.....+|+|+||.|+     -+|+-+|.|.+.++.+..........+|-.+|++++.++||.+--.|.+.+.+|+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            33467778899999999776     3799999999988877766666778889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          228 VTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+..|.||+|.-+|.+.+  .+++..++.|+.+|+.||++||+.+   ||.||+||+|||+|+.|+++|+|+|||..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999887765  5999999999999999999999999   99999999999999999999999999998877


Q ss_pred             CCCCceeeccCCC
Q 020981          306 KEDRPLTCQDTSC  318 (319)
Q Consensus       306 ~~~~~~~~~~~~~  318 (319)
                      ++.... -+||..
T Consensus       340 g~~~~~-rvGT~G  351 (591)
T KOG0986|consen  340 GKPIRG-RVGTVG  351 (591)
T ss_pred             CCcccc-ccCccc
Confidence            643332 377764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.1e-24  Score=182.94  Aligned_cols=161  Identities=27%  Similarity=0.402  Sum_probs=150.6

Q ss_pred             ccccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEE
Q 020981          155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .+|.....||+|+|..|.     .+.+.+|+|+++++...+.+...+.+.|-.+..+- +||++|-+..+|+++..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            478889999999998764     46789999999999888888889999999999887 499999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      .||++||+|-..++++++++++.++.+..+|+.||.|||++|   ||.||||.+|+|+|..|++||+|+|+++.-..+.+
T Consensus       330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            999999999999998889999999999999999999999999   99999999999999999999999999999988889


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      ...+.+|||-
T Consensus       407 ~tstfcgtpn  416 (593)
T KOG0695|consen  407 TTSTFCGTPN  416 (593)
T ss_pred             ccccccCCCc
Confidence            9999999994

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.90  E-value=2.9e-23  Score=183.94  Aligned_cols=144  Identities=28%  Similarity=0.482  Sum_probs=128.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.+|+|+|+.+|.     .++.|++|.+.............+.+|+.+++.++||||+++++.+..+...+++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            466778899999998873     467899999876544344455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            9999999999988888999999999999999999999998   99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.90  E-value=7.3e-23  Score=176.50  Aligned_cols=146  Identities=28%  Similarity=0.493  Sum_probs=127.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.+|.|+||.++.     ++..+|+|.+....  .....+.+.+|+.+++.++|||++++++.+..+...|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            366778999999998863     57889999886432  23445678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+++   ++|+||||+||++++++.++|+|||++..+...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            99999999988653  34789999999999999999999999   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=5.1e-23  Score=177.94  Aligned_cols=146  Identities=33%  Similarity=0.541  Sum_probs=129.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|.|+|+.+|.     ++..+++|.+....   ....+.+.+|+.+++.++|||++++++.+......|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            3577788899999998874     35789999987542   235578889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            999999999999876 67999999999999999999999999   999999999999999999999999999876543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.90  E-value=3.1e-23  Score=188.02  Aligned_cols=144  Identities=28%  Similarity=0.425  Sum_probs=121.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC------
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------  223 (319)
                      .+|.....||.|+||.||.     +|..+|+|.+..... .......+.+|+.+++.++||||+++++++....      
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            3688889999999999874     478999999875432 3344566778999999999999999999886543      


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ..|+||||++ ++|...+..  .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         100 DVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             eeEEEEeCCC-cCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            4799999996 567666643  4788899999999999999999999   999999999999999999999999999865


Q ss_pred             cc
Q 020981          304 TV  305 (319)
Q Consensus       304 ~~  305 (319)
                      ..
T Consensus       174 ~~  175 (359)
T cd07876         174 CT  175 (359)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.90  E-value=3.1e-23  Score=190.08  Aligned_cols=145  Identities=30%  Similarity=0.500  Sum_probs=124.4

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCc
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~  224 (319)
                      +|.....||.|+||.||..          +..||+|.+....  .....+.+.+|+.+++.+. ||||+++++++.....
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            5677789999999999742          2369999987542  3344567889999999996 9999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHc------------------------------------------------------------
Q 020981          225 MMIVTEYLPKGDLRAFLKRK------------------------------------------------------------  244 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~------------------------------------------------------------  244 (319)
                      .|+||||+++|+|.+++..+                                                            
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            99999999999999988643                                                            


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC
Q 020981          245 ------------------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD  288 (319)
Q Consensus       245 ------------------------------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~  288 (319)
                                                          ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                                13667778899999999999999999   999999999999999


Q ss_pred             CCCEEEEecCccccccc
Q 020981          289 SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       289 ~~~~kl~DFgla~~~~~  305 (319)
                      ++.+||+|||+++.+..
T Consensus       273 ~~~~kL~DfGla~~~~~  289 (400)
T cd05105         273 GKIVKICDFGLARDIMH  289 (400)
T ss_pred             CCEEEEEeCCcceeccc
Confidence            99999999999986643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.90  E-value=3.2e-24  Score=198.74  Aligned_cols=155  Identities=34%  Similarity=0.521  Sum_probs=136.9

Q ss_pred             cccceeeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ...+.+.||.|.||.|+.        +...||||.++.  .....+...|..|..+|.++.||||++|.|+.....+..|
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~--GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA--GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeecc--CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            455677899999999984        346899999974  3456677889999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |.|||++|+|+.||.++ +.++..+..-+.+.|+.||.||-..+   +|||||.++|||++.+-.+|++||||+|.+.++
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999999876 45888999999999999999999999   999999999999999999999999999998777


Q ss_pred             CCCceeecc
Q 020981          307 EDRPLTCQD  315 (319)
Q Consensus       307 ~~~~~~~~~  315 (319)
                      .+..++..|
T Consensus       785 ~~~~ytt~G  793 (996)
T KOG0196|consen  785 PEAAYTTLG  793 (996)
T ss_pred             CCccccccC
Confidence            655554443

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.90  E-value=3e-23  Score=192.71  Aligned_cols=151  Identities=24%  Similarity=0.401  Sum_probs=120.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-------
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------  222 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-------  222 (319)
                      .+|.....+|+|+||.||.     +++.||||.+....       ....+|+.+++.++||||+++++++...       
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            4688889999999999984     46899999886432       1234699999999999999998876432       


Q ss_pred             -CceEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEe
Q 020981          223 -SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVAD  296 (319)
Q Consensus       223 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~D  296 (319)
                       ..+++||||++ +++.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence             24679999996 577776643    456899999999999999999999999   99999999999999665 799999


Q ss_pred             cCcccccccCCCCceeeccCC
Q 020981          297 FGVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       297 Fgla~~~~~~~~~~~~~~~~~  317 (319)
                      ||+|+.+..... .....||+
T Consensus       215 FGla~~~~~~~~-~~~~~~t~  234 (440)
T PTZ00036        215 FGSAKNLLAGQR-SVSYICSR  234 (440)
T ss_pred             cccchhccCCCC-cccCCCCc
Confidence            999997765432 22344555

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.90  E-value=2.8e-23  Score=179.42  Aligned_cols=147  Identities=29%  Similarity=0.450  Sum_probs=132.2

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |...+.+|.|+|+.+|.     ++..+|+|.+.+.........+.+.+|+.++++++||||+++++.+......++++||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            66778899999988774     4789999999876555545667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +.+++|.+++.....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999999988778999999999999999999999999   999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=2.3e-23  Score=190.94  Aligned_cols=139  Identities=26%  Similarity=0.401  Sum_probs=123.3

Q ss_pred             cccceeeeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      +|.....+|.|+||.||.       .+..+|+|.+...        ....+|+.+++.++||||+++++.+......|++
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            688889999999999884       2467899987642        2245799999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||++ +++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       165 ~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9999 4789999977778999999999999999999999999   999999999999999999999999999876554

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.90  E-value=4.5e-23  Score=183.68  Aligned_cols=146  Identities=28%  Similarity=0.543  Sum_probs=125.3

Q ss_pred             ccccceeeeecceEEEEEEe-----ce----EeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          155 LDFTNSVEITKGTFILAFWR-----GI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~-----~~----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      .+|.....+|+|+||.||..     +.    .||+|.+...  ......+.+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            46888899999999998742     22    4899998643  2334456788999999999999999999988764 57


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++++||+++|+|.+++..+. .+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            89999999999999998753 5888899999999999999999999   9999999999999999999999999999775


Q ss_pred             cC
Q 020981          305 VK  306 (319)
Q Consensus       305 ~~  306 (319)
                      ..
T Consensus       161 ~~  162 (316)
T cd05108         161 AD  162 (316)
T ss_pred             CC
Confidence            44

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.90  E-value=4.6e-23  Score=180.61  Aligned_cols=145  Identities=31%  Similarity=0.529  Sum_probs=125.4

Q ss_pred             cccceeeeecceEEEEEE---------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      +|.....+|+|+||.||.         .+..+++|.+...  ........+.+|+.+++.++||||+++++++......|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            466678899999998875         2368999988743  23445567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC
Q 020981          227 IVTEYLPKGDLRAFLKRK-----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~  289 (319)
                      ++|||+++++|.+++..+                 ..+++..+..++.|++.||.|||+++   ++||||||+|||++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence            999999999999998632                 23678888999999999999999999   9999999999999999


Q ss_pred             CCEEEEecCccccccc
Q 020981          290 GNLKVADFGVSKLLTV  305 (319)
Q Consensus       290 ~~~kl~DFgla~~~~~  305 (319)
                      +.+||+|||+++....
T Consensus       161 ~~~kl~dfg~~~~~~~  176 (283)
T cd05090         161 LHVKISDLGLSREIYS  176 (283)
T ss_pred             CcEEeccccccccccC
Confidence            9999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.2e-23  Score=181.25  Aligned_cols=145  Identities=28%  Similarity=0.435  Sum_probs=128.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.+|.     ++..+|+|.+...   .....+.+.+|+.+++.++|||++++++.+..+...|+|||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            467777899999998874     4678999998643   34555778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999998764 46899999999999999999999999   999999999999999999999999998766443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.90  E-value=6.6e-23  Score=179.66  Aligned_cols=146  Identities=32%  Similarity=0.582  Sum_probs=126.1

Q ss_pred             ccccceeeeecceEEEEEE---------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--CC
Q 020981          155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SS  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~  223 (319)
                      .+|.....+|.|+||.+|.         .+..||+|.+...   .....+.+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4677788999999999875         3678999998643   34445678899999999999999999987643  34


Q ss_pred             ceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            689999999999999999764 45889999999999999999999999   99999999999999999999999999987


Q ss_pred             cccC
Q 020981          303 LTVK  306 (319)
Q Consensus       303 ~~~~  306 (319)
                      ....
T Consensus       158 ~~~~  161 (284)
T cd05081         158 LPQD  161 (284)
T ss_pred             ccCC
Confidence            6543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.90  E-value=4.8e-23  Score=181.86  Aligned_cols=156  Identities=22%  Similarity=0.433  Sum_probs=132.1

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ..|.....+|.|+++.+|.     .++.+++|.+.....   ...+.+.+|+.+++.++|||++++++.+......|+||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            4678888999999998874     467999998875432   23466888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999999865 45889999999999999999999999   999999999999999999999999999876554333


Q ss_pred             ceeeccCC
Q 020981          310 PLTCQDTS  317 (319)
Q Consensus       310 ~~~~~~~~  317 (319)
                      .....|++
T Consensus       173 ~~~~~~~~  180 (296)
T cd06654         173 RSTMVGTP  180 (296)
T ss_pred             cCcccCCc
Confidence            33334443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.90  E-value=6e-23  Score=177.74  Aligned_cols=140  Identities=38%  Similarity=0.688  Sum_probs=122.6

Q ss_pred             ceeeeecceEEEEEE---e------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          159 NSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       159 ~~~~ig~G~f~~v~~---~------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ....||.|.||.|+.   .      +..|+||.+...  ......+.+.+|+..+++++||||+++++++......++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence            456899999998874   4      678999999542  34555788999999999999999999999999888899999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       230 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ||+++|+|.+++...  ..+++.....++.|++.||.|||+++   ++|++|+++||+++.++.+||+|||++...
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            999999999999987  56899999999999999999999999   999999999999999999999999999877

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.90  E-value=8.1e-23  Score=177.29  Aligned_cols=146  Identities=33%  Similarity=0.578  Sum_probs=126.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEeccccc--CCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~  226 (319)
                      +|.....+|+|+||.+|.     ++..||+|.+.....  ........+.+|+.+++.++||||+++++++...  ..++
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            577788999999998874     478999998764321  2234457888999999999999999999988663  4688


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++|||+++++|.+++.+...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||+++...
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            99999999999999988777899999999999999999999999   9999999999999999999999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.90  E-value=9.5e-23  Score=179.49  Aligned_cols=144  Identities=28%  Similarity=0.461  Sum_probs=127.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....+|.|+||.+|.     .+..+++|.+...   .....+.+.+|+.+++.++|||++++++.+..+...|+|||
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            477788899999999884     4688999998643   34556778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|..++.+ ...+++..+..++.|++.+|.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            9999999888765 356899999999999999999999999   99999999999999999999999999876543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.90  E-value=4.2e-23  Score=177.67  Aligned_cols=138  Identities=36%  Similarity=0.572  Sum_probs=122.2

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~  236 (319)
                      .+|+|+||.||.     ++..+|+|.+....  ..+....+.+|+.+++.++||||+++++++......++||||+++++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            579999998874     57789999876432  34455678899999999999999999999999999999999999999


Q ss_pred             HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          237 LRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       237 L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |.+++...+ .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence            999997654 5889999999999999999999999   9999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.90  E-value=5.1e-23  Score=181.74  Aligned_cols=156  Identities=23%  Similarity=0.437  Sum_probs=132.1

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|.|+||.+|.     .++.||+|.+.....   ...+.+.+|+.+++.++|||++++++.+......|+||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            4688888999999998874     578999999875432   23356788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.........
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999999999865 45788999999999999999999998   999999999999999999999999999876554333


Q ss_pred             ceeeccCC
Q 020981          310 PLTCQDTS  317 (319)
Q Consensus       310 ~~~~~~~~  317 (319)
                      .....+++
T Consensus       172 ~~~~~~~~  179 (297)
T cd06656         172 RSTMVGTP  179 (297)
T ss_pred             cCcccCCc
Confidence            33333443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.90  E-value=5.8e-23  Score=180.56  Aligned_cols=146  Identities=29%  Similarity=0.550  Sum_probs=118.6

Q ss_pred             cccceeeeecceEEEEEE------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc---CCCcccccceeEE-----e
Q 020981          156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT-----Q  221 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~-----~  221 (319)
                      +|.....+|+|+||.||.      .+..+|+|.+....... .....+.+|+.+++.+   .||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            467778999999999884      25789999887543222 1223445677777665   6999999999875     2


Q ss_pred             CCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                      ...++++|||+. ++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999995 6999998754  34889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccC
Q 020981          300 SKLLTVK  306 (319)
Q Consensus       300 a~~~~~~  306 (319)
                      ++.+...
T Consensus       157 ~~~~~~~  163 (290)
T cd07862         157 ARIYSFQ  163 (290)
T ss_pred             eEeccCC
Confidence            9876544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.90  E-value=4.9e-23  Score=177.74  Aligned_cols=142  Identities=34%  Similarity=0.621  Sum_probs=123.9

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|...+.+|.|+|+.+|.    .+..+|+|.+.....    ....+.+|+.+++.++||||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            466677899999998874    345899998764322    124678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +++|+|.+++... ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            9999999998754 45889999999999999999999999   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.90  E-value=5.9e-23  Score=178.08  Aligned_cols=145  Identities=28%  Similarity=0.581  Sum_probs=128.0

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccC---CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      +|.....+|.|+||.+|.    +++.+|+|.+......   .......+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            356677899999998874    5678999988654321   233456688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      +||+++++|.+++.+...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            999999999999988778899999999999999999999999   999999999999999999999999998765

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.90  E-value=6.6e-23  Score=177.50  Aligned_cols=141  Identities=26%  Similarity=0.424  Sum_probs=125.6

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      +|.|+++.+|.     .+..+++|.+.+.........+.+.+|+.+++.++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            46777777663     3789999999866554445567899999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       238 ~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      .+++.+...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||+++.....
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            999988777999999999999999999999999   999999999999999999999999999877654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.90  E-value=5.5e-23  Score=178.72  Aligned_cols=137  Identities=30%  Similarity=0.493  Sum_probs=117.0

Q ss_pred             eeecceEEEEEEe-------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          162 EITKGTFILAFWR-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       162 ~ig~G~f~~v~~~-------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      ++|+|+||.||..       ...+++|.+....  .......+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            5799999988742       2467888765432  334456788899999999999999999999999999999999999


Q ss_pred             CCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          235 GDLRAFLKRKGA-----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       235 g~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |+|.+++.....     .++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence            999999976432     456778899999999999999999   999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.90  E-value=8.7e-23  Score=178.85  Aligned_cols=143  Identities=31%  Similarity=0.571  Sum_probs=123.3

Q ss_pred             ccceeeeecceEEEEEE---------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--Cce
Q 020981          157 FTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM  225 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~  225 (319)
                      +.....+|+|+||.|+.         .+..+|+|.+....  .......+.+|+.+++.++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            36677899999998853         35689999987542  233456788899999999999999999987653  458


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++|||+++++|.+++... .+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            9999999999999999764 5899999999999999999999999   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.90  E-value=2.9e-24  Score=180.31  Aligned_cols=148  Identities=28%  Similarity=0.462  Sum_probs=124.0

Q ss_pred             ccccceeeeecceEEEEEEe---------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-CCc
Q 020981          155 LDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~---------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~  224 (319)
                      ..|....+||+|+||.||..         ...+|+|.+....-.+ ..-....+|+.+++.++|||++.+..++.. +..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            36778889999999999963         3479999987542111 112345679999999999999999998877 788


Q ss_pred             eEEEEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC----CCEEEE
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVA  295 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~  295 (319)
                      .++++||.+. +|...++-.     +.++...+..++.||+.|+.|||++=   |+||||||.|||+.-+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            9999999965 999998632     34889999999999999999999998   9999999999999866    899999


Q ss_pred             ecCcccccccCC
Q 020981          296 DFGVSKLLTVKE  307 (319)
Q Consensus       296 DFgla~~~~~~~  307 (319)
                      |||+|+.+..+-
T Consensus       179 DlGlaR~~~~pl  190 (438)
T KOG0666|consen  179 DLGLARLFNNPL  190 (438)
T ss_pred             cccHHHHhhccc
Confidence            999999997663

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-23  Score=203.03  Aligned_cols=143  Identities=38%  Similarity=0.620  Sum_probs=127.7

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      .......||+|.||.||..          ...||+|.+.+.  .+.+....|.+|..+|+.++|||||+++|++.+....
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4455668999999999841          245888888753  4677889999999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecC
Q 020981          226 MIVTEYLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFg  298 (319)
                      +|++|||++|+|..||++.       ..++......|+.||++|++||++++   +|||||.++|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999876       23888999999999999999999999   9999999999999999999999999


Q ss_pred             ccccc
Q 020981          299 VSKLL  303 (319)
Q Consensus       299 la~~~  303 (319)
                      +|+.+
T Consensus       848 lArDi  852 (1025)
T KOG1095|consen  848 LARDI  852 (1025)
T ss_pred             hhHhh
Confidence            99943

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=7.4e-23  Score=176.56  Aligned_cols=143  Identities=39%  Similarity=0.669  Sum_probs=128.3

Q ss_pred             ccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      .+|.....+|.|+||.||.   .|+.+|+|.+....    ...+.+.+|+.+++.++|+|++++++.+......+++|||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            3567778899999998874   68899999987543    1456788899999999999999999999989999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       232 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +++++|.+++....  .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            99999999998765  6899999999999999999999999   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.90  E-value=1.1e-22  Score=176.52  Aligned_cols=144  Identities=36%  Similarity=0.548  Sum_probs=127.5

Q ss_pred             cccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|.....+|+|+||.||..        ...+|+|.+....  .......+.+|+.+++.++||||+++++.+......++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            5777889999999988742        3478999886542  34455678889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +|||+++++|.+++... +.+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999999764 46899999999999999999999999   9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=1e-22  Score=176.65  Aligned_cols=145  Identities=36%  Similarity=0.635  Sum_probs=127.6

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCC------HHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      |.....+|.|++|.+|.     .+..+|+|.+.......      ....+.+.+|+.+++.++||||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            45567899999998874     46789999886543322      12345688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++++||+++++|.+++...+.+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||+++.+.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            999999999999999988888999999999999999999999999   9999999999999999999999999998775

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.90  E-value=1.2e-22  Score=177.87  Aligned_cols=143  Identities=31%  Similarity=0.485  Sum_probs=125.0

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |+....+|.|+||.+|.     .+..+++|.+...   .....+.+.+|+.+++.++|||++++++.+......|+++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            45566799999998874     4678899988643   344556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|..++.+ ..++++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence            999999988765 456899999999999999999999999   99999999999999999999999999976643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.90  E-value=5.3e-23  Score=181.93  Aligned_cols=144  Identities=28%  Similarity=0.530  Sum_probs=124.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.||.     ++..||+|.+......  .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            577888999999999884     4688999998654321  222456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |++ ++|.+++... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            996 6898888754 45889999999999999999999999   99999999999999999999999999976543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.90  E-value=1e-22  Score=176.89  Aligned_cols=146  Identities=36%  Similarity=0.547  Sum_probs=127.2

Q ss_pred             cccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|.....+|.|+||.+|..        +..+|+|.+....  .......+.+|+.+++.++||||+++++++..++..|+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4667788999999988742        2368999886542  23445678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +|||+++++|.+++... +.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||+++.+...
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999765 45889999999999999999999999   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.90  E-value=7.9e-23  Score=179.01  Aligned_cols=144  Identities=34%  Similarity=0.580  Sum_probs=125.4

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....+|+|+||.||..          ...+|+|.+....  .......+.+|+.+++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            5677788999999988742          2579999886432  344556788999999999999999999999988999


Q ss_pred             EEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC
Q 020981          226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~  289 (319)
                      +++|||+++++|.+++...                ..+++..+..++.|++.||.|||+++   ++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            9999999999999999764                34778889999999999999999999   9999999999999999


Q ss_pred             CCEEEEecCcccccc
Q 020981          290 GNLKVADFGVSKLLT  304 (319)
Q Consensus       290 ~~~kl~DFgla~~~~  304 (319)
                      +.+||+|||+++...
T Consensus       161 ~~~~L~dfg~~~~~~  175 (283)
T cd05048         161 LTVKISDFGLSRDIY  175 (283)
T ss_pred             CcEEECCCcceeecc
Confidence            999999999998653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.90  E-value=6.3e-23  Score=177.22  Aligned_cols=143  Identities=35%  Similarity=0.595  Sum_probs=124.9

Q ss_pred             cccceeeeecceEEEEEEe----ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|.....+|.|+||.+|..    +..+|+|.+......    ...+.+|+.+++.++||||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            5677788999999988742    346999988754321    25688899999999999999999999988999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +.+++|.+++... ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            9999999999764 35899999999999999999999999   99999999999999999999999999886644

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.90  E-value=5.8e-23  Score=185.94  Aligned_cols=144  Identities=26%  Similarity=0.405  Sum_probs=121.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------Cc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~  224 (319)
                      +|...+.+|+|+||.||.     .++.+|+|.+..... .......+.+|+.+++.++||||+++++++...      ..
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            688888999999999874     478899999875432 334456677899999999999999999988643      34


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .|++|||++ +++.+.+..  .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          97 VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             eEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            799999996 577776654  4788899999999999999999999   9999999999999999999999999998764


Q ss_pred             cC
Q 020981          305 VK  306 (319)
Q Consensus       305 ~~  306 (319)
                      ..
T Consensus       171 ~~  172 (355)
T cd07874         171 TS  172 (355)
T ss_pred             Cc
Confidence            43

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.90  E-value=7.6e-23  Score=179.23  Aligned_cols=148  Identities=26%  Similarity=0.446  Sum_probs=127.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+++.+|.     +++.+|+|.+..... .....+.+.+|+.+++.++|||++++++.+......+++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            466677899999998874     478999998864422 12223557789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |++++.|..+......+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999888887776667999999999999999999999999   9999999999999999999999999998775543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.90  E-value=9.6e-23  Score=180.52  Aligned_cols=147  Identities=31%  Similarity=0.574  Sum_probs=126.0

Q ss_pred             cccccceeeeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEE
Q 020981          154 ELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT  220 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~  220 (319)
                      ..+|.....+|+|+||.||..            +..+|+|.+....  .......+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            336777789999999988732            3468999886432  234456788999999999 7999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCE
Q 020981          221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI  284 (319)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Ni  284 (319)
                      .....|++|||+++++|.+++....                .+++..+..++.|++.||.|||+++   ++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            9999999999999999999997642                3677788999999999999999999   99999999999


Q ss_pred             EecCCCCEEEEecCccccccc
Q 020981          285 LRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       285 ll~~~~~~kl~DFgla~~~~~  305 (319)
                      +++.++.+||+|||+++.+..
T Consensus       169 li~~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNN  189 (304)
T ss_pred             EEcCCCcEEECCCccceeccc
Confidence            999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.90  E-value=8.5e-23  Score=179.96  Aligned_cols=145  Identities=32%  Similarity=0.531  Sum_probs=127.9

Q ss_pred             ccccceeeeecceEEEEEEe---------------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCccc
Q 020981          155 LDFTNSVEITKGTFILAFWR---------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV  213 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~---------------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv  213 (319)
                      .+|.....+|+|+||.+|..                     +..+|+|.+....  .....+.+.+|+.+++.++|||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEe
Confidence            36777889999999988741                     2468999987543  234567788999999999999999


Q ss_pred             ccceeEEeCCceEEEEeecCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 020981          214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS  282 (319)
Q Consensus       214 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~  282 (319)
                      ++++++......+++|||+++++|.+++....           .+++..+..++.|++.||.|||+++   ++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            99999999999999999999999999998765           6889999999999999999999999   999999999


Q ss_pred             CEEecCCCCEEEEecCcccccc
Q 020981          283 NILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       283 Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ||+++.++.++|+|||+++...
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~  181 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLY  181 (296)
T ss_pred             ceeecCCCceEEccccceeecc
Confidence            9999999999999999998653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.90  E-value=1.1e-22  Score=179.50  Aligned_cols=150  Identities=23%  Similarity=0.476  Sum_probs=130.6

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      .....|.....+|.|+++.+|.     +++.+++|.+.....   ...+.+.+|+.+++.++|||++++++.+......|
T Consensus        16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            3345688888999999998873     578999998865432   23466788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +|+||+++++|..++... .+++.++..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++......
T Consensus        93 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          93 VVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            999999999999988754 5899999999999999999999999   999999999999999999999999998876554


Q ss_pred             CC
Q 020981          307 ED  308 (319)
Q Consensus       307 ~~  308 (319)
                      ..
T Consensus       169 ~~  170 (296)
T cd06655         169 QS  170 (296)
T ss_pred             cc
Confidence            33

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.90  E-value=7.1e-23  Score=179.41  Aligned_cols=145  Identities=29%  Similarity=0.554  Sum_probs=124.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+++.+|.     ++..||+|.+..... .......+.+|+.+++.++|||++++++.+..+...|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            366678899999998875     478899999865432 22233567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |++ ++|.+++...   ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.....
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            996 6898887643   45889999999999999999999999   99999999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.90  E-value=9.3e-23  Score=177.00  Aligned_cols=147  Identities=31%  Similarity=0.633  Sum_probs=128.5

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCC---HHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      |.....+|+|++|.+|.     ++..+|+|.+.......   ....+.+.+|+.+++.++||||+++++.+...+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            56667899999998884     57889999987533211   22457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEecCcccccccC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK  306 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DFgla~~~~~~  306 (319)
                      +||+++++|.+++.+.+++++..+..++.|++.||.|||+++   ++|+||+|+||+++.++ .+||+|||++..+...
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            999999999999988888999999999999999999999999   99999999999998776 5999999999877543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=8.5e-23  Score=180.10  Aligned_cols=144  Identities=30%  Similarity=0.559  Sum_probs=124.8

Q ss_pred             cccceeeeecceEEEEEEe-------------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccc
Q 020981          156 DFTNSVEITKGTFILAFWR-------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL  216 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~-------------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~  216 (319)
                      +|...+.+|+|+||.||..                   ...||+|.++...  .......+.+|++++++++|||+++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            5777788999999998741                   2358999987542  344556789999999999999999999


Q ss_pred             eeEEeCCceEEEEeecCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCE
Q 020981          217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI  284 (319)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Ni  284 (319)
                      +++......+++|||+++++|.+++....            .+++..+..++.|++.||.|||+++   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999986532            2577888999999999999999999   99999999999


Q ss_pred             EecCCCCEEEEecCcccccc
Q 020981          285 LRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       285 ll~~~~~~kl~DFgla~~~~  304 (319)
                      +++.++.+||+|||+++.+.
T Consensus       161 ll~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             EEcCCCcEEecccccccccc
Confidence            99999999999999998654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.90  E-value=2.8e-23  Score=169.34  Aligned_cols=148  Identities=24%  Similarity=0.387  Sum_probs=128.6

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC---
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---  223 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---  223 (319)
                      ....+|.....+|+|+|..|+.     ++..||+|++...   ..+..+..++|++..++++|||++++++....+.   
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            3455789999999999998884     5789999998754   3456677889999999999999999988765443   


Q ss_pred             --ceEEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          224 --PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       224 --~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                        ..|++++|...|+|.+.+...    ..+++.+...|+.++++||++||+..| |+.||||||.|||+++++.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEec
Confidence              499999999999999998753    359999999999999999999999986 6999999999999999999999999


Q ss_pred             Cccccc
Q 020981          298 GVSKLL  303 (319)
Q Consensus       298 gla~~~  303 (319)
                      |.+...
T Consensus       174 GS~~~a  179 (302)
T KOG2345|consen  174 GSATQA  179 (302)
T ss_pred             cCcccc
Confidence            998754

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=9.3e-23  Score=199.65  Aligned_cols=162  Identities=21%  Similarity=0.393  Sum_probs=131.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI  227 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l  227 (319)
                      .+|.....||.|+||.||.     .+..+|+|.+..... .......+..|+.+++.++||||++++++|...  ..+|+
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            3688899999999999984     467899999875543 334456788999999999999999999988543  56899


Q ss_pred             EEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEEcCCCCCCEEecC-----------
Q 020981          228 VTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKP----VPIIHRDLEPSNILRDD-----------  288 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~----~~ivH~Dlk~~Nill~~-----------  288 (319)
                      ||||+++++|.+++...    +.+++..++.|+.||+.||.|||+.++    .+|+||||||+||||+.           
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            99999999999998752    468999999999999999999998532    13999999999999964           


Q ss_pred             ------CCCEEEEecCcccccccCCCCceeeccCCC
Q 020981          289 ------SGNLKVADFGVSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       289 ------~~~~kl~DFgla~~~~~~~~~~~~~~~~~~  318 (319)
                            .+.+||+|||+++.+.... ....+.||++
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~  206 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPY  206 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccc-cccccCCCcc
Confidence                  2358999999998765432 2334566664

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.90  E-value=1e-22  Score=180.55  Aligned_cols=153  Identities=31%  Similarity=0.566  Sum_probs=129.1

Q ss_pred             CCccccCCCcccccceeeeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCc
Q 020981          145 VPEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN  211 (319)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~  211 (319)
                      .+.|++..  .+|...+.||+|+||.||..            ...+|+|.+....  .......+.+|+.+++.+ +|||
T Consensus        10 ~~~~~~~~--~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~   85 (307)
T cd05098          10 DPRWEVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN   85 (307)
T ss_pred             CCcceeeh--HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCC
Confidence            34444443  36788889999999998742            2469999987542  234456788899999999 6999


Q ss_pred             ccccceeEEeCCceEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 020981          212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPII  275 (319)
Q Consensus       212 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~iv  275 (319)
                      |+++++++......|++|||+++++|.+++...+                .+++..+..++.|++.||+|||+++   ++
T Consensus        86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~  162 (307)
T cd05098          86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CI  162 (307)
T ss_pred             EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999999997642                3788889999999999999999998   99


Q ss_pred             EcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          276 HRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       276 H~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ||||||+||+++.++.+||+|||+++.+.
T Consensus       163 H~dlkp~Nill~~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         163 HRDLAARNVLVTEDNVMKIADFGLARDIH  191 (307)
T ss_pred             cccccHHheEEcCCCcEEECCCccccccc
Confidence            99999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.90  E-value=9.2e-23  Score=178.53  Aligned_cols=140  Identities=24%  Similarity=0.365  Sum_probs=117.8

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHh---cCCCcccccceeEEeCCceEEEEeecCC
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK---IRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~---l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      +|+|+||.||.     ++..+|+|.+.+...........+.+|..+++.   ..||+++.+++.+...+..++||||+++
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG   81 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence            68999998884     468999999876543333323334445444444   4699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ++|.+++..++.+++..+..++.|++.||+|||+++   ++||||||+|||+++++.++|+|||++.....
T Consensus        82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            999999988888999999999999999999999999   99999999999999999999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.90  E-value=8.7e-23  Score=180.78  Aligned_cols=142  Identities=37%  Similarity=0.635  Sum_probs=122.0

Q ss_pred             cccceeeeecceEEEEEEe-----ce--EeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFWR-----GI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~-----~~--~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|.....+|+|+||.||..     +.  .+++|.+...  ........+.+|+.++.++ +||||+++++++...+..|+
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            5677788999999988752     32  4577766532  2344556788899999999 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC
Q 020981          228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      +|||+++++|.+++...+                .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999997543                4688899999999999999999999   999999999999999999


Q ss_pred             EEEEecCcccc
Q 020981          292 LKVADFGVSKL  302 (319)
Q Consensus       292 ~kl~DFgla~~  302 (319)
                      +||+|||+++.
T Consensus       163 ~kl~dfg~~~~  173 (303)
T cd05088         163 AKIADFGLSRG  173 (303)
T ss_pred             EEeCccccCcc
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.90  E-value=7.3e-23  Score=178.83  Aligned_cols=139  Identities=27%  Similarity=0.441  Sum_probs=122.2

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      +|.|+||.+|.     .|..+|+|.+.............+..|+.+++.++|||++++++.+......|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            57888888874     4789999998765433334455677899999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       238 ~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .+++.+..  .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||++....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            99998765  6899999999999999999999999   9999999999999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.90  E-value=1.2e-22  Score=178.67  Aligned_cols=146  Identities=25%  Similarity=0.390  Sum_probs=127.2

Q ss_pred             ccceeeeecceEEEEEE--------eceEeEEEEecccccC-CHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceE
Q 020981          157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~  226 (319)
                      |.....+|.|+||.+|.        +|..+|+|.+...... .....+.+.+|+.+++.+ +|++|+++++.+..+...|
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            56677899999998873        5688999998754321 223346678899999999 4999999999999989999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +|+||+++++|.+++.....+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||+++....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999999988888999999999999999999999999   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=6.2e-23  Score=190.56  Aligned_cols=151  Identities=23%  Similarity=0.300  Sum_probs=126.7

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ...|.....+|.|+||.||.     .++.||+|....         ..+.+|+.++++++|+||+++++++......+++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            34688889999999999985     467899996321         2345799999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||++ .++|..++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+....
T Consensus       239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            9999 47898888764 46899999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CC--ceeeccCC
Q 020981          308 DR--PLTCQDTS  317 (319)
Q Consensus       308 ~~--~~~~~~~~  317 (319)
                      ..  .....||+
T Consensus       315 ~~~~~~~~~GT~  326 (461)
T PHA03211        315 STPFHYGIAGTV  326 (461)
T ss_pred             ccccccccCCCc
Confidence            22  12345665

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.90  E-value=5.9e-23  Score=180.04  Aligned_cols=147  Identities=27%  Similarity=0.473  Sum_probs=127.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.+|.|+|+.+|.     .++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++......|+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            466778899999998874     46889999886543322 334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|..+......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+..+
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999888888776667899999999999999999999998   999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.90  E-value=1.3e-22  Score=175.09  Aligned_cols=140  Identities=34%  Similarity=0.621  Sum_probs=125.0

Q ss_pred             eeecceEEEEEE---e-----ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecC
Q 020981          162 EITKGTFILAFW---R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       162 ~ig~G~f~~v~~---~-----~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      .+|.|+||.+|.   .     +..+++|.+......  .....+.+|+.+++.++|+|++++++++......+++|||++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            578999998874   2     678999998765322  246788899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          234 KGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       234 ~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +++|.+++...         ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999875         67899999999999999999999999   9999999999999999999999999998776


Q ss_pred             cC
Q 020981          305 VK  306 (319)
Q Consensus       305 ~~  306 (319)
                      ..
T Consensus       157 ~~  158 (262)
T cd00192         157 DD  158 (262)
T ss_pred             cc
Confidence            54

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=2e-22  Score=173.80  Aligned_cols=158  Identities=28%  Similarity=0.420  Sum_probs=130.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-CCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~  229 (319)
                      +|...+.+|.|+++.+|.     .++.+|+|.+..... .....+.+.+|+.+++.++|+|++++++.+.. ....|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            366778899999998873     467899999875433 23445678889999999999999999988764 44689999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       230 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||+++++|.+++...  ..+++.++..++.|++.|+++||+.+   ++|+||||+||+++.++.++|+|||++..+....
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999999763  35899999999999999999999999   9999999999999999999999999998775544


Q ss_pred             CCceeeccCC
Q 020981          308 DRPLTCQDTS  317 (319)
Q Consensus       308 ~~~~~~~~~~  317 (319)
                      .......|++
T Consensus       157 ~~~~~~~~~~  166 (257)
T cd08223         157 DMASTLIGTP  166 (257)
T ss_pred             CccccccCCc
Confidence            3333334443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-24  Score=208.74  Aligned_cols=164  Identities=26%  Similarity=0.429  Sum_probs=142.5

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      ....+|.....||.|.||.||.     +|...|+|.+..+... ....+...+|..++..++|||+|++||+-..++..+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            3445778888999999999995     6888999998766544 455677889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |.||||++|+|.+++...+..++.....|..|++.|+.|||++|   ||||||||.||+++.+|.+|++|||.|..+..+
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            99999999999999998877888888899999999999999999   999999999999999999999999999988765


Q ss_pred             C-CCc---eeeccCCCC
Q 020981          307 E-DRP---LTCQDTSCR  319 (319)
Q Consensus       307 ~-~~~---~~~~~~~~~  319 (319)
                      . ..+   ....|||-|
T Consensus      1388 ~~~~~~el~~~~GT~~Y 1404 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMY 1404 (1509)
T ss_pred             hhcCCHHHHhhcCCchh
Confidence            3 222   256777743

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.90  E-value=8.3e-23  Score=179.99  Aligned_cols=153  Identities=24%  Similarity=0.441  Sum_probs=128.3

Q ss_pred             cceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      .....+|.|+|+.+|.     ++..+|+|.+...   .....+.+.+|+.+++.++|||++++++.+...+..|++|||+
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            3345689999998874     4678999988643   2344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCcee
Q 020981          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT  312 (319)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~  312 (319)
                      ++++|.+++.. +.+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||++............
T Consensus       102 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658         102 EGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            99999998754 46899999999999999999999999   999999999999999999999999999876544333333


Q ss_pred             eccCC
Q 020981          313 CQDTS  317 (319)
Q Consensus       313 ~~~~~  317 (319)
                      ..|++
T Consensus       178 ~~~~~  182 (292)
T cd06658         178 LVGTP  182 (292)
T ss_pred             eecCc
Confidence            44444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.90  E-value=1.3e-22  Score=175.27  Aligned_cols=140  Identities=28%  Similarity=0.445  Sum_probs=122.2

Q ss_pred             eeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       162 ~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      ++|+|+||.||.       ++..+|+|++.... ......+.+.+|+.+++.+.||||+++++.+. ....+++|||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            579999988874       36789999986543 23445677889999999999999999999875 4567999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++|.+++.....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++.+...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            999999988778999999999999999999999999   999999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.89  E-value=3.4e-22  Score=173.69  Aligned_cols=143  Identities=34%  Similarity=0.626  Sum_probs=122.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .+.....+|+|+||.+|.     ++..+++|.+....   ....+.+.+|+.+++.++|+||+++++++..+...++++|
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            344556899999999874     35679999886542   3445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-CCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~--~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DFgla~~~~  304 (319)
                      |+++++|.+++... ..+  ++..+..++.|++.||.|||+++   |+||||||+||+++. ++.+||+|||++....
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999764 445  77888899999999999999999   999999999999986 6799999999987654

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.89  E-value=2e-22  Score=174.25  Aligned_cols=139  Identities=29%  Similarity=0.492  Sum_probs=119.3

Q ss_pred             eeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       162 ~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      .+|.|+||.+|.       .+..+|+|.+....  .....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            479999998873       24569999887542  3444567889999999999999999999875 4578999999999


Q ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       235 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++|.+++.. ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+...
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            999999875 346899999999999999999999999   999999999999999999999999999866443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.89  E-value=1.2e-22  Score=177.35  Aligned_cols=144  Identities=28%  Similarity=0.526  Sum_probs=123.6

Q ss_pred             cccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....+|+|+||.+|.          .+..+|+|.+....  .......+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            577788999999998874          23579999876432  233456688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      ++||||+++++|.+++.+..          .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEEC
Confidence            99999999999999987532          2466788899999999999999998   9999999999999999999999


Q ss_pred             ecCcccccc
Q 020981          296 DFGVSKLLT  304 (319)
Q Consensus       296 DFgla~~~~  304 (319)
                      |||+++.+.
T Consensus       162 dfg~~~~~~  170 (277)
T cd05062         162 DFGMTRDIY  170 (277)
T ss_pred             CCCCccccC
Confidence            999987653

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.89  E-value=1.6e-22  Score=177.27  Aligned_cols=146  Identities=28%  Similarity=0.579  Sum_probs=126.4

Q ss_pred             cccceeeeecceEEEEEE---------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--Cc
Q 020981          156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~  224 (319)
                      -|.....+|+|+||.+|.         .+..+|+|.+....  .......+.+|+.+++.++|||++++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            466778899999998873         36789999986442  344456789999999999999999999988765  56


Q ss_pred             eEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .+++|||+++++|.+++.+.. .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            899999999999999997653 5889999999999999999999999   999999999999999999999999999876


Q ss_pred             ccC
Q 020981          304 TVK  306 (319)
Q Consensus       304 ~~~  306 (319)
                      ...
T Consensus       160 ~~~  162 (284)
T cd05079         160 ETD  162 (284)
T ss_pred             ccC
Confidence            543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.89  E-value=1.8e-22  Score=178.07  Aligned_cols=144  Identities=33%  Similarity=0.562  Sum_probs=125.3

Q ss_pred             cccceeeeecceEEEEEEe---------------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccc
Q 020981          156 DFTNSVEITKGTFILAFWR---------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ  214 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~---------------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~  214 (319)
                      +|...+.+|+|+||.+|..                     +..+|+|.+....  .......+.+|+.+++.++|+||++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence            5777888999999999852                     3468999987542  3444567889999999999999999


Q ss_pred             cceeEEeCCceEEEEeecCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 020981          215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN  283 (319)
Q Consensus       215 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~N  283 (319)
                      +++++......+++|||+++++|.+++....           .+++..+..++.|++.||+|||+++   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999999987642           2566789999999999999999999   9999999999


Q ss_pred             EEecCCCCEEEEecCcccccc
Q 020981          284 ILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       284 ill~~~~~~kl~DFgla~~~~  304 (319)
                      |+++.++.++|+|||+++.+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~  181 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLY  181 (296)
T ss_pred             EEEcCCCCEEeccCccccccc
Confidence            999999999999999998653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.89  E-value=1.9e-22  Score=173.91  Aligned_cols=147  Identities=31%  Similarity=0.550  Sum_probs=128.8

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEeccccc--CCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      |...+.+|.|++|.+|.     .+..+++|.+.....  ..++..+.+.+|+.+++.++|||++++++.+......++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            45567899999998874     478999998865321  22445677899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+++++|.+++.+...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999988777899999999999999999999999   999999999999999999999999998876443

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.89  E-value=9.4e-23  Score=176.05  Aligned_cols=142  Identities=34%  Similarity=0.587  Sum_probs=124.1

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|...+.+|.|+||.+|.    .+..+|+|.+.+....    ...+.+|+.+++.++||||+++++++......|++|||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            566778899999998874    3457999988654322    24577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +++++|.+++..+ ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence            9999999999764 45889999999999999999999999   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.89  E-value=1.1e-22  Score=175.88  Aligned_cols=143  Identities=33%  Similarity=0.564  Sum_probs=125.9

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|....++|+|++|.+|.    .+..+|+|.+....    ...+.+.+|+.+++.++|+||+++++.+......+++|||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            677788999999998874    35679999876432    2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence            9999999999753  45788889999999999999999998   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.6e-22  Score=175.12  Aligned_cols=142  Identities=32%  Similarity=0.520  Sum_probs=125.7

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|...+.+|.|+++.+|.    .+..||+|.+.....    ..+.+.+|+.++++++|||++++++++...+..+++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            467778999999998874    456899999875432    235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       232 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +++++|.+++....  .+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||+++.+.
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            99999999997654  5899999999999999999999999   9999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.4e-22  Score=178.95  Aligned_cols=147  Identities=28%  Similarity=0.461  Sum_probs=130.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|++|.+|.     .+..+|+|.+...........+.+..|+.+++.++||||+++++.+......|++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            467778899999998874     468999999987655444456778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999998764  45899999999999999999999999   99999999999999999999999999886643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.89  E-value=1.6e-22  Score=183.67  Aligned_cols=145  Identities=26%  Similarity=0.396  Sum_probs=121.9

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------C
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~  223 (319)
                      .+|.....+|+|+||.||.     .++.+|||.+..... .......+.+|+.+++.++||||+++++++...      .
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            3688888999999998874     478899999875432 333446677899999999999999999887543      3


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ..|+||||++ ++|.+.+..  .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence            5799999995 578777754  4788889999999999999999999   999999999999999999999999999876


Q ss_pred             ccC
Q 020981          304 TVK  306 (319)
Q Consensus       304 ~~~  306 (319)
                      ...
T Consensus       177 ~~~  179 (364)
T cd07875         177 GTS  179 (364)
T ss_pred             CCC
Confidence            443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.89  E-value=8.7e-23  Score=183.93  Aligned_cols=144  Identities=28%  Similarity=0.452  Sum_probs=121.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------Cc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~  224 (319)
                      .|.....+|.|+||.||.     ++..||+|.+..... .......+.+|+.+++.++||||+++++++...      ..
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            577788999999999874     467899999875432 223345677899999999999999999887533      35


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .|++++++ +++|.++++. ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          95 VYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence            79999988 7899887764 46899999999999999999999999   9999999999999999999999999998764


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       170 ~  170 (343)
T cd07878         170 D  170 (343)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.89  E-value=1.3e-22  Score=180.72  Aligned_cols=137  Identities=28%  Similarity=0.489  Sum_probs=113.7

Q ss_pred             eeeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--CCceEEEEee
Q 020981          161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTEY  231 (319)
Q Consensus       161 ~~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~  231 (319)
                      .++|+|+||.||.       .+..+|+|.+.....     ...+.+|+.+++.++||||+++++.+..  ....|++|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            4799999999984       346799998865422     1346679999999999999999998854  4568999999


Q ss_pred             cCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe----cCCCCEEEEecC
Q 020981          232 LPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFG  298 (319)
Q Consensus       232 ~~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DFg  298 (319)
                      +. ++|.+++...         ..+++..+..++.|++.||+|||+++   |+||||||+|||+    +..+.+||+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            94 6898887532         24888999999999999999999999   9999999999999    456789999999


Q ss_pred             cccccccC
Q 020981          299 VSKLLTVK  306 (319)
Q Consensus       299 la~~~~~~  306 (319)
                      +|+.+..+
T Consensus       158 ~a~~~~~~  165 (317)
T cd07868         158 FARLFNSP  165 (317)
T ss_pred             ceeccCCC
Confidence            99877543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.89  E-value=1.5e-22  Score=182.42  Aligned_cols=144  Identities=33%  Similarity=0.544  Sum_probs=122.2

Q ss_pred             cccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeC-C
Q 020981          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~  223 (319)
                      +|...+.||.|+||.||.          .++.||||.+....  .......+.+|+.++..+ +||||+++++++... .
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            677888999999999974          35789999987543  233456788899999999 589999999987654 5


Q ss_pred             ceEEEEeecCCCCHHHHHHHcC----------------------------------------------------------
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------  245 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  245 (319)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6899999999999999986431                                                          


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       246 ---------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                               .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                     2567788889999999999999999   9999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.89  E-value=1.1e-22  Score=178.98  Aligned_cols=145  Identities=28%  Similarity=0.522  Sum_probs=122.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|...+.||+|+|+.||.     ++..+|+|.+......  .....+.+|+.+++.++|+||+++++++..+...|+++
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4677888999999998874     4789999998654321  12235667999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+. +++.+++... ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9995 6777776543 45788889999999999999999999   99999999999999999999999999876533

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.89  E-value=2e-22  Score=177.10  Aligned_cols=144  Identities=28%  Similarity=0.494  Sum_probs=123.0

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....+|.|+||.||..          +..+|+|.+....  .......+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            5777889999999999842          3479999876432  233345678899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      +++|||+++|+|.+++...+          ..+...+..++.|++.||.|||+++   ++||||||+||+++.++.+||+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence            99999999999999997532          2355678889999999999999999   9999999999999999999999


Q ss_pred             ecCcccccc
Q 020981          296 DFGVSKLLT  304 (319)
Q Consensus       296 DFgla~~~~  304 (319)
                      |||+++.+.
T Consensus       162 Dfg~~~~~~  170 (288)
T cd05061         162 DFGMTRDIY  170 (288)
T ss_pred             cCCcccccc
Confidence            999998653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.89  E-value=2.7e-22  Score=175.50  Aligned_cols=141  Identities=28%  Similarity=0.460  Sum_probs=122.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.+|.|+||.+|.     +++.+|+|.+....  .......+.+|+.++++++||||+++++.+...+..+++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            456667899999998874     56889999986542  33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|..+    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            9999998654    34788889999999999999999999   99999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.89  E-value=2.7e-22  Score=173.66  Aligned_cols=145  Identities=29%  Similarity=0.542  Sum_probs=130.1

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|+|+.+|.     +++.+++|.+...... ....+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            56678899999998874     4678999998765433 45667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|.+++.....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            999999999988777899999999999999999999999   99999999999999999999999999987644

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.89  E-value=1.4e-22  Score=175.25  Aligned_cols=141  Identities=35%  Similarity=0.584  Sum_probs=124.8

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      +|.|+||.+|.     +++.+++|.+.............+.+|+.++++++|||++++++.+......|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            46778877763     4789999998765444445667889999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       238 ~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      .+++.+.+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....+
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            999988778999999999999999999999999   999999999999999999999999998765443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.89  E-value=2.3e-22  Score=173.45  Aligned_cols=147  Identities=26%  Similarity=0.511  Sum_probs=128.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.++.     .++.+|+|.+...... ......+.+|+.+++.++||||+++++.+...+..++++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            366778999999998874     5789999998754332 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+.+++|.+++....  .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            999999999987643  4788999999999999999999999   999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-22  Score=185.86  Aligned_cols=153  Identities=36%  Similarity=0.585  Sum_probs=129.7

Q ss_pred             ceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecC
Q 020981          159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       159 ~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      ....+|+|+||.||-     +...+|||.+....   ....+-+..|+.+-+.++|.|||+++|++.....+-|.||-++
T Consensus       579 ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  579 ERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             ceEEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            455789999999983     45678999987543   3445678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCcccccccCCCC
Q 020981          234 KGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       234 ~g~L~~~l~~~-~~~--~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+|.+++... +++  ++...-.|.+||++||.|||...   |||||||-+|+||+ -.|.+||+|||-++++..=...
T Consensus       656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            99999999875 566  78889999999999999999999   99999999999998 6799999999999988554333


Q ss_pred             ceeeccCC
Q 020981          310 PLTCQDTS  317 (319)
Q Consensus       310 ~~~~~~~~  317 (319)
                      .-++.||.
T Consensus       733 TETFTGTL  740 (1226)
T KOG4279|consen  733 TETFTGTL  740 (1226)
T ss_pred             ccccccch
Confidence            33444543

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.89  E-value=2.1e-22  Score=174.49  Aligned_cols=143  Identities=35%  Similarity=0.585  Sum_probs=125.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+++.+|.     .+..+|+|.+...    ......+.+|+.+++.++||||+++++.+......+++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            466777899999998864     3678999988643    2234668889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||++.....
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            999999999997643  4888999999999999999999999   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.89  E-value=2.5e-22  Score=178.74  Aligned_cols=144  Identities=33%  Similarity=0.589  Sum_probs=124.9

Q ss_pred             cccceeeeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeC
Q 020981          156 DFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS  222 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~  222 (319)
                      +|.....+|+|+||.+|..            ...+|+|.+....  .......+.+|+.+++.+ +||||+++++++...
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            6777889999999988752            3468999887432  234456788899999999 599999999999998


Q ss_pred             CceEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR  286 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill  286 (319)
                      ...|++|||+++|+|.+++...                ..+++..+..++.|++.||.|||+++   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            9999999999999999999763                23788889999999999999999999   9999999999999


Q ss_pred             cCCCCEEEEecCcccccc
Q 020981          287 DDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       287 ~~~~~~kl~DFgla~~~~  304 (319)
                      +.++.+||+|||+++...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         168 TEDNVMKIADFGLARGVH  185 (314)
T ss_pred             cCCCcEEEcccccccccc
Confidence            999999999999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.89  E-value=7.2e-23  Score=179.35  Aligned_cols=145  Identities=26%  Similarity=0.549  Sum_probs=124.1

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |...+.+|.|+|+.+|.     +|..+|+|.+..... .......+.+|+.+++.++|||++++++.+......++++||
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            56677899999998874     578999999875432 122234567799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       232 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++ ++|.+++.. ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+..+
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            96 588888765 456899999999999999999999999   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.89  E-value=2.7e-22  Score=176.27  Aligned_cols=144  Identities=34%  Similarity=0.589  Sum_probs=125.9

Q ss_pred             ccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      .+|.....+|.|+|+.+|..          +..+|+|.+...   .......+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            35777788999999988742          346889987643   34455678899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      .+++|||+++++|.+++...+             .+++..+..++.|++.||+|||+++   ++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999999997543             3889999999999999999999999   999999999999999999


Q ss_pred             EEEEecCcccccc
Q 020981          292 LKVADFGVSKLLT  304 (319)
Q Consensus       292 ~kl~DFgla~~~~  304 (319)
                      +||+|||+++...
T Consensus       159 ~kl~dfg~~~~~~  171 (288)
T cd05093         159 VKIGDFGMSRDVY  171 (288)
T ss_pred             EEeccCCcccccc
Confidence            9999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=1.6e-22  Score=183.19  Aligned_cols=136  Identities=26%  Similarity=0.396  Sum_probs=119.3

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|+|+||.||.     .+..||+|.....         ....|+.+++.++||||+++++++......++||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3688889999999999985     3568999975432         1235899999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       230 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |++ .++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            999 46888888654 56899999999999999999999999   999999999999999999999999999754

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.89  E-value=1.3e-22  Score=179.26  Aligned_cols=154  Identities=23%  Similarity=0.391  Sum_probs=127.9

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|+||.+|.     .++.+|+|.+.....   ...+.+.+|+.+++.++|||++++++.+..+...|+++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            33445789999998873     478899999864322   2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCce
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~  311 (319)
                      +++++|..++.. ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..+........
T Consensus       100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  175 (297)
T cd06659         100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  175 (297)
T ss_pred             CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence            999999997765 45899999999999999999999999   99999999999999999999999999986654433333


Q ss_pred             eeccCC
Q 020981          312 TCQDTS  317 (319)
Q Consensus       312 ~~~~~~  317 (319)
                      ...|++
T Consensus       176 ~~~~~~  181 (297)
T cd06659         176 SLVGTP  181 (297)
T ss_pred             ceecCc
Confidence            344443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=1.5e-22  Score=176.68  Aligned_cols=136  Identities=24%  Similarity=0.389  Sum_probs=115.4

Q ss_pred             eeecceEEEEEEec-----------------------------eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcc
Q 020981          162 EITKGTFILAFWRG-----------------------------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV  212 (319)
Q Consensus       162 ~ig~G~f~~v~~~~-----------------------------~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  212 (319)
                      .||+|+||.||...                             ..+++|.+....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            47899999888421                             358888876432   2334567889999999999999


Q ss_pred             cccceeEEeCCceEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-
Q 020981          213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-  290 (319)
Q Consensus       213 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-  290 (319)
                      +++++++......++||||+++|+|..++.. .+.+++..+..++.|++.||+|||+++   |+||||||+|||++..+ 
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence            9999999999999999999999999999875 456899999999999999999999998   99999999999998654 


Q ss_pred             ------CEEEEecCccccc
Q 020981          291 ------NLKVADFGVSKLL  303 (319)
Q Consensus       291 ------~~kl~DFgla~~~  303 (319)
                            .+|++|||++...
T Consensus       156 ~~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             ccCccceeeecCCcccccc
Confidence                  3899999988654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.89  E-value=3.1e-22  Score=173.19  Aligned_cols=150  Identities=32%  Similarity=0.517  Sum_probs=132.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+++.+|.     +++.+++|.+.....  ......+.+|+..++.++|+|++++++.+......++++|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            456678899999988774     478899999876532  2445778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      |+++++|.+++.....+++.....++.|++.|+.|||+ .+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            99999999999887889999999999999999999999 98   999999999999999999999999999887655444


Q ss_pred             c
Q 020981          310 P  310 (319)
Q Consensus       310 ~  310 (319)
                      .
T Consensus       157 ~  157 (264)
T cd06623         157 C  157 (264)
T ss_pred             c
Confidence            3

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=2e-22  Score=176.72  Aligned_cols=144  Identities=28%  Similarity=0.540  Sum_probs=126.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|+....+|.|+||.+|.     .+..+|+|.+....  .......+.+|+.++++++||||+++++.+......|++||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            466677899999998874     47899999886432  34445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+++++|..++...   ..+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.+||+|||++..+.
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999999998764   368999999999999999999997 47   9999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.89  E-value=1.7e-22  Score=185.08  Aligned_cols=150  Identities=31%  Similarity=0.521  Sum_probs=125.7

Q ss_pred             cccCCCcccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccc
Q 020981          148 YEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFL  216 (319)
Q Consensus       148 ~~~~~~~~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~  216 (319)
                      |+++..  ++.....+|+|+||.||..          +..||+|++....  .....+.+.+|+.++.++. ||||++++
T Consensus        32 ~~~~~~--~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          32 WEMPRD--NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             ceecHH--HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            444433  4556678999999999742          2579999997543  2334457889999999997 99999999


Q ss_pred             eeEEeCCceEEEEeecCCCCHHHHHHHcC---------------------------------------------------
Q 020981          217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG---------------------------------------------------  245 (319)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------  245 (319)
                      +.+......++||||+++|+|.+++..++                                                   
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            99999999999999999999999996532                                                   


Q ss_pred             -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcC
Q 020981          246 -----------------------------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD  278 (319)
Q Consensus       246 -----------------------------------------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~D  278 (319)
                                                                     .+++..+..++.|++.||+|||+.+   ++|||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrd  264 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRD  264 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCccc
Confidence                                                           2566678889999999999999998   99999


Q ss_pred             CCCCCEEecCCCCEEEEecCcccccc
Q 020981          279 LEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       279 lk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |||+|||+++++.+||+|||+++.+.
T Consensus       265 lkp~NiLl~~~~~~kL~DfGla~~~~  290 (401)
T cd05107         265 LAARNVLICEGKLVKICDFGLARDIM  290 (401)
T ss_pred             CCcceEEEeCCCEEEEEecCcceecc
Confidence            99999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.89  E-value=4.2e-22  Score=172.92  Aligned_cols=147  Identities=35%  Similarity=0.627  Sum_probs=127.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCcccccceeEEe--CCce
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~  225 (319)
                      .+|.....+|+|+||.+|.     ++..+++|.+......  .......+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3677888999999998874     4788999988654322  23345678899999999999999999998865  3578


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++++||+++++|.+++...+.+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            899999999999999988778999999999999999999999998   9999999999999999999999999998653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=4.6e-22  Score=171.00  Aligned_cols=148  Identities=32%  Similarity=0.627  Sum_probs=132.0

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|.++.+|.     .++.+++|.+...... ......+.+|++++++++|||++++++++......++++||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            56678899999998875     4678999998765432 34567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      +++++|.+++.....+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999999988788999999999999999999999999   99999999999999999999999999987765443

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.89  E-value=1.7e-22  Score=177.67  Aligned_cols=143  Identities=27%  Similarity=0.532  Sum_probs=123.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+++.+|.     .+..||+|.+......  .....+.+|+.+++.++||||+++++++......++|||
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            577788999999998874     4688999998754321  112345679999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+. ++|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccC
Confidence            997 5999988764 45889999999999999999999999   9999999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.89  E-value=3.5e-22  Score=178.79  Aligned_cols=140  Identities=17%  Similarity=0.360  Sum_probs=120.1

Q ss_pred             eeeeecc--eEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          160 SVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       160 ~~~ig~G--~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      ...||+|  +|+.++.     +|..||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            3467888  5666653     578899999875432 2344567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          233 PKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       233 ~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ++|+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++++||+.+...
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            999999999753  35889999999999999999999999   999999999999999999999999865443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.89  E-value=2.6e-22  Score=175.56  Aligned_cols=140  Identities=24%  Similarity=0.372  Sum_probs=117.2

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHH---HHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL---ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      ||+|+||.||.     +++.||+|.+.+...........+..|.   ..++...||+++++++.+......++||||+.+
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g   81 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG   81 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence            68899998873     4679999998765433222222233343   344455799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            999999988788999999999999999999999998   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.89  E-value=2.9e-22  Score=175.72  Aligned_cols=158  Identities=30%  Similarity=0.394  Sum_probs=128.2

Q ss_pred             CcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEE-----e
Q 020981          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT-----Q  221 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-----~  221 (319)
                      ...+|.....+|.|+|+.+|.     .+..+|+|.+....    .....+.+|+.+++.+ +|||++++++.+.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            344678888999999998874     56789999876421    2235677899999999 6999999999874     3


Q ss_pred             CCceEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      +...+++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df  168 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF  168 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence            4568999999999999998753    245888889999999999999999998   999999999999999999999999


Q ss_pred             CcccccccCCCCceeeccCC
Q 020981          298 GVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       298 gla~~~~~~~~~~~~~~~~~  317 (319)
                      |+++.+...........|++
T Consensus       169 g~~~~~~~~~~~~~~~~~~~  188 (286)
T cd06638         169 GVSAQLTSTRLRRNTSVGTP  188 (286)
T ss_pred             CceeecccCCCccccccCCC
Confidence            99987655433333344554

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.89  E-value=2.7e-22  Score=176.40  Aligned_cols=143  Identities=34%  Similarity=0.611  Sum_probs=123.1

Q ss_pred             ccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          157 FTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      |.....+|+|+||.+|..          ...+++|.+....  .......+.+|+.+++.++||||+++++.+......+
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            556678999999988752          1468888876443  2344577889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 020981          227 IVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS  282 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~  282 (319)
                      +++||+.+++|.+++...                        ..+++..+..++.|++.||.|||+++   ++||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence            999999999999998642                        23678888999999999999999999   999999999


Q ss_pred             CEEecCCCCEEEEecCcccccc
Q 020981          283 NILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       283 Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ||++++++.+||+|||+++.+.
T Consensus       157 nill~~~~~~kl~dfg~~~~~~  178 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVY  178 (290)
T ss_pred             eEEEcCCCcEEecccccccccc
Confidence            9999999999999999998653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.89  E-value=3.9e-22  Score=173.39  Aligned_cols=145  Identities=34%  Similarity=0.537  Sum_probs=126.6

Q ss_pred             cccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ++...+.+|.|+||.+|..        +..||+|.+....  .......|..|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            4667788999999988742        2369999986532  34556789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +|||+++++|.+++... +.+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||+++....
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999999764 45889999999999999999999999   99999999999999999999999999886644

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.89  E-value=3.4e-22  Score=176.96  Aligned_cols=147  Identities=31%  Similarity=0.509  Sum_probs=127.3

Q ss_pred             ccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCC
Q 020981          155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~  223 (319)
                      .+|.....+|.|+||.+|..          +..+|+|.+....  .....+.+.+|+.+++++ +||||+++++.+....
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            36777889999999988742          3479999887542  234456788999999999 7999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      ..|++|||+.+++|.+++....  .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997643  2899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccC
Q 020981          302 LLTVK  306 (319)
Q Consensus       302 ~~~~~  306 (319)
                      .+...
T Consensus       190 ~~~~~  194 (302)
T cd05055         190 DIMND  194 (302)
T ss_pred             cccCC
Confidence            76443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=2.7e-22  Score=179.23  Aligned_cols=144  Identities=22%  Similarity=0.260  Sum_probs=112.7

Q ss_pred             ccCCCcccccceeeeecceEEEEEE------eceEeEEEEeccccc--CCHHHHHHHHHHHHHHHhcCCCcccc-cceeE
Q 020981          149 EIDPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQ-FLGAV  219 (319)
Q Consensus       149 ~~~~~~~~~~~~~~ig~G~f~~v~~------~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~-l~~~~  219 (319)
                      ....-..+|.....||+|+||.||.      .++.+|||.+.....  ........+.+|+++++.++|+|++. +++. 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            3334444688889999999999984      356679998753321  13344567899999999999999985 4432 


Q ss_pred             EeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCC-CCCCEEecCCCCEEEEecC
Q 020981          220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFG  298 (319)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DFg  298 (319)
                         ...|+||||++|++|... .   ...   ...++.|+++||.|||+++   |+|||| ||+|||++.++.+||+|||
T Consensus        91 ---~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 ---GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             ---CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence               457999999999999632 1   111   1467899999999999999   999999 9999999999999999999


Q ss_pred             cccccccC
Q 020981          299 VSKLLTVK  306 (319)
Q Consensus       299 la~~~~~~  306 (319)
                      +|+.+...
T Consensus       158 lA~~~~~~  165 (365)
T PRK09188        158 LASVFRRR  165 (365)
T ss_pred             cceecccC
Confidence            99987554

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.89  E-value=2.5e-22  Score=176.74  Aligned_cols=145  Identities=32%  Similarity=0.587  Sum_probs=125.6

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCc
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  224 (319)
                      +|.....+|+|+||.+|..          ...+|+|.+....  .......+.+|+.+++++ +||||+++++.+.....
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            5777789999999988742          1578999887542  234456788999999999 79999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC
Q 020981          225 MMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD  288 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~  288 (319)
                      .+++|||+++++|.+++...                +.+++..+..++.|++.||+|||+++   |+||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence            99999999999999999653                34788899999999999999999999   999999999999999


Q ss_pred             CCCEEEEecCccccccc
Q 020981          289 SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       289 ~~~~kl~DFgla~~~~~  305 (319)
                      ++.+||+|||+++.+..
T Consensus       168 ~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         168 DHVMKIADFGLARDIHH  184 (293)
T ss_pred             CCeEEeCcccccccccc
Confidence            99999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=175.97  Aligned_cols=146  Identities=25%  Similarity=0.323  Sum_probs=117.4

Q ss_pred             eeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEe----CCceEEEEee
Q 020981          162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----SSPMMIVTEY  231 (319)
Q Consensus       162 ~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~----~~~~~lv~e~  231 (319)
                      .+|-|..|.|.     .+++.+|+|++...        +..++|+++--.. .|||||+++++|..    ...+.+|||+
T Consensus        69 vLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~  140 (400)
T KOG0604|consen   69 VLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC  140 (400)
T ss_pred             hhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence            56766666543     47889999998632        2345677765555 59999999998753    4578999999


Q ss_pred             cCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCcccccccC
Q 020981          232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgla~~~~~~  306 (319)
                      |+||.|.+.+..++.  +++.++..|++||+.|+.|||+.+   |.||||||+|+|...   +..+||+|||+|+.-..+
T Consensus       141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            999999999998765  999999999999999999999999   999999999999974   446899999999987765


Q ss_pred             CCCceeeccCCCC
Q 020981          307 EDRPLTCQDTSCR  319 (319)
Q Consensus       307 ~~~~~~~~~~~~~  319 (319)
                      ....+ .+-||||
T Consensus       218 ~~L~T-Pc~TPyY  229 (400)
T KOG0604|consen  218 GDLMT-PCFTPYY  229 (400)
T ss_pred             ccccC-Ccccccc
Confidence            44443 5566665

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.89  E-value=2.3e-22  Score=175.48  Aligned_cols=147  Identities=29%  Similarity=0.555  Sum_probs=132.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....+|.|+++.+|.     ++..+|+|++.............+.+|..++++++ ||||+++++++......+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            466777899999998874     57899999987655444555677888999999998 999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |++++++|.+++.+.+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999998878999999999999999999999999   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.89  E-value=2.5e-22  Score=180.42  Aligned_cols=144  Identities=33%  Similarity=0.557  Sum_probs=122.9

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEe-CC
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SS  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~-~~  223 (319)
                      +|...+.||.|+||.||..          ++.||+|++....  .....+.+..|+.++..+ +|+||+++++++.. ..
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            5777889999999999842          3689999987432  234456678899999999 79999999998764 45


Q ss_pred             ceEEEEeecCCCCHHHHHHHc-----------------------------------------------------------
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK-----------------------------------------------------------  244 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~-----------------------------------------------------------  244 (319)
                      .++++|||+++++|.+++...                                                           
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            789999999999999998642                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          245 --GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       245 --~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                        ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~  224 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  224 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcc
Confidence              25788889999999999999999998   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=4.4e-22  Score=171.88  Aligned_cols=139  Identities=32%  Similarity=0.564  Sum_probs=121.3

Q ss_pred             eeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecC
Q 020981          162 EITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       162 ~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      .||+|+||.++.        .+..+|+|.+......  ...+.+.+|+.+++.+.|||++++++++. ....+++|||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            589999998863        1268999998765432  34567888999999999999999999765 456899999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       234 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +++|.+++.....+++..+..++.|++.||+|||.++   ++|+||||+|||++.++.+||+|||+++.+...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            9999999988778999999999999999999999999   999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.89  E-value=1.5e-22  Score=175.07  Aligned_cols=145  Identities=32%  Similarity=0.522  Sum_probs=127.4

Q ss_pred             ccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .+|.....+|.|+|+.+|.    .+..+++|.+....   ......+..|+.+++.++||||+++++++......+++||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            4677788999999998874    36789999987543   2334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999999763  35889999999999999999999999   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.89  E-value=1.7e-22  Score=176.44  Aligned_cols=144  Identities=31%  Similarity=0.552  Sum_probs=125.7

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|+|+.+|.     .+..+|+|.+....  .....+.+.+|+.+++.++||||+++++.+......|+|+||
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45556789999998874     36789999886442  234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +++++|.+++.. +.+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||++..+...
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            999999998865 46889999999999999999999998   999999999999999999999999999876543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.89  E-value=4.7e-22  Score=173.97  Aligned_cols=145  Identities=31%  Similarity=0.558  Sum_probs=126.6

Q ss_pred             cccceeeeecceEEEEEEe---------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--CCc
Q 020981          156 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~---------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~  224 (319)
                      +|.....+|+|+||.+|..         +..+|+|.+......  .....+.+|+.+++.++||||+++++++..  ...
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            4666788999999988742         578999998754322  345778999999999999999999998876  567


Q ss_pred             eEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .+++|||+++++|.+++.... .+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            999999999999999997754 5899999999999999999999999   999999999999999999999999999887


Q ss_pred             cc
Q 020981          304 TV  305 (319)
Q Consensus       304 ~~  305 (319)
                      ..
T Consensus       160 ~~  161 (284)
T cd05038         160 PE  161 (284)
T ss_pred             cc
Confidence            63

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=1.1e-22  Score=191.66  Aligned_cols=158  Identities=18%  Similarity=0.293  Sum_probs=120.3

Q ss_pred             cccceeeeecceEEEEEEe------ceEeEEE--------------EecccccCCHHHHHHHHHHHHHHHhcCCCccccc
Q 020981          156 DFTNSVEITKGTFILAFWR------GIQVAVK--------------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF  215 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~------~~~vAvK--------------~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l  215 (319)
                      +|.....||+|+||.||.-      +...+.|              .+.+...........+.+|+.+++.++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            6888899999999998841      1111111              1111111223345668899999999999999999


Q ss_pred             ceeEEeCCceEEEEeecCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC
Q 020981          216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (319)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~  290 (319)
                      ++++......|++++++ +++|.+++....     ......+..++.|++.||+|||+++   |+||||||+|||++.++
T Consensus       229 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~  304 (501)
T PHA03210        229 EEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDG  304 (501)
T ss_pred             eEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence            99999999999999999 467877765421     2345667889999999999999999   99999999999999999


Q ss_pred             CEEEEecCcccccccCCC-CceeeccCC
Q 020981          291 NLKVADFGVSKLLTVKED-RPLTCQDTS  317 (319)
Q Consensus       291 ~~kl~DFgla~~~~~~~~-~~~~~~~~~  317 (319)
                      .+||+|||+++.+..... ......||+
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~  332 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTV  332 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCc
Confidence            999999999988755432 223345655

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.89  E-value=3.4e-22  Score=173.82  Aligned_cols=137  Identities=33%  Similarity=0.491  Sum_probs=116.9

Q ss_pred             eeecceEEEEEEe-------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          162 EITKGTFILAFWR-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       162 ~ig~G~f~~v~~~-------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      .||+|+||.||..       +..+|+|.+....  .......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            5799999988742       3568999886543  223345688899999999999999999999998999999999999


Q ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       235 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |+|.+++....     ..++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence            99999987532     3456677889999999999999999   999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.89  E-value=2.1e-22  Score=177.28  Aligned_cols=146  Identities=30%  Similarity=0.482  Sum_probs=125.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv  228 (319)
                      +|.....+|.|+||.+|.     ++..+++|.+...... ......+.+|+.++++++||||+++++++...  ...|++
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            577778899999998874     4678999998754322 22234566799999999999999999998877  899999


Q ss_pred             EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +||++ ++|.+++.... .+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||+++.+...
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99996 59999887644 4899999999999999999999999   999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.89  E-value=4.3e-22  Score=173.59  Aligned_cols=144  Identities=31%  Similarity=0.498  Sum_probs=126.1

Q ss_pred             ccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      .+|.....+|.|+||.+|..          ...+++|.+....  .......+.+|+.++++++||||+++++.+.....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            35777888999999998742          3578999876432  23345678899999999999999999999988899


Q ss_pred             eEEEEeecCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      .|++|||+++++|.+++....         .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence            999999999999999998765         6899999999999999999999999   9999999999999999999999


Q ss_pred             ecCccccc
Q 020981          296 DFGVSKLL  303 (319)
Q Consensus       296 DFgla~~~  303 (319)
                      |||+++..
T Consensus       160 ~~~~~~~~  167 (275)
T cd05046         160 LLSLSKDV  167 (275)
T ss_pred             cccccccc
Confidence            99998754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.89  E-value=3.6e-22  Score=174.88  Aligned_cols=145  Identities=29%  Similarity=0.629  Sum_probs=124.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+++.+|.     +|..+|+|.+.....  ......+.+|+.+++.++|||++++++.+...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            366778899999998874     478899999875432  2223556789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |++ ++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            997 5898888754   35899999999999999999999999   999999999999999999999999999866443

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.89  E-value=5.3e-22  Score=171.62  Aligned_cols=149  Identities=26%  Similarity=0.480  Sum_probs=126.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--CCceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv  228 (319)
                      +|.....+|.|+||.+|.     ++..+|+|.+..... .....+.+..|+.+++.++|||++++++.+..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            356677899999998874     567899999875443 34455778899999999999999999987754  4568999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLH-----ENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                      |||+++++|.+++..    ..++++..+..++.|++.||.|||     +.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence            999999999999875    356899999999999999999999     777   99999999999999999999999999


Q ss_pred             ccccccCCC
Q 020981          300 SKLLTVKED  308 (319)
Q Consensus       300 a~~~~~~~~  308 (319)
                      +........
T Consensus       157 ~~~~~~~~~  165 (265)
T cd08217         157 AKILGHDSS  165 (265)
T ss_pred             cccccCCcc
Confidence            998765543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.89  E-value=4.5e-22  Score=173.11  Aligned_cols=144  Identities=31%  Similarity=0.497  Sum_probs=121.7

Q ss_pred             cceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc-----
Q 020981          158 TNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----  224 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-----  224 (319)
                      .....+|+|+||.||..        +..+|+|.+..... .......+.+|+.+++.++|||++++++.+.....     
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            45567899999988742        36799999875432 34455778999999999999999999998765443     


Q ss_pred             -eEEEEeecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          225 -MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       225 -~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                       .++++||+++++|..++...      ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             79999999999999998542      24888999999999999999999999   999999999999999999999999


Q ss_pred             Cccccccc
Q 020981          298 GVSKLLTV  305 (319)
Q Consensus       298 gla~~~~~  305 (319)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05035         158 GLSKKIYS  165 (273)
T ss_pred             cceeeccc
Confidence            99987643

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=6e-22  Score=171.79  Aligned_cols=146  Identities=34%  Similarity=0.626  Sum_probs=126.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccc--cCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~  226 (319)
                      +|.....+|+|+||.+|.     ++..+|+|.+....  .........+.+|+.+++.++||||+++++.+...  ..++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            577788999999998874     47889999875321  12334556788999999999999999999988654  4588


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +++||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++...
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            99999999999999988777899999999999999999999999   9999999999999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.89  E-value=4.9e-22  Score=173.61  Aligned_cols=145  Identities=31%  Similarity=0.537  Sum_probs=127.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....+|.|+||.+|.     .+..+|+|.+....  .......+.+|+.+++.+.||||+++++.+......|+|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            355667899999998874     46789999887432  23455778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++.. +++++..+..++.|++.||+|+|+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            9999999998875 46889999999999999999999998   999999999999999999999999999776543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.89  E-value=6.7e-22  Score=171.73  Aligned_cols=145  Identities=33%  Similarity=0.560  Sum_probs=126.8

Q ss_pred             cccceeeeecceEEEEEEe-----c---eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFWR-----G---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~-----~---~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|+....+|+|+||.+|..     +   ..+++|.+....  .....+.+.+|+.+++.++|||++++.+++......++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            5677889999999988742     2   368999886542  23445678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +|||+++++|.+++... +.+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999999764 46899999999999999999999999   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.89  E-value=6.3e-22  Score=173.05  Aligned_cols=145  Identities=27%  Similarity=0.526  Sum_probs=124.4

Q ss_pred             ccccceeeeecceEEEEEE-----ece----EeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      .+|.....+|.|+||.+|.     ++.    .||+|.+....  .......+.+|..+++.++||||+++++.+.. ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            3677788999999999884     233    48999886542  34445678899999999999999999998865 457


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++++||+++|+|.+++..+ +.+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            8999999999999999764 46899999999999999999999999   9999999999999999999999999998775


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       161 ~  161 (279)
T cd05109         161 I  161 (279)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.89  E-value=3e-22  Score=174.97  Aligned_cols=143  Identities=36%  Similarity=0.572  Sum_probs=125.5

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....+|.|+|+.||..          +..+|+|.+....  ..+..+.+.+|+.+++.++||||+++++.+......
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            5667788999999988842          3679999987542  233457889999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC
Q 020981          226 MIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      +++|||+++++|.+++...+              .+++..+..++.|++.|+.|||+++   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999997642              3778889999999999999999999   999999999999999999


Q ss_pred             EEEEecCccccc
Q 020981          292 LKVADFGVSKLL  303 (319)
Q Consensus       292 ~kl~DFgla~~~  303 (319)
                      +||+|||+++.+
T Consensus       161 ~kl~d~g~~~~~  172 (280)
T cd05049         161 VKIGDFGMSRDV  172 (280)
T ss_pred             EEECCcccceec
Confidence            999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.2e-23  Score=187.27  Aligned_cols=152  Identities=34%  Similarity=0.617  Sum_probs=131.7

Q ss_pred             CccccCCCcccccceeeeecceEEEEE---Ee--ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEE
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~---~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~  220 (319)
                      ..|+....  ++.-..++|.|-||.||   |.  ...||||.++.+.    -+.++|..|..+|+.++|||+|+++|+|.
T Consensus       260 DkWEmeRt--dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT  333 (1157)
T KOG4278|consen  260 DKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCT  333 (1157)
T ss_pred             chhhccch--heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence            34555443  45556789999998887   43  4679999998653    45688999999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecC
Q 020981          221 QSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (319)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFg  298 (319)
                      .+..+|||+|||..|+|.+++.+..+  ++.-..+.++.||.+||+||..++   +|||||...|+|+.++..+|++|||
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccc
Confidence            99999999999999999999987643  677777888999999999999999   9999999999999999999999999


Q ss_pred             cccccccC
Q 020981          299 VSKLLTVK  306 (319)
Q Consensus       299 la~~~~~~  306 (319)
                      |+++++.+
T Consensus       411 LsRlMtgD  418 (1157)
T KOG4278|consen  411 LSRLMTGD  418 (1157)
T ss_pred             hhhhhcCC
Confidence            99998765

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=7.2e-22  Score=172.68  Aligned_cols=145  Identities=30%  Similarity=0.579  Sum_probs=125.7

Q ss_pred             cccceeeeecceEEEEEEe-----c----eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          156 DFTNSVEITKGTFILAFWR-----G----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~-----~----~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      +|...+.+|+|+||.+|..     |    ..+|+|.+....  .......+.+|+.+++.++|||++++++++.. ...+
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            5667788999999988752     2    268999876543  24455778899999999999999999998887 7899


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++||+++|+|.+++.++ ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999999875 45899999999999999999999998   99999999999999999999999999987654


Q ss_pred             C
Q 020981          306 K  306 (319)
Q Consensus       306 ~  306 (319)
                      .
T Consensus       162 ~  162 (279)
T cd05057         162 D  162 (279)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.6e-22  Score=174.28  Aligned_cols=154  Identities=29%  Similarity=0.536  Sum_probs=129.8

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC---CCcccccceeEEeCCceEEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv  228 (319)
                      |...+.+|.|+||.+|.     .+..+|+|.+....  .......+.+|+.+++.++   |||++++++.+......|++
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            55667899999998874     57889999987542  2334567888999999996   99999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||+++++|.+++.. +.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999999866 47899999999999999999999999   99999999999999999999999999987765543


Q ss_pred             CceeeccC
Q 020981          309 RPLTCQDT  316 (319)
Q Consensus       309 ~~~~~~~~  316 (319)
                      ......|+
T Consensus       157 ~~~~~~~~  164 (277)
T cd06917         157 KRSTFVGT  164 (277)
T ss_pred             ccccccCC
Confidence            33333343

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.88  E-value=5e-22  Score=178.33  Aligned_cols=152  Identities=33%  Similarity=0.605  Sum_probs=127.8

Q ss_pred             CccccCCCcccccceeeeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcc
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV  212 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i  212 (319)
                      |.|++..  .+|.....||+|+||.+|..            +..+|+|.+....  .......+.+|+.+++++ +||||
T Consensus         5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i   80 (334)
T cd05100           5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNI   80 (334)
T ss_pred             cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCe
Confidence            4455443  35777889999999988742            1368999876432  334557788999999999 79999


Q ss_pred             cccceeEEeCCceEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEE
Q 020981          213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH  276 (319)
Q Consensus       213 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH  276 (319)
                      +++++.+......++++||+++|+|.+++.+..                .+++..+..++.|++.||.|||+++   ++|
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH  157 (334)
T cd05100          81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH  157 (334)
T ss_pred             eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence            999999999999999999999999999997532                3677888899999999999999999   999


Q ss_pred             cCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          277 RDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       277 ~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |||||+||+++.++.+||+|||+++.+.
T Consensus       158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~  185 (334)
T cd05100         158 RDLAARNVLVTEDNVMKIADFGLARDVH  185 (334)
T ss_pred             cccccceEEEcCCCcEEECCcccceecc
Confidence            9999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.88  E-value=6.3e-22  Score=171.51  Aligned_cols=147  Identities=30%  Similarity=0.514  Sum_probs=129.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.+|.     .+..+++|.+......  .....+.+|+.+++.++|+|++++++.+......++++|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            567778899999998873     4678999998754332  255778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ++++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+..+.
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999764   35889999999999999999999999   9999999999999999999999999998776543

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.88  E-value=4.9e-22  Score=172.99  Aligned_cols=146  Identities=33%  Similarity=0.545  Sum_probs=127.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCC-------HHHHHHHHHHHHHHHhcCCCcccccceeEEeCC
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-------DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  223 (319)
                      .|...+.+|.|++|.+|.     +++.+|+|.+.......       ....+.+.+|+.+++.++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            456677899999999884     47889999876422111       122356788999999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||+++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            99999999999999999988788999999999999999999999998   999999999999999999999999999765


Q ss_pred             c
Q 020981          304 T  304 (319)
Q Consensus       304 ~  304 (319)
                      .
T Consensus       159 ~  159 (272)
T cd06629         159 D  159 (272)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.88  E-value=4.9e-22  Score=171.50  Aligned_cols=142  Identities=35%  Similarity=0.622  Sum_probs=122.7

Q ss_pred             cccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEE-eCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~  231 (319)
                      +|...+.+|+|+|+.+|.   .+..+|+|.+...     ...+.+.+|+.+++.++|++++++++++. .....++++||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            577778899999988774   6788999987643     22356888999999999999999998754 45678999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|.+++.+.+  .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence            99999999998654  3788999999999999999999999   99999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.88  E-value=7.4e-22  Score=169.65  Aligned_cols=138  Identities=39%  Similarity=0.628  Sum_probs=121.0

Q ss_pred             eeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          162 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       162 ~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      .+|.|+||.||.    .+..+|+|.+....  .......+.+|+.+++.++||||+++++.+......+++|||+++++|
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            578999998874    46789999887543  234445688999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       238 ~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .+++... ..+++..+..++.|++.||.|+|+++   ++|+||||+||+++.++.+||+|||++....
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence            9998754 35789999999999999999999999   9999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=4.3e-22  Score=173.76  Aligned_cols=145  Identities=28%  Similarity=0.510  Sum_probs=124.9

Q ss_pred             cccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....+|.|+||.||.          .+..+|+|.+....  .......+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            577788999999998873          12679999986432  234456788899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      +++|||+++++|.+++....          .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999997532          2577788999999999999999999   9999999999999999999999


Q ss_pred             ecCccccccc
Q 020981          296 DFGVSKLLTV  305 (319)
Q Consensus       296 DFgla~~~~~  305 (319)
                      |||+++.+..
T Consensus       162 dfg~~~~~~~  171 (277)
T cd05032         162 DFGMTRDIYE  171 (277)
T ss_pred             Ccccchhhcc
Confidence            9999876543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.88  E-value=6.5e-22  Score=174.11  Aligned_cols=144  Identities=33%  Similarity=0.547  Sum_probs=124.4

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....+|+|+||.+|..          +..+++|.+...   .....+.+.+|+.+++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            4666788999999988742          346888887643   233446788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC
Q 020981          226 MIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~  289 (319)
                      ++||||+++++|.+++....                .+++..+..++.|++.||+|||+++   ++||||||+||+++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence            99999999999999997542                3788899999999999999999999   9999999999999999


Q ss_pred             CCEEEEecCccccccc
Q 020981          290 GNLKVADFGVSKLLTV  305 (319)
Q Consensus       290 ~~~kl~DFgla~~~~~  305 (319)
                      +.+||+|||+++....
T Consensus       160 ~~~~l~dfg~a~~~~~  175 (291)
T cd05094         160 LLVKIGDFGMSRDVYS  175 (291)
T ss_pred             CcEEECCCCcccccCC
Confidence            9999999999976543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=4.4e-22  Score=173.51  Aligned_cols=146  Identities=32%  Similarity=0.486  Sum_probs=128.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+++.+|.     ++..+|+|.+....  .......+.+|+.+++.++|||++++++.+......|+++|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            355667789999998874     57899999987543  23445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++++|.+++... ++++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+....
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            99999999999875 7899999999999999999999999   9999999999999999999999999998876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.88  E-value=6.2e-22  Score=170.55  Aligned_cols=145  Identities=29%  Similarity=0.477  Sum_probs=128.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|.|+|+.+|.     .+..+++|.+....     ..+.+.+|+.+++.++|||++++++.+......|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            3577777899999988774     36789999986432     2578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       230 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            99999999999975 346899999999999999999999999   9999999999999999999999999998876554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.88  E-value=4.2e-22  Score=177.10  Aligned_cols=146  Identities=27%  Similarity=0.468  Sum_probs=122.5

Q ss_pred             ccceeeeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEE
Q 020981          157 FTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI  227 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l  227 (319)
                      |.....+|+|++|.+|.       .+..+|+|.+...........+.+.+|+.+++.++||||+++++.+...  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            56677899999998874       4689999998864322223335677899999999999999999999888  78999


Q ss_pred             EEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC----CCCEEEEecC
Q 020981          228 VTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----SGNLKVADFG  298 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~DFg  298 (319)
                      ||||++ +++.+++...     ..+++..+..++.|++.||.|||+++   ++||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            999996 5777776532     25889999999999999999999999   999999999999999    9999999999


Q ss_pred             cccccccC
Q 020981          299 VSKLLTVK  306 (319)
Q Consensus       299 la~~~~~~  306 (319)
                      +++.+...
T Consensus       158 ~~~~~~~~  165 (316)
T cd07842         158 LARLFNAP  165 (316)
T ss_pred             cccccCCC
Confidence            99876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.88  E-value=8.1e-22  Score=172.23  Aligned_cols=143  Identities=32%  Similarity=0.560  Sum_probs=125.5

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|+||.||.     .+..+|+|.+....  .......+.+|+.+++.++||||+++++.+..+...|+||||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            55667899999998884     46789999876432  234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|.+++.. ..+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            999999998865 46889999999999999999999999   99999999999999999999999999876644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.88  E-value=2.8e-22  Score=175.63  Aligned_cols=145  Identities=28%  Similarity=0.497  Sum_probs=124.6

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....+|.|+||.||..          +..+|+|.+....  .......+.+|..+++.++||||+++++.+......
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            4566778999999988752          4689999987542  234456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC
Q 020981          226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~  289 (319)
                      ++++||+.+++|.+++...                ..+++..+..++.|++.||+|+|+++   ++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence            9999999999999998532                24778888999999999999999999   9999999999999999


Q ss_pred             CCEEEEecCccccccc
Q 020981          290 GNLKVADFGVSKLLTV  305 (319)
Q Consensus       290 ~~~kl~DFgla~~~~~  305 (319)
                      +.+||+|||+++....
T Consensus       161 ~~~kl~Dfg~~~~~~~  176 (283)
T cd05091         161 LNVKISDLGLFREVYA  176 (283)
T ss_pred             CceEeccccccccccc
Confidence            9999999999887643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.88  E-value=4.7e-22  Score=173.02  Aligned_cols=143  Identities=30%  Similarity=0.505  Sum_probs=119.1

Q ss_pred             ceeeeecceEEEEEEe-----c--eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------Cce
Q 020981          159 NSVEITKGTFILAFWR-----G--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SPM  225 (319)
Q Consensus       159 ~~~~ig~G~f~~v~~~-----~--~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~~  225 (319)
                      ..+.+|+|+||.||..     +  ..+|+|.+.... ......+.+.+|+.+++.++||||+++++.+...      ...
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4567899999998741     2  268999887543 2445567888999999999999999999876432      357


Q ss_pred             EEEEeecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          226 MIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                      +++|||+++|+|.+++...      ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999887421      23788999999999999999999998   99999999999999999999999999


Q ss_pred             cccccc
Q 020981          300 SKLLTV  305 (319)
Q Consensus       300 a~~~~~  305 (319)
                      ++.+..
T Consensus       159 ~~~~~~  164 (272)
T cd05075         159 SKKIYN  164 (272)
T ss_pred             ccccCc
Confidence            987644

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.88  E-value=3.3e-22  Score=173.96  Aligned_cols=155  Identities=27%  Similarity=0.441  Sum_probs=126.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeC------C
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS------S  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~------~  223 (319)
                      .|.....+|.|+||.+|.     .++.+|+|.+....    .....+.+|+.+++++ +|||++++++.+...      .
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            456667899999998874     46789999986432    2235677899999998 699999999988653      4


Q ss_pred             ceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      .+|++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence            589999999999999998864  35889999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCCceeeccCC
Q 020981          302 LLTVKEDRPLTCQDTS  317 (319)
Q Consensus       302 ~~~~~~~~~~~~~~~~  317 (319)
                      .............|++
T Consensus       160 ~~~~~~~~~~~~~g~~  175 (272)
T cd06637         160 QLDRTVGRRNTFIGTP  175 (272)
T ss_pred             ecccccccCCcccccc
Confidence            7654333333334443

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.88  E-value=6.4e-22  Score=173.20  Aligned_cols=143  Identities=34%  Similarity=0.567  Sum_probs=125.1

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      ++....++|+|+||.||..          +..+|+|.+...   .......+.+|+.+++.++|+||+++++++......
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            5666788999999988852          457889987643   344556789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC
Q 020981          226 MIVTEYLPKGDLRAFLKRKG---------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~  290 (319)
                      +++|||+++++|.+++...+               .+++..+..++.|++.|++|||+++   ++||||||+|||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence            99999999999999997643               3788899999999999999999999   99999999999999999


Q ss_pred             CEEEEecCcccccc
Q 020981          291 NLKVADFGVSKLLT  304 (319)
Q Consensus       291 ~~kl~DFgla~~~~  304 (319)
                      .+||+|||+++...
T Consensus       160 ~~kL~dfg~~~~~~  173 (280)
T cd05092         160 VVKIGDFGMSRDIY  173 (280)
T ss_pred             CEEECCCCceeEcC
Confidence            99999999997653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.88  E-value=6.8e-22  Score=174.26  Aligned_cols=155  Identities=24%  Similarity=0.455  Sum_probs=130.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|...+.+|.|+||.+|.     ++..+++|.+....   ....+.+.+|+.+++.++|||++++++.+...+..|+|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            4677788999999998874     46789999886432   233466888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++++|.+++.+. .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.........
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            999999999998764 4788899999999999999999999   999999999999999999999999998876554433


Q ss_pred             ceeeccC
Q 020981          310 PLTCQDT  316 (319)
Q Consensus       310 ~~~~~~~  316 (319)
                      .....|+
T Consensus       172 ~~~~~~~  178 (293)
T cd06647         172 RSTMVGT  178 (293)
T ss_pred             cccccCC
Confidence            3333343

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.88  E-value=4.4e-22  Score=174.61  Aligned_cols=148  Identities=28%  Similarity=0.501  Sum_probs=127.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+++.+|.     +++.||+|.+..... .......+.+|+.+++.++|+||+++++++...+..+++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            466778899999998874     467899998875432 23344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |++++.+..+..+...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9988777766666667999999999999999999999999   9999999999999999999999999998776543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.88  E-value=8.4e-22  Score=169.15  Aligned_cols=141  Identities=33%  Similarity=0.527  Sum_probs=126.4

Q ss_pred             eecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       163 ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      +|.|+|+.+|.     .+..+++|.+.............+..|+.+++.++|||++++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            47888887763     3789999998876555555667889999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       238 ~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      .+++.....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            999998878999999999999999999999998   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.88  E-value=5.3e-22  Score=171.31  Aligned_cols=136  Identities=26%  Similarity=0.462  Sum_probs=115.8

Q ss_pred             eeecceEEEEEE---e--c----------eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          162 EITKGTFILAFW---R--G----------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       162 ~ig~G~f~~v~~---~--~----------~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      .+|+|+|+.+|.   .  +          ..+++|.+....    .....+.+|+.+++.++||||+++++++.. ...+
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            578999988873   1  2          246777665332    115678889999999999999999999887 7789


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-------CEEEEecC
Q 020981          227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFG  298 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl~DFg  298 (319)
                      +||||+++++|.+++.... .+++..+..++.|++.||.|||+++   ++||||||+||+++.++       .+||+|||
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999999998765 6899999999999999999999999   99999999999999887       79999999


Q ss_pred             ccccccc
Q 020981          299 VSKLLTV  305 (319)
Q Consensus       299 la~~~~~  305 (319)
                      ++.....
T Consensus       154 ~a~~~~~  160 (259)
T cd05037         154 IPITVLS  160 (259)
T ss_pred             ccccccc
Confidence            9987543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.88  E-value=7e-22  Score=172.90  Aligned_cols=144  Identities=27%  Similarity=0.520  Sum_probs=120.8

Q ss_pred             cccceeeeecceEEEEEE-----ece----EeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      +|...+.+|.|+|+.+|.     .+.    .+++|.+...  ........+..|+..++.+.||||+++++++. ....+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence            566777899999998874     233    4777776532  22344467788888999999999999999875 45678


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++||+++|+|.+++... +.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            899999999999999764 46899999999999999999999999   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.88  E-value=6.1e-22  Score=172.23  Aligned_cols=136  Identities=27%  Similarity=0.458  Sum_probs=114.4

Q ss_pred             eeecceEEEEEEe----c---eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          162 EITKGTFILAFWR----G---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       162 ~ig~G~f~~v~~~----~---~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      .||+|+||.+|..    +   ..+++|.+....  .....+.+.+|+.+++.++||||+++++.+......|++|||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            5799999988742    2   235566654322  234457788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          235 GDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       235 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      |+|.+++.+.    ...++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence            9999999754    23566677889999999999999998   99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.88  E-value=5.7e-22  Score=174.02  Aligned_cols=145  Identities=30%  Similarity=0.540  Sum_probs=117.4

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc---CCCcccccceeEEe-----CC
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ-----SS  223 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~-----~~  223 (319)
                      |.....+|+|+||.||.     +++.+|+|.+........ ....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            66778899999999874     478899999875432221 112344567666655   69999999998764     34


Q ss_pred             ceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      ..+++|||+. ++|.+++...  ..+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence            5899999996 5898888764  34899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccC
Q 020981          302 LLTVK  306 (319)
Q Consensus       302 ~~~~~  306 (319)
                      .+...
T Consensus       157 ~~~~~  161 (288)
T cd07863         157 IYSCQ  161 (288)
T ss_pred             cccCc
Confidence            76543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.88  E-value=6.3e-22  Score=176.19  Aligned_cols=137  Identities=28%  Similarity=0.493  Sum_probs=113.2

Q ss_pred             eeeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--CCceEEEEee
Q 020981          161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTEY  231 (319)
Q Consensus       161 ~~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~  231 (319)
                      .++|+|+||.||.       .+..+|+|.+.....     ...+.+|+.+++.++||||+++++++..  +...++++||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            5799999999984       236799998865422     1346789999999999999999998853  5678999999


Q ss_pred             cCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe----cCCCCEEEEecC
Q 020981          232 LPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFG  298 (319)
Q Consensus       232 ~~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DFg  298 (319)
                      ++ ++|.+++...         ..+++..+..++.|++.||.|||+++   |+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            95 5888877532         23788889999999999999999999   9999999999999    566789999999


Q ss_pred             cccccccC
Q 020981          299 VSKLLTVK  306 (319)
Q Consensus       299 la~~~~~~  306 (319)
                      +++.+..+
T Consensus       158 ~a~~~~~~  165 (317)
T cd07867         158 FARLFNSP  165 (317)
T ss_pred             ceeccCCC
Confidence            99877543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.88  E-value=1.2e-21  Score=172.00  Aligned_cols=143  Identities=25%  Similarity=0.482  Sum_probs=124.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .+.....+|.|++|.+|.     .+..+++|.+...   .....+.+.+|+.+++.++|||++++++.+...+..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            455567899999998874     4578999987532   23344568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++.. .++++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++.....
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            9999999999887 56899999999999999999999999   99999999999999999999999998876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.88  E-value=6.2e-22  Score=173.90  Aligned_cols=145  Identities=36%  Similarity=0.564  Sum_probs=125.5

Q ss_pred             ccccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      .+|.....+|.|+||.+|.          .+..+|+|.+....  .......+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            3577778899999998874          35789999887542  33445678899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS  282 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~  282 (319)
                      .+++|||+++++|.+++....                      .+++..+..++.|++.||.|||+++   ++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            999999999999999997532                      2677788999999999999999999   999999999


Q ss_pred             CEEecCCCCEEEEecCcccccc
Q 020981          283 NILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       283 Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ||+++.++.+||+|||+++.+.
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~  181 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIY  181 (288)
T ss_pred             heEecCCCceEECccccceecc
Confidence            9999999999999999987653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.2e-22  Score=165.50  Aligned_cols=141  Identities=18%  Similarity=0.203  Sum_probs=107.7

Q ss_pred             eeeecceEEEEEE----eceEeEEEEecccccCCHH-----------------------HHHHHHHHHHHHHhcCCCccc
Q 020981          161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDD-----------------------RVRAFRDELALLQKIRHPNVV  213 (319)
Q Consensus       161 ~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~iv  213 (319)
                      ..||.|+++.||.    +|+.||+|+++........                       .......|+.++..+.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            4689999999884    4789999999764321111                       012234599999999887775


Q ss_pred             ccceeEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEcCCCCCCEEecCCCCE
Q 020981          214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSGNL  292 (319)
Q Consensus       214 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~l-H~~~~~~ivH~Dlk~~Nill~~~~~~  292 (319)
                      .......  ...++||||++++++.........+++..+..++.|++.+|.++ |+.+   |+||||||+|||++ ++.+
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence            4433322  23489999998877765544456789999999999999999999 6888   99999999999998 4789


Q ss_pred             EEEecCcccccccCC
Q 020981          293 KVADFGVSKLLTVKE  307 (319)
Q Consensus       293 kl~DFgla~~~~~~~  307 (319)
                      +|+|||+|.....+.
T Consensus       157 ~LiDFG~a~~~~~~~  171 (190)
T cd05147         157 YIIDVSQSVEHDHPH  171 (190)
T ss_pred             EEEEccccccCCCcC
Confidence            999999998655443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=4.8e-22  Score=174.30  Aligned_cols=144  Identities=27%  Similarity=0.466  Sum_probs=127.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.+|+|+||.+|.     .+..+|+|.+....  .......+.+|+++++.++||||+++++.+......++|||
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            567778899999998874     37789999876432  23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ .+   ++||||||+||+++.++.++|+|||++..+.
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            99999999999887789999999999999999999997 46   9999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=5.6e-22  Score=186.13  Aligned_cols=158  Identities=30%  Similarity=0.420  Sum_probs=138.5

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEe-----CC
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ-----SS  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~-----~~  223 (319)
                      ..|...+.+|.|+++.||.     .++..|+|++....    +..+++..|..+++... |||++.+|++|..     ++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            3577788999999999884     57888999887543    22355667899999885 9999999999854     46


Q ss_pred             ceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      .+|||||||.+||.-++++.-  .++.|..+..|.+.++.|+.+||...   ++|||||-.|||++.++.+||+|||.++
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA  171 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence            799999999999999999753  46899999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCceeeccCCCC
Q 020981          302 LLTVKEDRPLTCQDTSCR  319 (319)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~  319 (319)
                      .++....+..+++||||.
T Consensus       172 QldsT~grRnT~iGtP~W  189 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYW  189 (953)
T ss_pred             eeecccccccCcCCCccc
Confidence            999999999999999984

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=2.7e-22  Score=176.88  Aligned_cols=155  Identities=30%  Similarity=0.453  Sum_probs=130.5

Q ss_pred             cccceeeeecceEEEEE---EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhc--CCCcccccceeEEeCC----ceE
Q 020981          156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~~----~~~  226 (319)
                      .......+|+|.||.|+   ..++.||||++.      .+.++.|++|-.+++..  +|+||+++++.-....    .++
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            45556688999999988   468999999986      34567888898888876  6999999998876544    799


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCC------CCeEEcCCCCCCEEecCCCCEEEEecCcc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP------VPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~------~~ivH~Dlk~~Nill~~~~~~kl~DFgla  300 (319)
                      ||++|.+.|+|.++|+.+ .+++....+++..+++||+|||+.-|      .+|+|||||++|||+..+++..|+|||||
T Consensus       285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            999999999999999986 47999999999999999999997543      26999999999999999999999999999


Q ss_pred             cccccCCCCc--eeeccCC
Q 020981          301 KLLTVKEDRP--LTCQDTS  317 (319)
Q Consensus       301 ~~~~~~~~~~--~~~~~~~  317 (319)
                      .++.+.....  ...+||.
T Consensus       364 l~~~p~~~~~d~~~qVGT~  382 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTR  382 (534)
T ss_pred             EEecCCCCCcchhhhhhhh
Confidence            9997654433  2346654

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.88  E-value=1e-21  Score=174.25  Aligned_cols=146  Identities=29%  Similarity=0.514  Sum_probs=127.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ..|.....+|.|+||.+|.     .++.||+|.+...........+.+.+|+.+++.++|||++++++++......|+|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            3577778899999998874     47899999987554445555677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       230 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ||+. |++.+++.. .+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9996 677777654 456899999999999999999999999   9999999999999999999999999997654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.88  E-value=7.2e-22  Score=171.18  Aligned_cols=143  Identities=35%  Similarity=0.557  Sum_probs=121.9

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|...+++|+|+||.||.    ....+|+|.+.....    ....+.+|+.+++.++||||+++++.+. ....+++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            477788999999998874    235799999875332    1246788999999999999999998764 4568999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +++++|.+++.+.  ..+++..+..++.|++.||+|+|+.+   ++||||||+||+++.++.+||+|||+++.+..+
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999763  34788999999999999999999999   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.88  E-value=9.2e-22  Score=172.80  Aligned_cols=147  Identities=25%  Similarity=0.386  Sum_probs=126.9

Q ss_pred             ccceeeeecceEEEEEE--------eceEeEEEEecccccC-CHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceE
Q 020981          157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~  226 (319)
                      |.....+|.|++|.+|.        .+..+|+|.+.+.... .......+.+|+.+++++ +||+|+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            56677899999998874        3567999998753322 223345678899999999 5999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+++.+...
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            99999999999999987777899999999999999999999998   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.88  E-value=6.9e-22  Score=170.55  Aligned_cols=138  Identities=35%  Similarity=0.571  Sum_probs=121.6

Q ss_pred             eeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecC
Q 020981          162 EITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       162 ~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      .+|.|++|.+|..        ...+|+|.+......  ...+.+.+|+.++++++||||+++++.+.. ...++++||++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            5788999888731        236899998865432  556788999999999999999999999888 88999999999


Q ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          234 KGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       234 ~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++|.+++....  .+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            999999998764  5889999999999999999999999   99999999999999999999999999987755

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.88  E-value=9.9e-22  Score=173.48  Aligned_cols=143  Identities=36%  Similarity=0.600  Sum_probs=121.6

Q ss_pred             cccceeeeecceEEEEEE-----ec--eEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~--~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|.....+|.|+||.+|.     .+  ..+++|.+...  ......+.+.+|+.+++++ +||||+++++.+......|+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            466777899999998874     22  24688877632  2334456788899999999 69999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC
Q 020981          228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      ++||+++++|.+++.+..                .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence            999999999999997542                3778899999999999999999999   999999999999999999


Q ss_pred             EEEEecCccccc
Q 020981          292 LKVADFGVSKLL  303 (319)
Q Consensus       292 ~kl~DFgla~~~  303 (319)
                      +||+|||++...
T Consensus       158 ~kl~dfg~~~~~  169 (297)
T cd05089         158 SKIADFGLSRGE  169 (297)
T ss_pred             EEECCcCCCccc
Confidence            999999998643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.88  E-value=6.9e-22  Score=173.15  Aligned_cols=144  Identities=27%  Similarity=0.569  Sum_probs=124.0

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|++|.+|.     ++..+|+|.+..... .......+.+|+.++++++||||+++++++......+++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            66778899999998874     478899998875432 222335688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +. ++|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            95 6898888653  45889999999999999999999999   99999999999999999999999999886643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.88  E-value=5.1e-23  Score=198.79  Aligned_cols=144  Identities=33%  Similarity=0.489  Sum_probs=122.9

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-------
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------  221 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-------  221 (319)
                      ..+|.....+|+|+||.|+.     +|+.||||++....  +......+.+|+.++++++|||+|++|..|..       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34788888999999999884     79999999998665  45556778889999999999999999864310       


Q ss_pred             ------------------------------------------------C-------------------------------
Q 020981          222 ------------------------------------------------S-------------------------------  222 (319)
Q Consensus       222 ------------------------------------------------~-------------------------------  222 (319)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             ---------------------------------CceEEEEeecCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHhh
Q 020981          223 ---------------------------------SPMMIVTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHE  268 (319)
Q Consensus       223 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~qi~~al~~lH~  268 (319)
                                                       ..+||-||||+...+.+++..+... .....+++++||++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                             1268999999988888888776544 477889999999999999999


Q ss_pred             CCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       269 ~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      .|   ||||||||.||++++++.+||+|||+|..
T Consensus       716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             Cc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence            99   99999999999999999999999999987

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.88  E-value=1.7e-21  Score=167.65  Aligned_cols=147  Identities=27%  Similarity=0.534  Sum_probs=129.0

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|++|.++.     ++..+++|.+..... .......+.+|+++++.++|||++++.+.+......++++||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            56677899999988773     478999999875433 234556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          232 LPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       232 ~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      +++++|.+++.+.    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999764    56899999999999999999999998   9999999999999999999999999998765553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.88  E-value=1.2e-21  Score=171.53  Aligned_cols=146  Identities=31%  Similarity=0.522  Sum_probs=127.6

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|+++.+|.     .+..+++|.+...... ......+.+|+.+++.++|||++++++.+..+...++|+||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            56677899999998874     4789999998765432 23346788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      + +++|.+++... ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 99999998653 56899999999999999999999999   9999999999999999999999999998775543

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=9.9e-22  Score=169.91  Aligned_cols=141  Identities=30%  Similarity=0.487  Sum_probs=118.7

Q ss_pred             eeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHH-HhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       161 ~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      +.+|.|+||.+|.     .++.+|+|.+.+...........+..|..++ ...+|||++++++.+...+..|+++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            3578999998874     4679999998754332233333444555544 445799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++...
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            999999998888999999999999999999999999   9999999999999999999999999987643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=7.4e-24  Score=175.11  Aligned_cols=153  Identities=28%  Similarity=0.523  Sum_probs=129.4

Q ss_pred             cccccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-----
Q 020981          154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----  223 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----  223 (319)
                      ..+.+...-||.|.||+|+     .+|+.||+|++.. .+..-...+.+-+|+.++..++|.|++..+++.+-..     
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            3455556679999999987     3689999998863 2333333456677999999999999999998876543     


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .+|+++|.|. .+|..++.+.+.++.+.+.-|..||+.||.|||+.+   |+||||||.|+|++++..+||||||+|+..
T Consensus       131 EiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  131 ELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            4788999994 699999999999999999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCce
Q 020981          304 TVKEDRPL  311 (319)
Q Consensus       304 ~~~~~~~~  311 (319)
                      ..++.+..
T Consensus       207 e~d~~~hM  214 (449)
T KOG0664|consen  207 DQRDRLNM  214 (449)
T ss_pred             chhhhhhh
Confidence            87776654

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=9.9e-22  Score=170.92  Aligned_cols=146  Identities=32%  Similarity=0.469  Sum_probs=124.9

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCC----
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS----  223 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~----  223 (319)
                      ..+|.....+|.|+++.+|.     .++.+++|.+....    .....+.+|+.+++++ .|+||+++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            34677888999999998874     45789999886432    2346788999999999 6999999999987654    


Q ss_pred             --ceEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       224 --~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                        ..|++|||+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence              48999999999999998865    346899999999999999999999999   999999999999999999999999


Q ss_pred             CcccccccC
Q 020981          298 GVSKLLTVK  306 (319)
Q Consensus       298 gla~~~~~~  306 (319)
                      |++......
T Consensus       158 ~~~~~~~~~  166 (275)
T cd06608         158 GVSAQLDST  166 (275)
T ss_pred             ccceecccc
Confidence            998766443

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.88  E-value=5.1e-22  Score=172.07  Aligned_cols=144  Identities=35%  Similarity=0.543  Sum_probs=126.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|.++.+|.     +++.+++|.+.....  ......+.+|+.+++.++||||+++++.+......++++|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            355566789999988874     478899999876432  3455678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+++++|.+++... ..+++..+..++.|++.||.|+|+ .+   ++|+||||+||+++.++.++|+|||.+....
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            99999999999876 678999999999999999999999 88   9999999999999999999999999987664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=1.1e-21  Score=169.61  Aligned_cols=143  Identities=35%  Similarity=0.549  Sum_probs=125.7

Q ss_pred             ccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .+|.....+|.|+||.+|.    .+..+|+|.+.....    ....+.+|+.+++.++|||++++++.+......+++||
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            3577778999999998874    346799999875432    23567889999999999999999999998899999999


Q ss_pred             ecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+++++|.+++....  .+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.+||+|||++..+.
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence            999999999997643  5889999999999999999999999   9999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.88  E-value=1.6e-21  Score=170.63  Aligned_cols=144  Identities=27%  Similarity=0.499  Sum_probs=119.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHH-HHhcCCCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....+|.|+||.+|.     +|..||+|.+..... .... ..+..|+.+ ++..+|||++++++.+......|++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            567788999999999885     478999999875432 2223 334445554 66678999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       230 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ||++ ++|.+++...    ..+++..+..++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9995 6888887642    3589999999999999999999997 7   9999999999999999999999999998764


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       156 ~  156 (283)
T cd06617         156 D  156 (283)
T ss_pred             c
Confidence            3

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.88  E-value=8.6e-22  Score=177.05  Aligned_cols=146  Identities=25%  Similarity=0.473  Sum_probs=125.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-----Cce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~  225 (319)
                      .|.....+|.|+|+.+|.     ++..||+|.+...... ......+.+|+.+++.++||||+++++++...     ...
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            577788999999998874     4789999998754322 22345667899999999999999999987644     358


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++||+. ++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            99999995 799999988888999999999999999999999999   99999999999999999999999999987655


Q ss_pred             C
Q 020981          306 K  306 (319)
Q Consensus       306 ~  306 (319)
                      .
T Consensus       161 ~  161 (337)
T cd07858         161 K  161 (337)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.88  E-value=9.9e-22  Score=169.31  Aligned_cols=144  Identities=38%  Similarity=0.666  Sum_probs=125.6

Q ss_pred             cceeeeecceEEEEEE---e------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          158 TNSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~---~------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .....+|.|+||.+|.   .      +..+|+|.+....  .......+..|+.+++.++|+|++++++.+......+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            3456789999998873   2      2789999986543  233567888999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |||+++++|.+++.....  +++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999986544  899999999999999999999999   999999999999999999999999999876543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.88  E-value=2.1e-21  Score=167.21  Aligned_cols=147  Identities=29%  Similarity=0.541  Sum_probs=127.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.+|.     +++.+|+|.+...... ......+.+|+.+++.++|||++++++.+......++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            366778899999998873     5788999998765433 3446788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++...  ..+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++ .+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999999764  34889999999999999999999999   99999999999998654 5899999999877544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.88  E-value=1e-21  Score=169.37  Aligned_cols=140  Identities=36%  Similarity=0.635  Sum_probs=122.0

Q ss_pred             cccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      +|.....+|.|+||.+|.   .+..+|+|.+....     ....+.+|+.+++.++|||++++++.+.. +..+++|||+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~   80 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELM   80 (254)
T ss_pred             HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECC
Confidence            577788999999998875   67889999886432     23568889999999999999999998865 4579999999


Q ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       233 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            9999999997653  4788899999999999999999998   9999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=1.3e-21  Score=169.69  Aligned_cols=137  Identities=23%  Similarity=0.420  Sum_probs=116.4

Q ss_pred             eeecceEEEEEEe-----------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          162 EITKGTFILAFWR-----------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       162 ~ig~G~f~~v~~~-----------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      .+|+|+||.||..                 ...+++|.+....   ......+.+|+.+++.++||||+++++++.....
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            5788988888743                 1258888876432   2334568889999999999999999999999899


Q ss_pred             eEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC-------EEEEe
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-------LKVAD  296 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~-------~kl~D  296 (319)
                      .+++|||+++++|..++... ..+++..+..++.|++.||+|||+++   ++||||||+|||++.++.       +|++|
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999999988754 46899999999999999999999999   999999999999987664       89999


Q ss_pred             cCcccccc
Q 020981          297 FGVSKLLT  304 (319)
Q Consensus       297 Fgla~~~~  304 (319)
                      ||++..+.
T Consensus       156 ~g~~~~~~  163 (262)
T cd05077         156 PGIPITVL  163 (262)
T ss_pred             CCCCcccc
Confidence            99987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.88  E-value=1.4e-21  Score=170.80  Aligned_cols=143  Identities=32%  Similarity=0.508  Sum_probs=122.8

Q ss_pred             cccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....+|+|++|.+|.          .+..+++|.+....  .......+.+|+.+++.++|+||+++++++......
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            567778899999998873          24578899876432  234446688899999999999999999999998999


Q ss_pred             EEEEeecCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC---CEEEE
Q 020981          226 MIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVA  295 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~  295 (319)
                      +++|||+++++|.+++...+       .+++..+..++.|++.||+|||+++   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            99999999999999997653       4788999999999999999999999   99999999999998765   59999


Q ss_pred             ecCccccc
Q 020981          296 DFGVSKLL  303 (319)
Q Consensus       296 DFgla~~~  303 (319)
                      |||+++.+
T Consensus       162 dfg~~~~~  169 (277)
T cd05036         162 DFGMARDI  169 (277)
T ss_pred             cCcccccc
Confidence            99999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.87  E-value=2.6e-21  Score=170.19  Aligned_cols=145  Identities=32%  Similarity=0.443  Sum_probs=123.2

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeC-----
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-----  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-----  222 (319)
                      ..+|.....+|.|+|+.+|.     +++.+|+|.+....    .....+.+|+.+++++ +|||++++++.+...     
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            45688888999999998874     47789999886431    1234567899999998 799999999988653     


Q ss_pred             CceEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecC
Q 020981          223 SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFg  298 (319)
                      ...++||||+++++|.++++.    ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecc
Confidence            358999999999999998863    346889999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccc
Q 020981          299 VSKLLTV  305 (319)
Q Consensus       299 la~~~~~  305 (319)
                      +++....
T Consensus       174 ~~~~~~~  180 (291)
T cd06639         174 VSAQLTS  180 (291)
T ss_pred             cchhccc
Confidence            9887654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.87  E-value=2.5e-21  Score=167.54  Aligned_cols=142  Identities=30%  Similarity=0.519  Sum_probs=123.2

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|...+.+|+|+|+.+|.    .+..+++|.+...    ......+.+|+.+++.++|+|++++++.+.. ...+++|||
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            677788999999999884    3457999987643    2334678889999999999999999998877 778999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|.+++.+.  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            9999999999764  34778889999999999999999998   99999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.87  E-value=1.7e-21  Score=171.55  Aligned_cols=145  Identities=28%  Similarity=0.515  Sum_probs=121.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|.++.+|.     +++.+|+|.+...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            467788999999998874     4678999988654322 2333567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-CCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DFgla~~~~~  305 (319)
                      |++ ++|.+++.....  +++..+..++.|++.||+|||+++   ++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            995 588888765443  577888899999999999999999   999999999999985 45799999999976543

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.87  E-value=1.3e-21  Score=172.41  Aligned_cols=141  Identities=24%  Similarity=0.449  Sum_probs=123.0

Q ss_pred             ceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecC
Q 020981          159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       159 ~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      ....+|+|+||.+|.     ++..+|+|.+...   .......+.+|+.+++.++|+|++++++.+...+..+++|||++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            345789999998874     4789999987532   23345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       234 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +++|.+++.. ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657         101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence            9999987754 46899999999999999999999999   999999999999999999999999998766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.87  E-value=2.2e-21  Score=169.67  Aligned_cols=147  Identities=29%  Similarity=0.441  Sum_probs=126.1

Q ss_pred             cccccceeeeecceEEEEEE----e-----ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-CC
Q 020981          154 ELDFTNSVEITKGTFILAFW----R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS  223 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~----~-----~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~  223 (319)
                      ..+|.....+|+|+||.||.    .     +..+++|.+...  ........+.+|+.+++.++|||++++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            34677788999999998873    2     578899987643  244556778899999999999999999998765 56


Q ss_pred             ceEEEEeecCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      ..+++++|+++++|.+++...        ..+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998763        34889999999999999999999999   9999999999999999999999


Q ss_pred             ecCccccccc
Q 020981          296 DFGVSKLLTV  305 (319)
Q Consensus       296 DFgla~~~~~  305 (319)
                      |||+++.+..
T Consensus       160 d~g~~~~~~~  169 (280)
T cd05043         160 DNALSRDLFP  169 (280)
T ss_pred             CCCCcccccC
Confidence            9999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PTZ00284 protein kinase; Provisional

Probab=99.87  E-value=1.6e-21  Score=182.75  Aligned_cols=154  Identities=19%  Similarity=0.255  Sum_probs=120.3

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCC------CcccccceeEEeC
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH------PNVVQFLGAVTQS  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~l~~~~~~~  222 (319)
                      ..+|.....||+|+||.||.     .++.||||++....    .....+..|+.+++.++|      ++++++++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            34688888999999999985     46789999986421    122345567777777654      4578888877654


Q ss_pred             -CceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCC----------
Q 020981          223 -SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG----------  290 (319)
Q Consensus       223 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~----------  290 (319)
                       ...|+|||++ +++|.+++.+.+.+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++          
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccc
Confidence             5789999988 78999999888889999999999999999999998 48   99999999999998765          


Q ss_pred             ------CEEEEecCcccccccCCCCceeeccCCC
Q 020981          291 ------NLKVADFGVSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       291 ------~~kl~DFgla~~~~~~~~~~~~~~~~~~  318 (319)
                            .+||+|||++.....   .....+||+.
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~  310 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERH---SRTAIVSTRH  310 (467)
T ss_pred             cCCCCceEEECCCCccccCcc---ccccccCCcc
Confidence                  499999998864322   2234566663

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.87  E-value=2.8e-22  Score=180.50  Aligned_cols=157  Identities=22%  Similarity=0.355  Sum_probs=131.1

Q ss_pred             ccccCCCcc-cccceeeeecceEEEEEE-----eceEeEEEEecccccCC-----HHHHHHHHHHHHHHHhcC---CCcc
Q 020981          147 EYEIDPHEL-DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIR---HPNV  212 (319)
Q Consensus       147 ~~~~~~~~~-~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~-----~~~~~~~~~E~~~l~~l~---h~~i  212 (319)
                      .++...... +|.....+|.|+||.|..     ....|+||.+.++.+-.     +......-.|+.+|..++   |+||
T Consensus       552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            344443333 688888999999998863     45789999988754321     111223457999999997   9999


Q ss_pred             cccceeEEeCCceEEEEeec-CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC
Q 020981          213 VQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       213 v~l~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      ++++++|++++++||+||-- +|.+|.+++..+..+++.++..|++|++.|+++||..+   |||||||-+|+.++.+|.
T Consensus       632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence            99999999999999999964 45699999998888999999999999999999999999   999999999999999999


Q ss_pred             EEEEecCcccccccC
Q 020981          292 LKVADFGVSKLLTVK  306 (319)
Q Consensus       292 ~kl~DFgla~~~~~~  306 (319)
                      +||+|||.|.....+
T Consensus       709 ~klidfgsaa~~ksg  723 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSG  723 (772)
T ss_pred             EEEeeccchhhhcCC
Confidence            999999999876554

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.87  E-value=1.8e-21  Score=168.38  Aligned_cols=141  Identities=31%  Similarity=0.544  Sum_probs=122.6

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|.....+|.|+||.+|.    .++.+|+|.+.....    ....+.+|+.+++.++|||++++++.+ .....+++|||
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~   81 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY   81 (260)
T ss_pred             HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence            577778999999998874    568899999875432    235678899999999999999999876 45678999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +.+++|.+++...  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            9999999998753  35888999999999999999999999   9999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.87  E-value=3.3e-22  Score=181.50  Aligned_cols=144  Identities=31%  Similarity=0.562  Sum_probs=124.3

Q ss_pred             ccceeeeecceEEEEEE-------ec--eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          157 FTNSVEITKGTFILAFW-------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-------~~--~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ......||.|-||.||.       .|  ..||||.-+.+.  +++..+.|..|..+|+.+.||||++++|++.. .+.||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            33456799999998873       22  357888766543  34557889999999999999999999998765 57999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |||.++-|.|..+++.++ .++......|+.||+.||.|||++.   +|||||..+|||+.+.-.+||+||||++.+...
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999998765 5888999999999999999999999   999999999999999999999999999977543

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.87  E-value=2.1e-21  Score=170.30  Aligned_cols=145  Identities=26%  Similarity=0.472  Sum_probs=127.8

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ..|.....+|.|.++.+|.     .+..+++|.+.....    ..+.+.+|+.+++.++|+|++++++.+......|+++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            3466667889999987774     477899999875322    4467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999998876 7999999999999999999999998   999999999999999999999999998766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.87  E-value=2.1e-21  Score=171.05  Aligned_cols=146  Identities=28%  Similarity=0.474  Sum_probs=121.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCc-----
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP-----  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~-----  224 (319)
                      +|.....+|.|+||.+|.     ++..||+|.+..... .......+.+|+.+++.+. ||||+++++++.....     
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            466778899999998874     478999998865432 1222356778999999996 6999999999887665     


Q ss_pred             eEEEEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-CCCEEEEecC
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFG  298 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DFg  298 (319)
                      .|++|||+++ +|.+++...     ..+++..+..++.|++.||.|||+++   ++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 898888643     34789999999999999999999999   999999999999998 8899999999


Q ss_pred             cccccccC
Q 020981          299 VSKLLTVK  306 (319)
Q Consensus       299 la~~~~~~  306 (319)
                      +++.+..+
T Consensus       157 ~~~~~~~~  164 (295)
T cd07837         157 LGRAFSIP  164 (295)
T ss_pred             cceecCCC
Confidence            99876443

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.87  E-value=2e-21  Score=169.12  Aligned_cols=136  Identities=38%  Similarity=0.662  Sum_probs=116.4

Q ss_pred             eeecceEEEEEEe-----c--eEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecC
Q 020981          162 EITKGTFILAFWR-----G--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       162 ~ig~G~f~~v~~~-----~--~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      .+|+|+||.||..     +  ..+++|.+...  ......+.+.+|+.++.++ +||||+++++++......+++|||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            4788999887742     2  25688887642  2334456788999999999 69999999999999999999999999


Q ss_pred             CCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          234 KGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       234 ~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      +++|.+++..+.                .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence            999999997643                3678899999999999999999998   999999999999999999999999


Q ss_pred             Ccccc
Q 020981          298 GVSKL  302 (319)
Q Consensus       298 gla~~  302 (319)
                      |++..
T Consensus       157 gl~~~  161 (270)
T cd05047         157 GLSRG  161 (270)
T ss_pred             CCccc
Confidence            99863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.87  E-value=2.3e-22  Score=161.94  Aligned_cols=130  Identities=18%  Similarity=0.114  Sum_probs=112.8

Q ss_pred             cccccccccccCchhhhh----hhhhcCCCCCCCCCCcchHHHHHHHcCCHH---HHHHHHHcCCCCcccC-CCCCCHHH
Q 020981            7 VRTTLLKQSSLAPDRERK----EAELNGLDDDGEEIKPEFRLMFLANERDVE---GIKELLDSGIDVNFRD-IDNRTALH   78 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~---~~~~Ll~~ga~vn~~d-~~g~tpLh   78 (319)
                      ..++++.|++.+.....+    ...-.+.++|..|..|+||||+||..|+.+   ++++|+++|+++|.+| ..|+||||
T Consensus        20 ~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh   99 (166)
T PHA02743         20 EQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLH   99 (166)
T ss_pred             CCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHH
Confidence            346788888888753222    334468889999999999999999998865   4899999999999998 58999999


Q ss_pred             HHHHcCCHHHHHHhhh-CCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           79 VAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        79 ~A~~~~~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      +|+..|+.+++++|++ .|++++.+|..|+||+|+|+..++.+++++|++.|++...+.
T Consensus       100 ~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~  158 (166)
T PHA02743        100 IAASTKNYELAEWLCRQLGVNLGAINYQHETAYHIAYKMRDRRMMEILRANGAVCDDPL  158 (166)
T ss_pred             HHHHhCCHHHHHHHHhccCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence            9999999999999995 799999999999999999999999999999999998875444

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.87  E-value=2.2e-21  Score=175.56  Aligned_cols=145  Identities=26%  Similarity=0.410  Sum_probs=122.8

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------C
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~  223 (319)
                      .+|.....+|+|+||.++.     ++..+|+|.+..... .......+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            3688888999999998874     578999999865432 333445677899999999999999999987643      3


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ..|+||||+. ++|.+.+...  +++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++..
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            5799999995 5888887654  888999999999999999999999   999999999999999999999999999876


Q ss_pred             ccC
Q 020981          304 TVK  306 (319)
Q Consensus       304 ~~~  306 (319)
                      ...
T Consensus       169 ~~~  171 (353)
T cd07850         169 GTS  171 (353)
T ss_pred             CCC
Confidence            543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.87  E-value=2.6e-21  Score=167.41  Aligned_cols=142  Identities=35%  Similarity=0.550  Sum_probs=120.6

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|.....+|.|+++.+|.    .+..+|+|.+.....    ..+.+.+|+.+++.++|||++++++++. ....+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            466778899999998874    234799998764322    2256778999999999999999998764 5678999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            99999999997643  3788899999999999999999999   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.87  E-value=1.9e-21  Score=168.25  Aligned_cols=142  Identities=37%  Similarity=0.569  Sum_probs=122.5

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|.....+|.|+|+.+|.    .+..+|+|.+......    ...+.+|+.++++++||+++++++.+. ....+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            567778899999998874    3567999998754332    245888999999999999999998774 5668999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++..+..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            9999999999764  34889999999999999999999999   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.87  E-value=3e-21  Score=171.68  Aligned_cols=140  Identities=19%  Similarity=0.340  Sum_probs=121.0

Q ss_pred             eeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          161 VEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       161 ~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      ...|.|+++.++.   ++..+|+|.+..... .......+.+|+.+++.++||||+++++++......+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3445566665553   688999999876532 344567899999999999999999999999999999999999999999


Q ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          238 RAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       238 ~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .+++...  ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||.+..+.
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence            9999864  35889999999999999999999999   9999999999999999999999999887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.87  E-value=2.2e-21  Score=169.81  Aligned_cols=144  Identities=31%  Similarity=0.590  Sum_probs=124.3

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|+++.+|.     +|..+|+|++...... ......+.+|+.+++.++|||++++++.+......|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            34567889999998874     5789999998754322 22335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       232 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ++ ++|.+++....  .+++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            94 69999988765  6899999999999999999999998   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.87  E-value=2.1e-21  Score=167.38  Aligned_cols=157  Identities=26%  Similarity=0.499  Sum_probs=130.5

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |...+.+|.|+|+.+|.     .|..+|+|.+....... ...+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            56677899999998874     46789999987543322 3345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC-EEEEecCcccccccCCC
Q 020981          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKED  308 (319)
Q Consensus       232 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~DFgla~~~~~~~~  308 (319)
                      +++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||||+||++++++. +||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987643  4789999999999999999999999   999999999999998864 69999999987765544


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                      ....+.|++
T Consensus       158 ~~~~~~~~~  166 (257)
T cd08225         158 LAYTCVGTP  166 (257)
T ss_pred             cccccCCCc
Confidence            433444444

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.87  E-value=2.4e-21  Score=169.61  Aligned_cols=143  Identities=28%  Similarity=0.474  Sum_probs=121.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEe------CC
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ------SS  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~------~~  223 (319)
                      .|.....+|.|+||.+|.     .++.+|+|.+...    ......+..|+.+++++ +|||++++++++..      ..
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            567778899999998874     4678999987542    23345678899999998 69999999998853      45


Q ss_pred             ceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      ..|++|||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            789999999999999999764  34788888999999999999999999   9999999999999999999999999988


Q ss_pred             cccc
Q 020981          302 LLTV  305 (319)
Q Consensus       302 ~~~~  305 (319)
                      ....
T Consensus       170 ~~~~  173 (282)
T cd06636         170 QLDR  173 (282)
T ss_pred             hhhc
Confidence            6643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.87  E-value=2.5e-21  Score=166.97  Aligned_cols=142  Identities=33%  Similarity=0.613  Sum_probs=124.7

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|...+.+|.|+||.+|.    .+..+|+|.+......    ...+.+|+.+++.++||+++++++.+......+++|||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            566678899999998874    3678999988754332    24577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +++++|.+++... +.+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            9999999998764 45889999999999999999999999   9999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.87  E-value=3.5e-21  Score=167.45  Aligned_cols=144  Identities=28%  Similarity=0.523  Sum_probs=123.2

Q ss_pred             cccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|.....+|.|+||.+|..        ...+++|......  .....+.+.+|+.+++.++||||+++++++.. ...|+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            5677789999999988742        1368899876432  24455678999999999999999999998765 56789


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +|||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            999999999999998754 4899999999999999999999999   99999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.87  E-value=2.5e-21  Score=166.41  Aligned_cols=138  Identities=36%  Similarity=0.593  Sum_probs=121.1

Q ss_pred             eeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          162 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       162 ~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      .+|.|+||.+|.    .++.+++|.+.....  ......+.+|+.+++.+.||||+++++++......+++|||+.+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            578888887763    278899998875432  24456788999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       238 ~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            9998653 45788999999999999999999999   9999999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.87  E-value=4.7e-21  Score=170.75  Aligned_cols=146  Identities=29%  Similarity=0.517  Sum_probs=126.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....+|+|+|+.+|.     ++..+|+|.+.............+.+|+.+++.++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            366777899999998874     467899999875544444556678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+. |++.+++.. ..++++..+..++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||++.....
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            996 578777754 456899999999999999999999999   99999999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.87  E-value=1.1e-21  Score=176.18  Aligned_cols=146  Identities=24%  Similarity=0.454  Sum_probs=124.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe----CCce
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~  225 (319)
                      .+|.....+|.|++|.+|.     ++..||+|.+..... .......+.+|+.+++.++||||+++++++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            3577778899999998873     578999999875432 22334567789999999999999999988753    3468


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ++||||+. ++|.+++.....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            99999995 699999987777999999999999999999999999   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA02791 ankyrin-like protein; Provisional

Probab=99.87  E-value=4.2e-22  Score=172.77  Aligned_cols=119  Identities=22%  Similarity=0.124  Sum_probs=60.0

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|||+.|+..++....+...-.|.++|..+  |.||||+|+..|+.++++.|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        31 ~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~~g~~e  108 (284)
T PHA02791         31 HSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVDSGNMQ  108 (284)
T ss_pred             CcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHH
Confidence            345555555555444444444444444432  345555555555555555555555555555555555555555555555


Q ss_pred             HHHHhhhCCCcccCCCCCCC-CCcccccccccHHHHHHHHhh
Q 020981           88 VVSLLLERGADVDPKDRWGS-TPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~-tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      ++++|+++|++++.++..|+ ||+|+|+..|+.+++++|++.
T Consensus       109 ivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~  150 (284)
T PHA02791        109 TVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSE  150 (284)
T ss_pred             HHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhc
Confidence            55555555555555544443 455555555555555555544

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.87  E-value=6.5e-21  Score=163.29  Aligned_cols=146  Identities=32%  Similarity=0.552  Sum_probs=129.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+++.+|.     .+..+++|.+.....   .....+.+|+.+++.++||+++++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            356677899999988874     367899999875432   345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++++|.+++... ..+++..+..++.|++.||.+||.++   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            99999999999876 57899999999999999999999998   9999999999999999999999999998876553

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.87  E-value=2.4e-21  Score=171.96  Aligned_cols=147  Identities=35%  Similarity=0.546  Sum_probs=123.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI  227 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l  227 (319)
                      .+|.....+|.|+||.+|.     +|..||+|.+....... .....+.+|+.++++++|+|++++++++...  ...++
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            3677888999999998874     47899999987543221 1123455799999999999999999998654  46899


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||||++ ++|.+++... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..+...
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999996 5898888753 56899999999999999999999999   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.87  E-value=3.1e-21  Score=170.86  Aligned_cols=145  Identities=28%  Similarity=0.539  Sum_probs=122.4

Q ss_pred             ccccceeeeecceEEEEEEe-----ce----EeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          155 LDFTNSVEITKGTFILAFWR-----GI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~-----~~----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      .+|...+.+|.|+||.+|..     +.    .+|+|.+....  .......+.+|+.+++.++||||+++++.+... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            35677788999999988852     32    57888876432  233445688899999999999999999988654 46


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++++||+++|+|.+++.... .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            79999999999999987654 5888999999999999999999999   9999999999999999999999999998765


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       161 ~  161 (303)
T cd05110         161 G  161 (303)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.87  E-value=3.8e-22  Score=158.68  Aligned_cols=145  Identities=26%  Similarity=0.505  Sum_probs=121.1

Q ss_pred             cccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +......+|+|++|.+.     .+|...|+|.++... .+ .....+.+|+.+..+. .+|++|.+||....+...|+.|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-Ch-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            44456689999999764     478999999987543 33 3445667788887776 5999999999999999999999


Q ss_pred             eecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |.| ..||..+.+    ..+.+++.-.-+++..+..||.|||++-  .++|||+||+||||+.+|.+||||||++-.+..
T Consensus       125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            999 568877654    4567999999999999999999999974  499999999999999999999999999876643

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=7.8e-21  Score=166.90  Aligned_cols=144  Identities=30%  Similarity=0.489  Sum_probs=122.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv  228 (319)
                      +|.....+|.|+++.+|.     .++.+|+|.+....  .......+.+|+++++.++||||+++++++...  ..+|++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            466778899999998873     46889999887542  224456788899999999999999999988653  468999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999988753    245888999999999999999999999   9999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.86  E-value=4.6e-21  Score=165.05  Aligned_cols=146  Identities=28%  Similarity=0.482  Sum_probs=127.2

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|.|+++.+|.     ++..+++|.+...... ......+.+|+.+++.++|+||+++++.+......++++||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            56677899999988874     4678999998754432 34456778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          232 LPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       232 ~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999876    345888999999999999999999999   999999999999999999999999999877554

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.86  E-value=4.5e-21  Score=165.91  Aligned_cols=138  Identities=34%  Similarity=0.589  Sum_probs=116.2

Q ss_pred             eeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEE-eCCceEEEEeec
Q 020981          162 EITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL  232 (319)
Q Consensus       162 ~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~~  232 (319)
                      .+|+|+||.+|.        ....+|+|.+...  ........+.+|+.+++.++|||++++++.+. .+...+++|||+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            578999998873        1357999987532  23445577888999999999999999999765 455689999999


Q ss_pred             CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          233 PKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       233 ~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .+++|.+++.... ..++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+.
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999997643 4677788889999999999999998   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=4.2e-21  Score=158.28  Aligned_cols=140  Identities=19%  Similarity=0.150  Sum_probs=108.5

Q ss_pred             eeeecceEEEEEE----eceEeEEEEecccccCC---------------------H--HHHHHHHHHHHHHHhcCCCccc
Q 020981          161 VEITKGTFILAFW----RGIQVAVKKLGEEVISD---------------------D--DRVRAFRDELALLQKIRHPNVV  213 (319)
Q Consensus       161 ~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~---------------------~--~~~~~~~~E~~~l~~l~h~~iv  213 (319)
                      ..||.|+++.||.    +|+.||||+++......                     .  .....+..|...+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            4689999998874    48899999988653110                     0  0022346799999999999875


Q ss_pred             ccceeEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCE
Q 020981          214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNL  292 (319)
Q Consensus       214 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~  292 (319)
                      ........  ..++||||++|+++.........++......++.|++.++.++|+ .+   |+||||||+||+++ ++.+
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~  156 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCE
Confidence            54443333  248999999887554433334567888999999999999999999 88   99999999999999 8999


Q ss_pred             EEEecCcccccccC
Q 020981          293 KVADFGVSKLLTVK  306 (319)
Q Consensus       293 kl~DFgla~~~~~~  306 (319)
                      +|+|||+|+....+
T Consensus       157 ~liDFG~a~~~~~~  170 (190)
T cd05145         157 YIIDVSQAVELDHP  170 (190)
T ss_pred             EEEEcccceecCCC
Confidence            99999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.1e-23  Score=172.27  Aligned_cols=146  Identities=28%  Similarity=0.477  Sum_probs=120.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--------C
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------S  222 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--------~  222 (319)
                      .|....++|+|+||.||.     +|+.||+|++..+........ ...+|+.+|..++|+|++.+++.|..        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpi-talreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPI-TALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcH-HHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            466667899999998773     678899997654332222222 23569999999999999999887743        2


Q ss_pred             CceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      ..+|+||++|+ .+|..++... .+++..++.+++.+++.||.|+|...   |+|||+||+|+||+.+|.+||+|||+++
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence            34899999996 5999988765 56999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccC
Q 020981          302 LLTVK  306 (319)
Q Consensus       302 ~~~~~  306 (319)
                      .++..
T Consensus       173 ~fs~~  177 (376)
T KOG0669|consen  173 AFSTS  177 (376)
T ss_pred             ceecc
Confidence            77543

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.86  E-value=9.6e-21  Score=168.51  Aligned_cols=143  Identities=29%  Similarity=0.511  Sum_probs=123.7

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....+|+|+||.+|.     ++..+++|.+.............+.+|+.+++.++|||++++++++......|++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            44456799999998875     4778999998765444455556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       232 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      +. +++.+++.. ..++++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.+||+|||++...
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            95 678777765 456899999999999999999999999   999999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.86  E-value=5.7e-21  Score=166.28  Aligned_cols=144  Identities=34%  Similarity=0.504  Sum_probs=119.5

Q ss_pred             cceeeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC------
Q 020981          158 TNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------  223 (319)
                      .....+|+|+||.+|.        +++.+|+|.+..... .....+.+.+|+.+++.++|||++++++.+....      
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            3455789999988773        257899999876543 3445677889999999999999999999875432      


Q ss_pred             ceEEEEeecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      ..+++++|+.+|+|.+++...      ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            247889999999999887532      14788889999999999999999999   999999999999999999999999


Q ss_pred             Cccccccc
Q 020981          298 GVSKLLTV  305 (319)
Q Consensus       298 gla~~~~~  305 (319)
                      |+++....
T Consensus       158 g~~~~~~~  165 (273)
T cd05074         158 GLSKKIYS  165 (273)
T ss_pred             cccccccC
Confidence            99987643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.86  E-value=3.1e-21  Score=173.22  Aligned_cols=142  Identities=29%  Similarity=0.422  Sum_probs=122.3

Q ss_pred             ceeeeecceEEEEEE-----eceEeEEEEecccccCCHH-----------HHHHHHHHHHHHHhcCCCcccccceeEEeC
Q 020981          159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD-----------RVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (319)
Q Consensus       159 ~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  222 (319)
                      ....||.|+||.+|.     .++.||+|.+.........           ....+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            345699999998874     4788999998654322100           012467899999999999999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      ...+++|||+. ++|.+++.....+++.....++.|++.||+|||+++   ++|+||+|+||+++.++.+||+|||++..
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~  168 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR  168 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence            99999999996 699999988778999999999999999999999999   99999999999999999999999999987


Q ss_pred             cc
Q 020981          303 LT  304 (319)
Q Consensus       303 ~~  304 (319)
                      +.
T Consensus       169 ~~  170 (335)
T PTZ00024        169 YG  170 (335)
T ss_pred             cc
Confidence            65

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.86  E-value=8.6e-21  Score=163.22  Aligned_cols=147  Identities=33%  Similarity=0.577  Sum_probs=130.8

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEEEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT  229 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~  229 (319)
                      |...+.+|.|++|.+|.     ++..+++|.+...... +...+.+.+|+.++++++||||+++++.+...  ...++++
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            55667899999998874     4788999998754322 45567889999999999999999999999888  8899999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||+++++|.+++.+...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            99999999999988778999999999999999999999998   9999999999999999999999999998876654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA02741 hypothetical protein; Provisional

Probab=99.86  E-value=4.4e-22  Score=160.96  Aligned_cols=125  Identities=17%  Similarity=0.173  Sum_probs=112.7

Q ss_pred             cccccccccccCchhhhhhhh------hcCCCCCCCCCCcchHHHHHHHcCC----HHHHHHHHHcCCCCcccCC-CCCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAE------LNGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDI-DNRT   75 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~t~L~~a~~~~~----~~~~~~Ll~~ga~vn~~d~-~g~t   75 (319)
                      -.|+|+.|++.++....+...      ..+.++|.+|..|.||||+|+..|+    .++++.|+++|+|+|.+|. +|+|
T Consensus        21 g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~T  100 (169)
T PHA02741         21 GENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEGDT  100 (169)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCC
Confidence            368999999999977666542      2468899999999999999999999    5899999999999999995 8999


Q ss_pred             HHHHHHHcCCHHHHHHhhh-CCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCC
Q 020981           76 ALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (319)
Q Consensus        76 pLh~A~~~~~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~  131 (319)
                      |||+|+..++.+++++|++ .|++++.+|..|+||+++|...++.+++++|.+.++.
T Consensus       101 pLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tpL~~A~~~~~~~iv~~L~~~~~~  157 (169)
T PHA02741        101 ALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSPFELAIDNEDVAMMQILREIVAT  157 (169)
T ss_pred             HHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence            9999999999999999997 5999999999999999999999999999999987654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.86  E-value=4.6e-21  Score=172.25  Aligned_cols=143  Identities=27%  Similarity=0.526  Sum_probs=121.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-----Cce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~  225 (319)
                      +|.....+|+|+||.+|.     +|..||+|.+...  ........+.+|+.+++.++||||+++++++...     ...
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            678888999999998874     5789999998642  2223345677899999999999999999876544     358


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++||+. ++|.+++.. +.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          84 YIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            99999995 588887754 46899999999999999999999999   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA02791 ankyrin-like protein; Provisional

Probab=99.86  E-value=6.2e-22  Score=171.70  Aligned_cols=127  Identities=15%  Similarity=0.099  Sum_probs=99.5

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCC-CHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~-tpLh~A~~~~~~   86 (319)
                      .|||+.|+..++....+.....|.|+|.+|.+|+||||+||..|+.++++.|+++|+++|.++..|+ ||||+|+..|+.
T Consensus        62 ~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~  141 (284)
T PHA02791         62 EFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDV  141 (284)
T ss_pred             CCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCH
Confidence            5788888888887777777778888888888888888888888888888888888888888887774 788888888888


Q ss_pred             HHHHHhhhCCCcccCCC-CCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           87 EVVSLLLERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~-~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      ++|++|++++.+.  .| ..|.||||+|+..|+.+++++|+++|+++...+
T Consensus       142 eivk~LL~~~~~~--~d~~~g~TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d  190 (284)
T PHA02791        142 SIVSYFLSEIPST--FDLAILLSCIHITIKNGHVDMMILLLDYMTSTNTNN  190 (284)
T ss_pred             HHHHHHHhcCCcc--cccccCccHHHHHHHcCCHHHHHHHHHCCCCCCccc
Confidence            8888888876543  23 247888888888888888888888887765443

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.86  E-value=5.9e-21  Score=169.21  Aligned_cols=148  Identities=29%  Similarity=0.437  Sum_probs=122.8

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-----
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----  223 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----  223 (319)
                      ..+|.....+|.|+|+.+|.     +++.+|+|.+....... .....+.+|+.+++.++||||+++++++....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            34688889999999998874     47899999886543221 12234567999999999999999999876543     


Q ss_pred             ---ceEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          224 ---PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       224 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                         ..++||||+. ++|.+++.... .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence               4599999995 58888876543 6899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccC
Q 020981          300 SKLLTVK  306 (319)
Q Consensus       300 a~~~~~~  306 (319)
                      +..+...
T Consensus       166 ~~~~~~~  172 (310)
T cd07865         166 ARAFSLS  172 (310)
T ss_pred             cccccCC
Confidence            9877543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.86  E-value=5.4e-22  Score=164.08  Aligned_cols=156  Identities=28%  Similarity=0.464  Sum_probs=128.3

Q ss_pred             cccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +......+|.|+-|.|.     .+|...|||.+.+.  ...++.+.+...+.++...+ +|+||+.+|+|......++.|
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            34455678999988775     35789999999864  35667788888999888886 999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |.| ...++.+++. .+++++.-+-++..-+..||.||-++.  .|+|||+||+|||+|+.|++|+||||++-++.+...
T Consensus       171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            998 5567777765 457899888899999999999999876  499999999999999999999999999988866533


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                      .. ...|+|
T Consensus       248 ht-rsAGC~  255 (391)
T KOG0983|consen  248 HT-RSAGCA  255 (391)
T ss_pred             cc-cccCCc
Confidence            22 245555

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.86  E-value=5.2e-22  Score=180.44  Aligned_cols=137  Identities=26%  Similarity=0.262  Sum_probs=120.6

Q ss_pred             cccccccccCchhhhhhhhhc-CCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCCHHHHHHHcCCH
Q 020981            9 TTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFT   86 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d-~~g~tpLh~A~~~~~~   86 (319)
                      .....|++.|.....+.+.-. +.++|..|.+|.|+|||||.+|+++++++|+++|||||+.+ .-|.||||+||++|+.
T Consensus        46 ~~~v~A~q~G~l~~v~~lve~~g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~  125 (600)
T KOG0509|consen   46 DDIVKATQYGELETVKELVESEGESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHI  125 (600)
T ss_pred             hhhhhHhhcchHHHHHHHHhhcCcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcH
Confidence            445677888876666665555 99999999999999999999999999999999999999998 6689999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccCCC
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV  145 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~~  145 (319)
                      .+|++|+++|||++.+|..|.||+|.|+.+++.-++.+++..+++....+....++...
T Consensus       126 ~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpLmw  184 (600)
T KOG0509|consen  126 SVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPLMW  184 (600)
T ss_pred             HHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHHHH
Confidence            99999999999999999999999999999999999999999998877766655555433

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.4e-21  Score=169.73  Aligned_cols=145  Identities=32%  Similarity=0.512  Sum_probs=120.7

Q ss_pred             ccccceeeeecceEEEEE---EeceEeEEEEecccccCCHHHHHHHHHHHHHHHh--cCCCcccccceeEEeCC----ce
Q 020981          155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQSS----PM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~~----~~  225 (319)
                      .+....+.||+|.||.|+   |+|..||||++..     .++...| +|.++++.  ++|+||+.+++.-..++    .+
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~s-----rdE~SWf-rEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSS-----RDERSWF-RETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecc-----cchhhhh-hHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            356778899999999876   7999999999863     2333344 36666654  69999999998876543    58


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCeEEcCCCCCCEEecCCCCEEEEecCcc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-----NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-----~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla  300 (319)
                      |||++|-+.|||.|||.+ ..++.....+++..+++||.+||.     +|.+.|.|||||+.|||+.++|.+-|+|+|||
T Consensus       285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999999998 468999999999999999999994     34345999999999999999999999999999


Q ss_pred             cccccC
Q 020981          301 KLLTVK  306 (319)
Q Consensus       301 ~~~~~~  306 (319)
                      -.....
T Consensus       364 v~h~~~  369 (513)
T KOG2052|consen  364 VRHDSD  369 (513)
T ss_pred             EEeccc
Confidence            877654

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.86  E-value=5.7e-21  Score=171.34  Aligned_cols=144  Identities=24%  Similarity=0.422  Sum_probs=120.7

Q ss_pred             ccceeeeecceEEEEEE-----e--ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEe----CCc
Q 020981          157 FTNSVEITKGTFILAFW-----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ----SSP  224 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~----~~~  224 (319)
                      |.....+|.|+||.+|.     .  +..+|+|.+.... ......+.+.+|+.+++++. ||||+++++.+..    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            56677899999998874     3  5689999987432 22333456778999999995 9999999886532    245


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .|++++|+. ++|.+.+.....+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            789999984 799999988778999999999999999999999999   9999999999999999999999999998765


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       157 ~  157 (332)
T cd07857         157 E  157 (332)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.86  E-value=4.2e-21  Score=171.91  Aligned_cols=137  Identities=24%  Similarity=0.420  Sum_probs=117.8

Q ss_pred             eeecc--eEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          162 EITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       162 ~ig~G--~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      .||.|  +|+.||.     .|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++..+...++++||+.+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            34554  7777763     578999999875432 334567889999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       235 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      ++|.+++....  .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+|++||+.+..
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            99999988643  4888999999999999999999999   99999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.86  E-value=3.3e-21  Score=172.64  Aligned_cols=146  Identities=32%  Similarity=0.529  Sum_probs=126.8

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-----ceE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PMM  226 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~~  226 (319)
                      |.....+|.|++|.+|.     .+..+|+|.+.... ......+.+.+|+.+++.++||||+++++++....     ..|
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            56677899999998874     36899999987543 22344567888999999999999999999987765     789


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++|||++ ++|.+++.+...+++..+..++.|++.||.|||+++   ++|+||||+|||++.++.++|+|||++......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9999996 589999988778999999999999999999999999   999999999999999999999999999987655


Q ss_pred             C
Q 020981          307 E  307 (319)
Q Consensus       307 ~  307 (319)
                      .
T Consensus       157 ~  157 (330)
T cd07834         157 E  157 (330)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-22  Score=166.73  Aligned_cols=145  Identities=29%  Similarity=0.442  Sum_probs=120.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +.+...+||.|+||.|..     .|+..|||.++....  ..+.++|+.|.+...+- +.||||++||....+...|+.|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            455667899999999863     789999999986543  44556777788876665 5999999999999999999999


Q ss_pred             eecCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       230 e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+| ..||..+.+     .+..+++.-.-.+..-.+.||+||-..-  .|||||+||+|||++..|.+||||||++-.+.
T Consensus       143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            999 578877764     3456888888888888999999998764  39999999999999999999999999987664


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       220 ~  220 (361)
T KOG1006|consen  220 D  220 (361)
T ss_pred             H
Confidence            3

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.86  E-value=2.1e-21  Score=167.81  Aligned_cols=138  Identities=21%  Similarity=0.374  Sum_probs=116.4

Q ss_pred             eeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          162 EITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       162 ~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.|+|+.||..            ...+++|.+...   .....+.+.+|..+++.+.|||++++++.+......++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            5799999988742            224777776532   2334467888999999999999999999999989999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC--------EEEEecCcc
Q 020981          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LKVADFGVS  300 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~DFgla  300 (319)
                      ||+++|+|.+++..++ .+++.....++.|++.||+|||+++   |+||||||+||+++.++.        ++++|||++
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999998654 4889999999999999999999999   999999999999987764        699999998


Q ss_pred             ccccc
Q 020981          301 KLLTV  305 (319)
Q Consensus       301 ~~~~~  305 (319)
                      .....
T Consensus       156 ~~~~~  160 (258)
T cd05078         156 ITVLP  160 (258)
T ss_pred             cccCC
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.86  E-value=6.9e-21  Score=166.74  Aligned_cols=145  Identities=34%  Similarity=0.536  Sum_probs=125.3

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEEEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT  229 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~  229 (319)
                      |.....+|.|++|.+|.     .+..+|+|.+.... ........+.+|+.+++.++|||++++++.+...  ...++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            34567899999998875     46899999998654 2333445678899999999999999999999887  8899999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||++ ++|.+++... ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9996 5898888765 56899999999999999999999999   999999999999999999999999999877554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.86  E-value=1.2e-21  Score=179.87  Aligned_cols=150  Identities=30%  Similarity=0.541  Sum_probs=131.4

Q ss_pred             cccceeeeecceEEEEE---E-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAF---W-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~---~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +....+.+|+|.||.|.   |     +...||||.++.....  .....|++|+.+|.+++|||+++|||+..+ ....+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            45667789999999887   3     2357999999865443  256889999999999999999999999887 67899


Q ss_pred             EEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |||+++.|+|.+.|..  +..|.....-.|+.||+.||.||.+++   +|||||...|+|+.....+||+||||.+.+..
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            9999999999999987  234778888999999999999999999   99999999999999999999999999999988


Q ss_pred             CCCCce
Q 020981          306 KEDRPL  311 (319)
Q Consensus       306 ~~~~~~  311 (319)
                      +++.+.
T Consensus       265 ned~Yv  270 (1039)
T KOG0199|consen  265 NEDMYV  270 (1039)
T ss_pred             CCcceE
Confidence            877763

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.86  E-value=7.6e-23  Score=186.79  Aligned_cols=159  Identities=29%  Similarity=0.451  Sum_probs=146.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|.|+||.||.     ++...|+|+++....   ..+..+++|+-+++.++||||+.+++.+......|++|
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            4688888999999999984     578899999986543   33566788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      |||.+|+|++..+-.+++++.++....++.+.|+.|||+.+   =+|||||-.||++++.|.+|++|||.+..++.--.+
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            99999999999888889999999999999999999999999   899999999999999999999999999999999999


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      ..+..||||.
T Consensus       169 rksfiGtpyw  178 (829)
T KOG0576|consen  169 RKSFIGTPYW  178 (829)
T ss_pred             hhcccCCccc
Confidence            9999999983

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=6.5e-21  Score=166.58  Aligned_cols=144  Identities=31%  Similarity=0.595  Sum_probs=124.6

Q ss_pred             cceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      .....+|.|.++.+|.     +++.+|+|.+..... .....+.+..|+.+++.++|+|++++++++......++++||+
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            3456789999988874     478999999876532 2233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       233 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      + ++|.+++.+. ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            6 5999999876 57999999999999999999999999   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.85  E-value=8.6e-21  Score=166.59  Aligned_cols=144  Identities=33%  Similarity=0.505  Sum_probs=120.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ++.....+|.|+||.||.     ++..+|+|.+.....  ......+.+|+.++.++. ||||+++++.+..+...+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            455567899999998874     578999999875432  244567888999999996 999999999999999999999


Q ss_pred             eecCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       230 e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ||+. +++.++..     ....+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||+++.+
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            9985 56655432     235689999999999999999999975 7   999999999999999999999999999765


Q ss_pred             cc
Q 020981          304 TV  305 (319)
Q Consensus       304 ~~  305 (319)
                      ..
T Consensus       159 ~~  160 (288)
T cd06616         159 VD  160 (288)
T ss_pred             cc
Confidence            43

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.85  E-value=1.3e-20  Score=169.88  Aligned_cols=144  Identities=26%  Similarity=0.464  Sum_probs=123.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC------c
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~  224 (319)
                      +|.....+|.|+||.+|.     ++..||+|.+.... ........+.+|+.+++.++||||+++++++....      .
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            577888999999998874     47889999986543 23334456788999999999999999999887543      3


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            58999999 7799888764 46899999999999999999999999   9999999999999999999999999998664


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       170 ~  170 (343)
T cd07880         170 S  170 (343)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.85  E-value=6.1e-21  Score=171.46  Aligned_cols=145  Identities=27%  Similarity=0.496  Sum_probs=122.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeC--CceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~--~~~~l  227 (319)
                      +|.....+|.|+|+.+|.     ++..+|+|.+..... .......+.+|+.+++++ +||||+++++++...  ...|+
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            577778899999998874     468899998865322 233345677899999999 999999999987643  46899


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||||++ ++|..++... .+++.....++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            999996 6999988765 6888889999999999999999999   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.85  E-value=1.1e-21  Score=178.43  Aligned_cols=135  Identities=28%  Similarity=0.286  Sum_probs=118.8

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCC-CCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .|.|||||-..+.-..+-....|+|+|... .-+-|||||||++|+..+|+.|+++|||++.+|..|.||||+||+.|+.
T Consensus        79 ~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~  158 (600)
T KOG0509|consen   79 VTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHT  158 (600)
T ss_pred             ccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCch
Confidence            478999999999888888999999999997 7888999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc-cccccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP-MHVKHA  142 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~-~~~~~~  142 (319)
                      -+|-+|+..|+++|.+|..|+||+++|+..|....+..|+..++.....+ .+..+|
T Consensus       159 ~~vayll~~~~d~d~~D~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~Tp  215 (600)
T KOG0509|consen  159 ALVAYLLSKGADIDLRDNNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTP  215 (600)
T ss_pred             HHHHHHHHhcccCCCcCCCCCCHHHHHHHhcccHHHHHHHHhcccccccccccCCch
Confidence            99999999999999999999999999999988877888888888776555 333333

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=3.8e-21  Score=163.03  Aligned_cols=149  Identities=21%  Similarity=0.332  Sum_probs=130.1

Q ss_pred             CcccccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceE
Q 020981          153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~  226 (319)
                      ....|...++||+|+||..+     +.+++||||.-...     .+..+++.|...++.|. .++|+..|-+...+.+..
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            44578999999999999887     46899999986543     23467888999999996 899999999888888999


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-----CEEEEecCcc
Q 020981          227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVS  300 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~DFgla  300 (319)
                      +|+|++ |.||++++.-++ +|+..++..++.|++.-++|+|++.   +|.|||||+|+||...+     .+.|+|||+|
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence            999998 899999998765 5999999999999999999999999   99999999999998544     4899999999


Q ss_pred             cccccCCCCc
Q 020981          301 KLLTVKEDRP  310 (319)
Q Consensus       301 ~~~~~~~~~~  310 (319)
                      +.+.++..+-
T Consensus       177 K~YrDp~Tkq  186 (449)
T KOG1165|consen  177 KEYRDPKTKQ  186 (449)
T ss_pred             hhhcCccccc
Confidence            9998876543

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.85  E-value=6.7e-21  Score=168.33  Aligned_cols=146  Identities=28%  Similarity=0.468  Sum_probs=122.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-------
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-------  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-------  223 (319)
                      +|.....+|.|+||.+|.     .+..+|+|.+...... ......+.+|+.+++.++|||++++++.+....       
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            577788899999998874     4678999998754321 122345678999999999999999999887654       


Q ss_pred             ---ceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          224 ---PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       224 ---~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                         ..++++||+++ ++..++... ..+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccc
Confidence               79999999965 777777654 45899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccC
Q 020981          300 SKLLTVK  306 (319)
Q Consensus       300 a~~~~~~  306 (319)
                      +..+...
T Consensus       163 ~~~~~~~  169 (302)
T cd07864         163 ARLYNSE  169 (302)
T ss_pred             cccccCC
Confidence            9876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.85  E-value=1.9e-20  Score=162.68  Aligned_cols=148  Identities=20%  Similarity=0.432  Sum_probs=122.7

Q ss_pred             ccceeeeecceEEEEEE------eceEeEEEEeccccc-------CCHHHHHHHHHHHHHHHh-cCCCcccccceeEEeC
Q 020981          157 FTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI-------SDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQS  222 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~------~~~~vAvK~l~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~~  222 (319)
                      |.....+|.|+|+.+|.      .+..+|+|.+.....       ........+.+|+.++.. ++|||++++++.+...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            56677899999998873      357899998754221       223445567778888875 6899999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          223 SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      ...+++|||+++++|.+++..    ...+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999988743    3458899999999999999999996 56   999999999999999999999999


Q ss_pred             CcccccccCC
Q 020981          298 GVSKLLTVKE  307 (319)
Q Consensus       298 gla~~~~~~~  307 (319)
                      |++.......
T Consensus       159 g~~~~~~~~~  168 (269)
T cd08528         159 GLAKQKQPES  168 (269)
T ss_pred             cceeeccccc
Confidence            9998765543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.85  E-value=7.5e-21  Score=165.19  Aligned_cols=138  Identities=32%  Similarity=0.548  Sum_probs=117.9

Q ss_pred             eeecceEEEEEEe-----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          162 EITKGTFILAFWR-----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       162 ~ig~G~f~~v~~~-----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .+|.|+||.||..           +..+|+|.+....  .......+.+|+.+++.++||||+++++++......+++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            4789999988742           1578999876432  22345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-----CEEEEecC
Q 020981          231 YLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFG  298 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~DFg  298 (319)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++     .+||+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999998642       23778889999999999999999998   99999999999999877     89999999


Q ss_pred             cccccc
Q 020981          299 VSKLLT  304 (319)
Q Consensus       299 la~~~~  304 (319)
                      +++...
T Consensus       157 ~~~~~~  162 (269)
T cd05044         157 LARDIY  162 (269)
T ss_pred             cccccc
Confidence            997653

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.85  E-value=3.2e-21  Score=161.11  Aligned_cols=126  Identities=23%  Similarity=0.181  Sum_probs=77.3

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcC--CHHHHHHHHHcCCCCcccC-CCCCCHHHHHHHc-
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQ-   83 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~--~~~~~~~Ll~~ga~vn~~d-~~g~tpLh~A~~~-   83 (319)
                      -|||+.|++.++....+...-   .+|..+..|.||||+|+..+  +.++++.|+++|+|+|.++ ..|+||||+|+.. 
T Consensus        22 ~~pL~~A~~~~~~~~vk~Li~---~~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~   98 (209)
T PHA02859         22 CNPLFYYVEKDDIEGVKKWIK---FVNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFN   98 (209)
T ss_pred             CcHHHHHHHhCcHHHHHHHHH---hhhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhC
Confidence            356666666666555555432   14455666666666666543  6666666666666666665 3566666666543 


Q ss_pred             --CCHHHHHHhhhCCCcccCCCCCCCCCcccccc--cccHHHHHHHHhhCCCCCCcc
Q 020981           84 --GFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        84 --~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~--~~~~~i~~~L~~~g~~~~~~~  136 (319)
                        ++.+++++|+++|++++.+|..|.||+|.|+.  .++.+++++|++.|++....+
T Consensus        99 ~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d  155 (209)
T PHA02859         99 KNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKD  155 (209)
T ss_pred             ccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccc
Confidence              35666666666666666666666666666543  245666666666666654433

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-21  Score=170.68  Aligned_cols=150  Identities=28%  Similarity=0.446  Sum_probs=125.3

Q ss_pred             cccceeeeecceEEEEE-----EeceEeEEEEecccccCCHHH----HHHHHHHHHHHHhcCCCcccccceeEE-eCCce
Q 020981          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT-QSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~-----~~~~~vAvK~l~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  225 (319)
                      .|-....+|+|+|+.||     ...+.||+|+-....-+.++.    .+...+|..+-+.+.||-||++|++|. +.+.+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            45556678999998776     356789999854432222222    244678999999999999999999985 45678


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec---CCCCEEEEecCcccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKL  302 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DFgla~~  302 (319)
                      |-|+|||+|.+|..+++.++.+++.+++.|+.||+.||.||.+..| ||||-||||.|||+.   ..|.+||+||||++.
T Consensus       544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            9999999999999999999999999999999999999999999985 699999999999996   457899999999999


Q ss_pred             cccC
Q 020981          303 LTVK  306 (319)
Q Consensus       303 ~~~~  306 (319)
                      +...
T Consensus       623 Mddd  626 (775)
T KOG1151|consen  623 MDDD  626 (775)
T ss_pred             ccCC
Confidence            8654

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.85  E-value=1.9e-20  Score=163.75  Aligned_cols=145  Identities=28%  Similarity=0.508  Sum_probs=124.7

Q ss_pred             cceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      .....+|.|+++.+|.     .+..+++|.+...... +.....+.+|+.+++.++|++|+++++.+..+...++++||+
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            4556789999988874     4788999998765432 234467778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       233 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      + +++.+++... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.+.....+.
T Consensus        81 ~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 D-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             C-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            6 4888887664 57899999999999999999999999   9999999999999999999999999998776543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.85  E-value=1.7e-20  Score=163.09  Aligned_cols=133  Identities=23%  Similarity=0.402  Sum_probs=112.7

Q ss_pred             eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCC
Q 020981          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       162 ~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      .+|.|+||.+|.     ++..+|+|.+........        |......+ +|||++++++.+...+..|+||||++++
T Consensus        23 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~   94 (267)
T PHA03390         23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDG   94 (267)
T ss_pred             eecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCC
Confidence            369999998874     467899999875432211        22222222 6999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEecCccccccc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTV  305 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DFgla~~~~~  305 (319)
                      +|.+++..+..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++ .++|+|||+++....
T Consensus        95 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            99999988778999999999999999999999999   99999999999999988 999999999876543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.85  E-value=2e-20  Score=163.61  Aligned_cols=142  Identities=25%  Similarity=0.427  Sum_probs=118.3

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeC--CceEEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMIV  228 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~lv  228 (319)
                      |.....+|+|+||.+|.     ++..+|+|.+..... ..... ...+|+.+++++. |||++++++++.+.  ...++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            34567889999998874     478899999875432 22222 3346888888885 99999999999887  889999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |||++ +++.+++... ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||+++....
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            99996 5888888764 46899999999999999999999999   999999999999999 9999999999987644

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.85  E-value=1.1e-21  Score=158.44  Aligned_cols=144  Identities=20%  Similarity=0.447  Sum_probs=122.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeC--CceE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMM  226 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~  226 (319)
                      .+|+...++|+|.|+.||.     +...++||++++      -..+.+.+|+.+|..+. ||||++++++..+.  ....
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            3677788999999988873     567899999863      34577889999999997 99999999988654  4578


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-CCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DFgla~~~~~  305 (319)
                      +++||+.+.+...+..   .++...++.++.|++.||.|+|+.|   |+|||+||.|+|||. ...++|+|+|||.++.+
T Consensus       112 LiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9999999888877654   3788889999999999999999999   999999999999995 45699999999999988


Q ss_pred             CCCCc
Q 020981          306 KEDRP  310 (319)
Q Consensus       306 ~~~~~  310 (319)
                      +.+-.
T Consensus       186 ~~eYn  190 (338)
T KOG0668|consen  186 GKEYN  190 (338)
T ss_pred             Cceee
Confidence            75443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.85  E-value=3.3e-20  Score=167.32  Aligned_cols=144  Identities=30%  Similarity=0.483  Sum_probs=121.1

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------C
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~  223 (319)
                      .+|.....+|+|+||.+|.     ++..||+|.+..... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            3678888999999998873     578999999875422 223345677899999999999999999987543      3


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ..|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccc
Confidence            478888887 7899887765 35899999999999999999999999   999999999999999999999999998865


Q ss_pred             c
Q 020981          304 T  304 (319)
Q Consensus       304 ~  304 (319)
                      .
T Consensus       171 ~  171 (345)
T cd07877         171 D  171 (345)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.85  E-value=8e-22  Score=157.12  Aligned_cols=126  Identities=19%  Similarity=0.128  Sum_probs=106.2

Q ss_pred             cccccccccccCchhhh---hhhhh--cCCCCCCCCCCcchHHHHHHHcCCH---HHHHHHHHcCCCCcccCC-CCCCHH
Q 020981            7 VRTTLLKQSSLAPDRER---KEAEL--NGLDDDGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRDI-DNRTAL   77 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~t~L~~a~~~~~~---~~~~~Ll~~ga~vn~~d~-~g~tpL   77 (319)
                      -.|||+.|++.++....   .....  +....+..|.+|.||||+||..|+.   ++++.|++.|+|+|.+|. +|+|||
T Consensus        17 g~tpLh~A~~~g~~~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~L   96 (154)
T PHA02736         17 GENILHYLCRNGGVTDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPL   96 (154)
T ss_pred             CCCHHHHHHHhCCHHHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHH
Confidence            47999999999973211   11111  1222345688999999999999987   468999999999999984 899999


Q ss_pred             HHHHHcCCHHHHHHhhh-CCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           78 HVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        78 h~A~~~~~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      |+|+..|+.+++++|++ .|++++.+|..|.||+|+|+..++.+++++|+..|++.
T Consensus        97 h~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL~~A~~~~~~~i~~~Ll~~ga~~  152 (154)
T PHA02736         97 HIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVACERHDAKMMNILRAKGAQC  152 (154)
T ss_pred             HHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence            99999999999999998 59999999999999999999999999999999998764

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.85  E-value=3.7e-20  Score=163.31  Aligned_cols=147  Identities=18%  Similarity=0.211  Sum_probs=109.7

Q ss_pred             ccccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHH--------HHHHHHHHHHHHhcCCCccccccee
Q 020981          155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDR--------VRAFRDELALLQKIRHPNVVQFLGA  218 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~l~~~  218 (319)
                      ..|...+.||+|+||.||..        +..+|+|...........+        ......+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            46888889999999999852        3456666543221110000        0112234445566789999999987


Q ss_pred             EEeCC----ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEE
Q 020981          219 VTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV  294 (319)
Q Consensus       219 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl  294 (319)
                      +....    ..+++++++ ..++.+.+......++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|
T Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence            65543    347788877 4578777776555788889999999999999999999   999999999999999999999


Q ss_pred             EecCccccccc
Q 020981          295 ADFGVSKLLTV  305 (319)
Q Consensus       295 ~DFgla~~~~~  305 (319)
                      +|||+|+.+..
T Consensus       168 ~DFGla~~~~~  178 (294)
T PHA02882        168 IDYGIASHFII  178 (294)
T ss_pred             EEcCCceeecc
Confidence            99999987743

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.85  E-value=2.1e-20  Score=165.86  Aligned_cols=146  Identities=29%  Similarity=0.514  Sum_probs=124.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....+|.|+||.+|.     .+..+|+|.+.............+.+|+.+++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            466667899999998873     467899998875433344555678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+. |++.+.+.. ...+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||++.....
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            996 688777754 445899999999999999999999998   99999999999999999999999999886543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.85  E-value=2.9e-20  Score=162.69  Aligned_cols=143  Identities=27%  Similarity=0.470  Sum_probs=121.9

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEe
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      |.....||.|++|.+|.     .+..+++|.+...... . ......+|+..+++++ |||++++++.+......++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-h-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            34566799999998874     3678999998754322 1 1223456899999999 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+ +++|.+++....  .+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            99 789999888764  6899999999999999999999999   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.5e-20  Score=156.15  Aligned_cols=139  Identities=17%  Similarity=0.259  Sum_probs=105.5

Q ss_pred             cccceeeeecceEEEEEEe--ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-----CCCcccccceeEEeCC---c-
Q 020981          156 DFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-----RHPNVVQFLGAVTQSS---P-  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~~~~---~-  224 (319)
                      ++.....||+|+|+.||..  ....+||++....   ....+.+.+|+.+++.+     .||||+++++++.++.   . 
T Consensus         3 ~L~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          3 RLSEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             ecCCcceecCCCceEEEECCCCcCeEEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            3455678999999999852  1223677765432   22346789999999999     5799999999998874   3 


Q ss_pred             eEEEEee--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEEcCCCCCCEEecCC----CCEEEEec
Q 020981          225 MMIVTEY--LPKGDLRAFLKRKGALKPSTAVRFALDIARGM-NYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADF  297 (319)
Q Consensus       225 ~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al-~~lH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DF  297 (319)
                      +.+|+||  +.+++|.+++++. .+++.  ..++.|++.++ +|||+++   |+||||||+|||++..    +.++|+||
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            3378999  5579999999764 46555  35678888887 9999999   9999999999999843    37999995


Q ss_pred             Cccccc
Q 020981          298 GVSKLL  303 (319)
Q Consensus       298 gla~~~  303 (319)
                      +-++.+
T Consensus       154 ~G~~~~  159 (210)
T PRK10345        154 IGESTF  159 (210)
T ss_pred             CCCcce
Confidence            444433

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.85  E-value=3.5e-21  Score=180.90  Aligned_cols=131  Identities=24%  Similarity=0.248  Sum_probs=84.5

Q ss_pred             ccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCH--------------------------------
Q 020981            6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDV--------------------------------   53 (319)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~--------------------------------   53 (319)
                      .+.|||+.|+..++....+...-.|+|+|..+.+|.||||+||..|+.                                
T Consensus        36 ~~~tPLh~A~~~g~~e~vk~Ll~~gadvn~~d~~g~TpLh~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~l~~a~~~~~~e  115 (477)
T PHA02878         36 IPFIPLHQAVEARNLDVVKSLLTRGHNVNQPDHRDLTPLHIICKEPNKLGMKEMIRSINKCSVFYTLVAIKDAFNNRNVE  115 (477)
T ss_pred             cCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCccHhHHHHHHHHHhccccccchhhHHHHHHcCCHH
Confidence            345666666666666666666666666666666666666666654332                                


Q ss_pred             --------------------------------HHHHHHHHcCCCCcccCCC-CCCHHHHHHHcCCHHHHHHhhhCCCccc
Q 020981           54 --------------------------------EGIKELLDSGIDVNFRDID-NRTALHVAACQGFTEVVSLLLERGADVD  100 (319)
Q Consensus        54 --------------------------------~~~~~Ll~~ga~vn~~d~~-g~tpLh~A~~~~~~~~v~~Ll~~g~~~~  100 (319)
                                                      ++++.|+++|||+|.+|.+ |+||||+|+..|+.+++++|+++|++++
T Consensus       116 i~~~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~~Ll~~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n  195 (477)
T PHA02878        116 IFKIILTNRYKNIQTIDLVYIDKKSKDDIIEAEITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVN  195 (477)
T ss_pred             HHHHHHhCcccCcccCcHHHHhhccchhhHHHHHHHHHHHcCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCC
Confidence                                            2455555666666666666 6666666666666666666666666666


Q ss_pred             CCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981          101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus       101 ~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      .+|..|.||||.|+..++.+++++|++.|++....+
T Consensus       196 ~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d  231 (477)
T PHA02878        196 IPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARD  231 (477)
T ss_pred             CcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCC
Confidence            666666666666666666666666666666554433

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=6.5e-21  Score=171.05  Aligned_cols=160  Identities=23%  Similarity=0.300  Sum_probs=134.2

Q ss_pred             CcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEE
Q 020981          153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~l  227 (319)
                      ....|+..++||.|+-+.||.    ..+.||+|++..... +......|.+|+..|.+|+ |.+|+++|++-..+..+|+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            344688889999999988885    347788888765443 4566788999999999996 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||||- ..+|..+|++... .+...++.|..|++.|+.++|++|   |||.||||.|+|+-+ |.+||+|||+|..+..+
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            99965 6799999998765 333578889999999999999999   999999999999987 89999999999988766


Q ss_pred             CC--CceeeccCCC
Q 020981          307 ED--RPLTCQDTSC  318 (319)
Q Consensus       307 ~~--~~~~~~~~~~  318 (319)
                      ..  ...+.+||+-
T Consensus       513 TTsI~kdsQvGT~N  526 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVN  526 (677)
T ss_pred             ccceeeccccCccc
Confidence            43  2346778773

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.84  E-value=4.6e-21  Score=178.81  Aligned_cols=152  Identities=28%  Similarity=0.496  Sum_probs=132.0

Q ss_pred             cccceeeeecceEEEEEEe---------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          156 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~---------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      .....+++|.|+||.||..         ..+||+|++....  ......++..|..+|.++.|||++++++++..+. ..
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            4556778999999999842         4689999987543  3445678899999999999999999999998776 88


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||++|++.|+|.++++.+ ..+.....+.|..||++||.|||.++   ++||||-.+|+|+.+...+||.|||+|+.+..
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            999999999999999865 45888889999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCceee
Q 020981          306 KEDRPLTC  313 (319)
Q Consensus       306 ~~~~~~~~  313 (319)
                      .+......
T Consensus       851 d~~ey~~~  858 (1177)
T KOG1025|consen  851 DEKEYSAP  858 (1177)
T ss_pred             cccccccc
Confidence            76555433

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.84  E-value=1.8e-20  Score=162.03  Aligned_cols=149  Identities=28%  Similarity=0.476  Sum_probs=120.1

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      |.....+|.|+||.+|.     .+..+++|.+......  .......+..|+.+++.++|||++++++.+......++++
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            56677899999999884     2344566665432111  1222345667899999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++. +.+||+|||+++.+..
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999988864    345899999999999999999999999   999999999999975 6799999999987755


Q ss_pred             CCCC
Q 020981          306 KEDR  309 (319)
Q Consensus       306 ~~~~  309 (319)
                      +...
T Consensus       158 ~~~~  161 (260)
T cd08222         158 SCDL  161 (260)
T ss_pred             Cccc
Confidence            4433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.84  E-value=2.1e-20  Score=159.60  Aligned_cols=128  Identities=20%  Similarity=0.310  Sum_probs=109.4

Q ss_pred             ceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCHHHH
Q 020981          166 GTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF  240 (319)
Q Consensus       166 G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  240 (319)
                      |.|+.|+.     +++.+|+|.+....        .+.+|...+....|||++++++.+......+++|||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            66666653     67899999987542        122344445556799999999999999999999999999999999


Q ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       241 l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +.+...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++++|||++....
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~  136 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE  136 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence            988778999999999999999999999999   9999999999999999999999999876553

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.84  E-value=2.1e-20  Score=165.78  Aligned_cols=147  Identities=33%  Similarity=0.514  Sum_probs=121.4

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------  222 (319)
                      ..+|.....+|.|+|+.+|.     ++..+|+|.+........ ....+.+|+.+++.++||||+++++.+...      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            34688888999999998884     468899998865432221 123456799999999999999999887543      


Q ss_pred             --CceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          223 --SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       223 --~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                        ..+++++||+. +++...+... ..+++..+..++.|+++||+|||+++   ++|+||||+||++++++.+||+|||+
T Consensus        86 ~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          86 KRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             cCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence              34699999995 5777776643 46999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccc
Q 020981          300 SKLLTV  305 (319)
Q Consensus       300 a~~~~~  305 (319)
                      ++....
T Consensus       162 ~~~~~~  167 (311)
T cd07866         162 ARPYDG  167 (311)
T ss_pred             chhccC
Confidence            987654

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.84  E-value=2.9e-20  Score=167.55  Aligned_cols=144  Identities=31%  Similarity=0.478  Sum_probs=123.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc------
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP------  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~------  224 (319)
                      +|.....+|.|++|.+|.     ++..+|+|.+..... .......+.+|+.+++.++|||++++.+.+.....      
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            577888999999998874     468899998865432 23344567789999999999999999988766554      


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .++|+||+ +++|.+++.. .++++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            89999999 6799998876 46899999999999999999999999   9999999999999999999999999998764


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       170 ~  170 (343)
T cd07851         170 D  170 (343)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.84  E-value=6e-21  Score=159.45  Aligned_cols=135  Identities=19%  Similarity=0.149  Sum_probs=116.4

Q ss_pred             ccccccccccC--chhhhhhhhhcCCCCCCCC-CCcchHHHHHHHc---CCHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Q 020981            8 RTTLLKQSSLA--PDRERKEAELNGLDDDGEE-IKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAA   81 (319)
Q Consensus         8 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~t~L~~a~~~---~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~   81 (319)
                      .|||+.++..+  +....+...-.|.|+|.++ ..|.||||+|+..   ++.++++.|+++|||+|.+|.+|+||||+|+
T Consensus        52 ~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~  131 (209)
T PHA02859         52 ETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYM  131 (209)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence            68888887643  5666777777899999997 4899999998864   4799999999999999999999999999997


Q ss_pred             H--cCCHHHHHHhhhCCCcccCCCCCCCCCccc-ccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           82 C--QGFTEVVSLLLERGADVDPKDRWGSTPLGD-AIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        82 ~--~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~-a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      .  .++.+++++|++.|++++.+|..|.||+|. |...++.+++++|++.|+++...+....++
T Consensus       132 ~~~~~~~~iv~~Li~~gadin~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~d~~g~tp  195 (209)
T PHA02859        132 CNFNVRINVIKLLIDSGVSFLNKDFDNNNILYSYILFHSDKKIFDFLTSLGIDINETNKSGYNC  195 (209)
T ss_pred             HhccCCHHHHHHHHHcCCCcccccCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence            6  468999999999999999999999999995 566789999999999999887666555444

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.84  E-value=8.5e-20  Score=159.89  Aligned_cols=145  Identities=30%  Similarity=0.564  Sum_probs=120.0

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc---CCCcccccceeEEeCCc----
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSP----  224 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~----  224 (319)
                      |.....+|.|+||.+|.     .+..+|+|.+...... ......+.+|+.+++.+   .|||++++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            45567889999998874     3689999998754332 22234566687777666   59999999999988776    


Q ss_pred             -eEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          225 -MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       225 -~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                       .+++|||+. ++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence             999999996 58999887643  4899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccC
Q 020981          302 LLTVK  306 (319)
Q Consensus       302 ~~~~~  306 (319)
                      .+...
T Consensus       156 ~~~~~  160 (287)
T cd07838         156 IYSFE  160 (287)
T ss_pred             eccCC
Confidence            76543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.84  E-value=2.1e-21  Score=170.28  Aligned_cols=122  Identities=27%  Similarity=0.320  Sum_probs=113.5

Q ss_pred             ccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHH
Q 020981           10 TLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV   89 (319)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v   89 (319)
                      |+--|+.-||....+...-.|+++|..+...-|||..||..|+.++|++|+++|||++..|..|.|.||+||+.|+.+|+
T Consensus        87 pLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~  166 (615)
T KOG0508|consen   87 PLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIA  166 (615)
T ss_pred             hhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHH
Confidence            34445556778888888889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCC
Q 020981           90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (319)
Q Consensus        90 ~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~  131 (319)
                      ++|++.|||+|.++..|.|+||.+++.|+.+++++|+.+|+.
T Consensus       167 qyLle~gADvn~ks~kGNTALH~caEsG~vdivq~Ll~~ga~  208 (615)
T KOG0508|consen  167 QYLLEQGADVNAKSYKGNTALHDCAESGSVDIVQLLLKHGAK  208 (615)
T ss_pred             HHHHHhCCCcchhcccCchHHHhhhhcccHHHHHHHHhCCce
Confidence            999999999999999999999999999999999999998764

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.84  E-value=1.1e-19  Score=160.35  Aligned_cols=145  Identities=32%  Similarity=0.477  Sum_probs=120.5

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .+|.....+|.|++|.+|.     +++.+|+|.+.....  ......+..|+.++.... ||||+++++.+......|++
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            4677788999999998874     378999999875432  233445566777666665 99999999999999999999


Q ss_pred             EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |||+ ++++.+++.. ...+++..+..++.|++.||.|||+ .+   ++||||+|+||++++++.+||+|||++..+..
T Consensus        93 ~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          93 MELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9998 4578877765 3568899999999999999999997 47   99999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.84  E-value=5.8e-20  Score=164.55  Aligned_cols=145  Identities=30%  Similarity=0.487  Sum_probs=123.0

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-CCceEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMI  227 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~l  227 (319)
                      ..+|.....+|.|+|+.+|.     ++..+|+|.+.+... .....+.+..|+.+++.++|||++++++++.. ....++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            34688888999999998874     578899998865432 22334667789999999999999999998865 567899


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++||+ +++|..++.. ..+++..+..++.|+++||.|||+.+   ++||||+|+||+++.++.+||+|||++....
T Consensus        88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            99999 6789888764 45788888899999999999999999   9999999999999999999999999997653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.83  E-value=7.9e-21  Score=175.45  Aligned_cols=126  Identities=22%  Similarity=0.172  Sum_probs=65.1

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCC-CCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDD-GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .||++.|+..++....+...-.|.+.+ ..+.+|.||||+||..|+.++++.|+++|||+|.+|..|+||||+|+..|+.
T Consensus        69 ~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~  148 (413)
T PHA02875         69 ESELHDAVEEGDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDI  148 (413)
T ss_pred             ccHHHHHHHCCCHHHHHHHHHcCCcccccccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCH
Confidence            345555555555444444444443332 2234455555555555555555555555555555555555555555555555


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCC
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~  133 (319)
                      +++++|+++|++++.+|..|+||||+|+..|+.+++++|++.|+++.
T Consensus       149 ~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n  195 (413)
T PHA02875        149 KGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANID  195 (413)
T ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCC
Confidence            55555555555555555555555555555555555555555555443

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.83  E-value=1.4e-20  Score=176.83  Aligned_cols=105  Identities=31%  Similarity=0.453  Sum_probs=53.9

Q ss_pred             hcCCCCCCCCCC-cchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCC
Q 020981           28 LNGLDDDGEEIK-PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (319)
Q Consensus        28 ~~~~~~~~~~~~-~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g  106 (319)
                      -.|+|+|..+.. |.||||+||..|+.++++.|++.|||+|.+|..|+||||+|+..|+.+++++|++.|++++.+|..|
T Consensus       155 ~~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g  234 (477)
T PHA02878        155 SYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCG  234 (477)
T ss_pred             HcCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCC
Confidence            345555555544 5555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCCccccccc-ccHHHHHHHHhhCCCC
Q 020981          107 STPLGDAIYY-KNHEVIKLLEKHGAKP  132 (319)
Q Consensus       107 ~tpl~~a~~~-~~~~i~~~L~~~g~~~  132 (319)
                      .||||+|+.. ++.+++++|++.|++.
T Consensus       235 ~TpLh~A~~~~~~~~iv~~Ll~~gadv  261 (477)
T PHA02878        235 NTPLHISVGYCKDYDILKLLLEHGVDV  261 (477)
T ss_pred             CCHHHHHHHhcCCHHHHHHHHHcCCCC
Confidence            5555555433 3445555555555443

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.83  E-value=1.4e-20  Score=173.90  Aligned_cols=128  Identities=24%  Similarity=0.242  Sum_probs=118.3

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-.|+|+|..+.+|.||||+|+..|+.++++.|+++|+++|.+|..|+||||+|+..|+.+
T Consensus       103 ~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~e  182 (413)
T PHA02875        103 MTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIA  182 (413)
T ss_pred             CCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHH
Confidence            58999999999988888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCC-CCcccccccccHHHHHHHHhhCCCCCCc
Q 020981           88 VVSLLLERGADVDPKDRWGS-TPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~-tpl~~a~~~~~~~i~~~L~~~g~~~~~~  135 (319)
                      ++++|+++|++++..+..|. ||+|+|+..++.+++++|++.|+++...
T Consensus       183 iv~~Ll~~ga~~n~~~~~~~~t~l~~A~~~~~~~iv~~Ll~~gad~n~~  231 (413)
T PHA02875        183 ICKMLLDSGANIDYFGKNGCVAALCYAIENNKIDIVRLFIKRGADCNIM  231 (413)
T ss_pred             HHHHHHhCCCCCCcCCCCCCchHHHHHHHcCCHHHHHHHHHCCcCcchH
Confidence            99999999999999998875 7888899999999999999999987643

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.83  E-value=7.6e-20  Score=175.54  Aligned_cols=152  Identities=35%  Similarity=0.574  Sum_probs=132.8

Q ss_pred             ccccCCCcccccceeeeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCccc
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVV  213 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv  213 (319)
                      .|+++...+.+..  .+|.|.||.+++.            ...||||.++....  ..+.+.+..|+.+|+.+. ||||+
T Consensus       290 ~~e~~~~~l~~~~--~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  290 KWEIPRENLKLGK--YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             ceeechhhccccc--eeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchh
Confidence            6777776664444  8999999988641            46799999886543  366788999999999996 99999


Q ss_pred             ccceeEEeCCceEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEc
Q 020981          214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR  277 (319)
Q Consensus       214 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~  277 (319)
                      .++|++..+...++|+||++.|+|.+++..++                .++......++.||+.|++||++..   +|||
T Consensus       366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR  442 (609)
T KOG0200|consen  366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR  442 (609)
T ss_pred             hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence            99999999999999999999999999998766                3788899999999999999999998   9999


Q ss_pred             CCCCCCEEecCCCCEEEEecCccccccc
Q 020981          278 DLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       278 Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||-++|||+.++..+||+|||+|+....
T Consensus       443 DLAaRNVLi~~~~~~kIaDFGlar~~~~  470 (609)
T KOG0200|consen  443 DLAARNVLITKNKVIKIADFGLARDHYN  470 (609)
T ss_pred             hhhhhhEEecCCCEEEEccccceeccCC
Confidence            9999999999999999999999996544

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.83  E-value=1.4e-20  Score=163.30  Aligned_cols=118  Identities=19%  Similarity=0.160  Sum_probs=104.5

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCC----CCcchHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCCHHHHHHHc
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEE----IKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQ   83 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d-~~g~tpLh~A~~~   83 (319)
                      ++++.|++.++....+...-.|+|+|..+    ..|.||||+||..++.++++.|+++|||+|.++ ..|.||||+|+..
T Consensus        35 ~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~  114 (300)
T PHA02884         35 NILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLH  114 (300)
T ss_pred             HHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHc
Confidence            45666666677777778888899999974    589999999999999999999999999999964 6799999999999


Q ss_pred             CCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHH
Q 020981           84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE  126 (319)
Q Consensus        84 ~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~  126 (319)
                      |+.+++++|+++|++++.+|..|.||+|+|+..++.+++.++.
T Consensus       115 ~~~eivklLL~~GAdin~kd~~G~TpL~~A~~~~~~~~~~~~~  157 (300)
T PHA02884        115 GCLKCLEILLSYGADINIQTNDMVTPIELALMICNNFLAFMIC  157 (300)
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHhCChhHHHHhc
Confidence            9999999999999999999999999999999888888765554

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.83  E-value=2.1e-20  Score=185.72  Aligned_cols=131  Identities=26%  Similarity=0.253  Sum_probs=118.1

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHH-----
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC-----   82 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~-----   82 (319)
                      .++++.||+.++....+...-.|.|+|..|.+|.||||+||..|+.++++.|+++|+|+|.+|.+|+||||+|+.     
T Consensus       526 ~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~  605 (823)
T PLN03192        526 ASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHK  605 (823)
T ss_pred             hhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHH
Confidence            367888999999888888888999999999999999999999999999999999999999999999999886554     


Q ss_pred             --------------------------cCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           83 --------------------------QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        83 --------------------------~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                                                .|+.+++++|+++|+++|.+|..|+||+|+|+..|+.+++++|++.|++....+
T Consensus       606 iv~~L~~~~~~~~~~~~~~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~  685 (823)
T PLN03192        606 IFRILYHFASISDPHAAGDLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKAN  685 (823)
T ss_pred             HHHHHHhcCcccCcccCchHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCC
Confidence                                      555566777888999999999999999999999999999999999999876655


Q ss_pred             cc
Q 020981          137 MH  138 (319)
Q Consensus       137 ~~  138 (319)
                      ..
T Consensus       686 ~~  687 (823)
T PLN03192        686 TD  687 (823)
T ss_pred             CC
Confidence            43

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.82  E-value=1e-19  Score=163.83  Aligned_cols=142  Identities=28%  Similarity=0.502  Sum_probs=119.3

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-------
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------  222 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-------  222 (319)
                      .+|.....||.|+||.+|.     ++..||+|.+.....   ...+.+.+|+.+++.++||||+++++.+...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            4678888999999998874     478999998865432   3346678899999999999999999776543       


Q ss_pred             -------CceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-CCCEEE
Q 020981          223 -------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKV  294 (319)
Q Consensus       223 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-~~~~kl  294 (319)
                             ...|++|||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+   ++||||||+||+++. ++.+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                   35799999996 689888764 46899999999999999999999999   999999999999984 567899


Q ss_pred             EecCcccccc
Q 020981          295 ADFGVSKLLT  304 (319)
Q Consensus       295 ~DFgla~~~~  304 (319)
                      +|||+++...
T Consensus       157 ~dfg~~~~~~  166 (342)
T cd07854         157 GDFGLARIVD  166 (342)
T ss_pred             CCcccceecC
Confidence            9999997653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.82  E-value=1.7e-20  Score=144.14  Aligned_cols=117  Identities=25%  Similarity=0.182  Sum_probs=97.3

Q ss_pred             cccccccCchhhhhhh-hhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHH
Q 020981           11 LLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV   89 (319)
Q Consensus        11 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v   89 (319)
                      +.||+-.+...+.+.. ....--+|.+|.+|+||||-|+++|++++|+.|+..|||++++...||||||-||..++.+++
T Consensus        67 ~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va  146 (228)
T KOG0512|consen   67 LLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVA  146 (228)
T ss_pred             HHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHH
Confidence            5666666664444444 445556899999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhhCCCcccCCCCCCCCCcccccccccHH-HHHHHHh
Q 020981           90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHE-VIKLLEK  127 (319)
Q Consensus        90 ~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~-i~~~L~~  127 (319)
                      .+|+++|+|+|......+||||+|+...+.. .+.+|+.
T Consensus       147 ~~LLqhgaDVnA~t~g~ltpLhlaa~~rn~r~t~~~Ll~  185 (228)
T KOG0512|consen  147 GRLLQHGADVNAQTKGLLTPLHLAAGNRNSRDTLELLLH  185 (228)
T ss_pred             HHHHhccCcccccccccchhhHHhhcccchHHHHHHHhh
Confidence            9999999999999999999999999876543 4444443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.8e-19  Score=166.47  Aligned_cols=149  Identities=21%  Similarity=0.309  Sum_probs=112.1

Q ss_pred             cccccceeeeecceEEEEEE---------------------eceEeEEEEecccccCCHH-----------HHHHHHHHH
Q 020981          154 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDD-----------RVRAFRDEL  201 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~---------------------~~~~vAvK~l~~~~~~~~~-----------~~~~~~~E~  201 (319)
                      ..+|....+||+|+||.||.                     .++.||||.+.........           ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            44788899999999999984                     2357999998643211000           011233467


Q ss_pred             HHHHhcCCCcc-----cccceeEEe--------CCceEEEEeecCCCCHHHHHHHcC-----------------------
Q 020981          202 ALLQKIRHPNV-----VQFLGAVTQ--------SSPMMIVTEYLPKGDLRAFLKRKG-----------------------  245 (319)
Q Consensus       202 ~~l~~l~h~~i-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~-----------------------  245 (319)
                      .++.+++|.++     +++++++..        ....|+||||+++++|.++++...                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766544     566666542        356899999999999999886421                       


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          246 -ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       246 -~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                       .+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  361 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT  361 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence             1345677889999999999999999   99999999999999999999999999976543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.6e-20  Score=169.24  Aligned_cols=140  Identities=28%  Similarity=0.473  Sum_probs=118.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....+|.|+|+.+..     +++..++|++.+...       .-.+|+.++...+ ||||+++.+.+.+....|+||
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            455666789999987753     678999999986522       2335777777774 999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe-cCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~DFgla~~~~~~  306 (319)
                      |.+.|+-+.+.+.....+. ..+..|++||+.|+.|||++|   +|||||||+|||+ +..|+++|+|||.++.....
T Consensus       396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999998888887765555 778889999999999999999   9999999999999 69999999999999887655

>PHA02795 ankyrin-like protein; Provisional

Probab=99.81  E-value=2.7e-20  Score=167.80  Aligned_cols=126  Identities=21%  Similarity=0.165  Sum_probs=109.3

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCC------CCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEE------IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA   81 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~   81 (319)
                      .||+++|+..++....+-....|++.+...      ..|.|++|.|+..++.++++.|+++|||+|.+|..|+||||+|+
T Consensus       150 ~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa  229 (437)
T PHA02795        150 LNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAI  229 (437)
T ss_pred             CCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHH
Confidence            578888888888888888888887443332      45788999999999999999999999999999999999999999


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccc--------cHHHHHHHHhhCCCCC
Q 020981           82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK--------NHEVIKLLEKHGAKPL  133 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~--------~~~i~~~L~~~g~~~~  133 (319)
                      ..|+.+++++|+++||+++.+|..|+||||+|+..|        +.+++++|++.|++..
T Consensus       230 ~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g~~~~~~~~~~eIvelLL~~gadI~  289 (437)
T PHA02795        230 YAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRGSVIARRETHLKILEILLREPLSID  289 (437)
T ss_pred             HcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCcccccccHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999999999999887        4689999999887553

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.81  E-value=2.7e-19  Score=161.19  Aligned_cols=142  Identities=27%  Similarity=0.476  Sum_probs=118.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC------c
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~  224 (319)
                      +|.....+|.|+||.+|.     ++..+|+|.+..... .......+.+|+.+++.++||||+++++++....      .
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            577788999999998874     478999999875432 2223356778999999999999999999886543      4


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +|+++||+. .+|..+..  ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        95 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             EEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            699999995 57776653  35889999999999999999999999   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.81  E-value=6e-20  Score=170.58  Aligned_cols=108  Identities=32%  Similarity=0.481  Sum_probs=101.0

Q ss_pred             cCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCC
Q 020981           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (319)
Q Consensus        29 ~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  108 (319)
                      .|.|+|..+..|.||||+||..|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|+|
T Consensus       113 ~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~t  192 (434)
T PHA02874        113 CGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGES  192 (434)
T ss_pred             CcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence            46778889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccccccccHHHHHHHHhhCCCCCCcc
Q 020981          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus       109 pl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      |+|+|+..|+.+++++|++.|++.....
T Consensus       193 pL~~A~~~g~~~iv~~Ll~~g~~i~~~~  220 (434)
T PHA02874        193 PLHNAAEYGDYACIKLLIDHGNHIMNKC  220 (434)
T ss_pred             HHHHHHHcCCHHHHHHHHhCCCCCcCCC
Confidence            9999999999999999999998765443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=2.9e-19  Score=145.55  Aligned_cols=143  Identities=20%  Similarity=0.257  Sum_probs=122.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .|....+||.|+||..|.     .|..||||+-+...-     ..++..|..+++.++ -..|+.+..++..+.+..+||
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            678889999999998874     689999998765432     245778999999997 578888888888999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgla~~~~~  305 (319)
                      +.+ |.+|++++.-. +.++..++..++-|++.-++|+|.++   +|||||||+|+|..-   ...+.++|||||+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 89999998643 46999999999999999999999999   999999999999763   34689999999998865


Q ss_pred             CC
Q 020981          306 KE  307 (319)
Q Consensus       306 ~~  307 (319)
                      ..
T Consensus       167 ~~  168 (341)
T KOG1163|consen  167 IR  168 (341)
T ss_pred             cc
Confidence            43

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.80  E-value=7.8e-20  Score=175.46  Aligned_cols=135  Identities=18%  Similarity=0.088  Sum_probs=110.4

Q ss_pred             ccccccccc--cCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCC--HHHHHHHHHcCCCCcccCCCCCCHHHHH---
Q 020981            8 RTTLLKQSS--LAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNFRDIDNRTALHVA---   80 (319)
Q Consensus         8 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~--~~~~~~Ll~~ga~vn~~d~~g~tpLh~A---   80 (319)
                      .|||+.++.  .++....+-..-+|+|+|.+|.+|.||||+|+..|+  .++|+.|+++|||+|.+|..|+||||+|   
T Consensus       178 ~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~  257 (764)
T PHA02716        178 YGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIIN  257 (764)
T ss_pred             CcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHh
Confidence            577776542  234455666666899999999999999999999985  5899999999999999999999999975   


Q ss_pred             ----------------------------------HHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccc--cccHHHHHH
Q 020981           81 ----------------------------------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKL  124 (319)
Q Consensus        81 ----------------------------------~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~--~~~~~i~~~  124 (319)
                                                        +..|+.+++++|+++|++++.+|..|+||||+|+.  .++.+++++
T Consensus       258 a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVkl  337 (764)
T PHA02716        258 IDNINPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKL  337 (764)
T ss_pred             hhccCHHHHHHHHHhccccccccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHH
Confidence                                              44578899999999999999999999999998754  467899999


Q ss_pred             HHhhCCCCCCcccccccc
Q 020981          125 LEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       125 L~~~g~~~~~~~~~~~~~  142 (319)
                      |++.|++....+....+|
T Consensus       338 LLe~GADIN~kD~~G~TP  355 (764)
T PHA02716        338 LHEYGNDLNEPDNIGNTV  355 (764)
T ss_pred             HHHcCCCCccCCCCCCCH
Confidence            999998876555444443

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.80  E-value=8.8e-20  Score=175.10  Aligned_cols=137  Identities=23%  Similarity=0.186  Sum_probs=117.7

Q ss_pred             cccccccccccCch--hhhhhhhhcCCCCCCCCCCcchHHHHH-------------------------------------
Q 020981            7 VRTTLLKQSSLAPD--RERKEAELNGLDDDGEEIKPEFRLMFL-------------------------------------   47 (319)
Q Consensus         7 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~t~L~~a-------------------------------------   47 (319)
                      -.|||+.|++.++.  ...+.+.-.|+|+|.++..|.||||+|                                     
T Consensus       212 G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~i~A  291 (764)
T PHA02716        212 LITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIPMILHSYITL  291 (764)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccccchhhhHHHHHH
Confidence            36899999998853  456667778999999999999999975                                     


Q ss_pred             HHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHH--cCCHHHHHHhhhCCCcccCCCCCCCCCcccccc----------
Q 020981           48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC--QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY----------  115 (319)
Q Consensus        48 ~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~--~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~----------  115 (319)
                      |..|+.++++.|++.||++|.+|.+|+||||+|+.  .++.+++++|+++|++++.+|..|+||||+|+.          
T Consensus       292 A~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~~G~TPLH~A~~~lav~~~ld~  371 (764)
T PHA02716        292 ARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVLHTYLSMLSVVNILDP  371 (764)
T ss_pred             HHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCCCCCCHHHHHHHhhhhhccccc
Confidence            44588999999999999999999999999999875  468999999999999999999999999998754          


Q ss_pred             ----cccHHHHHHHHhhCCCCCCccccccccC
Q 020981          116 ----YKNHEVIKLLEKHGAKPLMAPMHVKHAR  143 (319)
Q Consensus       116 ----~~~~~i~~~L~~~g~~~~~~~~~~~~~~  143 (319)
                          .++.+++++|++.|+++...+....+|.
T Consensus       372 ~~~~~~~~eVVklLL~~GADIn~kn~~G~TPL  403 (764)
T PHA02716        372 ETDNDIRLDVIQCLISLGADITAVNCLGYTPL  403 (764)
T ss_pred             cccccChHHHHHHHHHCCCCCCCcCCCCCChH
Confidence                3678999999999999876665555544

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.80  E-value=1.4e-19  Score=168.17  Aligned_cols=131  Identities=30%  Similarity=0.311  Sum_probs=120.8

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcC-----------------------
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-----------------------   63 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~g-----------------------   63 (319)
                      ..||++.|+..++....+-..-.|+|+|..+..|.||||.|+..|+.+++++|+++|                       
T Consensus        35 ~~tpL~~A~~~g~~~iv~~Ll~~Ga~~n~~~~~~~t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ll~~g  114 (434)
T PHA02874         35 TTTPLIDAIRSGDAKIVELFIKHGADINHINTKIPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILDCG  114 (434)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHHHHHCc
Confidence            369999999999999999888899999999999999999999999999999998766                       


Q ss_pred             CCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        64 a~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      +|+|.+|..|.||||+|+..|+.++|++|+++|++++.+|..|.||+|+|+..++.+++++|++.|++....+.
T Consensus       115 ~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~  188 (434)
T PHA02874        115 IDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDN  188 (434)
T ss_pred             CCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCC
Confidence            45778899999999999999999999999999999999999999999999999999999999999987655443

>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]

Probab=99.80  E-value=1.1e-19  Score=144.89  Aligned_cols=133  Identities=23%  Similarity=0.189  Sum_probs=115.4

Q ss_pred             CCCCccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Q 020981            2 ETKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA   81 (319)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~   81 (319)
                      |-++++-+|+-++.-+.+.....  .....-+|..|..|.|||+||+..|++++|++||+.|||+++..+...|+|++|+
T Consensus       124 evs~~p~s~~slsVhql~L~~~~--~~~~n~VN~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt  201 (296)
T KOG0502|consen  124 EVSLMPWSPLSLSVHQLHLDVVD--LLVNNKVNACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLAT  201 (296)
T ss_pred             ccccccCChhhHHHHHHHHHHHH--HHhhccccCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHh
Confidence            45667777777776666432222  1234457899999999999999999999999999999999999999999999999


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      ..|..++|++|+..+.|+|.-|-+|-|||-+|++.++.++++.|+..|+++....
T Consensus       202 ~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAvrgnhvkcve~Ll~sGAd~t~e~  256 (296)
T KOG0502|consen  202 RGGYTDIVELLLTREVDVNVYDWNGGTPLLYAVRGNHVKCVESLLNSGADVTQED  256 (296)
T ss_pred             cCChHHHHHHHHhcCCCcceeccCCCceeeeeecCChHHHHHHHHhcCCCccccc
Confidence            9999999999999999999999999999999999999999999999999875444

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.80  E-value=7.8e-20  Score=171.08  Aligned_cols=144  Identities=31%  Similarity=0.445  Sum_probs=114.9

Q ss_pred             ccceeeeecceEEEE----EEeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILA----FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v----~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |...+.+|.|+-|.+    .+.|+.||||.+....      ....++|+.+++... ||||+++|+.-.++...||..|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            334445666665533    3578999999986433      345678999999996 99999999998999999999999


Q ss_pred             cCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CC--CEEEEecCcccc
Q 020981          232 LPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SG--NLKVADFGVSKL  302 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~--~~kl~DFgla~~  302 (319)
                      | ..+|.+++.....    ......+....|+++||++||+.+   ||||||||+||||+.   ++  .++|+|||+|+.
T Consensus       585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            9 5799999987411    111345678899999999999998   999999999999986   34  689999999999


Q ss_pred             cccCCCCc
Q 020981          303 LTVKEDRP  310 (319)
Q Consensus       303 ~~~~~~~~  310 (319)
                      +..+.+..
T Consensus       661 l~~~~sS~  668 (903)
T KOG1027|consen  661 LAGGKSSF  668 (903)
T ss_pred             cCCCcchh
Confidence            98776544

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.4e-19  Score=149.61  Aligned_cols=141  Identities=21%  Similarity=0.399  Sum_probs=117.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCccccccee-EEeCCceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGA-VTQSSPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~-~~~~~~~~lv  228 (319)
                      .|.....+|+|-||....     +...+++|.+..+.    .....|.+|+..--.|. |.||+.-|+. |++.+.+.++
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            578888999999997764     46789999987643    34577888888766665 8999988765 5677788899


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC--CCCEEEEecCcccccc
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLT  304 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DFgla~~~~  304 (319)
                      +||++.|+|.+-+...+ +-+....+++.|+++|++|||+++   +||||||.+||||-.  .-.+||||||+.+...
T Consensus       101 qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999988776644 678889999999999999999999   999999999999863  3479999999987654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=7.6e-19  Score=146.62  Aligned_cols=139  Identities=10%  Similarity=0.184  Sum_probs=113.1

Q ss_pred             cccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHH------HHHHHHHHHhcCCCcccccceeEEeC----
Q 020981          156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRA------FRDELALLQKIRHPNVVQFLGAVTQS----  222 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~------~~~E~~~l~~l~h~~iv~l~~~~~~~----  222 (319)
                      .|.....+|.|+|+.|+.   .+..+|+|.+++.....+.....      +.+|+..+.++.||+|..+.+.+...    
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~  111 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT  111 (232)
T ss_pred             ceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence            577888999999998885   45689999998765555444334      57899999999999999998876533    


Q ss_pred             ----CceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecC
Q 020981          223 ----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (319)
Q Consensus       223 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFg  298 (319)
                          ...+++|||++|.+|.++..    +++    ....+++.+|..+|..+   ++|||+||+||+++.+| ++|+|||
T Consensus       112 ~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg  179 (232)
T PRK10359        112 LRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLS  179 (232)
T ss_pred             ccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECC
Confidence                35899999999999987632    333    24569999999999999   99999999999999999 9999999


Q ss_pred             cccccccC
Q 020981          299 VSKLLTVK  306 (319)
Q Consensus       299 la~~~~~~  306 (319)
                      ..+....+
T Consensus       180 ~~~~~~e~  187 (232)
T PRK10359        180 GKRCTAQR  187 (232)
T ss_pred             Ccccccch
Confidence            98876443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.80  E-value=3.1e-18  Score=144.25  Aligned_cols=144  Identities=34%  Similarity=0.606  Sum_probs=126.6

Q ss_pred             cceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      .....+|.|+++.+|.     .+..+++|.+......  ...+.+.+|+..++.++|+|++++++.+......++++|++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            4456788888887764     3688999998765332  24578889999999999999999999999889999999999


Q ss_pred             CCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       233 ~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++++|.+++..... +++.....++.+++.++.+||+.+   ++|+|++|+||+++.++.++|+|||++..+..+
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            99999999988766 899999999999999999999998   999999999999999999999999999887655

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.80  E-value=1.3e-19  Score=170.65  Aligned_cols=129  Identities=33%  Similarity=0.388  Sum_probs=66.5

Q ss_pred             cccccccccC--chhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCC------CCHHHHH
Q 020981            9 TTLLKQSSLA--PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------RTALHVA   80 (319)
Q Consensus         9 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g------~tpLh~A   80 (319)
                      ||++.|+..+  +....+-..-.|.|+|..+..|.||||+|+..|+.++++.|+++|++++..+..|      .||||+|
T Consensus       143 t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~~a  222 (480)
T PHA03100        143 NLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLHIA  222 (480)
T ss_pred             cHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHHHH
Confidence            3444444444  3333333333444444444444444444444444444444444444444444444      4444444


Q ss_pred             HHcCC--HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           81 ACQGF--TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        81 ~~~~~--~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      +..|+  .+++++|+++|++++.+|..|.||||+|+..++.+++++|++.|+++.....
T Consensus       223 ~~~~~~~~~iv~~Ll~~g~din~~d~~g~TpL~~A~~~~~~~iv~~Ll~~gad~n~~d~  281 (480)
T PHA03100        223 ACYNEITLEVVNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNK  281 (480)
T ss_pred             HHhCcCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCC
Confidence            44444  5555555555555666666666666666666666666666666665544443

>PHA02946 ankyin-like protein; Provisional

Probab=99.80  E-value=2.5e-19  Score=165.93  Aligned_cols=119  Identities=21%  Similarity=0.220  Sum_probs=102.6

Q ss_pred             hhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcC--CHHHHHHhhhCCC
Q 020981           20 DRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGA   97 (319)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~--~~~~v~~Ll~~g~   97 (319)
                      ....+...-+|.|+|.+|.+|.||||+||..|+.++|+.|+++|||+|.+|.+|+||||+|+..+  ..+++++|+++|+
T Consensus        52 ~~iv~~Ll~~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Ga  131 (446)
T PHA02946         52 ERFVEELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGA  131 (446)
T ss_pred             HHHHHHHHHCcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCC
Confidence            44566666789999999999999999999999999999999999999999999999999998866  4789999999999


Q ss_pred             cccC-CCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccc
Q 020981           98 DVDP-KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (319)
Q Consensus        98 ~~~~-~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~  139 (319)
                      +++. .|..|.||++ |+..++.+++++|++.|++....+...
T Consensus       132 din~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G  173 (446)
T PHA02946        132 KINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFG  173 (446)
T ss_pred             CcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCCC
Confidence            9995 6889999997 566788899999999888775554433

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.79  E-value=3.3e-19  Score=159.13  Aligned_cols=148  Identities=25%  Similarity=0.380  Sum_probs=126.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC------CCcccccceeEEeCCc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVTQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~l~~~~~~~~~  224 (319)
                      .|......|+|.|+.|..     .|+.||||++...-    ...+.-+.|+++|++|+      --|.++++..|...++
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            567777889999998864     57899999998542    33345567999999995      2489999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEecCcc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVS  300 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DFgla  300 (319)
                      +|+|+|.+ ..+|.+++++.+.   +....+..|+.|+..||..|-..+   |+|.||||+|||+++.. .+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence            99999988 5799999998654   788899999999999999999999   99999999999999765 5799999999


Q ss_pred             cccccCCCCce
Q 020981          301 KLLTVKEDRPL  311 (319)
Q Consensus       301 ~~~~~~~~~~~  311 (319)
                      .+...++-.|+
T Consensus       585 ~~~~eneitPY  595 (752)
T KOG0670|consen  585 SFASENEITPY  595 (752)
T ss_pred             cccccccccHH
Confidence            99888877766

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.79  E-value=9.4e-19  Score=166.53  Aligned_cols=142  Identities=22%  Similarity=0.329  Sum_probs=100.6

Q ss_pred             cccccceeeeecceEEEEEE-----e----ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCccccccee------
Q 020981          154 ELDFTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------  218 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~----~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~------  218 (319)
                      ..+|.....||+|+||.||.     +    +..||+|.+.....     .+....|  .++...+.++..++..      
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            34788889999999999985     2    67899998764221     1111111  1111122222222221      


Q ss_pred             EEeCCceEEEEeecCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcC
Q 020981          219 VTQSSPMMIVTEYLPKGDLRAFLKRKGA--------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRD  278 (319)
Q Consensus       219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~D  278 (319)
                      .......++|+||+.+++|.+++.....                    .....+..++.|++.||.|||+++   |+|||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCc
Confidence            2345679999999999999999875421                    112345679999999999999999   99999


Q ss_pred             CCCCCEEecC-CCCEEEEecCccccccc
Q 020981          279 LEPSNILRDD-SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       279 lk~~Nill~~-~~~~kl~DFgla~~~~~  305 (319)
                      |||+|||++. ++.+||+|||+|+.+..
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~  308 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRV  308 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCcccccc
Confidence            9999999995 58999999999986643

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.79  E-value=9.3e-20  Score=178.46  Aligned_cols=125  Identities=32%  Similarity=0.296  Sum_probs=117.6

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      -|+++-++........+...-.|++++.++.+|+||||.||.+|++++|++||++|||+|++|+.|+||||.||..|+.+
T Consensus       508 l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~  587 (1143)
T KOG4177|consen  508 LTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHND  587 (1143)
T ss_pred             cchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHH
Confidence            45677777777777777888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      ++++|+++||++|..|.+|.||+++|...|+.++++.+...++.+
T Consensus       588 i~~LLlk~GA~vna~d~~g~TpL~iA~~lg~~~~~k~l~~~~~~~  632 (1143)
T KOG4177|consen  588 IAELLLKHGASVNAADLDGFTPLHIAVRLGYLSVVKLLKVVTATP  632 (1143)
T ss_pred             HHHHHHHcCCCCCcccccCcchhHHHHHhcccchhhHHHhccCcc
Confidence            999999999999999999999999999999999999999998883

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.79  E-value=8.5e-20  Score=154.08  Aligned_cols=153  Identities=28%  Similarity=0.402  Sum_probs=118.4

Q ss_pred             ccceeeeecceEE--EEE--EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------CceE
Q 020981          157 FTNSVEITKGTFI--LAF--WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SPMM  226 (319)
Q Consensus       157 ~~~~~~ig~G~f~--~v~--~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~~~  226 (319)
                      |....-++.|.-.  .++  ..+++||+|++..+.. .....+...+|..++..++|+|+++++.+|...      ...|
T Consensus        19 y~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y   97 (369)
T KOG0665|consen   19 YVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY   97 (369)
T ss_pred             eeeecccCCCCceEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence            4444445555442  222  3688999999877643 333445566799999999999999999988543      3589


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +|||+| ..+|..++..  .+.-.....++.|++.|++|+|+.+   |+||||||+||++..++.+||.|||+|+.-...
T Consensus        98 ~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   98 LVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             HHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc
Confidence            999999 5699888873  3677889999999999999999999   999999999999999999999999999865444


Q ss_pred             CCCceeeccCC
Q 020981          307 EDRPLTCQDTS  317 (319)
Q Consensus       307 ~~~~~~~~~~~  317 (319)
                       .+.+..+.|.
T Consensus       172 -~~mtpyVvtR  181 (369)
T KOG0665|consen  172 -FMMTPYVVTR  181 (369)
T ss_pred             -cccCchhhee
Confidence             3333344443

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.79  E-value=3.7e-19  Score=128.15  Aligned_cols=87  Identities=44%  Similarity=0.583  Sum_probs=76.6

Q ss_pred             HHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHH
Q 020981           44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK  123 (319)
Q Consensus        44 L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~  123 (319)
                      ||+||..|+.++++.|++.|++++.    |+||||+|+..|+.+++++|+++|++++.+|..|+||+|+|+..++.++++
T Consensus         1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~   76 (89)
T PF12796_consen    1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK   76 (89)
T ss_dssp             HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred             CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence            7899999999999999999888887    889999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCC
Q 020981          124 LLEKHGAKPLM  134 (319)
Q Consensus       124 ~L~~~g~~~~~  134 (319)
                      +|+++|+++..
T Consensus        77 ~Ll~~g~~~~~   87 (89)
T PF12796_consen   77 LLLEHGADVNI   87 (89)
T ss_dssp             HHHHTTT-TTS
T ss_pred             HHHHcCCCCCC
Confidence            99998877643

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>PHA02741 hypothetical protein; Provisional

Probab=99.79  E-value=2.7e-19  Score=144.61  Aligned_cols=105  Identities=20%  Similarity=0.179  Sum_probs=93.6

Q ss_pred             CCCCCCCcchHHHHHHHcCCHHHHHHHHH------cCCCCcccCCCCCCHHHHHHHcCC----HHHHHHhhhCCCcccCC
Q 020981           33 DDGEEIKPEFRLMFLANERDVEGIKELLD------SGIDVNFRDIDNRTALHVAACQGF----TEVVSLLLERGADVDPK  102 (319)
Q Consensus        33 ~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~------~ga~vn~~d~~g~tpLh~A~~~~~----~~~v~~Ll~~g~~~~~~  102 (319)
                      .+.++.+|.||||+||..|+.++++.|+.      .|+++|.+|..|+||||+|+..|+    .+++++|++.|++++.+
T Consensus        14 ~~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~   93 (169)
T PHA02741         14 IAEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQ   93 (169)
T ss_pred             hhccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCC
Confidence            45677889999999999999999999864      379999999999999999999999    58999999999999999


Q ss_pred             CC-CCCCCcccccccccHHHHHHHHh-hCCCCCCccc
Q 020981          103 DR-WGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPM  137 (319)
Q Consensus       103 ~~-~g~tpl~~a~~~~~~~i~~~L~~-~g~~~~~~~~  137 (319)
                      |. .|+||||+|+..++.+++++|+. .+++....+.
T Consensus        94 ~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~  130 (169)
T PHA02741         94 EMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNA  130 (169)
T ss_pred             CcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCC
Confidence            95 99999999999999999999997 4776654443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=2.1e-18  Score=141.09  Aligned_cols=133  Identities=17%  Similarity=0.147  Sum_probs=102.0

Q ss_pred             ceeeeecceEEEEEEe---ceEeEEEEecccccCCH-HHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEeecC
Q 020981          159 NSVEITKGTFILAFWR---GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       159 ~~~~ig~G~f~~v~~~---~~~vAvK~l~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      ....++.++||.+++.   +.+++.+.+........ -....+.+|+.+|++++ ++++++++++    ...+++|||+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            3457899999999874   45666665554332211 11235789999999996 5789998875    44799999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCC-CCCCEEecCCCCEEEEecCccccccc
Q 020981          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       234 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |.+|......      . ...++.|++.+|+++|++|   |+|||| ||+|||++.++.++|+|||+|.....
T Consensus        82 G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         82 GAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             CccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            9888654321      1 2357889999999999999   999999 79999999999999999999986554

>PHA03095 ankyrin-like protein; Provisional

Probab=99.78  E-value=3.3e-19  Score=167.45  Aligned_cols=125  Identities=30%  Similarity=0.326  Sum_probs=66.2

Q ss_pred             ccccccccccC---chhhhhhhhhcCCCCCCCCCCcchHHHHHHHcC-CHHHHHHHHHcCCCCcccCCCCCCHHHHHH--
Q 020981            8 RTTLLKQSSLA---PDRERKEAELNGLDDDGEEIKPEFRLMFLANER-DVEGIKELLDSGIDVNFRDIDNRTALHVAA--   81 (319)
Q Consensus         8 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~-~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~--   81 (319)
                      .|||+.+++.+   .....+...-.|+|+|..+..|.||||+|+..| +.++++.|+++|+|+|.+|..|+||||+|+  
T Consensus        48 ~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~~~~g~tpLh~a~~~  127 (471)
T PHA03095         48 KTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKVGRTPLHVYLSG  127 (471)
T ss_pred             CCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHhhC
Confidence            34555555544   344444444455555555555555555555555 355555555555555555555555555555  


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccc--cHHHHHHHHhhCCCC
Q 020981           82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK--NHEVIKLLEKHGAKP  132 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~--~~~i~~~L~~~g~~~  132 (319)
                      ..++.+++++|+++|++++.+|..|.||+|+|+..+  +.+++++|++.|++.
T Consensus       128 ~~~~~~iv~~Ll~~gad~~~~d~~g~tpL~~a~~~~~~~~~iv~~Ll~~g~~~  180 (471)
T PHA03095        128 FNINPKVIRLLLRKGADVNALDLYGMTPLAVLLKSRNANVELLRLLIDAGADV  180 (471)
T ss_pred             CcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCC
Confidence            334455555555555555555555555555544433  345555555555444

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.78  E-value=2.4e-19  Score=166.66  Aligned_cols=139  Identities=27%  Similarity=0.214  Sum_probs=126.1

Q ss_pred             CCccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHH-cC-CCCcccCCCCCCHHHHHH
Q 020981            4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SG-IDVNFRDIDNRTALHVAA   81 (319)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~-~g-a~vn~~d~~g~tpLh~A~   81 (319)
                      ...--||+|-||+.|+-+...-..-.|+|+|.++.++.||||.||.+|+.++|+.||+ .| ...|..|-.|.||||+|+
T Consensus       270 d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa  349 (929)
T KOG0510|consen  270 DNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAA  349 (929)
T ss_pred             cccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhh
Confidence            3445699999999999999999999999999999999999999999999999999999 55 578999999999999999


Q ss_pred             HcCCHHHHHHhhhCCCccc---CCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           82 CQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~---~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      ..||..++++|++.||+..   ..|.+|.||||.|+.+|+..++++|+.+|++....+....++
T Consensus       350 ~~gH~~v~qlLl~~GA~~~~~~e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n~~g~SA  413 (929)
T KOG0510|consen  350 KSGHDRVVQLLLNKGALFLNMSEADSDGNTALHLAAKYGNTSAVQKLISHGADIGVKNKKGKSA  413 (929)
T ss_pred             hcCHHHHHHHHHhcChhhhcccccccCCchhhhHHHHhccHHHHHHHHHcCCceeecccccccc
Confidence            9999999999999999887   569999999999999999999999999999886655444444

>PHA03095 ankyrin-like protein; Provisional

Probab=99.78  E-value=6.3e-19  Score=165.53  Aligned_cols=128  Identities=27%  Similarity=0.291  Sum_probs=115.0

Q ss_pred             ccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcC---CHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcC-CHH
Q 020981           12 LKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-FTE   87 (319)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~---~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~-~~~   87 (319)
                      ..+++.......+...-.|.|+|..+..|.||||+|+..+   +.++++.|++.|+|+|.+|..|+||||+|+..| ..+
T Consensus        19 ~~~~~~~~~~~v~~Ll~~ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~   98 (471)
T PHA03095         19 LLNASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLD   98 (471)
T ss_pred             HHcCCCCCHHHHHHHHHcCCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHH
Confidence            3456666667777777889999999999999999999998   999999999999999999999999999999999 599


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCccccc--ccccHHHHHHHHhhCCCCCCccccc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAI--YYKNHEVIKLLEKHGAKPLMAPMHV  139 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~--~~~~~~i~~~L~~~g~~~~~~~~~~  139 (319)
                      ++++|+++|++++.+|..|.||||+|+  ..++.+++++|++.|+++...+...
T Consensus        99 iv~lLl~~ga~in~~~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g  152 (471)
T PHA03095         99 VIKLLIKAGADVNAKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYG  152 (471)
T ss_pred             HHHHHHHcCCCCCCCCCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCC
Confidence            999999999999999999999999999  5568899999999999876554433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.78  E-value=6.4e-18  Score=140.16  Aligned_cols=139  Identities=40%  Similarity=0.701  Sum_probs=120.4

Q ss_pred             eecceEEEEEE---e--ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCH
Q 020981          163 ITKGTFILAFW---R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (319)
Q Consensus       163 ig~G~f~~v~~---~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L  237 (319)
                      +|.|.++.+|.   .  ++.+++|.+.......  ....+.+|+..++.++|++++++++.+......++++|++.+++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            46677776653   3  7889999987543221  346788999999999999999999999988999999999998999


Q ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-CCCEEEEecCcccccccC
Q 020981          238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       238 ~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DFgla~~~~~~  306 (319)
                      .+++... ..+++..+..++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+......
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            9999876 46889999999999999999999998   999999999999999 899999999999876554

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PHA02946 ankyin-like protein; Provisional

Probab=99.78  E-value=3.7e-19  Score=164.82  Aligned_cols=135  Identities=17%  Similarity=0.189  Sum_probs=115.3

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcC--CHHHHHHHHHcCCCCcc-cCCCCCCHHHHHHHc
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNF-RDIDNRTALHVAACQ   83 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~--~~~~~~~Ll~~ga~vn~-~d~~g~tpLh~A~~~   83 (319)
                      -.|||+.|++.++....+-+.-.|+|+|.+|.+|.||||+|+..+  ..++++.|+++||++|. .|.+|.|||| ||..
T Consensus        72 G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-aa~~  150 (446)
T PHA02946         72 GNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-ACTD  150 (446)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-HHHC
Confidence            469999999999998888888899999999999999999998865  48999999999999995 6888999997 6677


Q ss_pred             CCHHHHHHhhhCCCcccCCCCCCCCCcccccccc--cHHHHHHHHhhCCCCCCcccccccc
Q 020981           84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK--NHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        84 ~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~--~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      |+.+++++|++.|++++.+|..|+||+|.|+..+  +.+++++|++.|+++...+....+|
T Consensus       151 ~~~~vv~~Ll~~gad~~~~d~~G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~~G~Tp  211 (446)
T PHA02946        151 PSERVFKKIMSIGFEARIVDKFGKNHIHRHLMSDNPKASTISWMMKLGISPSKPDHDGNTP  211 (446)
T ss_pred             CChHHHHHHHhccccccccCCCCCCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence            8899999999999999999999999999877654  4578889999888876655444443

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.78  E-value=1.2e-19  Score=159.36  Aligned_cols=124  Identities=28%  Similarity=0.266  Sum_probs=116.8

Q ss_pred             CCCccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Q 020981            3 TKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC   82 (319)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~   82 (319)
                      |..---|||..|+.-|+..+.|-..-+|+|.+..|..|.|+||+||..|+.+++++|++.|||+|.++..|+|+||.++.
T Consensus       113 tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTALH~caE  192 (615)
T KOG0508|consen  113 TTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTALHDCAE  192 (615)
T ss_pred             ccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchHHHhhhh
Confidence            34445689999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHh
Q 020981           83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK  127 (319)
Q Consensus        83 ~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~  127 (319)
                      .|+.+++++|+++|+.++. |..|.|||..|+..|+.+++..|+.
T Consensus       193 sG~vdivq~Ll~~ga~i~~-d~~GmtPL~~Aa~tG~~~iVe~L~~  236 (615)
T KOG0508|consen  193 SGSVDIVQLLLKHGAKIDV-DGHGMTPLLLAAVTGHTDIVERLLQ  236 (615)
T ss_pred             cccHHHHHHHHhCCceeee-cCCCCchHHHHhhhcchHHHHHHhc
Confidence            9999999999999999865 6679999999999999999999996

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.3e-19  Score=147.70  Aligned_cols=115  Identities=27%  Similarity=0.312  Sum_probs=105.4

Q ss_pred             hcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCC
Q 020981           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (319)
Q Consensus        28 ~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~  107 (319)
                      -.+-|.|.-|--|.+||||||+.|+..+|+.|+..||.||..+....||||+|+..||.++|+.|++..+|+|..|..|.
T Consensus        22 ~tehdln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgn  101 (448)
T KOG0195|consen   22 DTEHDLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGN  101 (448)
T ss_pred             CcccccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCC
Confidence            34667788888999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       108 tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      ||||||+..|...+++-|+..|+....-+.....+
T Consensus       102 tplhyacfwgydqiaedli~~ga~v~icnk~g~tp  136 (448)
T KOG0195|consen  102 TPLHYACFWGYDQIAEDLISCGAAVNICNKKGMTP  136 (448)
T ss_pred             CchhhhhhhcHHHHHHHHHhccceeeecccCCCCc
Confidence            99999999999999999999999876555544444

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.78  E-value=8.6e-19  Score=151.24  Aligned_cols=145  Identities=28%  Similarity=0.346  Sum_probs=118.9

Q ss_pred             cccccceeeeecceEEEEE--E---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC--CC----cccccceeEEeC
Q 020981          154 ELDFTNSVEITKGTFILAF--W---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HP----NVVQFLGAVTQS  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~--~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~iv~l~~~~~~~  222 (319)
                      ...|.....+|+|+||.|.  |   ++..||||+++.-    ....+...-|+.++.++.  -|    -++.+.++|...
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            3467888899999999875  2   4789999998631    233455667999999994  22    367788889999


Q ss_pred             CceEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC------------
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------  288 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~------------  288 (319)
                      ++.|||+|.+ |.|+.++++++.  +++...++.++.|+++++.|||+.+   ++|-||||+|||+.+            
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence            9999999988 779999999865  5889999999999999999999999   999999999999842            


Q ss_pred             --------CCCEEEEecCcccccccC
Q 020981          289 --------SGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       289 --------~~~~kl~DFgla~~~~~~  306 (319)
                              +-.+||+|||.|.+-...
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~  265 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH  265 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC
Confidence                    235899999999875443

>PHA02798 ankyrin-like protein; Provisional

Probab=99.77  E-value=6e-19  Score=166.19  Aligned_cols=94  Identities=27%  Similarity=0.261  Sum_probs=61.5

Q ss_pred             cccccccccc-----CchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcC---CHHHHHHHHHcCCCCcccCCCCCCHHHH
Q 020981            8 RTTLLKQSSL-----APDRERKEAELNGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHV   79 (319)
Q Consensus         8 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~---~~~~~~~Ll~~ga~vn~~d~~g~tpLh~   79 (319)
                      .|||+.++..     +.....+...-.|+|+|.+|.+|.||||+|+..+   +.+++++|+++|||+|.+|.+|+||||+
T Consensus        72 ~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~  151 (489)
T PHA02798         72 STPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQV  151 (489)
T ss_pred             CChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHH
Confidence            3555554432     2334444455567777777777777777777654   5677777777777777777777777777


Q ss_pred             HHHcCC---HHHHHHhhhCCCcccC
Q 020981           80 AACQGF---TEVVSLLLERGADVDP  101 (319)
Q Consensus        80 A~~~~~---~~~v~~Ll~~g~~~~~  101 (319)
                      |+..|+   .+++++|+++|++++.
T Consensus       152 a~~~~~~~~~~vv~~Ll~~gadin~  176 (489)
T PHA02798        152 YLQSNHHIDIEIIKLLLEKGVDINT  176 (489)
T ss_pred             HHHcCCcchHHHHHHHHHhCCCccc
Confidence            777666   6666666666665543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.77  E-value=3.3e-18  Score=173.93  Aligned_cols=136  Identities=21%  Similarity=0.400  Sum_probs=112.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .+.....+|+|+||.||.     .+..||+|.+......       ...|+..+++++||||+++++++......|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            345566899999999884     4689999988643211       1246888999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      |+++|+|.++++.   +++.....++.|++.||+|||.....+|+||||||+||+++.++..++. ||.+..
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            9999999999964   7889999999999999999995432349999999999999999888875 666543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=8e-18  Score=141.10  Aligned_cols=136  Identities=23%  Similarity=0.337  Sum_probs=111.7

Q ss_pred             eeeecceEEEEEE---eceEeEEEEecccccCCH-----HHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          161 VEITKGTFILAFW---RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       161 ~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      ..+|+|++|.||.   .|..+++|.........+     .....+.+|+.++..+.|++++....++......+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            3578999988874   578999998664433222     12345778999999999999887777777777889999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +|++|.+++....   + ....++.+++.+|.++|+.+   ++|+|++|+|||++ ++.++|+|||+++...
T Consensus        82 ~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         82 EGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             CCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            9999999987643   2 77889999999999999999   99999999999999 7899999999998643

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.77  E-value=6.4e-19  Score=172.49  Aligned_cols=135  Identities=27%  Similarity=0.257  Sum_probs=109.6

Q ss_pred             ccccccccccCc-hhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC-
Q 020981            8 RTTLLKQSSLAP-DRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-   85 (319)
Q Consensus         8 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~-   85 (319)
                      .||++.|+..++ ........-.|.|+|.+|..|.||||+|+..|+.++++.|++.|+|++..+..|.||||+|+..++ 
T Consensus       342 ~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~  421 (682)
T PHA02876        342 ITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNP  421 (682)
T ss_pred             CcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCH
Confidence            467777776543 444445555788899999999999999999999999999999999999999899999999887665 


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccc-cHHHHHHHHhhCCCCCCcccccccc
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYK-NHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~-~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      ..++++|++.|+++|.+|..|+||||+|+..+ +.+++++|++.|+++...+....++
T Consensus       422 ~~~vk~Ll~~gadin~~d~~G~TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~tp  479 (682)
T PHA02876        422 YMSVKTLIDRGANVNSKNKDLSTPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQYP  479 (682)
T ss_pred             HHHHHHHHhCCCCCCcCCCCCChHHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            46789999999999999999999999998876 6799999999999887665544444

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.77  E-value=9.1e-18  Score=142.70  Aligned_cols=136  Identities=38%  Similarity=0.624  Sum_probs=118.4

Q ss_pred             ceEEEEEE--eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCCCCHHHHHHH
Q 020981          166 GTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR  243 (319)
Q Consensus       166 G~f~~v~~--~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  243 (319)
                      |..+.+..  ++..+++|++........  .+.+.+|+..+++++|++++++++.+......++++||+++++|.+++..
T Consensus         3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        3 GKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             eEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            44444444  468999999875543221  57888999999999999999999999998999999999998899999987


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       244 ~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ...+++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            666899999999999999999999998   999999999999999999999999999877654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=6.2e-18  Score=140.47  Aligned_cols=132  Identities=25%  Similarity=0.357  Sum_probs=105.8

Q ss_pred             eecceEEEEE---EeceEeEEEEecccccCC-----HHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          163 ITKGTFILAF---WRGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       163 ig~G~f~~v~---~~~~~vAvK~l~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      ||+|++|.||   +.+..+++|.........     ......+.+|+.+++.+.++++......+......+++|||++|
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            6889998877   467899999865433222     12235678899999999988766555555666778999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ++|.+++.....       .++.|++.+|.++|+.+   ++|+|++|+||+++ ++.++++|||+++....
T Consensus        82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~  141 (199)
T TIGR03724        82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE  141 (199)
T ss_pred             ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence            999988765321       78899999999999999   99999999999999 79999999999987543

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.77  E-value=8.8e-19  Score=164.93  Aligned_cols=127  Identities=24%  Similarity=0.162  Sum_probs=82.4

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHH-----HHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMF-----LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA   81 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~-----a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~   81 (319)
                      ..||++.|++.++....+...-+|.|+|..+..|.||||+     |+..++.++++.|++.|+++|.+|..|+||||+|+
T Consensus        35 ~~t~L~~A~~~~~~~ivk~Ll~~g~~~~~~~~~~~t~L~~~~~~~a~~~~~~~iv~~Ll~~ga~i~~~d~~g~tpL~~A~  114 (480)
T PHA03100         35 PVLPLYLAKEARNIDVVKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAI  114 (480)
T ss_pred             cchhhhhhhccCCHHHHHHHHHcCCCCCCccccCcCHHHHHHHHHHHhhchHHHHHHHHHCCCCCCCCCCCCCchhhHHH
Confidence            3566666666666666666666666666666666666666     66666666666666666666666666666666666


Q ss_pred             --HcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccc--cHHHHHHHHhhCCCCC
Q 020981           82 --CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK--NHEVIKLLEKHGAKPL  133 (319)
Q Consensus        82 --~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~--~~~i~~~L~~~g~~~~  133 (319)
                        ..|+.+++++|+++|++++..|..|.||+|+|+..+  +.+++++|++.|++..
T Consensus       115 ~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din  170 (480)
T PHA03100        115 SKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDIN  170 (480)
T ss_pred             hcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcc
Confidence              666666666666666666666666666666666666  6666666666665543

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.77  E-value=1.1e-18  Score=125.56  Aligned_cols=89  Identities=35%  Similarity=0.373  Sum_probs=78.0

Q ss_pred             cccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHH
Q 020981           11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS   90 (319)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~   90 (319)
                      |+.|++.++....+...-.+.+.+.    |+||||+||..|+.+++++|++.|+|+|.+|.+|+||||+|+..|+.++++
T Consensus         1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~   76 (89)
T PF12796_consen    1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK   76 (89)
T ss_dssp             HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred             CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence            4567777777777777667777777    889999999999999999999999999999999999999999999999999


Q ss_pred             HhhhCCCcccCCC
Q 020981           91 LLLERGADVDPKD  103 (319)
Q Consensus        91 ~Ll~~g~~~~~~~  103 (319)
                      +|+++|++++.+|
T Consensus        77 ~Ll~~g~~~~~~n   89 (89)
T PF12796_consen   77 LLLEHGADVNIRN   89 (89)
T ss_dssp             HHHHTTT-TTSS-
T ss_pred             HHHHcCCCCCCcC
Confidence            9999999999876

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>PHA02798 ankyrin-like protein; Provisional

Probab=99.77  E-value=1.2e-18  Score=164.13  Aligned_cols=117  Identities=24%  Similarity=0.246  Sum_probs=105.8

Q ss_pred             chhhhhhhhhcCCCCCCCCCCcchHHHHHHHc-----CCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcC---CHHHHH
Q 020981           19 PDRERKEAELNGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVS   90 (319)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~-----~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~---~~~~v~   90 (319)
                      .....+-..-+|+|+|..+..|.||||.|+..     +..++++.|+++|||+|.+|.+|+||||+|+..+   +.++++
T Consensus        50 ~~~iv~~Ll~~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~  129 (489)
T PHA02798         50 STDIVKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILL  129 (489)
T ss_pred             CHHHHHHHHHCCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHH
Confidence            44556666668999999999999999999864     6799999999999999999999999999999875   789999


Q ss_pred             HhhhCCCcccCCCCCCCCCccccccccc---HHHHHHHHhhCCCCCCc
Q 020981           91 LLLERGADVDPKDRWGSTPLGDAIYYKN---HEVIKLLEKHGAKPLMA  135 (319)
Q Consensus        91 ~Ll~~g~~~~~~~~~g~tpl~~a~~~~~---~~i~~~L~~~g~~~~~~  135 (319)
                      +|+++||+++.+|..|.||+|+|+..++   .+++++|++.|++....
T Consensus       130 ~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~  177 (489)
T PHA02798        130 FMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH  177 (489)
T ss_pred             HHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence            9999999999999999999999999887   89999999999886543

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.76  E-value=4.6e-19  Score=151.01  Aligned_cols=114  Identities=32%  Similarity=0.353  Sum_probs=70.2

Q ss_pred             cccCchhhhhhhhhcCCCCCCCCC-CcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhh
Q 020981           15 SSLAPDRERKEAELNGLDDDGEEI-KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL   93 (319)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll   93 (319)
                      -....+.......+.-.|+|.+-. -|.|+|++|+..|++++|+.||..|||||.+|.+|.|+||.||.+||.|++++||
T Consensus       314 lk~~~d~~vV~~LF~mgnVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLL  393 (452)
T KOG0514|consen  314 LKQPADRTVVERLFKMGDVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLL  393 (452)
T ss_pred             hcchhhHHHHHHHHhccCcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHh
Confidence            334444455555555556665533 4666666666666666666666666666666666666666666666666666666


Q ss_pred             hC-CCcccCCCCCCCCCcccccccccHHHHHHHHhh
Q 020981           94 ER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        94 ~~-g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      .. ++|+...|.+|.|+|.+|...|+.||.-+|..+
T Consensus       394 A~p~cd~sLtD~DgSTAl~IAleagh~eIa~mlYa~  429 (452)
T KOG0514|consen  394 AVPSCDISLTDVDGSTALSIALEAGHREIAVMLYAH  429 (452)
T ss_pred             ccCcccceeecCCCchhhhhHHhcCchHHHHHHHHH
Confidence            53 566666666666666666666666666555543

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.76  E-value=9.8e-19  Score=140.79  Aligned_cols=108  Identities=20%  Similarity=0.200  Sum_probs=95.6

Q ss_pred             cCCCCCCCCCCcchHHHHHHHcCCH----HHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHH---HHHhhhCCCcccC
Q 020981           29 NGLDDDGEEIKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV---VSLLLERGADVDP  101 (319)
Q Consensus        29 ~~~~~~~~~~~~~t~L~~a~~~~~~----~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~---v~~Ll~~g~~~~~  101 (319)
                      +++|++..+.++.++||.||..|+.    ++++.|++.|+++|.+|.+|+||||+|+..|+.+.   +++|++.|++++.
T Consensus         9 ~~~~~~~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~   88 (166)
T PHA02743          9 NNLGAVEIDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINA   88 (166)
T ss_pred             cchHHhhhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCC
Confidence            5777888888888999999999998    66677888999999999999999999999988664   8999999999999


Q ss_pred             CC-CCCCCCcccccccccHHHHHHHHh-hCCCCCCcc
Q 020981          102 KD-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAP  136 (319)
Q Consensus       102 ~~-~~g~tpl~~a~~~~~~~i~~~L~~-~g~~~~~~~  136 (319)
                      +| ..|+||||+|+..++.+++++|+. .+++.....
T Consensus        89 ~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d  125 (166)
T PHA02743         89 RELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAIN  125 (166)
T ss_pred             CCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcC
Confidence            98 589999999999999999999995 687765444

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=7.1e-18  Score=143.40  Aligned_cols=145  Identities=19%  Similarity=0.123  Sum_probs=109.1

Q ss_pred             cccceeeeecceEEEEEE------eceEeEEEEecccccCC-------------------H--HHHHHHHHHHHHHHhcC
Q 020981          156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISD-------------------D--DRVRAFRDELALLQKIR  208 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~------~~~~vAvK~l~~~~~~~-------------------~--~~~~~~~~E~~~l~~l~  208 (319)
                      .|.....+|.|++|.||.      +|+.||+|.++......                   .  .....+..|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            355667899999998863      46899999987542110                   0  01234578999999997


Q ss_pred             CC--cccccceeEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe
Q 020981          209 HP--NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR  286 (319)
Q Consensus       209 h~--~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill  286 (319)
                      +.  .+++.++.    ...++||||+++.+|.........+....+..++.|++.++.+||+++  .++||||||+||++
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli  182 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILV  182 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEE
Confidence            53  33444432    235899999998888766544445666677899999999999999987  39999999999999


Q ss_pred             cCCCCEEEEecCcccccccCC
Q 020981          287 DDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       287 ~~~~~~kl~DFgla~~~~~~~  307 (319)
                      + ++.++|+|||.|.....+.
T Consensus       183 ~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      183 H-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             E-CCCEEEEEChhhhccCCcc
Confidence            9 8899999999998766654

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.76  E-value=2.5e-18  Score=132.24  Aligned_cols=95  Identities=35%  Similarity=0.431  Sum_probs=89.4

Q ss_pred             hHHHHHHHcCCHHHHHHHHHcCCC-CcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHH
Q 020981           42 FRLMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE  120 (319)
Q Consensus        42 t~L~~a~~~~~~~~~~~Ll~~ga~-vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~  120 (319)
                      -.+.+|+..+.+..|+.||+..|+ ||.+|.+|.||||.|+++|+++||+.|+..||+++.+...||||||-|+.+++.+
T Consensus        65 rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~  144 (228)
T KOG0512|consen   65 RLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFE  144 (228)
T ss_pred             HHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchh
Confidence            347899999999999999999886 8999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhCCCCCCcc
Q 020981          121 VIKLLEKHGAKPLMAP  136 (319)
Q Consensus       121 i~~~L~~~g~~~~~~~  136 (319)
                      ++..|+++|++.....
T Consensus       145 va~~LLqhgaDVnA~t  160 (228)
T KOG0512|consen  145 VAGRLLQHGADVNAQT  160 (228)
T ss_pred             HHHHHHhccCcccccc
Confidence            9999999999875443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.6e-17  Score=157.91  Aligned_cols=138  Identities=23%  Similarity=0.227  Sum_probs=110.9

Q ss_pred             ccceeeeecceEEEEEE---eceEeEEEEecccccC-----CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      +.....||+|+|+.||.   .+..+++|+.......     .....+.+.+|+.+++.++|++++.....+......++|
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            34567899999999986   4555666654322211     112345688999999999999998877777777788999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |||+++++|.+++.        ....++.|++.+|.+||+.+   ++||||||+|||+ .++.++|+|||+|+.....
T Consensus       415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~~~~  480 (535)
T PRK09605        415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYSDLI  480 (535)
T ss_pred             EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccCCch
Confidence            99999999999876        34678999999999999999   9999999999999 6789999999999876543

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.75  E-value=3.5e-18  Score=148.37  Aligned_cols=107  Identities=18%  Similarity=0.065  Sum_probs=92.2

Q ss_pred             CCCCcch-HHHHHHHcCCHHHHHHHHHcCCCCcccC----CCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCC-CCCCCC
Q 020981           36 EEIKPEF-RLMFLANERDVEGIKELLDSGIDVNFRD----IDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTP  109 (319)
Q Consensus        36 ~~~~~~t-~L~~a~~~~~~~~~~~Ll~~ga~vn~~d----~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~-~~g~tp  109 (319)
                      +|..|.| +||.|+..|+.++++.|+++|||+|.++    ..|.||||+|+..|+.+++++|+++||+++.++ ..|.||
T Consensus        28 ~d~~~~~~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~Tp  107 (300)
T PHA02884         28 KNKICIANILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITP  107 (300)
T ss_pred             cCcCCCCHHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCH
Confidence            3444444 5677777799999999999999999984    589999999999999999999999999999974 689999


Q ss_pred             cccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981          110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       110 l~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      +|.|+..++.+++++|+..|+++........+|
T Consensus       108 Lh~Aa~~~~~eivklLL~~GAdin~kd~~G~Tp  140 (300)
T PHA02884        108 LYISVLHGCLKCLEILLSYGADINIQTNDMVTP  140 (300)
T ss_pred             HHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            999999999999999999999887665444444

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.74  E-value=2.7e-18  Score=146.43  Aligned_cols=119  Identities=30%  Similarity=0.246  Sum_probs=106.3

Q ss_pred             cccccccccCchhh-hhhhhhcCCCCCCCCCCcchHHHHHHHc-----CCHHHHHHHHHcCCCCcccC-CCCCCHHHHHH
Q 020981            9 TTLLKQSSLAPDRE-RKEAELNGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRD-IDNRTALHVAA   81 (319)
Q Consensus         9 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~t~L~~a~~~-----~~~~~~~~Ll~~ga~vn~~d-~~g~tpLh~A~   81 (319)
                      |+||-+.+-.+... .--++...+|+|.++.-|+||.++||..     .+.++|+.|++.| |||++- ..|+|+||+|+
T Consensus       270 TALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mg-nVNaKAsQ~gQTALMLAV  348 (452)
T KOG0514|consen  270 TALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMG-DVNAKASQHGQTALMLAV  348 (452)
T ss_pred             eeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhcc-Ccchhhhhhcchhhhhhh
Confidence            67888888877444 3456678899999999999999999984     6689999999987 999987 46999999999


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhh
Q 020981           82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      .+|+.++|+.||..|||+|++|.+|.|+|+.|+.+|++||+++|+..
T Consensus       349 SHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~  395 (452)
T KOG0514|consen  349 SHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAV  395 (452)
T ss_pred             hcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhcc
Confidence            99999999999999999999999999999999999999999999974

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.74  E-value=6.4e-18  Score=159.39  Aligned_cols=105  Identities=21%  Similarity=0.268  Sum_probs=51.3

Q ss_pred             hcCCCCCCCCCCcchHHHHHHHc---CCHHHHHHHHHcCCCC-cccCCCCCCHHHHHHHc--CCHHHHHHhhhCCCcccC
Q 020981           28 LNGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDV-NFRDIDNRTALHVAACQ--GFTEVVSLLLERGADVDP  101 (319)
Q Consensus        28 ~~~~~~~~~~~~~~t~L~~a~~~---~~~~~~~~Ll~~ga~v-n~~d~~g~tpLh~A~~~--~~~~~v~~Ll~~g~~~~~  101 (319)
                      -+|+|+|.++..|.||||.|+..   |+.+++++|+++|||+ +.+|..|+||||+|+..  ++.++|++|+++|++++.
T Consensus        96 ~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~  175 (494)
T PHA02989         96 KFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE  175 (494)
T ss_pred             HCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence            34555555555555555544432   3445555555555555 44555555555554432  344555555555555554


Q ss_pred             -CCCCCCCCccccccc----ccHHHHHHHHhhCCCC
Q 020981          102 -KDRWGSTPLGDAIYY----KNHEVIKLLEKHGAKP  132 (319)
Q Consensus       102 -~~~~g~tpl~~a~~~----~~~~i~~~L~~~g~~~  132 (319)
                       .+..|.||+|.|+..    ++.+++++|++.|++.
T Consensus       176 ~~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~v  211 (494)
T PHA02989        176 KTSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNI  211 (494)
T ss_pred             cccccCCChHHHHHhcccccccHHHHHHHHhCCCCc
Confidence             344555555544332    2445555555555443

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.74  E-value=2.1e-18  Score=118.75  Aligned_cols=102  Identities=21%  Similarity=0.194  Sum_probs=88.5

Q ss_pred             cccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHH
Q 020981           11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS   90 (319)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~   90 (319)
                      ..|+.+.+..-+.+..-..|.|+|..- .|.||||+||-.|.++++++|++-||+|+.+|++|-|||.-|++.||.++|+
T Consensus         6 ~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVk   84 (117)
T KOG4214|consen    6 VAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVK   84 (117)
T ss_pred             HhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHH
Confidence            567788887777777777777887765 8999999999999999999999999999999999999999999999999999


Q ss_pred             HhhhCCCcccCCCCCCCCCcccc
Q 020981           91 LLLERGADVDPKDRWGSTPLGDA  113 (319)
Q Consensus        91 ~Ll~~g~~~~~~~~~g~tpl~~a  113 (319)
                      +|+++||+-..+..+|.+.+..+
T Consensus        85 lLL~~GAdrt~~~PdG~~~~eat  107 (117)
T KOG4214|consen   85 LLLQNGADRTIHAPDGTALIEAT  107 (117)
T ss_pred             HHHHcCcccceeCCCchhHHhhc
Confidence            99999999888888888776644

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.74  E-value=6.2e-18  Score=165.57  Aligned_cols=129  Identities=31%  Similarity=0.302  Sum_probs=107.1

Q ss_pred             ccccccccccCch-hhhhhhhhcCCCCCCCCCCcchHHHHHHHcC-CHHHHHHHHHcCCCCcccCCCCCCHHHHHHHc-C
Q 020981            8 RTTLLKQSSLAPD-RERKEAELNGLDDDGEEIKPEFRLMFLANER-DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-G   84 (319)
Q Consensus         8 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~-~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~-~   84 (319)
                      .|||+.|++.++. ...+...-.|.|+|.++.+|.||||+|+..| +.++++.|+..|+++|.+|..|+||||+|+.. +
T Consensus       274 ~TpLh~Aa~~~~~~~iv~lLl~~gadin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~  353 (682)
T PHA02876        274 NTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDR  353 (682)
T ss_pred             CCHHHHHHhCCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCC
Confidence            5888888887774 3455555678889999999999999999888 58888888888999988888888999888875 4


Q ss_pred             CHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      +.+++++|++.|++++.+|..|.||||+|+..++.++++.|++.|++.....
T Consensus       354 ~~~iv~lLl~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~  405 (682)
T PHA02876        354 NKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALS  405 (682)
T ss_pred             cHHHHHHHHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccC
Confidence            7888888888899998888889999999888888888888888888765443

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.73  E-value=8.1e-18  Score=158.71  Aligned_cols=135  Identities=16%  Similarity=0.150  Sum_probs=97.6

Q ss_pred             cccccccc---ccCchhhhhhhhhcCCCC-CCCCCCcchHHHHHHHc--CCHHHHHHHHHcCCCCcc-cCCCCCCHHHHH
Q 020981            8 RTTLLKQS---SLAPDRERKEAELNGLDD-DGEEIKPEFRLMFLANE--RDVEGIKELLDSGIDVNF-RDIDNRTALHVA   80 (319)
Q Consensus         8 ~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~t~L~~a~~~--~~~~~~~~Ll~~ga~vn~-~d~~g~tpLh~A   80 (319)
                      .|||+.|+   ..++....+-..-+|+|+ +..+..|+||||+|+..  ++.++++.|+++|||+|. .+..|.||||+|
T Consensus       109 ~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~~~~~g~tpL~~a  188 (494)
T PHA02989        109 VSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEKTSLYGLTPMNIY  188 (494)
T ss_pred             CcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccccccCCChHHHH
Confidence            45665433   334455556666678888 78888888888887654  578888888888888887 577788888888


Q ss_pred             HHcC----CHHHHHHhhhCCCcccC--------------------------------------CCCCCCCCccccccccc
Q 020981           81 ACQG----FTEVVSLLLERGADVDP--------------------------------------KDRWGSTPLGDAIYYKN  118 (319)
Q Consensus        81 ~~~~----~~~~v~~Ll~~g~~~~~--------------------------------------~~~~g~tpl~~a~~~~~  118 (319)
                      +..+    +.+++++|+++|++++.                                      +|..|+||||+|+..++
T Consensus       189 ~~~~~~~~~~~iv~~Ll~~Ga~vn~~~~~~~t~l~~~~~~~~~~~~~~~~il~~l~~~advn~~d~~G~TpL~~Aa~~~~  268 (494)
T PHA02989        189 LRNDIDVISIKVIKYLIKKGVNIETNNNGSESVLESFLDNNKILSKKEFKVLNFILKYIKINKKDKKGFNPLLISAKVDN  268 (494)
T ss_pred             HhcccccccHHHHHHHHhCCCCccccCCccccHHHHHHHhchhhcccchHHHHHHHhCCCCCCCCCCCCCHHHHHHHhcC
Confidence            7654    77888888887776543                                      34558888888888888


Q ss_pred             HHHHHHHHhhCCCCCCcccccccc
Q 020981          119 HEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       119 ~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      .+++++|++.|+++...+....++
T Consensus       269 ~~~v~~LL~~Gadin~~d~~G~Tp  292 (494)
T PHA02989        269 YEAFNYLLKLGDDIYNVSKDGDTV  292 (494)
T ss_pred             HHHHHHHHHcCCCccccCCCCCCH
Confidence            888888888888776555444333

>PHA02917 ankyrin-like protein; Provisional

Probab=99.73  E-value=7.1e-18  Score=162.37  Aligned_cols=134  Identities=25%  Similarity=0.247  Sum_probs=103.6

Q ss_pred             cccccccccc---CchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcC---------------------------------
Q 020981            8 RTTLLKQSSL---APDRERKEAELNGLDDDGEEIKPEFRLMFLANER---------------------------------   51 (319)
Q Consensus         8 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~---------------------------------   51 (319)
                      .||||.|+..   ++....+-..-.|+|++.++..|.||||+|+..|                                 
T Consensus        33 ~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~~~~~~~~~~a~~  112 (661)
T PHA02917         33 NNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNINDFNIFSYMKSK  112 (661)
T ss_pred             CcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCCCCcchHHHHHhh
Confidence            5788876444   5577777777788888888888888888777643                                 


Q ss_pred             --CHHHHHHHHHcCCCCcccCCCCCCHHHHHH--HcCCHHHHHHhhhCCCcccCCCC---CC-----------CCCcccc
Q 020981           52 --DVEGIKELLDSGIDVNFRDIDNRTALHVAA--CQGFTEVVSLLLERGADVDPKDR---WG-----------STPLGDA  113 (319)
Q Consensus        52 --~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~--~~~~~~~v~~Ll~~g~~~~~~~~---~g-----------~tpl~~a  113 (319)
                        +.++|++|+++|||+|.+|.+|+||||+|+  ..|+.++|++|+++||+++.+|.   .|           .||||+|
T Consensus       113 ~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~~~g~~~~~~~~~~~~t~L~~a  192 (661)
T PHA02917        113 NVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDDEYGYAYDDYQPRNCGTVLHLY  192 (661)
T ss_pred             cCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccccccccccccccccccccccHHHHH
Confidence              467788888999999999999999998544  46899999999999999986653   34           4999988


Q ss_pred             cc-----------cccHHHHHHHHhhCCCCCCccccccc
Q 020981          114 IY-----------YKNHEVIKLLEKHGAKPLMAPMHVKH  141 (319)
Q Consensus       114 ~~-----------~~~~~i~~~L~~~g~~~~~~~~~~~~  141 (319)
                      +.           .++.+++++|+++|++....+....+
T Consensus       193 ~~~~~~~~~~~~~~~~~eiv~~Li~~Gadvn~~d~~G~T  231 (661)
T PHA02917        193 IISHLYSESDTRAYVRPEVVKCLINHGIKPSSIDKNYCT  231 (661)
T ss_pred             HhhcccccccccccCcHHHHHHHHHCCCCcccCCCCCCc
Confidence            64           45788999999999887665544333

>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]

Probab=99.73  E-value=9.9e-19  Score=139.43  Aligned_cols=120  Identities=22%  Similarity=0.155  Sum_probs=113.1

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      -|||+|||+.|+..-.....-.|+|++....+-.|+|.+|+..|..++|+.||+++.|||.-|-+|-|||-||++.|+.+
T Consensus       161 fTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAvrgnhvk  240 (296)
T KOG0502|consen  161 FTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYAVRGNHVK  240 (296)
T ss_pred             chHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeeeecCChHH
Confidence            48999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhh
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      +|+.|+..||+++..++.|.+++..|...|+. +++.+++.
T Consensus       241 cve~Ll~sGAd~t~e~dsGy~~mdlAValGyr-~Vqqvie~  280 (296)
T KOG0502|consen  241 CVESLLNSGADVTQEDDSGYWIMDLAVALGYR-IVQQVIEK  280 (296)
T ss_pred             HHHHHHhcCCCcccccccCCcHHHHHHHhhhH-HHHHHHHH
Confidence            99999999999999999999999999999988 55544443

>PHA02730 ankyrin-like protein; Provisional

Probab=99.73  E-value=6.8e-18  Score=159.37  Aligned_cols=112  Identities=17%  Similarity=0.110  Sum_probs=59.7

Q ss_pred             hhhhhhhhcCCCCCCCCCCcchHHHHHHHcCC----HHHHHHHHHcCC--CCcccCCCCCCHHHH---HHHcC-------
Q 020981           21 RERKEAELNGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGI--DVNFRDIDNRTALHV---AACQG-------   84 (319)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~----~~~~~~Ll~~ga--~vn~~d~~g~tpLh~---A~~~~-------   84 (319)
                      ...+-+..+|+|+|.. ..|.||||+|+..++    .++++.|+++||  |+|.+|.+|+||||.   |...+       
T Consensus       360 eIvelLIs~GAdIN~k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e  438 (672)
T PHA02730        360 PILRCMLDNGATMDKT-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYE  438 (672)
T ss_pred             HHHHHHHHCCCCCCcC-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccc
Confidence            3344444455555553 455566665555543    555666665554  455555555665552   22221       


Q ss_pred             --CHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCC
Q 020981           85 --FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (319)
Q Consensus        85 --~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~  133 (319)
                        ..+++++|+++||++|.+|..|+||||+|+..++.+++++|++.|++..
T Consensus       439 ~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN  489 (672)
T PHA02730        439 TILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVN  489 (672)
T ss_pred             hhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCC
Confidence              1234555555565566555556666665555555555555555555543

>PHA02917 ankyrin-like protein; Provisional

Probab=99.72  E-value=7.5e-18  Score=162.22  Aligned_cols=121  Identities=21%  Similarity=0.135  Sum_probs=102.2

Q ss_pred             cccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHH--HcCCHHHHHHHHHcCCCCcccCC---CC-----------C
Q 020981           11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLA--NERDVEGIKELLDSGIDVNFRDI---DN-----------R   74 (319)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~--~~~~~~~~~~Ll~~ga~vn~~d~---~g-----------~   74 (319)
                      +..|+..++....+-+..+|+|+|.+|.+|.||||.|+  ..|+.+++++|+++|||+|.+|.   .|           .
T Consensus       107 ~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~~~g~~~~~~~~~~~~  186 (661)
T PHA02917        107 SYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDDEYGYAYDDYQPRNCG  186 (661)
T ss_pred             HHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccccccccccccccccccccc
Confidence            34555566666666677799999999999999999654  47899999999999999997764   34           5


Q ss_pred             CHHHHHHH-----------cCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccH--HHHHHHHhhCCCC
Q 020981           75 TALHVAAC-----------QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH--EVIKLLEKHGAKP  132 (319)
Q Consensus        75 tpLh~A~~-----------~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~--~i~~~L~~~g~~~  132 (319)
                      ||||+|+.           .++.++|++|+++||++|.+|..|.||||+|+..|+.  ++++.|++ |++.
T Consensus       187 t~L~~a~~~~~~~~~~~~~~~~~eiv~~Li~~Gadvn~~d~~G~TpLh~A~~~g~~~~eivk~Li~-g~d~  256 (661)
T PHA02917        187 TVLHLYIISHLYSESDTRAYVRPEVVKCLINHGIKPSSIDKNYCTALQYYIKSSHIDIDIVKLLMK-GIDN  256 (661)
T ss_pred             cHHHHHHhhcccccccccccCcHHHHHHHHHCCCCcccCCCCCCcHHHHHHHcCCCcHHHHHHHHh-CCcc
Confidence            99999986           5689999999999999999999999999999999875  79999975 6543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.72  E-value=4.7e-17  Score=145.24  Aligned_cols=140  Identities=24%  Similarity=0.366  Sum_probs=116.0

Q ss_pred             cccceeeeecceEEEEEEe------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC----CCcccccceeE-EeCCc
Q 020981          156 DFTNSVEITKGTFILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAV-TQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~----h~~iv~l~~~~-~~~~~  224 (319)
                      .|.....||+|+||.+|..      ...+|+|..........   ..+..|..++..+.    .+++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            6888999999999999852      24689998765322111   15667888888886    36899999988 57788


Q ss_pred             eEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC-----CCEEEEec
Q 020981          225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-----GNLKVADF  297 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~DF  297 (319)
                      .|+||+.+ |.+|.++....  +.++..++.+++.|++.+|++||+.|   ++||||||+|+++...     ..+.|.||
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence            99999988 89999988654  46999999999999999999999999   9999999999999865     46999999


Q ss_pred             Ccccc
Q 020981          298 GVSKL  302 (319)
Q Consensus       298 gla~~  302 (319)
                      |+|+.
T Consensus       172 Glar~  176 (322)
T KOG1164|consen  172 GLARR  176 (322)
T ss_pred             CCCcc
Confidence            99993

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=4e-17  Score=135.56  Aligned_cols=138  Identities=20%  Similarity=0.115  Sum_probs=104.2

Q ss_pred             ccceeeeecceEEEEEE----eceEeEEEEecccccCCH-------------------HHHHHHHHHHHHHHhcCCCc--
Q 020981          157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-------------------DRVRAFRDELALLQKIRHPN--  211 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~~--  211 (319)
                      +.....||.|+|+.+|.    +|+.+|||++........                   ........|+.++..+.+++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            44556799999998873    478999998764321000                   11123567899999987764  


Q ss_pred             ccccceeEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC
Q 020981          212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       212 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      +++.++    ....+++|||++|++|......      .....++.+++.++.++|+.+   ++||||||+||++++++.
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence            444443    2456899999999998765331      335678899999999999998   999999999999999999


Q ss_pred             EEEEecCcccccccCC
Q 020981          292 LKVADFGVSKLLTVKE  307 (319)
Q Consensus       292 ~kl~DFgla~~~~~~~  307 (319)
                      ++|+|||++.....+.
T Consensus       164 ~~liDfg~~~~~~~~~  179 (198)
T cd05144         164 IYIIDWPQMVSTDHPN  179 (198)
T ss_pred             EEEEECCccccCCCcc
Confidence            9999999997766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PHA02795 ankyrin-like protein; Provisional

Probab=99.72  E-value=1.2e-17  Score=150.77  Aligned_cols=134  Identities=17%  Similarity=0.012  Sum_probs=117.6

Q ss_pred             cccccccccc--cCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccC------CCCCCHHH
Q 020981            7 VRTTLLKQSS--LAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD------IDNRTALH   78 (319)
Q Consensus         7 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d------~~g~tpLh   78 (319)
                      ..|+||-++.  .++....+-...+|+|+|..  ++.||||.|+..|+.+++++|+++||+.+...      ..|.||+|
T Consensus       116 ~~~~L~~~~~n~~n~~eiV~~LI~~GADIn~~--~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~  193 (437)
T PHA02795        116 VQDLLLYYLSNAYVEIDIVDFMVDHGAVIYKI--ECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGF  193 (437)
T ss_pred             ccHHHHHHHHhcCCCHHHHHHHHHCCCCCCCC--CCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhH
Confidence            4788888888  88888889999999999985  45899999999999999999999998543332      34889999


Q ss_pred             HHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           79 VAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        79 ~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      .|+..++.+++++|+++||++|.+|..|.||||+|+..|+.+++++|++.|++.......+.++
T Consensus       194 ~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~Tp  257 (437)
T PHA02795        194 LVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTC  257 (437)
T ss_pred             HHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence            9999999999999999999999999999999999999999999999999999887665444443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=1.2e-16  Score=136.14  Aligned_cols=136  Identities=21%  Similarity=0.228  Sum_probs=105.8

Q ss_pred             eeeecceEEEEEEeceEeEEEEeccccc----------CCHHHHHHHHHHHHHHHhcCCCcc--cccceeEEeCC----c
Q 020981          161 VEITKGTFILAFWRGIQVAVKKLGEEVI----------SDDDRVRAFRDELALLQKIRHPNV--VQFLGAVTQSS----P  224 (319)
Q Consensus       161 ~~ig~G~f~~v~~~~~~vAvK~l~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~~----~  224 (319)
                      +..|.|+++.++..+..++||.......          .+......+.+|+.++..+.|+++  ++.++....+.    .
T Consensus        41 ~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~  120 (239)
T PRK01723         41 SAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYR  120 (239)
T ss_pred             cCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCccee
Confidence            4678899999988899999998754211          112334567889999999998775  66666543322    2


Q ss_pred             eEEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .++|||+++| .+|.+++.. .++++.    .+.|++.+|.+||++|   |+||||||+|||++.++.++|+|||.++..
T Consensus       121 ~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        121 ADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             eeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            3599999997 689888765 345543    3578999999999999   999999999999999899999999999886


Q ss_pred             c
Q 020981          304 T  304 (319)
Q Consensus       304 ~  304 (319)
                      .
T Consensus       193 ~  193 (239)
T PRK01723        193 T  193 (239)
T ss_pred             C
Confidence            5

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.72  E-value=2e-17  Score=144.53  Aligned_cols=137  Identities=23%  Similarity=0.423  Sum_probs=119.3

Q ss_pred             cccceeeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceE
Q 020981          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~  226 (319)
                      .|....+||.|+|+.|+.        ..+.||+|.+..-  +.+   ..+.+|+++|..+. +.||+++.+++..++...
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCc---hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            567778999999998873        4678999988643  233   45778999999996 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLL  303 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgla~~~  303 (319)
                      +|+||++.....++...   ++...+..+++.++.||.++|++|   ||||||||+|+|.+ ..+.-.|+|||||..+
T Consensus       112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHH
Confidence            99999999998888765   678889999999999999999999   99999999999998 4577899999999843

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.70  E-value=2.6e-17  Score=161.47  Aligned_cols=135  Identities=32%  Similarity=0.351  Sum_probs=102.3

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHH
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV   88 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~   88 (319)
                      ||++-+++.++........-.+...+.....|.|+||.|+..+.+.+++.++++|++++.++.+|.||||+||..|+.++
T Consensus       476 T~Lhlaaq~Gh~~~~~llle~~~~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~  555 (1143)
T KOG4177|consen  476 TPLHLAAQEGHTEVVQLLLEGGANDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDL  555 (1143)
T ss_pred             cchhhhhccCCchHHHHhhhcCCccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchH
Confidence            44444444444443333333344444444455555555555555555566667788899999999999999999999999


Q ss_pred             HHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccC
Q 020981           89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR  143 (319)
Q Consensus        89 v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~  143 (319)
                      |++|+++|||++.+++.|+||||.|+..|+.+++.+|+++|+.+........++.
T Consensus       556 VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~TpL  610 (1143)
T KOG4177|consen  556 VKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADLDGFTPL  610 (1143)
T ss_pred             HHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccccCcchh
Confidence            9999999999999999999999999999999999999999999877665555543

>PHA02730 ankyrin-like protein; Provisional

Probab=99.70  E-value=4.5e-17  Score=153.91  Aligned_cols=216  Identities=13%  Similarity=0.079  Sum_probs=143.7

Q ss_pred             cccccccccccCc----hhhhhhhhhcCC--CCCCCCCCcchHHHH---HHHcC---------CHHHHHHHHHcCCCCcc
Q 020981            7 VRTTLLKQSSLAP----DRERKEAELNGL--DDDGEEIKPEFRLMF---LANER---------DVEGIKELLDSGIDVNF   68 (319)
Q Consensus         7 ~~~~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~~t~L~~---a~~~~---------~~~~~~~Ll~~ga~vn~   68 (319)
                      -.|||+.|+....    ....+-+..+|.  |+|.++.+|.||||.   |+..+         ..+++++|+++|||+|+
T Consensus       378 G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ivk~LIs~GADINa  457 (672)
T PHA02730        378 NNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILIDVFDILSKYMDDIDM  457 (672)
T ss_pred             CCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHHHHHHHHhcccchhc
Confidence            3689998888774    455555555776  799999999999984   33332         23679999999999999


Q ss_pred             cCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCC-CCCCCccccccc--ccHHHHHHHHhhCCCCCCccccccccCCC
Q 020981           69 RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYY--KNHEVIKLLEKHGAKPLMAPMHVKHAREV  145 (319)
Q Consensus        69 ~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~-~g~tpl~~a~~~--~~~~i~~~L~~~g~~~~~~~~~~~~~~~~  145 (319)
                      +|..|+||||+|+..++.+++++|+++||+++.+|. .|.||+|.|+..  ++.+++++|+++|++...-......  . 
T Consensus       458 kD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~~~g~TaL~~Aa~~~~~~~eIv~~LLs~ga~i~~I~~Tf~~--~-  534 (672)
T PHA02730        458 IDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSRSIINTAIQKSSYRRENKTKLVDLLLSYHPTLETMIDAFNR--D-  534 (672)
T ss_pred             cCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCCcCCcCHHHHHHHhhcCcHHHHHHHHHcCCCHHHHHHHHHh--h-
Confidence            999999999999999999999999999999999997 699999999874  7899999999999765211100000  0 


Q ss_pred             CccccCCCcccccceeeee---cceEEEEEEeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC
Q 020981          146 PEYEIDPHELDFTNSVEIT---KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig---~G~f~~v~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  222 (319)
                               ..|...+.+.   .-.|-.   .  +.--+.+................|+..|+...=.+. .+++++...
T Consensus       535 ---------~~~~~~k~ik~~I~Y~f~l---d--p~~y~~~~~~ii~~~~~I~~ckkei~~Mk~~~i~~~-Svydiif~~  599 (672)
T PHA02730        535 ---------IRYLYPEPLLACIRYALIL---D--NDFPSKVKYDIAGRHKELKRYRADINRMKNAYISGV-SMFDILFKR  599 (672)
T ss_pred             ---------HHhhHHHHHHHHHHHHHhc---C--hhhhhhhhhHHhhChHHHHHHHHHHHHHHhhhcCCc-eeEeEeecc
Confidence                     0010000000   000000   0  000010011111123445666788888888765554 788877765


Q ss_pred             CceEEEEeecCCCCHHHHH
Q 020981          223 SPMMIVTEYLPKGDLRAFL  241 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l  241 (319)
                      +. .+...|+....+..++
T Consensus       600 n~-~~~~ry~~n~~~~k~~  617 (672)
T PHA02730        600 NR-RHRLRYAKNPTFINFV  617 (672)
T ss_pred             CC-cccceeecChHHHHHH
Confidence            44 3445777666666654

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.68  E-value=4.7e-17  Score=151.56  Aligned_cols=126  Identities=27%  Similarity=0.240  Sum_probs=109.8

Q ss_pred             ccccccccccCchhhhhhhhhcC---------------CCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCC
Q 020981            8 RTTLLKQSSLAPDRERKEAELNG---------------LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID   72 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~   72 (319)
                      .||||-|+..++....+...-++               .-+|..|.+|.||||+||+.|+.++++.|+..||++|.++.+
T Consensus       226 ~~pLhlAve~g~~e~lk~~L~n~~~~a~~~~~~~~q~kelv~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d  305 (929)
T KOG0510|consen  226 ATPLHLAVEGGDIEMLKMCLQNGKKIADVQLDAMQQEKELVNDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKD  305 (929)
T ss_pred             CcchhhhhhcCCHHHHHHHHhCccccchhhhHHHHHHHHHhhcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCC
Confidence            46788888877765554443332               234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCHHHHHHhhh-CC-CcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCC
Q 020981           73 NRTALHVAACQGFTEVVSLLLE-RG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (319)
Q Consensus        73 g~tpLh~A~~~~~~~~v~~Ll~-~g-~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~  133 (319)
                      +.||||.||+.|+.+.|+-|++ .| ...|..|-.|.||+|+|+..|+..+++.|+..|+...
T Consensus       306 ~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~  368 (929)
T KOG0510|consen  306 EESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFL  368 (929)
T ss_pred             CCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhh
Confidence            9999999999999999999998 44 6788999999999999999999999999999998776

>PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A

Probab=99.68  E-value=1.1e-17  Score=108.83  Aligned_cols=55  Identities=53%  Similarity=0.668  Sum_probs=21.4

Q ss_pred             HHHcC-CCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccc
Q 020981           59 LLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA  113 (319)
Q Consensus        59 Ll~~g-a~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a  113 (319)
                      ||++| +++|.+|..|.||||+||+.|+.++|++|++.|++++.+|..|+||+|+|
T Consensus         1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A   56 (56)
T PF13857_consen    1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA   56 (56)
T ss_dssp             -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred             CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence            45555 56666666666666666666666666666666666666666666666554

>PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A

Probab=99.67  E-value=1.1e-16  Score=103.58  Aligned_cols=54  Identities=39%  Similarity=0.524  Sum_probs=46.6

Q ss_pred             cchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhh
Q 020981           40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL   93 (319)
Q Consensus        40 ~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll   93 (319)
                      |.||||+||..|+.+++++|++.|+|+|.+|.+|+||||+|++.|+.+++++|+
T Consensus         1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll   54 (54)
T PF13637_consen    1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL   54 (54)
T ss_dssp             SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred             CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence            789999999999999999999999999999999999999999999999999986

...

>PHA02792 ankyrin-like protein; Provisional

Probab=99.67  E-value=8.2e-17  Score=150.65  Aligned_cols=123  Identities=15%  Similarity=0.082  Sum_probs=104.2

Q ss_pred             ccccccccCchhhhhhhhhcCCCCCCCCCCc--chHHHHHHHcCCH---HHHHHHHHcCCCCcccCCCCCCHHHHHHHcC
Q 020981           10 TLLKQSSLAPDRERKEAELNGLDDDGEEIKP--EFRLMFLANERDV---EGIKELLDSGIDVNFRDIDNRTALHVAACQG   84 (319)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~t~L~~a~~~~~~---~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~   84 (319)
                      +++.|+..++....+-+..+|+|+|.+|.+|  .||||+|+..+..   ++++.|+++|||+|.+|..|+||||+|+..+
T Consensus       342 ~~~~Aa~~gn~eIVelLIs~GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~  421 (631)
T PHA02792        342 KYFQKFDNRDPKVVEYILKNGNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESH  421 (631)
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcC
Confidence            3666777777777788888999999998875  6999998887664   4688999999999999999999999999999


Q ss_pred             CHHHHHHhhhCCCcccCCCCCCCCCcccccc---c-------ccHHHHHHHHhhCCCC
Q 020981           85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIY---Y-------KNHEVIKLLEKHGAKP  132 (319)
Q Consensus        85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~---~-------~~~~i~~~L~~~g~~~  132 (319)
                      +.+++++|+++|++++.+|..|.||+++|..   .       ...++++++++.+.+.
T Consensus       422 n~eivelLLs~GADIN~kD~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i  479 (631)
T PHA02792        422 SVSLVEWLIDNGADINITTKYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTI  479 (631)
T ss_pred             CHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCCh
Confidence            9999999999999999999999999999875   1       2245677888777554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.67  E-value=2.2e-15  Score=133.24  Aligned_cols=148  Identities=32%  Similarity=0.554  Sum_probs=125.9

Q ss_pred             ccceeeeecceEEEEEEe--ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-cccccceeEEeCCceEEEEeecC
Q 020981          157 FTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      |.....+|.|+|+.++..  ...+++|.+.............+.+|...++.+.|+ +++++++.+......+++++++.
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            455677889999877643  256899998876554444567888999999999988 79999999977777899999999


Q ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEecCcccccccCC
Q 020981          234 KGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE  307 (319)
Q Consensus       234 ~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DFgla~~~~~~~  307 (319)
                      ++++.+++....   .++......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||+++.+....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999998877764   6899999999999999999999999   99999999999999988 79999999998665554

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=5.6e-16  Score=127.35  Aligned_cols=137  Identities=23%  Similarity=0.216  Sum_probs=95.6

Q ss_pred             eeeecceEEEEEE----eceEeEEEEecccccCCHHHHHH---------------------HHHHHHHHHhcCCCc--cc
Q 020981          161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRA---------------------FRDELALLQKIRHPN--VV  213 (319)
Q Consensus       161 ~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~~--iv  213 (319)
                      ..+|+|+||.+|.    .+++||||++.............                     ...|...+..+.+..  ++
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            4689999998885    48899999987543221111111                     134666666665432  34


Q ss_pred             ccceeEEeCCceEEEEeecCCCCHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCC
Q 020981          214 QFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       214 ~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      +.++.    ...+++|||++++.+.. .+.... . ...+..++.+++.++.++|. .+   ++|+||||+||+++ ++.
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCc
Confidence            44432    24689999998854321 122111 1 15678899999999999999 88   99999999999999 899


Q ss_pred             EEEEecCcccccccCC
Q 020981          292 LKVADFGVSKLLTVKE  307 (319)
Q Consensus       292 ~kl~DFgla~~~~~~~  307 (319)
                      ++|+|||.+.....+.
T Consensus       153 ~~liDfg~a~~~~~~~  168 (187)
T cd05119         153 VYIIDVPQAVEIDHPN  168 (187)
T ss_pred             EEEEECcccccccCcc
Confidence            9999999998776643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms]

Probab=99.67  E-value=9.8e-17  Score=143.43  Aligned_cols=131  Identities=30%  Similarity=0.278  Sum_probs=94.0

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCC---c------------------
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV---N------------------   67 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~v---n------------------   67 (319)
                      |++|+++--.+....+...-+|+++|.+|..|+||||.|+..|+..++++|+++||++   |                  
T Consensus        75 Talhq~~id~~~e~v~~l~e~ga~Vn~~d~e~wtPlhaaascg~~~i~~~li~~gA~~~avNsdg~~P~dl~e~ea~~~~  154 (527)
T KOG0505|consen   75 TALHQACIDDNLEMVKFLVENGANVNAQDNEGWTPLHAAASCGYLNIVEYLIQHGANLLAVNSDGNMPYDLAEDEATLDV  154 (527)
T ss_pred             hhHHHHHhcccHHHHHHHHHhcCCccccccccCCcchhhcccccHHHHHHHHHhhhhhhhccCCCCCccccccCcchhHH
Confidence            5666666666666666666677777777777777777777777777777777666641   1                  


Q ss_pred             --------------------------------------ccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCC
Q 020981           68 --------------------------------------FRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (319)
Q Consensus        68 --------------------------------------~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tp  109 (319)
                                                            .++..|-|+||.|+.+|..++.++|+++|.+++++|.+||||
T Consensus       155 l~~~~~r~gi~iea~R~~~e~~ml~D~~q~l~~G~~~d~~~~rG~T~lHvAaa~Gy~e~~~lLl~ag~~~~~~D~dgWtP  234 (527)
T KOG0505|consen  155 LETEMARQGIDIEAARKAEEQTMLDDARQWLNAGAELDARHARGATALHVAAANGYTEVAALLLQAGYSVNIKDYDGWTP  234 (527)
T ss_pred             HHHHHHHhcccHHHHhhhhHHHHHHHHHHHHhccccccccccccchHHHHHHhhhHHHHHHHHHHhccCcccccccCCCc
Confidence                                                  223346777777777777777777777777888888888888


Q ss_pred             cccccccccHHHHHHHHhhCCCCCCccccc
Q 020981          110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (319)
Q Consensus       110 l~~a~~~~~~~i~~~L~~~g~~~~~~~~~~  139 (319)
                      +|.|+.+|..+++++|..+|++..+.....
T Consensus       235 lHAAA~Wg~~~~~elL~~~ga~~d~~t~~g  264 (527)
T KOG0505|consen  235 LHAAAHWGQEDACELLVEHGADMDAKTKMG  264 (527)
T ss_pred             ccHHHHhhhHhHHHHHHHhhcccchhhhcC
Confidence            888888888888888888888765444333

>KOG1710 consensus MYND Zn-finger and ankyrin repeat protein [General function prediction only]

Probab=99.67  E-value=5.7e-17  Score=134.28  Aligned_cols=123  Identities=22%  Similarity=0.192  Sum_probs=109.5

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcc-cCCCCCCHHHHHHHcCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF-RDIDNRTALHVAACQGF   85 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~-~d~~g~tpLh~A~~~~~   85 (319)
                      +..+|.++...+...+...+.....++|..|..|+|+|..|++.|+.++|+.||++|||||. ++..+.||||+||..|+
T Consensus        12 ~~~~Lle~i~Kndt~~a~~LLs~vr~vn~~D~sGMs~LahAaykGnl~~v~lll~~gaDvN~~qhg~~YTpLmFAALSGn   91 (396)
T KOG1710|consen   12 PKSPLLEAIDKNDTEAALALLSTVRQVNQRDPSGMSVLAHAAYKGNLTLVELLLELGADVNDKQHGTLYTPLMFAALSGN   91 (396)
T ss_pred             hhhHHHHHHccCcHHHHHHHHHHhhhhhccCCCcccHHHHHHhcCcHHHHHHHHHhCCCcCcccccccccHHHHHHHcCC
Confidence            45667777777766666666666677999999999999999999999999999999999996 56779999999999999


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhC
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g  129 (319)
                      .++.++|++.|+.+...|.-|+|+-++|+..|+.+.+..+..+-
T Consensus        92 ~dvcrllldaGa~~~~vNsvgrTAaqmAAFVG~H~CV~iINN~~  135 (396)
T KOG1710|consen   92 QDVCRLLLDAGARMYLVNSVGRTAAQMAAFVGHHECVAIINNHI  135 (396)
T ss_pred             chHHHHHHhccCccccccchhhhHHHHHHHhcchHHHHHHhccc
Confidence            99999999999999999999999999999999999998877653

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.65  E-value=1.3e-16  Score=109.87  Aligned_cols=93  Identities=28%  Similarity=0.504  Sum_probs=87.0

Q ss_pred             hHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHH
Q 020981           42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV  121 (319)
Q Consensus        42 t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i  121 (319)
                      .-..|+..+|..+.|+..+..|-|||..- .|+||||+|+-.|..+++++|+..||+++.+|+.|-|||--|.+.|+.++
T Consensus         4 ~~~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~c   82 (117)
T KOG4214|consen    4 MSVAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDC   82 (117)
T ss_pred             hhHhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHH
Confidence            44789999999999999999999999664 89999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCc
Q 020981          122 IKLLEKHGAKPLMA  135 (319)
Q Consensus       122 ~~~L~~~g~~~~~~  135 (319)
                      +++|++.|++....
T Consensus        83 VklLL~~GAdrt~~   96 (117)
T KOG4214|consen   83 VKLLLQNGADRTIH   96 (117)
T ss_pred             HHHHHHcCccccee
Confidence            99999999986543

>COG0666 Arp FOG: Ankyrin repeat [General function prediction only]

Probab=99.65  E-value=5.5e-16  Score=130.59  Aligned_cols=123  Identities=33%  Similarity=0.402  Sum_probs=113.7

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCC-----HHHHHHHHHcCC---CCcccCCCCCCHHH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERD-----VEGIKELLDSGI---DVNFRDIDNRTALH   78 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~-----~~~~~~Ll~~ga---~vn~~d~~g~tpLh   78 (319)
                      ..++++.++..+...........+.|++..+.+|.||||+|+..++     .++++.|++.|+   +.+.+|.+|+||||
T Consensus        73 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~~~~~ll~~g~~~~~~~~~~~~g~tpl~  152 (235)
T COG0666          73 GRLPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADLDVNNLRDEDGNTPLH  152 (235)
T ss_pred             ccCHHHHHHHcCcHHHHHHHHHcCCCcccccCCCCcHHHHHHhcCCcccchHHHHHHHHHcCCCCCCccccCCCCCchhH
Confidence            4567777877788777778888999999999999999999999999     999999999999   56667999999999


Q ss_pred             HHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhC
Q 020981           79 VAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        79 ~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g  129 (319)
                      +|+..|+.+++++|++.|++++.++..|.||++.|+..++.++.+.+...+
T Consensus       153 ~A~~~~~~~~~~~ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~l~~~~  203 (235)
T COG0666         153 WAALNGDADIVELLLEAGADPNSRNSYGVTALDPAAKNGRIELVKLLLDKG  203 (235)
T ss_pred             HHHHcCchHHHHHHHhcCCCCcccccCCCcchhhhcccchHHHHHHHHhcC
Confidence            999999999999999999999999999999999999999999999999876

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.65  E-value=1.7e-16  Score=157.89  Aligned_cols=109  Identities=26%  Similarity=0.243  Sum_probs=97.5

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHH-------------------------------HHcCCHHH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFL-------------------------------ANERDVEG   55 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a-------------------------------~~~~~~~~   55 (319)
                      -.||||.|++.++....+-..-.|+|+|.+|.+|+||||+|                               |..|+.++
T Consensus       558 G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~~~~L~~Aa~~g~~~~  637 (823)
T PLN03192        558 GRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAGDLLCTAAKRNDLTA  637 (823)
T ss_pred             CCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccCchHHHHHHHhCCHHH
Confidence            47999999999998888888889999999999999998855                               55566677


Q ss_pred             HHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCC-CCCcccccc
Q 020981           56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG-STPLGDAIY  115 (319)
Q Consensus        56 ~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g-~tpl~~a~~  115 (319)
                      ++.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++||+++..|..| .||..++..
T Consensus       638 v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g~~t~~~l~~~  698 (823)
T PLN03192        638 MKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDDDFSPTELREL  698 (823)
T ss_pred             HHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Confidence            778899999999999999999999999999999999999999999999988 888876543

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.65  E-value=5.1e-16  Score=123.59  Aligned_cols=94  Identities=17%  Similarity=0.144  Sum_probs=84.1

Q ss_pred             cccccccccccCchh---hhhhhhhcCCCCCCCC-CCcchHHHHHHHcCCHHHHHHHHHc-CCCCcccCCCCCCHHHHHH
Q 020981            7 VRTTLLKQSSLAPDR---ERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAA   81 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~t~L~~a~~~~~~~~~~~Ll~~-ga~vn~~d~~g~tpLh~A~   81 (319)
                      -.|||+.|++.++..   ..+.....|.|+|.++ .+|+||||+|+..|+.++++.|+++ |+|+|.+|..|+||||+|+
T Consensus        55 g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL~~A~  134 (154)
T PHA02736         55 GKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVAC  134 (154)
T ss_pred             CCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHHHHHH
Confidence            368999999988753   2345566899999998 5999999999999999999999984 9999999999999999999


Q ss_pred             HcCCHHHHHHhhhCCCccc
Q 020981           82 CQGFTEVVSLLLERGADVD  100 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~  100 (319)
                      ..|+.+++++|+++|++++
T Consensus       135 ~~~~~~i~~~Ll~~ga~~~  153 (154)
T PHA02736        135 ERHDAKMMNILRAKGAQCK  153 (154)
T ss_pred             HcCCHHHHHHHHHcCCCCC
Confidence            9999999999999999865

>cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

Probab=99.63  E-value=8.9e-16  Score=116.87  Aligned_cols=95  Identities=46%  Similarity=0.623  Sum_probs=63.3

Q ss_pred             CCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCccccccc
Q 020981           37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY  116 (319)
Q Consensus        37 ~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~  116 (319)
                      +.+|.||||.|+..++.++++.|++.|++++.++..|.||||+|+..++.+++++|++.|++++..+..|.||+|.|+..
T Consensus         4 ~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~~   83 (126)
T cd00204           4 DEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARN   83 (126)
T ss_pred             CcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHc
Confidence            35566666666666666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             ccHHHHHHHHhhCCC
Q 020981          117 KNHEVIKLLEKHGAK  131 (319)
Q Consensus       117 ~~~~i~~~L~~~g~~  131 (319)
                      ++.+++++|...+.+
T Consensus        84 ~~~~~~~~L~~~~~~   98 (126)
T cd00204          84 GNLDVVKLLLKHGAD   98 (126)
T ss_pred             CcHHHHHHHHHcCCC
Confidence            666666666665533

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=1.6e-15  Score=134.88  Aligned_cols=128  Identities=27%  Similarity=0.376  Sum_probs=105.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-----C---CcccccceeEEe
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----H---PNVVQFLGAVTQ  221 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~l~~~~~~  221 (319)
                      -.|....++|.|-|+.|+.     ..+.||+|+.+..    +.-.+....|+.+|++++     |   ..||+|++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            3677888999999987763     4678999998743    233456677999999984     2   369999999854


Q ss_pred             ----CCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC
Q 020981          222 ----SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (319)
Q Consensus       222 ----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~  289 (319)
                          +.++|+|+|++ |.+|..+|+..  +.++...++.|++||+.||.|||.+.  +|||-||||+|||+...
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence                56899999999 88999999864  45999999999999999999999975  49999999999999754

>PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

Probab=99.62  E-value=1.5e-15  Score=147.22  Aligned_cols=87  Identities=44%  Similarity=0.555  Sum_probs=84.7

Q ss_pred             hHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHH
Q 020981           42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV  121 (319)
Q Consensus        42 t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i  121 (319)
                      ++|+.||..|+.+.++.|++.|+|+|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|+||||+|+..++.++
T Consensus        84 ~~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~i  163 (664)
T PTZ00322         84 VELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREV  163 (664)
T ss_pred             HHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHH
Confidence            35899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhh
Q 020981          122 IKLLEKH  128 (319)
Q Consensus       122 ~~~L~~~  128 (319)
                      +++|+.+
T Consensus       164 v~~Ll~~  170 (664)
T PTZ00322        164 VQLLSRH  170 (664)
T ss_pred             HHHHHhC
Confidence            9999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=2.4e-15  Score=118.62  Aligned_cols=133  Identities=19%  Similarity=0.175  Sum_probs=106.6

Q ss_pred             eeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCC--CcccccceeEEeCCceEEEEeecCCC
Q 020981          161 VEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       161 ~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      ..++.|.++.+|.   .+..+++|.......     ...+..|...++.+++  ..+++++.....++..+++|||++++
T Consensus         4 ~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             eecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4678888877764   446899998765422     3567889999999976  58888888887778899999999887


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      .+..+       +......++.+++.++.++|.....+++|+|++|+||++++.+.++++|||.++....
T Consensus        79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~  141 (155)
T cd05120          79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP  141 (155)
T ss_pred             ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCCh
Confidence            77654       4456677889999999999985322399999999999999989999999999986543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A

Probab=99.62  E-value=5.6e-16  Score=100.81  Aligned_cols=50  Identities=30%  Similarity=0.351  Sum_probs=33.6

Q ss_pred             CCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHH
Q 020981           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA   80 (319)
Q Consensus        31 ~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A   80 (319)
                      .|+|.+|..|+||||+||..|+.+++++|++.|+|++.+|..|+||||+|
T Consensus         7 ~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A   56 (56)
T PF13857_consen    7 ADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA   56 (56)
T ss_dssp             --TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred             CCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence            78999999999999999999999999999999999999999999999997

>KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms]

Probab=99.61  E-value=7.7e-16  Score=137.74  Aligned_cols=103  Identities=24%  Similarity=0.299  Sum_probs=92.1

Q ss_pred             cccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHH
Q 020981           11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS   90 (319)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~   90 (319)
                      ...|+..+...+.....-.|.++|-.+.+|.|+||-||...+.+||++|+++||+||.+|..||||||.|+..|+..+++
T Consensus        44 ~l~A~~~~d~~ev~~ll~~ga~~~~~n~DglTalhq~~id~~~e~v~~l~e~ga~Vn~~d~e~wtPlhaaascg~~~i~~  123 (527)
T KOG0505|consen   44 FLEACSRGDLEEVRKLLNRGASPNLCNVDGLTALHQACIDDNLEMVKFLVENGANVNAQDNEGWTPLHAAASCGYLNIVE  123 (527)
T ss_pred             HHhccccccHHHHHHHhccCCCccccCCccchhHHHHHhcccHHHHHHHHHhcCCccccccccCCcchhhcccccHHHHH
Confidence            46677777778888888889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhhCCCcccCCCCCCCCCcccc
Q 020981           91 LLLERGADVDPKDRWGSTPLGDA  113 (319)
Q Consensus        91 ~Ll~~g~~~~~~~~~g~tpl~~a  113 (319)
                      +|+++||++-..|..|..|+..+
T Consensus       124 ~li~~gA~~~avNsdg~~P~dl~  146 (527)
T KOG0505|consen  124 YLIQHGANLLAVNSDGNMPYDLA  146 (527)
T ss_pred             HHHHhhhhhhhccCCCCCccccc
Confidence            99999998888777755554433

>cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

Probab=99.60  E-value=4.6e-15  Score=112.89  Aligned_cols=119  Identities=39%  Similarity=0.427  Sum_probs=111.3

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++..........+.+.+..+..|.||||.|+..++.++++.|++.|++++..+..|.||+|+|+..++.+
T Consensus         8 ~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~~~~~~   87 (126)
T cd00204           8 RTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLD   87 (126)
T ss_pred             CCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCcHH
Confidence            47889999999987777777788888999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHH
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE  126 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~  126 (319)
                      ++++|++.|.+++..|..|.||++.|...++.+++++|+
T Consensus        88 ~~~~L~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~Ll  126 (126)
T cd00204          88 VVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL  126 (126)
T ss_pred             HHHHHHHcCCCCcccCCCCCCHHHHHHhcCCHHHHHHhC
Confidence            999999999999999999999999999999998888763

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats.

>PHA02792 ankyrin-like protein; Provisional

Probab=99.59  E-value=1.2e-15  Score=142.84  Aligned_cols=114  Identities=18%  Similarity=0.093  Sum_probs=100.5

Q ss_pred             cccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHH-cCCHHHHHHHHHcCCCCc--------------------------
Q 020981           15 SSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLAN-ERDVEGIKELLDSGIDVN--------------------------   67 (319)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~-~~~~~~~~~Ll~~ga~vn--------------------------   67 (319)
                      +..++....+-+..+|+|+|.++..|.||||+|+. .++.|++++||+.|||++                          
T Consensus        80 s~n~~lElvk~LI~~GAdvN~~~n~~~~~l~ya~~~~~~~eivk~Ll~~Gad~~~~~~~g~~~~~~~~~~~~~~~~~~~~  159 (631)
T PHA02792         80 SDNIDIELLKLLISKGLEINSIKNGINIVEKYATTSNPNVDVFKLLLDKGIPTCSNIQYGYKIIIEQITRAEYYNWDDEL  159 (631)
T ss_pred             HhcccHHHHHHHHHcCCCcccccCCCCcceeEeecCCCChHHHHHHHHCCCCcccccccCcchhhhhcccccccchhhhc
Confidence            34455677777777999999999999999999966 699999999999998732                          


Q ss_pred             ----------ccCCCCCCHHHHHHHcC-------CHHHHHHhhhCCCcccCCCCCCCCCcccccccc--cHHHHHHHHhh
Q 020981           68 ----------FRDIDNRTALHVAACQG-------FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK--NHEVIKLLEKH  128 (319)
Q Consensus        68 ----------~~d~~g~tpLh~A~~~~-------~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~--~~~i~~~L~~~  128 (319)
                                .+|..|.||||+|+..+       +.+++++|+++|++++.+|..|.||||+|+...  ..|++++|...
T Consensus       160 ~~~~~~~~i~~~~~~g~t~L~~~i~~~s~~~~~~~~~v~k~Li~~g~~~~~~d~~g~t~l~~~~~~~~i~~ei~~~L~~~  239 (631)
T PHA02792        160 DDYDYDYTTDYDDRMGKTVLYYYIITRSQDGYATSLDVINYLISHEKEMRYYTYREHTTLYYYVDKCDIKREIFDALFDS  239 (631)
T ss_pred             cccccccccccCCCCCCchHHHHHhhCCcccccCCHHHHHHHHhCCCCcCccCCCCChHHHHHHHcccchHHHHHHHHhc
Confidence                      45667999999999999       899999999999999999999999999999998  88999999874

>KOG0515 consensus p53-interacting protein 53BP/ASPP, contains ankyrin and SH3 domains [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=3.3e-15  Score=133.03  Aligned_cols=90  Identities=32%  Similarity=0.383  Sum_probs=66.0

Q ss_pred             HHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHH
Q 020981           44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK  123 (319)
Q Consensus        44 L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~  123 (319)
                      |.-|+..|.+++|+..+..--|+...|..|.||||.|+..||.+||+|||++|+|+|..|.+||||||.|+..++.-+++
T Consensus       554 LLDaaLeGEldlVq~~i~ev~DpSqpNdEGITaLHNAiCaghyeIVkFLi~~ganVNa~DSdGWTPLHCAASCNnv~~ck  633 (752)
T KOG0515|consen  554 LLDAALEGELDLVQRIIYEVTDPSQPNDEGITALHNAICAGHYEIVKFLIEFGANVNAADSDGWTPLHCAASCNNVPMCK  633 (752)
T ss_pred             HHhhhhcchHHHHHHHHHhhcCCCCCCccchhHHhhhhhcchhHHHHHHHhcCCcccCccCCCCchhhhhhhcCchHHHH
Confidence            56677777777777777766677777777777777777777777777777777777777777777777777777777777


Q ss_pred             HHHhhCCCCC
Q 020981          124 LLEKHGAKPL  133 (319)
Q Consensus       124 ~L~~~g~~~~  133 (319)
                      .|++.|+...
T Consensus       634 qLVe~Gaavf  643 (752)
T KOG0515|consen  634 QLVESGAAVF  643 (752)
T ss_pred             HHHhccceEE
Confidence            7777776543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=9.1e-15  Score=142.69  Aligned_cols=150  Identities=24%  Similarity=0.335  Sum_probs=118.1

Q ss_pred             ccccCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC---CCcccccceeE
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAV  219 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~  219 (319)
                      ..+.......|.+...+|+|+||.||+    .|+.+|+|+-++.....=...      .+++.+|+   -+.|..+..+.
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHH
Confidence            344455556788899999999999996    588999999876543321111      22333333   34566666666


Q ss_pred             EeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-------CCCE
Q 020981          220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-------SGNL  292 (319)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-------~~~~  292 (319)
                      ...+..++|+||.+-|+|.+++...+.+++..+..|+.|++..++.||..+   |||+||||+|+||..       .--+
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence            777788999999999999999998888999999999999999999999999   999999999999963       2348


Q ss_pred             EEEecCccccccc
Q 020981          293 KVADFGVSKLLTV  305 (319)
Q Consensus       293 kl~DFgla~~~~~  305 (319)
                      +|+|||.|-.+..
T Consensus       841 ~lIDfG~siDm~l  853 (974)
T KOG1166|consen  841 YLIDFGRSIDMKL  853 (974)
T ss_pred             EEEecccceeeeE
Confidence            9999999976654

>PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

Probab=99.57  E-value=5.4e-15  Score=143.29  Aligned_cols=105  Identities=25%  Similarity=0.319  Sum_probs=97.3

Q ss_pred             ccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHH
Q 020981           10 TLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV   89 (319)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v   89 (319)
                      ++..++..++....+...-.|.|+|.+|..|.||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++
T Consensus        85 ~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~iv  164 (664)
T PTZ00322         85 ELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREVV  164 (664)
T ss_pred             HHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHH
Confidence            46778888888888888889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhhC-------CCcccCCCCCCCCCccccc
Q 020981           90 SLLLER-------GADVDPKDRWGSTPLGDAI  114 (319)
Q Consensus        90 ~~Ll~~-------g~~~~~~~~~g~tpl~~a~  114 (319)
                      ++|+++       |++++..+..|.+|+..+.
T Consensus       165 ~~Ll~~~~~~~~~ga~~~~~~~~g~~~~~~~~  196 (664)
T PTZ00322        165 QLLSRHSQCHFELGANAKPDSFTGKPPSLEDS  196 (664)
T ss_pred             HHHHhCCCcccccCCCCCccccCCCCccchhh
Confidence            999998       9999999998888876544

>TIGR00870 trp transient-receptor-potential calcium channel protein

Probab=99.54  E-value=6e-15  Score=145.82  Aligned_cols=122  Identities=16%  Similarity=-0.025  Sum_probs=72.5

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCC--------------CCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEE--------------IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID   72 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~   72 (319)
                      -.||||.|+..++....+-..-+|+|+|.+.              ..|.||||+|+..|+.++++.|++.|||+|.+|..
T Consensus       128 G~TpLhlAa~~~~~eiVklLL~~GAdv~~~~~~~~~~~~~~~~~~~~g~tpL~~Aa~~~~~~iv~lLl~~gadin~~d~~  207 (743)
T TIGR00870       128 GITALHLAAHRQNYEIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLNAAACLGSPSIVALLSEDPADILTADSL  207 (743)
T ss_pred             CCcHHHHHHHhCCHHHHHHHHhCCCCCCcCcCCchhhcCCCCCcccccccHHHHHHHhCCHHHHHHHhcCCcchhhHhhh
Confidence            4566666666666666666655666665432              24666666666666666666666666666666666


Q ss_pred             CCCHHHHHHHcC---------CHHHHHHhhhCCCcc-------cCCCCCCCCCcccccccccHHHHHHHHhh
Q 020981           73 NRTALHVAACQG---------FTEVVSLLLERGADV-------DPKDRWGSTPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        73 g~tpLh~A~~~~---------~~~~v~~Ll~~g~~~-------~~~~~~g~tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      |+||||+|+..+         ...+.+++++.++..       +..|.+|.||+++|+..|+.++++.+++.
T Consensus       208 g~T~Lh~A~~~~~~~~~~~~l~~~~~~~l~~ll~~~~~~~el~~i~N~~g~TPL~~A~~~g~~~l~~lLL~~  279 (743)
T TIGR00870       208 GNTLLHLLVMENEFKAEYEELSCQMYNFALSLLDKLRDSKELEVILNHQGLTPLKLAAKEGRIVLFRLKLAI  279 (743)
T ss_pred             hhHHHHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCChHhhhhhcCCCCCCchhhhhhcCCccHHHHHHHH
Confidence            666666666654         223444454444332       44566666666666666666666666653

after chronic exposure to capsaicin. (McCleskey and Gold, 1999).

>KOG0507 consensus CASK-interacting adaptor protein (caskin) and related proteins with ankyrin repeats and SAM domain [Signal transduction mechanisms]

Probab=99.53  E-value=6.6e-15  Score=136.45  Aligned_cols=104  Identities=24%  Similarity=0.191  Sum_probs=57.6

Q ss_pred             CCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcc
Q 020981           32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG  111 (319)
Q Consensus        32 ~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~  111 (319)
                      ++|.+|.+|+|+||.||.+|+.++++.|+++.+-++..|..|.+|||+|++.|+.++|++|+.++..+|+.+..|.||+|
T Consensus        41 s~n~qd~~gfTalhha~Lng~~~is~llle~ea~ldl~d~kg~~plhlaaw~g~~e~vkmll~q~d~~na~~~e~~tplh  120 (854)
T KOG0507|consen   41 SHNLQDYSGFTLLHHAVLNGQNQISKLLLDYEALLDLCDTKGILPLHLAAWNGNLEIVKMLLLQTDILNAVNIENETPLH  120 (854)
T ss_pred             cccccCccchhHHHHHHhcCchHHHHHHhcchhhhhhhhccCcceEEehhhcCcchHHHHHHhcccCCCcccccCcCccc
Confidence            34444555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             cccccccHHHHHHHHhhCCCCCCc
Q 020981          112 DAIYYKNHEVIKLLEKHGAKPLMA  135 (319)
Q Consensus       112 ~a~~~~~~~i~~~L~~~g~~~~~~  135 (319)
                      .|+.+|+.+++.+|+.+++++.+.
T Consensus       121 laaqhgh~dvv~~Ll~~~adp~i~  144 (854)
T KOG0507|consen  121 LAAQHGHLEVVFYLLKKNADPFIR  144 (854)
T ss_pred             hhhhhcchHHHHHHHhcCCCcccc
Confidence            555555555555555555554433

>KOG0507 consensus CASK-interacting adaptor protein (caskin) and related proteins with ankyrin repeats and SAM domain [Signal transduction mechanisms]

Probab=99.53  E-value=3.5e-15  Score=138.20  Aligned_cols=121  Identities=27%  Similarity=0.164  Sum_probs=114.4

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      -|+++-|+-.++..+.+-..-...-.+..+.+|.+|||+||+.|+.+.++.|+.++..+|+.+..|.||||.|+..|+.+
T Consensus        50 fTalhha~Lng~~~is~llle~ea~ldl~d~kg~~plhlaaw~g~~e~vkmll~q~d~~na~~~e~~tplhlaaqhgh~d  129 (854)
T KOG0507|consen   50 FTLLHHAVLNGQNQISKLLLDYEALLDLCDTKGILPLHLAAWNGNLEIVKMLLLQTDILNAVNIENETPLHLAAQHGHLE  129 (854)
T ss_pred             hhHHHHHHhcCchHHHHHHhcchhhhhhhhccCcceEEehhhcCcchHHHHHHhcccCCCcccccCcCccchhhhhcchH
Confidence            46788888888888888777778888888999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhh
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      +|.+|+++|+|+-++|..+.|++.+|+++|..+++++|++.
T Consensus       130 vv~~Ll~~~adp~i~nns~~t~ldlA~qfgr~~Vvq~ll~~  170 (854)
T KOG0507|consen  130 VVFYLLKKNADPFIRNNSKETVLDLASRFGRAEVVQMLLQK  170 (854)
T ss_pred             HHHHHHhcCCCccccCcccccHHHHHHHhhhhHHHHHHhhh
Confidence            99999999999999999999999999999999999999987

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	319
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-26
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-15
4hqd_A	169	Crystal Structure Of Engineered Protein. Northeast		5e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-14
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-14
4gpm_A	169	Crystal Structure Of Engineered Protein. Northeast		8e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-13
4gmr_A	169	Crystal Structure Of Engineered Protein. Northeast		2e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-13
1n0r_A	126	4ank: A Designed Ankyrin Repeat Protein With Four I		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-13
1n0q_A	93	3ank: A Designed Ankyrin Repeat Protein With Three		3e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-13
4dui_A	169	Darpin D1 Binding To Tubulin Beta Chain (not In Com		8e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
4hb5_A	169	Crystal Structure Of Engineered Protein. Northeast		9e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-12
4drx_E	169	Gtp-Tubulin In Complex With A Darpin Length = 169		1e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-12
4atz_D	154	Ad5 Knob In Complex With A Designed Ankyrin Repeat		2e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-12
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-12
1mj0_A	166	Sank E3_5: An Artificial Ankyrin Repeat Protein Len		5e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-12
2l6b_A	115	Nrc Consensus Ankyrin Repeat Protein Solution Struc		5e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-12
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-11
2xeh_A	157	Structural Determinants For Improved Thermal Stabil		2e-11
2xee_A	157	Structural Determinants For Improved Thermal Stabil		2e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-11
2y0b_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4_		2e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
2qyj_A	166	Crystal Structure Of A Designed Full Consensus Anky		3e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
3zu7_B	169	Crystal Structure Of A Designed Selected Ankyrin Re		3e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-11
2bkg_A	166	Crystal Structure Of E3_19 An Designed Ankyrin Repe		4e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
3q9u_C	158	In Silico And In Vitro Co-Evolution Of A High Affin		5e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-11
1svx_A	169	Crystal Structure Of A Designed Selected Ankyrin Re		6e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-11
4f6r_D	169	Tubulin:stathmin-Like Domain Complex Length = 169		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-10
2xzd_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4		1e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
3utm_A	351	Crystal Structure Of A Mouse Tankyrase-Axin Complex		2e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-10
2p2c_P	169	Inhibition Of Caspase-2 By A Designed Ankyrin Repea		4e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-10
2v4h_C	136	Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13		5e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-10
2xzt_G	136	Caspase-3 In Complex With Darpin-3.4_i78s Length =		7e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-10
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-09
3zuv_B	136	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
3twr_A	165	Crystal Structure Of Arc4 From Human Tankyrase 2 In		1e-09
3twq_A	175	Crystal Structure Of Arc4 From Human Tankyrase 2 (A		1e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-09
3twu_A	167	Crystal Structure Of Arc4 From Human Tankyrase 2 In		1e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-09
3noc_D	169	Designed Ankyrin Repeat Protein (Darpin) Binders To		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-09
2j8s_D	169	Drug Export Pathway Of Multidrug Exporter Acrb Reve		3e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-09
2v5q_C	167	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-09
3nog_D	169	Designed Ankyrin Repeat Protein (Darpin) Binders To		5e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-09
2y1l_E	169	Caspase-8 In Complex With Darpin-8.4 Length = 169		6e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-09
2bkk_B	169	Crystal Structure Of Aminoglycoside Phosphotransfer		8e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-08
2xen_A	91	Structural Determinants For Improved Thermal Stabil		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
1k1b_A	241	Crystal Structure Of The Ankyrin Repeat Domain Of B		1e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
3hg0_D	136	Crystal Structure Of A Darpin In Complex With Orf49		2e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
4grg_A	135	Crystal Structure Of Ige Complexed With E2_79, An A		2e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-08
2jab_A	136	A Designed Ankyrin Repeat Protein Evolved To Picomo		5e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-08
3b7b_A	237	Euhmt1 (Glp) Ankyrin Repeat Domain (Structure 1) Le		1e-07
2zgg_A	92	Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom		1e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
1awc_B	153	Mouse Gabp AlphaBETA DOMAIN BOUND TO DNA Length = 1		1e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-07
3v2o_A	183	Crystal Structure Of The Peptide Bound Complex Of T		1e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
3so8_A	162	Crystal Structure Of Ankra Length = 162		1e-07
3v2x_A	167	Crystal Structure Of The Peptide Bound Complex Of T		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
2zgd_A	110	Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom		2e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-07
4b93_B	269	Complex Of Vamp7 Cytoplasmic Domain With 2nd Ankyri		2e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-07
1uoh_A	226	Human Gankyrin Length = 226		8e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-07
3aji_A	231	Structure Of Gankyrin-S6atpase Photo-Cross-Linked S		8e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-07
1qym_A	227	X-Ray Structure Of Human Gankyrin Length = 227		8e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-07
1n11_A	437	D34 Region Of Human Ankyrin-R And Linker Length = 4		8e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
2dvw_A	231	Structure Of The Oncoprotein Gankyrin In Complex Wi		1e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-06
2rfm_A	192	Structure Of A Thermophilic Ankyrin Repeat Protein		3e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-06
1oy3_D	282	Crystal Structure Of An IkbbetaNF-Kb P65 Homodimer		5e-06
1k3z_D	282	X-Ray Crystal Structure Of The IkbbNF-Kb P65 Homodi		5e-06
3aaa_C	123	Crystal Structure Of Actin Capping Protein In Compl		5e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-06
1s70_B	299	Complex Between Protein Ser/thr Phosphatase-1 (delt		6e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-06
1myo_A	118	Solution Structure Of Myotrophin, Nmr, 44 Structure		6e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-06
3uxg_A	172	Crystal Structure Of Rfxank Length = 172		7e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-05
4a63_B	239	Crystal Structure Of The P73-Aspp2 Complex At 2.6a		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-05
1ycs_B	239	P53-53bp2 Complex Length = 239		1e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-05

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 65/140 (46%), Positives = 87/140 (62%), Gaps = 5/140 (3%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           GT   A W G  VAVK L E+    + RV  F  E+A+++++RHPN+V F+GAVTQ   +
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109
Query: 226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            IVTEYL +G L   L + GA   L     +  A D+A+GMNYLH   P PI+HRDL+  
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRDLKSP 168
Query: 283 NILRDDSGNLKVADFGVSKL 302
           N+L D    +KV DFG+S+L
Sbjct: 169 NLLVDKKYTVKVCDFGLSRL 188

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 64/140 (45%), Positives = 87/140 (62%), Gaps = 5/140 (3%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           GT   A W G  VAVK L E+    + RV  F  E+A+++++RHPN+V F+GAVTQ   +
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109
Query: 226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            IVTEYL +G L   L + GA   L     +  A D+A+GMNYLH   P PI+HR+L+  
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSP 168
Query: 283 NILRDDSGNLKVADFGVSKL 302
           N+L D    +KV DFG+S+L
Sbjct: 169 NLLVDKKYTVKVCDFGLSRL 188

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 89/162 (54%), Gaps = 14/162 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELA 202
           ++ IDP EL F    EI  G F    L +W    +VA+K + E  +S++D    F +E  
Sbjct: 2   KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
           ++ K+ HP +VQ  G   + +P+ +VTE++  G L  +L+ ++G     T +   LD+  
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           GM YL E     +IHRDL   N L  ++  +KV+DFG+++ +
Sbjct: 116 GMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 85/147 (57%), Gaps = 10/147 (6%)
Query: 171 AFWRGIQVAVKKLGEEVIS------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
            F + I+V  ++ GE ++       D++  R F  E+ +++ + HPNV++F+G + +   
Sbjct: 22  CFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           +  +TEY+  G LR  +K   +  P S  V FA DIA GM YLH    + IIHRDL   N
Sbjct: 82  LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHN 138
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRP 310
            L  ++ N+ VADFG+++L+  ++ +P
Sbjct: 139 CLVRENKNVVVADFGLARLMVDEKTQP 165

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 86/159 (54%), Gaps = 14/159 (8%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F    L +W    +VA+K + E  +S+DD    F +E  ++ 
Sbjct: 24  IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD----FIEEAEVMM 77
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  GM 
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 137
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +
Sbjct: 138 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 173

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 84/152 (55%), Gaps = 14/152 (9%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG +
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 220 T-QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           RDL   N+L  +    KV+DFG++K  +  +D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 88/162 (54%), Gaps = 14/162 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELA 202
           ++ IDP EL F    EI  G F    L +W    +VA+K + E  +S++D    F +E  
Sbjct: 4   KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 57
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
           ++ K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 117
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           GM YL E     +IHRDL   N L  ++  +KV+DFG+++ +
Sbjct: 118 GMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 84/152 (55%), Gaps = 14/152 (9%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG +
Sbjct: 29  IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 220 T-QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           RDL   N+L  +    KV+DFG++K  +  +D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 86/159 (54%), Gaps = 14/159 (8%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F    L +W    +VA+K + E  +S++D    F +E  ++ 
Sbjct: 4   IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 57
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  GM 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +
Sbjct: 118 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 153

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 86/159 (54%), Gaps = 14/159 (8%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F    L +W    +VA+K + E  +S++D    F +E  ++ 
Sbjct: 4   IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 57
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  GM 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +
Sbjct: 118 YLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFV 153

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 84/152 (55%), Gaps = 14/152 (9%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG +
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 220 T-QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 125
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           RDL   N+L  +    KV+DFG++K  +  +D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 84/152 (55%), Gaps = 14/152 (9%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG +
Sbjct: 20  IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 220 T-QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 131
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           RDL   N+L  +    KV+DFG++K  +  +D
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 163

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 86/159 (54%), Gaps = 14/159 (8%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F    L +W    +VA+K + E  +S++D    F +E  ++ 
Sbjct: 2   IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  GM 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +
Sbjct: 116 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/144 (39%), Positives = 79/144 (54%), Gaps = 13/144 (9%)
Query: 166 GTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
           G   +  W+   + VAVK L E    D   V  F  E A++++I+HPN+VQ LG  T   
Sbjct: 46  GEVYVGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEP 101
Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAV---RFALDIARGMNYLHENKPVPIIHRDLE 280
           P  IVTEY+P G+L  +L R+   +  TAV     A  I+  M YL +      IHRDL 
Sbjct: 102 PFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLYMATQISSAMEYLEKKN---FIHRDLA 157
Query: 281 PSNILRDDSGNLKVADFGVSKLLT 304
             N L  ++  +KVADFG+S+L+T
Sbjct: 158 ARNCLVGENHVVKVADFGLSRLMT 181

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 84/163 (51%), Gaps = 11/163 (6%)
Query: 149 EIDPHELDFTNSVEITK-GTFILAFWRGIQVAVKKLGEEVISD-DDRVRAFRDELALLQK 206
           EID  EL     + I   G    AFW G +VAVK    +   D    +   R E  L   
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++HPN++   G   +   + +V E+   G L   L  K  + P   V +A+ IARGMNYL
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYL 121
Query: 267 HENKPVPIIHRDLEPSNIL---RDDSGN-----LKVADFGVSK 301
           H+   VPIIHRDL+ SNIL   + ++G+     LK+ DFG+++
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/140 (35%), Positives = 76/140 (54%), Gaps = 9/140 (6%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   L  W+G   VAVK + E  +S+D+    F  E   + K+ HP +V+F G  ++  P
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTMMKLSHPKLVKFYGVCSKEYP 77
Query: 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           + IVTEY+  G L  +L+  G  L+PS  +    D+  GM +L  ++    IHRDL   N
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARN 134
Query: 284 ILRDDSGNLKVADFGVSKLL 303
            L D    +KV+DFG+++ +
Sbjct: 135 CLVDRDLCVKVSDFGMTRYV 154

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 3   WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 56
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 57  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 116
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +
Sbjct: 117 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 154

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 4   WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 117
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +
Sbjct: 118 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 155

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 167

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 4   WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 117
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +
Sbjct: 118 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 155

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 17  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 67
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 128 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 160

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/131 (38%), Positives = 73/131 (55%), Gaps = 9/131 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           + VAVK L E    D   V  F  E A++++I+HPN+VQ LG  T+  P  I+TE++  G
Sbjct: 37  LTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 92
Query: 236 DLRAFLKRKGALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           +L  +L+     + S  V    A  I+  M YL +      IHRDL   N L  ++  +K
Sbjct: 93  NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVK 149
Query: 294 VADFGVSKLLT 304
           VADFG+S+L+T
Sbjct: 150 VADFGLSRLMT 160

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 10  WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 63
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 64  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 123
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +
Sbjct: 124 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 161

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 19  WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 72
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 19  WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 72
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDP 201

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 31  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 88
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 89  SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 145
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 146 ARNILINSNLVCKVSDFGLSRVL---EDDP 172

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 76/139 (54%), Gaps = 3/139 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK L  + I   D V   R E+  L+  RHP++++    ++  S + +V EY+  
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++ + G L    + R    I  G++Y H +    ++HRDL+P N+L D   N K+
Sbjct: 101 GELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 157
Query: 295 ADFGVSKLLTVKEDRPLTC 313
           ADFG+S +++  E    +C
Sbjct: 158 ADFGLSNMMSDGEFLRXSC 176

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDP 201

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 58  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 115
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 116 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 172
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 173 ARNILINSNLVCKVSDFGLSRVL---EDDP 199

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDP 201

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDP 201

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDP 201

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 81/150 (54%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R + VA+K L  +V   + + R F  E +++ +  HPN++   G VT+
Sbjct: 37  EVCSGRLKLPGKRELPVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTK 94
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L  FLK+  G       V     I+ GM YL +   +  +HRDL 
Sbjct: 95  SKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSD---MGYVHRDLA 151
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 152 ARNILINSNLVCKVSDFGLSRVL---EDDP 178

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 83/150 (55%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 48  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 105
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 106 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 162
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 163 ARNILINSNLVCKVSDFGLSRVL---EDDP 189

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 32  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 82
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 83  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 143 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 175

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 167

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 20  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 70
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 71  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 131 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 163

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 21  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 132 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 164

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 167

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 23  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 73
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 134 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 21  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 132 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 164

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 21  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 132 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 164

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 167

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   +   R I VA+K L  +    D + R F  E +++ +  HPN++   G VT+
Sbjct: 29  EVCSGRLKVPGKREICVAIKTL--KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 86
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P+MI+TEY+  G L AFL++  G       V     I  GM YL +   +  +HRDL 
Sbjct: 87  CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYVHRDLA 143
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 144 ARNILVNSNLVCKVSDFGMSRVL---EDDP 170

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   +   R I VA+K L  +    D + R F  E +++ +  HPN++   G VT+
Sbjct: 23  EVCSGRLKVPGKREICVAIKTL--KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 80
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P+MI+TEY+  G L AFL++  G       V     I  GM YL +   +  +HRDL 
Sbjct: 81  CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYVHRDLA 137
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 138 ARNILVNSNLVCKVSDFGMSRVL---EDDP 164

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 17  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 67
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 68  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 128 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 160

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 83/150 (55%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG++++L   ED P
Sbjct: 175 ARNILINSNLVCKVSDFGLARVL---EDDP 201

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   +   R I VA+K L  +    D + R F  E +++ +  HPN++   G VT+
Sbjct: 44  EVCSGRLKVPGKREICVAIKTL--KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 101
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P+MI+TEY+  G L AFL++  G       V     I  GM YL +   +  +HRDL 
Sbjct: 102 CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLA 158
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 159 ARNILVNSNLVCKVSDFGMSRVL---EDDP 185

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 226 HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 276
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHR+L   N L  ++  +KVADFG+S+L+T
Sbjct: 337 KN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 14/159 (8%)
Query: 150 IDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  ++ 
Sbjct: 1   IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMN 264
            + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   M 
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           YL   +    +HRDL   N L +D G +KV+DFG+S+ +
Sbjct: 115 YLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 82/150 (54%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+ ++L   ED P
Sbjct: 175 ARNILINSNLVCKVSDFGLGRVL---EDDP 201

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 51/143 (35%), Positives = 77/143 (53%), Gaps = 6/143 (4%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R I VA+K L       + + R F  E +++ +  HPNV+   G VT+
Sbjct: 48  EVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 105
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S+P+MI+TE++  G L +FL++  G       V     IA GM YL +   +  +HRDL 
Sbjct: 106 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLA 162
Query: 281 PSNILRDDSGNLKVADFGVSKLL 303
             NIL + +   KV+DFG+S+ L
Sbjct: 163 ARNILVNSNLVCKVSDFGLSRFL 185

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 167

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 20  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 70
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 71  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 131 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 163

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 265 HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 315
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 IHR+L   N L  ++  +KVADFG+S+L+T
Sbjct: 376 KN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 408

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 82/150 (54%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 31  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 88
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTE +  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 89  SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 145
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 146 ARNILINSNLVCKVSDFGLSRVL---EDDP 172

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 82/150 (54%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTE +  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDP 201

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 82/150 (54%), Gaps = 9/150 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTE +  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
             NIL + +   KV+DFG+S++L   ED P
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDP 201

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/157 (35%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R + VA+K L  +V   + + R F  E +++ +  HPNVV   G VT+
Sbjct: 58  EVCSGRLKLPGKRDVAVAIKTL--KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTR 115
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P+MIV E++  G L AFL++  G       V     IA GM YL +   +  +HRDL 
Sbjct: 116 GKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLAD---MGYVHRDLA 172
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
             NIL + +   KV+DFG+S+++   ED P     T+
Sbjct: 173 ARNILVNSNLVCKVSDFGLSRVI---EDDPEAVYTTT 206

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 94/167 (56%), Gaps = 19/167 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL 201
           +YE D +     + V + KGT+ + +        +++A+K++ E    D    +   +E+
Sbjct: 18  DYEYDEN----GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEI 70
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPS--TAVRFALD 258
           AL + ++H N+VQ+LG+ +++  + I  E +P G L A L+ K G LK +  T   +   
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 304
           I  G+ YLH+N+   I+HRD++  N+L +  SG LK++DFG SK L 
Sbjct: 131 ILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 71/139 (51%), Gaps = 11/139 (7%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           G    A WR   VA+K+     I  +   +AF  EL  L ++ HPN+V+  GA    +P+
Sbjct: 23  GVVCKAKWRAKDVAIKQ-----IESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPV 75
Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTA---VRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            +V EY   G L   L     L   TA   + + L  ++G+ YLH  +P  +IHRDL+P 
Sbjct: 76  CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 135
Query: 283 NILRDDSGN-LKVADFGVS 300
           N+L    G  LK+ DFG +
Sbjct: 136 NLLLVAGGTVLKICDFGTA 154

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 71/139 (51%), Gaps = 11/139 (7%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           G    A WR   VA+K+     I  +   +AF  EL  L ++ HPN+V+  GA    +P+
Sbjct: 22  GVVCKAKWRAKDVAIKQ-----IESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPV 74
Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTA---VRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            +V EY   G L   L     L   TA   + + L  ++G+ YLH  +P  +IHRDL+P 
Sbjct: 75  CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134
Query: 283 NILRDDSGN-LKVADFGVS 300
           N+L    G  LK+ DFG +
Sbjct: 135 NLLLVAGGTVLKICDFGTA 153

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 75/143 (52%), Gaps = 22/143 (15%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           +  A+K++ E    DD R   F  EL +L K+  HPN++  LGA      + +  EY P 
Sbjct: 53  MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
           G+L  FL++   L+  P+ A+               FA D+ARGM+YL + +    IHRD
Sbjct: 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 167
Query: 279 LEPSNILRDDSGNLKVADFGVSK 301
           L   NIL  ++   K+ADFG+S+
Sbjct: 168 LAARNILVGENYVAKIADFGLSR 190

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 92/174 (52%), Gaps = 15/174 (8%)
Query: 146 PEYEIDPHELDFTNSVEITK-GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           PE+E+    L     +   + G   + ++ G  +VAVK L +  +S D    AF  E  L
Sbjct: 2   PEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANL 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIAR 261
           +++++H  +V+    VTQ  P+ I+TEY+  G L  FLK    +K +    +  A  IA 
Sbjct: 58  MKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 116
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           GM ++ E      IHR+L  +NIL  D+ + K+ADFG+++L+   ED   T ++
Sbjct: 117 GMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLI---EDNEYTARE 164

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 75/143 (52%), Gaps = 22/143 (15%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           +  A+K++ E    DD R   F  EL +L K+  HPN++  LGA      + +  EY P 
Sbjct: 43  MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 100
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
           G+L  FL++   L+  P+ A+               FA D+ARGM+YL + +    IHRD
Sbjct: 101 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 157
Query: 279 LEPSNILRDDSGNLKVADFGVSK 301
           L   NIL  ++   K+ADFG+S+
Sbjct: 158 LAARNILVGENYVAKIADFGLSR 180

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 22  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 76
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 133
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           NIL  D+ + K+ADFG+++L+   ED   T ++
Sbjct: 134 NILVSDTLSCKIADFGLARLI---EDNEYTARE 163

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 32  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 86
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 87  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 143
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           NIL  D+ + K+ADFG+++L+   ED   T ++
Sbjct: 144 NILVSDTLSCKIADFGLARLI---EDNEYTARE 173

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 144
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           NIL  D+ + K+ADFG+++L+   ED   T ++
Sbjct: 145 NILVSDTLSCKIADFGLARLI---EDNEYTARE 174

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           NIL  D+ + K+ADFG+++L+   ED   T ++
Sbjct: 139 NILVSDTLSCKIADFGLARLI---EDNEYTARE 168

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 94/167 (56%), Gaps = 19/167 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL 201
           +YE D +     + V + KGT+ + +        +++A+K++ E    D    +   +E+
Sbjct: 4   DYEYDEN----GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEI 56
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPS--TAVRFALD 258
           AL + ++H N+VQ+LG+ +++  + I  E +P G L A L+ K G LK +  T   +   
Sbjct: 57  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 116
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 304
           I  G+ YLH+N+   I+HRD++  N+L +  SG LK++DFG SK L 
Sbjct: 117 ILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 160

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           NIL  D+ + K+ADFG+++L+   ED   T ++
Sbjct: 139 NILVSDTLSCKIADFGLARLI---EDNEXTARE 168

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 37  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 91
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 92  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 148
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           NIL  D+ + K+ADFG+++L+   ED   T ++
Sbjct: 149 NILVSDTLSCKIADFGLARLI---EDNEYTARE 178

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 79/141 (56%), Gaps = 11/141 (7%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 283 NILRDDSGNLKVADFGVSKLL 303
           NIL  D+ + K+ADFG+++L+
Sbjct: 139 NILVSDTLSCKIADFGLARLI 159

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 28  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 139
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           NIL  D+ + K+ADFG+++L+   ED   T ++
Sbjct: 140 NILVSDTLSCKIADFGLARLI---EDNEXTARE 169

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 29  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 83
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 84  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 140
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           NIL  D+ + K+ADFG+++L+   ED   T ++
Sbjct: 141 NILVSDTLSCKIADFGLARLI---EDNEXTARE 170

>pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 61/107 (57%), Gaps = 5/107 (4%)
Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K A++N  D DG        L + A E   E +K L+  G DVN +D D RT LH AA +
Sbjct: 59  KGADVNAKDSDGR-----TPLHYAAKEGHKEIVKLLISKGADVNAKDSDGRTPLHYAAKE 113
Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           G  E+V LL+ +GADV+  D  G TPL  A  + N E++KLLEK G 
Sbjct: 114 GHKEIVKLLISKGADVNTSDSDGRTPLDLAREHGNEEIVKLLEKQGG 160

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/177 (33%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGE 185
           +PL     V   R VP+ +   +  D     +I +G F   F   ++     VAVK    
Sbjct: 90  QPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-R 148
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
           E +  D + + F  E  +L++  HPN+V+ +G  TQ  P+ IV E +  GD   FL+ +G
Sbjct: 149 ETLPPDLKAK-FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG 207
Query: 246 A-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           A L+  T ++   D A GM YL E+K    IHRDL   N L  +   LK++DFG+S+
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYL-ESKCC--IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 79/141 (56%), Gaps = 11/141 (7%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 283 NILRDDSGNLKVADFGVSKLL 303
           NIL  D+ + K+ADFG+++L+
Sbjct: 139 NILVSDTLSCKIADFGLARLI 159

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/177 (33%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGE 185
           +PL     V   R VP+ +   +  D     +I +G F   F   ++     VAVK    
Sbjct: 90  QPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-R 148
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
           E +  D + + F  E  +L++  HPN+V+ +G  TQ  P+ IV E +  GD   FL+ +G
Sbjct: 149 ETLPPDLKAK-FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG 207
Query: 246 A-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           A L+  T ++   D A GM YL E+K    IHRDL   N L  +   LK++DFG+S+
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYL-ESKCC--IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 79/141 (56%), Gaps = 11/141 (7%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 35  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 89
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 90  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 146
Query: 283 NILRDDSGNLKVADFGVSKLL 303
           NIL  D+ + K+ADFG+++L+
Sbjct: 147 NILVSDTLSCKIADFGLARLI 167

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 78/141 (55%), Gaps = 12/141 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK L    +S    V+AF +E  L++ ++H  +V+    VT+  P+ I+TEY+ KG 
Sbjct: 39  KVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGS 94
Query: 237 LRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK    G +     + F+  IA GM Y+        IHRDL  +N+L  +S   K+
Sbjct: 95  LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKI 151
Query: 295 ADFGVSKLLTVKEDRPLTCQD 315
           ADFG+++++   ED   T ++
Sbjct: 152 ADFGLARVI---EDNEYTARE 169

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 79/141 (56%), Gaps = 11/141 (7%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 144
Query: 283 NILRDDSGNLKVADFGVSKLL 303
           NIL  D+ + K+ADFG+++L+
Sbjct: 145 NILVSDTLSCKIADFGLARLI 165

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 79/141 (56%), Gaps = 11/141 (7%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 36  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 90
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 91  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 147
Query: 283 NILRDDSGNLKVADFGVSKLL 303
           NIL  D+ + K+ADFG+++L+
Sbjct: 148 NILVSDTLSCKIADFGLARLI 168

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/149 (37%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++KIRH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKIRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI 164

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 244
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 245 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI 330

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 81/145 (55%), Gaps = 15/145 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTEYL 232
           G QVAVK L  E  S  + +   + E+ +L+ + H N+V++ G  T+   + + ++ E+L
Sbjct: 50  GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 107
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G L+ +L K K  +     +++A+ I +GM+YL   +    +HRDL   N+L +    
Sbjct: 108 PSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 164
Query: 292 LKVADFGVSKLL-------TVKEDR 309
           +K+ DFG++K +       TVK+DR
Sbjct: 165 VKIGDFGLTKAIETDKEXXTVKDDR 189

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 81/145 (55%), Gaps = 15/145 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTEYL 232
           G QVAVK L  E  S  + +   + E+ +L+ + H N+V++ G  T+   + + ++ E+L
Sbjct: 38  GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 95
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G L+ +L K K  +     +++A+ I +GM+YL   +    +HRDL   N+L +    
Sbjct: 96  PSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 152
Query: 292 LKVADFGVSKLL-------TVKEDR 309
           +K+ DFG++K +       TVK+DR
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDR 177

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 244
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 245 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI 330

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R I VA+K L       + + R F  E +++ +  HPNV+   G VT+
Sbjct: 22  EVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 79
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S+P+MI+TE++  G L +FL++  G       V     IA GM YL +   +  +HR L 
Sbjct: 80  STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRALA 136
Query: 281 PSNILRDDSGNLKVADFGVSKLL 303
             NIL + +   KV+DFG+S+ L
Sbjct: 137 ARNILVNSNLVCKVSDFGLSRFL 159

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 75/139 (53%), Gaps = 3/139 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK L  + I   D V   + E+  L+  RHP++++    ++  +   +V EY+  
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++ + G ++   A R    I   ++Y H +    ++HRDL+P N+L D   N K+
Sbjct: 96  GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 152
Query: 295 ADFGVSKLLTVKEDRPLTC 313
           ADFG+S +++  E    +C
Sbjct: 153 ADFGLSNMMSDGEFLRTSC 171

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 17  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 71
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 72  YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 128
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLI 157

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 14  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 68
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 69  YAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 125
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLI 154

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 327
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 328 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 384
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLI 413

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 29/148 (19%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   +    +R    E  +L+++ HP+V++  GA +Q  P++++ EY   G L
Sbjct: 56  VAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 238 RAFLKRKGALKPST------------------------AVRFALDIARGMNYLHENKPVP 273
           R FL+    + P                           + FA  I++GM YL E K   
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--- 170
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSK 301
           ++HRDL   NIL  +   +K++DFG+S+
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 29/148 (19%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   +    +R    E  +L+++ HP+V++  GA +Q  P++++ EY   G L
Sbjct: 56  VAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 238 RAFLKRKGALKPST------------------------AVRFALDIARGMNYLHENKPVP 273
           R FL+    + P                           + FA  I++GM YL E K   
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--- 170
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSK 301
           ++HRDL   NIL  +   +K++DFG+S+
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 75/143 (52%), Gaps = 22/143 (15%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           +  A+K++ E    DD R   F  EL +L K+  HPN++  LGA      + +  EY P 
Sbjct: 50  MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 107
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
           G+L  FL++   L+  P+ A+               FA D+ARGM+YL + +    IHR+
Sbjct: 108 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRN 164
Query: 279 LEPSNILRDDSGNLKVADFGVSK 301
           L   NIL  ++   K+ADFG+S+
Sbjct: 165 LAARNILVGENYVAKIADFGLSR 187

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 15  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 69
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 70  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 126
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLI 155

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 13  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 68  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 124
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLI 153

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI 164

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLI 164

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 74/128 (57%), Gaps = 4/128 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+K +  +++   D       E++ L+ +RHP++++    +T  + +++V EY   G+
Sbjct: 36  KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGE 94
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++  K  +      RF   I   + Y H +K   I+HRDL+P N+L DD+ N+K+AD
Sbjct: 95  LFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIAD 151
Query: 297 FGVSKLLT 304
           FG+S ++T
Sbjct: 152 FGLSNIMT 159

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 72/130 (55%), Gaps = 3/130 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK L  + I   D V   + E+  L+  RHP++++    ++  +   +V EY+  
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++ + G ++   A R    I   ++Y H +    ++HRDL+P N+L D   N K+
Sbjct: 96  GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 152
Query: 295 ADFGVSKLLT 304
           ADFG+S +++
Sbjct: 153 ADFGLSNMMS 162

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 17/152 (11%)
Query: 173 WRGI-----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           W G      +VAVK L    +S    V+AF +E  L++ ++H  +V+    VT+  P+ I
Sbjct: 29  WMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 84
Query: 228 VTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +TE++ KG L  FLK    G +     + F+  IA GM Y+        IHRDL  +N+L
Sbjct: 85  ITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVL 141
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
             +S   K+ADFG+++++   ED   T ++ +
Sbjct: 142 VSESLMCKIADFGLARVI---EDNEYTAREGA 170

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI 164

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 29/148 (19%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   +    +R    E  +L+++ HP+V++  GA +Q  P++++ EY   G L
Sbjct: 56  VAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 238 RAFLKRKGALKPST------------------------AVRFALDIARGMNYLHENKPVP 273
           R FL+    + P                           + FA  I++GM YL E   + 
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MS 170
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSK 301
           ++HRDL   NIL  +   +K++DFG+S+
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 63/117 (53%), Gaps = 4/117 (3%)
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
           R F  E +++ +  HPN+++  G VT S P+MI+TE++  G L +FL+   G       V
Sbjct: 62  REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV 121
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
                IA GM YL E   +  +HRDL   NIL + +   KV+DFG+S+ L      P
Sbjct: 122 GMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 175

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 63/117 (53%), Gaps = 4/117 (3%)
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
           R F  E +++ +  HPN+++  G VT S P+MI+TE++  G L +FL+   G       V
Sbjct: 60  REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV 119
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
                IA GM YL E   +  +HRDL   NIL + +   KV+DFG+S+ L      P
Sbjct: 120 GMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 173

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 21  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 75
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  +  IA GM Y+     +  
Sbjct: 76  YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNY 132
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI 161

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 21  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 75
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  +  IA GM Y+     +  
Sbjct: 76  YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNY 132
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI 161

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 77/141 (54%), Gaps = 11/141 (7%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   +  W G  +VA+K L    +S +    +F +E  +++K++H  +VQ L AV    P
Sbjct: 23  GEVWMGTWNGNTKVAIKTLKPGTMSPE----SFLEEAQIMKKLKHDKLVQ-LYAVVSEEP 77
Query: 225 MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + IVTEY+ KG L  FLK     ALK    V  A  +A GM Y+     +  IHRDL  +
Sbjct: 78  IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 134
Query: 283 NILRDDSGNLKVADFGVSKLL 303
           NIL  +    K+ADFG+++L+
Sbjct: 135 NILVGNGLICKIADFGLARLI 155

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 17/152 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAV--------TQSSPM 225
           G + A+K+L   + +++++ RA   E+  ++K+  HPN+VQF  A         T  +  
Sbjct: 53  GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 226 MIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           +++TE L KG L  FLK+   +G L   T ++      R + ++H  KP PIIHRDL+  
Sbjct: 110 LLLTE-LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVE 167
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
           N+L  + G +K+ DFG +  ++   D   + Q
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 81/149 (54%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 191 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE----AFLQEAQVMKKLRHEKLVQ-L 245
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 246 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 302
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+ +L+
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLI 331

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 75/127 (59%), Gaps = 7/127 (5%)
Query: 178 VAVKK--LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+KK  LG    + D   R    E+ LLQ++ HPN++  L A    S + +V +++ + 
Sbjct: 38  VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ET 96
Query: 236 DLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL   +K     L PS    + L   +G+ YLH++    I+HRDL+P+N+L D++G LK+
Sbjct: 97  DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKL 153
Query: 295 ADFGVSK 301
           ADFG++K
Sbjct: 154 ADFGLAK 160

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 81/149 (54%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 244
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 245 YAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI 330

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 81/149 (54%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI 164

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 9/137 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK+L     S  D+ R F+ E+ +L+ +    +V++ G         + +V EYL
Sbjct: 40  GALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 96
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR FL+R  A L  S  + ++  I +GM YL   +    +HRDL   NIL +   +
Sbjct: 97  PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAH 153
Query: 292 LKVADFGVSKLLTVKED 308
           +K+ADFG++KLL + +D
Sbjct: 154 VKIADFGLAKLLPLDKD 170

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 9/137 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK+L     S  D+ R F+ E+ +L+ +    +V++ G         + +V EYL
Sbjct: 39  GALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 95
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR FL+R  A L  S  + ++  I +GM YL   +    +HRDL   NIL +   +
Sbjct: 96  PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAH 152
Query: 292 LKVADFGVSKLLTVKED 308
           +K+ADFG++KLL + +D
Sbjct: 153 VKIADFGLAKLLPLDKD 169

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 75/130 (57%), Gaps = 4/130 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + ++V++  D       E++ L+ +RHP++++    +     +++V EY   
Sbjct: 39  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AG 97
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            +L  ++ ++  +    A RF   I   + Y H +K   I+HRDL+P N+L D+  N+K+
Sbjct: 98  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI 154
Query: 295 ADFGVSKLLT 304
           ADFG+S ++T
Sbjct: 155 ADFGLSNIMT 164

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 75/130 (57%), Gaps = 4/130 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + ++V++  D       E++ L+ +RHP++++    +     +++V EY   
Sbjct: 29  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AG 87
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            +L  ++ ++  +    A RF   I   + Y H +K   I+HRDL+P N+L D+  N+K+
Sbjct: 88  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI 144
Query: 295 ADFGVSKLLT 304
           ADFG+S ++T
Sbjct: 145 ADFGLSNIMT 154

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 9/137 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK+L     S  D+ R F+ E+ +L+ +    +V++ G         + +V EYL
Sbjct: 52  GALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR FL+R  A L  S  + ++  I +GM YL   +    +HRDL   NIL +   +
Sbjct: 109 PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAH 165
Query: 292 LKVADFGVSKLLTVKED 308
           +K+ADFG++KLL + +D
Sbjct: 166 VKIADFGLAKLLPLDKD 182

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 75/130 (57%), Gaps = 4/130 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + ++V++  D       E++ L+ +RHP++++    +     +++V EY   
Sbjct: 38  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AG 96
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            +L  ++ ++  +    A RF   I   + Y H +K   I+HRDL+P N+L D+  N+K+
Sbjct: 97  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI 153
Query: 295 ADFGVSKLLT 304
           ADFG+S ++T
Sbjct: 154 ADFGLSNIMT 163

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 81/149 (54%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI 164

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 81/149 (54%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI 164

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 75/130 (57%), Gaps = 4/130 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + ++V++  D       E++ L+ +RHP++++    +     +++V EY   
Sbjct: 33  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AG 91
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            +L  ++ ++  +    A RF   I   + Y H +K   I+HRDL+P N+L D+  N+K+
Sbjct: 92  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI 148
Query: 295 ADFGVSKLLT 304
           ADFG+S ++T
Sbjct: 149 ADFGLSNIMT 158

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 52  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 108
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL   N + D+ 
Sbjct: 109 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 164
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 165 FTVKVADFGLARDMYDKE 182

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 57  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 113
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL   N + D+ 
Sbjct: 114 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 169
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 170 FTVKVADFGLARDMYDKE 187

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 83/162 (51%), Gaps = 18/162 (11%)
Query: 152 PHELDFTNSVE-ITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
           PHE   T+S   I KG F + +           IQ A+K L    I++  +V AF  E  
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGL 74
Query: 203 LLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDI 259
           L++ + HPNV+  +G +     +  ++  Y+  GDL  F+ R     P+    + F L +
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQV 133
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           ARGM YL E K    +HRDL   N + D+S  +KVADFG+++
Sbjct: 134 ARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 56  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 112
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL   N + D+ 
Sbjct: 113 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 168
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 169 FTVKVADFGLARDMYDKE 186

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 56  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 112
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL   N + D+ 
Sbjct: 113 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 168
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 169 FTVKVADFGLARDMYDKE 186

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 57  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 113
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL   N + D+ 
Sbjct: 114 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 169
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 170 FTVKVADFGLARDMYDKE 187

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/137 (36%), Positives = 78/137 (56%), Gaps = 9/137 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MMIVTEYL 232
           G  VAVK+L     S  D+ R F+ E+ +L+ +    +V++ G +     P + +V EYL
Sbjct: 36  GALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYL 92
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR FL+R  A L  S  + ++  I +GM YL   +    +HRDL   NIL +   +
Sbjct: 93  PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAH 149
Query: 292 LKVADFGVSKLLTVKED 308
           +K+ADFG++KLL + +D
Sbjct: 150 VKIADFGLAKLLPLDKD 166

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 54  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 110
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL   N + D+ 
Sbjct: 111 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 166
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 167 FTVKVADFGLARDMYDKE 184

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/149 (34%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 64  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 121
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 122 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 176
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           L   N + D+   +KVADFG+++ +  KE
Sbjct: 177 LAARNCMLDEKFTVKVADFGLARDMYDKE 205

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 55  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 111
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL   N + D+ 
Sbjct: 112 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 167
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 168 FTVKVADFGLARDMYDKE 185

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 42  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 99  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 155
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 156 VKIGDFGLTKVL 167

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 49  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 105
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL   N + D+ 
Sbjct: 106 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 161
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 162 FTVKVADFGLARDMYDKE 179

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 76  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 132
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL   N + D+ 
Sbjct: 133 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 188
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 189 FTVKVADFGLARDMYDKE 206

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 38  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 94
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 95  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 151
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 152 VKIGDFGLTKVL 163

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 39  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 96  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 152
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 153 VKIGDFGLTKVL 164

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 37  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 93
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 94  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 150
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 151 VKIGDFGLTKVL 162

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 44  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 100
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 101 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 157
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 158 VKIGDFGLTKVL 169

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 39  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 96  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 152
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 153 VKIGDFGLTKVL 164

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 45  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 101
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 102 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 158
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 159 VKIGDFGLTKVL 170

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 57  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 114 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 170
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 171 VKIGDFGLTKVL 182

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 39  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 96  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 152
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 153 VKIGDFGLTKVL 164

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 70  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 126
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 127 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 183
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 184 VKIGDFGLTKVL 195

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 46  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 102
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 103 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 159
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 160 VKIGDFGLTKVL 171

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 43  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 99
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 100 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 156
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 157 VKIGDFGLTKVL 168

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 81/149 (54%), Gaps = 14/149 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           +HRDL  +NIL  ++   KVADFG+++L+
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI 164

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 57  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 114 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 170
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 171 VKIGDFGLTKVL 182

>pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/107 (44%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K A++N  D DG        L   A     E +K L+  G DVN +D D RT LH AA  
Sbjct: 59  KGADVNAKDSDGR-----TPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAEN 113
Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           G  EVV LL+ +GADV+  D  G TPL  A  + N EV+KLLEK G 
Sbjct: 114 GHKEVVKLLISKGADVNTSDSDGRTPLDLAREHGNEEVVKLLEKQGG 160

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 14/153 (9%)
Query: 161 VEITKGTFILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214
           +EI +G+F   + +G      ++VA  +L +  ++  +R R F++E   L+ ++HPN+V+
Sbjct: 32  IEIGRGSFKTVY-KGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEXLKGLQHPNIVR 89
Query: 215 FL----GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
           F       V     +++VTE    G L+ +LKR    K      +   I +G+ +LH   
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 271 PVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKL 302
           P PIIHRDL+  NI +   +G++K+ D G++ L
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +E++    +V    DE  +L  + HP +++  G    +  + ++ +Y+  
Sbjct: 31  GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L + L++        A  +A ++   + YLH      II+RDL+P NIL D +G++K+
Sbjct: 91  GELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKI 147
Query: 295 ADFGVSKLL 303
            DFG +K +
Sbjct: 148 TDFGFAKYV 156

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ E+L
Sbjct: 42  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFL 98
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 99  PYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 155
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 156 VKIGDFGLTKVL 167

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 163 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 217
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           L   N + D+   +KVADFG+++ +  KE
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARDMYDKE 246

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 55  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 111
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM +L   K    +HRDL   N + D+ 
Sbjct: 112 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEK 167
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 168 FTVKVADFGLARDMYDKE 185

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 51  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 108
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 109 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 163
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           L   N + D+   +KVADFG+++ +  KE
Sbjct: 164 LAARNCMLDEKFTVKVADFGLARDMYDKE 192

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 47  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 105 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 159
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           L   N + D+   +KVADFG+++ +  KE
Sbjct: 160 LAARNCMLDEKFTVKVADFGLARDMYDKE 188

>pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/90 (46%), Positives = 55/90 (61%)
Query: 43  RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           RL+  A   + + +K+LL++G DVN  D D +T LH+AA  G  EVV LLL +GAD + K
Sbjct: 7   RLIEAAENGNKDRVKDLLENGADVNASDSDGKTPLHLAAENGHKEVVKLLLSQGADPNAK 66
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           D  G TPL  A    + EV+KLL   GA P
Sbjct: 67  DSDGKTPLHLAAENGHKEVVKLLLSQGADP 96

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 47  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 105 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 159
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           L   N + D+   +KVADFG+++ +  KE
Sbjct: 160 LAARNCMLDEKFTVKVADFGLARDMLDKE 188

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 40  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 96
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHR+L   NIL ++   
Sbjct: 97  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRNLATRNILVENENR 153
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 154 VKIGDFGLTKVL 165

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 73/145 (50%), Gaps = 22/145 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 59  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 233 PKGDLRAFLKRKG------ALKPS----------TAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +       +  PS            V  A  +ARGM YL   K    IH
Sbjct: 117 SKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 57  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 113
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM +L   K    +HRDL   N + D+ 
Sbjct: 114 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEK 169
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 170 FTVKVADFGLARDMYDKE 187

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEY 231
           + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S  SP+ +V  Y
Sbjct: 57  KKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 113
Query: 232 LPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +  GDLR F+ R     P+    + F L +A+GM +L   K    +HRDL   N + D+ 
Sbjct: 114 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEK 169
Query: 290 GNLKVADFGVSKLLTVKE 307
             +KVADFG+++ +  KE
Sbjct: 170 FTVKVADFGLARDMYDKE 187

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 59  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 117 SKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 44  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 101
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 102 SKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 158
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 159 RDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 59  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 117 SKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 51  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 108
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 109 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 165
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 166 RDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 52  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 109
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 110 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 166
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 167 RDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 48  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 105
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 106 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 162
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 163 RDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/101 (44%), Positives = 60/101 (59%)
Query: 30  GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
           G D + ++      L   A    +E +K LL++G DVN +D + RT LH+AA  G  EVV
Sbjct: 25  GADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVV 84
Query: 90  SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            LLLE GADV+ KD+ G TPL  A    + EV+KLL + GA
Sbjct: 85  KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 75/143 (52%), Gaps = 9/143 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           + VA+K L +   ++  RV  F  E  ++ +  H N+++  G +++  PMMI+TEY+  G
Sbjct: 74  VPVAIKTL-KAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 131
Query: 236 DLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  FL+ K G       V     IA GM YL     +  +HRDL   NIL + +   KV
Sbjct: 132 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKV 188
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS 317
           +DFG+S++L   ED P     TS
Sbjct: 189 SDFGLSRVL---EDDPEATYTTS 208

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 59  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 117 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 3/125 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + ++   + + VR    EL ++Q + HP +V    +      M +V + L  GDLR
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L++    K  T   F  ++   ++YL   +   IIHRD++P NIL D+ G++ + DF 
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160
Query: 299 VSKLL 303
           ++ +L
Sbjct: 161 IAAML 165

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
           +S E+  G   +   R + VA+K L  +    + + R F  E +++ +  HPN+++  G 
Sbjct: 61  DSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           VT+    MIVTEY+  G L  FL+   G       V     +  GM YL +   +  +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHR 175
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           DL   N+L D +   KV+DFG+S++L   ED P     T+
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAXTTT 212

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
           +S E+  G   +   R + VA+K L  +    + + R F  E +++ +  HPN+++  G 
Sbjct: 61  DSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           VT+    MIVTEY+  G L  FL+   G       V     +  GM YL +   +  +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHR 175
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           DL   N+L D +   KV+DFG+S++L   ED P     T+
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTT 212

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 20/141 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 77  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 235 GDLRAFLKRKG---------ALKPSTA-----VRFALDIARGMNYLHENKPVPIIHRDLE 280
           GDL  FL+RK          A+  STA     + F+  +A+GM +L        IHRD+ 
Sbjct: 135 GDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVA 191
Query: 281 PSNILRDDSGNLKVADFGVSK 301
             N+L  +    K+ DFG+++
Sbjct: 192 ARNVLLTNGHVAKIGDFGLAR 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 100 RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 157
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 158 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 214
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL   N+L  +   +K+ADFG+++
Sbjct: 215 RDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/87 (49%), Positives = 55/87 (63%)
Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    +E +K LL++G DVN +D + RT LH+AA  G  EVV LLLE GADV+ KD
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + G TPL  A    + EV+KLL + GA
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGA 92

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 73/140 (52%), Gaps = 7/140 (5%)
Query: 166 GTFILAFWRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G     +     VAVKKL   V I+ ++  + F  E+ ++ K +H N+V+ LG  +    
Sbjct: 45  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST---AVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V  Y+P G L   L       P +     + A   A G+N+LHEN     IHRD++ 
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKS 161
Query: 282 SNILRDDSGNLKVADFGVSK 301
           +NIL D++   K++DFG+++
Sbjct: 162 ANILLDEAFTAKISDFGLAR 181

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 73/140 (52%), Gaps = 7/140 (5%)
Query: 166 GTFILAFWRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G     +     VAVKKL   V I+ ++  + F  E+ ++ K +H N+V+ LG  +    
Sbjct: 45  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST---AVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V  Y+P G L   L       P +     + A   A G+N+LHEN     IHRD++ 
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKS 161
Query: 282 SNILRDDSGNLKVADFGVSK 301
           +NIL D++   K++DFG+++
Sbjct: 162 ANILLDEAFTAKISDFGLAR 181

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 89/163 (54%), Gaps = 15/163 (9%)
Query: 148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
           +EI+  E+    S  I  G+F   +   W G  VAVK L + V    ++ +AFR+E+A+L
Sbjct: 31  WEIEASEVML--STRIGSGSFGTVYKGKWHG-DVAVKIL-KVVDPTPEQFQAFRNEVAVL 86
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
           +K RH N++ F+G +T+ + + IVT++     L   L  ++   +    +  A   A+GM
Sbjct: 87  RKTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 145
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
           +YLH      IIHRD++ +NI   +   +K+ DFG   L TVK
Sbjct: 146 DYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFG---LATVK 182

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 73/140 (52%), Gaps = 7/140 (5%)
Query: 166 GTFILAFWRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G     +     VAVKKL   V I+ ++  + F  E+ ++ K +H N+V+ LG  +    
Sbjct: 39  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 98
Query: 225 MMIVTEYLPKGDL---RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V  Y+P G L    + L     L      + A   A G+N+LHEN     IHRD++ 
Sbjct: 99  LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKS 155
Query: 282 SNILRDDSGNLKVADFGVSK 301
           +NIL D++   K++DFG+++
Sbjct: 156 ANILLDEAFTAKISDFGLAR 175

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++   +D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEED--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 182 DLAARNVLVTENNVMKIADFGLAR 205

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 73/132 (55%), Gaps = 9/132 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 42  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L+     +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 99  PYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 155
Query: 292 LKVADFGVSKLL 303
           +K+ DFG++K+L
Sbjct: 156 VKIGDFGLTKVL 167

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 68/127 (53%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           GD+ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G +KV
Sbjct: 126 GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 295 ADFGVSK 301
           ADFG +K
Sbjct: 183 ADFGFAK 189

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 68/127 (53%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           GD+ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G +KV
Sbjct: 126 GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 295 ADFGVSK 301
           ADFG +K
Sbjct: 183 ADFGFAK 189

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 71/122 (58%), Gaps = 8/122 (6%)
Query: 186 EVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +VI D    ++F+   D +  +  + H ++V+ LG    SS + +VT+YLP G L   ++
Sbjct: 66  KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVR 124
Query: 243 R-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           + +GAL P   + + + IA+GM YL E+    ++HR+L   N+L      ++VADFGV+ 
Sbjct: 125 QHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 181
Query: 302 LL 303
           LL
Sbjct: 182 LL 183

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 69/136 (50%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P+G++   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 145 LLGSAGELKIADFGWS 160

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 71/122 (58%), Gaps = 8/122 (6%)
Query: 186 EVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +VI D    ++F+   D +  +  + H ++V+ LG    SS + +VT+YLP G L   ++
Sbjct: 48  KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVR 106
Query: 243 R-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           + +GAL P   + + + IA+GM YL E+    ++HR+L   N+L      ++VADFGV+ 
Sbjct: 107 QHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163
Query: 302 LL 303
           LL
Sbjct: 164 LL 165

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 65/123 (52%), Gaps = 3/123 (2%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           +A+K L +  +  +      R E+ +   +RHPN+++          + ++ E+ P+G+L
Sbjct: 43  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 102
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L++ G      +  F  ++A  ++Y HE K   +IHRD++P N+L    G LK+ADF
Sbjct: 103 YKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADF 159
Query: 298 GVS 300
           G S
Sbjct: 160 GWS 162

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 65/123 (52%), Gaps = 3/123 (2%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           +A+K L +  +  +      R E+ +   +RHPN+++          + ++ E+ P+G+L
Sbjct: 42  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L++ G      +  F  ++A  ++Y HE K   +IHRD++P N+L    G LK+ADF
Sbjct: 102 YKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADF 158
Query: 298 GVS 300
           G S
Sbjct: 159 GWS 161

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 54  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 111
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 112 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 168
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 169 DLTARNVLVTENNVMKIADFGLAR 192

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 182 DLAARNVLVTENNVMKIADFGLAR 205

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 69/136 (50%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P+G++   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 145 LLGSAGELKIADFGWS 160

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 59  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 116
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 117 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 173
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 174 DLAARNVLVTENNVMKIADFGLAR 197

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 113 AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 170
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 227
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 228 DLAARNVLVTENNVMKIADFGLAR 251

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 56  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 113
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 114 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 170
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 171 DLAARNVLVTENNVMKIADFGLAR 194

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 182 DLAARNVLVTENNVMKIADFGLAR 205

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 89/168 (52%), Gaps = 14/168 (8%)
Query: 143 REVPEYEIDPHEL-DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRA 196
           R+ P   +D  +L DF   + + KG+F   +LA  +G +   A+K L ++V+  DD V  
Sbjct: 6   RKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVEC 65
Query: 197 FRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
              E   LALL K   P + Q          +  V EY+  GDL   +++ G  K   AV
Sbjct: 66  TMVEKRVLALLDK--PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            +A +I+ G+ +LH+     II+RDL+  N++ D  G++K+ADFG+ K
Sbjct: 124 FYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 168

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 182 DLAARNVLVTENNVMKIADFGLAR 205

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 182 DLAARNVLVTENNVMKIADFGLAR 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 76/143 (53%), Gaps = 7/143 (4%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G +       I VAVK   ++   D+     F  E  +++ + HP++V+ +G + +
Sbjct: 27  EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIG-IIE 83
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P  I+ E  P G+L  +L+R K +LK  T V ++L I + M YL   + +  +HRD+ 
Sbjct: 84  EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIA 140
Query: 281 PSNILRDDSGNLKVADFGVSKLL 303
             NIL      +K+ DFG+S+ +
Sbjct: 141 VRNILVASPECVKLGDFGLSRYI 163

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 75/143 (52%), Gaps = 7/143 (4%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G +       I VAVK   ++   D+     F  E  +++ + HP++V+ +G + +
Sbjct: 39  EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIG-IIE 95
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P  I+ E  P G+L  +L+R K +LK  T V ++L I + M YL     +  +HRD+ 
Sbjct: 96  EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIA 152
Query: 281 PSNILRDDSGNLKVADFGVSKLL 303
             NIL      +K+ DFG+S+ +
Sbjct: 153 VRNILVASPECVKLGDFGLSRYI 175

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 76/143 (53%), Gaps = 7/143 (4%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G +       I VAVK   ++   D+     F  E  +++ + HP++V+ +G + +
Sbjct: 23  EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIG-IIE 79
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P  I+ E  P G+L  +L+R K +LK  T V ++L I + M YL   + +  +HRD+ 
Sbjct: 80  EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIA 136
Query: 281 PSNILRDDSGNLKVADFGVSKLL 303
             NIL      +K+ DFG+S+ +
Sbjct: 137 VRNILVASPECVKLGDFGLSRYI 159

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 58/119 (48%), Gaps = 19/119 (15%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--------------- 241
           FR E  L  +++HPNVV  LG VT+  P+ ++  Y   GDL  FL               
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 242 -KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
              K AL+P   V     IA GM YL  +    ++H+DL   N+L  D  N+K++D G+
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGL 191

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 59/121 (48%), Gaps = 19/121 (15%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--------------- 241
           FR E  L  +++HPNVV  LG VT+  P+ ++  Y   GDL  FL               
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 242 -KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              K AL+P   V     IA GM YL  +    ++H+DL   N+L  D  N+K++D G+ 
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLF 175
Query: 301 K 301
           +
Sbjct: 176 R 176

>pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 63/120 (52%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  +      L   A    +E ++ LL  G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNATDASGLTPLHLAATYGHLEIVEVLLKHGADVNAID 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           I   T LH+AA  G  E+V +LL+ GADV+  D WG TPL  A    + E++++L KHGA
Sbjct: 78  IXGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVLLKHGA 137

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 182 DLAARNVLVTENNVMKIADFGLAR 205

>pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/107 (42%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K A+ N  D DG        L + A     E +K LL  G D N +D D RT LH AA  
Sbjct: 59  KGADPNAKDSDGR-----TPLHYAAENGHKEIVKLLLSKGADPNAKDSDGRTPLHYAAEN 113
Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           G  E+V LLL +GAD +  D  G TPL  A  + N E++KLLEK G 
Sbjct: 114 GHKEIVKLLLSKGADPNTSDSDGRTPLDLAREHGNEEIVKLLEKQGG 160

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 86/159 (54%), Gaps = 10/159 (6%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQ 205
           +DP EL FT    I KG+F   + +GI    K++    I D    +D +   + E+ +L 
Sbjct: 15  VDPEEL-FTKLDRIGKGSFGEVY-KGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLS 72
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           +   P + ++ G+  +S+ + I+ EYL  G     LK  G L+ +       +I +G++Y
Sbjct: 73  QCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDY 131
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH  +    IHRD++ +N+L  + G++K+ADFGV+  LT
Sbjct: 132 LHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT 167

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 98/178 (55%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 9   EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE- 64
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA---- 252
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P+ A    
Sbjct: 65  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPAMANNPV 121
Query: 253 ---------VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                    ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 122 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 92/167 (55%), Gaps = 31/167 (18%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIE-FLNEASVMKEF 85
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------------VR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P+ A             ++
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPAMANNPVLAPPSLSKMIQ 142
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 143 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 63/120 (52%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  +      L   A    +E ++ LL  G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNATDASGLTPLHLAATYGHLEIVEVLLKHGADVNAID 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           I   T LH+AA  G  E+V +LL+ GADV+  D WG TPL  A    + E++++L KHGA
Sbjct: 78  IMGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVLLKHGA 137

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 73/138 (52%), Gaps = 16/138 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM-MIVT 229
           ++VAVK L  ++I+  D +  F  E A +++  HP+V + +G   +S      P+ M++ 
Sbjct: 52  VKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVIL 110
Query: 230 EYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
            ++  GDL AFL   R G     L   T VRF +DIA GM YL        IHRDL   N
Sbjct: 111 PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARN 167
Query: 284 ILRDDSGNLKVADFGVSK 301
            +  +   + VADFG+S+
Sbjct: 168 CMLAEDMTVCVADFGLSR 185

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 11/133 (8%)
Query: 168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           FILA     +  ++K G E           R E+ +   +RHPN+++  G    S+ + +
Sbjct: 34  FILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDSTRVYL 85
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           + EY P G +   L++           +  ++A  ++Y H  K   +IHRD++P N+L  
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK---VIHRDIKPENLLLG 142
Query: 288 DSGNLKVADFGVS 300
            +G LK+ADFG S
Sbjct: 143 SAGELKIADFGWS 155

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 19/139 (13%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VAVK L +   + D+  + F  E  LL  ++H ++V+F G   +  P+++V EY+  G
Sbjct: 44  ILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 100
Query: 236 DLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           DL  FL+  G              L  S  +  A  IA GM YL        +HRDL   
Sbjct: 101 DLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 157
Query: 283 NILRDDSGNLKVADFGVSK 301
           N L  ++  +K+ DFG+S+
Sbjct: 158 NCLVGENLLVKIGDFGMSR 176

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 20/141 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 77  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 235 GDLRAFLKRKG---------ALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLE 280
           GDL  FL+RK          A+  ST      + F+  +A+GM +L        IHRD+ 
Sbjct: 135 GDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN---CIHRDVA 191
Query: 281 PSNILRDDSGNLKVADFGVSK 301
             N+L  +    K+ DFG+++
Sbjct: 192 ARNVLLTNGHVAKIGDFGLAR 212

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +++ADFG+++
Sbjct: 182 DLAARNVLVTENNVMRIADFGLAR 205

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KG+F   +       G++VA+K + ++ +     V+  ++E+ +  +++HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST---AVRFALDIARGMNYLH 267
           ++++       S+ + +V E    G++  +LK +  +KP +   A  F   I  GM YLH
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLH 129
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            +    I+HRDL  SN+L   + N+K+ADFG++  L +  ++  T   T
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGT 175

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 70/137 (51%), Gaps = 16/137 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 69  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 126
Query: 235 GDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           GDL  FL+RK            L+    + F+  +A+GM +L        IHRD+   N+
Sbjct: 127 GDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 183
Query: 285 LRDDSGNLKVADFGVSK 301
           L  +    K+ DFG+++
Sbjct: 184 LLTNGHVAKIGDFGLAR 200

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 97/178 (54%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 4   EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIE- 59
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP------- 249
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P       
Sbjct: 60  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPV 116
Query: 250 ------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 117 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 70/137 (51%), Gaps = 16/137 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 77  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 235 GDLRAFLKRKGA----------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           GDL  FL+RK            L+    + F+  +A+GM +L        IHRD+   N+
Sbjct: 135 GDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 191
Query: 285 LRDDSGNLKVADFGVSK 301
           L  +    K+ DFG+++
Sbjct: 192 LLTNGHVAKIGDFGLAR 208

>pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 66/120 (55%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  +      L   A    +E ++ LL +G DVN  D
Sbjct: 6   LLEAARAGQDDEVRILMANGADANAYDHYGRTPLHMAAAVGHLEIVEVLLRNGADVNAVD 65
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            +  T LH+AA  G  E+V +LL+ GADV+ KD  G TPL  A Y+ + E++++L KHGA
Sbjct: 66  TNGTTPLHLAASLGHLEIVEVLLKYGADVNAKDATGITPLYLAAYWGHLEIVEVLLKHGA 125

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 97/178 (54%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 6   EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE- 61
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP------- 249
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P       
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPV 118
Query: 250 ------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 68/127 (53%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G +KV
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 295 ADFGVSK 301
           ADFG +K
Sbjct: 183 ADFGFAK 189

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 97/178 (54%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 13  EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE- 68
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP------- 249
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P       
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPV 125
Query: 250 ------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 61/104 (58%), Gaps = 3/104 (2%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           + E  +L++++HP +V  + A      + ++ EYL  G+L   L+R+G     TA  +  
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           +I+  + +LH+     II+RDL+P NI+ +  G++K+ DFG+ K
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 97/178 (54%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 12  EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE- 67
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP------- 249
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P       
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPV 124
Query: 250 ------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 97/178 (54%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 12  EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE- 67
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP------- 249
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P       
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPV 124
Query: 250 ------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 61/104 (58%), Gaps = 3/104 (2%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           + E  +L++++HP +V  + A      + ++ EYL  G+L   L+R+G     TA  +  
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           +I+  + +LH+     II+RDL+P NI+ +  G++K+ DFG+ K
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 97/178 (54%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 10  EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE- 65
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP------- 249
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P       
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPV 122
Query: 250 ------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 123 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 71/140 (50%), Gaps = 7/140 (5%)
Query: 166 GTFILAFWRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G     +     VAVKKL   V I+ ++  + F  E+ +  K +H N+V+ LG  +    
Sbjct: 36  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDD 95
Query: 225 MMIVTEYLPKGDLR---AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V  Y P G L    + L     L      + A   A G+N+LHEN     IHRD++ 
Sbjct: 96  LCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKS 152
Query: 282 SNILRDDSGNLKVADFGVSK 301
           +NIL D++   K++DFG+++
Sbjct: 153 ANILLDEAFTAKISDFGLAR 172

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQ 205
           +DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L 
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           +   P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++Y
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDY 119
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH  K    IHRD++ +N+L  + G +K+ADFGV+  LT
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT 155

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQ 205
           +DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L 
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           +   P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++Y
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDY 119
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH  K    IHRD++ +N+L  + G +K+ADFGV+  LT
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT 155

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 91/167 (54%), Gaps = 31/167 (18%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIE-FLNEASVMKEF 85
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 142
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 143 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 97/178 (54%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 13  EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE- 68
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP------- 249
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P       
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPV 125
Query: 250 ------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 97/178 (54%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 41  EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE- 96
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP------- 249
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P       
Sbjct: 97  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPV 153
Query: 250 ------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 154 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 67/116 (57%), Gaps = 9/116 (7%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPS 250
           ++ + F+ E+ ++  + HPN+V+  G +   +P  +V E++P GDL    L +   +K S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNL--KVADFGVSK 301
             +R  LDIA G+ Y+    P PI+HRDL   NI     D++  +  KVADFG+S+
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 29/150 (19%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 62  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 119
Query: 235 GDLRAFLKRK--GALKPSTA---------------------VRFALDIARGMNYLHENKP 271
           GDL  FL+RK    L PS A                     + F+  +A+GM +L     
Sbjct: 120 GDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN- 178
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
              IHRD+   N+L  +    K+ DFG+++
Sbjct: 179 --CIHRDVAARNVLLTNGHVAKIGDFGLAR 206

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 73/136 (53%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K+ H N+V+ +G   QS P  I+ E +  G
Sbjct: 76  LQVAVKTL-PEVCSEQDELD-FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 134 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 190
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 191 PGPGRVAKIGDFGMAR 206

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQ 205
           +DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L 
Sbjct: 23  MDPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 80
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           +   P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++Y
Sbjct: 81  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDY 139
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH  K    IHRD++ +N+L  + G +K+ADFGV+  LT
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT 175

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++  Y  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 182 DLAARNVLVTENNVMKIADFGLAR 205

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 48  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 99
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 100 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 156
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 157 LLGSAGELKIADFGWS 172

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 9/167 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ +++ 
Sbjct: 12  PHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKI 70
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 130
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           H+     I+HRDL+  N+L D   N+K+ADFG S   TV       C
Sbjct: 131 HQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC 174

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 66/116 (56%), Gaps = 9/116 (7%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPS 250
           ++ + F+ E+ ++  + HPN+V+  G +   +P  +V E++P GDL    L +   +K S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNL--KVADFGVSK 301
             +R  LDIA G+ Y+    P PI+HRDL   NI     D++  +  KVADFG S+
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 10/160 (6%)
Query: 156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +F+N   + +G F   +      G  VAVK+L EE     +    F+ E+ ++    H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL--QFQTEVEMISMAVHRN 96
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS----TAVRFALDIARGMNYLH 267
           +++  G     +  ++V  Y+  G + + L+ +   +P        R AL  ARG+ YLH
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 156
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           ++    IIHRD++ +NIL D+     V DFG++KL+  K+
Sbjct: 157 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 196

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 57  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 108
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 109 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 165
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 166 LLGSAGELKIADFGWS 181

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 57  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 108
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 109 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 165
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 166 LLGSAGELKIADFGWS 181

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 32  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 83
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 84  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 140
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           L   +G LK+ADFG S         P + +DT C
Sbjct: 141 LLGSAGELKIADFGWSV------HAPSSRRDTLC 168

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 73/136 (53%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K+ H N+V+ +G   QS P  I+ E +  G
Sbjct: 62  LQVAVKTL-PEVCSEQDELD-FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGG 119
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 120 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 176
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 177 PGPGRVAKIGDFGMAR 192

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 133 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 174

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAP 93
Query: 234 KGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            G L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 150
Query: 293 KVADFGVSKLLTVKED 308
           K+ DFG+ + L   +D
Sbjct: 151 KIGDFGLMRALPQNDD 166

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 143 LLGSAGELKIADFGWS 158

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 140 LLGSAGELKIADFGWS 155

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 32  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 83
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 84  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 140
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 141 LLGSAGELKIADFGWS 156

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 145 LLGSAGELKIADFGWS 160

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 33  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 84
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 85  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 141
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 142 LLGSAGELKIADFGWS 157

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 76  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 133
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 134 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 190
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 191 PGPGRVAKIGDFGMAR 206

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 141 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 145 LLGSAGELKIADFGWS 160

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 10/158 (6%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
           DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L +
Sbjct: 19  DPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 76
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
              P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++YL
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYL 135
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           H  K    IHRD++ +N+L  + G +K+ADFGV+  LT
Sbjct: 136 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT 170

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P
Sbjct: 45  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAP 103
Query: 234 KGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            G L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +
Sbjct: 104 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 160
Query: 293 KVADFGVSKLLTVKED 308
           K+ DFG+ + L   +D
Sbjct: 161 KIGDFGLMRALPQNDD 176

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 140 LLGSAGELKIADFGWS 155

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 140 LLGSAGELKIADFGWS 155

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAP 93
Query: 234 KGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            G L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 150
Query: 293 KVADFGVSKLLTVKED 308
           K+ DFG+ + L   +D
Sbjct: 151 KIGDFGLMRALPQNDD 166

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 61  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 118
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 175
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 176 PGPGRVAKIGDFGMAR 191

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 140 LLGSAGELKIADFGWS 155

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P
Sbjct: 45  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAP 103
Query: 234 KGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            G L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +
Sbjct: 104 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 160
Query: 293 KVADFGVSKLLTVKED 308
           K+ DFG+ + L   +D
Sbjct: 161 KIGDFGLMRALPQNDD 176

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 145 LLGSAGELKIADFGWS 160

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P
Sbjct: 39  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAP 97
Query: 234 KGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            G L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +
Sbjct: 98  LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 154
Query: 293 KVADFGVSKLLTVKED 308
           K+ DFG+ + L   +D
Sbjct: 155 KIGDFGLMRALPQNDD 170

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 78  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 135
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 136 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 192
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 193 PGPGRVAKIGDFGMAR 208

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAP 93
Query: 234 KGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            G L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 150
Query: 293 KVADFGVSKLLTVKED 308
           K+ DFG+ + L   +D
Sbjct: 151 KIGDFGLMRALPQNDD 166

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 74/142 (52%), Gaps = 10/142 (7%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           GT     W G  VAVK L     +   +++AF++E+ +L+K RH N++ F+G  T+   +
Sbjct: 26  GTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-L 82
Query: 226 MIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
            IVT++     L   L   +   +    +  A   ARGM+YLH      IIHRDL+ +NI
Sbjct: 83  AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNI 139
Query: 285 LRDDSGNLKVADFGVSKLLTVK 306
              +   +K+ DFG   L TVK
Sbjct: 140 FLHEDNTVKIGDFG---LATVK 158

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 22/144 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++  Y  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK 301
           DL   N+L  ++  +K+ADFG+++
Sbjct: 182 DLAARNVLVTENNVMKIADFGLAR 205

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 102 LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 159
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 160 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 216
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 217 PGPGRVAKIGDFGMAR 232

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 53  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 110
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 111 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 167
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 168 PGPGRVAKIGDFGMAR 183

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 143 LLGSAGELKIADFGWS 158

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P
Sbjct: 39  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAP 97
Query: 234 KGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            G L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +
Sbjct: 98  LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 154
Query: 293 KVADFGVSKLLTVKED 308
           K+ DFG+ + L   +D
Sbjct: 155 KIGDFGLMRALPQNDD 170

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 117 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 158

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 30  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 82  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 138
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 139 LLGSAGELKIADFGWS 154

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 69/151 (45%), Gaps = 35/151 (23%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L EE  +  D    F+ E AL+ +  +PN+V+ LG      PM ++ EY+  GDL
Sbjct: 80  VAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 238 RAFLKRKGALKPSTAVRF---------------------------ALDIARGMNYLHENK 270
             FL+   ++ P T                               A  +A GM YL E K
Sbjct: 138 NEFLR---SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
               +HRDL   N L  ++  +K+ADFG+S+
Sbjct: 195 ---FVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 143 LLGSAGELKIADFGWS 158

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 143 LLGSAGELKIADFGWS 158

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 32  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 83
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 84  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 140
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 141 LLGSAGELKIADFGWS 156

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 61  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 118
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 175
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 176 PGPGRVAKIGDFGMAR 191

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 79  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 136
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 137 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 193
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 194 PGPGRVAKIGDFGMAR 209

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 62  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 119
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 120 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 176
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 177 PGPGRVAKIGDFGMAR 192

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 20  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 70
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 71  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           ARGM+YLH      IIHRDL+ +NI   +   +K+ DFG++
Sbjct: 130 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 140 LLGSAGELKIADFGWS 155

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 11/133 (8%)
Query: 168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ + +
Sbjct: 31  FILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           + EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+L  
Sbjct: 83  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLG 139
Query: 288 DSGNLKVADFGVS 300
            +G LK+ADFG S
Sbjct: 140 SAGELKIADFGWS 152

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 140 LLGSAGELKIADFGWS 155

>pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 62/105 (59%), Gaps = 5/105 (4%)
Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N  D+DG    P   L   A+   +E ++ LL +G DVN  D+   T LH+AA  G 
Sbjct: 38  ADVNATDNDG--YTP---LHLAASNGHLEIVEVLLKNGADVNASDLTGITPLHLAAATGH 92
Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            E+V +LL+ GADV+  D  G TPL  A  Y + E++++L KHGA
Sbjct: 93  LEIVEVLLKHGADVNAYDNDGHTPLHLAAKYGHLEIVEVLLKHGA 137

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 88  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 145
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 146 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 202
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 203 PGPGRVAKIGDFGMAR 218

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 140 LLGSAGELKIADFGWS 155

>pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/87 (43%), Positives = 51/87 (58%)
Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A     E +K+LL  G DVN R  D  T LH+AA  G  E+V LLL +GADV+ + 
Sbjct: 13  LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + G+TP   A    +HE++KLL+  GA
Sbjct: 73  KDGNTPEHLAKKNGHHEIVKLLDAKGA 99

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 35  QSKFILALKVLFKTQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 86
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 87  VYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 143
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           L   +G LK+ADFG S         P + +DT C
Sbjct: 144 LLGSNGELKIADFGWSV------HAPSSRRDTLC 171

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 68  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 125
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 126 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 182
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 183 PGPGRVAKIGDFGMAR 198

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 143 LLGSAGELKIADFGWS 158

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 35  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 86
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 87  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 143
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 144 LLGSAGELKIADFGWS 159

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 62  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 119
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 120 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 176
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 177 PGPGRVAKIGDFGMAQ 192

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 176 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 217

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 96/178 (53%), Gaps = 33/178 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  
Sbjct: 6   EWEVAREKI--TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE- 61
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP------- 249
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P       
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPV 118
Query: 250 ------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 S  ++ A +IA GM YL+ NK    +HRDL   N    +   +K+ DFG+++
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 20  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 70
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T +  + IVT++     L   L   +   +    +  A   
Sbjct: 71  VGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           ARGM+YLH      IIHRDL+ +NI   +   +K+ DFG++
Sbjct: 130 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 76  LQVAVKTL-PEVYSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 134 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 190
Query: 289 SGNLKVA---DFGVSK 301
            G  +VA   DFG+++
Sbjct: 191 PGPGRVAKIGDFGMAR 206

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VA+K + +  ++     + FR E+ +++ 
Sbjct: 12  PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKI 70
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + ++ EY   G++  +L   G +K   A      I   + Y 
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           H+ +   I+HRDL+  N+L D   N+K+ADFG S   TV
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VA+K + +  ++     + FR E+ +++ 
Sbjct: 9   PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKI 67
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + ++ EY   G++  +L   G +K   A      I   + Y 
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 127
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           H+ +   I+HRDL+  N+L D   N+K+ADFG S   TV
Sbjct: 128 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 163

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VAVK+L EE     +    F+ E+ ++    H N+++  G     +  ++V  Y+  
Sbjct: 54  GXLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 235 GDLRAFLKRKGALKPS----TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           G + + L+ +   +P        R AL  ARG+ YLH++    IIHRD++ +NIL D+  
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 291 NLKVADFGVSKLLTVKE 307
              V DFG++KL+  K+
Sbjct: 172 EAVVGDFGLAKLMDYKD 188

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 35  QSKFILALKVLFKTQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 86
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 87  VYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 143
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+ADFG S
Sbjct: 144 LLGSNGELKIADFGWS 159

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 77  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 235 GDLRAFLKRK------GALKPSTA----------VRFALDIARGMNYLHENKPVPIIHRD 278
           GDL  FL+RK       +  PS            + F+  +A+GM +L        IHRD
Sbjct: 135 GDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKN---CIHRD 191
Query: 279 LEPSNILRDDSGNLKVADFGVSK 301
           +   N+L  +    K+ DFG+++
Sbjct: 192 VAARNVLLTNGHVAKIGDFGLAR 214

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 79/141 (56%), Gaps = 13/141 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK +    +S    V AF  E  +++ ++H  +V+ L AV    P+ I+TE++ KG 
Sbjct: 41  KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 95
Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK  +G+ +P    + F+  IA GM ++ +      IHRDL  +NIL   S   K+
Sbjct: 96  LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 152
Query: 295 ADFGVSKLLTVKEDRPLTCQD 315
           ADFG+++++   ED   T ++
Sbjct: 153 ADFGLARVI---EDNEYTARE 170

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 79/141 (56%), Gaps = 13/141 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK +    +S    V AF  E  +++ ++H  +V+ L AV    P+ I+TE++ KG 
Sbjct: 214 KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 268
Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK  +G+ +P    + F+  IA GM ++ +      IHRDL  +NIL   S   K+
Sbjct: 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 325
Query: 295 ADFGVSKLLTVKEDRPLTCQD 315
           ADFG+++++   ED   T ++
Sbjct: 326 ADFGLARVI---EDNEYTARE 343

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 68/124 (54%), Gaps = 4/124 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 34  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 93
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 94  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 150
Query: 298 GVSK 301
           G+ K
Sbjct: 151 GMCK 154

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 33  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 84
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 85  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 141
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+A+FG S
Sbjct: 142 LLGSAGELKIANFGWS 157

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 68/124 (54%), Gaps = 4/124 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 49  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 109 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 165
Query: 298 GVSK 301
           G+ K
Sbjct: 166 GMCK 169

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 138 HVKHAREVPEYE---IDPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVI 188
           H   A +VP  +    DP EL FT    I KG+F   F +GI       VA+K +  ++ 
Sbjct: 4   HSPVAVQVPGMQNNIADPEEL-FTKLERIGKGSFGEVF-KGIDNRTQQVVAIKII--DLE 59
Query: 189 SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK 248
             +D +   + E+ +L +     V ++ G+  + S + I+ EYL  G     L R G   
Sbjct: 60  EAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL-RAGPFD 118
Query: 249 PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                    +I +G++YLH  K    IHRD++ +N+L  + G++K+ADFGV+  LT
Sbjct: 119 EFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT 171

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 68/124 (54%), Gaps = 4/124 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 98  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 298 GVSK 301
           G+ K
Sbjct: 155 GMCK 158

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 68/130 (52%), Gaps = 3/130 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            I+VA+K +       ++ ++ F  E+    ++ H N+V  +    +     +V EY+  
Sbjct: 36  NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
             L  +++  G L   TA+ F   I  G+ + H+ +   I+HRD++P NIL D +  LK+
Sbjct: 96  PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKI 152
Query: 295 ADFGVSKLLT 304
            DFG++K L+
Sbjct: 153 FDFGIAKALS 162

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 52  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 111
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 112 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 168
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 169 TDFGFAK 175

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 4/139 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK + +  ++     + FR E+ +++ + HPN+V+    +     + +V EY   
Sbjct: 32  GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 90
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++  +L   G +K   A      I   + Y H+     I+HRDL+  N+L D   N+K+
Sbjct: 91  GEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK---FIVHRDLKAENLLLDADMNIKI 147
Query: 295 ADFGVSKLLTVKEDRPLTC 313
           ADFG S   T        C
Sbjct: 148 ADFGFSNEFTFGNKLDTFC 166

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVS 300
           L   +G LK+A+FG S
Sbjct: 143 LLGSAGELKIANFGWS 158

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 9/167 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 173

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 9/167 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 173

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 59  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 118
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 119 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 175
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 176 TDFGFAK 182

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 9/167 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC 173

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 66/107 (61%), Gaps = 5/107 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E+++L++++H N+V+    +     +++V E+L + DL+  L   +G L+  TA  F L 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           +  G+ Y H+ +   ++HRDL+P N+L +  G LK+ADFG+++   +
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 66/116 (56%), Gaps = 9/116 (7%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPS 250
           ++ + F+ E+ ++  + HPN+V+  G +   +P  +V E++P GDL    L +   +K S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNL--KVADFGVSK 301
             +R  LDIA G+ Y+    P PI+HRDL   NI     D++  +  KVADF +S+
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 66/107 (61%), Gaps = 5/107 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E+++L++++H N+V+    +     +++V E+L + DL+  L   +G L+  TA  F L 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           +  G+ Y H+ +   ++HRDL+P N+L +  G LK+ADFG+++   +
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 66/107 (61%), Gaps = 5/107 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E+++L++++H N+V+    +     +++V E+L + DL+  L   +G L+  TA  F L 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           +  G+ Y H+ +   ++HRDL+P N+L +  G LK+ADFG+++   +
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 59  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 118
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 119 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 175
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 176 TDFGFAK 182

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 5/103 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
           E++LL+ ++H N+V     +     + +V EYL K DL+ +L   G +     V+ F   
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           + RG+ Y H  K   ++HRDL+P N+L ++ G LK+ADFG+++
Sbjct: 109 LLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 87  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 146
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 147 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 203
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 204 TDFGFAK 210

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 69/129 (53%), Gaps = 8/129 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYL 232
           G  VAVK L  +  +       ++ E+ +L+ + H +++++ G      ++ + +V EY+
Sbjct: 60  GEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G LR +L R  ++  +  + FA  I  GM YLH       IHRDL   N+L D+   +
Sbjct: 118 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLV 173
Query: 293 KVADFGVSK 301
           K+ DFG++K
Sbjct: 174 KIGDFGLAK 182

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 69/127 (54%), Gaps = 4/127 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +  +   DRVR  + E  +L  + HP VV+   A      + ++ ++L  
Sbjct: 56  GHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRG 114
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           GDL   L ++          +  ++A G+++LH    + II+RDL+P NIL D+ G++K+
Sbjct: 115 GDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKL 171
Query: 295 ADFGVSK 301
            DFG+SK
Sbjct: 172 TDFGLSK 178

>pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 68/120 (56%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D + ++      L   A E  +E ++ LL +G DVN +D
Sbjct: 6   LLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKD 65
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            D  T LH+AA +G  E+V +LL+ GADV+ KD+ G TPL  A    + E++++L K GA
Sbjct: 66  KDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGA 125

>pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 68/120 (56%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D + ++      L   A E  +E ++ LL +G DVN +D
Sbjct: 6   LLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKD 65
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            D  T LH+AA +G  E+V +LL+ GADV+ KD+ G TPL  A    + E++++L K GA
Sbjct: 66  KDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGA 125

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 9/159 (5%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L F++  EI  G+F  + F R ++    VA+KK+       +++ +    E+  LQ
Sbjct: 51  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           K+RHPN +Q+ G   +     +V EY            K  L+            +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH +    +IHRD++  NIL  + G +K+ DFG + ++ 
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 68/124 (54%), Gaps = 4/124 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A++ + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 298 GVSK 301
           G+ K
Sbjct: 198 GMCK 201

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 77/137 (56%), Gaps = 10/137 (7%)
Query: 168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           ++  + +  +VAVK +    +S    V AF  E  +++ ++H  +V+ L AV    P+ I
Sbjct: 199 WMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYI 253
Query: 228 VTEYLPKGDLRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +TE++ KG L  FLK  +G+ +P    + F+  IA GM ++ +      IHRDL  +NIL
Sbjct: 254 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANIL 310
Query: 286 RDDSGNLKVADFGVSKL 302
              S   K+ADFG++++
Sbjct: 311 VSASLVCKIADFGLARV 327

>pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/102 (40%), Positives = 61/102 (59%), Gaps = 5/102 (4%)
Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G  + P   L   A    +E ++ LL  G DVN RDI  RT LH+AA  G 
Sbjct: 38  ADVNAMDDAG--VTP---LHLAAKRGHLEIVEVLLKHGADVNARDIWGRTPLHLAATVGH 92
Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
            E+V +LLE GADV+ +D++G T    +I   N ++ ++L+K
Sbjct: 93  LEIVEVLLEYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 134

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 9/159 (5%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L F++  EI  G+F  + F R ++    VA+KK+       +++ +    E+  LQ
Sbjct: 12  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           K+RHPN +Q+ G   +     +V EY            K  L+            +G+ Y
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH +    +IHRD++  NIL  + G +K+ DFG + ++ 
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 29/150 (19%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           IQVAVK L E+  +D     A   EL ++ ++  H N+V  LGA T S P+ ++ EY   
Sbjct: 76  IQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 133
Query: 235 GDLRAFLKRK-----------------------GALKPSTAVRFALDIARGMNYLHENKP 271
           GDL  +L+ K                         L     + FA  +A+GM +L     
Sbjct: 134 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 193
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           V   HRDL   N+L      +K+ DFG+++
Sbjct: 194 V---HRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +     +    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 295 ADFGVSK 301
            DFG++K
Sbjct: 183 TDFGLAK 189

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 71/129 (55%), Gaps = 7/129 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      +    F DE  ++  + HP++V+ LG V  S  + +VT+ +P G
Sbjct: 68  IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 124
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  ++ + K  +     + + + IA+GM YL E +   ++HRDL   N+L     ++K+
Sbjct: 125 CLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 181
Query: 295 ADFGVSKLL 303
            DFG+++LL
Sbjct: 182 TDFGLARLL 190

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  + Q +  P +V+   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G +KV
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 183
Query: 295 ADFGVSK 301
           ADFG +K
Sbjct: 184 ADFGFAK 190

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 40  ALAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 96
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 97  GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 153
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 154 LGDFGLSRYM 163

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 66  ALAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 122
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 123 GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 179
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 180 LGDFGLSRYM 189

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 35  ALAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 91
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 92  GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 148
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 149 LGDFGLSRYM 158

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 41  ALAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 97
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 98  GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 154
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 155 LGDFGLSRYM 164

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 38  ALAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 94
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 95  GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 151
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 152 LGDFGLSRYM 161

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 38  AMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 94
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 95  GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 151
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 152 LGDFGLSRYM 161

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 66/131 (50%), Gaps = 7/131 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NIL   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVK 156
Query: 294 VADFGVSKLLT 304
           V DFG+++ + 
Sbjct: 157 VVDFGIARAIA 167

>pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 68/120 (56%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D + ++      L   A E  +E ++ LL +G DVN +D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            D  T LH+AA +G  E+V +LL+ GADV+ KD+ G TPL  A    + E++++L K GA
Sbjct: 78  KDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGA 137

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 71/129 (55%), Gaps = 7/129 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      +    F DE  ++  + HP++V+ LG V  S  + +VT+ +P G
Sbjct: 45  IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 101
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  ++ + K  +     + + + IA+GM YL E +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 158
Query: 295 ADFGVSKLL 303
            DFG+++LL
Sbjct: 159 TDFGLARLL 167

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 9/167 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAV+ + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 173

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 43  ALAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 99
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 100 GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 156
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 157 LGDFGLSRYM 166

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 7/131 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156
Query: 294 VADFGVSKLLT 304
           V DFG+++ + 
Sbjct: 157 VMDFGIARAIA 167

>pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 65/120 (54%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  + +    L   A     E ++ LL  G DVN RD
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAHDDQGSTPLHLAAWIGHPEIVEVLLKHGADVNARD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            D  T LH+AA  G  E+V +LL+ GADV+ +D +G TPL  A    + E++++L KHGA
Sbjct: 78  TDGWTPLHLAADNGHLEIVEVLLKYGADVNAQDAYGLTPLHLAADRGHLEIVEVLLKHGA 137

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 9/165 (5%)
Query: 143 REVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAF 197
           +E P  +I     DF     + KG+F   F    +      A+K L ++V+  DD V   
Sbjct: 5   KERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 198 RDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
             E  +L     HP +            +  V EYL  GDL   ++       S A  +A
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            +I  G+ +LH      I++RDL+  NIL D  G++K+ADFG+ K
Sbjct: 125 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G Q  +K++    +S  +R  + R E+A+L  ++HPN+VQ+  +  ++  + IV +Y   
Sbjct: 49  GRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 235 GDL-RAFLKRKGAL-KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL +    +KG L +    + + + I   + ++H+ K   I+HRD++  NI     G +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV 164
Query: 293 KVADFGVSKLLTVKEDRPLTCQDT 316
           ++ DFG++++L    +    C  T
Sbjct: 165 QLGDFGIARVLNSTVELARACIGT 188

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 65/107 (60%), Gaps = 5/107 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E++LL+++ HPN+V  +  +     + +V E++ K DL+  L + K  L+ S    +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           + RG+ + H+++   I+HRDL+P N+L +  G LK+ADFG+++   +
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 38  AMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 94
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 95  GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 151
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 152 LGDFGLSRYM 161

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 65/107 (60%), Gaps = 5/107 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E++LL+++ HPN+V  +  +     + +V E++ K DL+  L + K  L+ S    +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           + RG+ + H+++   I+HRDL+P N+L +  G LK+ADFG+++   +
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAV+ + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           H+     I+HRDL+  N+L D   N+K+ADFG S   T
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 9/165 (5%)
Query: 143 REVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAF 197
           +E P  +I     DF     + KG+F   F    +      A+K L ++V+  DD V   
Sbjct: 6   KERPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 65
Query: 198 RDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
             E  +L     HP +            +  V EYL  GDL   ++       S A  +A
Sbjct: 66  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 125
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            +I  G+ +LH      I++RDL+  NIL D  G++K+ADFG+ K
Sbjct: 126 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 167

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 38  AMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 94
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 95  GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVK 151
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 152 LGDFGLSRYM 161

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 418 AMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 474
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 475 GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 531
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 532 LGDFGLSRYM 541

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 XLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 159 TDFGLAKLLGAEE 171

>pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/120 (36%), Positives = 66/120 (55%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D + E+   +  L   A    +E ++ LL +G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAEDTYGDTPLHLAARVGHLEIVEVLLKNGADVNALD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               T LH+AA +G  E+V +LL+ GADV+  D  GSTPL  A    + E++++L K+GA
Sbjct: 78  FSGSTPLHLAAKRGHLEIVEVLLKYGADVNADDTIGSTPLHLAADTGHLEIVEVLLKYGA 137

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 74/144 (51%), Gaps = 13/144 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K + +E +  + +  +  +E+A+L KI+HPN+V           + ++ + +  G+L
Sbjct: 46  VAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKV 294
              +  KG      A R    +   + YLH+   + I+HRDL+P N+L    D+   + +
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
           +DFG+SK+     + P +   T+C
Sbjct: 161 SDFGLSKM-----EDPGSVLSTAC 179

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 74/144 (51%), Gaps = 13/144 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K + +E +  + +  +  +E+A+L KI+HPN+V           + ++ + +  G+L
Sbjct: 46  VAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKV 294
              +  KG      A R    +   + YLH+   + I+HRDL+P N+L    D+   + +
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
           +DFG+SK+     + P +   T+C
Sbjct: 161 SDFGLSKM-----EDPGSVLSTAC 179

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 23/142 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++TE+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 280 EPSNILRDDSGNLKVADFGVSK 301
              NIL  +   +K+ DFG+++
Sbjct: 166 AARNILLSEKNVVKICDFGLAR 187

>pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/125 (37%), Positives = 68/125 (54%), Gaps = 10/125 (8%)
Query: 11  LLKQSSLAPDRERK-----EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
           LL+ ++   D E +      A++N  DD+G  + P   L   A    +E ++ LL +G D
Sbjct: 10  LLEAAAAGQDDEVRILMANGADVNATDDNG--LTP---LHLAAANGQLEIVEVLLKNGAD 64
Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
           VN  D    T LH+AA  G  E+V +LL+ GADV+  DR G TPL  A      E++++L
Sbjct: 65  VNASDSAGITPLHLAAYDGHLEIVEVLLKHGADVNAYDRAGWTPLHLAALSGQLEIVEVL 124
Query: 126 EKHGA 130
            KHGA
Sbjct: 125 LKHGA 129

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 39  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 95
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 96  CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 152
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 153 TDFGLAKLLGAEE 165

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 51  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 107
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 108 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 164
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 165 TDFGLAKLLGAEE 177

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 159 TDFGLAKLLGAEE 171

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 418 AMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 474
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 475 GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVK 531
Query: 294 VADFGVSKLL 303
           + DFG+S+ +
Sbjct: 532 LGDFGLSRYM 541

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 159 TDFGLAKLLGAEE 171

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 52  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 108
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 109 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 165
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 166 TDFGLAKLLGAEE 178

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 74/144 (51%), Gaps = 13/144 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K + +E +  + +  +  +E+A+L KI+HPN+V           + ++ + +  G+L
Sbjct: 46  VAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKV 294
              +  KG      A R    +   + YLH+   + I+HRDL+P N+L    D+   + +
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
           +DFG+SK+     + P +   T+C
Sbjct: 161 SDFGLSKM-----EDPGSVLSTAC 179

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 23/142 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++TE+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 280 EPSNILRDDSGNLKVADFGVSK 301
              NIL  +   +K+ DFG+++
Sbjct: 166 AARNILLSEKNVVKICDFGLAR 187

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 23/142 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++TE+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 280 EPSNILRDDSGNLKVADFGVSK 301
              NIL  +   +K+ DFG+++
Sbjct: 166 AARNILLSEKNVVKICDFGLAR 187

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 161 TDFGLAKLLGAEE 173

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 159 TDFGLAKLLGAEE 171

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 2/104 (1%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK    +      + ++ +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            RG+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L
Sbjct: 124 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 165

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 55  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 111
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 112 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 168
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 169 TDFGLAKLLGAEE 181

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 52  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 108
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 109 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 165
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 166 TDFGLAKLLGAEE 178

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 48  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 104
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 105 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 161
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 162 TDFGLAKLLGAEE 174

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 48  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 104
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 105 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 161
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 162 TDFGLAKLLGAEE 174

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 70  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 126
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 127 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 183
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 184 TDFGLAKLLGAEE 196

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 48  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 104
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 105 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 161
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 162 TDFGLAKLLGAEE 174

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +     +    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG++K
Sbjct: 183 TDFGLAK 189

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 7/131 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156
Query: 294 VADFGVSKLLT 304
           V DFG+++ + 
Sbjct: 157 VMDFGIARAIA 167

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P + +   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P + +   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 7/131 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156
Query: 294 VADFGVSKLLT 304
           V DFG+++ + 
Sbjct: 157 VMDFGIARAIA 167

>pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN  D    T LH+AA  G  E+V +LL+ GADVD  D +G TPL  A Y
Sbjct: 30  VRILMANGADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAY 89
Query: 116 YKNHEVIKLLEKHGA------KPLMAPMHV 139
           + + E++++L K+GA         M P+H+
Sbjct: 90  WGHLEIVEVLLKNGADVNAMDSDGMTPLHL 119

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 7/131 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156
Query: 294 VADFGVSKLLT 304
           V DFG+++ + 
Sbjct: 157 VMDFGIARAIA 167

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P + +   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 127 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 71/127 (55%), Gaps = 8/127 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVR-AFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
           ++V  ++L  E + +   VR A R E  +L+++  HP+++  + +   SS M +V + + 
Sbjct: 127 MEVTAERLSPEQLEE---VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           KG+L  +L  K AL           +   +++LH N    I+HRDL+P NIL DD+  ++
Sbjct: 184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240
Query: 294 VADFGVS 300
           ++DFG S
Sbjct: 241 LSDFGFS 247

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 7/131 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 116
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 117 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 173
Query: 294 VADFGVSKLLT 304
           V DFG+++ + 
Sbjct: 174 VMDFGIARAIA 184

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 66/140 (47%), Gaps = 22/140 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L +  ++     + F+ E  LL  ++H ++V+F G      P+++V EY+  GDL
Sbjct: 48  VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 104
Query: 238 RAFLK----------------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL+                 KG L  S  +  A  IA GM YL        +HRDL  
Sbjct: 105 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLAT 161
Query: 282 SNILRDDSGNLKVADFGVSK 301
            N L   +  +K+ DFG+S+
Sbjct: 162 RNCLVGANLLVKIGDFGMSR 181

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 9/167 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ + + 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G  K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC 173

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 53  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 112
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D+ G ++V
Sbjct: 113 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQV 169
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 170 TDFGFAK 176

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           H  +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++
Sbjct: 2   HMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNY 265
            HPN+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
            H ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 120 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 156

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 2/127 (1%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   
Sbjct: 176 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 235
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   ++YLH  K V  ++RDL+  N++ D  G++K+
Sbjct: 236 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKI 293
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 294 TDFGLCK 300

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 88/157 (56%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+++ H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 9/161 (5%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
           P++ +  +E ++     + KGTF   IL   +  G   A+K L +EVI   D V     E
Sbjct: 141 PKHRVTMNEFEYLKL--LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
             +LQ  RHP +     +      +  V EY   G+L   L R+       A  +  +I 
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
             ++YLH  K V  ++RDL+  N++ D  G++K+ DFG+ K
Sbjct: 259 SALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/75 (42%), Positives = 50/75 (66%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN  D   +T LH+AA +G  E+V +LL+ GADV+  D+ G TPL  A  
Sbjct: 30  VRILMANGADVNAEDDSGKTPLHLAAIKGHLEIVEVLLKHGADVNAADKMGDTPLHLAAL 89
Query: 116 YKNHEVIKLLEKHGA 130
           Y + E++++L K+GA
Sbjct: 90  YGHLEIVEVLLKNGA 104

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 2/127 (1%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   
Sbjct: 35  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 94
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   ++YLH  K V  ++RDL+  N++ D  G++K+
Sbjct: 95  GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKI 152
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 153 TDFGLCK 159

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 2/127 (1%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   
Sbjct: 33  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 92
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   ++YLH  K V  ++RDL+  N++ D  G++K+
Sbjct: 93  GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKI 150
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 151 TDFGLCK 157

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 21/139 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   + +   + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL
Sbjct: 51  VAVKALKE---ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 107
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             FL+                 G L     +  A  +A GM YL     +  +HRDL   
Sbjct: 108 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATR 164
Query: 283 NILRDDSGNLKVADFGVSK 301
           N L      +K+ DFG+S+
Sbjct: 165 NCLVGQGLVVKIGDFGMSR 183

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 2/127 (1%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   
Sbjct: 34  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 93
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   ++YLH  K V  ++RDL+  N++ D  G++K+
Sbjct: 94  GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKI 151
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 152 TDFGLCK 158

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK L  +          ++ E+ +L+ + H +++++ G         + +V EY+
Sbjct: 43  GEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G LR +L R  ++  +  + FA  I  GM YLH       IHR+L   N+L D+   +
Sbjct: 101 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHSQH---YIHRNLAARNVLLDNDRLV 156
Query: 293 KVADFGVSK 301
           K+ DFG++K
Sbjct: 157 KIGDFGLAK 165

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 42  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 98
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 99  CLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 155
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 156 TDFGLAKLLGAEE 168

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 60/102 (58%), Gaps = 5/102 (4%)
Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G  + P   L   A    +E ++ LL  G DVN  DI  RT LH+AA  G 
Sbjct: 38  ADVNAMDDAG--VTP---LHLAAKRGHLEIVEVLLKHGADVNASDIWGRTPLHLAATVGH 92
Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
            E+V +LLE GADV+ +D++G T    +I   N ++ ++L+K
Sbjct: 93  LEIVEVLLEYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 134

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 21/139 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   + +   + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL
Sbjct: 45  VAVKALKE---ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 101
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             FL+                 G L     +  A  +A GM YL     +  +HRDL   
Sbjct: 102 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATR 158
Query: 283 NILRDDSGNLKVADFGVSK 301
           N L      +K+ DFG+S+
Sbjct: 159 NCLVGQGLVVKIGDFGMSR 177

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 21/139 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   + +   + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL
Sbjct: 74  VAVKALKE---ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             FL+                 G L     +  A  +A GM YL     +  +HRDL   
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATR 187
Query: 283 NILRDDSGNLKVADFGVSK 301
           N L      +K+ DFG+S+
Sbjct: 188 NCLVGQGLVVKIGDFGMSR 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 140 ERDNLKISDFGLATVF 155

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 21  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 81  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 137
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 138 ERDNLKISDFGLATVF 153

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 9/152 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF   + + KG+F   +L+  +G     AVK L ++V+  DD V     E  +L     P
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
             +  L +  Q+   +  V EY+  GDL   +++ G  K   AV +A +IA G+ +L   
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
               II+RDL+  N++ D  G++K+ADFG+ K
Sbjct: 141 G---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 140 ERDNLKISDFGLATVF 155

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 19/138 (13%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           +L  +L+ K              L     + ++  +A+GM +L   K    IHRDL   N
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK---XIHRDLAARN 174
Query: 284 ILRDDSGNLKVADFGVSK 301
           IL  +   +K+ DFG+++
Sbjct: 175 ILLSEKNVVKICDFGLAR 192

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 9   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 59
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 60  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK 
Sbjct: 119 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKS 160

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 140 ERDNLKISDFGLATVF 155

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 140 ERDNLKISDFGLATVF 155

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 140 ERDNLKISDFGLATVF 155

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 140 ERDNLKISDFGLATVF 155

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK L  +          ++ E+ +L+ + H +++++ G         + +V EY+
Sbjct: 43  GEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G LR +L R  ++  +  + FA  I  GM YLH       IHR+L   N+L D+   +
Sbjct: 101 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRNLAARNVLLDNDRLV 156
Query: 293 KVADFGVSK 301
           K+ DFG++K
Sbjct: 157 KIGDFGLAK 165

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 4/123 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 56  AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L ++          +  ++A  +++LH    + II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 299 VSK 301
           +SK
Sbjct: 172 LSK 174

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 61  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 120
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 121 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 177
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 178 TDFGFAK 184

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 157

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 9   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 59
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 60  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK 
Sbjct: 119 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKS 160

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 4/123 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 57  AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 115
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L ++          +  ++A  +++LH    + II+RDL+P NIL D+ G++K+ DFG
Sbjct: 116 TRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 172
Query: 299 VSK 301
           +SK
Sbjct: 173 LSK 175

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 66
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 159

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 10/143 (6%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           GT     W G  VAVK L     +   +++AF++E+ +L+K RH N++ F+G  T+   +
Sbjct: 24  GTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-L 80
Query: 226 MIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
            IVT++     L   L   +   +    +  A   A+GM+YLH      IIHRDL+ +NI
Sbjct: 81  AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNI 137
Query: 285 LRDDSGNLKVADFGVSKLLTVKE 307
              +   +K+ DFG   L TVK 
Sbjct: 138 FLHEDLTVKIGDFG---LATVKS 157

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 4/123 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 56  AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L ++          +  ++A  +++LH    + II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 299 VSK 301
           +SK
Sbjct: 172 LSK 174

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 184 TDFGFAK 190

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 66
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 159

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 157

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE 307
            DFG +KLL  +E
Sbjct: 159 TDFGRAKLLGAEE 171

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 4   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 54
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 55  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG++
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE 307
            DFG +KLL  +E
Sbjct: 161 TDFGRAKLLGAEE 173

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 32  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 82
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 83  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 141
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG++
Sbjct: 142 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 31  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 81
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 82  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 140
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK 
Sbjct: 141 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKS 182

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 24  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 74
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 75  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 133
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG++
Sbjct: 134 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 162

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 19/138 (13%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           +L  +L+ K              L     + ++  +A+GM +L   K    IHRDL   N
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAARN 174
Query: 284 ILRDDSGNLKVADFGVSK 301
           IL  +   +K+ DFG+++
Sbjct: 175 ILLSEKNVVKIXDFGLAR 192

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 32  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 82
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 83  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 141
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK 
Sbjct: 142 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKS 183

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 156

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 52  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 108
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 109 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 165
Query: 295 ADFGVSKLLTVKE 307
            DFG +KLL  +E
Sbjct: 166 TDFGRAKLLGAEE 178

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 156

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 22/141 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 61  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 118
Query: 236 DLRAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           +L  +L+ K                 L     + ++  +A+GM +L   K    IHRDL 
Sbjct: 119 NLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175
Query: 281 PSNILRDDSGNLKVADFGVSK 301
             NIL  +   +K+ DFG+++
Sbjct: 176 ARNILLSEKNVVKICDFGLAR 196

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 9/152 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF   + + KG+F   +L+  +G     AVK L ++V+  DD V     E  +L     P
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
             +  L +  Q+   +  V EY+  GDL   +++ G  K   AV +A +IA G+ +L   
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
               II+RDL+  N++ D  G++K+ADFG+ K
Sbjct: 462 G---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 74/144 (51%), Gaps = 13/144 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K + ++ +  + +  +  +E+A+L KI+HPN+V           + ++ + +  G+L
Sbjct: 46  VAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKV 294
              +  KG      A R    +   + YLH+   + I+HRDL+P N+L    D+   + +
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
           +DFG+SK+     + P +   T+C
Sbjct: 161 SDFGLSKM-----EDPGSVLSTAC 179

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L         +++AF++E
Sbjct: 4   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNE 54
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 55  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG++ +
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 162

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 21/140 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 62  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 236 DLRAFLKRKG----ALKPSTA----------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
           +L  +L+ K       KP             + ++  +A+GM +L   K    IHRDL  
Sbjct: 120 NLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAA 176
Query: 282 SNILRDDSGNLKVADFGVSK 301
            NIL  +   +K+ DFG+++
Sbjct: 177 RNILLSEKNVVKICDFGLAR 196

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 124 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV 157

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 87  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 146
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 147 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 203
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 204 TDFGFAK 210

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV 156

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           E+A+L+K+ HPNVV+ +  +   +   + +V E + +G +      K  L    A  +  
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYFQ 144
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           D+ +G+ YLH  K   IIHRD++PSN+L  + G++K+ADFGVS
Sbjct: 145 DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|3UTM|A Chain A, Crystal Structure Of A Mouse Tankyrase-Axin Complex Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/137 (35%), Positives = 58/137 (42%), Gaps = 12/137 (8%)
Query: 28  LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
           +N    DG +  P   L   A    V  ++ LL  G DV+ +D      LH A   G  E
Sbjct: 49  VNCHASDGRKSTP---LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYE 105
Query: 88  VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA----- 142
           V  LLL+ GA V+  D W  TPL +A      EV  LL  HGA P +   H K A     
Sbjct: 106 VTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAP 165
Query: 143 ----REVPEYEIDPHEL 155
               RE   YE   H L
Sbjct: 166 TPELRERLTYEFKGHSL 182

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 46  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 102
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 103 XLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 159
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 160 TDFGLAKLLGAEE 172

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L         +++AF++E
Sbjct: 4   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNE 54
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T +  + IVT++     L   L   +   +    +  A   
Sbjct: 55  VGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG++ +
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 87  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 146
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 147 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 203
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 204 TDFGFAK 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ +   + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 140 ERDNLKISDFGLATVF 155

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 140 ERDNLKISDFGLATVF 155

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 23/142 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 108
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 280 EPSNILRDDSGNLKVADFGVSK 301
              NIL  +   +K+ DFG+++
Sbjct: 166 AARNILLSEKNVVKICDFGLAR 187

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 189 SDDDR-VRAFR----DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
           SDD++ +  F     +E++LL+ + HPN+++            +VTE+   G+L   +  
Sbjct: 80  SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVS 300
           +       A      I  G+ YLH++    I+HRD++P NIL ++     N+K+ DFG+S
Sbjct: 140 RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 301 KLLT 304
              +
Sbjct: 197 SFFS 200

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLL 303
           +  NLK++DFG++ + 
Sbjct: 139 ERDNLKISDFGLATVF 154

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTE 230
           ++VAVK +  +  S    +  F  E A ++   HPNV++ LG   + S       M++  
Sbjct: 63  LKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 231 YLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           ++  GDL  +L           +   T ++F +DIA GM YL        +HRDL   N 
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNC 178
Query: 285 LRDDSGNLKVADFGVSK 301
           +  D   + VADFG+SK
Sbjct: 179 MLRDDMTVCVADFGLSK 195

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 23/142 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 280 EPSNILRDDSGNLKVADFGVSK 301
              NIL  +   +K+ DFG+++
Sbjct: 175 AARNILLSEKNVVKICDFGLAR 196

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 23/142 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 280 EPSNILRDDSGNLKVADFGVSK 301
              NIL  +   +K+ DFG+++
Sbjct: 175 AARNILLSEKNVVKICDFGLAR 196

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 86/157 (54%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L   DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 125 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV 158

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 23/142 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 280 EPSNILRDDSGNLKVADFGVSK 301
              NIL  +   +K+ DFG+++
Sbjct: 175 AARNILLSEKNVVKICDFGLAR 196

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 86/157 (54%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L   DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV 156

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 159 TDFGLAKLLGAEE 171

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALD 258
           E+ +L    HPN+V+ L A    + + I+ E+   G + A  L+ +  L  S        
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
               +NYLH+NK   IIHRDL+  NIL    G++K+ADFGVS
Sbjct: 144 TLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 76/139 (54%), Gaps = 16/139 (11%)
Query: 175 GIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           G+ VA+K  KL  E  +    +R    E++L+++++H N+V+    +   + + +V E++
Sbjct: 30  GVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85
Query: 233 PKGDLRAFLKRKG------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
              DL+ ++  +        L+ +    F   + +G+ + HENK   I+HRDL+P N+L 
Sbjct: 86  -DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLI 141
Query: 287 DDSGNLKVADFGVSKLLTV 305
           +  G LK+ DFG+++   +
Sbjct: 142 NKRGQLKLGDFGLARAFGI 160

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 46  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 102
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 103 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 159
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 160 TDFGLAKLLGAEE 172

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 23/142 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 97  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211
Query: 280 EPSNILRDDSGNLKVADFGVSK 301
              NIL  +   +K+ DFG+++
Sbjct: 212 AARNILLSEKNVVKICDFGLAR 233

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 23/142 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 62  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 120 NLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 176
Query: 280 EPSNILRDDSGNLKVADFGVSK 301
              NIL  +   +K+ DFG+++
Sbjct: 177 AARNILLSEKNVVKICDFGLAR 198

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 58/125 (46%), Gaps = 22/125 (17%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 88  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 147
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 148 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 204
Query: 297 FGVSK 301
           FG+++
Sbjct: 205 FGLAR 209

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALD 258
           E+ +L    HPN+V+ L A    + + I+ E+   G + A  L+ +  L  S        
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
               +NYLH+NK   IIHRDL+  NIL    G++K+ADFGVS
Sbjct: 144 TLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 161 TDFGLAKLLGAEE 173

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 58/125 (46%), Gaps = 22/125 (17%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 90  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 149
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 150 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 206
Query: 297 FGVSK 301
           FG+++
Sbjct: 207 FGLAR 211

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 48  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 104
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 105 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 161
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 162 TDFGLAKLLGAEE 174

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 49  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 105
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 106 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 162
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 163 TDFGLAKLLGAEE 175

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALD 258
           E+ +L    HPN+V+ L A    + + I+ E+   G + A  L+ +  L  S        
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
               +NYLH+NK   IIHRDL+  NIL    G++K+ADFGVS
Sbjct: 144 TLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV 155

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 7/127 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + AVK + +    + D     R E+ LL+K+ HPN+++    +  SS   IV E    G+
Sbjct: 49  EYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLK 293
           L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   ++K
Sbjct: 108 LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164
Query: 294 VADFGVS 300
           + DFG+S
Sbjct: 165 IIDFGLS 171

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 52  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 108
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 109 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 165
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 166 TDFGLAKLLGAEE 178

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQV--AVKKLGEEVI---SDDDRVRAFRDELALLQKI 207
           DF     I KG+F   +LA  +  +V  AVK L ++ I    ++  + + R+   LL+ +
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN--VLLKNV 96
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
           +HP +V    +   +  +  V +Y+  G+L   L+R+       A  +A +IA  + YLH
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
               + I++RDL+P NIL D  G++ + DFG+ K
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 187

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 58/125 (46%), Gaps = 22/125 (17%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 297 FGVSK 301
           FG+++
Sbjct: 189 FGLAR 193

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 11/117 (9%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--------RKGALKPST 251
           E+  + +  HPN+V +  +      + +V + L  G +   +K        + G L  ST
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
                 ++  G+ YLH+N     IHRD++  NIL  + G++++ADFGVS  L    D
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 4/128 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
           G   AVK L ++VI  DD V     E  +L   R HP + Q          +  V E++ 
Sbjct: 48  GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            GDL   +++      + A  +A +I   + +LH+     II+RDL+  N+L D  G+ K
Sbjct: 108 GGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCK 164
Query: 294 VADFGVSK 301
           +ADFG+ K
Sbjct: 165 LADFGMCK 172

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQV 182
Query: 295 ADFGVSK 301
            DFG +K
Sbjct: 183 TDFGFAK 189

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+ +L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 79  IPVAIMELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 135
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 136 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 192
Query: 295 ADFGVSKLLTVKE 307
            DFG++KLL  +E
Sbjct: 193 TDFGLAKLLGAEE 205

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 58/125 (46%), Gaps = 22/125 (17%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 211
Query: 297 FGVSK 301
           FG+++
Sbjct: 212 FGLAR 216

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 7/127 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + AVK + +    + D     R E+ LL+K+ HPN+++    +  SS   IV E    G+
Sbjct: 49  EYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLK 293
           L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   ++K
Sbjct: 108 LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164
Query: 294 VADFGVS 300
           + DFG+S
Sbjct: 165 IIDFGLS 171

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 11/117 (9%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--------RKGALKPST 251
           E+  + +  HPN+V +  +      + +V + L  G +   +K        + G L  ST
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
                 ++  G+ YLH+N     IHRD++  NIL  + G++++ADFGVS  L    D
Sbjct: 118 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 171

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 72/136 (52%), Gaps = 7/136 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G+ VA+KK+    + D         E+ LL+++ HPNV+++  +  + + + IV E    
Sbjct: 57  GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           GDL    + F K+K  +   T  ++ + +   + ++H  +   ++HRD++P+N+    +G
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATG 173
Query: 291 NLKVADFGVSKLLTVK 306
            +K+ D G+ +  + K
Sbjct: 174 VVKLGDLGLGRFFSSK 189

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 58/125 (46%), Gaps = 22/125 (17%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 211
Query: 297 FGVSK 301
           FG+++
Sbjct: 212 FGLAR 216

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 86/157 (54%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L   DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 7/127 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + AVK + +    + D     R E+ LL+K+ HPN+++    +  SS   IV E    G+
Sbjct: 49  EYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLK 293
           L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   ++K
Sbjct: 108 LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164
Query: 294 VADFGVS 300
           + DFG+S
Sbjct: 165 IIDFGLS 171

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 86/157 (54%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L   DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 157

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEY 231
           G  VAVK L E       ++R+ ++ E+ +L+ + H ++V++ G         + +V EY
Sbjct: 37  GEMVAVKALKEGC---GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 93
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           +P G LR +L R   +  +  + FA  I  GM YLH       IHR L   N+L D+   
Sbjct: 94  VPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRL 149
Query: 292 LKVADFGVSK 301
           +K+ DFG++K
Sbjct: 150 VKIGDFGLAK 159

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEY 231
           G  VAVK L E       ++R+ ++ E+ +L+ + H ++V++ G         + +V EY
Sbjct: 38  GEMVAVKALKEGC---GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 94
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           +P G LR +L R   +  +  + FA  I  GM YLH       IHR L   N+L D+   
Sbjct: 95  VPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRL 150
Query: 292 LKVADFGVSK 301
           +K+ DFG++K
Sbjct: 151 VKIGDFGLAK 160

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFAL 257
           E+ +L    HP +V+ LGA      + I+ E+ P G + A +    +G  +P   V    
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCR 124
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            +   +N+LH  +   IIHRDL+  N+L    G++++ADFGVS
Sbjct: 125 QMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+KK  E   SDDD++  +    E+ LL+++RH N+V  L    +     +V E++   
Sbjct: 53  VAIKKFLE---SDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
            L         L      ++   I  G+ + H +    IIHRD++P NIL   SG +K+ 
Sbjct: 110 ILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLC 166
Query: 296 DFGVSKLLT 304
           DFG ++ L 
Sbjct: 167 DFGFARTLA 175

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFAL 257
           E+ +L    HP +V+ LGA      + I+ E+ P G + A +    +G  +P   V    
Sbjct: 58  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCR 116
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            +   +N+LH  +   IIHRDL+  N+L    G++++ADFGVS
Sbjct: 117 QMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +   W G +VA++ +  E   ++D+++AF+ E+   ++ RH NVV F+GA 
Sbjct: 41  IGKGRFGQVYHGRWHG-EVAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 220 TQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
                + I+T       L + ++  K  L  +   + A +I +GM YLH      I+H+D
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTV 305
           L+  N+  D+ G + + DFG+  +  V
Sbjct: 156 LKSKNVFYDN-GKVVITDFGLFSISGV 181

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E++ + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154

>pdb|2P2C|P Chain P, Inhibition Of Caspase-2 By A Designed Ankyrin Repeat Protein (Darpin) Length = 169

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/120 (36%), Positives = 63/120 (52%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  +      L   A    +E ++ LL  G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNATDWLGHTPLHLAAKTGHLEIVEVLLKYGADVNAWD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               T LH+AA  G  E+V +LL+ GADV+ KD  G TPL  A Y  + E++++L K+GA
Sbjct: 78  NYGATPLHLAADNGHLEIVEVLLKHGADVNAKDYEGFTPLHLAAYDGHLEIVEVLLKYGA 137

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 60/114 (52%), Gaps = 7/114 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ LL++++H N+V+    +     + +V E+  +   + F    G L P     F   +
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
            +G+ + H      ++HRDL+P N+L + +G LK+ADFG+++   +    P+ C
Sbjct: 111 LKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI----PVRC 157

>pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 63/117 (53%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  + K    L   A+   +E ++ LL  G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNANDRKGNTPLHLAADYDHLEIVEVLLKHGADVNAHD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
            D  T LH+AA  G  E+V +LL+ GADV+ +D++G T    +I   N ++ ++L+K
Sbjct: 78  NDGSTPLHLAALFGHLEIVEVLLKHGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 134

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      ++     DE  ++  +  P V + LG +  +S + +VT+ +P G
Sbjct: 47  IPVAIKVLRENTSPKANK--EILDEAYVMAGVGSPYVSRLLG-ICLTSTVQLVTQLMPYG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L   ++  +G L     + + + IA+GM+YL +   V ++HRDL   N+L     ++K+
Sbjct: 104 CLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKI 160
Query: 295 ADFGVSKLLTVKE 307
            DFG+++LL + E
Sbjct: 161 TDFGLARLLDIDE 173

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     A      +  V EY   
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   + YLH      +++RD++  N++ D  G++K+
Sbjct: 90  GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKI 146
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 147 TDFGLCK 153

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E++ + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     A      +  V EY   
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   + YLH      +++RD++  N++ D  G++K+
Sbjct: 90  GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKI 146
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 147 TDFGLCK 153

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     A      +  V EY   
Sbjct: 35  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 94
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   + YLH      +++RD++  N++ D  G++K+
Sbjct: 95  GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKI 151
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 152 TDFGLCK 158

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     A      +  V EY   
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   + YLH      +++RD++  N++ D  G++K+
Sbjct: 90  GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKI 146
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 147 TDFGLCK 153

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     A      +  V EY   
Sbjct: 33  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 92
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   + YLH      +++RD++  N++ D  G++K+
Sbjct: 93  GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKI 149
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 150 TDFGLCK 156

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 3/127 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     A      +  V EY   
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   + YLH      +++RD++  N++ D  G++K+
Sbjct: 90  GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKI 146
Query: 295 ADFGVSK 301
            DFG+ K
Sbjct: 147 TDFGLCK 153

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 86/157 (54%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+ K+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 86/157 (54%), Gaps = 12/157 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+ K+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 73/133 (54%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE 307
            DFG +KLL  +E
Sbjct: 161 TDFGRAKLLGAEE 173

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 8/151 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
              +++RD++  N++ D  G++K+ DFG+ K
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 59/102 (57%), Gaps = 5/102 (4%)
Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G  + P   L   A    +E ++ LL  G DVN  D   RT LH+AA  G 
Sbjct: 38  ADVNAMDDAG--VTP---LHLAAKRGHLEIVEVLLKHGADVNASDSWGRTPLHLAATVGH 92
Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
            E+V +LLE GADV+ +D++G T    +I   N ++ ++L+K
Sbjct: 93  LEIVEVLLEYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 134

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 73/133 (54%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 49  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 105
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 106 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 162
Query: 295 ADFGVSKLLTVKE 307
            DFG +KLL  +E
Sbjct: 163 TDFGRAKLLGAEE 175

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 73/133 (54%), Gaps = 7/133 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE 307
            DFG +KLL  +E
Sbjct: 161 TDFGRAKLLGAEE 173

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 18/154 (11%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA----VT 220
           G      W G  VAVK     + S  D    FR+ E+     +RH N++ F+ +      
Sbjct: 22  GEVWRGLWHGESVAVK-----IFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRN 76
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENKPVPI 274
            S+ + ++T Y   G L  FL+R+  L+P  A+R A+  A G+ +LH      + KP  I
Sbjct: 77  SSTQLWLITHYHEHGSLYDFLQRQ-TLEPHLALRLAVSAACGLAHLHVEIFGTQGKPA-I 134
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            HRD +  N+L   +    +AD G++ + +   D
Sbjct: 135 AHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSD 168

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 73/138 (52%), Gaps = 21/138 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK 301
            +      +K+ DFG+++
Sbjct: 161 CMVAHDFTVKIGDFGMTR 178

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 68/132 (51%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G+++AVKKL     S     R +R EL LL+ ++H NV+  L   T ++ +     + + 
Sbjct: 76  GLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLV 134
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 135 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 190
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 191 CELKILDFGLAR 202

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKSQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+ +
Sbjct: 162 SELKILDFGLCR 173

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 73/138 (52%), Gaps = 21/138 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 48  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 105
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 106 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 159
Query: 284 ILRDDSGNLKVADFGVSK 301
            +      +K+ DFG+++
Sbjct: 160 CMVAHDFTVKIGDFGMTR 177

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 73/138 (52%), Gaps = 21/138 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 46  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 103
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 104 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 157
Query: 284 ILRDDSGNLKVADFGVSK 301
            +      +K+ DFG+++
Sbjct: 158 CMVAHDFTVKIGDFGMTR 175

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 73/138 (52%), Gaps = 21/138 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK 301
            +      +K+ DFG+++
Sbjct: 161 CMVAHDFTVKIGDFGMTR 178

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 73/138 (52%), Gaps = 21/138 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK 301
            +      +K+ DFG+++
Sbjct: 161 CMVAHDFTVKIGDFGMTR 178

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 73/138 (52%), Gaps = 21/138 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK 301
            +      +K+ DFG+++
Sbjct: 161 CMVAHDFTVKIGDFGMTR 178

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 111
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 112 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 167
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 168 SELKILDFGLAR 179

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 26/169 (15%)
Query: 154 ELDFTNSVEITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
           E+ +TN   I  G+F + F   +    +VA+KK     +  D R +    EL +++ ++H
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK-----VLQDKRFK--NRELQIMRIVKH 91
Query: 210 PNVVQFLGAVTQSSP-------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFALDI 259
           PNVV  L A   S+        + +V EY+P+   RA   + K K  +       +   +
Sbjct: 92  PNVVD-LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            R + Y+H    + I HRD++P N+L D  SG LK+ DFG +K+L   E
Sbjct: 151 LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 64  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGE 123
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 124 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 180
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 181 FGTAKVLS 188

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKXQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 60/104 (57%), Gaps = 11/104 (10%)
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF------AL 257
           L   RHP++V  +G   + + M+++ +Y+  G+L+  L   G+  P+ ++ +       +
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICI 146
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
             ARG++YLH      IIHRD++  NIL D++   K+ DFG+SK
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 108 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 163
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 164 SELKILDFGLAR 175

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKXQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 XELKILDFGLAR 173

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 34  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 93
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 94  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 150
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 151 FGTAKVLS 158

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 60/104 (57%), Gaps = 11/104 (10%)
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF------AL 257
           L   RHP++V  +G   + + M+++ +Y+  G+L+  L   G+  P+ ++ +       +
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICI 146
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
             ARG++YLH      IIHRD++  NIL D++   K+ DFG+SK
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 41  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 100
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 101 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 157
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 158 FGTAKVLS 165

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 35  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 95  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 151
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 152 FGTAKVLS 159

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 18/168 (10%)
Query: 162 EITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215
           ++ KG + +  W+ I       VAVKK+ +   +  D  R FR+ + L +   H N+V  
Sbjct: 16  KLGKGAYGIV-WKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 216 LGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
           L  +   +   + +V +Y+ + DL A + R   L+P         + + + YLH      
Sbjct: 75  LNVLRADNDRDVYLVFDYM-ETDLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG--- 129
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLT----VKEDRPLTCQDTS 317
           ++HRD++PSNIL +   ++KVADFG+S+       V  + PL+  + +
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 56  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 115
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 116 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 172
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 173 FGTAKVLS 180

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 173
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 174 FGTAKVLS 181

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 37  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 96
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 97  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 153
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 154 FGTAKVLS 161

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 56  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 115
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 116 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 172
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 173 FGTAKVLS 180

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 68/132 (51%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL +   S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 59  GLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 117
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 118 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 173
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 174 CELKILDFGLAR 185

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 111
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 112 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 167
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 168 CELKILDFGLAR 179

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALD 258
           E++++Q+   P+VV++ G+  +++ + IV EY   G +   ++ R   L           
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
             +G+ YLH  +    IHRD++  NIL +  G+ K+ADFGV+  LT
Sbjct: 134 TLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLT 176

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 142 AREVPEYEIDPHELD-----FTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRA 196
           A  VP+Y ID    D     F    E+ +G   + +    +   K    +V+      + 
Sbjct: 35  ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI 94
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
            R E+ +L ++ HPN+++        + + +V E +  G+L   +  KG      A    
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLL 303
             I   + YLHEN    I+HRDL+P N+L         LK+ADFG+SK++
Sbjct: 155 KQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 176 FGTAKVLS 183

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 173
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 174 FGTAKVLS 181

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 36  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 95
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 96  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 152
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 153 FGTAKVLS 160

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 173
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 174 FGTAKVLS 181

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 173
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 174 FGTAKVLS 181

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 176 FGTAKVLS 183

>pdb|3ZUV|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 136

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/75 (44%), Positives = 49/75 (65%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN  D D  T LH+AA  G  E+V +LL+ GADV+ +D +G TPL  A  
Sbjct: 30  VRILMANGADVNALDEDGLTPLHLAAQLGHLEIVEVLLKYGADVNAEDNFGITPLHLAAI 89
Query: 116 YKNHEVIKLLEKHGA 130
             + E++++L KHGA
Sbjct: 90  RGHLEIVEVLLKHGA 104

>pdb|3TWR|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human 3bp2 Length = 165

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 53/105 (50%), Gaps = 3/105 (2%)
Query: 28  LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
           +N  D +G +  P   L F A    V  ++ LL  G DV+ +D      LH A   G  E
Sbjct: 33  VNCRDIEGRQSTP---LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYE 89
Query: 88  VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           V  LL++ GA V+  D W  TPL +A     +E+ KLL +HGA P
Sbjct: 90  VAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADP 134

>pdb|3TWQ|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 (Apo Form) Length = 175

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 53/105 (50%), Gaps = 3/105 (2%)
Query: 28  LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
           +N  D +G +  P   L F A    V  ++ LL  G DV+ +D      LH A   G  E
Sbjct: 37  VNCRDIEGRQSTP---LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYE 93
Query: 88  VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           V  LL++ GA V+  D W  TPL +A     +E+ KLL +HGA P
Sbjct: 94  VAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADP 138

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 176 FGTAKVLS 183

>pdb|3TWU|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human Mcl1 Length = 167

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 53/105 (50%), Gaps = 3/105 (2%)
Query: 28  LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
           +N  D +G +  P   L F A    V  ++ LL  G DV+ +D      LH A   G  E
Sbjct: 35  VNCRDIEGRQSTP---LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYE 91
Query: 88  VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           V  LL++ GA V+  D W  TPL +A     +E+ KLL +HGA P
Sbjct: 92  VAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADP 136

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 113 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 168
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 169 CELKILDFGLAR 180

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 110
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 111 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 166
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 167 CELKILDFGLAR 178

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 108 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 163
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 164 CELKILDFGLAR 175

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 111
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 112 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 167
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 168 CELKILDFGLAR 179

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 60  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 119
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 120 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 176
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 177 FGTAKVLS 184

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 23/150 (15%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGAVT 220
           E+ +G+     W+G  VAVK     + S  D    FR+ EL     +RH N++ F+ +  
Sbjct: 23  EVWRGS-----WQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 221 ----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENK 270
                S+ + ++T Y   G L  +L+    L   + +R  L IA G+ +LH      + K
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           P  I HRDL+  NIL   +G   +AD G++
Sbjct: 132 PA-IAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 176 FGTAKVLS 183

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 113 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 168
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 169 CELKILDFGLAR 180

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 113 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 168
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 169 CELKILDFGLAR 180

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 110
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 111 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 166
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 167 CELKILDFGLAR 178

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 46  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 104
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 105 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 160
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 161 CELKILDFGLAR 172

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 60/114 (52%), Gaps = 7/114 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ LL++++H N+V+    +     + +V E+  +   + F    G L P     F   +
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
            +G+ + H      ++HRDL+P N+L + +G LK+A+FG+++   +    P+ C
Sbjct: 111 LKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI----PVRC 157

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 60  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 119
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 120 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 176
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 177 FGTAKVLS 184

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 128
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 129 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 184
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 185 CELKILDFGLAR 196

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 63/117 (53%), Gaps = 8/117 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFL----KRKGALKPSTAV 253
           E+ LL++++HPN+V++   +    ++ + IV EY   GDL + +    K +  L     +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 254 RFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           R    +   +   H   +    ++HRDL+P+N+  D   N+K+ DFG++++L   ED
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 62  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 121
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 122 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 178
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 179 FGTAKVLS 186

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 58/105 (55%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ HPN++         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 116
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 117 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 172
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 173 CELKILDFGLAR 184

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 108 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 163
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 164 CELKILDFGLAR 175

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 23/150 (15%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGAVT 220
           E+ +G+     W+G  VAVK     + S  D    FR+ EL     +RH N++ F+ +  
Sbjct: 52  EVWRGS-----WQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 101
Query: 221 ----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENK 270
                S+ + ++T Y   G L  +L+    L   + +R  L IA G+ +LH      + K
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 160
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           P  I HRDL+  NIL   +G   +AD G++
Sbjct: 161 PA-IAHRDLKSKNILVKKNGQCCIADLGLA 189

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 113 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 168
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 169 CELKILDFGLAR 180

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 102
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 103 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 158
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 159 CELKILDFGLAR 170

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 128
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 129 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 184
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 185 CELKILDFGLAR 196

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 43  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 102 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 157
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 158 CELKILDFGLAR 169

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 102
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 103 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 158
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 159 CELKILDFGLAR 170

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 117
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 118 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 173
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 174 CELKILDFGLAR 185

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 176 FGTAKVLS 183

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 117
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 118 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 173
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 174 CELKILDFGLAR 185

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 23/150 (15%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGAVT 220
           E+ +G+     W+G  VAVK     + S  D    FR+ EL     +RH N++ F+ +  
Sbjct: 23  EVWRGS-----WQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 221 ----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENK 270
                S+ + ++T Y   G L  +L+    L   + +R  L IA G+ +LH      + K
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           P  I HRDL+  NIL   +G   +AD G++
Sbjct: 132 PA-IAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 45  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 103
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 104 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 159
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 160 CELKILDFGLAR 171

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 110
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 111 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 166
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 167 XELKILDFGLAR 178

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 116
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 117 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 172
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 173 XELKILDFGLAR 184

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 108 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 163
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 164 CELKILDFGLAR 175

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 66  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 124
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 125 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 180
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 181 CELKILDFGLAR 192

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 110
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 111 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 166
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 167 XELKILDFGLAR 178

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 67  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 126 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 181
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 182 CELKILDFGLAR 193

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           PE   D    D  +  EI +G +     ++    G  +AVK++    + + ++ +   D 
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDL 71
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK---PSTAV-RFA 256
             +++    P +VQF GA+ +     I  E +     + +      L    P   + +  
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
           L   + +N+L EN  + IIHRD++PSNIL D SGN+K+ DFG+S  L    D     +D 
Sbjct: 132 LATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186
Query: 317 SCR 319
            CR
Sbjct: 187 GCR 189

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 73/141 (51%), Gaps = 17/141 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF------LGAVTQSSPMMIV 228
           G QVA+K+  +E +S  +R R +  E+ +++K+ HPNVV        L  +  +   ++ 
Sbjct: 40  GEQVAIKQCRQE-LSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 97
Query: 229 TEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI- 284
            EY   GDLR +L +      LK         DI+  + YLHEN+   IIHRDL+P NI 
Sbjct: 98  MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 154
Query: 285 LRDDSGNL--KVADFGVSKLL 303
           L+     L  K+ D G +K L
Sbjct: 155 LQPGPQRLIHKIIDLGYAKEL 175

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 150 IDPHELDFTNSV-EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR 208
           ID  +L+F   + E   G      W+G  + VK L     S   + R F +E   L+   
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFS 65
Query: 209 HPNVVQFLGAVTQSSPM---MIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGM 263
           HPNV+  LGA  QS P     ++T ++P G L   L       +  S AV+FALD+ARGM
Sbjct: 66  HPNVLPVLGAC-QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 264 NYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVS 300
            +LH  +P+ I    L   +++ D+  +  + +AD   S
Sbjct: 125 AFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFS 162

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 73/141 (51%), Gaps = 17/141 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF------LGAVTQSSPMMIV 228
           G QVA+K+  +E +S  +R R +  E+ +++K+ HPNVV        L  +  +   ++ 
Sbjct: 39  GEQVAIKQCRQE-LSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 229 TEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI- 284
            EY   GDLR +L +      LK         DI+  + YLHEN+   IIHRDL+P NI 
Sbjct: 97  MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 153
Query: 285 LRDDSGNL--KVADFGVSKLL 303
           L+     L  K+ D G +K L
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL 174

>pdb|3NOC|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/75 (44%), Positives = 48/75 (64%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN RD    T LH+AA  G  E+V +LL+ GADV+ KD  G TPL  A  
Sbjct: 30  VRILMANGADVNARDFTGWTPLHLAAHFGHLEIVEVLLKNGADVNAKDSLGVTPLHLAAR 89
Query: 116 YKNHEVIKLLEKHGA 130
             + E++++L K+GA
Sbjct: 90  RGHLEIVEVLLKNGA 104

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 73/138 (52%), Gaps = 21/138 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 50  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 107
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HR+L   N
Sbjct: 108 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARN 161
Query: 284 ILRDDSGNLKVADFGVSK 301
            +      +K+ DFG+++
Sbjct: 162 CMVAHDFTVKIGDFGMTR 179

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 73/138 (52%), Gaps = 21/138 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HR+L   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK 301
            +      +K+ DFG+++
Sbjct: 161 CMVAHDFTVKIGDFGMTR 178

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ D+G+++
Sbjct: 162 CELKILDYGLAR 173

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L++IRHPN++         + ++++ E +  G+L  FL  K +L    A +F   I
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300
             G++YLH  +   I H DL+P NI+  D       +K+ DFG++
Sbjct: 125 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 166

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L++IRHPN++         + ++++ E +  G+L  FL  K +L    A +F   I
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300
             G++YLH  +   I H DL+P NI+  D       +K+ DFG++
Sbjct: 118 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

>pdb|2J8S|D Chain D, Drug Export Pathway Of Multidrug Exporter Acrb Revealed By Darpin Inhibitors Length = 169

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/120 (35%), Positives = 64/120 (53%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  ++     L   A    +E ++ LL +G DVN  D
Sbjct: 18  LLEAARAGRDDEVRILMANGADVNAADVVGWTPLHLAAYWGHLEIVEVLLKNGADVNAYD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               T LH+AA  G  E+V +LL+ GADV+ KD  G TPL  A    + E++++L K+GA
Sbjct: 78  TLGSTPLHLAAHFGHLEIVEVLLKNGADVNAKDDNGITPLHLAANRGHLEIVEVLLKYGA 137

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 11/110 (10%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
           L+   HPNVV+     T S     + + +V E++ + DL  +L +  +  +   T     
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
             + RG+++LH ++   ++HRDL+P NIL   SG +K+ADFG++++ + +
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 68
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            KP  I HRDL+  NIL   +G   +AD G++
Sbjct: 128 GKP-AIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 11/110 (10%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
           L+   HPNVV+     T S     + + +V E++ + DL  +L +  +  +   T     
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
             + RG+++LH ++   ++HRDL+P NIL   SG +K+ADFG++++ + +
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 66
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            KP  I HRDL+  NIL   +G   +AD G++
Sbjct: 126 GKP-AIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            KP  I HRDL+  NIL   +G   +AD G++
Sbjct: 125 GKP-AIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|2V5Q|C Chain C, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 167

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/75 (42%), Positives = 47/75 (62%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN  D    T LH+AA  G  E+V +LL+ GADVD  D +G TPL  A  
Sbjct: 30  VRILIANGADVNAVDNTGLTPLHLAAVSGHLEIVEVLLKHGADVDAADVYGFTPLHLAAM 89
Query: 116 YKNHEVIKLLEKHGA 130
             + E++++L K+GA
Sbjct: 90  TGHLEIVEVLLKYGA 104

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L++IRHPN++         + ++++ E +  G+L  FL  K +L    A +F   I
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300
             G++YLH  +   I H DL+P NI+  D       +K+ DFG++
Sbjct: 139 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 180

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 91
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            KP  I HRDL+  NIL   +G   +AD G++
Sbjct: 151 GKPA-IAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 60/115 (52%), Gaps = 11/115 (9%)
Query: 196 AFRD-----ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS 250
           AFRD     E+A+L+KI+H N+V        ++   +V + +  G+L   +  +G     
Sbjct: 47  AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK 106
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKL 302
            A      +   + YLHEN    I+HRDL+P N+L    +++  + + DFG+SK+
Sbjct: 107 DASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 71
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            KP  I HRDL+  NIL   +G   +AD G++
Sbjct: 131 GKP-AIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 11/110 (10%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
           L+   HPNVV+     T S     + + +V E++ + DL  +L +  +  +   T     
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
             + RG+++LH ++   ++HRDL+P NIL   SG +K+ADFG++++ + +
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 63/128 (49%), Gaps = 3/128 (2%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G 
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGC 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT 304
           FG +K+L+
Sbjct: 176 FGTAKVLS 183

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 69/133 (51%), Gaps = 12/133 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            +L   DL   +K   A      V+F +  I RG+ Y+H      IIHRDL+PSN+  ++
Sbjct: 102 THLMGADLNNIVK--CAKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 156
Query: 289 SGNLKVADFGVSK 301
              LK+ DFG+++
Sbjct: 157 DCELKILDFGLAR 169

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            KP  I HRDL+  NIL   +G   +AD G++
Sbjct: 164 GKPA-IAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 53  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 111
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 112 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 167
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 168 CELKILDFGLAR 179

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 57  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 116
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 117 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 173
Query: 292 LKVADFGVS 300
           +++ DFG+S
Sbjct: 174 IRIIDFGLS 182

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 35  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 95  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNV 151
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 152 PKPRIKIIDFGLA 164

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 35  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 95  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNV 151
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 152 PKPRIKIIDFGLA 164

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|3NOG|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/120 (36%), Positives = 63/120 (52%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  +      L   A    +E ++ LL +G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNASDHVGWTPLHLAAYFGHLEIVEVLLKNGADVNADD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               T LH+AA +G  EVV +LL+ GADV+  D  G TPL  A    + E++++L KHGA
Sbjct: 78  SLGVTPLHLAADRGHLEVVEVLLKNGADVNANDHNGFTPLHLAANIGHLEIVEVLLKHGA 137

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 51  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 167
Query: 292 LKVADFGVS 300
           +++ DFG+S
Sbjct: 168 IRIIDFGLS 176

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/131 (33%), Positives = 67/131 (51%), Gaps = 12/131 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SPMMIVTE 230
           +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +      S + +VT 
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L   DL   +K + AL           + RG+ Y+H      IIHRDL+PSN+  ++  
Sbjct: 114 -LMGADLNNIVKSQ-ALSDEHVQFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDS 168
Query: 291 NLKVADFGVSK 301
            L++ DFG+++
Sbjct: 169 ELRILDFGLAR 179

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 102 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 157
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 158 CELKILDFGLAR 169

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 162 CELKILDFGLAR 173

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 126 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 181
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 182 CELKILDFGLAR 193

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 57  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 115
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 116 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 171
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 172 CELKILDFGLAR 183

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 126 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 181
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 182 CELKILDFGLAR 193

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVS 300
               +K+ DFG++
Sbjct: 153 PKPRIKIIDFGLA 165

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 66  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 124
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 125 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 180
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 181 CELKILDFGLAR 192

>pdb|2Y1L|E Chain E, Caspase-8 In Complex With Darpin-8.4 Length = 169

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 63/120 (52%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D + E+      L   A    +E ++ LL +G DVN  D
Sbjct: 18  LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               T L +AA  G  E+V +LL+ GADV+  D  G TPL  A  + + E++++L K+GA
Sbjct: 78  HAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGA 137

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 102 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 157
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 158 CELKILDFGLAR 169

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 74  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 133
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 134 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 190
Query: 292 LKVADFGVS 300
           +++ DFG+S
Sbjct: 191 IRIIDFGLS 199

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 75  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 134
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 135 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 191
Query: 292 LKVADFGVS 300
           +++ DFG+S
Sbjct: 192 IRIIDFGLS 200

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G QVA+KK+        +  R  R EL +L+  +H N++     +  + P      + V 
Sbjct: 79  GQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 137
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
             L + DL   +     L       F   + RG+ Y+H  +   +IHRDL+PSN+L +++
Sbjct: 138 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNEN 194
Query: 290 GNLKVADFGVSKLLTV 305
             LK+ DFG+++ L  
Sbjct: 195 CELKIGDFGMARGLCT 210

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 9/137 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G QVA+KK+        +  R  R EL +L+  +H N++     +  + P      + V 
Sbjct: 80  GQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 138
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
             L + DL   +     L       F   + RG+ Y+H  +   +IHRDL+PSN+L +++
Sbjct: 139 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNEN 195
Query: 290 GNLKVADFGVSKLLTVK 306
             LK+ DFG+++ L   
Sbjct: 196 CELKIGDFGMARGLCTS 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 128
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 129 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 128
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 129 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 118
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 119 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 61/112 (54%), Gaps = 8/112 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFL----KRKGALKPSTAV 253
           E+ LL++++HPN+V++   +    ++ + IV EY   GDL + +    K +  L     +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 254 RFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           R    +   +   H   +    ++HRDL+P+N+  D   N+K+ DFG++++L
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 61/112 (54%), Gaps = 8/112 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFL----KRKGALKPSTAV 253
           E+ LL++++HPN+V++   +    ++ + IV EY   GDL + +    K +  L     +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 254 RFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           R    +   +   H   +    ++HRDL+P+N+  D   N+K+ DFG++++L
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 50  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 108
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 109 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 48  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 106
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 107 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 54  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 112
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 113 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 54  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 112
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 113 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 68  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 126
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 127 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       K A   + 
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 180
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
            V  ALD    M +         IHRD++P N+L D SG+LK+ADFG 
Sbjct: 181 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGT 219

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/131 (33%), Positives = 67/131 (51%), Gaps = 12/131 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SPMMIVTE 230
           +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +      S + +VT 
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L   DL   +K + AL           + RG+ Y+H      IIHRDL+PSN+  ++  
Sbjct: 114 -LMGADLNNIVKCQ-ALSDEHVQFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDS 168
Query: 291 NLKVADFGVSK 301
            L++ DFG+++
Sbjct: 169 ELRILDFGLAR 179

>pdb|2BKK|B Chain B, Crystal Structure Of Aminoglycoside Phosphotransferase Aph (3')-Iiia In Complex With The Inhibitor Ar_3a Length = 169

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 62/120 (51%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  +      L  + N   +E I+ LL    DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNANDWFGITPLHLVVNNGHLEIIEVLLKYAADVNASD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               T LH+AA +G  E+V +LL+ GADV+  D  G TPL  A    + E++++L K+GA
Sbjct: 78  KSGWTPLHLAAYRGHLEIVEVLLKYGADVNAMDYQGYTPLHLAAEDGHLEIVEVLLKYGA 137

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       K A   + 
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 175
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
            V  ALD    M +         IHRD++P N+L D SG+LK+ADFG 
Sbjct: 176 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGT 214

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       K A   + 
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 180
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
            V  ALD    M +         IHRD++P N+L D SG+LK+ADFG 
Sbjct: 181 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGT 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+  FG+++
Sbjct: 162 CELKILGFGLAR 173

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAV 219
           +  GT+   + +G  V   +L    + D   D     + E+ +L+K   H N+  + GA 
Sbjct: 32  VGNGTYGQVY-KGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 220 TQSSP------MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKP 271
            + +P      + +V E+   G +   +K  +   LK         +I RG+++LH++K 
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
             +IHRD++  N+L  ++  +K+ DFGVS  L
Sbjct: 150 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 8/136 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           G  VA+KK  E   S+DD V  +    E+ +L++++HPN+V  L    +   + +V EY 
Sbjct: 28  GQIVAIKKFLE---SEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
               L    + +  +             + +N+ H++     IHRD++P NIL      +
Sbjct: 85  DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVI 141
Query: 293 KVADFGVSKLLTVKED 308
           K+ DFG ++LLT   D
Sbjct: 142 KLCDFGFARLLTGPSD 157

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 64/117 (54%), Gaps = 14/117 (11%)
Query: 200 ELALLQKIR---HPNVVQFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRKG--ALKP 249
           E+ALL+++    HPNVV+ +     S       + +V E++ + DLR +L +     L  
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++ + +
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 165

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 64/117 (54%), Gaps = 14/117 (11%)
Query: 200 ELALLQKIR---HPNVVQFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRKG--ALKP 249
           E+ALL+++    HPNVV+ +     S       + +V E++ + DLR +L +     L  
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++ + +
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 165

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 64/117 (54%), Gaps = 14/117 (11%)
Query: 200 ELALLQKIR---HPNVVQFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRKG--ALKP 249
           E+ALL+++    HPNVV+ +     S       + +V E++ + DLR +L +     L  
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++ + +
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 165

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 64/117 (54%), Gaps = 14/117 (11%)
Query: 200 ELALLQKIR---HPNVVQFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRKG--ALKP 249
           E+ALL+++    HPNVV+ +     S       + +V E++ + DLR +L +     L  
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++ + +
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 200 ELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           E+ +L+K+  HPN++Q       ++   +V + + KG+L  +L  K  L      +    
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           +   +  LH+   + I+HRDL+P NIL DD  N+K+ DFG S
Sbjct: 120 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 158

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/131 (33%), Positives = 67/131 (51%), Gaps = 12/131 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SPMMIVTE 230
           +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +      S + +VT 
Sbjct: 47  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 105
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L   DL   +K + AL           + RG+ Y+H      IIHRDL+PSN+  ++  
Sbjct: 106 -LMGADLNNIVKCQ-ALSDEHVQFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDC 160
Query: 291 NLKVADFGVSK 301
            L++ DFG+++
Sbjct: 161 ELRILDFGLAR 171

>pdb|2XEN|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module Length = 91

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 48/72 (66%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN +D D  T LH+AA +G  E+V +LL+ GADV+ +D++G T    +I 
Sbjct: 18  VRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAQDKFGKTAFDISID 77
Query: 116 YKNHEVIKLLEK 127
             N ++ ++L+K
Sbjct: 78  NGNEDLAEILQK 89

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA----VT 220
           G   +  WRG +VAVK     V    +    FR+ E+     +RH N++ F+ A      
Sbjct: 51  GEVWMGKWRGEKVAVK-----VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENKPVPI 274
             + + ++T+Y   G L  +LK    L   + ++ A     G+ +LH      + KP  I
Sbjct: 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA-I 163
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVS 300
            HRDL+  NIL   +G   +AD G++
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLA 189

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 200 ELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           E+ +L+K+  HPN++Q       ++   +V + + KG+L  +L  K  L      +    
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           +   +  LH+   + I+HRDL+P NIL DD  N+K+ DFG S
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 4/119 (3%)
Query: 200 ELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           E+ +L+K+  HPN++Q       ++   +V + + KG+L  +L  K  L      +    
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           +   +  LH+   + I+HRDL+P NIL DD  N+K+ DFG S  L   E     C   S
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPS 188

>pdb|1K1B|A Chain A, Crystal Structure Of The Ankyrin Repeat Domain Of Bcl-3: A Unique Member Of The Ikappab Protein Family Length = 241

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/87 (40%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 50  ERDVEGIKELLDSG----IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-R 104
            R    ++ LLDS     +D+  R+ D  TALHVA      E V LLLERGAD+D  D +
Sbjct: 89  HRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIK 148
Query: 105 WGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            G +PL  A+   +  +++LL +HGA 
Sbjct: 149 SGRSPLIHAVENNSLSMVQLLLQHGAN 175

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 412 ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 470
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 471 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 413 ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 471
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 472 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ D G+++
Sbjct: 162 CELKILDAGLAR 173

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 129 GAKPLMAPMHVKHAREVPEYEIDPHELD-FTNSVEITKGTFILAFWRGIQ-----VAVKK 182
           G+ P  AP+     +E+P+  +DP  +  +     + KG F   +           A K 
Sbjct: 4   GSDPKSAPL-----KEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 58
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           + + ++    +      E+A+ + + +P+VV F G       + +V E   +  L    K
Sbjct: 59  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 118
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           R+ A+    A  F     +G+ YLH N+   +IHRDL+  N+  +D  ++K+ DFG++
Sbjct: 119 RRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 67/128 (52%), Gaps = 9/128 (7%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I+ A KK+ +  + D DR   F+ E+ +++ + HPN+++       ++ + +V E    G
Sbjct: 52  IRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 108
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-RDDSGN--L 292
           +L   +  K   + S A R   D+   + Y H+   + + HRDL+P N L   DS +  L
Sbjct: 109 ELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPL 165
Query: 293 KVADFGVS 300
           K+ DFG++
Sbjct: 166 KLIDFGLA 173

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 67/128 (52%), Gaps = 9/128 (7%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I+ A KK+ +  + D DR   F+ E+ +++ + HPN+++       ++ + +V E    G
Sbjct: 35  IRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 91
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-RDDSGN--L 292
           +L   +  K   + S A R   D+   + Y H+   + + HRDL+P N L   DS +  L
Sbjct: 92  ELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPL 148
Query: 293 KVADFGVS 300
           K+ DFG++
Sbjct: 149 KLIDFGLA 156

>pdb|3HG0|D Chain D, Crystal Structure Of A Darpin In Complex With Orf49 From Lactococcal Phage Tp901-1 Length = 136

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/75 (41%), Positives = 45/75 (60%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN  D    T LH+AA     E+V +LL+ GADV+  D  G TPL     
Sbjct: 30  VRILMANGADVNAEDKVGLTPLHLAAMNDHLEIVEVLLKNGADVNAIDAIGETPLHLVAM 89
Query: 116 YKNHEVIKLLEKHGA 130
           Y + E++++L KHGA
Sbjct: 90  YGHLEIVEVLLKHGA 104

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 69/130 (53%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE-YLP 233
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T +S +    + YL 
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 234 KGDLRAFLKRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
              ++  L++   LK S          + +G+ Y+H      ++HRDL+P N+  ++   
Sbjct: 108 MPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCE 164
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 165 LKILDFGLAR 174

>pdb|4GRG|A Chain A, Crystal Structure Of Ige Complexed With E2_79, An Anti-Ige Inhibitor Length = 135

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/75 (41%), Positives = 45/75 (60%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L  +G DVN  D    T LH+AA  G  E+V +LL+ GADV+     G TPL  A +
Sbjct: 30  VRILTANGADVNANDYWGHTPLHLAAMLGHLEIVEVLLKNGADVNATGNTGRTPLHLAAW 89
Query: 116 YKNHEVIKLLEKHGA 130
             + E++++L KHGA
Sbjct: 90  ADHLEIVEVLLKHGA 104

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 60/129 (46%), Gaps = 6/129 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+ +            +V E    
Sbjct: 51  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTG 110
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y H+NK   I+HRDL+P N+L   +    N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK---IVHRDLKPENLLLESKSKDAN 167
Query: 292 LKVADFGVS 300
           +++ DFG+S
Sbjct: 168 IRIIDFGLS 176

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 59/112 (52%), Gaps = 12/112 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
           E+  L  ++H N++QF+GA  + +     + ++T +  KG L  FLK    +  +     
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHI 126
Query: 256 ALDIARGMNYLHENKPV-------PIIHRDLEPSNILRDDSGNLKVADFGVS 300
           A  +ARG+ YLHE+ P         I HRD++  N+L  ++    +ADFG++
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ D G+++
Sbjct: 162 CELKILDRGLAR 173

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ D G+++
Sbjct: 162 CELKILDGGLAR 173

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           EL   N   + +G + +   + I VA+K  K G E    ++ +R    E  ++ ++ +P 
Sbjct: 17  ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNPY 71
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENK 270
           +V+ +G V Q+  +M+V E    G L  FL  K    P + V   L  ++ GM YL E  
Sbjct: 72  IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
               +HRDL   N+L  +    K++DFG+SK L
Sbjct: 131 ---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 60/126 (47%), Gaps = 9/126 (7%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK +      D++  R    E+   + +RHPN+V+F   +   + + I+ EY   G+L
Sbjct: 48  VAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVA 295
              +   G      A  F   +  G++Y H  +   I HRDL+  N L D S    LK+ 
Sbjct: 104 YERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKIC 160
Query: 296 DFGVSK 301
           DFG SK
Sbjct: 161 DFGYSK 166

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 13/128 (10%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++ ++  R      E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 47  VAVKYIERGEKIAANVKR------EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 100
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLK 157
Query: 294 VADFGVSK 301
           + DFG SK
Sbjct: 158 ICDFGYSK 165

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 156 DFTNSVEITKGTFILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
           D  N  E+  GT     W+      G  +AVK++      ++++ R   D   +L+    
Sbjct: 26  DLENLGEMGSGT-CGQVWKMRFRKTGHVIAVKQMRRSGNKEENK-RILMDLDVVLKSHDC 83
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           P +VQ  G    ++ + I  E +     +   + +G +      +  + I + + YL E 
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT--VKEDRPLTC 313
             V  IHRD++PSNIL D+ G +K+ DFG+S  L     +DR   C
Sbjct: 144 HGV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGC 187

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 79/142 (55%), Gaps = 23/142 (16%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF--------------LGAVTQS 222
           +VA+KK+   V++D   V+    E+ +++++ H N+V+               +G++T+ 
Sbjct: 38  RVAIKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + + IV EY+ + DL   L+ +G L    A  F   + RG+ Y+H      ++HRDL+P+
Sbjct: 95  NSVYIVQEYM-ETDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 149
Query: 283 NI-LRDDSGNLKVADFGVSKLL 303
           N+ +  +   LK+ DFG+++++
Sbjct: 150 NLFINTEDLVLKIGDFGLARIM 171

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 50/109 (45%), Gaps = 14/109 (12%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       K A   + 
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA 181
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            V  ALD    M          +IHRD++P N+L D  G+LK+ADFG  
Sbjct: 182 EVVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTC 221

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 4/106 (3%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
           V  FR+E  +L       + Q   A    + + +V EY   GDL   L + G   P+   
Sbjct: 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 254 RFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           RF L +I   ++ +H    +  +HRD++P NIL D  G++++ADFG
Sbjct: 165 RFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 63/116 (54%), Gaps = 18/116 (15%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL------RAFLKRKGALKP 249
           +  +E+A+L+KI+H N+V         + + +V + +  G+L      + F   K A   
Sbjct: 66  SIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDA--- 122
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKL 302
           ST +R  LD    + YLH    + I+HRDL+P N+L   +D+   + ++DFG+SK+
Sbjct: 123 STLIRQVLD---AVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM 172

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 65/132 (49%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSK 301
             LK+ DF +++
Sbjct: 162 CELKILDFYLAR 173

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 182 KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL 241
           K   + IS   +   F++EL ++  I++   +   G +T    + I+ EY+    +  F 
Sbjct: 75  KSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD 134
Query: 242 -------KRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
                  K      P   ++  +  +    +Y+H  K   I HRD++PSNIL D +G +K
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVK 192
Query: 294 VADFGVSKLLTVKE 307
           ++DFG S+ +  K+
Sbjct: 193 LSDFGESEYMVDKK 206

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           LL+  +HPN++           + +VTE +  G+L   + R+       A      I + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 263 MNYLHENKPVPIIHRDLEPSNILR-DDSGN---LKVADFGVSKLL 303
           + YLH      ++HRDL+PSNIL  D+SGN   +++ DFG +K L
Sbjct: 129 VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 32/229 (13%)
Query: 95  RGADVDPKDRWGSTPLGDAIYYKNHE--VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDP 152
           RG DVD +   G    G      N++  V  + +++  +P+     +KH   +  Y+I  
Sbjct: 5   RGYDVDEQ---GKIVRGKGTVSSNYDNYVFDIWKQYYPQPV----EIKHDHVLDHYDI-- 55
Query: 153 HELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           HE       E+  G F     +     G   A K +     SD + VR    E+  +  +
Sbjct: 56  HE-------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVL 105
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNYL 266
           RHP +V    A    + M+++ E++  G+L          +    AV +   + +G+ ++
Sbjct: 106 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 267 HENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           HEN     +H DL+P NI+     S  LK+ DFG++  L  K+   +T 
Sbjct: 166 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 211

>pdb|2JAB|A Chain A, A Designed Ankyrin Repeat Protein Evolved To Picomolar Affinity To Her2 Length = 136

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 46/75 (61%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN +D    T L++A   G  E+V +LL+ GADV+  D  G TPL  A +
Sbjct: 30  VRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAF 89
Query: 116 YKNHEVIKLLEKHGA 130
             + E+ ++L KHGA
Sbjct: 90  IGHLEIAEVLLKHGA 104

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 65/128 (50%), Gaps = 13/128 (10%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++   D+ V+    E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 47  VAVKYIERGEKI---DENVKR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 100
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ---VAHRDLKLENTLLDGSPAPRLK 157
Query: 294 VADFGVSK 301
           +ADFG SK
Sbjct: 158 IADFGYSK 165

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 64/128 (50%), Gaps = 13/128 (10%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++   D+ V+    E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 46  VAVKYIERGEKI---DENVKR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 99
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 100 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLK 156
Query: 294 VADFGVSK 301
           + DFG SK
Sbjct: 157 ICDFGYSK 164

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           EL   N   + +G + +   + I VA+K  K G E    ++ +R    E  ++ ++ +P 
Sbjct: 343 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNPY 397
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENK 270
           +V+ +G V Q+  +M+V E    G L  FL  K    P + V   L  ++ GM YL E  
Sbjct: 398 IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
               +HR+L   N+L  +    K++DFG+SK L
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKAL 486

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY--- 231
           G +VA+KKL     S+    RA+R EL LL+ +RH NV+  L   T    +   T++   
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 232 LP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +P    DL   +K +  L           + +G+ Y+H      IIHRDL+P N+  ++ 
Sbjct: 109 MPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNED 164
Query: 290 GNLKVADFGVSK 301
             LK+ DFG+++
Sbjct: 165 CELKILDFGLAR 176

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 14/126 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 118 GFQCAVKKV---------RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLE 168
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K +G L    A+ +      G+ YLH  +   I+H D++  N+ L  D  + 
Sbjct: 169 GGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHA 225
Query: 293 KVADFG 298
            + DFG
Sbjct: 226 ALCDFG 231

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 64/137 (46%), Gaps = 21/137 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           GI VAVKKL     +     RA+R EL LL+ + H N++  L   T   P   + E+   
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKTLEEF--- 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 284
            D+   ++   A      +   LD  R          G+ +LH      IIHRDL+PSNI
Sbjct: 102 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 157
Query: 285 LRDDSGNLKVADFGVSK 301
           +      LK+ DFG+++
Sbjct: 158 VVKSDCTLKILDFGLAR 174

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 70/130 (53%), Gaps = 9/130 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G+++A K +    + D + V+   +E++++ ++ H N++Q   A    + +++V EY+  
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170
Query: 235 GDL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGN 291
           G+L    +     L     + F   I  G+ ++H+   + I+H DL+P NIL    D+  
Sbjct: 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQ 227
Query: 292 LKVADFGVSK 301
           +K+ DFG+++
Sbjct: 228 IKIIDFGLAR 237

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 150 IDPHELDFTNSV-EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR 208
           ID  +L+F   + E   G      W+G  + VK L     S   + R F +E   L+   
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFS 65
Query: 209 HPNVVQFLGAVTQSSPM---MIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGM 263
           HPNV+  LGA  QS P     ++T + P G L   L       +  S AV+FALD ARG 
Sbjct: 66  HPNVLPVLGAC-QSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGX 124
Query: 264 NYLHENKPV 272
            +LH  +P+
Sbjct: 125 AFLHTLEPL 133

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 95  RGADVDPKDRWGSTPLGDAIYYKNHE--VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDP 152
           RG DVD +   G    G      N++  V  + +++  +P+     +KH   +  Y+I  
Sbjct: 111 RGYDVDEQ---GKIVRGKGTVSSNYDNYVFDIWKQYYPQPV----EIKHDHVLDHYDI-- 161
Query: 153 HELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           HE       E+  G F     +     G   A K +     SD + VR    E+  +  +
Sbjct: 162 HE-------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVL 211
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNYL 266
           RHP +V    A    + M+++ E++  G+L          +    AV +   + +G+ ++
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 267 HENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLT 312
           HEN     +H DL+P NI+     S  LK+ DFG++  L  K+   +T
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 14/126 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 99  GFQCAVKKV---------RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLE 149
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K +G L    A+ +      G+ YLH  +   I+H D++  N+ L  D  + 
Sbjct: 150 GGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHA 206
Query: 293 KVADFG 298
            + DFG
Sbjct: 207 ALCDFG 212

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 59/117 (50%), Gaps = 3/117 (2%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+A+ + + +P+VV F G       + +V E   +  L    KR+ A+    A  F    
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            +G+ YLH N+   +IHRDL+  N+  +D  ++K+ DFG++  +    +R  T   T
Sbjct: 152 IQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGT 205

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+A+ + + +P+VV F G       + +V E   +  L    KR+ A+    A  F    
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            +G+ YLH N+   +IHRDL+  N+  +D  ++K+ DFG++
Sbjct: 152 IQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 3/123 (2%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K L +  I  +      R E+ +   + HPN+++          + ++ EY P+G+L
Sbjct: 51  VALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL 110
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L++              ++A  + Y H  K   +IHRD++P N+L    G LK+ADF
Sbjct: 111 YKELQKSCTFDEQRTATIMEELADALMYCHGKK---VIHRDIKPENLLLGLKGELKIADF 167
Query: 298 GVS 300
           G S
Sbjct: 168 GWS 170

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+A+ + + +P+VV F G       + +V E   +  L    KR+ A+    A  F    
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            +G+ YLH N+   +IHRDL+  N+  +D  ++K+ DFG++
Sbjct: 152 IQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 56/126 (44%), Gaps = 14/126 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 97  GFQCAVKKV---------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 147
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K+ G L    A+ +      G+ YLH  +   I+H D++  N+ L  D    
Sbjct: 148 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRA 204
Query: 293 KVADFG 298
            + DFG
Sbjct: 205 ALCDFG 210

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 56/126 (44%), Gaps = 14/126 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 99  GFQCAVKKV---------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 149
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K+ G L    A+ +      G+ YLH  +   I+H D++  N+ L  D    
Sbjct: 150 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRA 206
Query: 293 KVADFG 298
            + DFG
Sbjct: 207 ALCDFG 212

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 56/126 (44%), Gaps = 14/126 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 83  GFQCAVKKV---------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K+ G L    A+ +      G+ YLH  +   I+H D++  N+ L  D    
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRA 190
Query: 293 KVADFG 298
            + DFG
Sbjct: 191 ALCDFG 196

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 64/137 (46%), Gaps = 21/137 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           GI VAVKKL     +     RA+R EL LL+ + H N++  L   T   P   + E+   
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKTLEEF--- 99
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 284
            D+   ++   A      +   LD  R          G+ +LH      IIHRDL+PSNI
Sbjct: 100 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 155
Query: 285 LRDDSGNLKVADFGVSK 301
           +      LK+ DFG+++
Sbjct: 156 VVKSDCTLKILDFGLAR 172

>pdb|3B7B|A Chain A, Euhmt1 (Glp) Ankyrin Repeat Domain (Structure 1) Length = 237

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 51/88 (57%), Gaps = 1/88 (1%)
Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
           LM  A    +E +K L+ +G  V+ +D +  T LH+AA +G  EVV  LL  G  DV+ +
Sbjct: 48  LMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQ 107
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D  G TP+  A  YK+ +++KLL   G+
Sbjct: 108 DDGGWTPMIWATEYKHVDLVKLLLSKGS 135

>pdb|2ZGG|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 92

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/71 (39%), Positives = 45/71 (63%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DV  +D +  T LH+AA  G  EVV LLLE GADV+ +D++G T    +I 
Sbjct: 22  VRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVNAQDKFGKTAFDISID 81
Query: 116 YKNHEVIKLLE 126
             N ++ ++L+
Sbjct: 82  NGNEDLAEILQ 92

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 69/130 (53%), Gaps = 7/130 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE-YLP 233
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T +S +    + YL 
Sbjct: 67  GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125
Query: 234 KGDLRAFLKRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
              ++  L++   ++ S          + +G+ Y+H      ++HRDL+P N+  ++   
Sbjct: 126 MPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCE 182
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 183 LKILDFGLAR 192

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           LL+  +HPN++           + +VTE +  G+L   + R+       A      I + 
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKT 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILR-DDSGN---LKVADFGVSKLL 303
           + YLH      ++HRDL+PSNIL  D+SGN   L++ DFG +K L
Sbjct: 134 VEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL 175

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 7/105 (6%)
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           LL+  +HPN++           + +VTE    G+L   + R+       A      I + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 263 MNYLHENKPVPIIHRDLEPSNILR-DDSGN---LKVADFGVSKLL 303
           + YLH      ++HRDL+PSNIL  D+SGN   +++ DFG +K L
Sbjct: 129 VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 190 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLL 303
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L
Sbjct: 249 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 40/191 (20%)
Query: 146 PEYEIDPHELDFTNSV-------EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDR 193
           P  + D  E  F + V       +I +GTF   F       G +VA+KK+  E   +   
Sbjct: 2   PAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP 61
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAV-TQSSP-------MMIVTEYLPKGDLRAFLKRKG 245
           + A R E+ +LQ ++H NVV  +    T++SP       + +V ++  + DL   L    
Sbjct: 62  ITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLS--- 116
Query: 246 ALKPSTAVRFALD--------IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
               +  V+F L         +  G+ Y+H NK   I+HRD++ +N+L    G LK+ADF
Sbjct: 117 ----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 169
Query: 298 GVSKLLTVKED 308
           G+++  ++ ++
Sbjct: 170 GLARAFSLAKN 180

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 204 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLL 303
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L
Sbjct: 263 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 306

>pdb|1AWC|B Chain B, Mouse Gabp AlphaBETA DOMAIN BOUND TO DNA Length = 153

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/72 (41%), Positives = 45/72 (62%)
Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
           LL +G+  + R   +RT LH+AA +G   +V +LL+ GADV+ KD    T L  A  + +
Sbjct: 53  LLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNH 112
Query: 119 HEVIKLLEKHGA 130
            EV++LL K+GA
Sbjct: 113 QEVVELLIKYGA 124

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 40/191 (20%)
Query: 146 PEYEIDPHELDFTNSV-------EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDR 193
           P  + D  E  F + V       +I +GTF   F       G +VA+KK+  E   +   
Sbjct: 2   PAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP 61
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAV-TQSSP-------MMIVTEYLPKGDLRAFLKRKG 245
           + A R E+ +LQ ++H NVV  +    T++SP       + +V ++  + DL   L    
Sbjct: 62  ITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFC-EHDLAGLLS--- 116
Query: 246 ALKPSTAVRFALD--------IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
               +  V+F L         +  G+ Y+H NK   I+HRD++ +N+L    G LK+ADF
Sbjct: 117 ----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 169
Query: 298 GVSKLLTVKED 308
           G+++  ++ ++
Sbjct: 170 GLARAFSLAKN 180

>pdb|3V2O|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Ankra2 Length = 183

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 5/112 (4%)
Query: 21  RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA 80
           R  +E  +N  D++G    P   LM+ A    +  ++ LL +G D         +AL +A
Sbjct: 38  RIEQENVINHTDEEG--FTP---LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLA 92
Query: 81  ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             +G+T++V +LL+ G DV+  D  G TPL  A++  + + +K+L + GA P
Sbjct: 93  CSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADP 144

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + +VT 
Sbjct: 69  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT- 125
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           +L   DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 126 HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTX 181
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 182 DLKICDFGLARV 193

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFA 256
           +E  +L+K+    VV    A      + +V   +  GDL+  +   G      + AV +A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            +I  G+  LH  +   I++RDL+P NIL DD G+++++D G++
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 40/191 (20%)
Query: 146 PEYEIDPHELDFTNSV-------EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDR 193
           P  + D  E  F + V       +I +GTF   F       G +VA+KK+  E   +   
Sbjct: 2   PAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP 61
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAV-TQSSP-------MMIVTEYLPKGDLRAFLKRKG 245
           + A R E+ +LQ ++H NVV  +    T++SP       + +V ++  + DL   L    
Sbjct: 62  ITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLS--- 116
Query: 246 ALKPSTAVRFALD--------IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
               +  V+F L         +  G+ Y+H NK   I+HRD++ +N+L    G LK+ADF
Sbjct: 117 ----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 169
Query: 298 GVSKLLTVKED 308
           G+++  ++ ++
Sbjct: 170 GLARAFSLAKN 180

>pdb|3SO8|A Chain A, Crystal Structure Of Ankra Length = 162

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 5/112 (4%)
Query: 21  RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA 80
           R  +E  +N  D++G    P   LM+ A    +  ++ LL +G D         +AL +A
Sbjct: 20  RIEQENVINHTDEEG--FTP---LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLA 74
Query: 81  ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             +G+T++V +LL+ G DV+  D  G TPL  A++  + + +K+L + GA P
Sbjct: 75  CSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADP 126

>pdb|3V2X|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Ankra2 Length = 167

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 5/112 (4%)
Query: 21  RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA 80
           R  +E  +N  D++G    P   LM+ A    +  ++ LL +G D         +AL +A
Sbjct: 22  RIEQENVINHTDEEG--FTP---LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLA 76
Query: 81  ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             +G+T++V +LL+ G DV+  D  G TPL  A++  + + +K+L + GA P
Sbjct: 77  CSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADP 128

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLL 303
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 64  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLL 303
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L
Sbjct: 123 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 166

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 59/118 (50%), Gaps = 21/118 (17%)
Query: 200 ELALLQKIRHPNVVQFLGAV----------------TQSSPMMIVTEYLPKGDLRAFL-K 242
           E+  L K+ H N+V + G                  +++  + I  E+  KG L  ++ K
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 243 RKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
           R+G  L    A+     I +G++Y+H  K   +I+RDL+PSNI   D+  +K+ DFG+
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGL 168

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLL 303
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLL 303
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 12/109 (11%)
Query: 207 IRHPNVVQFLGA---VTQSSPM--MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
           + H N+ +F+     VT    M  ++V EY P G L  +L    +   S+  R A  + R
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC-RLAHSVTR 122
Query: 262 GMNYLHENKPV------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           G+ YLH   P        I HRDL   N+L  + G   ++DFG+S  LT
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  +AVK++   V S + + R   D    ++ +  P  V F GA+ +   + I  E L  
Sbjct: 32  GQIMAVKRIRATVNSQEQK-RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME-LMD 89
Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
             L  F K+   KG   P   + + A+ I + + +LH    + +IHRD++PSN+L +  G
Sbjct: 90  TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALG 147
Query: 291 NLKVADFGVSKLLT 304
            +K+ DFG+S  L 
Sbjct: 148 QVKMCDFGISGYLV 161

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 87
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 145
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 88
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 146
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 147 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 179

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 79
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 137
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 138 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 170

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 86
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFA 256
           +E  +L+K+    VV    A      + +V   +  GDL+  +   G      + AV +A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            +I  G+  LH  +   I++RDL+P NIL DD G+++++D G++
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 80
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 138
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           LL+  +HPN++           + +VTE +  G+L   + R+       A      I + 
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKT 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILR-DDSGN---LKVADFGVSKLL 303
           + YLH      ++HRDL+PSNIL  D+SGN   L++ DFG +K L
Sbjct: 134 VEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL 175

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 71  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLL 303
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L
Sbjct: 130 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 173

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 68/133 (51%), Gaps = 10/133 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV---QFLGAVT-QSSPMMIVT 229
           R  +VA+KK+           +    E+ +L + RH NV+     L A T ++   + + 
Sbjct: 67  RKTRVAIKKISP--FEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIV 124
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           + L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + +
Sbjct: 125 QDLMETDLYKLLKSQ-QLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTT 180
Query: 290 GNLKVADFGVSKL 302
            +LK+ DFG++++
Sbjct: 181 CDLKICDFGLARI 193

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 80
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 138
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 86
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 87
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 145
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  +AVK++   V S + + R   D    ++ +  P  V F GA+ +   + I  E +  
Sbjct: 76  GQIMAVKRIRATVNSQEQK-RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-D 133
Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
             L  F K+   KG   P   + + A+ I + + +LH    + +IHRD++PSN+L +  G
Sbjct: 134 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALG 191
Query: 291 NLKVADFGVSKLL 303
            +K+ DFG+S  L
Sbjct: 192 QVKMCDFGISGYL 204

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 151 DPHEL--DFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           DP E   +F    E + G   +A  +  G QVAVKK+    +    R     +E+ +++ 
Sbjct: 42  DPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRD 98
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
             H NVV    +      + +V E+L  G L   +      +   A    L + R ++YL
Sbjct: 99  YHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLSVLRALSYL 157
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           H      +IHRD++  +IL    G +K++DFG
Sbjct: 158 HNQG---VIHRDIKSDSILLTSDGRIKLSDFG 186

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + IV +
Sbjct: 49  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 106
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 107 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 161
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 162 DLKICDFGLARV 173

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 86
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKCQ-HLSNDHICYFLYQILRGLKYI 144
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 86
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + IV +
Sbjct: 57  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 114
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 115 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 169
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 170 DLKICDFGLARV 181

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + IV +
Sbjct: 49  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 106
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 107 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 161
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 162 DLKICDFGLARV 173

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/135 (22%), Positives = 67/135 (49%), Gaps = 7/135 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 45  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 295 ADFGVSKLLTVKEDR 309
            DFG    +T ++ +
Sbjct: 158 TDFGFCAQITPEQSK 172

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/135 (22%), Positives = 67/135 (49%), Gaps = 7/135 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 46  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 103 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 158
Query: 295 ADFGVSKLLTVKEDR 309
            DFG    +T ++ +
Sbjct: 159 TDFGFCAQITPEQSK 173

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + IV +
Sbjct: 51  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 108
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 109 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 163
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 164 DLKICDFGLARV 175

>pdb|2ZGD|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 110

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/71 (39%), Positives = 44/71 (61%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DV  +D +  T LH+AA  G  EVV LLLE GADV  +D++G T    +I 
Sbjct: 40  VRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISID 99
Query: 116 YKNHEVIKLLE 126
             N ++ ++L+
Sbjct: 100 NGNEDLAEILQ 110

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + IV +
Sbjct: 69  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 126
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 127 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 181
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 182 DLKICDFGLARV 193

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/135 (22%), Positives = 67/135 (49%), Gaps = 7/135 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 45  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 295 ADFGVSKLLTVKEDR 309
            DFG    +T ++ +
Sbjct: 158 TDFGFCAQITPEQSK 172

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/135 (22%), Positives = 67/135 (49%), Gaps = 7/135 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 45  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 295 ADFGVSKLLTVKEDR 309
            DFG    +T ++ +
Sbjct: 158 TDFGFCAQITPEQSK 172

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGA---LKPSTA 252
            + E ++   ++HP++V+ L   +    + +V E++   DL    +KR  A      + A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVS 300
             +   I   + Y H+N    IIHRD++P N+L   +++S  +K+ DFGV+
Sbjct: 133 SHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA 180

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 22/147 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQF------LGAVTQSSPM 225
           G+ VA+KK     +  D R R    EL ++Q +    HPN+VQ       LG   +    
Sbjct: 48  GMSVAIKK-----VIQDPRFR--NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100
Query: 226 M-IVTEYLPKG---DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V EY+P       R + +R+ A  P     F   + R +  LH    V + HRD++P
Sbjct: 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKP 159
Query: 282 SNILRDDS-GNLKVADFGVSKLLTVKE 307
            N+L +++ G LK+ DFG +K L+  E
Sbjct: 160 HNVLVNEADGTLKLCDFGSAKKLSPSE 186

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 48/82 (58%), Gaps = 5/82 (6%)
Query: 220 TQSSPMMIVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           +++  + I  E+  KG L  ++ KR+G  L    A+     I +G++Y+H  K   +IHR
Sbjct: 104 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LIHR 160
Query: 278 DLEPSNILRDDSGNLKVADFGV 299
           DL+PSNI   D+  +K+ DFG+
Sbjct: 161 DLKPSNIFLVDTKQVKIGDFGL 182

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 17/125 (13%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQF-------------LGAVTQSSPMMIVTEYLPKGDL 237
           ++++     E+ LL  + H  VV++             + AV + S + I  EY   G L
Sbjct: 43  EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL 102
Query: 238 RAFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              +  +   +      R    I   ++Y+H      IIHRDL+P NI  D+S N+K+ D
Sbjct: 103 YDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159
Query: 297 FGVSK 301
           FG++K
Sbjct: 160 FGLAK 164

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + IV +
Sbjct: 49  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 106
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 107 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTX 161
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 162 DLKICDFGLARV 173

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIRH 209
           +TN   I +G + +          ++VA+KK+   E        +R    E+ +L + RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR----EIKILLRFRH 84
Query: 210 PNVVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
            N++          + Q   + IV + L + DL   LK +  L       F   I RG+ 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLK 142
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           Y+H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 61/129 (47%), Gaps = 6/129 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + A+K + +  ++      A  DE+A+L+++ HPN+++            +V E    
Sbjct: 29  GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRG 88
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--- 291
           G+L   +  +       A      +  G  YLH++    I+HRDL+P N+L +       
Sbjct: 89  GELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDAL 145
Query: 292 LKVADFGVS 300
           +K+ DFG+S
Sbjct: 146 IKIVDFGLS 154

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 61/129 (47%), Gaps = 6/129 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + A+K + +  ++      A  DE+A+L+++ HPN+++            +V E    
Sbjct: 46  GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--- 291
           G+L   +  +       A      +  G  YLH++    I+HRDL+P N+L +       
Sbjct: 106 GELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDAL 162
Query: 292 LKVADFGVS 300
           +K+ DFG+S
Sbjct: 163 IKIVDFGLS 171

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + IV +
Sbjct: 49  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 106
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 107 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTX 161
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 162 DLKICDFGLARV 173

>pdb|4B93|B Chain B, Complex Of Vamp7 Cytoplasmic Domain With 2nd Ankyrin Repeat Domain Of Varp Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 50/114 (43%), Gaps = 3/114 (2%)
Query: 22  ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALH 78
           E  E +L   +D      PEF        +     K L     SG+ VN    D  + LH
Sbjct: 32  EWTEEDLEDAEDTVSAADPEFCHPLCQCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLH 91
Query: 79  VAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           VAA  G  +++ LLL+ GA+   ++   + PL  A    + +V+K L    AKP
Sbjct: 92  VAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKP 145

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 33/168 (19%)
Query: 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I +GTF   F       G +VA+KK+  E   +   + A R E+ +LQ ++H NVV  +
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 82
Query: 217 GAV-TQSSP-------MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD--------IA 260
               T++SP       + +V ++  + DL   L        +  V+F L         + 
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLS-------NVLVKFTLSEIKRVMQMLL 134
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            G+ Y+H NK   I+HRD++ +N+L    G LK+ADFG+++  ++ ++
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 57/108 (52%), Gaps = 10/108 (9%)
Query: 200 ELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 254
           E+ +L + RH N++          + Q   + IV + L + DL   LK +  L       
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICY 132
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           F   I RG+ Y+H      ++HRDL+PSN+L + + +LK+ DFG++++
Sbjct: 133 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 65/132 (49%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L   RH N++          + Q   + IV +
Sbjct: 51  VRVAIKKISP--FEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQD 108
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 109 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTS 163
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 164 DLKICDFGLARV 175

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 27/172 (15%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQ 205
           P E+ +T++  I  G+F + +       G  VA+KK+ +         +AF++ EL +++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMR 68
Query: 206 KIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFA 256
           K+ H N+V+       S        + +V +Y+P+   R    + + K  L       + 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
             + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 9/165 (5%)
Query: 142 AREVPEYEIDPHELDFTNSVE-ITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP           + KG F   F           A K + + ++    +  
Sbjct: 3   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 63  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 122
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++
Sbjct: 123 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 9/165 (5%)
Query: 142 AREVPEYEIDPHELDFTNSVE-ITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP           + KG F   F           A K + + ++    +  
Sbjct: 3   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 63  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 122
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++
Sbjct: 123 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 9/165 (5%)
Query: 142 AREVPEYEIDPHELDFTNSVE-ITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP           + KG F   F           A K + + ++    +  
Sbjct: 1   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 61  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 27/172 (15%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQ 205
           P E+ +T++  I  G+F + +       G  VA+KK+ +         +AF++ EL +++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMR 68
Query: 206 KIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFA 256
           K+ H N+V+       S        + +V +Y+P+   R    + + K  L       + 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
             + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + IV +
Sbjct: 49  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 106
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 107 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTX 161
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 162 DLKIXDFGLARV 173

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 9/165 (5%)
Query: 142 AREVPEYEIDPHELDFTNSVE-ITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP           + KG F   F           A K + + ++    +  
Sbjct: 7   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 66
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 67  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 126
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++
Sbjct: 127 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 65/132 (49%), Gaps = 12/132 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L   RH N++          + Q   + IV +
Sbjct: 51  VRVAIKKISP--FEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQD 108
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 109 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 163
Query: 291 NLKVADFGVSKL 302
           +LK+ DFG++++
Sbjct: 164 DLKICDFGLARV 175

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 13/128 (10%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++   D+ V+    E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 47  VAVKYIERGEKI---DENVKR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 100
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLK 157
Query: 294 VADFGVSK 301
           +  FG SK
Sbjct: 158 ICAFGYSK 165

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 13/128 (10%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++   D+ V+    E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 47  VAVKYIERGEKI---DENVKR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 100
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLK 157
Query: 294 VADFGVSK 301
           +  FG SK
Sbjct: 158 ICAFGYSK 165

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 27/172 (15%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQ 205
           P E+ +T++  I  G+F + +       G  VA+KK+ +         +AF++ EL +++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMR 68
Query: 206 KIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFA 256
           K+ H N+V+       S        + +V +Y+P    R    + + K  L       + 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
             + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 129 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +   I
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 148
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
             G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++
Sbjct: 149 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           AVK++   V S + + R   D     + +  P  V F GA+ +   + I  E L    L 
Sbjct: 63  AVKRIRATVNSQEQK-RLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE-LXDTSLD 120
Query: 239 AFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            F K+   KG   P   + + A+ I + + +LH    + +IHRD++PSN+L +  G +K 
Sbjct: 121 KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKX 178
Query: 295 ADFGVSKLLT 304
            DFG+S  L 
Sbjct: 179 CDFGISGYLV 188

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +   I
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
             G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++
Sbjct: 151 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/135 (21%), Positives = 67/135 (49%), Gaps = 7/135 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 46  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHR+++  NIL    G++K+
Sbjct: 103 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRNIKSDNILLGMDGSVKL 158
Query: 295 ADFGVSKLLTVKEDR 309
            DFG    +T ++ +
Sbjct: 159 TDFGFCAQITPEQSK 173

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 21  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 73
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 74  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 134 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 181

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 25  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 77
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 78  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 138 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 185

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 36  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 88
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 89  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 149 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 196

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 30  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 82
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 83  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 143 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 190

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 22  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 74
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 75  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 135 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 81
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 142 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 18  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 70
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 71  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 131 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 178

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 81
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 142 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 12/113 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVR 254
           E  +L+K+ H N+V+       T +   +++ E+ P G L   L+       L  S  + 
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGVSKLL 303
              D+  GMN+L EN    I+HR+++P NI+R    D     K+ DFG ++ L
Sbjct: 117 VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 12/113 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVR 254
           E  +L+K+ H N+V+       T +   +++ E+ P G L   L+       L  S  + 
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGVSKLL 303
              D+  GMN+L EN    I+HR+++P NI+R    D     K+ DFG ++ L
Sbjct: 117 VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 103
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 164 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 45  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 97
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 98  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 158 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 103
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 164 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|1UOH|A Chain A, Human Gankyrin Length = 226

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 47/89 (52%)
Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L +  +    E ++ LL  G+ VN +D    + LH+AA  G  E+V  LL +GA V+  +
Sbjct: 44  LHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVN 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + G TPL  A     HE+  +L + GA P
Sbjct: 104 QNGCTPLHYAASKNRHEIAVMLLEGGANP 132

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 55  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 107
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 108 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 168 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215

>pdb|3AJI|A Chain A, Structure Of Gankyrin-S6atpase Photo-Cross-Linked Site-Specifically, And Incoporated By Genetic Code Expansion Length = 231

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 47/89 (52%)
Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L +  +    E ++ LL  G+ VN +D    + LH+AA  G  E+V  LL +GA V+  +
Sbjct: 44  LHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVN 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + G TPL  A     HE+  +L + GA P
Sbjct: 104 QNGCTPLHYAASKNRHEIAVMLLEGGANP 132

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 96  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 148
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 149 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 209 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256

>pdb|1QYM|A Chain A, X-Ray Structure Of Human Gankyrin Length = 227

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 47/89 (52%)
Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L +  +    E ++ LL  G+ VN +D    + LH+AA  G  E+V  LL +GA V+  +
Sbjct: 45  LHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVN 104
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + G TPL  A     HE+  +L + GA P
Sbjct: 105 QNGCTPLHYAASKNRHEIAVMLLEGGANP 133

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 53  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 105
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 106 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 165
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E
Sbjct: 166 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213

>pdb|1N11|A Chain A, D34 Region Of Human Ankyrin-R And Linker Length = 437

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 47/101 (46%)
Query: 30  GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
           G   + E ++    L   A E   E +  LL    + N  +    T LH+ A +G   V 
Sbjct: 235 GGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVA 294
Query: 90  SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            +L++ G  VD   R G TPL  A +Y N +++K L +H A
Sbjct: 295 DVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQA 335

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 16/140 (11%)
Query: 175 GIQVAVKKLGEEV--------ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPM 225
           GI VA+K++   V        +SD    +    E+ LL    HPN++           P 
Sbjct: 46  GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105
Query: 226 M----IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           M    +VTE +     +    ++  + P     F   I  G++ LHE     ++HRDL P
Sbjct: 106 MHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHP 162
Query: 282 SNILRDDSGNLKVADFGVSK 301
            NIL  D+ ++ + DF +++
Sbjct: 163 GNILLADNNDITICDFNLAR 182

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 16/140 (11%)
Query: 175 GIQVAVKKLGEEV--------ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPM 225
           GI VA+K++   V        +SD    +    E+ LL    HPN++           P 
Sbjct: 46  GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105
Query: 226 M----IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           M    +VTE +     +    ++  + P     F   I  G++ LHE     ++HRDL P
Sbjct: 106 MHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHP 162
Query: 282 SNILRDDSGNLKVADFGVSK 301
            NIL  D+ ++ + DF +++
Sbjct: 163 GNILLADNNDITICDFNLAR 182

>pdb|2DVW|A Chain A, Structure Of The Oncoprotein Gankyrin In Complex With S6 Atpase Of The 26s Proteasome Length = 231

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 47/89 (52%)
Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L +  +    E ++ LL  G+ VN +D    + LH+AA  G  E+V  LL +GA V+  +
Sbjct: 44  LHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLVKGAHVNAVN 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + G TPL  A     HE+  +L + GA P
Sbjct: 104 QNGCTPLHYAASKNRHEIAVMLLEGGANP 132

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRF 255
           E  +L K+    +V    A    + + +V   +  GD+R  +          +   A+ +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              I  G+ +LH+     II+RDL+P N+L DD GN++++D G++
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 198 RDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAV 253
           + E+ LL+++RH NV+Q +  +   +   M +V EY   G ++  L    +       A 
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAH 112
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
            +   +  G+ YLH      I+H+D++P N+L    G LK++  GV++ L      P   
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL-----HPFAA 164
Query: 314 QDTSCR 319
            DT CR
Sbjct: 165 DDT-CR 169

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRF 255
           E  +L K+    +V    A    + + +V   +  GD+R  +          +   A+ +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              I  G+ +LH+     II+RDL+P N+L DD GN++++D G++
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRF 255
           E  +L K+    +V    A    + + +V   +  GD+R  +          +   A+ +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              I  G+ +LH+     II+RDL+P N+L DD GN++++D G++
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDATLKILDFGLAR 174

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRF 255
           E  +L K+    +V    A    + + +V   +  GD+R  +          +   A+ +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              I  G+ +LH+     II+RDL+P N+L DD GN++++D G++
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDATLKILDFGLAR 174

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDATLKILDFGLAR 174

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDATLKILDFGLAR 174

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDATLKILDFGLAR 174

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFT---PQKTLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDXTLKILDFGLAR 174

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 21/149 (14%)
Query: 176 IQVAVKK------LGEEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAV-TQSSP 224
           +QVA+K       LG   +SD         E+ALL K+     HP V++ L    TQ   
Sbjct: 57  LQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALLWKVGAGGGHPGVIRLLDWFETQEGF 113
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           M+++   LP  DL  ++  KG L    +  F   +   + + H      ++HRD++  NI
Sbjct: 114 MLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENI 170
Query: 285 LRD-DSGNLKVADFGVSKLLTVKEDRPLT 312
           L D   G  K+ DFG   LL    D P T
Sbjct: 171 LIDLRRGCAKLIDFGSGALL---HDEPYT 196

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/111 (22%), Positives = 59/111 (53%), Gaps = 9/111 (8%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E++LL++++H N+++    +  +  + ++ EY  + DL+ ++ +   +       F   +
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL-----RDDSGNLKVADFGVSKLLTV 305
             G+N+ H  +    +HRDL+P N+L       ++  LK+ DFG+++   +
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 142
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 143 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 198
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 199 SDCTLKILDFGLAR 212

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 105
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 106 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 161
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 162 SDCTLKILDFGLAR 175

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       +V E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLXQVIQME--LDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXT 164
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 165 LKILDFGLAR 174

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFT---PQKTLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YLVMELMDA-NLXQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDXTLKILDFGLAR 174

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDCTLKILDFGLAR 174

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDCTLKILDFGLAR 174

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 17/125 (13%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQF-------------LGAVTQSSPMMIVTEYLPKGDL 237
           ++++     E+ LL  + H  VV++             + AV + S + I  EY     L
Sbjct: 43  EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL 102
Query: 238 RAFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              +  +   +      R    I   ++Y+H      IIHRDL+P NI  D+S N+K+ D
Sbjct: 103 YDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159
Query: 297 FGVSK 301
           FG++K
Sbjct: 160 FGLAK 164

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 142
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 143 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 198
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 199 SDCTLKILDFGLAR 212

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 105
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 106 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 161
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 162 SDCTLKILDFGLAR 175

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 98
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 99  YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 154
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 155 SDCTLKILDFGLAR 168

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 161 SDCTLKILDFGLAR 174

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 97
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 98  YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 153
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 154 SDCTLKILDFGLAR 167

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 103
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 104 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 159
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 160 SDCTLKILDFGLAR 173

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 98
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 99  YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 154
Query: 288 DSGNLKVADFGVSK 301
               LK+ DFG+++
Sbjct: 155 SDCTLKILDFGLAR 168

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 103
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 104 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 158
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 159 LKILDFGLAR 168

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       +V E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLXQVIQME--LDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXT 164
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 165 LKILDFGLAR 174

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       +V E 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME- 102
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 103 LMDANLXQVIQME--LDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXT 157
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 158 LKILDFGLAR 167

>pdb|2RFM|A Chain A, Structure Of A Thermophilic Ankyrin Repeat Protein Length = 192

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 44/77 (57%), Gaps = 1/77 (1%)
Query: 55  GIKE-LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           GI E LL  G +VN +D   +T L  +   G++E+   LLE GA+V+ ++  G TPL  A
Sbjct: 82  GIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVA 141
Query: 114 IYYKNHEVIKLLEKHGA 130
             Y   E++K L + GA
Sbjct: 142 SKYGRSEIVKKLLELGA 158

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 165 LKILDFGLAR 174

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 165 LKILDFGLAR 174

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
           G + A K L +     D R      E+A+L+  +  P V+        +S ++++ EY  
Sbjct: 54  GQEYAAKFLKKRRRGQDCRAEILH-EIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112
Query: 234 KGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-- 289
            G++ +    + A  +  +  +R    I  G+ YLH+N    I+H DL+P NIL      
Sbjct: 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169
Query: 290 -GNLKVADFGVSK 301
            G++K+ DFG+S+
Sbjct: 170 LGDIKIVDFGMSR 182

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 165 LKILDFGLAR 174

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 114
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 115 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 169
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 170 LKILDFGLAR 179

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 110
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 111 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 165
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 166 LKILDFGLAR 175

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 165 LKILDFGLAR 174

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 165 LKILDFGLAR 174

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 13/130 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 111
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 112 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 166
Query: 292 LKVADFGVSK 301
           LK+ DFG+++
Sbjct: 167 LKILDFGLAR 176

>pdb|1OY3|D Chain D, Crystal Structure Of An IkbbetaNF-Kb P65 Homodimer Complex Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 44/81 (54%), Gaps = 1/81 (1%)
Query: 51  RDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
           +D E ++ L D+G D+N  +    RT LH+A       V+ LLL+ GAD   +   G TP
Sbjct: 169 KDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTP 228
Query: 110 LGDAIYYKNHEVIKLLEKHGA 130
           LG A+   N  + +LL  HGA
Sbjct: 229 LGSALLRPNPILARLLRAHGA 249

>pdb|1K3Z|D Chain D, X-Ray Crystal Structure Of The IkbbNF-Kb P65 Homodimer Complex Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 44/81 (54%), Gaps = 1/81 (1%)
Query: 51  RDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
           +D E ++ L D+G D+N  +    RT LH+A       V+ LLL+ GAD   +   G TP
Sbjct: 169 KDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTP 228
Query: 110 LGDAIYYKNHEVIKLLEKHGA 130
           LG A+   N  + +LL  HGA
Sbjct: 229 LGSALLRPNPILARLLRAHGA 249

>pdb|3AAA|C Chain C, Crystal Structure Of Actin Capping Protein In Complex With V-1 Length = 123

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 45/88 (51%)
Query: 43  RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
             M+     D++ +K+ +  G DVN      R  LH AA  G  E++  LL +GAD++  
Sbjct: 10  EFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAP 69
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D+   TPL  A+Y  +   +KLL   GA
Sbjct: 70  DKHHITPLLSAVYEGHVSCVKLLLSKGA 97

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/129 (24%), Positives = 64/129 (49%), Gaps = 7/129 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +    E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 31  GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 90  GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146
Query: 292 LKVADFGVS 300
           +K+ADFG++
Sbjct: 147 VKLADFGLA 155

>pdb|1S70|B Chain B, Complex Between Protein Ser/thr Phosphatase-1 (delta) And The Myosin Phosphatase Targeting Subunit 1 (mypt1) Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 39  KPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGA 97
           K E R+M     RD    ++ L+SG   + R      TALHVAA +G+TEV+ LL++   
Sbjct: 171 KEEERIML----RDA---RQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARY 223
Query: 98  DVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
           DV+ KD  G TPL  A ++   E  ++L
Sbjct: 224 DVNIKDYDGWTPLHAAAHWGKEEACRIL 251

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/129 (24%), Positives = 64/129 (49%), Gaps = 7/129 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +    E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 30  GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 88
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 89  GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 145
Query: 292 LKVADFGVS 300
           +K+ADFG++
Sbjct: 146 VKLADFGLA 154

>pdb|1MYO|A Chain A, Solution Structure Of Myotrophin, Nmr, 44 Structures Length = 118

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 45/88 (51%)
Query: 43  RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
             M+     D++ +K+ +  G DVN      R  LH AA  G  E++  LL +GAD++  
Sbjct: 5   EFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAP 64
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D+   TPL  A+Y  +   +KLL   GA
Sbjct: 65  DKHHITPLLSAVYEGHVSCVKLLLSKGA 92

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +  R E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 31  GLEFAAKIINTKKLSARDFQKLER-EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 90  GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146
Query: 292 LKVADFGVS 300
           +K+ADFG++
Sbjct: 147 VKLADFGLA 155

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 13/106 (12%)
Query: 207 IRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           ++H N++QF+ A  + S     + ++T +  KG L  +LK    +  +     A  ++RG
Sbjct: 66  MKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLK-GNIITWNELCHVAETMSRG 124
Query: 263 MNYLHENKPV--------PIIHRDLEPSNILRDDSGNLKVADFGVS 300
           ++YLHE+ P          I HRD +  N+L        +ADFG++
Sbjct: 125 LSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 56/125 (44%), Gaps = 17/125 (13%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGA-------------VTQSSPMMIVTEYLPKGDL 237
           ++++     E+ LL  + H  VV++  A             V + S + I  EY     L
Sbjct: 43  EEKLSTILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL 102
Query: 238 RAFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              +  +   +      R    I   ++Y+H      IIHR+L+P NI  D+S N+K+ D
Sbjct: 103 YDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGD 159
Query: 297 FGVSK 301
           FG++K
Sbjct: 160 FGLAK 164

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L+L+     P +V    A      +  + + +  GDL   L + G    +    +A +I 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            G+ ++H      +++RDL+P+NIL D+ G+++++D G++
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L+L+     P +V    A      +  + + +  GDL   L + G    +    +A +I 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            G+ ++H      +++RDL+P+NIL D+ G+++++D G++
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK +  E  +   R R FR+   L Q   + N+++ +      +   +V E L  
Sbjct: 38  GKEYAVKII--EKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQG 95
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GN 291
           G + A ++++       A R   D+A  +++LH      I HRDL+P NIL +       
Sbjct: 96  GSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSP 152
Query: 292 LKVADF 297
           +K+ DF
Sbjct: 153 VKICDF 158

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L+L+     P +V    A      +  + + +  GDL   L + G    +    +A +I 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            G+ ++H      +++RDL+P+NIL D+ G+++++D G++
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L+L+     P +V    A      +  + + +  GDL   L + G    +    +A +I 
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            G+ ++H      +++RDL+P+NIL D+ G+++++D G++
Sbjct: 302 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 338

>pdb|3UXG|A Chain A, Crystal Structure Of Rfxank Length = 172

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 55/96 (57%), Gaps = 4/96 (4%)
Query: 39  KPEFR----LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
           KP+ R    L++ +   ++E ++ LL+ G D +    +  +AL +A+  G+T++V LLLE
Sbjct: 31  KPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLE 90
Query: 95  RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           R  D++  D  G TPL  A++  + + ++ L   GA
Sbjct: 91  RDVDINIYDWNGGTPLLYAVHGNHVKCVEALLARGA 126

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 10/115 (8%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL----KRKGALKPSTAVRF 255
           E+ +L+ + HPN+++          M IV E    G+L   +     R  AL        
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKE 307
              +   + Y H      ++H+DL+P NIL  D+     +K+ DFG+++L    E
Sbjct: 130 MKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
           HPN+V+            +V E L  G+L   +K+K     + A      +   ++++H+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 269 NKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKL 302
              V ++HRDL+P N+L    +D+  +K+ DFG ++L
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 16/179 (8%)
Query: 129 GAKPLMAPMHVKHA--REVPEYEIDPHE----LD-FTNSVEITKGTFILAFWR--GIQVA 179
           G+ P   P  V H   R   +  +DP +    LD F    E + G   +A  R  G  VA
Sbjct: 1   GSSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVA 60
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
           VKK+    +    R     +E+ +++  +H NVV+   +      + +V E+L  G L  
Sbjct: 61  VKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 117
Query: 240 FLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
            +      +   A    L + + ++ LH      +IHRD++  +IL    G +K++DFG
Sbjct: 118 IVTHTRMNEEQIAA-VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 172

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/129 (24%), Positives = 64/129 (49%), Gaps = 7/129 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +    E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 54  GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 113 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 169
Query: 292 LKVADFGVS 300
           +K+ADFG++
Sbjct: 170 VKLADFGLA 178

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/111 (26%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGA---LKPSTA 252
            + E ++   ++HP++V+ L   +    + +V E++   DL    +KR  A      + A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVS 300
             +   I   + Y H+N    IIHRD++P  +L   +++S  +K+  FGV+
Sbjct: 133 SHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/108 (25%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           +E+A+L+ + HPN+++            +V E    G+L   +  +       A      
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQ 144
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLL 303
           +  G+ YLH++    I+HRDL+P N+L   ++    +K+ DFG+S + 
Sbjct: 145 VLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189

>pdb|4A63|B Chain B, Crystal Structure Of The P73-Aspp2 Complex At 2.6a Resolution Length = 239

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/56 (44%), Positives = 32/56 (57%)
Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           TALH A C G TE+V  L++ G +V+  D  G TPL  A    N +V K L + GA
Sbjct: 72  TALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGA 127

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 164 TKGTFILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT- 220
           + G   LA+ +  +  VA+KK+        D  R  R E+ +L +++   +++    +  
Sbjct: 38  SYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIP 96
Query: 221 ----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
               +   + IV E +   DL+   K    L          ++  G N++HE+    IIH
Sbjct: 97  DDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIH 152
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           RDL+P+N L +   ++KV DFG+++ +  ++D
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/116 (22%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA----LKPSTAV 253
           ++E++++ ++ HP ++    A      M+++ E+L  G+L     R  A    +  +  +
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVI 152
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE 307
            +      G+ ++HE+    I+H D++P NI+ +   + ++K+ DFG++  L   E
Sbjct: 153 NYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/111 (26%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR-AFLKRKGA---LKPSTA 252
            + E ++   ++HP++V+ L   +    + +V E++   DL    +KR  A      + A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVS 300
             +   I   + Y H+N    IIHRD++P  +L   +++S  +K+  FGV+
Sbjct: 135 SHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 182

>pdb|1YCS|B Chain B, P53-53bp2 Complex Length = 239

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/56 (44%), Positives = 32/56 (57%)
Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           TALH A C G TE+V  L++ G +V+  D  G TPL  A    N +V K L + GA
Sbjct: 72  TALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGA 127

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 86/184 (46%), Gaps = 18/184 (9%)
Query: 134 MAPMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEE 186
           MAP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKD 79
Query: 187 VISDDDRV---RAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMIVTEYL-PKGDLRAF 240
            ISD   +        E+ LL+K+      V++ L    +    +++ E   P  DL  F
Sbjct: 80  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 139
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGV 299
           +  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DFG 
Sbjct: 140 ITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 196
Query: 300 SKLL 303
             LL
Sbjct: 197 GALL 200

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/111 (27%), Positives = 56/111 (50%), Gaps = 4/111 (3%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           R E  +L+ IR  P +V    A    + + ++ +Y+  G+L   L ++          + 
Sbjct: 106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 165
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
            +I   + +LH+   + II+RD++  NIL D +G++ + DFG+SK     E
Sbjct: 166 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	319
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-42
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-42
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-42
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-38
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-37
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-37
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-37
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-36
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-36
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-34
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-28
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-27
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-27
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-27
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-25
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-24
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	2e-24
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	5e-23
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	1e-22
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	2e-16
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	3e-13
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	3e-24
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	4e-24
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	2e-20
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	1e-07
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	6e-04
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-24
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	3e-24
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	1e-17
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	1e-15
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	3e-24
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	5e-21
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	8e-20
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	3e-19
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	4e-19
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	7e-19
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	5e-17
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	5e-24
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	2e-20
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	3e-20
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	3e-19
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	6e-18
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	1e-17
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	3e-09
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	3e-08
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-23
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	2e-23
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	4e-22
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	2e-21
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-18
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	9e-16
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-15
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	5e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-23
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	2e-23
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	6e-23
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	7e-22
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	6e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	7e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	5e-19
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	8e-18
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-13
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-10
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	2e-05
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	2e-23
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	3e-18
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	1e-16
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-23
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	3e-23
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	9e-22
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	5e-20
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	1e-19
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	6e-19
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	1e-07
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	4e-23
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	3e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	4e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	6e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	7e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	4e-21
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-19
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-05
3v30_A	172	DNA-binding protein rfxank; structural genomics co	4e-23
3v30_A	172	DNA-binding protein rfxank; structural genomics co	3e-22
3v30_A	172	DNA-binding protein rfxank; structural genomics co	1e-21
3v30_A	172	DNA-binding protein rfxank; structural genomics co	1e-16
3v30_A	172	DNA-binding protein rfxank; structural genomics co	6e-14
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	4e-23
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	4e-21
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	2e-20
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	2e-16
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	4e-13
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	5e-12
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	1e-07
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-23
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	5e-23
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-21
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	5e-20
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	8e-20
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	2e-18
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	7e-15
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	3e-09
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	7e-23
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	7e-18
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	2e-08
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	3e-06
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	6e-05
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-23
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	8e-23
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	3e-17
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	2e-09
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	8e-23
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	6e-21
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	9e-21
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	5e-15
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	1e-22
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	1e-21
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	8e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-22
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	1e-22
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	5e-21
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	7e-21
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	1e-20
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	2e-20
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	1e-08
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	1e-22
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	6e-21
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	7e-21
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	7e-15
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	1e-22
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	3e-22
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	1e-20
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	1e-18
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-15
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	2e-22
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	3e-20
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	6e-20
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	3e-14
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	1e-06
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-22
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	2e-22
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	5e-22
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	2e-21
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	4e-16
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	3e-22
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	1e-21
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	4e-20
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	3e-12
3hra_A	201	Ankyrin repeat family protein; structural protein;	3e-22
3hra_A	201	Ankyrin repeat family protein; structural protein;	2e-18
3hra_A	201	Ankyrin repeat family protein; structural protein;	3e-17
3hra_A	201	Ankyrin repeat family protein; structural protein;	1e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-22
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	3e-22
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	3e-21
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	3e-15
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	6e-10
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	3e-07
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-05
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	3e-22
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	1e-15
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	2e-11
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	7e-08
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	3e-22
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	1e-20
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	1e-15
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	3e-22
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	2e-21
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	3e-20
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	4e-11
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	5e-22
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	2e-21
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	1e-11
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	9e-11
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	5e-22
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	3e-21
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	3e-20
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	3e-19
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	3e-19
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	5e-22
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	5e-21
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	8e-20
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	9e-20
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	4e-19
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	3e-17
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	7e-10
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	5e-22
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	7e-22
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	6e-17
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	2e-09
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	6e-22
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	8e-21
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	4e-20
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	6e-18
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	2e-16
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	8e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-21
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	1e-21
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	4e-19
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	1e-18
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	3e-13
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	4e-12
2rfa_A	232	Transient receptor potential cation channel subfa	1e-21
2rfa_A	232	Transient receptor potential cation channel subfa	2e-17
2rfa_A	232	Transient receptor potential cation channel subfa	9e-17
2rfa_A	232	Transient receptor potential cation channel subfa	3e-16
2rfa_A	232	Transient receptor potential cation channel subfa	3e-13
2rfa_A	232	Transient receptor potential cation channel subfa	6e-09
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	2e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	2e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	1e-20
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	5e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-21
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	3e-21
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	8e-18
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	1e-14
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	5e-14
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	9e-08
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	3e-21
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	7e-20
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	1e-16
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	2e-13
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-21
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-21
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	8e-21
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	2e-20
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	1e-18
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	9e-13
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	4e-12
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	1e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	6e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	7e-19
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	1e-17
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-16
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	3e-14
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	7e-09
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	4e-04
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-20
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-20
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	9e-20
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	1e-19
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-18
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	4e-15
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-14
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-20
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	3e-20
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	2e-15
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	2e-14
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	2e-14
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	3e-07
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	3e-20
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	5e-19
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	1e-09
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	5e-20
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-18
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	8e-18
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	4e-16
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-15
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	4e-15
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-12
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	8e-11
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	5e-06
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-20
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-18
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-18
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-18
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-17
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-16
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	8e-16
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	7e-13
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	5e-08
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	7e-08
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-15
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	3e-15
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	2e-13
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	1e-09
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	1e-07
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	4e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-15
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	5e-15
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	4e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-15
2pnn_A	273	Transient receptor potential cation channel subfa	9e-15
2pnn_A	273	Transient receptor potential cation channel subfa	2e-09
2pnn_A	273	Transient receptor potential cation channel subfa	6e-09
2pnn_A	273	Transient receptor potential cation channel subfa	3e-07
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-14
2etb_A	256	Transient receptor potential cation channel subfam	4e-14
2etb_A	256	Transient receptor potential cation channel subfam	4e-13
2etb_A	256	Transient receptor potential cation channel subfam	1e-12
2etb_A	256	Transient receptor potential cation channel subfam	4e-10
2etb_A	256	Transient receptor potential cation channel subfam	4e-08
2etb_A	256	Transient receptor potential cation channel subfam	8e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-14
3jxi_A	260	Vanilloid receptor-related osmotically activated p	6e-14
3jxi_A	260	Vanilloid receptor-related osmotically activated p	1e-11
3jxi_A	260	Vanilloid receptor-related osmotically activated p	4e-11
3jxi_A	260	Vanilloid receptor-related osmotically activated p	1e-09
3jxi_A	260	Vanilloid receptor-related osmotically activated p	4e-06
3jxi_A	260	Vanilloid receptor-related osmotically activated p	2e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-13
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	2e-13
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	1e-10
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-13
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	2e-11
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	3e-10
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	2e-10
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	4e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-04
3agd_A	456	Salt-tolerant glutaminase; glutaminase super famil	5e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  198 bits (506), Expect = 5e-62
 Identities = 69/181 (38%), Positives = 102/181 (56%), Gaps = 10/181 (5%)

Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
             P    ++ + A +  + +I   +L+     +I  G+F     A W G  VAVK L E+
Sbjct: 14  DIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQ 71

Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
               + RV  F  E+A+++++RHPN+V F+GAVTQ   + IVTEYL +G L   L + GA
Sbjct: 72  DFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130

Query: 247 ---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
              L     +  A D+A+GMNYLH   P PI+HR+L+  N+L D    +KV DFG+S+L 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189

Query: 304 T 304
            
Sbjct: 190 A 190

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  190 bits (484), Expect = 7e-59
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 16/165 (9%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
            + ID  E++      + +G F     A WR   VA+K++       +   +AF  EL  
Sbjct: 2   LHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQI-----ESESERKAFIVELRQ 54

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIA 260
           L ++ HPN+V+  GA     P+ +V EY   G L   L   +       + A+ + L  +
Sbjct: 55  LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLT 304
           +G+ YLH  +P  +IHRDL+P N+L    G  LK+ DFG +  + 
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  187 bits (478), Expect = 3e-58
 Identities = 59/168 (35%), Positives = 79/168 (47%), Gaps = 15/168 (8%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISD-DDRVRAFRDELALL 204
           EID  EL       I  G F     AFW G +VAVK    +   D    +   R E  L 
Sbjct: 3   EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
             ++HPN++   G   +   + +V E+   G L   L  K  + P   V +A+ IARGMN
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSG--------NLKVADFGVSKLLT 304
           YLH+   VPIIHRDL+ SNIL              LK+ DFG+++   
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  182 bits (464), Expect = 4e-56
 Identities = 49/173 (28%), Positives = 79/173 (45%), Gaps = 20/173 (11%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFW--RGIQVAVKKLGEEVISDD----DRVRAF 197
              +  +E+++    +I KG F              VA+K L       +    ++ + F
Sbjct: 13  LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFA 256
           + E+ ++  + HPN+V+  G +    P  +V E++P GDL   L  +   +K S  +R  
Sbjct: 71  QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVSKLLT 304
           LDIA G+ Y+    P PI+HRDL   NI             KVADFG+S+   
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  180 bits (458), Expect = 2e-55
 Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 11/167 (6%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
              ID  +L+F    ++ +          W+G  + VK L     S   + R F +E   
Sbjct: 4   HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60

Query: 204 LQKIRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFALDI 259
           L+   HPNV+  LGA     +    ++T ++P G L   L       +  S AV+FALD+
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
           ARGM +LH  +P  I    L   +++ D+    +++   V       
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  180 bits (459), Expect = 6e-55
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 12/163 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           E++I   +L+      I KG F       W G +VA++ +  E   ++D+++AF+ E+  
Sbjct: 27  EWDIPFEQLEIGE--LIGKGRFGQVYHGRWHG-EVAIRLIDIERD-NEDQLKAFKREVMA 82

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
            ++ RH NVV F+GA      + I+T       L + +   K  L  +   + A +I +G
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           M YLH      I+H+DL+  N+  D+ G + + DFG+  +  V
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGV 181

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  176 bits (448), Expect = 2e-53
 Identities = 56/172 (32%), Positives = 88/172 (51%), Gaps = 14/172 (8%)

Query: 145 VPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRD 199
           +P     P +L       + KG F   I    R  G  + +K+L      D++  R F  
Sbjct: 2   MPHRIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLK 56

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALD 258
           E+ +++ + HPNV++F+G + +   +  +TEY+  G LR  +K        S  V FA D
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310
           IA GM YLH      IIHRDL   N L  ++ N+ VADFG+++L+  ++ +P
Sbjct: 117 IASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  173 bits (441), Expect = 1e-52
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 12/160 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           ++EI   ++       I  G+F       W G  VAVK L         +++AF++E+ +
Sbjct: 18  DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGV 73

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
           L+K RH N++ F+G  T    + IVT++     L   L   +   +    +  A   ARG
Sbjct: 74  LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           M+YLH      IIHRDL+ +NI   +   +K+ DFG++  
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATE 169

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  157 bits (399), Expect = 6e-46
 Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 19/170 (11%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
                  ++      +I KG +    +  WRG +VAVK       + ++       E+  
Sbjct: 31  VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQ 84

Query: 204 LQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
              +RH N++ F+ A  + +     + ++T+Y   G L  +LK    L   + ++ A   
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143

Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
             G+ +LH           I HRDL+  NIL   +G   +AD G++    
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  150 bits (381), Expect = 1e-43
 Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 17/168 (10%)

Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           + KG +       W+G  VAVK           R      EL     +RH N++ F+ + 
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET----ELYNTVMLRHENILGFIASD 71

Query: 220 TQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV--- 272
             S      + ++T Y   G L  +L+    L   + +R  L IA G+ +LH        
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130

Query: 273 --PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
              I HRDL+  NIL   +G   +AD G++ + +   ++     +   
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  149 bits (378), Expect = 1e-42
 Identities = 42/169 (24%), Positives = 66/169 (39%), Gaps = 19/169 (11%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
                   +       I KG F       WRG +VAVK           R      E+  
Sbjct: 36  VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA----EIYQ 89

Query: 204 LQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
              +RH N++ F+ A  + +     + +V++Y   G L  +L R   +     ++ AL  
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST 148

Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           A G+ +LH           I HRDL+  NIL   +G   +AD G++   
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  148 bits (374), Expect = 3e-42
 Identities = 46/191 (24%), Positives = 71/191 (37%), Gaps = 25/191 (13%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
              E  +D   L       I +G +            VAVK       S  +R + F +E
Sbjct: 4   AASEPSLDLDNLKLLEL--IGRGRYGAVYKGSLDERPVAVKVF-----SFANR-QNFINE 55

Query: 201 LA--LLQKIRHPNVVQFLGA-----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
                +  + H N+ +F+              ++V EY P G L  +L         ++ 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114

Query: 254 RFALDIARGMNYLHENKPV------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           R A  + RG+ YLH   P        I HRDL   N+L  + G   ++DFG+S  LT   
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 308 DRPLTCQDTSC 318
                 +D + 
Sbjct: 175 LVRPGEEDNAA 185

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  145 bits (368), Expect = 5e-42
 Identities = 54/162 (33%), Positives = 89/162 (54%), Gaps = 14/162 (8%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
           ++ IDP EL F    EI  G F    L +W    +VA+K + E  +S++D    F +E  
Sbjct: 2   KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
           ++ K+ HP +VQ  G   + +P+ +VTE++  G L  +L+ ++G     T +   LD+  
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           GM YL E     +IHRDL   N L  ++  +KV+DFG+++ +
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 154

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  145 bits (369), Expect = 7e-42
 Identities = 49/166 (29%), Positives = 89/166 (53%), Gaps = 16/166 (9%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVAVKKLGEEVISDDDRVRAFRDE 200
            ++E++  ++   +  ++  G +       W+   + VAVK L E+ +  ++    F  E
Sbjct: 6   DKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKE 59

Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALD 258
            A++++I+HPN+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           I+  M YL +      IHRDL   N L  ++  +KVADFG+S+L+T
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  146 bits (371), Expect = 7e-42
 Identities = 43/177 (24%), Positives = 72/177 (40%), Gaps = 21/177 (11%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
                    L         +G F     A      VAVK    +    D +      E+ 
Sbjct: 17  ENLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVY 70

Query: 203 LLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
            L  ++H N++QF+GA  + +     + ++T +  KG L  FLK    +  +     A  
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129

Query: 259 IARGMNYLHENKPV-------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           +ARG+ YLHE+ P         I HRD++  N+L  ++    +ADFG++      + 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  144 bits (366), Expect = 1e-41
 Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 16/162 (9%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
             + ++  EL       I KG F   +L  +RG +VAVK +  +  +       F  E +
Sbjct: 14  SGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-----FLAEAS 66

Query: 203 LLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
           ++ ++RH N+VQ LG + +    + IVTEY+ KG L  +L+   +  L     ++F+LD+
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
              M YL  N     +HRDL   N+L  +    KV+DFG++K
Sbjct: 127 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  149 bits (378), Expect = 2e-41
 Identities = 49/196 (25%), Positives = 95/196 (48%), Gaps = 16/196 (8%)

Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
           +    + +     + A     P     +    ++E++  ++   +  ++  G +      
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGGQYGEVYEG 239

Query: 172 FWRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
            W+   + VAVK L E+ +  ++    F  E A++++I+HPN+VQ LG  T+  P  I+T
Sbjct: 240 VWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295

Query: 230 EYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           E++  G+L  +L+   +  +     +  A  I+  M YL +      IHR+L   N L  
Sbjct: 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVG 352

Query: 288 DSGNLKVADFGVSKLL 303
           ++  +KVADFG+S+L+
Sbjct: 353 ENHLVKVADFGLSRLM 368

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  147 bits (372), Expect = 2e-41
 Identities = 56/185 (30%), Positives = 82/185 (44%), Gaps = 15/185 (8%)

Query: 127 KHGAKPLMAPMHVKHAREVP--EYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVA 179
               +PL     V   R VP  ++ ++  +L      +I +G F        R     VA
Sbjct: 86  LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVA 143

Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
           VK   E +  D      F  E  +L++  HPN+V+ +G  TQ  P+ IV E +  GD   
Sbjct: 144 VKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201

Query: 240 FLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           FL+     L+  T ++   D A GM YL        IHRDL   N L  +   LK++DFG
Sbjct: 202 FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG 258

Query: 299 VSKLL 303
           +S+  
Sbjct: 259 MSREE 263

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (370), Expect = 1e-40
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 16/178 (8%)

Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
            K +   +  +       + ++  EL       I KG F   +L  +RG +VAVK     
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK----- 222

Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLKRKG 245
            I +D   +AF  E +++ ++RH N+VQ LG + +    + IVTEY+ KG L  +L+ +G
Sbjct: 223 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282

Query: 246 --ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
              L     ++F+LD+   M YL  N     +HRDL   N+L  +    KV+DFG++K
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  142 bits (360), Expect = 1e-40
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 14/162 (8%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
            +EIDP +L F    E+  G F       WRG   VA+K + E  +S+D+    F +E  
Sbjct: 18  SWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAK 71

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
           ++  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+  
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            M YL   +    +HRDL   N L +D G +KV+DFG+S+ +
Sbjct: 132 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  143 bits (362), Expect = 1e-40
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 114 IYYKNH--EVIKLLEKHGAKPLMAPMHVKHAREVPEY-------EIDPHELDFTNSV--- 161
           +++ +H     + L   G  P        H  E P         EI+   +     +   
Sbjct: 1   MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60

Query: 162 ---EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
              E+  G   +   R + VA+K L       + + R F  E +++ +  HPN+++  G 
Sbjct: 61  DSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGV 118

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           VT+    MIVTEY+  G L  FL+   G       V     +  GM YL +      +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHR 175

Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           DL   N+L D +   KV+DFG+S++L    D
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  141 bits (358), Expect = 2e-40
 Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 14/160 (8%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALL 204
           E+   E+      E+  G F    L  W+G   VAVK + E  +S+D+    F  E   +
Sbjct: 4   ELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTM 57

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
            K+ HP +V+F G  ++  P+ IVTEY+  G L  +L+     L+PS  +    D+  GM
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            +L  ++    IHRDL   N L D    +KV+DFG+++ +
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  142 bits (360), Expect = 3e-40
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---IL 170
            ++ +H    +          A       R+    + +   L F    ++ KG F    +
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMGSAFEDRD--PTQFEERHLKFLQ--QLGKGNFGSVEM 59

Query: 171 AFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223
             +          VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +  
Sbjct: 60  CRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116

Query: 224 -PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
             + ++ EYLP G LR +L++ K  +     +++   I +GM YL   +    IHRDL  
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLAT 173

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKED 308
            NIL ++   +K+ DFG++K+L   ++
Sbjct: 174 RNILVENENRVKIGDFGLTKVLPQDKE 200

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  140 bits (356), Expect = 5e-40
 Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 20/174 (11%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
             + +   L F    ++ KG F    +  +          VAVKKL     S ++ +R F
Sbjct: 4   PTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDF 58

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
             E+ +L+ ++H N+V++ G    +    + ++ EYLP G LR +L++ K  +     ++
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           +   I +GM YL   +    IHRDL   NIL ++   +K+ DFG++K+L   ++
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  140 bits (355), Expect = 7e-40
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 15/171 (8%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVRAFR 198
              I   +L      ++  G+F       W       + VAVK L  +V+S  + +  F 
Sbjct: 12  TCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL 257
            E+  +  + H N+++  G V    PM +VTE  P G L   L+  +G     T  R+A+
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +A GM YL   +    IHRDL   N+L      +K+ DFG+ + L   +D
Sbjct: 129 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  140 bits (354), Expect = 9e-40
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 13/169 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRD 199
           E  +D   L   +  E+  G F      +++       VAVK L  E  +D         
Sbjct: 10  EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLA 67

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E  ++Q++ +P +V+ +G        M+V E    G L  +L++   +K    +     +
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           + GM YL E+     +HRDL   N+L       K++DFG+SK L   E+
Sbjct: 127 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  140 bits (354), Expect = 1e-39
 Identities = 46/177 (25%), Positives = 88/177 (49%), Gaps = 19/177 (10%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRV 194
           EV     +   L      ++ +G F    L  +       G QVAVK L  E  S  + +
Sbjct: 12  EVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHI 67

Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKR-KGALKPST 251
              + E+ +L+ + H N+V++ G  T+   + + ++ E+LP G L+ +L + K  +    
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            +++A+ I +GM+YL   +    +HRDL   N+L +    +K+ DFG++K +   ++
Sbjct: 128 QLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  140 bits (354), Expect = 2e-39
 Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 20/174 (11%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
               +   L + +  ++ KG F    L  +          VAVK+L     S  D+ R F
Sbjct: 17  PTIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDF 71

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVR 254
           + E+ +L+ +    +V++ G         + +V EYLP G LR FL + +  L  S  + 
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           ++  I +GM YL   +    +HRDL   NIL +   ++K+ADFG++KLL + +D
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  137 bits (347), Expect = 7e-39
 Identities = 53/164 (32%), Positives = 84/164 (51%), Gaps = 16/164 (9%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDEL 201
            E+E+    L       +  G F    + ++ G  +VAVK L +  +S D     F  E 
Sbjct: 6   DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
            L+++++H  +V+    VTQ  P+ I+TEY+  G L  FLK      L  +  +  A  I
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           A GM ++ E      IHRDL  +NIL  D+ + K+ADFG+++L+
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  137 bits (347), Expect = 2e-38
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 19/171 (11%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
                 L      ++ +G F    L  +          VAVK L  +  +       ++ 
Sbjct: 27  VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQ 82

Query: 200 ELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           E+ +L+ + H +++++ G    +  + + +V EY+P G LR +L  + ++  +  + FA 
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQ 141

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            I  GM YLH       IHRDL   N+L D+   +K+ DFG++K +    +
Sbjct: 142 QICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  135 bits (343), Expect = 4e-38
 Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 15/171 (8%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
            +  +    L   + +E+  G F       +R     I VA+K L +   ++        
Sbjct: 2   KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 58

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
            E  ++ ++ +P +V+ +G    +  +M+V E    G L  FL  ++  +  S       
Sbjct: 59  REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            ++ GM YL E      +HRDL   N+L  +    K++DFG+SK L   + 
Sbjct: 118 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  136 bits (345), Expect = 5e-38
 Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 17/172 (9%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
             EI P  +       I  G F        +       + VA+K L     ++  R   F
Sbjct: 38  TTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQR-VDF 93

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
             E  ++ +  H N+++  G +++  PMMI+TEY+  G L  FL+ + G       V   
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
             IA GM YL        +HRDL   NIL + +   KV+DFG+S++L    +
Sbjct: 154 RGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  136 bits (345), Expect = 5e-38
 Identities = 42/146 (28%), Positives = 78/146 (53%), Gaps = 8/146 (5%)

Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
           KG +I    +  I VA+K+L E   +     +   DE  ++  + +P+V + LG     S
Sbjct: 33  KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89

Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            + ++T+ +P G L  ++ + K  +     + + + IA+GMNYL + +   ++HRDL   
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146

Query: 283 NILRDDSGNLKVADFGVSKLLTVKED 308
           N+L     ++K+ DFG++KLL  +E 
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEK 172

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  135 bits (342), Expect = 6e-38
 Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 15/180 (8%)

Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGE 185
           ++ ++ +  + V    I P  L    +  I +G F               I  AVK L  
Sbjct: 4   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63

Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFL-KR 243
             I+D   V  F  E  +++   HPNV+  LG   +S    ++V  Y+  GDLR F+   
Sbjct: 64  --ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121

Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
                    + F L +A+GM YL   K    +HRDL   N + D+   +KVADFG+++ +
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  135 bits (343), Expect = 8e-38
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 35/192 (18%)

Query: 138 HVKHAREVPEY----EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEE 186
           H  H +  P+      +D +++ F +   I +G F   + A  +     +  A+K++ E 
Sbjct: 6   HHHHGKNNPDPTIYPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63

Query: 187 VISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK- 244
             S DD  R F  EL +L K+  HPN++  LGA      + +  EY P G+L  FL++  
Sbjct: 64  A-SKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121

Query: 245 ---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
                            L     + FA D+ARGM+YL + +    IHRDL   NIL  ++
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178

Query: 290 GNLKVADFGVSK 301
              K+ADFG+S+
Sbjct: 179 YVAKIADFGLSR 190

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  137 bits (346), Expect = 1e-37
 Identities = 53/167 (31%), Positives = 80/167 (47%), Gaps = 12/167 (7%)

Query: 149 EIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
           E+D   +     V      E+  G   L   + I VA+K L       + + R F  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEAS 98

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIAR 261
           ++ +  HPN+++  G VT+S P+MIVTEY+  G L +FL K          V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           GM YL +      +HRDL   NIL + +   KV+DFG+ ++L    +
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  134 bits (340), Expect = 1e-37
 Identities = 39/167 (23%), Positives = 84/167 (50%), Gaps = 13/167 (7%)

Query: 144 EVPEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAF 197
              +YEI    ++    +      ++ +G ++      + VA+K       + D     F
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKF 63

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
             E   +++  HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
             ++  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +
Sbjct: 123 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (341), Expect = 1e-37
 Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 25/194 (12%)

Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQV 178
            H +  L+     +   ++ +  ID + L       + +G F   +    +      ++V
Sbjct: 8   HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKV 65

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEYLP 233
           AVK +  +  S  +    F  E A ++   HPNV++ LG   + S       M++  ++ 
Sbjct: 66  AVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124

Query: 234 KGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
            GDL  +L           +   T ++F +DIA GM YL        +HRDL   N +  
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181

Query: 288 DSGNLKVADFGVSK 301
           D   + VADFG+SK
Sbjct: 182 DDMTVCVADFGLSK 195

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  133 bits (338), Expect = 2e-37
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 13/165 (7%)

Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
           P+Y I   ++     +      E+ +G +       I VAVK   ++     D    F  
Sbjct: 5   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMS 62

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E  +++ + HP++V+ +G + +  P  I+ E  P G+L  +L+R K +LK  T V ++L 
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           I + M YL        +HRD+   NIL      +K+ DFG+S+ +
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  136 bits (343), Expect = 2e-37
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 15/198 (7%)

Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAF 172
               E +     +     ++ ++ +  + V    I P  L    +  I +G F       
Sbjct: 50  KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGT 109

Query: 173 WRG-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMM 226
                   I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S    +
Sbjct: 110 LLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167

Query: 227 IVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +V  Y+  GDLR F+            + F L +A+GM +L   K    +HRDL   N +
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCM 224

Query: 286 RDDSGNLKVADFGVSKLL 303
            D+   +KVADFG+++ +
Sbjct: 225 LDEKFTVKVADFGLARDM 242

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  137 bits (347), Expect = 3e-37
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 23/190 (12%)

Query: 127 KHGAKPLM-------APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG- 175
           K G   L             +   E   +EI    L      ++  G F    +A +   
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKH 212

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
            +VAVK +    +S +     F  E  +++ ++H  +V+    VT+  P+ I+TE++ KG
Sbjct: 213 TKVAVKTMKPGSMSVEA----FLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKG 267

Query: 236 DLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            L  FLK            + F+  IA GM ++ +      IHRDL  +NIL   S   K
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK 324

Query: 294 VADFGVSKLL 303
           +ADFG+++++
Sbjct: 325 IADFGLARVI 334

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  134 bits (339), Expect = 4e-37
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 18/169 (10%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
                EL       +  G F       W        I V +K + ++  S     +A  D
Sbjct: 9   IFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTD 64

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALD 258
            +  +  + H ++V+ LG     S + +VT+YLP G L   ++  +GAL P   + + + 
Sbjct: 65  HMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           IA+GM YL E+    ++HR+L   N+L      ++VADFGV+ LL   +
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  133 bits (338), Expect = 5e-37
 Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 26/178 (14%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
           ++ +  I   +        + KG F     A  +      ++VAVK L  ++I+  D   
Sbjct: 14  KLEDVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-E 70

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLKR------ 243
            F  E A +++  HP+V + +G   +S         M++  ++  GDL AFL        
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130

Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
              L   T VRF +DIA GM YL        IHRDL   N +  +   + VADFG+S+
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSR 185

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  133 bits (337), Expect = 6e-37
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 41/190 (21%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
           P++E     L       + +G F   + A    +        VAVK L E   +    +R
Sbjct: 16  PKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELR 71

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------- 244
               E  +L+++ HP+V++  GA +Q  P++++ EY   G LR FL+             
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131

Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
                         AL     + FA  I++GM YL E K   ++HRDL   NIL  +   
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRK 188

Query: 292 LKVADFGVSK 301
           +K++DFG+S+
Sbjct: 189 MKISDFGLSR 198

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (336), Expect = 7e-37
 Identities = 53/184 (28%), Positives = 75/184 (40%), Gaps = 36/184 (19%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
            ++E   + L F     +  G F   + A   G+        VAVK L     +      
Sbjct: 16  HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK          
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 245 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
                    AL     + F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188

Query: 297 FGVS 300
           FG++
Sbjct: 189 FGLA 192

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  133 bits (337), Expect = 1e-36
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 41/212 (19%)

Query: 124 LLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---- 176
           LL++    P+   M +    ++   E   + +++    +I +G F     A   G+    
Sbjct: 18  LLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYE 75

Query: 177 ---QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
               VAVK L EE  S D +   F+ E AL+ +  +PN+V+ LG      PM ++ EY+ 
Sbjct: 76  PFTMVAVKMLKEEA-SADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133

Query: 234 KGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHEN 269
            GDL  FL+                            L  +  +  A  +A GM YL E 
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           K    +HRDL   N L  ++  +K+ADFG+S+
Sbjct: 194 K---FVHRDLATRNCLVGENMVVKIADFGLSR 222

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  133 bits (336), Expect = 1e-36
 Identities = 45/176 (25%), Positives = 89/176 (50%), Gaps = 27/176 (15%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
            E+E+   ++  +   E+ +G+F        +G+       +VA+K + E   S  +R  
Sbjct: 18  DEWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRER-I 73

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------G 245
            F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+             
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133

Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
               S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  135 bits (342), Expect = 1e-36
 Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 18/196 (9%)

Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
           YY  H     L                      +EI    L      ++ +G F    + 
Sbjct: 148 YYSKHA--DGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMG 203

Query: 172 FWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
            W G  +VA+K L    +S +     F  E  +++K+RH  +VQ    V++  P+ IVTE
Sbjct: 204 TWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTE 258

Query: 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           Y+ KG L  FLK +    L+    V  A  IA GM Y+        +HRDL  +NIL  +
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGE 315

Query: 289 SGNLKVADFGVSKLLT 304
           +   KVADFG+++L+ 
Sbjct: 316 NLVCKVADFGLARLIE 331

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  132 bits (334), Expect = 1e-36
 Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 15/170 (8%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
           EV +  I    +   +   I KG F       +       IQ A+K L    I++  +V 
Sbjct: 10  EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVE 67

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
           AF  E  L++ + HPNV+  +G +     +  ++  Y+  GDL  F++  +        +
Sbjct: 68  AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127

Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
            F L +ARGM YL E K    +HRDL   N + D+S  +KVADFG+++ +
Sbjct: 128 SFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  134 bits (338), Expect = 1e-36
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 36/216 (16%)

Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
           ++ +   I   E    + ++A +      E P +E+    L       + +G F   +LA
Sbjct: 31  HHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGAFGQVVLA 88

Query: 172 FWRGI---------QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221
              G+         +VAVK L  +  ++ D       E+ +++ I +H N++  LGA TQ
Sbjct: 89  EAIGLDKDKPNRVTKVAVKMLKSDA-TEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQ 146

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNY 265
             P+ ++ EY  KG+LR +L+ +                  L     V  A  +ARGM Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           L   K    IHRDL   N+L  +   +K+ADFG+++
Sbjct: 207 LASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR 239

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  135 bits (342), Expect = 3e-36
 Identities = 54/164 (32%), Positives = 83/164 (50%), Gaps = 16/164 (9%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
            +EI    L      ++ +G F    +  W G  +VA+K L    +S +     F  E  
Sbjct: 261 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 314

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIA 260
           +++K+RH  +VQ    V++  P+ IVTEY+ KG L  FLK +    L+    V  A  IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
            GM Y+        +HRDL  +NIL  ++   KVADFG+++L+ 
Sbjct: 374 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (333), Expect = 3e-36
 Identities = 42/146 (28%), Positives = 78/146 (53%), Gaps = 8/146 (5%)

Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
           KG +I    +  I VA+K+L E   +     +   DE  ++  + +P+V + LG     S
Sbjct: 33  KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89

Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            + ++T+ +P G L  ++ + K  +     + + + IA+GMNYL + +   ++HRDL   
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146

Query: 283 NILRDDSGNLKVADFGVSKLLTVKED 308
           N+L     ++K+ DFG++KLL  +E 
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEK 172

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  131 bits (332), Expect = 5e-36
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 36/200 (18%)

Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------QV 178
            P++A +      E P++E    +L       + +G F   ++A   GI          V
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++  ++ D       E+ +++ I +H N++  LGA TQ  P+ ++ EY  KG+L
Sbjct: 71  AVKMLKDDA-TEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128

Query: 238 RAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           R +L+ +                  +     V     +ARGM YL   K    IHRDL  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185

Query: 282 SNILRDDSGNLKVADFGVSK 301
            N+L  ++  +K+ADFG+++
Sbjct: 186 RNVLVTENNVMKIADFGLAR 205

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  130 bits (330), Expect = 7e-36
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 32/178 (17%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
            ++E   + L F     +  G F   + A   G+       +VAVK L     +  D   
Sbjct: 39  EKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKE 94

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
           A   EL ++  + +H N+V  LGA T   P++++TEY   GDL  FL+RK          
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154

Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
                       + F+  +A+GM +L        IHRD+   N+L  +    K+ DFG
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFG 209

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  130 bits (328), Expect = 8e-36
 Identities = 52/178 (29%), Positives = 75/178 (42%), Gaps = 33/178 (18%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
           EI    + F    E+ +  F         G         VA+K L ++      R   FR
Sbjct: 5   EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLR-EEFR 60

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--------------- 243
            E  L  +++HPNVV  LG VT+  P+ ++  Y   GDL  FL                 
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120

Query: 244 -KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            K AL+P   V     IA GM YL  +    ++H+DL   N+L  D  N+K++D G+ 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLF 175

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  131 bits (332), Expect = 1e-35
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 36/201 (17%)

Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------Q 177
             P++A +      E P++E    +L       + +G F   ++A   GI          
Sbjct: 58  DTPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVT 115

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           VAVK L ++  + +  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  KG+
Sbjct: 116 VAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173

Query: 237 LRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           LR +L+ +                  +     V     +ARGM YL   K    IHRDL 
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 230

Query: 281 PSNILRDDSGNLKVADFGVSK 301
             N+L  ++  +K+ADFG+++
Sbjct: 231 ARNVLVTENNVMKIADFGLAR 251

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  130 bits (329), Expect = 1e-35
 Identities = 55/192 (28%), Positives = 81/192 (42%), Gaps = 40/192 (20%)

Query: 141 HAREVPEY-------EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKL 183
           H  E P+Y        I   ++      E+ +G F    LA    +        VAVK L
Sbjct: 22  HIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79

Query: 184 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
            E   S+  R + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL  FL+ 
Sbjct: 80  KEA--SESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136

Query: 244 ---------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
                           G L     +  A  +A GM YL        +HRDL   N L   
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193

Query: 289 SGNLKVADFGVS 300
              +K+ DFG+S
Sbjct: 194 GLVVKIGDFGMS 205

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (330), Expect = 1e-35
 Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 41/189 (21%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
            ++E     L+F     +  G F   + A   GI       QVAVK L E+  +D     
Sbjct: 38  LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 93

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
           A   EL ++ ++  H N+V  LGA T S P+ ++ EY   GDL  +L+ K          
Sbjct: 94  ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153

Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
                          L     + FA  +A+GM +L        +HRDL   N+L      
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKV 210

Query: 292 LKVADFGVS 300
           +K+ DFG++
Sbjct: 211 VKICDFGLA 219

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  129 bits (327), Expect = 2e-35
 Identities = 51/175 (29%), Positives = 73/175 (41%), Gaps = 27/175 (15%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
             E+    +       +  G F         G+       QVAVK L E   S+ D    
Sbjct: 24  LKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-LD 79

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALKP 249
           F  E  ++ K  H N+V+ +G   QS P  I+ E +  GDL++FL+          +L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSK 301
              +  A DIA G  YL EN     IHRD+   N L    G     K+ DFG+++
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (324), Expect = 3e-35
 Identities = 51/178 (28%), Positives = 76/178 (42%), Gaps = 34/178 (19%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
            I   ++      E+ +G F    LA    +        VAVK L +   +   R + F+
Sbjct: 11  HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR-KDFQ 65

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---------------- 242
            E  LL  ++H ++V+F G      P+++V EY+  GDL  FL+                
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
            KG L  S  +  A  IA GM YL        +HRDL   N L   +  +K+ DFG+S
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS 180

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (322), Expect = 4e-35
 Identities = 37/177 (20%), Positives = 75/177 (42%), Gaps = 29/177 (16%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRG---------IQVAVKKLGEEVISDDDRVR 195
           ++I   +L F     + +GTF        R           +V +K L +   +  +   
Sbjct: 3   HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSE 57

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
           +F +  +++ K+ H ++V   G        ++V E++  G L  +LK+ K  +     + 
Sbjct: 58  SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNIL--------RDDSGNLKVADFGVSKLL 303
            A  +A  M++L EN    +IH ++   NIL          +   +K++D G+S  +
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  129 bits (326), Expect = 6e-35
 Identities = 51/176 (28%), Positives = 73/176 (41%), Gaps = 27/176 (15%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
              E+    +       +  G F         G+       QVAVK L E   S+ D   
Sbjct: 64  DLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-L 119

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALK 248
            F  E  ++ K  H N+V+ +G   QS P  I+ E +  GDL++FL+          +L 
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179

Query: 249 PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSK 301
               +  A DIA G  YL EN     IHRD+   N L    G     K+ DFG+++
Sbjct: 180 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  132 bits (334), Expect = 9e-35
 Identities = 39/165 (23%), Positives = 83/165 (50%), Gaps = 13/165 (7%)

Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
            +YEI    ++    +      ++ +G ++      + VA+K       + D     F  
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQ 440

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E   +++  HP++V+ +G +T++ P+ I+ E    G+LR+FL  RK +L  ++ + +A  
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
           ++  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  126 bits (319), Expect = 2e-34
 Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 35/183 (19%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
           ++E     L       + +G F   I A   GI        VAVK L E   +     RA
Sbjct: 21  KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 76

Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKR----------- 243
              EL +L  I  H NVV  LGA T+   P+M++ E+   G+L  +L+            
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 244 -----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
                K  L     + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFG 193

Query: 299 VSK 301
           +++
Sbjct: 194 LAR 196

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  129 bits (326), Expect = 9e-34
 Identities = 39/171 (22%), Positives = 73/171 (42%), Gaps = 15/171 (8%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
            +  +    L   + +E+  G F       +R     I VA+K L +   ++        
Sbjct: 328 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 384

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
            E  ++ ++ +P +V+ +G    +  +M+V E    G L  FL  ++  +  S       
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            ++ GM YL E      +HR+L   N+L  +    K++DFG+SK L   + 
Sbjct: 444 QVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  123 bits (312), Expect = 1e-33
 Identities = 45/171 (26%), Positives = 85/171 (49%), Gaps = 12/171 (7%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
            +          +EI +G+F            ++VA  +L +  ++  +R + F++E  +
Sbjct: 20  GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEM 78

Query: 204 LQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           L+ ++HPN+V+F  +    V     +++VTE +  G L+ +LKR   +K      +   I
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDR 309
            +G+ +LH   P PIIHRDL+  NI     +G++K+ D G++ L      +
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  118 bits (297), Expect = 6e-31
 Identities = 35/141 (24%), Positives = 72/141 (51%), Gaps = 6/141 (4%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G Q  +K++    +S  +R  + R E+A+L  ++HPN+VQ+  +  ++  + IV +Y   
Sbjct: 49  GRQYVIKEINISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107

Query: 235 GDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL   +        +    + + + I   + ++H+ K   I+HRD++  NI     G +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV 164

Query: 293 KVADFGVSKLLTVKEDRPLTC 313
           ++ DFG++++L    +    C
Sbjct: 165 QLGDFGIARVLNSTVELARAC 185

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  116 bits (292), Expect = 1e-30
 Identities = 51/164 (31%), Positives = 85/164 (51%), Gaps = 17/164 (10%)

Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           + KGT+            +++A+K    E+   D    +   +E+AL + ++H N+VQ+L
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIK----EIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAV--RFALDIARGMNYLHENKPVP 273
           G+ +++  + I  E +P G L A L+ K G LK +      +   I  G+ YLH+N+   
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142

Query: 274 IIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
           I+HRD++  N+L +  SG LK++DFG SK L        T   T
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  116 bits (292), Expect = 1e-30
 Identities = 33/155 (21%), Positives = 59/155 (38%), Gaps = 10/155 (6%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
            F     +  G++        +  G   AVK+         DR R   +  +  +  +HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHEN 269
             V+   A  +   + + TE      L+   +  GA L  +    +  D    + +LH  
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
               ++H D++P+NI     G  K+ DFG+   L 
Sbjct: 177 G---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  114 bits (287), Expect = 1e-29
 Identities = 36/161 (22%), Positives = 76/161 (47%), Gaps = 12/161 (7%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I +G F     A     G+ VA+KK+    + D         E+ LL+++ HPNV+++ 
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPV 272
            +  + + + IV E    GDL   +K        +   T  ++ + +   + ++H  +  
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
            ++HRD++P+N+    +G +K+ D G+ +  + K     + 
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  112 bits (282), Expect = 3e-29
 Identities = 34/147 (23%), Positives = 71/147 (48%), Gaps = 9/147 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYL 232
           G  +  K+L    +++ ++      E+ LL++++HPN+V++   +    ++ + IV EY 
Sbjct: 31  GKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89

Query: 233 PKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVP--IIHRDLEPSNILR 286
             GDL + + +    +  L     +R    +   +   H        ++HRDL+P+N+  
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTC 313
           D   N+K+ DFG++++L        T 
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTF 176

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  112 bits (281), Expect = 1e-28
 Identities = 33/146 (22%), Positives = 72/146 (49%), Gaps = 10/146 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
               A+K +  E   +   + ++R+E+A L K++  +  +++          + +V E  
Sbjct: 33  KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 90

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
              DL ++LK+K ++ P     +  ++   ++ +H++    I+H DL+P+N L  D G L
Sbjct: 91  GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 146

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC 318
           K+ DFG++  +  + D     +D+  
Sbjct: 147 KLIDFGIANQM--QPDTTSVVKDSQV 170

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  111 bits (279), Expect = 1e-28
 Identities = 33/146 (22%), Positives = 72/146 (49%), Gaps = 10/146 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
               A+K +  E   +   + ++R+E+A L K++  +  +++          + +V E  
Sbjct: 52  KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 109

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
              DL ++LK+K ++ P     +  ++   ++ +H++    I+H DL+P+N L  D G L
Sbjct: 110 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 165

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC 318
           K+ DFG++  +  + D     +D+  
Sbjct: 166 KLIDFGIANQM--QPDTTSVVKDSQV 189

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  110 bits (277), Expect = 3e-28
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 17/165 (10%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
            +YE        T+   + +G+F        +  G Q AVKK+  EV   +        E
Sbjct: 49  VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------E 100

Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L     +  P +V   GAV +   + I  E L  G L   +K+ G L    A+ +     
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLT 304
            G+ YLH  +   I+H D++  N+L    G+   + DFG +  L 
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  111 bits (280), Expect = 3e-28
 Identities = 33/146 (22%), Positives = 72/146 (49%), Gaps = 10/146 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
               A+K +  E   +   + ++R+E+A L K++  +  +++          + +V E  
Sbjct: 80  KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
              DL ++LK+K ++ P     +  ++   ++ +H++    I+H DL+P+N L  D G L
Sbjct: 138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 193

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC 318
           K+ DFG++  +  + D     +D+  
Sbjct: 194 KLIDFGIANQM--QPDTTSVVKDSQV 217

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (275), Expect = 3e-28
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 13/183 (7%)

Query: 142 AREVPEYEIDPHEL-DFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP     +     + KG F     I         A K + + ++    +  
Sbjct: 1   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 61  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++  +    +R    + 
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER----KK 173

Query: 316 TSC 318
             C
Sbjct: 174 VLC 176

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  109 bits (274), Expect = 6e-28
 Identities = 38/153 (24%), Positives = 63/153 (41%), Gaps = 19/153 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
           G   A+K            V     E  +L+K+ H N+V+      +++      + E+ 
Sbjct: 34  GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91

Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
           P G L   L+       L  S  +    D+  GMN+L EN    I+HR+++P NI+R   
Sbjct: 92  PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148

Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
            D     K+ DFG ++ L   +D       +  
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLY 176

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  108 bits (273), Expect = 7e-28
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 26/168 (15%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + +G F   + A         A+KK+     +++        E+ LL  + H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILS-EVMLLASLNHQ 62

Query: 211 NVVQFLGA-------------VTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFA 256
            VV++  A             V + S + I  EY   G L   +  +   +      R  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
             I   ++Y+H      IIHRDL+P NI  D+S N+K+ DFG++K + 
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  109 bits (275), Expect = 7e-28
 Identities = 34/144 (23%), Positives = 64/144 (44%), Gaps = 7/144 (4%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
               A K + + ++    +      E+++ + + H +VV F G    +  + +V E   +
Sbjct: 66  KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
             L    KR+ AL    A  +   I  G  YLH N+   +IHRDL+  N+  ++   +K+
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKI 182

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
            DFG++  +    +R    +   C
Sbjct: 183 GDFGLATKVEYDGER----KKVLC 202

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  109 bits (274), Expect = 9e-28
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 14/140 (10%)

Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           G +VA+K+      + +    +  F  E+  L   RHP++V  +G   + + M+++ +Y+
Sbjct: 63  GAKVALKRR-----TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 233 PKGDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
             G+L+  L               +   +  ARG++YLH      IIHRD++  NIL D+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174

Query: 289 SGNLKVADFGVSKLLTVKED 308
           +   K+ DFG+SK  T  + 
Sbjct: 175 NFVPKITDFGISKKGTELDQ 194

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  108 bits (271), Expect = 9e-28
 Identities = 35/144 (24%), Positives = 67/144 (46%), Gaps = 9/144 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
              +A+K L +  +         R E+ +   +RHPN+++  G    ++ + ++ EY P 
Sbjct: 34  KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G +   L++           +  ++A  ++Y H  +   +IHRD++P N+L   +G LK+
Sbjct: 94  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKI 150

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
           ADFG S         P + +   C
Sbjct: 151 ADFGWSVHA------PSSRRTDLC 168

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  107 bits (269), Expect = 2e-27
 Identities = 46/191 (24%), Positives = 80/191 (41%), Gaps = 34/191 (17%)

Query: 147 EYEIDPHEL-DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
            + +D     DF     I  G F     A  R  G    +K++        +  +A R E
Sbjct: 2   AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAER-E 54

Query: 201 LALLQKIRHPNVVQFLGA----------------VTQSSPMMIVTEYLPKGDLRAFLKRK 244
           +  L K+ H N+V + G                  +++  + I  E+  KG L  +++++
Sbjct: 55  VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114

Query: 245 GA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
               L    A+     I +G++Y+H  K   +I+RDL+PSNI   D+  +K+ DFG+   
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 303 LTVKEDRPLTC 313
           L     R  + 
Sbjct: 172 LKNDGKRTRSK 182

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  109 bits (274), Expect = 2e-27
 Identities = 38/153 (24%), Positives = 63/153 (41%), Gaps = 19/153 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
           G   A+K            V     E  +L+K+ H N+V+      +++      + E+ 
Sbjct: 34  GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91

Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
           P G L   L+       L  S  +    D+  GMN+L EN    I+HR+++P NI+R   
Sbjct: 92  PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148

Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
            D     K+ DFG ++ L   +D       +  
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLY 176

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (268), Expect = 3e-27
 Identities = 37/177 (20%), Positives = 63/177 (35%), Gaps = 31/177 (17%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I  G F        R  G   A+K+  + +    D   A R+  A     +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYL 266
           +VV++  A  +   M+I  EY   G L   +          K +      L + RG+ Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNL-------------------KVADFGVSKLLT 304
           H      ++H D++PSNI    +                      K+ D G    ++
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  107 bits (268), Expect = 3e-27
 Identities = 34/158 (21%), Positives = 64/158 (40%), Gaps = 20/158 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------------VTQS 222
               A+K++      +  R +  R E+  L K+ HP +V++  A             +  
Sbjct: 30  DCNYAIKRIRLPN-RELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87

Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDL 279
             + I  +   K +L+ ++  +  ++    S  +   L IA  + +LH      ++HRDL
Sbjct: 88  VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDL 144

Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           +PSNI       +KV DFG+   +   E+         
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  106 bits (267), Expect = 4e-27
 Identities = 39/144 (27%), Positives = 69/144 (47%), Gaps = 9/144 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
              +A+K L +  +  +      R E+ +   +RHPN+++          + ++ E+ P+
Sbjct: 39  KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L++ G      +  F  ++A  ++Y HE K   +IHRD++P N+L    G LK+
Sbjct: 99  GELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKI 155

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
           ADFG S         P   + T C
Sbjct: 156 ADFGWSVH------APSLRRRTMC 173

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  106 bits (268), Expect = 4e-27
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 7/138 (5%)

Query: 175 GIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              VAVKKL   V    +   + F  E+ ++ K +H N+V+ LG  +    + +V  Y+P
Sbjct: 54  NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113

Query: 234 KGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            G L   L       P       + A   A G+N+LHEN     IHRD++ +NIL D++ 
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170

Query: 291 NLKVADFGVSKLLTVKED 308
             K++DFG+++       
Sbjct: 171 TAKISDFGLARASEKFAQ 188

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  106 bits (267), Expect = 7e-27
 Identities = 28/148 (18%), Positives = 55/148 (37%), Gaps = 14/148 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----IVTE 230
           G   A+K++   +  +       + E  + +   HPN+++ +    +         ++  
Sbjct: 54  GHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110

Query: 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
           +  +G L   ++R       L     +   L I RG+  +H        HRDL+P+NIL 
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILL 167

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
            D G   + D G      +  +      
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQAL 195

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  106 bits (267), Expect = 7e-27
 Identities = 39/144 (27%), Positives = 69/144 (47%), Gaps = 9/144 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + +  ++     + FR E+ +++ + HPN+V+    +     + ++ EY   
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++  +L   G +K   A      I   + Y H+ +   I+HRDL+  N+L D   N+K+
Sbjct: 99  GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
           ADFG S          L   D  C
Sbjct: 156 ADFGFSNE--FTVGGKL---DAFC 174

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  104 bits (263), Expect = 3e-26
 Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 6/137 (4%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VAVK+L EE     +    F+ E+ ++    H N+++  G     +  ++V  Y+  
Sbjct: 54  GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111

Query: 235 GDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           G + + L+ +   +P        R AL  ARG+ YLH++    IIHRD++ +NIL D+  
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171

Query: 291 NLKVADFGVSKLLTVKE 307
              V DFG++KL+  K+
Sbjct: 172 EAVVGDFGLAKLMDYKD 188

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  104 bits (260), Expect = 8e-26
 Identities = 41/179 (22%), Positives = 74/179 (41%), Gaps = 33/179 (18%)

Query: 165 KGTF---ILAFWRGIQVAVKKL--------------GEEVISDDDRVRAFRDELALLQKI 207
           +G F   IL        A+KK                 + IS   +   F++EL ++  I
Sbjct: 41  QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR------ 261
           ++   +   G +T    + I+ EY+    +  F +    L  +      + + +      
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160

Query: 262 --GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
               +Y+H  K   I HRD++PSNIL D +G +K++DFG S+ +    D+ +     S 
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIK---GSR 211

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  106 bits (266), Expect = 9e-26
 Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 22/156 (14%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL------GAVTQSSPMMIV 228
           G QVA+K+   + +S  +R R    E+ +++K+ HPNVV           +  +   ++ 
Sbjct: 39  GEQVAIKQC-RQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96

Query: 229 TEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
            EY   GDLR +L +      LK         DI+  + YLHEN+   IIHRDL+P NI+
Sbjct: 97  MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 153

Query: 286 RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC 318
                     K+ D G +K L   +    T      
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL--DQGELCT---EFV 184

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (255), Expect = 2e-25
 Identities = 40/145 (27%), Positives = 77/145 (53%), Gaps = 8/145 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++VA+K + ++ +     V+  ++E+ +  +++HP++++       S+ + +V E    
Sbjct: 36  GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95

Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G++  +LK R      + A  F   I  GM YLH +    I+HRDL  SN+L   + N+K
Sbjct: 96  GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK 152

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSC 318
           +ADFG++  L +  ++      T C
Sbjct: 153 IADFGLATQLKMPHEK----HYTLC 173

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  102 bits (257), Expect = 2e-25
 Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 7/138 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK  E       +  A R E+ +L++++HPN+V  L    +   + +V EY     +
Sbjct: 31  VAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV 88

Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              L R     P   V+       + +N+ H++     IHRD++P NIL      +K+ D
Sbjct: 89  LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCD 145

Query: 297 FGVSKLLTVKEDRPLTCQ 314
           FG ++LLT         +
Sbjct: 146 FGFARLLTG-PSDYYDDE 162

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  101 bits (254), Expect = 2e-25
 Identities = 44/144 (30%), Positives = 76/144 (52%), Gaps = 8/144 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK L  + I   D V   + E+  L+  RHP++++    ++  +   +V EY+  
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++ + G ++   A R    I   ++Y H +    ++HRDL+P N+L D   N K+
Sbjct: 96  GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 152

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
           ADFG+S ++   +   L    TSC
Sbjct: 153 ADFGLSNMM--SDGEFL---RTSC 171

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  101 bits (253), Expect = 5e-25
 Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 3/128 (2%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+K +       ++ ++ F  E+    ++ H N+V  +    +     +V EY+    
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  +++  G L   TA+ F   I  G+ + H+ +   I+HRD++P NIL D +  LK+ D
Sbjct: 98  LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154

Query: 297 FGVSKLLT 304
           FG++K L+
Sbjct: 155 FGIAKALS 162

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  101 bits (255), Expect = 6e-25
 Identities = 49/141 (34%), Positives = 77/141 (54%), Gaps = 10/141 (7%)

Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           VA+KK+         D     A R E+ LLQ++ HPN++  L A    S + +V +++  
Sbjct: 38  VAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96

Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            DL   +K     L PS    + L   +G+ YLH++    I+HRDL+P+N+L D++G LK
Sbjct: 97  -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152

Query: 294 VADFGVSKLLTVKEDRPLTCQ 314
           +ADFG++K      +R  T Q
Sbjct: 153 LADFGLAKSFGS-PNRAYTHQ 172

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (250), Expect = 1e-24
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 14/123 (11%)

Query: 200 ELALLQKIRHPNVVQF---LGAVTQSSPMMIVTEYLPKGDLRAF-LKRKGALKPSTAVRF 255
           E+A+L+K+ HPNVV+    L    +   + +V E + +G +    +     L    A  +
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKPLSEDQARFY 142

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             D+ +G+ YLH  K   IIHRD++PSN+L  + G++K+ADFGVS       D  L+   
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLS--- 195

Query: 316 TSC 318
            + 
Sbjct: 196 NTV 198

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (251), Expect = 2e-24
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 15/154 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--------M 225
           G + A+K+L   + +++++ RA   E+  ++K+  HPN+VQF  A +             
Sbjct: 53  GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109

Query: 226 MIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           +++TE      +    K   +G L   T ++      R + ++H  KP PIIHRDL+  N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVEN 168

Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           +L  + G +K+ DFG +  ++   D   + Q  +
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  102 bits (255), Expect = 2e-24
 Identities = 56/189 (29%), Positives = 90/189 (47%), Gaps = 18/189 (9%)

Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
            PM  K   +     I  + L  T    +  GTF    +      G +VAVK L  + I 
Sbjct: 1   GPMAEKQKHDGRVK-IGHYILGDT----LGVGTFGKVKVGKHELTGHKVAVKILNRQKIR 55

Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
             D V   R E+  L+  RHP++++    ++  S + +V EY+  G+L  ++ + G L  
Sbjct: 56  SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE 115

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
             + R    I  G++Y H +    ++HRDL+P N+L D   N K+ADFG+S ++   +  
Sbjct: 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGE 170

Query: 310 PLTCQDTSC 318
            L    TSC
Sbjct: 171 FL---RTSC 176

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 99.2 bits (248), Expect = 2e-24
 Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 11/146 (7%)

Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              VAVK +  +  +   + ++  + E+ + + + H NVV+F G   + +   +  EY  
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G+L   ++    +    A RF   +  G+ YLH      I HRD++P N+L D+  NLK
Sbjct: 89  GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145

Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC 318
           ++DFG++ +      +R L   +  C
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMC 168

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  101 bits (253), Expect = 2e-24
 Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 17/152 (11%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
             +VA++     K       + D       E+ +L+K+ HP +++       +    IV 
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
           E +  G+L   +     LK +T   +   +   + YLHEN    IIHRDL+P N+L   +
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 275

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           ++   +K+ DFG SK+  + E   +    T C
Sbjct: 276 EEDCLIKITDFGHSKI--LGETSLMR---TLC 302

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 95.9 bits (240), Expect = 2e-24
 Identities = 21/87 (24%), Positives = 37/87 (42%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +  LA + ++  +   ++    +N  D +  T L  AA  G   VV  LL+ GAD     
Sbjct: 7   VHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLG 66

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           +   + L  A      +++K+L   G 
Sbjct: 67  KGRESALSLACSKGYTDIVKMLLDCGV 93

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 92.5 bits (231), Expect = 5e-23
 Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 5/106 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+   L    E       L    ++   + +K LLD G+DVN  D +  T L  A     
Sbjct: 60  ADPQLLGKGRE--SA---LSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNH 114

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            + V +LLE GAD   +   G   +  A+      V +++E H  K
Sbjct: 115 VKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLK 160

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 91.3 bits (228), Expect = 1e-22
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 5/107 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           +E  +N  D++G    P   LM+ A    +  ++ LL +G D         +AL +A  +
Sbjct: 25  QENVINHTDEEGF--TP---LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSK 79

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           G+T++V +LL+ G DV+  D  G TPL  A++  + + +K+L + GA
Sbjct: 80  GYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGA 126

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 74.7 bits (185), Expect = 2e-16
 Identities = 17/61 (27%), Positives = 30/61 (49%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            N  ++H  A QG    ++  +E+   ++  D  G TPL  A  +    V++ L ++GA 
Sbjct: 2   ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61

Query: 132 P 132
           P
Sbjct: 62  P 62

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 65.9 bits (162), Expect = 3e-13
 Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 5/79 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            ++N  D +G    P   L++  +   V+ +K LL+SG D          ++ +A   G+
Sbjct: 93  VDVNEYDWNGG--TP---LLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGY 147

Query: 86  TEVVSLLLERGADVDPKDR 104
             V  ++      +    +
Sbjct: 148 RSVQQVIESHLLKLLQNIK 166

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 94.8 bits (237), Expect = 3e-24
 Identities = 29/89 (32%), Positives = 45/89 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   + + D+  ++ LL +G D N +D    T LH A   G  +VV LLL+  A V+   
Sbjct: 14  LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               +PL DA    + +++KLL  +GA  
Sbjct: 74  YQNDSPLHDAAKNGHVDIVKLLLSYGASR 102

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 94.4 bits (236), Expect = 4e-24
 Identities = 21/75 (28%), Positives = 34/75 (45%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ LL     VN     N + LH AA  G  ++V LLL  GA  +  + +G  P+     
Sbjct: 59  VELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDD 118

Query: 116 YKNHEVIKLLEKHGA 130
                ++ L EK+ +
Sbjct: 119 ESMKSLLLLPEKNES 133

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 84.8 bits (211), Expect = 2e-20
 Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 1/68 (1%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           GID    +    T LH+A+ +G    V  LL+ G+D + KD  G TPL +A  + + +V+
Sbjct: 1   GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59

Query: 123 KLLEKHGA 130
           +LL +H A
Sbjct: 60  ELLLQHKA 67

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 49.0 bits (118), Expect = 1e-07
 Identities = 7/43 (16%), Positives = 15/43 (34%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
           +K LL  G   N  +I     +     +    ++ L  +  + 
Sbjct: 92  VKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNESS 134

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 38.6 bits (91), Expect = 6e-04
 Identities = 9/37 (24%), Positives = 16/37 (43%), Gaps = 1/37 (2%)

Query: 96  GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           G D    +  G T L  A    +   ++ L ++G+ P
Sbjct: 1   GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDP 36

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 7/138 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK  E       +  A R E+ LL+++RH N+V  L    +     +V E++    +
Sbjct: 53  VAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110

Query: 238 RAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              L+     L      ++   I  G+ + H +    IIHRD++P NIL   SG +K+ D
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCD 167

Query: 297 FGVSKLLTVKEDRPLTCQ 314
           FG ++ L          +
Sbjct: 168 FGFARTLAAP-GEVYDDE 184

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 94.0 bits (235), Expect = 3e-24
 Identities = 30/89 (33%), Positives = 45/89 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
            M+     D++ +K+ +  G DVN      R  LH AA  G  E++  LL +GAD++  D
Sbjct: 11  FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           +   TPL  A+Y  +   +KLL   GA  
Sbjct: 71  KHHITPLLSAVYEGHVSCVKLLLSKGADK 99

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 76.7 bits (190), Expect = 1e-17
 Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 5/100 (5%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K  ++N   + G   KP   L + A+   +E ++ LL  G D+N  D  + T L  A  +
Sbjct: 29  KGEDVNRTLEGGR--KP---LHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           G    V LLL +GAD   K   G T            +++
Sbjct: 84  GHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ 123

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 70.9 bits (175), Expect = 1e-15
 Identities = 14/59 (23%), Positives = 21/59 (35%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                   A   G  + V   + +G DV+     G  PL  A      E+++ L   GA
Sbjct: 6   MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGA 64

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 98.3 bits (246), Expect = 5e-24
 Identities = 25/89 (28%), Positives = 39/89 (43%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +   A       ++ L+  G  VN    D+ + LH A   G    V +LL+ GA V+   
Sbjct: 63  MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               TPL +A    + + + LL +HGA  
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHGASV 151

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 88.3 bits (220), Expect = 2e-20
 Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 7/105 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             ++          P   L      +    +K+LL+SG DVN +     + LH       
Sbjct: 181 GNIDHKISHLG--TP---LYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVRTAS 234

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            E+  LL++ GAD   K+  G  P+      ++      LE+ GA
Sbjct: 235 EELACLLMDFGADTQAKNAEGKRPVELVP-PESPLAQLFLEREGA 278

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 87.5 bits (218), Expect = 3e-20
 Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 1/77 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +  L+  G +++ +     T L++A        V  LLE GADV+ + +   +PL   + 
Sbjct: 173 VNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVR 231

Query: 116 YKNHEVIKLLEKHGAKP 132
             + E+  LL   GA  
Sbjct: 232 TASEELACLLMDFGADT 248

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 84.9 bits (211), Expect = 3e-19
 Identities = 28/107 (26%), Positives = 43/107 (40%), Gaps = 6/107 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             +N +  D     P   L        +  +K LL  G  VN    D  T L  A   G 
Sbjct: 83  WAVNIITADHV--SP---LHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGS 137

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            + V+LLL+ GA V P+    ++P+ +A    + E +  L  +G   
Sbjct: 138 WDCVNLLLQHGASVQPESD-LASPIHEAARRGHVECVNSLIAYGGNI 183

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 81.4 bits (202), Expect = 6e-18
 Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 6/107 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++NG+  D     P   L         + +  LL  G  V   + D  + +H AA +G 
Sbjct: 116 AQVNGVTADWH--TP---LFNACVSGSWDCVNLLLQHGASVQ-PESDLASPIHEAARRGH 169

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            E V+ L+  G ++D K     TPL  A   +    +K L + GA  
Sbjct: 170 VECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADV 216

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 80.6 bits (200), Expect = 1e-17
 Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 3/84 (3%)

Query: 49  NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
             RD  GI+ LL + +  +   + + + +H AA  G    +  L+ +G  V+       +
Sbjct: 38  GPRDFPGIR-LLSNPLMGD--AVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVS 94

Query: 109 PLGDAIYYKNHEVIKLLEKHGAKP 132
           PL +A    +   +K+L KHGA+ 
Sbjct: 95  PLHEACLGGHLSCVKILLKHGAQV 118

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 56.0 bits (136), Expect = 3e-09
 Identities = 12/80 (15%), Positives = 22/80 (27%), Gaps = 12/80 (15%)

Query: 56  IKELLDSGIDVNFRD-----IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
              L+  G  +   D     +D           G       LL      D       +P+
Sbjct: 11  SSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPGI-----RLLSNPLMGDAVS--DWSPM 63

Query: 111 GDAIYYKNHEVIKLLEKHGA 130
            +A  + +   ++ L   G 
Sbjct: 64  HEAAIHGHQLSLRNLISQGW 83

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 52.9 bits (128), Expect = 3e-08
 Identities = 7/45 (15%), Positives = 17/45 (37%), Gaps = 1/45 (2%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
              L+D G D   ++ + +  + +   +     +  L   GA + 
Sbjct: 238 ACLLMDFGADTQAKNAEGKRPVELVPPESPLAQL-FLEREGASLP 281

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 98.8 bits (247), Expect = 5e-24
 Identities = 42/140 (30%), Positives = 81/140 (57%), Gaps = 11/140 (7%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K++  +  ++D+ +   A R E++LL+++ HPN+V  +  +     + +V E++ K 
Sbjct: 48  VALKRIRLD--AEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103

Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL+  L   K  L+ S    +   + RG+ + H+++   I+HRDL+P N+L +  G LK+
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL 160

Query: 295 ADFGVSKLLTVKEDRPLTCQ 314
           ADFG+++   +   R  T +
Sbjct: 161 ADFGLARAFGI-PVRSYTHE 179

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 98.0 bits (245), Expect = 7e-24
 Identities = 38/140 (27%), Positives = 75/140 (53%), Gaps = 11/140 (7%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K++  +   DD+ V   A R E+ LL++++H N+V+    +     + +V E+  + 
Sbjct: 30  VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85

Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL+ +     G L P     F   + +G+ + H      ++HRDL+P N+L + +G LK+
Sbjct: 86  DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142

Query: 295 ADFGVSKLLTVKEDRPLTCQ 314
           A+FG+++   +   R  + +
Sbjct: 143 ANFGLARAFGI-PVRCYSAE 161

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.5 bits (246), Expect = 7e-24
 Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 11/146 (7%)

Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              VAVK +  +  +   + ++  + E+ + + + H NVV+F G   + +   +  EY  
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G+L   ++    +    A RF   +  G+ YLH      I HRD++P N+L D+  NLK
Sbjct: 89  GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145

Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC 318
           ++DFG++ +      +R L   +  C
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMC 168

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 97.6 bits (244), Expect = 8e-24
 Identities = 42/140 (30%), Positives = 80/140 (57%), Gaps = 11/140 (7%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
            A+KK+  E   +D+ +     R E+++L++++H N+V+    +     +++V E+L + 
Sbjct: 29  FALKKIRLE--KEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84

Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL+  L   +G L+  TA  F L +  G+ Y H+ +   ++HRDL+P N+L +  G LK+
Sbjct: 85  DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKI 141

Query: 295 ADFGVSKLLTVKEDRPLTCQ 314
           ADFG+++   +   R  T +
Sbjct: 142 ADFGLARAFGI-PVRKYTHE 160

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.1 bits (245), Expect = 8e-24
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 17/152 (11%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
             +VA+K     K       + D       E+ +L+K+ HP +++       +    IV 
Sbjct: 35  CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
           E +  G+L   +     LK +T   +   +   + YLHEN    IIHRDL+P N+L   +
Sbjct: 94  ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 150

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           ++   +K+ DFG SK+  + E   +    T C
Sbjct: 151 EEDCLIKITDFGHSKI--LGETSLMR---TLC 177

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 97.6 bits (244), Expect = 9e-24
 Identities = 39/141 (27%), Positives = 79/141 (56%), Gaps = 12/141 (8%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+KK+  +  ++ + V   A R E++LL+++ HPN+V+ L  +   + + +V E+L + 
Sbjct: 31  VALKKIRLD--TETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 86

Query: 236 DLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           DL+ F+       +       +   + +G+ + H ++   ++HRDL+P N+L +  G +K
Sbjct: 87  DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIK 143

Query: 294 VADFGVSKLLTVKEDRPLTCQ 314
           +ADFG+++   V   R  T +
Sbjct: 144 LADFGLARAFGV-PVRTYTHE 163

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.8 bits (246), Expect = 1e-23
 Identities = 43/130 (33%), Positives = 67/130 (51%), Gaps = 4/130 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G+ +A K +  E I    R +  R EL +L +   P +V F GA      + I  E++  
Sbjct: 58  GLVMARKLIHLE-IKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   LK+ G +      + ++ + +G+ YL E     I+HRD++PSNIL +  G +K+
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKL 173

Query: 295 ADFGVSKLLT 304
            DFGVS  L 
Sbjct: 174 CDFGVSGQLI 183

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 43/144 (29%), Positives = 78/144 (54%), Gaps = 9/144 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             +VA+K +  +++   D       E++ L+ +RHP++++    +T  + +++V EY   
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++  K  +      RF   I   + Y H +K   I+HRDL+P N+L DD+ N+K+
Sbjct: 93  GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKI 149

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC 318
           ADFG+S ++   +   L    TSC
Sbjct: 150 ADFGLSNIM--TDGNFL---KTSC 168

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 96.8 bits (242), Expect = 2e-23
 Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 4/105 (3%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A +N  +++G    P   L         + ++ LL  G D   R  +  T   +AA  G 
Sbjct: 29  ANVNFQEEEGGWT-P---LHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGS 84

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            +++ L L +GADV+  D +G T   +A  Y   + +K L K GA
Sbjct: 85  VKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGA 129

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 92.9 bits (232), Expect = 4e-22
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPK 102
           L+      DV+ +++LL+ G +VNF++ +   T LH A      ++V LLL  GAD   +
Sbjct: 9   LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            + G+TP   A    + +++KL    GA
Sbjct: 69  KKNGATPFLLAAIAGSVKLLKLFLSKGA 96

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 91.0 bits (227), Expect = 2e-21
 Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 10/112 (8%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE----LLDSGIDVNFRDIDNRTALHVAA 81
           A++N  D+ G        L+      D   ++     LLD G DVN R    +T L +A 
Sbjct: 173 ADVNACDNMGR--NA---LIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227

Query: 82  CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +    +V  LLE+   +++  D  G T L  A+  K  ++ +LL K GA  
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 83.3 bits (207), Expect = 1e-18
 Identities = 34/116 (29%), Positives = 51/116 (43%), Gaps = 16/116 (13%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+      +G    P    +  A    V+ +K  L  G DVN  D    TA   AA  G 
Sbjct: 63  ADPVLRKKNGA--TP---FLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGK 117

Query: 86  TEVVSLLLERGADVDPKD----------RWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
            + +  L +RGA+V+ +           + G+T L DA    + EV+K LL++ GA
Sbjct: 118 VKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGA 173

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 75.2 bits (186), Expect = 9e-16
 Identities = 37/120 (30%), Positives = 49/120 (40%), Gaps = 20/120 (16%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN----------RT 75
           A++N  D  G         M  A    V+ +K L   G +VN R               T
Sbjct: 96  ADVNECDFYGF--TA---FMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGAT 150

Query: 76  ALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLLEKHGA 130
           AL  AA +G  EV+ +LL E GADV+  D  G   L  A+   +      +  LL  HGA
Sbjct: 151 ALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGA 210

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 74.8 bits (185), Expect = 1e-15
 Identities = 19/62 (30%), Positives = 35/62 (56%), Gaps = 1/62 (1%)

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKH 128
            +++   L  A      ++V  LLE GA+V+ ++   G TPL +A+     ++++LL +H
Sbjct: 2   AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61

Query: 129 GA 130
           GA
Sbjct: 62  GA 63

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 67.1 bits (165), Expect = 5e-13
 Identities = 22/79 (27%), Positives = 40/79 (50%), Gaps = 6/79 (7%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
           A++N   + G+   P   L+    ++ +  ++ LL+   I++N  D D +TAL +A    
Sbjct: 210 ADVNVRGERGK--TP---LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264

Query: 85  FTEVVSLLLERGADVDPKD 103
             ++  LL +RGA  D  D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 97.5 bits (243), Expect = 2e-23
 Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 14/150 (9%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
             +V VK     K+ E+   +D ++     E+A+L ++ H N+++ L          +V 
Sbjct: 49  NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108

Query: 230 E-YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           E +    DL AF+ R   L    A      +   + YL       IIHRD++  NI+  +
Sbjct: 109 EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAE 165

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
              +K+ DFG +    ++  +      T C
Sbjct: 166 DFTIKLIDFGSAAY--LERGKLF---YTFC 190

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 97.6 bits (244), Expect = 2e-23
 Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
           A+     +  ++      L+  A   + E +  LL    ++ +  D    T LH+AA   
Sbjct: 15  AKAVLTGEYKKDE-----LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYN 69

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              +V LLL+ GADV  KD+ G  PL +A  Y ++EV +LL KHGA
Sbjct: 70  RVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGA 115

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 96.4 bits (241), Expect = 6e-23
 Identities = 35/89 (39%), Positives = 42/89 (47%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    V  ++ LL  G DV+ +D      LH A   G  EV  LLL+ GA V+  D
Sbjct: 62  LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            W  TPL +A      EV  LL  HGA P
Sbjct: 122 LWQFTPLHEAASKNRVEVCSLLLSHGADP 150

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 93.3 bits (233), Expect = 7e-22
 Identities = 25/77 (32%), Positives = 41/77 (53%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
            + LL  G +VN ++ D  T LHVAA +   +V+ +L + GA ++  D  G T L  A  
Sbjct: 230 AELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAAL 289

Query: 116 YKNHEVIKLLEKHGAKP 132
             + +  +LL  +G+ P
Sbjct: 290 AGHLQTCRLLLSYGSDP 306

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 90.6 bits (226), Expect = 6e-21
 Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 6/110 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+++  D  G    P   L    +    E  + LL  G  VN  D+   T LH AA +  
Sbjct: 82  ADVHAKDKGGL--VP---LHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNR 136

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
            EV SLLL  GAD    +  G + +  A   +  E +    K  +  L A
Sbjct: 137 VEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHS-LLQA 185

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 90.6 bits (226), Expect = 7e-21
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVD 100
           L+  A E D+  +K+ L   I    +   + TALH A         +V  LLL +GA+V+
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241

Query: 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            K++   TPL  A    +++V+++L KHGAK 
Sbjct: 242 EKNKDFMTPLHVAAERAHNDVMEVLHKHGAKM 273

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 85.2 bits (212), Expect = 5e-19
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
             +L D            +  L  AA  G   ++++LL     +    D   STPL  A 
Sbjct: 7   ALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAA 66

Query: 115 YYKNHEVIKLLEKHGA 130
            Y    +++LL +HGA
Sbjct: 67  GYNRVRIVQLLLQHGA 82

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 81.8 bits (203), Expect = 8e-18
 Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 5/77 (6%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L   G  +N  D   +TALH AA  G  +   LLL  G+D       G T       
Sbjct: 263 MEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMG-- 320

Query: 116 YKNHEVIKLLEKHGAKP 132
              +E ++ +       
Sbjct: 321 ---NEAVQQILSESTPM 334

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 69.8 bits (172), Expect = 1e-13
 Identities = 26/131 (19%), Positives = 43/131 (32%), Gaps = 29/131 (22%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA----- 80
           A +N +D       P   L   A++  VE    LL  G D    +   ++A+ +A     
Sbjct: 115 ACVNAMDLWQF--TP---LHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPEL 169

Query: 81  ----------------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA---IYYKNHEV 121
                           A +     V   L        + +   T L  A   ++ K  +V
Sbjct: 170 RERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQV 229

Query: 122 IKLLEKHGAKP 132
            +LL + GA  
Sbjct: 230 AELLLRKGANV 240

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 61.0 bits (149), Expect = 1e-10
 Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 10/83 (12%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N LD  G+       L   A    ++  + LL  G D +   +   TA  +      
Sbjct: 271 AKMNALDSLGQTA-----LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN---- 321

Query: 86  TEVVSLLLERGADVDPKDRWGST 108
            E V  +L     +   D     
Sbjct: 322 -EAVQQILSESTPMRTSDVDYRL 343

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 44.4 bits (106), Expect = 2e-05
 Identities = 9/60 (15%), Positives = 17/60 (28%), Gaps = 14/60 (23%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGA 130
             ++AL              L +  A       +    L +A    N  +++ LL     
Sbjct: 3   FGKSALD-------------LADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNV 49

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 92.1 bits (230), Expect = 2e-23
 Identities = 38/87 (43%), Positives = 51/87 (58%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A     E +K+LL  G DVN R  D  T LH+AA  G  E+V LLL +GADV+ + 
Sbjct: 13  LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + G+TP   A    +HE++KLL+  GA
Sbjct: 73  KDGNTPEHLAKKNGHHEIVKLLDAKGA 99

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 78.2 bits (194), Expect = 3e-18
 Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 2/68 (2%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G        D  T LH AA  G  E V  LL +GADV+ + + G+TPL  A    + E++
Sbjct: 1   GHMWG--SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIV 58

Query: 123 KLLEKHGA 130
           KLL   GA
Sbjct: 59  KLLLAKGA 66

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 73.6 bits (182), Expect = 1e-16
 Identities = 30/85 (35%), Positives = 38/85 (44%), Gaps = 5/85 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N    DG    P   L   A     E +K LL  G DVN R  D  T  H+A   G 
Sbjct: 33  ADVNARSKDGN--TP---LHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGH 87

Query: 86  TEVVSLLLERGADVDPKDRWGSTPL 110
            E+V LL  +GADV+ +    S   
Sbjct: 88  HEIVKLLDAKGADVNARSWGSSHHH 112

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 96.9 bits (242), Expect = 2e-23
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 7/132 (5%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL--GAVTQSSPMM--IVTEYL 232
            VAVK L  ++  D      FR E      + HP +V     G     +  +  IV EY+
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
               LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155

Query: 293 KVADFGVSKLLT 304
           KV DFG+++ + 
Sbjct: 156 KVMDFGIARAIA 167

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 94.4 bits (236), Expect = 3e-23
 Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 6/113 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G+       L + A   +V+    LL +G + + ++    T L +AA +G 
Sbjct: 116 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 170

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
            E   +LL+  A+ D  D     P   A    +H++++LL+++        +H
Sbjct: 171 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRS-PQLH 222

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 90.5 bits (226), Expect = 9e-22
 Identities = 27/87 (31%), Positives = 44/87 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A       +++L++S  DVN  D   ++ALH AA     +   +LL+ GA+ D ++
Sbjct: 96  LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 155

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               TPL  A    ++E  K+L  H A
Sbjct: 156 NREETPLFLAAREGSYETAKVLLDHFA 182

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 85.9 bits (214), Expect = 5e-20
 Identities = 25/90 (27%), Positives = 37/90 (41%), Gaps = 1/90 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
           L   A     +  K LL++  D N +D   RT LH A       V  +L+   A D+D +
Sbjct: 29  LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 88

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
              G+TPL  A       +++ L    A  
Sbjct: 89  MHDGTTPLILAARLAVEGMLEDLINSHADV 118

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 85.2 bits (212), Expect = 1e-19
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)

Query: 56  IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
           I + +  G  + N  D    TALH+AA    ++    LLE  AD + +D  G TPL  A+
Sbjct: 7   ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66

Query: 115 YYKNHEVIKLLEKHGAK 131
                 V ++L ++ A 
Sbjct: 67  SADAQGVFQILIRNRAT 83

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 82.8 bits (206), Expect = 6e-19
 Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
           A+ N  D+ G    P   L    +       + L+ +   D++ R  D  T L +AA   
Sbjct: 49  ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 103

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              ++  L+   ADV+  D  G + L  A    N +   +L K+GA
Sbjct: 104 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 149

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 50.5 bits (122), Expect = 1e-07
 Identities = 14/48 (29%), Positives = 21/48 (43%), Gaps = 1/48 (2%)

Query: 84  GFTEVVSLLLERGADV-DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               V+S  + +GA + +  DR G T L  A  Y   +  K L +  A
Sbjct: 2   DAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASA 49

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 97.9 bits (245), Expect = 4e-23
 Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
               G  + G    P   L   +    +  +K LL  G   N  ++   T LH+AA  G 
Sbjct: 5   ISGGGGGESGL--TP---LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGH 59

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           TEV   LL+  A V+ K +   TPL  A    +  ++KLL ++ A P
Sbjct: 60  TEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANP 106

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.4 bits (241), Expect = 1e-22
 Identities = 32/107 (29%), Positives = 45/107 (42%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
              N     G    P   L   A E   E +  LL    + N  +    T LH+ A +G 
Sbjct: 236 GSANAESVQGV--TP---LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGH 290

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             V  +L++ G  VD   R G TPL  A +Y N +++K L +H A  
Sbjct: 291 VPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADV 337

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.4 bits (241), Expect = 1e-22
 Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 5/109 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K+A  N  +  G    P   L  +A E  V     L+  G+ V+       T LHVA+  
Sbjct: 267 KQANGNLGNKSGL--TP---LHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHY 321

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           G  ++V  LL+  ADV+ K + G +PL  A    + +++ LL K+GA P
Sbjct: 322 GNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASP 370

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.4 bits (241), Expect = 1e-22
 Identities = 36/107 (33%), Positives = 46/107 (42%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  N     G    P   L   A E  VE +  LL+             T LHVAA  G 
Sbjct: 104 ANPNLATTAGH--TP---LHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGK 158

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             V  LLLER A  +   + G TPL  A+++ N +++KLL   G  P
Sbjct: 159 VRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSP 205

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.0 bits (240), Expect = 2e-22
 Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 5/109 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           ++A  N    +G    P   L    +  +++ +K LL  G   +    +  T LH+AA Q
Sbjct: 168 RDAHPNAAGKNGL--TP---LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQ 222

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
              EV   LL+ G   + +   G TPL  A    + E++ LL    A  
Sbjct: 223 NQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANG 271

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 95.3 bits (238), Expect = 3e-22
 Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 5/110 (4%)

Query: 23  RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
           + +A++N    D +   P   L   A       +K LL++  + N       T LH+AA 
Sbjct: 68  QNKAKVNAKAKDDQT--P---LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAR 122

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           +G  E V  LLE+ A      + G TPL  A  Y    V +LL +  A P
Sbjct: 123 EGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHP 172

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 31/109 (28%), Positives = 40/109 (36%), Gaps = 5/109 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           KEA    +   G    P   L   A    V   + LL+     N    +  T LHVA   
Sbjct: 135 KEASQACMTKKGF--TP---LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHH 189

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
              ++V LLL RG         G TPL  A      EV + L ++G   
Sbjct: 190 NNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSA 238

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 94.5 bits (236), Expect = 6e-22
 Identities = 34/109 (31%), Positives = 46/109 (42%), Gaps = 5/109 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           + A  N  +   E   P   L   A     E  K LL +   VN +  D++T LH AA  
Sbjct: 36  RGASPNVSNVKVE--TP---LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 90

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           G T +V LLLE  A+ +     G TPL  A    + E +  L +  A  
Sbjct: 91  GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQ 139

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 94.1 bits (235), Expect = 7e-22
 Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 5/106 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             ++     G    P   L   ++  +++ +K LL    DVN +     + LH AA QG 
Sbjct: 302 VMVDATTRMGY--TP---LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGH 356

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
           T++V+LLL+ GA  +     G+TPL  A       V  +L+    +
Sbjct: 357 TDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDE 402

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 92.2 bits (230), Expect = 4e-21
 Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
              +    +G    P   L   A +  VE  + LL  G   N   +   T LH+AA +G 
Sbjct: 203 GSPHSPAWNGY--TP---LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGH 257

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            E+V+LLL + A+ +  ++ G TPL       +  V  +L KHG   
Sbjct: 258 AEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMV 304

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 87.9 bits (219), Expect = 1e-19
 Identities = 24/70 (34%), Positives = 32/70 (45%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           GI          T LHVA+  G   +V  LL+RGA  +  +    TPL  A    + EV 
Sbjct: 4   GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVA 63

Query: 123 KLLEKHGAKP 132
           K L ++ AK 
Sbjct: 64  KYLLQNKAKV 73

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 44.8 bits (107), Expect = 2e-05
 Identities = 11/38 (28%), Positives = 16/38 (42%)

Query: 95  RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            G         G TPL  A +  +  ++K L + GA P
Sbjct: 3   PGISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASP 40

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 92.9 bits (232), Expect = 4e-23
 Identities = 27/107 (25%), Positives = 46/107 (42%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+ + L  + E       L   +     + +  LL+  +D+N  D +  T L  A     
Sbjct: 60  ADPHILAKERE--SA---LSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNH 114

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            + V  LL RGAD+  +   G TP+  A+     +V +++E H  K 
Sbjct: 115 VKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKL 161

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 90.2 bits (225), Expect = 3e-22
 Identities = 27/87 (31%), Positives = 50/87 (57%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L++ +   ++E ++ LL+ G D +    +  +AL +A+  G+T++V LLLER  D++  D
Sbjct: 40  LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A+   + + ++ L   GA
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGA 126

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 88.6 bits (221), Expect = 1e-21
 Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 1/90 (1%)

Query: 44  LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           +  LA + +++ +KE L  G + VN  D    T L  A+  G  E V  LLE GAD    
Sbjct: 6   IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +   + L  A      +++ LL +     
Sbjct: 66  AKERESALSLASTGGYTDIVGLLLERDVDI 95

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 75.1 bits (186), Expect = 1e-16
 Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 5/84 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            ++N  D +G    P   L++      V+ ++ LL  G D+        T + +A   G+
Sbjct: 93  VDINIYDWNGG--TP---LLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAVALGY 147

Query: 86  TEVVSLLLERGADVDPKDRWGSTP 109
            +V  ++      +   +   + P
Sbjct: 148 RKVQQVIENHILKLFQSNLVPADP 171

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 67.8 bits (167), Expect = 6e-14
 Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 1/61 (1%)

Query: 73  NRTALHVAACQGFTEVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
           +  ++H  A QG  + +   L +G + V+  D  G TPL  A  +   E ++ L + GA 
Sbjct: 2   DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61

Query: 132 P 132
           P
Sbjct: 62  P 62

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 96.0 bits (240), Expect = 4e-23
 Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 17/141 (12%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            +     DDG         +   +  D E +  LL+ G D+N+ ++D  TALH A     
Sbjct: 32  KKTKVKFDDGAV------FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDN 85

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLMA 135
            ++V  L+E GA+++  D  G  PL  A      ++ + L   GA           PL  
Sbjct: 86  VDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDI 145

Query: 136 PMHVKHAREVPEYEIDPHELD 156
                   E+ + E++   +D
Sbjct: 146 AEEEAM-EELLQNEVNRQGVD 165

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 90.3 bits (225), Expect = 4e-21
 Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 1/78 (1%)

Query: 56  IKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
            ++ L+S  I+         TALHVAA +G+TEV+ LL++   DV+ KD  G TPL  A 
Sbjct: 181 ARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAA 240

Query: 115 YYKNHEVIKLLEKHGAKP 132
           ++   E  ++L ++    
Sbjct: 241 HWGKEEACRILVENLCDM 258

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 88.3 bits (220), Expect = 2e-20
 Identities = 22/76 (28%), Positives = 35/76 (46%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +K L+ +  DVN +D D  T LH AA  G  E   +L+E   D++  ++ G T    A  
Sbjct: 215 LKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADE 274

Query: 116 YKNHEVIKLLEKHGAK 131
                + +L +K    
Sbjct: 275 DILGYLEELQKKQNLL 290

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 77.5 bits (192), Expect = 2e-16
 Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 1/77 (1%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
             ++  +        +  D+      A   G TE V  LLERGAD++  +  G T L  A
Sbjct: 22  TDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQA 80

Query: 114 IYYKNHEVIKLLEKHGA 130
               N +++K L ++GA
Sbjct: 81  CIDDNVDMVKFLVENGA 97

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 67.5 bits (166), Expect = 4e-13
 Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 11/105 (10%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A +  ++ +G+   P   L     E   E ++  ++         +D   A         
Sbjct: 130 AHVGAVNSEGD--TP---LDIAEEEAMEELLQNEVNRQ------GVDIEAARKEEERIML 178

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            +    L     +     + G T L  A      EV+KLL +   
Sbjct: 179 RDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARY 223

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 64.4 bits (158), Expect = 5e-12
 Identities = 10/67 (14%), Positives = 20/67 (29%), Gaps = 1/67 (1%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
           +   D   +    +    G    +   + +      K   G+  L  A    + E +  L
Sbjct: 1   MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFL-AACSSGDTEEVLRL 59

Query: 126 EKHGAKP 132
            + GA  
Sbjct: 60  LERGADI 66

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 51.0 bits (123), Expect = 1e-07
 Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 5/78 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            ++N  D DG    P   L   A+    E  + L+++  D+   +   +TA  VA     
Sbjct: 223 YDVNIKDYDGWT--P---LHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDIL 277

Query: 86  TEVVSLLLERGADVDPKD 103
             +  L  ++      K 
Sbjct: 278 GYLEELQKKQNLLHSEKR 295

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 95.8 bits (239), Expect = 4e-23
 Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 17/179 (9%)

Query: 134 MAPMHVKHA-REVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV 187
           MA   V+     +   + DP EL FT   +I KG+F   F          VA+K +  E 
Sbjct: 1   MAHSPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE- 58

Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
              +D +   + E+ +L +   P V ++ G+  + + + I+ EYL  G     L+     
Sbjct: 59  -EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117

Query: 248 KPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           +   A   R  L   +G++YLH  K    IHRD++ +N+L  + G +K+ADFGV+  LT
Sbjct: 118 ETQIATILREIL---KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 95.8 bits (239), Expect = 5e-23
 Identities = 33/128 (25%), Positives = 53/128 (41%), Gaps = 3/128 (2%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
            VA+K + E + SD       + E     +++ P+VV           + +    +   D
Sbjct: 61  IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L A L+R+G L P  AV     I   ++  H        HRD++P NIL        + D
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177

Query: 297 FGVSKLLT 304
           FG++   T
Sbjct: 178 FGIASATT 185

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 94.8 bits (237), Expect = 5e-23
 Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 5/105 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G+       L + A   +V+    LL +G + + ++    T L +AA +G 
Sbjct: 148 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 202

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            E   +LL+  A+ D  D     P   A    +H++++LL+    
Sbjct: 203 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHH 247

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 91.0 bits (227), Expect = 1e-21
 Identities = 27/87 (31%), Positives = 44/87 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A       +++L++S  DVN  D   ++ALH AA     +   +LL+ GA+ D ++
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               TPL  A    ++E  K+L  H A
Sbjct: 188 NREETPLFLAAREGSYETAKVLLDHFA 214

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 86.4 bits (215), Expect = 5e-20
 Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
           A+ N  D+ G    P   L    +       + L+ +   D++ R  D  T L +AA   
Sbjct: 81  ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 135

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              ++  L+   ADV+  D  G + L  A    N +   +L K+GA
Sbjct: 136 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 181

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 86.0 bits (214), Expect = 8e-20
 Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
           L   A     +  K LL++  D N +D   RT LH A       V  +L+   A D+D +
Sbjct: 61  LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 120

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              G+TPL  A       +++ L    A
Sbjct: 121 MHDGTTPLILAARLAVEGMLEDLINSHA 148

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 82.5 bits (205), Expect = 2e-18
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)

Query: 56  IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
           I + +  G  + N  D    TALH+AA    ++    LLE  AD + +D  G TPL  A+
Sbjct: 39  ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 98

Query: 115 YYKNHEVIKLLEKHGAK 131
                 V ++L ++ A 
Sbjct: 99  SADAQGVFQILIRNRAT 115

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 72.1 bits (178), Expect = 7e-15
 Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 14/83 (16%)

Query: 64  IDVNFRDIDNRTALHVAACQGFT-------------EVVSLLLERGADV-DPKDRWGSTP 109
           +DVN R  D  T L +A+C G                V+S  + +GA + +  DR G T 
Sbjct: 1   MDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETA 60

Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
           L  A  Y   +  K L +  A  
Sbjct: 61  LHLAARYSRSDAAKRLLEASADA 83

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 55.6 bits (135), Expect = 3e-09
 Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 5/77 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  +  ++  E   P   L   A E   E  K LLD   + +  D  +R    +A  +  
Sbjct: 181 ANKDMQNNREE--TP---LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMH 235

Query: 86  TEVVSLLLERGADVDPK 102
            ++V LL          
Sbjct: 236 HDIVRLLDLEHHHHHHH 252

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 93.9 bits (234), Expect = 7e-23
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 2/108 (1%)

Query: 23  RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
           RK               P   L+  A   ++E +++ +    D +  + +  TALH A C
Sbjct: 6   RKAGSPRKARRARLN--PLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAIC 63

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                +V  L+  GA+V+  D  G TPL  A    +  +   L +HGA
Sbjct: 64  GANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGA 111

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 80.0 bits (198), Expect = 7e-18
 Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 8/109 (7%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            + +  +++G        L       +   +  L+ +G +VN  D    T LH AA    
Sbjct: 45  NDPSQPNEEGI--TA---LHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCND 99

Query: 86  TEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKN--HEVIKLLEKHGAK 131
           T +   L++ GA +       G+T       Y+    +    L      
Sbjct: 100 TVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQS 148

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 53.0 bits (128), Expect = 2e-08
 Identities = 10/67 (14%), Positives = 18/67 (26%), Gaps = 1/67 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
              L D    +   +     AL   +   F + +S        V  +D    T    A  
Sbjct: 139 ATYLADVEQSMGLMNSGAVYALWDYS-AEFGDELSFREGESVTVLRRDGPEETDWWWAAL 197

Query: 116 YKNHEVI 122
           +     +
Sbjct: 198 HGQEGYV 204

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 46.5 bits (111), Expect = 3e-06
 Identities = 11/88 (12%), Positives = 21/88 (23%), Gaps = 7/88 (7%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
            E  +  ++            ++  +    + +       + V  RD    T    AA  
Sbjct: 145 VEQSMGLMNSGAVY------ALWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALH 198

Query: 84  GFTEVV-SLLLERGADVDPKDRWGSTPL 110
           G    V          V P+        
Sbjct: 199 GQEGYVPRNYFGLFPRVKPQRSKVKHHH 226

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 42.6 bits (101), Expect = 6e-05
 Identities = 9/47 (19%), Positives = 14/47 (29%), Gaps = 3/47 (6%)

Query: 89  VSLLLERGADVDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           +  +L +        R        L DA      EV++   K    P
Sbjct: 1   MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDP 47

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 95.7 bits (239), Expect = 7e-23
 Identities = 42/141 (29%), Positives = 73/141 (51%), Gaps = 14/141 (9%)

Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           VA+K++    EE         A R E++LL+ ++H N+V     +     + +V EYL K
Sbjct: 30  VALKEIRLEHEEGAP----CTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84

Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            DL+ +L   G  +       F   + RG+ Y H  K   ++HRDL+P N+L ++ G LK
Sbjct: 85  -DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK 140

Query: 294 VADFGVSKLLTVKEDRPLTCQ 314
           +ADFG+++  ++   +    +
Sbjct: 141 LADFGLARAKSI-PTKTYDNE 160

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 89.7 bits (224), Expect = 8e-23
 Identities = 40/74 (54%), Positives = 50/74 (67%)

Query: 57  KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
           K LL++G DVN +D + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A   
Sbjct: 19  KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78

Query: 117 KNHEVIKLLEKHGA 130
            + EV+KLL + GA
Sbjct: 79  GHLEVVKLLLEAGA 92

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 74.3 bits (184), Expect = 3e-17
 Identities = 32/59 (54%), Positives = 39/59 (66%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A    + EV+KLL + GA
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 52.7 bits (128), Expect = 2e-09
 Identities = 32/74 (43%), Positives = 42/74 (56%), Gaps = 5/74 (6%)

Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
            A++N  D +G    P   L   A    +E +K LL++G DVN +D + RT LH+AA  
Sbjct: 24 AGADVNAKDKNGR--TP---LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78

Query: 84 GFTEVVSLLLERGA 97
          G  EVV LLLE GA
Sbjct: 79 GHLEVVKLLLEAGA 92

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 91.3 bits (228), Expect = 8e-23
 Identities = 32/87 (36%), Positives = 48/87 (55%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A        + LL +G+  + R   +RT LH+AA +G   +V +LL+ GADV+ KD
Sbjct: 38  LHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKD 97

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               T L  A  + + EV++LL K+GA
Sbjct: 98  MLKMTALHWATEHNHQEVVELLIKYGA 124

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 86.7 bits (216), Expect = 6e-21
 Identities = 28/83 (33%), Positives = 44/83 (53%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A+E     ++ LL  G DVN +D+   TALH A      EVV LL++ GADV  + 
Sbjct: 71  LHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQS 130

Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
           ++  T    +I   N ++ ++L+
Sbjct: 131 KFCKTAFDISIDNGNEDLAEILQ 153

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 85.9 bits (214), Expect = 9e-21
 Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 1/87 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A     + ++ L+ +G      D    + LH+AA  G      +LL  G   D + 
Sbjct: 6   LLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDART 64

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           +   TPL  A    +  ++++L KHGA
Sbjct: 65  KVDRTPLHMAASEGHANIVEVLLKHGA 91

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 70.1 bits (173), Expect = 5e-15
 Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 1/59 (1%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D    L  AA  G  + V +L+  GA     D  G++PL  A  Y +    ++L + G 
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGV 58

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 91.7 bits (229), Expect = 1e-22
 Identities = 20/85 (23%), Positives = 33/85 (38%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +++LL    D+N  +      LH A   G  +V   L+  GA V   +++G  P+  A  
Sbjct: 88  VQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKA 147

Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVK 140
                + +  EK G      P    
Sbjct: 148 PLRELLRERAEKMGQNLNRIPYKDT 172

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 89.0 bits (222), Expect = 1e-21
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 5/111 (4%)

Query: 22  ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
           +  E +LN  DD G    P   L +   E     ++ L+  G  +N  +  + T LH+AA
Sbjct: 26  DNTENDLNQGDDHGF--SP---LHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAA 80

Query: 82  CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             G  ++V  LL+  AD++  +  G+ PL  A ++   +V + L  +GA  
Sbjct: 81  SHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALV 131

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 67.5 bits (166), Expect = 8e-14
 Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
             +    +     +G    V L L+    D++  D  G +PL  A       V+++L   
Sbjct: 2   SPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMR 61

Query: 129 GA 130
           GA
Sbjct: 62  GA 63

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 34/144 (23%), Positives = 74/144 (51%), Gaps = 15/144 (10%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K++  E   +++ V   A R E++LL++++H N+++    +  +  + ++ EY    
Sbjct: 62  VAIKRIRLE--HEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----RDDSG 290
           DL+ ++ +   +       F   +  G+N+ H  +    +HRDL+P N+L       ++ 
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQ 314
            LK+ DFG+++   +   R  T +
Sbjct: 175 VLKIGDFGLARAFGI-PIRQFTHE 197

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 93.2 bits (233), Expect = 1e-22
 Identities = 30/88 (34%), Positives = 43/88 (48%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    V+    L+ +G +++    D RT L  AA     E V  L++ GA VDPKD
Sbjct: 15  LHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKD 74

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
             GST L  A    ++EV++ L  +G  
Sbjct: 75  AEGSTCLHLAAKKGHYEVVQYLLSNGQM 102

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 88.6 bits (221), Expect = 5e-21
 Identities = 21/75 (28%), Positives = 34/75 (45%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
            + LL +  D++  +I   + LH+AA +   + V L L R +DV  K++ G TPL  A  
Sbjct: 160 AEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASL 219

Query: 116 YKNHEVIKLLEKHGA 130
                    + K   
Sbjct: 220 NSQVWSALQMSKALQ 234

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 88.6 bits (221), Expect = 7e-21
 Identities = 21/75 (28%), Positives = 34/75 (45%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +K LL  G D+N RD +    LH AA  G  ++  +LL    D+   +  G +PL  A  
Sbjct: 127 VKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAAR 186

Query: 116 YKNHEVIKLLEKHGA 130
              ++ + L     +
Sbjct: 187 ENRYDCVVLFLSRDS 201

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 87.9 bits (219), Expect = 1e-20
 Identities = 20/67 (29%), Positives = 34/67 (50%)

Query: 64  IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           ++      + R+ LH AA  G  ++  +L++ GA++D       TPL +A    + E +K
Sbjct: 2   MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVK 61

Query: 124 LLEKHGA 130
            L K GA
Sbjct: 62  YLIKAGA 68

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 87.5 bits (218), Expect = 2e-20
 Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 6/108 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
           A ++  D +G        L   A +   E ++ LL +G +DVN +D    T +  A    
Sbjct: 68  ALVDPKDAEGS--TC---LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYK 122

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             ++V LLL +G+D++ +D   +  L  A +    ++ ++L       
Sbjct: 123 HVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDL 170

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 53.6 bits (130), Expect = 1e-08
 Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 5/75 (6%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
            + +L+ ++  G+   P   L   A E   + +   L    DV  ++ +  T L  A+  
Sbjct: 166 AKCDLHAVNIHGD--SP---LHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLN 220

Query: 84  GFTEVVSLLLERGAD 98
                   + +   D
Sbjct: 221 SQVWSALQMSKALQD 235

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 90.9 bits (227), Expect = 1e-22
 Identities = 26/77 (33%), Positives = 39/77 (50%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           E  + LL  G + + +D      +H AA  GF + +  LLE  ADV+ +D  G+ PL  A
Sbjct: 51  EIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLA 110

Query: 114 IYYKNHEVIKLLEKHGA 130
               +  V++ L KH A
Sbjct: 111 AKEGHLRVVEFLVKHTA 127

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 86.7 bits (216), Expect = 6e-21
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 1/87 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   D+E +  LL + ++VN ++   RTAL V    G  E+   LL RGA+ D KD
Sbjct: 9   LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKD 67

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           R G   + DA      + ++ L +  A
Sbjct: 68  RTGFAVIHDAARAGFLDTLQTLLEFQA 94

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 86.3 bits (215), Expect = 7e-21
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  +  D  G        +   A    ++ ++ LL+   DVN  D +    LH+AA +G 
Sbjct: 61  ANPDLKDRTGF--AV---IHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGH 115

Query: 86  TEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             VV  L++  A +V  ++  G T    A  Y  +EV+ L++ +GA
Sbjct: 116 LRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 70.1 bits (173), Expect = 7e-15
 Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 1/61 (1%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
                L  AA +G  E ++ LL+   +V+ ++ +G T L       N E+ + L   GA 
Sbjct: 4   PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGAN 62

Query: 132 P 132
           P
Sbjct: 63  P 63

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 94.1 bits (235), Expect = 1e-22
 Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)

Query: 28  LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
              + +DG+       L      +    +  LL        ++ ++   +TALH+AA  G
Sbjct: 2   FGYVTEDGD--TA---LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               V  L   GA V   +R G T L  A   + H    +L +     
Sbjct: 57  EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 93.4 bits (233), Expect = 3e-22
 Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 6/108 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQG 84
            +L   + DG    P   L      +D E ++ L D+G D+N  +    RT LH+A    
Sbjct: 149 LQLEAENYDGH--TP---LHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQ 203

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
              V+ LLL+ GAD   +   G TPLG A+   N  + +LL  HGA  
Sbjct: 204 AASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPE 251

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 88.4 bits (220), Expect = 1e-20
 Identities = 30/115 (26%), Positives = 47/115 (40%), Gaps = 1/115 (0%)

Query: 19  PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALH 78
             R+  +  L    D   +       +      + E      D  + +   + D  T LH
Sbjct: 104 HPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLH 163

Query: 79  VAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           VA      E+V LL + GAD++  +   G TPL  A+  +   V++LL K GA P
Sbjct: 164 VAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADP 218

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 14/74 (18%), Positives = 26/74 (35%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ LL +G D   R    RT L  A  +    +  LL   GA          +P   +  
Sbjct: 208 LELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGS 267

Query: 116 YKNHEVIKLLEKHG 129
             + +     +++ 
Sbjct: 268 DSDSDNRDEGDEYD 281

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 74.5 bits (184), Expect = 2e-15
 Identities = 14/101 (13%), Positives = 24/101 (23%), Gaps = 14/101 (13%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   +   +++L  +G  V   +    TALH+A          +LL+         
Sbjct: 49  LHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDA 108

Query: 104 RWGSTPLGDAIYYKN--------------HEVIKLLEKHGA 130
                                        +E     E    
Sbjct: 109 SDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRL 149

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 90.9 bits (227), Expect = 2e-22
 Identities = 35/89 (39%), Positives = 46/89 (51%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L F A    V  ++ LL  G DV+ +D      LH A   G  EV  LL++ GA V+  D
Sbjct: 46  LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVAD 105

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            W  TPL +A     +E+ KLL +HGA P
Sbjct: 106 LWKFTPLHEAAAKGKYEICKLLLQHGADP 134

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 84.7 bits (211), Expect = 3e-20
 Identities = 28/72 (38%), Positives = 39/72 (54%), Gaps = 1/72 (1%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
           L+  G  VN  D+   T LH AA +G  E+  LLL+ GAD   K+R G+TPL D +   +
Sbjct: 94  LVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL-DLVKDGD 152

Query: 119 HEVIKLLEKHGA 130
            ++  LL    A
Sbjct: 153 TDIQDLLRGDAA 164

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 84.0 bits (209), Expect = 6e-20
 Identities = 35/88 (39%), Positives = 47/88 (53%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           L+  A   DVE +K+L     ++    +    T LH AA      VV  LL+ GADV  K
Sbjct: 12  LLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAK 71

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D+ G  PL +A  Y ++EV +LL KHGA
Sbjct: 72  DKGGLVPLHNACSYGHYEVAELLVKHGA 99

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 68.2 bits (168), Expect = 3e-14
 Identities = 20/69 (28%), Positives = 26/69 (37%), Gaps = 4/69 (5%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEV 121
           G   N    +    L  AA  G  E V  L      +    +   STPL  A  Y    V
Sbjct: 1   GAMGN---SEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSV 57

Query: 122 IKLLEKHGA 130
           ++ L +HGA
Sbjct: 58  VEYLLQHGA 66

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 46.6 bits (112), Expect = 1e-06
 Identities = 13/42 (30%), Positives = 18/42 (42%), Gaps = 1/42 (2%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA 97
            K LL  G D   ++ D  T L +    G T++  LL    A
Sbjct: 124 CKLLLQHGADPTKKNRDGNTPLDLVK-DGDTDIQDLLRGDAA 164

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 13/150 (8%)

Query: 175 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTE 230
             + AVK L ++ +           + E+ LL+++RH NV+Q +  +       +  V E
Sbjct: 30  LCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88

Query: 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           Y   G         +       A  +   +  G+ YLH      I+H+D++P N+L    
Sbjct: 89  YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145

Query: 290 GNLKVADFGVSKLL-TVKEDRPLTCQDTSC 318
           G LK++  GV++ L     D       TS 
Sbjct: 146 GTLKISALGVAEALHPFAADDTC---RTSQ 172

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 18/152 (11%)

Query: 175 GIQVAVKKLGEEVISD----DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIV 228
            + VA+K + ++ ISD     +  R    E+ LL+K+      V++ L    +    +++
Sbjct: 68  NLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126

Query: 229 TEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
            E   P  DL  F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 183

Query: 288 -DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
            + G LK+ DFG   LL    D          
Sbjct: 184 LNRGELKLIDFGSGALLK---DTVY---TDFD 209

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 90.5 bits (226), Expect = 2e-22
 Identities = 33/87 (37%), Positives = 51/87 (58%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A     + ++ L+ +G DVN  D    T LH+AA  G  E+V +LL+ GADV+  D
Sbjct: 18  LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVD 77

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A  + + E++++L K+GA
Sbjct: 78  HAGMTPLRLAALFGHLEIVEVLLKNGA 104

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 89.7 bits (224), Expect = 5e-22
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 5/105 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N  D  G    P   L   A    +E ++ LL +G DVN  D    T L +AA  G 
Sbjct: 38  ADVNAEDASGW--TP---LHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGH 92

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            E+V +LL+ GADV+  D  G TPL  A  + + E++++L K+GA
Sbjct: 93  LEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGA 137

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 88.6 bits (221), Expect = 2e-21
 Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 5/103 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +D  G    P   L   A    +E ++ LL +G DVN  D++  T LH+AA  G 
Sbjct: 71  ADVNAVDHAGM--TP---LRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGH 125

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
            E+V +LL+ GADV+ +D++G T    +I   N ++ ++L+K 
Sbjct: 126 LEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL 168

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 73.9 bits (183), Expect = 4e-16
 Identities = 22/61 (36%), Positives = 34/61 (55%)

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
             D    L  AA  G  + V +L+  GADV+ +D  G TPL  A +  + E++++L K+G
Sbjct: 11  GSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNG 70

Query: 130 A 130
           A
Sbjct: 71  A 71

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 90.2 bits (225), Expect = 3e-22
 Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 2/88 (2%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           L   A   DV+ ++ LL    +  +  +   +TAL V    G T +   LL++GA  + +
Sbjct: 6   LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ 64

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D  G++P+ DA      + +K+L +HGA
Sbjct: 65  DTSGTSPVHDAARTGFLDTLKVLVEHGA 92

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 88.6 bits (221), Expect = 1e-21
 Identities = 23/73 (31%), Positives = 36/73 (49%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
             ELL  G   N +D    + +H AA  GF + + +L+E GADV+  D  G+ P+  A+ 
Sbjct: 51  ALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQ 110

Query: 116 YKNHEVIKLLEKH 128
             +  V+  L   
Sbjct: 111 EGHTAVVSFLAAE 123

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 84.0 bits (209), Expect = 4e-20
 Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 6/103 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  N  D  G    P   +   A    ++ +K L++ G DVN  D      +H+A  +G 
Sbjct: 59  ASPNVQDTSGT--SP---VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGH 113

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
           T VVS L    +D+  +D  G TPL  A+     +++ +L+ H
Sbjct: 114 TAVVSFLAA-ESDLHRRDARGLTPLELALQRGAQDLVDILQGH 155

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 62.4 bits (153), Expect = 3e-12
 Identities = 17/60 (28%), Positives = 24/60 (40%), Gaps = 4/60 (6%)

Query: 75  TALHVAACQGFTEVV-SLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGAKP 132
             L  AA +G  + V  LL       D  +R+G T L   ++      +   L K GA P
Sbjct: 4   DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMF--GSTAIALELLKQGASP 61

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 91.4 bits (228), Expect = 3e-22
 Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           L+  AN+RD + +KE+L      V+  D +  T L++A      E+   L++RGAD++ +
Sbjct: 9   LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           +    +P   A      E++  + KH  
Sbjct: 69  NSISDSPYLYAGAQGRTEILAYMLKHAT 96

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 81.0 bits (201), Expect = 2e-18
 Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 44  LMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAAC-----QGFTEVVSLLLERGA 97
           L+  A +  ++ +K LL+ G  D++F++    TAL  A       Q + ++V LL+E GA
Sbjct: 110 LIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGA 169

Query: 98  DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
           D   KD  G T +  A      E+ K+L ++
Sbjct: 170 DQSIKDNSGRTAMDYANQKGYTEISKILAQY 200

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 77.5 bits (192), Expect = 3e-17
 Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 7/82 (8%)

Query: 56  IKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPLGDA 113
           +  +L     D+N  +     AL  AA +G  + V LLLE G  D+D ++ +G T L +A
Sbjct: 88  LAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEA 147

Query: 114 IYY----KNH-EVIKLLEKHGA 130
           +      + + +++KLL ++GA
Sbjct: 148 VGLREGNQLYQDIVKLLMENGA 169

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 75.9 bits (188), Expect = 1e-16
 Identities = 17/62 (27%), Positives = 28/62 (45%)

Query: 69  RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
           +  +    L  A  +   +V  +L +    VD  D  G+TPL  A++  + E+ K L   
Sbjct: 2   KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61

Query: 129 GA 130
           GA
Sbjct: 62  GA 63

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 93.8 bits (234), Expect = 3e-22
 Identities = 37/146 (25%), Positives = 75/146 (51%), Gaps = 19/146 (13%)

Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           VA+K++    EE         A R E++L+++++H N+V+    +   + + +V E++  
Sbjct: 33  VALKEVKLDSEEGTP----STAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87

Query: 235 GDLRAFLK------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            DL+ ++           L+ +    F   + +G+ + HENK   I+HRDL+P N+L + 
Sbjct: 88  -DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINK 143

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQ 314
            G LK+ DFG+++   +      + +
Sbjct: 144 RGQLKLGDFGLARAFGI-PVNTFSSE 168

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 92.3 bits (230), Expect = 3e-22
 Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 6/107 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQG 84
            +++ +D++G        L+F+A     + ++ L ++G D++ RD+    TALH+AA   
Sbjct: 68  RDVDAVDENGR--TA---LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYV 122

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
             EVV  L+E GAD++ +D  G T L  A             + G +
Sbjct: 123 RPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 169

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 89.6 bits (223), Expect = 3e-21
 Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
               A + D + + +LL    DV+  D + RTAL   A  G  + V LL E GAD+D +D
Sbjct: 49  WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 107

Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            R G T L  A  Y   EV++ L + GA  
Sbjct: 108 MRGGLTALHMAAGYVRPEVVEALVELGADI 137

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 73.0 bits (180), Expect = 3e-15
 Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 3/87 (3%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A     E ++ L++ G D+   D    TAL +A     T      ++ G  +  + 
Sbjct: 115 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 174

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                 + +   ++  EV +++EK G 
Sbjct: 175 ---VINVLEGQVFEYAEVDEIVEKRGK 198

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 57.6 bits (140), Expect = 6e-10
 Identities = 9/69 (13%), Positives = 17/69 (24%), Gaps = 4/69 (5%)

Query: 64  IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           I  +    +      +    G +          ADV  +     TP   A    + + + 
Sbjct: 6   IIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQALS 62

Query: 124 LLEKHGAKP 132
            L       
Sbjct: 63  QL-LEDRDV 70

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 49.5 bits (119), Expect = 3e-07
 Identities = 12/106 (11%), Positives = 27/106 (25%), Gaps = 16/106 (15%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++   D+ G        L               +  G  +    +     +       +
Sbjct: 135 ADIEVEDERGL--TA---LELAREILKTTPKGNPMQFGRRIGLEKV---INVLEGQVFEY 186

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            EV  ++ +RG         G        +    +   +   H A+
Sbjct: 187 AEVDEIVEKRGK--------GKDVEYLVRWKDGGDCEWVKGVHVAE 224

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 44.1 bits (105), Expect = 2e-05
 Identities = 4/48 (8%), Positives = 14/48 (29%), Gaps = 2/48 (4%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
             ++  +    +   ++   +   +   +     A+   KD      L
Sbjct: 189 VDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD--YEDGL 234

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 90.9 bits (226), Expect = 3e-22
 Identities = 19/120 (15%), Positives = 36/120 (30%), Gaps = 18/120 (15%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANE------RDVEGIKELLDSGIDVNFRDIDNRTALHV 79
           A++     +G           L            E  K  L+ G D+       +  +  
Sbjct: 66  ADIKSRTKEGT--TL---FFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFK 120

Query: 80  AACQGFTEVVS-------LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
                F +          +  + G  +  KD+WG T L      +    +K++E +  K 
Sbjct: 121 NIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKY 180

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 72.8 bits (179), Expect = 1e-15
 Identities = 16/96 (16%), Positives = 34/96 (35%), Gaps = 9/96 (9%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN---RTALHVAACQGFTEVVSLLLERGADVD 100
           +   A     E   EL + G +     + +      L     +   ++   L+ +GAD+ 
Sbjct: 10  VSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIK 69

Query: 101 PKDRWGSTPLGDAIYYKNH------EVIKLLEKHGA 130
            + + G+T          +      E+ K+  + GA
Sbjct: 70  SRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 10/85 (11%), Positives = 25/85 (29%), Gaps = 12/85 (14%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE-------LLDSGIDVNFRDIDNRTALH 78
           A++  L    +       +        V+  +           SG+ +  +D    TAL 
Sbjct: 105 ADITALYKPYK--IV---VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALE 159

Query: 79  VAACQGFTEVVSLLLERGADVDPKD 103
                     + ++ +     + K+
Sbjct: 160 FVKRCQKPIALKMMEDYIKKYNLKE 184

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 50.8 bits (122), Expect = 7e-08
 Identities = 12/63 (19%), Positives = 20/63 (31%), Gaps = 3/63 (4%)

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
           +     +  AA  G  E    L E+G +      K       L +      +++   L  
Sbjct: 4   MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63

Query: 128 HGA 130
            GA
Sbjct: 64  KGA 66

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 89.4 bits (223), Expect = 3e-22
 Identities = 32/87 (36%), Positives = 50/87 (57%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A     + ++ L+ +G DVN +D    T L++A   G  E+V +LL+ GADV+  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVD 77

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A +  + E+ ++L KHGA
Sbjct: 78  AIGFTPLHLAAFIGHLEIAEVLLKHGA 104

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 85.1 bits (212), Expect = 1e-20
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N  D+ G    P   L        +E ++ LL +G DVN  D    T LH+AA  G 
Sbjct: 38  ADVNAKDEYGL--TP---LYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGH 92

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
            E+  +LL+ GADV+ +D++G T    +I   N ++ ++L+K 
Sbjct: 93  LEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKL 135

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 71.6 bits (177), Expect = 1e-15
 Identities = 23/59 (38%), Positives = 35/59 (59%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D    L  AA  G  + V +L+  GADV+ KD +G TPL  A  + + E++++L K+GA
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGA 71

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 89.0 bits (222), Expect = 3e-22
 Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 1/76 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
            + LL  G + N  D    T  +H AA +GF + + +L   GA +D  D WG  P+  A 
Sbjct: 60  AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAE 119

Query: 115 YYKNHEVIKLLEKHGA 130
              + ++ + L     
Sbjct: 120 EQGHRDIARYLHAATG 135

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 87.5 bits (218), Expect = 2e-21
 Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 7/106 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             ++ L    +       L   A    VE +++LL++G D N  +   R  + V    G 
Sbjct: 3   PGIHMLGGSSD--AG---LATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGS 56

Query: 86  TEVVSLLLERGADVDPKDRWGST-PLGDAIYYKNHEVIKLLEKHGA 130
            +V  LLL  GA+ +  D    T P+ DA      + + +L + GA
Sbjct: 57  AQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGA 102

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 84.0 bits (209), Expect = 3e-20
 Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 3/71 (4%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EV 121
              ++     +   L  AA +G  E V  LLE GAD +  +R+G  P+   +      +V
Sbjct: 2   SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM--GSAQV 59

Query: 122 IKLLEKHGAKP 132
            +LL  HGA+P
Sbjct: 60  AELLLLHGAEP 70

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 59.0 bits (144), Expect = 4e-11
 Identities = 16/73 (21%), Positives = 28/73 (38%), Gaps = 4/73 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           AE N  D      +P   +   A E  ++ +  L  +G  ++  D   R  + +A  QG 
Sbjct: 68  AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGH 123

Query: 86  TEVVSLLLERGAD 98
            ++   L     D
Sbjct: 124 RDIARYLHAATGD 136

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 90.2 bits (225), Expect = 5e-22
 Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
               A + D + + +LL    DV+  D + RTAL   A  G  + V LL E GAD+D +D
Sbjct: 48  WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 106

Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            R G T L  A  Y   EV++ L + GA  
Sbjct: 107 MRGGLTALHMAAGYVRPEVVEALVELGADI 136

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 88.7 bits (221), Expect = 2e-21
 Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 10/109 (9%)

Query: 26  AELNGLDDDGEEIKPEFR--LMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAAC 82
            +++ +D++G       R  L+F+A     + ++ L ++G D++ RD+    TALH+AA 
Sbjct: 67  RDVDAVDENG-------RTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
               EVV  L+E GAD++ +D  G T L  A             + G +
Sbjct: 120 YVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 168

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 61.7 bits (151), Expect = 1e-11
 Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 17/85 (20%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A     E ++ L++ G D+   D    TAL +A     T      ++ G  +  + 
Sbjct: 114 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 173

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKH 128
                            VI +LE  
Sbjct: 174 -----------------VINVLEGQ 181

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 59.0 bits (144), Expect = 9e-11
 Identities = 9/69 (13%), Positives = 18/69 (26%), Gaps = 4/69 (5%)

Query: 62  SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
           + I  +    +      +    G +          ADV  +     TP   A    + + 
Sbjct: 3   NKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQA 59

Query: 122 IKLLEKHGA 130
           +  L     
Sbjct: 60  LSQL-LEDR 67

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 91.7 bits (229), Expect = 5e-22
 Identities = 21/105 (20%), Positives = 36/105 (34%), Gaps = 19/105 (18%)

Query: 47  LANERDVEG-------------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
           +A   D +G                   +      G +++  +   +T LH+A       
Sbjct: 1   MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60

Query: 88  VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           VV LL+  GA     DR G T    A  +++   ++ L    A  
Sbjct: 61  VVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPG 105

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 89.8 bits (224), Expect = 3e-21
 Identities = 22/87 (25%), Positives = 39/87 (44%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+       +  ++ LL  G +VN +     +ALH A+ +G   +V  L+  GAD   K+
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 213

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               TPL  A   +  ++++      A
Sbjct: 214 CHNDTPLMVARSRRVIDILRGKATRPA 240

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 87.1 bits (217), Expect = 3e-20
 Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 1/78 (1%)

Query: 56  IKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
           ++ LL+ G D++  DI + R+ L  A       +V LLL+ GA+V+ +   GS+ L  A 
Sbjct: 132 VQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSAS 191

Query: 115 YYKNHEVIKLLEKHGAKP 132
                 +++ L + GA  
Sbjct: 192 GRGLLPLVRTLVRSGADS 209

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 84.0 bits (209), Expect = 3e-19
 Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 9/109 (8%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            EL+  ++  +   P   L           ++ L+ +G      D   +TA H+A     
Sbjct: 37  RELDIYNNLRQ--TP---LHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRS 91

Query: 86  TEVVSLLLERGA----DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              +  LL+  A    D++ ++  G T L  A+  +  E ++LL + GA
Sbjct: 92  PTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGA 140

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 84.0 bits (209), Expect = 3e-19
 Identities = 39/110 (35%), Positives = 53/110 (48%), Gaps = 10/110 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG----IDVNFRDIDNRTALHVAA 81
           A    LD  G+              R    ++ LLDS     +D+  R+ D  TALHVA 
Sbjct: 70  ASPMALDRHGQ--TA---AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAV 124

Query: 82  CQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGA 130
                E V LLLERGAD+D  D   G +PL  A+   +  +++LL +HGA
Sbjct: 125 NTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGA 174

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 91.7 bits (229), Expect = 5e-22
 Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 1/90 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           ++        E  +EL+++G DV   D +N T LH AA     ++V   + +GA VD   
Sbjct: 13  IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72

Query: 104 R-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               STPL  A    +  ++  L K+GA P
Sbjct: 73  GDLNSTPLHWATRQGHLSMVVQLMKYGADP 102

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 89.0 bits (222), Expect = 5e-21
 Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 3/84 (3%)

Query: 49  NERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
           +  D    + LL   + VN  D     TALH A   G T V+SLLLE GA+VD ++  G 
Sbjct: 154 HSVDP--TRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGE 211

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAK 131
           + L  A   KN  +I  L++    
Sbjct: 212 SALDLAKQRKNVWMINHLQEARQA 235

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 85.6 bits (213), Expect = 8e-20
 Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 1/76 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           + +L+  G D +  D +  + +H+AA  G T +V+ L+ +G DVD  D+ G TPL  A Y
Sbjct: 92  VVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAY 151

Query: 116 YKNH-EVIKLLEKHGA 130
             +  +  +LL     
Sbjct: 152 RTHSVDPTRLLLTFNV 167

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 85.6 bits (213), Expect = 9e-20
 Identities = 28/134 (20%), Positives = 49/134 (36%), Gaps = 16/134 (11%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQG 84
            ++   D +         L + A    ++ +K  +  G  V+    D N T LH A  QG
Sbjct: 33  YDVRQPDKENV--TL---LHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQG 87

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLM 134
              +V  L++ GAD    D  G + +  A  + +  ++  L   G            PLM
Sbjct: 88  HLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLM 147

Query: 135 APMHVKHAREVPEY 148
              +  H+ +    
Sbjct: 148 WAAYRTHSVDPTRL 161

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 83.6 bits (208), Expect = 4e-19
 Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 7/107 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+ + +D +G        +   A       +  L+  G DV+  D +  T L  AA +  
Sbjct: 100 ADPSLIDGEGC--SC---IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTH 154

Query: 86  T-EVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGA 130
           + +   LLL     V+  D++  +T L  A+   N  VI LL + GA
Sbjct: 155 SVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 201

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 78.2 bits (194), Expect = 3e-17
 Identities = 16/65 (24%), Positives = 24/65 (36%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
           +   D  +   +  A   G  E    L+E G DV   D+   T L  A      +++K  
Sbjct: 2   MTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYY 61

Query: 126 EKHGA 130
              GA
Sbjct: 62  ISKGA 66

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 57.4 bits (140), Expect = 7e-10
 Identities = 12/60 (20%), Positives = 27/60 (45%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L +     +   I  LL++G +V+ ++I   +AL +A  +    +++ L E        +
Sbjct: 181 LHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDN 240

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 88.6 bits (221), Expect = 5e-22
 Identities = 40/75 (53%), Positives = 51/75 (68%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +K LL++G DVN +D + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A  
Sbjct: 18  VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAAR 77

Query: 116 YKNHEVIKLLEKHGA 130
             + EV+KLL + GA
Sbjct: 78  NGHLEVVKLLLEAGA 92

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 88.2 bits (220), Expect = 7e-22
 Identities = 40/74 (54%), Positives = 50/74 (67%)

Query: 57  KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
           K LL++G DVN +D + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A   
Sbjct: 52  KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 111

Query: 117 KNHEVIKLLEKHGA 130
            + EV+KLL + GA
Sbjct: 112 GHLEVVKLLLEAGA 125

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 74.7 bits (185), Expect = 6e-17
 Identities = 32/59 (54%), Positives = 39/59 (66%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A    + EV+KLL + GA
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 53.9 bits (131), Expect = 2e-09
 Identities = 24/42 (57%), Positives = 30/42 (71%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA 97
           +K LL++G DVN +D + RT LH+AA  G  EVV LLLE GA
Sbjct: 84  VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 92.2 bits (230), Expect = 6e-22
 Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 2/87 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
             +   + +V  +  LL++G   N  +  N   LH AA    T++V +LL  G D    D
Sbjct: 35  SYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFD 92

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G+T L  A+   N + +KL  K   
Sbjct: 93  DKGNTALYYAVDSGNMQTVKLFVKKNW 119

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 89.5 bits (223), Expect = 8e-21
 Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 3/85 (3%)

Query: 48  ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
            N    + +K  L S  D    D+   +A + A       +V  LL  GA  +  +    
Sbjct: 7   INTWKSKQLKSFL-SSKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NE 63

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
            PL  A   ++ +++K+L   G   
Sbjct: 64  FPLHQAATLEDTKIVKILLFSGLDD 88

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 87.2 bits (217), Expect = 4e-20
 Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   D + +K LL SG+D +  D    TAL+ A   G  + V L +++   +    
Sbjct: 66  LHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYG 125

Query: 104 RWG-STPLGDAIYYKNHEVIKLLEKHGA 130
           + G  T    A+   +  ++        
Sbjct: 126 KTGWKTSFYHAVMLNDVSIVSYFLSEIP 153

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 81.0 bits (201), Expect = 6e-18
 Identities = 18/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             L      G +              DV  +   L       F      + +H+    G 
Sbjct: 119 WRLMFYGKTGWKT-S---FYHAVMLNDVSIVSYFLSEI-PSTFDLAILLSCIHITIKNGH 173

Query: 86  TEVVSLLLERGADVDPKDRWGSTP-LGDAIYYKNHEVIKLLEKHGA 130
            +++ LLL+     +  +     P +  AI  K+ E+++ L K+  
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDI 219

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 77.2 bits (191), Expect = 2e-16
 Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 8/81 (9%)

Query: 53  VEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111
           V+ +  LLD     N  +       + +A      E++  L +   ++        +   
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIY-------SANL 226

Query: 112 DAIYYKNHEVIKLLEKHGAKP 132
           + +   + E+ K++ +   + 
Sbjct: 227 ENVLLDDAEIAKMIIEKHVEY 247

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 60.6 bits (148), Expect = 8e-11
 Identities = 11/97 (11%), Positives = 29/97 (29%), Gaps = 13/97 (13%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
              N  +           +    + +D+E ++ L    I++        +A         
Sbjct: 185 TSTNTNNSLLFIPD----IKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDD 233

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
            E+  +++E+  +           +      K  E+I
Sbjct: 234 AEIAKMIIEKHVEYKSDSYTKDLDI--VKNNKLDEII 268

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 92.0 bits (229), Expect = 1e-21
 Identities = 36/159 (22%), Positives = 75/159 (47%), Gaps = 13/159 (8%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +  +T   +I +G     +       G +VA++++    +    +     +E+ +++
Sbjct: 17  DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           + ++PN+V +L +      + +V EYL  G L   +      +   A     +  + + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH N+   +IHRD++  NIL    G++K+ DFG    +T
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.0 bits (229), Expect = 1e-21
 Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 10/163 (6%)

Query: 147 EYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
            Y+ + ++L+     E+  GT    +       G  +AVK++     + ++  R   D  
Sbjct: 19  RYQAEINDLENLG--EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLD 75

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
            +L+    P +VQ  G    ++ + I  E +     +   + +G +      +  + I +
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
            + YL E     +IHRD++PSNIL D+ G +K+ DFG+S  L 
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 90.4 bits (225), Expect = 1e-21
 Identities = 28/87 (32%), Positives = 46/87 (52%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  + E + + ++ ++    D +  + +  TALH A C G TE+V  L++ G +V+  D
Sbjct: 41  LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A    N +V K L + GA
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGA 127

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 83.8 bits (208), Expect = 4e-19
 Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 8/110 (7%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            + +  +D+G  I     L         E +K L+  G++VN  D D  T LH AA    
Sbjct: 61  DDPSLPNDEG--ITA---LHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNN 115

Query: 86  TEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +V   L+E GA V      D   +    + +     +  + L     K 
Sbjct: 116 VQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 165

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 82.7 bits (205), Expect = 1e-18
 Identities = 16/77 (20%), Positives = 33/77 (42%), Gaps = 1/77 (1%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           +   E +  G+ V F        L  ++ +G  ++V  ++    D    +  G T L +A
Sbjct: 19  KTGSERIAHGMRVKFNP-LPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNA 77

Query: 114 IYYKNHEVIKLLEKHGA 130
           +   + E++K L + G 
Sbjct: 78  VCAGHTEIVKFLVQFGV 94

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 67.3 bits (165), Expect = 3e-13
 Identities = 8/63 (12%), Positives = 19/63 (30%), Gaps = 1/63 (1%)

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
           +I  + +L         +  S  +  G  V          L D+      ++++ +    
Sbjct: 2   EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60

Query: 130 AKP 132
             P
Sbjct: 61  DDP 63

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 64.2 bits (157), Expect = 4e-12
 Identities = 25/124 (20%), Positives = 44/124 (35%), Gaps = 13/124 (10%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN---FRDIDNRTALHVAAC 82
             +N  D DG    P   L   A+  +V+  K L++SG  V    + D+           
Sbjct: 94  VNVNAADSDGW--TP---LHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEME 148

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142
           +G+T+    L      +   ++     L     Y+     +L  K G    M  +H +  
Sbjct: 149 EGYTQCSQFLYGVQEKMGIMNKGVIYAL---WDYEPQNDDELPMKEGDC--MTIIHREDE 203

Query: 143 REVP 146
            E+ 
Sbjct: 204 DEIE 207

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 90.4 bits (225), Expect = 1e-21
 Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 6/93 (6%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP- 101
           L+  A E DV+ + +LL   G +V+ R     TALH+AA     E   +L+E   ++   
Sbjct: 7   LLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFE 66

Query: 102 ----KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               +   G T L  A+  +N  +++ L   GA
Sbjct: 67  PMTSELYEGQTALHIAVINQNVNLVRALLARGA 99

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 78.8 bits (195), Expect = 2e-17
 Identities = 28/105 (26%), Positives = 40/105 (38%), Gaps = 17/105 (16%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN-------------RTALHVAACQGFTEVVS 90
           L      ++V  ++ LL  G  V+ R   +                L  AAC G  E+V 
Sbjct: 79  LHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR 138

Query: 91  LLLERGADVDPKDRWGSTPLGDAIYYKNHEV----IKLLEKHGAK 131
           LL+E GAD+  +D  G+T L   I   N         LL  +   
Sbjct: 139 LLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGG 183

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 76.9 bits (190), Expect = 9e-17
 Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 23/123 (18%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVA 80
            E++     GE       L   A   ++E    L+++  ++          + +TALH+A
Sbjct: 28  CEVHQRGAMGETA-----LHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIA 82

Query: 81  ACQGFTEVVSLLLERGADVDPKDR-------------WGSTPLGDAIYYKNHEVIKLLEK 127
                  +V  LL RGA V  +               +G  PL  A    + E+++LL +
Sbjct: 83  VINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIE 142

Query: 128 HGA 130
           HGA
Sbjct: 143 HGA 145

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 75.3 bits (186), Expect = 3e-16
 Identities = 22/97 (22%), Positives = 33/97 (34%), Gaps = 10/97 (10%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS----LLLERGADV 99
           L F A     E ++ L++ G D+  +D    T LH+   Q           LLL      
Sbjct: 125 LSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184

Query: 100 DPK------DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             K      +  G TP   A    N  + + L +   
Sbjct: 185 HLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRK 221

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 66.9 bits (164), Expect = 3e-13
 Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 1/67 (1%)

Query: 75  TALHVAACQGFTEVVS-LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
           + L +AA +   + +S LL   G +V  +   G T L  A  Y N E   +L +   + +
Sbjct: 5   SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELV 64

Query: 134 MAPMHVK 140
             PM  +
Sbjct: 65  FEPMTSE 71

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 89.0 bits (222), Expect = 2e-21
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)

Query: 46  FLANERDVEG---------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS 90
           FL N RD                  I +L+++   +  +DI+  TAL  A       +  
Sbjct: 26  FLRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAE 85

Query: 91  LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            LL +G++V+ KD  G TPL  +I +   E+   L +HGA
Sbjct: 86  KLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGA 125

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 88.6 bits (221), Expect = 2e-21
 Identities = 28/87 (32%), Positives = 47/87 (54%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L++      +   ++LL  G +VN +D   +T L  +   G++E+   LLE GA+V+ ++
Sbjct: 72  LIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRN 131

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A  Y   E++K L + GA
Sbjct: 132 LEGETPLIVASKYGRSEIVKKLLELGA 158

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 86.7 bits (216), Expect = 1e-20
 Identities = 30/87 (34%), Positives = 44/87 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           LM+       E    LL+ G +VN R+++  T L VA+  G +E+V  LLE GAD+  +D
Sbjct: 105 LMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARD 164

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G T    A  +   EVIK+  +   
Sbjct: 165 LTGLTAEASARIFGRQEVIKIFTEVRR 191

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 51.2 bits (124), Expect = 5e-08
 Identities = 9/64 (14%), Positives = 19/64 (29%), Gaps = 6/64 (9%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
           +  D +      +   +   + +  L         +D +  TPL  A        I  L 
Sbjct: 2   SHMDKNGEIVEKIKDEKSINQNLDFLRNY------RDSYNRTPLMVACMLGMENAIDKLV 55

Query: 127 KHGA 130
           ++  
Sbjct: 56  ENFD 59

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 47/191 (24%), Positives = 75/191 (39%), Gaps = 28/191 (14%)

Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
            P+ +    +   Y+            +I  G F    L   +     VAVK +      
Sbjct: 9   GPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGAA- 58

Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
            D+ V+  R E+   + +RHPN+V+F   +   + + I+ EY   G+L   +   G    
Sbjct: 59  IDENVQ--R-EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE 115

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307
             A  F   +  G++Y H  +   I HRDL+  N L D S    LK+ DFG SK      
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VL 170

Query: 308 DRPLTCQDTSC 318
                   ++ 
Sbjct: 171 HSQP---KSTV 178

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 13/162 (8%)

Query: 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           ++DP+E+ +    E+  G F   +       G   A K +       ++ +  +  E+ +
Sbjct: 14  DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEI 69

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARG 262
           L    HP +V+ LGA      + I+ E+ P G + A +           ++     +   
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           +N+LH  +   IIHRDL+  N+L    G++++ADFGVS    
Sbjct: 130 LNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 14/150 (9%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228
           G + AVK              ++   A R E  +L+++  HP+++  + +   SS M +V
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            + + KG+L  +L  K AL           +   +++LH N    I+HRDL+P NIL DD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           +  ++++DFG S    ++    L      C
Sbjct: 236 NMQIRLSDFGFSCH--LEPGEKLR---ELC 260

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 89.2 bits (222), Expect = 3e-21
 Identities = 26/108 (24%), Positives = 46/108 (42%), Gaps = 6/108 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SGIDVNFRDIDNRTALHVAACQG 84
             +NGLD  G        L +  +    + ++ L     I++N ++    TALH AA +G
Sbjct: 97  VGVNGLDKAGS--TA---LYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKG 151

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + ++V LLL +GA  D ++         A       ++K  +   A  
Sbjct: 152 YADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVR 199

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 79.6 bits (197), Expect = 8e-18
 Identities = 18/108 (16%), Positives = 39/108 (36%), Gaps = 11/108 (10%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           +E ++  + D  +            ++      +  L     V  +       LH AA +
Sbjct: 34  EEGDIIYITDMSDT-----NWWKGTSK-----GRTGLIPSNYVAEQAESIDNPLHEAAKR 83

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
           G    +   L+    V+  D+ GST L  A +  + ++++ L  +   
Sbjct: 84  GNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNI 131

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 70.7 bits (174), Expect = 1e-14
 Identities = 11/89 (12%), Positives = 24/89 (26%), Gaps = 5/89 (5%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +       +     EL     D+ +    + T       +G T ++         V  + 
Sbjct: 16  VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
                PL +A    N   ++    +    
Sbjct: 71  ESIDNPLHEAAKRGNLSWLRECLDNRVGV 99

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 69.2 bits (170), Expect = 5e-14
 Identities = 9/58 (15%), Positives = 20/58 (34%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           ++ LL  G   + R+I+ + A  +A       ++       A     +        D+
Sbjct: 156 VQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDS 213

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 50.7 bits (122), Expect = 9e-08
 Identities = 7/66 (10%), Positives = 12/66 (18%), Gaps = 5/66 (7%)

Query: 74  RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL-----EKH 128
           +  +  A           L     D+        T            +I         + 
Sbjct: 13  QVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQAES 72

Query: 129 GAKPLM 134
              PL 
Sbjct: 73  IDNPLH 78

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 87.1 bits (217), Expect = 3e-21
 Identities = 22/76 (28%), Positives = 35/76 (46%), Gaps = 1/76 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
            + LL  G + N  D    T  +H AA +GF + + +L   GA +D +D WG  P+  A 
Sbjct: 60  AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAE 119

Query: 115 YYKNHEVIKLLEKHGA 130
              + +V + L     
Sbjct: 120 ELGHRDVARYLRAAAG 135

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 83.7 bits (208), Expect = 7e-20
 Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 2/90 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    VE ++ LL++G + N  +   R  + V    G   V  LLL  GA+ +  D
Sbjct: 16  LATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCAD 74

Query: 104 RWGST-PLGDAIYYKNHEVIKLLEKHGAKP 132
               T P+ DA      + + +L + GA+ 
Sbjct: 75  PATLTRPVHDAAREGFLDTLVVLHRAGARL 104

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 74.8 bits (185), Expect = 1e-16
 Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 5/74 (6%)

Query: 60  LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           ++     +     +   L  AA +G  E V  LLE GA+ +  + +G  P+   +     
Sbjct: 1   MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMM--GS 56

Query: 120 -EVIKLLEKHGAKP 132
             V +LL  HGA+P
Sbjct: 57  ARVAELLLLHGAEP 70

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 66.0 bits (162), Expect = 2e-13
 Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 9/96 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           AE N  D      +P   +   A E  ++ +  L  +G  ++ RD   R  + +A   G 
Sbjct: 68  AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGH 123

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
            +V   L             GS            ++
Sbjct: 124 RDVARYLRAAAGGTR-----GSNHARIDAAEGPSDI 154

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 90.7 bits (226), Expect = 4e-21
 Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 14/150 (9%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G F    L   R  G   A+K + +     D  +    +E+A+L+KI+H N+V   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                ++   +V + +  G+L   +  +G      A      +   + YLHEN    I+H
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129

Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLL 303
           RDL+P N+L    +++  + + DFG+SK+ 
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKME 159

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 90.2 bits (224), Expect = 4e-21
 Identities = 26/134 (19%), Positives = 51/134 (38%), Gaps = 11/134 (8%)

Query: 172 FWRGI------QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           FW+ +      QVA+  +  + +  DD ++        L +I  P V + L  V   +  
Sbjct: 47  FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106

Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           ++V E++  G L+       +  P  A+R    +A   +  H      +      PS + 
Sbjct: 107 LVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVR 161

Query: 286 RDDSGNLKVADFGV 299
               G++ +A    
Sbjct: 162 VSIDGDVVLAYPAT 175

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 90.5 bits (225), Expect = 4e-21
 Identities = 40/170 (23%), Positives = 69/170 (40%), Gaps = 18/170 (10%)

Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           D+     I  G   +        +  +VA+K++  E       +     E+  + +  HP
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHP 73

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA-LDIA-------RG 262
           N+V +  +      + +V + L  G +   +K   A     +       IA        G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           + YLH+N     IHRD++  NIL  + G++++ADFGVS  L    D    
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 90.5 bits (225), Expect = 5e-21
 Identities = 37/159 (23%), Positives = 70/159 (44%), Gaps = 13/159 (8%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP  L   + V+I +G+  +         G QVAVK +    +    R     +E+ +++
Sbjct: 42  DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
             +H NVV+   +      + ++ E+L  G L   +  +  L           + + + Y
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAY 156

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH      +IHRD++  +IL    G +K++DFG    ++
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 90.3 bits (224), Expect = 6e-21
 Identities = 28/141 (19%), Positives = 56/141 (39%), Gaps = 6/141 (4%)

Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
             +  +  +S    + A   ++  +      N V  L   +    + I  +   K +L+ 
Sbjct: 91  KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150

Query: 240 FLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           ++ R+ +L+       +   + IA  + +LH      ++HRDL+PSNI       +KV D
Sbjct: 151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 207

Query: 297 FGVSKLLTVKEDRPLTCQDTS 317
           FG+   +   E+         
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMP 228

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 90.2 bits (224), Expect = 8e-21
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 9/159 (5%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L F++  EI  G+F   +          VA+KK+       +++ +    E+  LQ
Sbjct: 51  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           K+RHPN +Q+ G   +     +V EY            K  L+            +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           LH +    +IHRD++  NIL  + G +K+ DFG + ++ 
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 88.4 bits (220), Expect = 8e-21
 Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 1/91 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
           L   +    +  ++ L+  G DVN ++  N RTALH+A      ++VSLLL+ GADV+  
Sbjct: 121 LHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRV 180

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
              G +P        +  + + L +   + L
Sbjct: 181 TYQGYSPYQLTWGRPSTRIQQQLGQLTLENL 211

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 86.8 bits (216), Expect = 2e-20
 Identities = 21/87 (24%), Positives = 38/87 (43%)

Query: 50  ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
              +E I+++      +NF++   +T LH+A      E+   LL  G D + +D  G+TP
Sbjct: 22  ALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTP 81

Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136
           L  A        + +L +    P +  
Sbjct: 82  LHLACEQGCLASVGVLTQSCTTPHLHS 108

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 82.2 bits (204), Expect = 1e-18
 Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 12/114 (10%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHV 79
            +    D  G    P   L     +  +  +  L  S         +   + +  T LH+
Sbjct: 69  CDPELRDFRGN--TP---LHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHL 123

Query: 80  AACQGFTEVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           A+  G+  +V LL+  GADV+ ++   G T L  A+  +N +++ LL K GA  
Sbjct: 124 ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADV 177

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 65.6 bits (161), Expect = 9e-13
 Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 4/67 (5%)

Query: 70  DIDNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
             D  + LH+A          EV+  +    A ++ ++    TPL  A+     E+ + L
Sbjct: 5   TEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEAL 64

Query: 126 EKHGAKP 132
              G  P
Sbjct: 65  LGAGCDP 71

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 64.1 bits (157), Expect = 4e-12
 Identities = 9/66 (13%), Positives = 17/66 (25%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +  LL  G DVN       +   +   +  T +   L +   +                 
Sbjct: 167 VSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEESYDTE 226

Query: 116 YKNHEV 121
            +  E 
Sbjct: 227 SEFTEF 232

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 89.2 bits (222), Expect = 9e-21
 Identities = 33/141 (23%), Positives = 66/141 (46%), Gaps = 9/141 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +    E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 31  GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 90  GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146

Query: 292 LKVADFGVSKLLTVKEDRPLT 312
           +K+ADFG++    V +     
Sbjct: 147 VKLADFGLAIE--VNDSEAWH 165

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 89.7 bits (223), Expect = 9e-21
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 15/160 (9%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
            P E+ F    ++ +G++   +       G  VA+K      +  +  ++    E++++Q
Sbjct: 26  QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQ 79

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           +   P+VV++ G+  +++ + IV EY   G +   ++ R   L             +G+ 
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           YLH  +    IHRD++  NIL +  G+ K+ADFGV+  LT
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 90.1 bits (224), Expect = 9e-21
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 16/168 (9%)

Query: 147 EYEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
            ++    +L      EI +G +     ++    G  +AVK++   V  + ++ +   D  
Sbjct: 16  HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLD 72

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-----AVRFA 256
            +++    P +VQF GA+ +     I  E +       F K   ++           +  
Sbjct: 73  VVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           L   + +N+L EN    IIHRD++PSNIL D SGN+K+ DFG+S  L 
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 89.2 bits (222), Expect = 9e-21
 Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 11/141 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            I+ A KK+ +  + D DR +    E+ +++ + HPN+++       ++ + +V E    
Sbjct: 34  RIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  K   + S A R   D+   + Y H+     + HRDL+P N L         
Sbjct: 91  GELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSP 147

Query: 292 LKVADFGVSKLLTVKEDRPLT 312
           LK+ DFG++     K  + + 
Sbjct: 148 LKLIDFGLAAR--FKPGKMMR 166

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 37/165 (22%), Positives = 74/165 (44%), Gaps = 13/165 (7%)

Query: 148 YEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
            E+   +L+     E+ +G +     +     G  +AVK++   V +  ++ R   D   
Sbjct: 2   MEVKADDLEPIM--ELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDI 58

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFALDI 259
            ++ +  P  V F GA+ +   + I  E +        +  + +   +      + A+ I
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
            + + +LH      +IHRD++PSN+L +  G +K+ DFG+S  L 
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 1/78 (1%)

Query: 55  GIKELLD-SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           G   + D   ++    D +N   +HVAA +G T+ V  L+E G     ++R+G T L  A
Sbjct: 1   GPGSMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLA 60

Query: 114 IYYKNHEVIKLLEKHGAK 131
             +   +  K L   G  
Sbjct: 61  CKFGCVDTAKYLASVGEV 78

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 20/111 (18%), Positives = 41/111 (36%), Gaps = 5/111 (4%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +   A +   + ++ L+++G+    ++    TALH+A   G  +    L   G       
Sbjct: 24  IHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH 83

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV---KHAREVPEYEID 151
             G  P+  A+     +++  L +   +    P  +      REV E    
Sbjct: 84  --GQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSH 132

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 88.0 bits (219), Expect = 6e-20
 Identities = 24/125 (19%), Positives = 47/125 (37%), Gaps = 10/125 (8%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-----GIDVNFRDIDNRTALHVA 80
           A     D   E   P   LM     R+ E +  ++D+      + +++ +    + LH A
Sbjct: 164 ASPTAKDKADE--TP---LMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWA 218

Query: 81  ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
               + +V    +E G DV+ +D   + PL  ++      + K L +     L+      
Sbjct: 219 ILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYH 278

Query: 141 HAREV 145
           +   V
Sbjct: 279 NGTTV 283

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 84.9 bits (211), Expect = 7e-19
 Identities = 14/86 (16%), Positives = 23/86 (26%)

Query: 47  LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
           L              +G  V    +     +  AA     EV+ LL E+  +V      G
Sbjct: 264 LQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTG 323

Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132
           +             V ++     A  
Sbjct: 324 AGGAVKRKKKAAPAVKRMKLAPSAPV 349

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 5/82 (6%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-----GADVDPKDRWGSTPL 110
           IK L+  G     +D  + T L  A      E + L+++         +D  ++ G++ L
Sbjct: 156 IKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHL 215

Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
             AI     +V     + G   
Sbjct: 216 HWAILINWEDVAMRFVEMGIDV 237

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 7/75 (9%)

Query: 63  GIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
            I  + +    +TALH     G  + E++ +L++ GA    KD+   TPL  A+ ++N E
Sbjct: 128 EIGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNRE 187

Query: 121 VIKLL-----EKHGA 130
            + L+      K   
Sbjct: 188 ALDLMMDTVPSKSSL 202

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 71.4 bits (176), Expect = 3e-14
 Identities = 13/100 (13%), Positives = 29/100 (29%), Gaps = 2/100 (2%)

Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+++       +     NG     + +     +   A+    E ++ L +   +V    
Sbjct: 263 LLQKT--DVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSL 320

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
                       +    V  + L   A V  + R  +   
Sbjct: 321 NTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSS 360

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 55.3 bits (134), Expect = 7e-09
 Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 14/91 (15%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +         + +  L++   +        +    +       EV             K 
Sbjct: 88  IHLAVMANKTDLVVALVEGAKE------RGQMPESLLNECDEREVN------EIGSHVKH 135

Query: 104 RWGSTPLGDAIYY-KNH-EVIKLLEKHGAKP 132
             G T L   +     + E+IK+L + GA P
Sbjct: 136 CKGQTALHWCVGLGPEYLEMIKILVQLGASP 166

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 40.6 bits (96), Expect = 4e-04
 Identities = 6/43 (13%), Positives = 13/43 (30%)

Query: 90  SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           S+      +    D      +  A      + ++ L + G  P
Sbjct: 4   SMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSP 46

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 41/151 (27%), Positives = 66/151 (43%), Gaps = 15/151 (9%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVR-AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227
             + AVK       G     +   +R A   E+ +L+K+  HPN++Q       ++   +
Sbjct: 42  CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101

Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           V + + KG+L  +L  K  L      +    +   +  LH+     I+HRDL+P NIL D
Sbjct: 102 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158

Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           D  N+K+ DFG S    +     L      C
Sbjct: 159 DDMNIKLTDFGFSCQ--LDPGEKLR---EVC 184

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 89.3 bits (222), Expect = 1e-20
 Identities = 43/154 (27%), Positives = 62/154 (40%), Gaps = 20/154 (12%)

Query: 175 GIQVAVKKLG----EEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAVTQSSPMM 226
            +QVA+K +            D V     E+ALL K+     HP V++ L         M
Sbjct: 56  RLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114

Query: 227 IVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +V E  LP  DL  ++  KG L    +  F   +   + + H      ++HRD++  NIL
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENIL 171

Query: 286 RD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
            D   G  K+ DFG   LL    D P        
Sbjct: 172 IDLRRGCAKLIDFGSGALL---HDEPY---TDFD 199

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 88.4 bits (220), Expect = 2e-20
 Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 9/141 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             + AVK + +    + D       E+ LL+K+ HPN+++    +  SS   IV E    
Sbjct: 47  QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162

Query: 292 LKVADFGVSKLLTVKEDRPLT 312
           +K+ DFG+S     +++  + 
Sbjct: 163 IKIIDFGLSTC--FQQNTKMK 181

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 87.1 bits (217), Expect = 2e-20
 Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 4/93 (4%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV--- 99
           L     E +   ++ELL S    +  +D D R  LH +      E+ S LL +  +V   
Sbjct: 6   LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 65

Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           D  D  G TP   A    N EV+K L     KP
Sbjct: 66  DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKP 98

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 85.2 bits (212), Expect = 9e-20
 Identities = 23/76 (30%), Positives = 35/76 (46%), Gaps = 3/76 (3%)

Query: 58  ELL---DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
           + L       D+N       T LH+A  + + EV   L+E GA V  KD++   PL  A 
Sbjct: 89  KSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAA 148

Query: 115 YYKNHEVIKLLEKHGA 130
              + ++I+LL   G 
Sbjct: 149 SVGSLKLIELLCGLGK 164

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 84.8 bits (211), Expect = 1e-19
 Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 7/109 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            +LN + + G        L     ++  E  + L+++G  V  +D  N+  LH AA  G 
Sbjct: 98  PDLNKITNQGV--TC---LHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGS 152

Query: 86  TEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLL-EKHGAKP 132
            +++ LL   G + V+ +D+ G TPL  A+   + +   LL EK+GA+ 
Sbjct: 153 LKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEY 201

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 81.7 bits (203), Expect = 2e-18
 Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 10/110 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI---DNRTALHVAAC 82
           + L   D DG    P   L +  + +  E    LL    +VN  D       T  H+A  
Sbjct: 27  SLLLQKDQDGR--IP---LHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACS 81

Query: 83  QGFTEVVSLLLER--GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            G  EVV  L +R    D++     G T L  A+  K  EV + L ++GA
Sbjct: 82  VGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGA 131

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 72.1 bits (178), Expect = 4e-15
 Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 10/105 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQG 84
           A +   D   +   P   L   A+   ++ I+ L   G   VN++D    T L  A  +G
Sbjct: 131 ASVRIKDKFNQ--IP---LHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEG 185

Query: 85  FTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
             +   LL+E+ GA+ D  D  G+          N +V K    +
Sbjct: 186 HGDAAVLLVEKYGAEYDLVDNKGAKAE---DVALNEQVKKFFLNN 227

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 70.2 bits (173), Expect = 2e-14
 Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 1/59 (1%)

Query: 73  NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           +   LH A  +  F +V  LL  + + +  KD+ G  PL  ++ ++ HE+   L     
Sbjct: 2   SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKME 60

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 40/193 (20%), Positives = 81/193 (41%), Gaps = 18/193 (9%)

Query: 132 PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKK 182
           P MA M            +      F+++ ++ +    G F        +  G++ A K 
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +  + +S  D  +    E  + +K++HPN+V+   ++ + S   +V + +  G+L   + 
Sbjct: 62  INTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGV 299
            +     + A      I   + Y H N    I+HR+L+P N+L   +     +K+ADFG+
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177

Query: 300 SKLLTVKEDRPLT 312
           +    V +     
Sbjct: 178 AIE--VNDSEAWH 188

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 86.5 bits (214), Expect = 3e-20
 Identities = 44/183 (24%), Positives = 67/183 (36%), Gaps = 11/183 (6%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           +  LA    ++ +KE + +        D D+RTALH A   G TE+V  LL+ G  V+ K
Sbjct: 10  ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL------MAPMHV---KHAREVPEYEIDPH 153
           D  G +PL  A      E++K L   GA           P+H    K+  E+    ++  
Sbjct: 70  DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLE-G 128

Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
             +              A  +G    V  L     S + +       L L          
Sbjct: 129 GANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA 188

Query: 214 QFL 216
           +FL
Sbjct: 189 KFL 191

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 73.4 bits (180), Expect = 2e-15
 Identities = 11/60 (18%), Positives = 23/60 (38%)

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + N    ++A      E+   +L   +     D+   T L  A    + E+++ L + G 
Sbjct: 5   VSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGV 64

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 70.3 bits (172), Expect = 2e-14
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 5/106 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A +N ++ +G        L + A++   E    LL+ G + + +D  + TA+H AA +G 
Sbjct: 97  AHVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGN 151

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            ++V +LL   A  + +D  G+TPL  A   +  E  K L   GA 
Sbjct: 152 LKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGAS 197

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 70.3 bits (172), Expect = 2e-14
 Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 7/107 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  +  D           +   A + +++ +  LL      N +D +  T LH+A  +  
Sbjct: 130 ANPDAKDHYDATA-----MHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEER 184

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            E    L+ +GA +  +++   TPL  A       +I      G + 
Sbjct: 185 VEEAKFLVTQGASIYIENKEEKTPLQVA--KGGLGLILKRLAEGEEA 229

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 7/75 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  N  D +G        L    +E  VE  K L+  G  +   + + +T L VA   G 
Sbjct: 163 ASTNIQDTEGNTP-----LHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GG 215

Query: 86  TEVVSLLLERGADVD 100
             ++   L  G +  
Sbjct: 216 LGLILKRLAEGEEAS 230

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 83.0 bits (206), Expect = 3e-20
 Identities = 28/75 (37%), Positives = 37/75 (49%), Gaps = 3/75 (4%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
              L+  G  +     D    L  AA  G  + V +L+  GADV  KD+ GSTPL  A  
Sbjct: 10  SSGLVPRGSHMG---SDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAAR 66

Query: 116 YKNHEVIKLLEKHGA 130
             + EV+KLL + GA
Sbjct: 67  NGHLEVVKLLLEAGA 81

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 79.9 bits (198), Expect = 5e-19
 Identities = 30/83 (36%), Positives = 48/83 (57%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A     + ++ L+ +G DV  +D +  T LH+AA  G  EVV LLLE GADV  +D
Sbjct: 28  LLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQD 87

Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
           ++G T    +I   N ++ ++L+
Sbjct: 88  KFGKTAFDISIDNGNEDLAEILQ 110

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 54.1 bits (131), Expect = 1e-09
 Identities = 9/51 (17%), Positives = 19/51 (37%), Gaps = 3/51 (5%)

Query: 80  AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            +        S L+ RG+ +          L +A      + +++L  +GA
Sbjct: 1   GSSHHHHHHSSGLVPRGSHMGSD---LGKKLLEAARAGQDDEVRILMANGA 48

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 23/110 (20%), Positives = 53/110 (48%), Gaps = 4/110 (3%)

Query: 26  AELNGLDDDGEEIKPEFR---LMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAA 81
           A+++      ++ +       L + A   ++  +K L+ + G + + +D D +T + +AA
Sbjct: 262 AKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAA 321

Query: 82  CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            +G  EVV  L+++GA V+  D    T    A    +H ++ + ++   +
Sbjct: 322 QEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPE 371

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 18/72 (25%), Positives = 33/72 (45%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
              KE + +G DVN  D D  T L +A       +V+ L++ GAD    ++   + L  A
Sbjct: 147 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 206

Query: 114 IYYKNHEVIKLL 125
              ++  ++  +
Sbjct: 207 AANRDFGMMVYM 218

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 81.9 bits (203), Expect = 8e-18
 Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 11/124 (8%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +D D     P   LM     R    +  L+ +G D    +   R+ALH AA    
Sbjct: 157 ADVNAMDCDEN--TP---LMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRD 211

Query: 86  TEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKNHEVI---KLLEKHGAKPLMAPMHV 139
             ++  +L       D++  DR G T L    + +  + +   KLL + GAK        
Sbjct: 212 FGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAAR 271

Query: 140 KHAR 143
           K + 
Sbjct: 272 KDSE 275

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 9/87 (10%)

Query: 53  VEGIKELLDSGIDVNFR--------DIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKD 103
           V   K L++ G  V++             RTALH AA      +V  L+ E+G++ D +D
Sbjct: 251 VASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQD 310

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TP+  A      EV+  L + GA
Sbjct: 311 EDGKTPIMLAAQEGRIEVVMYLIQQGA 337

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 9/83 (10%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL--------ERGADVDPKDRWGS 107
            + +    +++      NRT LH  A     E    L+          GADV+  D   +
Sbjct: 109 TEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDEN 167

Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
           TPL  A+  +   ++  L K GA
Sbjct: 168 TPLMLAVLARRRRLVAYLMKAGA 190

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 14/111 (12%), Positives = 29/111 (26%), Gaps = 7/111 (6%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
            + + N L          +         +         +       + ++   LH  A  
Sbjct: 50  IKRQRNELQHYSL-----YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEA-A 103

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
           G   +   +     ++    R   T L       + E  + L  H AK  +
Sbjct: 104 GSYAITEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECI 153

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 9/116 (7%), Positives = 26/116 (22%), Gaps = 5/116 (4%)

Query: 19  PDRERKEAELNGL----DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR 74
            +R RK   +N        + EE   +      +++  +             N     + 
Sbjct: 3   GNRTRKRRMINASVWMPPMENEEKNRKNHQSITSSQHSLLEASYDGYIKRQRNELQHYSL 62

Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                    G   +              +      L       ++ + + + +   
Sbjct: 63  YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEAAG-SYAITEPITRESV 117

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 5/75 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           +  +  D+DG+   P   +M  A E  +E +  L+  G  V   D  + TA  +A     
Sbjct: 304 SNKDKQDEDGK--TP---IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNH 358

Query: 86  TEVVSLLLERGADVD 100
             +V +      + +
Sbjct: 359 HNIVDIFDRCRPERE 373

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 46.5 bits (111), Expect = 5e-06
 Identities = 6/72 (8%), Positives = 18/72 (25%), Gaps = 9/72 (12%)

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           +     +     ++ +L  A+  G+ +            +    +   P        N  
Sbjct: 25  EKNRKNHQSITSSQHSLLEASYDGYIKRQ---------RNELQHYSLYPNPQGYGNGNDF 75

Query: 121 VIKLLEKHGAKP 132
           +      +   P
Sbjct: 76  LGDFNHTNLQIP 87

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 87.3 bits (217), Expect = 6e-20
 Identities = 35/147 (23%), Positives = 65/147 (44%), Gaps = 16/147 (10%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G++ A K     +                 E+++L+++ H NV+         + ++++ 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
           E +  G+L  FL +K +L    A  F   I  G+NYLH  K   I H DL+P NI+    
Sbjct: 95  ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLT 312
                ++K+ DFG++  +  ++     
Sbjct: 152 NIPIPHIKLIDFGLAHEI--EDGVEFK 176

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 88.4 bits (219), Expect = 6e-20
 Identities = 32/198 (16%), Positives = 67/198 (33%), Gaps = 18/198 (9%)

Query: 134 MAPMHVKHAREVPEYEI----DPHELDFTNSVEITKGTFILAF-WRGIQ------VAVKK 182
           MA  H  H   +    +          +     I KG   L              V V++
Sbjct: 1   MAHHHHHHMENLYFQGMSSFLPEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR 59

Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +  E  S++  V   + EL + +   HPN+V +       + + +VT ++  G  +  + 
Sbjct: 60  INLEACSNEM-VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118

Query: 243 --RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
                 +           + + ++Y+H       +HR ++ S+IL    G + ++    +
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175

Query: 301 KLLTVKEDRPLTCQDTSC 318
             +     R     D   
Sbjct: 176 LSMISHGQRQRVVHDFPK 193

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 87.7 bits (218), Expect = 8e-20
 Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 14/130 (10%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MMIVT 229
           VA+KK+  E   +   + A R E+ +LQ ++H NVV  +      +         + +V 
Sbjct: 45  VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103

Query: 230 EYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           ++    DL   L         S   R    +  G+ Y+H NK   I+HRD++ +N+L   
Sbjct: 104 DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR 159

Query: 289 SGNLKVADFG 298
            G LK+ADFG
Sbjct: 160 DGVLKLADFG 169

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.8 bits (218), Expect = 9e-20
 Identities = 37/126 (29%), Positives = 66/126 (52%), Gaps = 3/126 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + ++   + + VR    EL ++Q + HP +V    +      M +V + L  GDLR
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L++    K  T   F  ++   ++YL   +   IIHRD++P NIL D+ G++ + DF 
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160

Query: 299 VSKLLT 304
           ++ +L 
Sbjct: 161 IAAMLP 166

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.5 bits (215), Expect = 9e-20
 Identities = 33/145 (22%), Positives = 60/145 (41%), Gaps = 14/145 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++  +K + ++       +     E+ +L+ + HPN+++          M IV E    
Sbjct: 47  GLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104

Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RD 287
           G+L     +   R  AL           +   + Y H      ++H+DL+P NIL     
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTS 161

Query: 288 DSGNLKVADFGVSKLLTVKEDRPLT 312
               +K+ DFG+++L   K D   T
Sbjct: 162 PHSPIKIIDFGLAEL--FKSDEHST 184

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 36/147 (24%), Positives = 65/147 (44%), Gaps = 16/147 (10%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G + A K     +L                E+ +L++IRHPN++         + ++++ 
Sbjct: 30  GKEYAAKFIKKRRLSSSRRGVS--REEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
           E +  G+L  FL  K +L    A +F   I  G++YLH  +   I H DL+P NI+    
Sbjct: 88  ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDK 144

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLT 312
              +  +K+ DFG++  +  +      
Sbjct: 145 NVPNPRIKLIDFGIAHKI--EAGNEFK 169

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 8/141 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 51  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 167

Query: 292 LKVADFGVSKLLTVKEDRPLT 312
           +++ DFG+S     +  + + 
Sbjct: 168 IRIIDFGLSTH--FEASKKMK 186

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 36/147 (24%), Positives = 62/147 (42%), Gaps = 16/147 (10%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G+Q A K     +                 E+++L++I+HPNV+         + ++++ 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVS--REDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
           E +  G+L  FL  K +L    A  F   I  G+ YLH  +   I H DL+P NI+    
Sbjct: 94  ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDR 150

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLT 312
                 +K+ DFG++  +         
Sbjct: 151 NVPKPRIKIIDFGLAHKI--DFGNEFK 175

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 23/184 (12%)

Query: 142 AREVPEYEIDPHELDFTNSV-----EITKGTF---ILAFWR--GIQVAVKKLGEEVISDD 191
           A  VP+Y ID    D  +       E+ +G          +      A+K     V+   
Sbjct: 35  ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKT 89

Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
              +  R E+ +L ++ HPN+++        + + +V E +  G+L   +  KG      
Sbjct: 90  VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKED 308
           A      I   + YLHEN    I+HRDL+P N+L         LK+ADFG+SK+  V+  
Sbjct: 150 AADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQ 204

Query: 309 RPLT 312
             + 
Sbjct: 205 VLMK 208

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 86.4 bits (214), Expect = 3e-19
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 24/136 (17%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKG 235
            A+K++    IS      A R E+ALL++++HPNV+         +   +  + +Y    
Sbjct: 51  YALKQIEGTGISMS----ACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104

Query: 236 DLRAFLK---------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
           DL   +K         +   L           I  G++YLH N    ++HRDL+P+NIL 
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILV 161

Query: 286 ---RDDSGNLKVADFG 298
                + G +K+AD G
Sbjct: 162 MGEGPERGRVKIADMG 177

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 86.4 bits (214), Expect = 4e-19
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 18/147 (12%)

Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
           GT +    +    VAVK++  E  S  DR      E+ LL++   HPNV+++        
Sbjct: 38  GTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQ 91

Query: 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
              I  E      L+ ++++K  A      +        G+ +LH      I+HRDL+P 
Sbjct: 92  FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPH 147

Query: 283 NILRDDSGN-----LKVADFGVSKLLT 304
           NIL             ++DFG+ K L 
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLA 174

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 29/150 (19%), Positives = 67/150 (44%), Gaps = 12/150 (8%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           E+ KG F           G + A   +  + +S  D  +    E  + + ++HPN+V+  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLH 76

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            ++++     ++ + +  G+L   +  +     + A      I   + + H+     ++H
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 133

Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLL 303
           R+L+P N+L   +     +K+ADFG++  +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEV 163

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 84.9 bits (211), Expect = 4e-19
 Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 18/134 (13%)

Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MM 226
           VA+K +             +   R E+ALL+++    HPNVV+ +     S       + 
Sbjct: 37  VALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95

Query: 227 IVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           +V E++ + DLR +L +     L   T         RG+++LH N    I+HRDL+P NI
Sbjct: 96  LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENI 151

Query: 285 LRDDSGNLKVADFG 298
           L    G +K+ADFG
Sbjct: 152 LVTSGGTVKLADFG 165

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 33/141 (23%), Positives = 63/141 (44%), Gaps = 18/141 (12%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G Q AVK     K         + ++    E ++   ++HP++V+ L   +    + +V 
Sbjct: 49  GQQFAVKIVDVAKFTSSPGLSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVF 105

Query: 230 EYLPKGDLRAFLKRKGALKPS----TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           E++   DL   + ++           A  +   I   + Y H+N    IIHRD++P  +L
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVL 162

Query: 286 ---RDDSGNLKVADFGVSKLL 303
              +++S  +K+  FGV+  L
Sbjct: 163 LASKENSAPVKLGGFGVAIQL 183

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 40/203 (19%)

Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGI----------QVAV 180
            PL  P  V           +  E+ +TN   I  G+F      G+          +VA+
Sbjct: 16  NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSF------GVVFQAKLVESDEVAI 69

Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPK 234
           KK     +  D R    R EL +++ ++HPNVV        +          +V EY+P+
Sbjct: 70  KK-----VLQDKR-FKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122

Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DS 289
             +    R + K K  +       +   + R + Y+H      I HRD++P N+L D  S
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPS 178

Query: 290 GNLKVADFGVSKLLTVKEDRPLT 312
           G LK+ DFG +K+L      P  
Sbjct: 179 GVLKLIDFGSAKILI--AGEPNV 199

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 84.6 bits (210), Expect = 6e-19
 Identities = 34/135 (25%), Positives = 66/135 (48%), Gaps = 5/135 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118

Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
            ++++ G+   +   RF   +I   + YLH      IIHRDL+P NIL ++  ++++ DF
Sbjct: 119 KYIRKIGSFDETCT-RFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 174

Query: 298 GVSKLLTVKEDRPLT 312
           G +K+L+ +  +   
Sbjct: 175 GTAKVLSPESKQARA 189

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.1 bits (211), Expect = 6e-19
 Identities = 35/138 (25%), Positives = 64/138 (46%), Gaps = 14/138 (10%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G++ A K     +                 E+++L+++ HPN++         + ++++ 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVC--REEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
           E +  G+L  FL +K +L    A  F   I  G+NYLH  K   I H DL+P NI+    
Sbjct: 95  ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151

Query: 286 RDDSGNLKVADFGVSKLL 303
                ++K+ DFG++  +
Sbjct: 152 NIPIPHIKLIDFGLAHEI 169

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.1 bits (211), Expect = 9e-19
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 24/149 (16%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
           G  VA+KK     +  D R    R EL +++K+ H N+V+       S          +V
Sbjct: 79  GELVAIKK-----VLQDKR-FKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131

Query: 229 TEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
            +Y+P+  +    R + + K  L       +   + R + Y+H      I HRD++P N+
Sbjct: 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNL 187

Query: 285 LRD-DSGNLKVADFGVSKLLTVKEDRPLT 312
           L D D+  LK+ DFG +K L      P  
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLV--RGEPNV 214

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.8 bits (208), Expect = 1e-18
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 19/133 (14%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MMI 227
           VA+K++  +  + ++ +     R E+A+L+ +    HPNVV+     T S       + +
Sbjct: 40  VALKRVRVQ--TGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96

Query: 228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           V E++ + DL  +L +     +   T       + RG+++LH ++   ++HRDL+P NIL
Sbjct: 97  VFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 152

Query: 286 RDDSGNLKVADFG 298
              SG +K+ADFG
Sbjct: 153 VTSSGQIKLADFG 165

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 9/141 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             + AVK + +    + D       E+ LL+K+ HPN+++    +  SS   IV E    
Sbjct: 47  QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162

Query: 292 LKVADFGVSKLLTVKEDRPLT 312
           +K+ DFG+S     +++  + 
Sbjct: 163 IKIIDFGLSTC--FQQNTKMK 181

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 43/175 (24%), Positives = 71/175 (40%), Gaps = 32/175 (18%)

Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
           GT +    ++G  VAVK++        D       E+ LL +   HPNV+++  + T   
Sbjct: 29  GTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82

Query: 224 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            + I  E     +L+  ++ K          K    +     IA G+ +LH  K   IIH
Sbjct: 83  FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIH 138

Query: 277 RDLEPSNIL-------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           RDL+P NIL               ++  + ++DFG+ K L   +    T  +   
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 35/129 (27%), Positives = 56/129 (43%), Gaps = 10/129 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
              VA+KK+        D  R  R E+A+L ++ H +VV+ L  V            +V 
Sbjct: 78  KRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           E     D +   +    L          ++  G+ Y+H      I+HRDL+P+N L +  
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD 192

Query: 290 GNLKVADFG 298
            ++KV DFG
Sbjct: 193 CSVKVCDFG 201

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 32/133 (24%), Positives = 55/133 (41%), Gaps = 13/133 (9%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVTEY 231
            V +K L      D +       E   L ++ HP++VQ    V  +         IV EY
Sbjct: 108 PVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           +    L+        L  + A+ + L+I   ++YLH      +++ DL+P NI+  +   
Sbjct: 166 VGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEEQ- 219

Query: 292 LKVADFGVSKLLT 304
           LK+ D G    + 
Sbjct: 220 LKLIDLGAVSRIN 232

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 36/135 (26%), Positives = 64/135 (47%), Gaps = 10/135 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
           G + A K L +     D R      E+A+L+  +  P V+        +S ++++ EY  
Sbjct: 54  GQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112

Query: 234 KGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
            G++      +    +  +  +R    I  G+ YLH+N    I+H DL+P NIL      
Sbjct: 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169

Query: 289 SGNLKVADFGVSKLL 303
            G++K+ DFG+S+ +
Sbjct: 170 LGDIKIVDFGMSRKI 184

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 31/141 (21%), Positives = 66/141 (46%), Gaps = 9/141 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            ++ A+K + +  +S     +   +E+A+L+ + HPN+++            +V E    
Sbjct: 62  HVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A      +  G+ YLH++    I+HRDL+P N+L   ++    
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL 177

Query: 292 LKVADFGVSKLLTVKEDRPLT 312
           +K+ DFG+S +   +  + + 
Sbjct: 178 IKIVDFGLSAV--FENQKKMK 196

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 3/123 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +EVI   D V     E  +LQ  RHP +     A      +  V EY   G+L 
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L R+       A  +  +I   + YLH      +++RD++  N++ D  G++K+ DFG
Sbjct: 94  FHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150

Query: 299 VSK 301
           + K
Sbjct: 151 LCK 153

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 27/197 (13%), Positives = 61/197 (30%), Gaps = 34/197 (17%)

Query: 138 HVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEV 187
            +   +   E+++    +   +   + +G F     A            +  +K      
Sbjct: 50  KLPAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107

Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA- 246
             +          +  L+       ++F  A    +  ++V E    G L   +      
Sbjct: 108 PWEFYIGT---QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164

Query: 247 ----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----------RDDSGN 291
               +     + FA+ +   +  +H+ +   IIH D++P N +            D S  
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 292 LKVADFGVSKLLTVKED 308
           L + D G S  + +   
Sbjct: 222 LALIDLGQSIDMKLFPK 238

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.0 bits (203), Expect = 7e-18
 Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 17/148 (11%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            ++ AVK      I D  +     +   LL+  +HPN++           + +VTE +  
Sbjct: 47  NMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSG 290
           G+L   + R+       A      I + + YLH      ++HRDL+PSNIL      +  
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           ++++ DFG +K L   E+  L    T C
Sbjct: 158 SIRICDFGFAKQLR-AENGLLM---TPC 181

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.9 bits (205), Expect = 7e-18
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 2/134 (1%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   G+L 
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L R+       A  +  +I   ++YLH  K   +++RDL+  N++ D  G++K+ DFG
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG 294

Query: 299 VSKLLTVKEDRPLT 312
           + K          T
Sbjct: 295 LCKEGIKDGATMKT 308

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 82.0 bits (203), Expect = 8e-18
 Identities = 36/123 (29%), Positives = 64/123 (52%), Gaps = 3/123 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  G++ 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L+R G      A  +A  I     YLH      +I+RDL+P N+L D  G ++V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 299 VSK 301
            +K
Sbjct: 187 FAK 189

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 35/151 (23%), Positives = 67/151 (44%), Gaps = 18/151 (11%)

Query: 175 GIQVAVK----------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
             + A+K          +  ++  + +       +E++LL+ + HPN+++          
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120

Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
             +VTE+   G+L   +  +       A      I  G+ YLH++    I+HRD++P NI
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177

Query: 285 L---RDDSGNLKVADFGVSKLLTVKEDRPLT 312
           L   ++   N+K+ DFG+S      +D  L 
Sbjct: 178 LLENKNSLLNIKIVDFGLSSF--FSKDYKLR 206

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 36/131 (27%), Positives = 59/131 (45%), Gaps = 4/131 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + +  +     V  FR+E  +L       + Q   A    + + +V EY   GDL 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149

Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
             L + G   P+   RF   +I   ++ +H       +HRD++P NIL D  G++++ADF
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206

Query: 298 GVSKLLTVKED 308
           G    L     
Sbjct: 207 GSCLKLRADGT 217

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 46/220 (20%), Positives = 93/220 (42%), Gaps = 24/220 (10%)

Query: 95  RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVP---EYEID 151
           R    + K+ W +  L + +  K+     L     A P      +  A++      Y + 
Sbjct: 33  RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92

Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
             E        +  G F           G+++A K +    + D + V+   +E++++ +
Sbjct: 93  KTE-------ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQ 142

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNY 265
           + H N++Q   A    + +++V EY+  G+L    +     L     + F   I  G+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRH 202

Query: 266 LHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLL 303
           +H+     I+H DL+P NIL    D+  +K+ DFG+++  
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 32/138 (23%), Positives = 62/138 (44%), Gaps = 7/138 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL- 237
           A KKL ++ +      +    E  +L K+    +V    A    + + +V   +  GD+ 
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273

Query: 238 ---RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
                  +     +   A+ +   I  G+ +LH+     II+RDL+P N+L DD GN+++
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRI 330

Query: 295 ADFGVSKLLTVKEDRPLT 312
           +D G++  L   + +   
Sbjct: 331 SDLGLAVELKAGQTKTKG 348

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 31/137 (22%), Positives = 64/137 (46%), Gaps = 8/137 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           A+K L ++ I          +E   L+L+     P +V    A      +  + + +  G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           DL   L + G    +    +A +I  G+ ++H      +++RDL+P+NIL D+ G+++++
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334

Query: 296 DFGVSKLLTVKEDRPLT 312
           D G++      + +P  
Sbjct: 335 DLGLACD--FSKKKPHA 349

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 80.3 bits (199), Expect = 2e-17
 Identities = 36/123 (29%), Positives = 67/123 (54%), Gaps = 3/123 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +E++    +V    DE  +L  + HP +++  G    +  + ++ +Y+  G+L 
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L++        A  +A ++   + YLH      II+RDL+P NIL D +G++K+ DFG
Sbjct: 95  SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151

Query: 299 VSK 301
            +K
Sbjct: 152 FAK 154

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 13/134 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A K +     SD + VR    E+  +  +RHP +V    A    + M+++ E++  
Sbjct: 182 GNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238

Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
           G+L  F         +    AV +   + +G+ ++HEN     +H DL+P NI+     S
Sbjct: 239 GEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRS 293

Query: 290 GNLKVADFGVSKLL 303
             LK+ DFG++  L
Sbjct: 294 NELKLIDFGLTAHL 307

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 28/134 (20%), Positives = 62/134 (46%), Gaps = 13/134 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G     K +      D   V+   +E++++ ++ HP ++    A      M+++ E+L  
Sbjct: 76  GRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132

Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
           G+L  F         +  +  + +      G+ ++HE+    I+H D++P NI+     +
Sbjct: 133 GEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKA 187

Query: 290 GNLKVADFGVSKLL 303
            ++K+ DFG++  L
Sbjct: 188 SSVKIIDFGLATKL 201

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 4/135 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++V+  DD V     E   L    + P + Q          +  V EY+  GDL
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              +++ G  K   AV +A +IA G+ +L       II+RDL+  N++ D  G++K+ADF
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486

Query: 298 GVSKLLTVKEDRPLT 312
           G+ K          T
Sbjct: 487 GMCKENIWDGVTTKT 501

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 13/130 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T +S +       +V
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
             ++   DL+  +  K              + +G+ Y+H      ++HRDL+P N+  ++
Sbjct: 108 MPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161

Query: 289 SGNLKVADFG 298
              LK+ DFG
Sbjct: 162 DCELKILDFG 171

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 79.7 bits (197), Expect = 4e-17
 Identities = 43/168 (25%), Positives = 80/168 (47%), Gaps = 22/168 (13%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP  + F     +  GT+   +       G   A+K +  +V  D++     + E+ +L+
Sbjct: 21  DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEE--EIKQEINMLK 75

Query: 206 KI-RHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFA 256
           K   H N+  + GA  + +P      + +V E+   G +   +K  +   LK        
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
            +I RG+++LH++K   +IHRD++  N+L  ++  +K+ DFGVS  L 
Sbjct: 136 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 36/125 (28%), Positives = 62/125 (49%), Gaps = 5/125 (4%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A KKL ++ I          +E  +L+K+    VV    A      + +V   +  GDL+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272

Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
             +   G      + AV +A +I  G+  LH  +   I++RDL+P NIL DD G+++++D
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329

Query: 297 FGVSK 301
            G++ 
Sbjct: 330 LGLAV 334

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 10/129 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
              VA+KK+        D  R  R E+ +L +++   +++    +     +      IV 
Sbjct: 51  EKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           E     DL+   K    L          ++  G N++HE+    IIHRDL+P+N L +  
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQD 165

Query: 290 GNLKVADFG 298
            ++KV DFG
Sbjct: 166 CSVKVCDFG 174

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 78.4 bits (194), Expect = 8e-17
 Identities = 25/143 (17%), Positives = 53/143 (37%), Gaps = 16/143 (11%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
                 K +  +           + E+++L   RH N++    +      ++++ E++  
Sbjct: 30  KKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85

Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
            D+  F         L     V +   +   + +LH +    I H D+ P NI+     S
Sbjct: 86  LDI--FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRS 140

Query: 290 GNLKVADFGVSKLLTVKEDRPLT 312
             +K+ +FG ++ L  K      
Sbjct: 141 STIKIIEFGQARQL--KPGDNFR 161

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 33/134 (24%), Positives = 60/134 (44%), Gaps = 13/134 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
               AVK     +IS        + E+  L+    HPN+V+            +V E L 
Sbjct: 36  NQAFAVK-----IISKRMEANTQK-EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
            G+L   +K+K     + A      +   ++++H+     ++HRDL+P N+L    +D+ 
Sbjct: 90  GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNL 146

Query: 291 NLKVADFGVSKLLT 304
            +K+ DFG ++L  
Sbjct: 147 EIKIIDFGFARLKP 160

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 31/138 (22%), Positives = 61/138 (44%), Gaps = 10/138 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
             + AVK + ++      RV     E+ +L + + H NV++ +    +     +V E + 
Sbjct: 38  SQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
            G + + + ++       A     D+A  +++LH      I HRDL+P NIL    +   
Sbjct: 95  GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVS 151

Query: 291 NLKVADFGVSKLLTVKED 308
            +K+ DF +   + +  D
Sbjct: 152 PVKICDFDLGSGIKLNGD 169

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 35/191 (18%), Positives = 58/191 (30%), Gaps = 53/191 (27%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
               A+K     K+ +    D +R++    E+ L++K+ HPN+ +          + +V 
Sbjct: 51  RAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107

Query: 230 EYLPKGDLRAFLKRKGALKPST-------------------------------------- 251
           E    G L   L                                                
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167

Query: 252 --AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
                    I   ++YLH      I HRD++P N L   + S  +K+ DFG+SK      
Sbjct: 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224

Query: 308 DRPLTCQDTSC 318
           +       T  
Sbjct: 225 NGEYYGMTTKA 235

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 40/124 (32%), Positives = 60/124 (48%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K L ++V+  DD V     E  +L     HP +            +  V EYL  GDL
Sbjct: 46  AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++       S A  +A +I  G+ +LH      I++RDL+  NIL D  G++K+ADF
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162

Query: 298 GVSK 301
           G+ K
Sbjct: 163 GMCK 166

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 38/124 (30%), Positives = 69/124 (55%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  + ++   HP +V         S +  V EY+  GDL
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 98  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154

Query: 298 GVSK 301
           G+ K
Sbjct: 155 GMCK 158

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 43/188 (22%), Positives = 77/188 (40%), Gaps = 29/188 (15%)

Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITK-----GTF---ILAFWR--GIQVAVKKLGE 185
             H     EV     +P +   T+  +++K     G     +  F R  G + A+K L  
Sbjct: 5   HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-- 62

Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFL 241
                 D  +A ++     Q    P++V  L            ++I+ E +  G+L + +
Sbjct: 63  -----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117

Query: 242 KRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVAD 296
           + +G    +   A     DI   + +LH +    I HRD++P N+L   ++    LK+ D
Sbjct: 118 QERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD 174

Query: 297 FGVSKLLT 304
           FG +K  T
Sbjct: 175 FGFAKETT 182

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 41/124 (33%), Positives = 64/124 (51%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++V+  DD V     E  +L    + P + Q          +  V EY+  GDL
Sbjct: 49  AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              +++ G  K   AV +A +IA G+ +L       II+RDL+  N++ D  G++K+ADF
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 165

Query: 298 GVSK 301
           G+ K
Sbjct: 166 GMCK 169

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 39/154 (25%), Positives = 62/154 (40%), Gaps = 22/154 (14%)

Query: 174 RGIQVAVKKLGEEVISDDDRV---------RAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
            GI VA+K++   V                R  R E+ LL    HPN++           
Sbjct: 45  EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEE 103

Query: 225 MM-----IVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
                  +VTE +   DL   +  ++  + P     F   I  G++ LHE     ++HRD
Sbjct: 104 PAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           L P NIL  D+ ++ + DF +++      D   T
Sbjct: 160 LHPGNILLADNNDITICDFNLAR--EDTADANKT 191

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 50/188 (26%), Positives = 76/188 (40%), Gaps = 30/188 (15%)

Query: 145 VPEYEIDPHELD-FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
               E    E+D F       +GTF    L   +  G+ VA+KK+        D     R
Sbjct: 12  AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNR 65

Query: 199 D--ELALLQKIRHPNVVQFLGAVTQSSP-------MMIVTEYLPKGDL----RAFLKRKG 245
           +   +  L  + HPN+VQ                 + +V EY+P   L    R + +R+ 
Sbjct: 66  ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV 124

Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLT 304
           A  P     F   + R +  LH    V + HRD++P N+L +   G LK+ DFG +K L+
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 305 VKEDRPLT 312
                P  
Sbjct: 184 --PSEPNV 189

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 32/131 (24%), Positives = 57/131 (43%), Gaps = 4/131 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +        FR+E  +L       +     A    + + +V +Y   GDL 
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162

Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
             L +     P    RF   ++   ++ +H+      +HRD++P NIL D +G++++ADF
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219

Query: 298 GVSKLLTVKED 308
           G    L     
Sbjct: 220 GSCLKLMEDGT 230

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 37/124 (29%), Positives = 69/124 (55%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A++ + +E+++DD+ +   + E  + ++   HP +V         S +  V EY+  GDL
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197

Query: 298 GVSK 301
           G+ K
Sbjct: 198 GMCK 201

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 41/130 (31%), Positives = 63/130 (48%), Gaps = 12/130 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
           G +VA+KKL     S+    RA+R EL LL+ +RH NV+  L   T    +       +V
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
             ++   DL   +K +  L           + +G+ Y+H      IIHRDL+P N+  ++
Sbjct: 109 MPFMGT-DLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNE 163

Query: 289 SGNLKVADFG 298
              LK+ DFG
Sbjct: 164 DCELKILDFG 173

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 38/130 (29%), Positives = 58/130 (44%), Gaps = 13/130 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
              VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV
Sbjct: 50  ERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            E +   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+   
Sbjct: 109 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162

Query: 289 SGNLKVADFG 298
              LK+ DFG
Sbjct: 163 DCTLKILDFG 172

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++VI  DD V     E  +L     HP + Q          +  V E++  GDL
Sbjct: 52  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              +++      + A  +A +I   + +LH+     II+RDL+  N+L D  G+ K+ADF
Sbjct: 112 MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168

Query: 298 GVSK 301
           G+ K
Sbjct: 169 GMCK 172

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.0 bits (190), Expect = 5e-16
 Identities = 36/123 (29%), Positives = 57/123 (46%), Gaps = 4/123 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +        F +E  ++     P VVQ   A      + +V EY+P GDL 
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L     +    A  +  ++   ++ +H       IHRD++P N+L D SG+LK+ADFG
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213

Query: 299 VSK 301
              
Sbjct: 214 TCM 216

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.2 bits (188), Expect = 7e-16
 Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 24/183 (13%)

Query: 134 MAPMHVKHAREVPEY---EIDPHELDFTNSVEITK-------GTFILAFWR--GIQVAVK 181
           MA  H  H++E P +   E++    +     +          G+   AF    G++VAVK
Sbjct: 1   MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60

Query: 182 KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPKG 235
           KL     S     R +R EL LL+ ++H NV+  L   T +  +       +VT  +   
Sbjct: 61  KLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA- 118

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++   LK+ 
Sbjct: 119 DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 174

Query: 296 DFG 298
           DFG
Sbjct: 175 DFG 177

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 76.1 bits (187), Expect = 8e-16
 Identities = 21/127 (16%), Positives = 35/127 (27%), Gaps = 2/127 (1%)

Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL       +R  K+   +      +     F          ++ +  LL S   V    
Sbjct: 66  LLCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQ 125

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGDAIYYKNHEVIKLLEKH 128
            +N  A  +AA  G   V++ L E                    A    +  V+  L + 
Sbjct: 126 AENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCEL 185

Query: 129 GAKPLMA 135
                 A
Sbjct: 186 APTEATA 192

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 17/87 (19%), Positives = 24/87 (27%), Gaps = 5/87 (5%)

Query: 57  KELLDSGIDVNFRDI--DNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGD 112
             L +         I  +N  A  +AA  G   V++ L E                    
Sbjct: 145 NRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRW 204

Query: 113 AIYYKNH-EVIKLLEKHGAKPLMAPMH 138
           A   + H  VI  L         A +H
Sbjct: 205 AAVGRGHHNVINFLLDCPVMLAYAEIH 231

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 15/118 (12%), Positives = 33/118 (27%), Gaps = 14/118 (11%)

Query: 24  KEAELNGLDD--DGEEIKPEFRLMFLANERDVEGIKELL---------DSGIDVNFRDID 72
           K +  +G+ D     E    F ++     R+ E + + +          +         D
Sbjct: 259 KLSNPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGD 318

Query: 73  NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               L +A   G     +LLL   + +                    ++  +  +H  
Sbjct: 319 ANELLRLALRLGNQGACALLLSIPSVLALTKA---NNYYINETGGRLDLRAVALEHHH 373

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 52.3 bits (125), Expect = 7e-08
 Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 12/91 (13%)

Query: 56  IKELLDSGIDVNFRDI--DNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWGSTPLGD 112
           +  L +         I  +N  A   AA   G   V++ LL+    +   +         
Sbjct: 179 LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFE---- 234

Query: 113 AIYYKNHEVIKLLEKHGA--KPLMAPMHVKH 141
              Y    V   + +H    K +     + +
Sbjct: 235 ---YGEKYVNPFIARHVNRLKEMHDAFKLSN 262

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 15/159 (9%), Positives = 29/159 (18%), Gaps = 35/159 (22%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT----- 229
               A+K       +    +    +      ++   +  +         P   V      
Sbjct: 87  LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 230 --------------------EYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARG 262
                                     DL             +G             + R 
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
              L       ++H    P N+     G L + D     
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW 242

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 37/130 (28%), Positives = 58/130 (44%), Gaps = 13/130 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
              VA+KKL     +     RA+R EL L++ + H N++  L   T    +       +V
Sbjct: 87  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            E +   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+   
Sbjct: 146 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 199

Query: 289 SGNLKVADFG 298
              LK+ DFG
Sbjct: 200 DCTLKILDFG 209

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 4/131 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 56  AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L ++          +  ++A  +++LH      II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171

Query: 299 VSKLLTVKEDR 309
           +SK     E +
Sbjct: 172 LSKESIDHEKK 182

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 38/124 (30%), Positives = 63/124 (50%), Gaps = 4/124 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++ I      +    E   LL+ ++HP +V    +   +  +  V +Y+  G+L
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L+R+       A  +A +IA  + YLH      I++RDL+P NIL D  G++ + DF
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183

Query: 298 GVSK 301
           G+ K
Sbjct: 184 GLCK 187

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 74.3 bits (182), Expect = 3e-15
 Identities = 21/125 (16%), Positives = 48/125 (38%), Gaps = 8/125 (6%)

Query: 14  QSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNF-R 69
           Q  L P+ +     L  +  + + E      +   ++ +  ++ + +   ++ +++N   
Sbjct: 68  QRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPV 127

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLL 125
           D    T LH        E+V  L++ G++    D  G + L  A+   N+        LL
Sbjct: 128 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL 187

Query: 126 EKHGA 130
           +    
Sbjct: 188 DYLYP 192

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 18/87 (20%), Positives = 33/87 (37%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K+          E+            +  +E +         +N +D +  T L++AA  
Sbjct: 234 KKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARL 293

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPL 110
           G   +V  LL+ GAD    ++ G  P+
Sbjct: 294 GNISIVDALLDYGADPFIANKSGLRPV 320

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 19/145 (13%), Positives = 46/145 (31%), Gaps = 22/145 (15%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-------FTEVVSLLLERG 96
           L +L +  ++E +K L+  G +  + D    + L  A           F  ++  L    
Sbjct: 135 LHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYL---Y 191

Query: 97  ADVDPKDRWGSTPL------------GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144
             +  +D    T L              A  Y    ++  + K   +P+ +  + K ++ 
Sbjct: 192 PCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKP 251

Query: 145 VPEYEIDPHELDFTNSVEITKGTFI 169
             +       +     ++      +
Sbjct: 252 NDKNGERKDSILENLDLKWIIANML 276

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 12/83 (14%), Positives = 25/83 (30%), Gaps = 4/83 (4%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAA----CQGFTEVVSLLLERGADVDPKDRWGSTP 109
             +  ++           + + +              E + L       ++ +D  G T 
Sbjct: 227 ILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTC 286

Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
           L  A    N  ++  L  +GA P
Sbjct: 287 LNIAARLGNISIVDALLDYGADP 309

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 46.6 bits (110), Expect = 4e-06
 Identities = 16/121 (13%), Positives = 30/121 (24%), Gaps = 21/121 (17%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLA---NERDVEGIKELLDSGI-DVNFRDIDNRTALHVAA 81
           +     D+ GE       L+      N  D    + LLD     +   D  NRT LH   
Sbjct: 155 SNRLYGDNMGE--SC---LVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHII 209

Query: 82  CQGFTE------------VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
                             ++  ++++                +    +  + I       
Sbjct: 210 ITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLK 269

Query: 130 A 130
            
Sbjct: 270 W 270

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.5 bits (181), Expect = 4e-15
 Identities = 34/137 (24%), Positives = 58/137 (42%), Gaps = 21/137 (15%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
             + A+K     ++ D  + R    E+ L  +  + P++V+ +            ++IV 
Sbjct: 43  QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94

Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
           E L  G+L  R   +   A     A      I   + YLH      I HRD++P N+L  
Sbjct: 95  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 151

Query: 286 -RDDSGNLKVADFGVSK 301
            +  +  LK+ DFG +K
Sbjct: 152 SKRPNAILKLTDFGFAK 168

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 27/93 (29%), Positives = 44/93 (47%)

Query: 48  ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
           AN+  +  +  ++ +G  ++ +  D  TALH AA     + + LLL+  A V   +  G 
Sbjct: 201 ANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGE 260

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
           T L  A    + E  +LLE+  A     P+HV 
Sbjct: 261 TALDIARKKHHKECEELLEQAQAGTFAFPLHVD 293

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 61.9 bits (150), Expect = 4e-11
 Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 9/93 (9%)

Query: 49  NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQGF---TEVVSLLLERGADV 99
             RD+  + E   +G D                 LH+A          +V  +++ G  +
Sbjct: 160 CNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHL 219

Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           D K   G+T L  A  Y   + +KLL K  A  
Sbjct: 220 DAKAADGNTALHYAALYNQPDCLKLLLKGRALV 252

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 74.0 bits (182), Expect = 5e-15
 Identities = 36/148 (24%), Positives = 60/148 (40%), Gaps = 23/148 (15%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
             + A+K     ++ D  + R    E+ L  +  + P++V+ +            ++IV 
Sbjct: 87  QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138

Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
           E L  G+L  R   +   A     A      I   + YLH      I HRD++P N+L  
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 195

Query: 286 -RDDSGNLKVADFGVSKLLTVKEDRPLT 312
            +  +  LK+ DFG +K         LT
Sbjct: 196 SKRPNAILKLTDFGFAKE--TTSHNSLT 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.5 bits (181), Expect = 7e-15
 Identities = 37/131 (28%), Positives = 61/131 (46%), Gaps = 16/131 (12%)

Query: 175 GIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----I 227
            ++VA+KK+   E         R  R E+ +L + RH N++     +   +        I
Sbjct: 52  KVRVAIKKISPFEHQT---YCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107

Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           V + +   DL   L +   L       F   I RG+ Y+H      ++HRDL+PSN+L +
Sbjct: 108 VQDLMET-DLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162

Query: 288 DSGNLKVADFG 298
            + +LK+ DFG
Sbjct: 163 TTCDLKICDFG 173

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.0 bits (180), Expect = 7e-15
 Identities = 36/132 (27%), Positives = 68/132 (51%), Gaps = 4/132 (3%)

Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K L    ++ +       + E  +L++++HP +V  + A      + ++ EYL  G+L
Sbjct: 49  AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L+R+G     TA  +  +I+  + +LH+     II+RDL+P NI+ +  G++K+ DF
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165

Query: 298 GVSKLLTVKEDR 309
           G+ K        
Sbjct: 166 GLCKESIHDGTV 177

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 72.1 bits (177), Expect = 9e-15
 Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 21/121 (17%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A LN  +   + I      + L   R  + +K+ +             +TALH+A  +  
Sbjct: 61  AMLNLHNGQNDTIA-----LLLDVARKTDSLKQFV--NASYTDSYYKGQTALHIAIERRN 113

Query: 86  TEVVSLLLERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAK 131
             +V+LL+E GADV                   +G  PL  A       ++K L ++  +
Sbjct: 114 MTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQ 173

Query: 132 P 132
           P
Sbjct: 174 P 174

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 56.7 bits (137), Expect = 2e-09
 Identities = 25/112 (22%), Positives = 38/112 (33%), Gaps = 22/112 (19%)

Query: 44  LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
           L   A    +  +K LL +     D++ RD    T LH                T + + 
Sbjct: 152 LSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNE 211

Query: 92  LLERGADVDP-------KDRWGSTPLGDAIYYKNHEVIKLL---EKHGAKPL 133
           +L  GA + P        +R G TPL  A       V+  +   E H  +  
Sbjct: 212 ILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECR 263

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 55.2 bits (133), Expect = 6e-09
 Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 8/64 (12%)

Query: 57  KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
            +L  +       +    T L +AA  G   V++ +L+R                 A ++
Sbjct: 217 AKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAHH 269

Query: 117 KNHE 120
            +H 
Sbjct: 270 -HHH 272

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 49.8 bits (119), Expect = 3e-07
 Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 11/88 (12%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-------RGADVDPKDR-WGSTPLGDA- 113
                   + +R ++  A  Q   + +  LL        R  D + KD   G T L  A 
Sbjct: 3   SAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAM 62

Query: 114 --IYYKNHEVIKLLEKHGAKPLMAPMHV 139
             ++   ++ I LL     K       V
Sbjct: 63  LNLHNGQNDTIALLLDVARKTDSLKQFV 90

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 37/130 (28%), Positives = 58/130 (44%), Gaps = 14/130 (10%)

Query: 175 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IV 228
           G  VA+KK+  E        +R  R E+ +L+  +H N++         S        I+
Sbjct: 36  GEIVAIKKI--EPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            E +   DL   +  +  L       F     R +  LH +    +IHRDL+PSN+L + 
Sbjct: 93  QELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINS 147

Query: 289 SGNLKVADFG 298
           + +LKV DFG
Sbjct: 148 NCDLKVCDFG 157

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 27/128 (21%), Positives = 55/128 (42%), Gaps = 16/128 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI--VTEY 231
             +V VK      +    + +  R E+ +L+ +R  PN++     V          V E+
Sbjct: 61  NEKVVVKI-----LKPVKKKKIKR-EIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSG 290
           +   D +   +    L       +  +I + ++Y H      I+HRD++P N++ D +  
Sbjct: 115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 168

Query: 291 NLKVADFG 298
            L++ D+G
Sbjct: 169 KLRLIDWG 176

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 70.2 bits (172), Expect = 4e-14
 Identities = 26/142 (18%), Positives = 45/142 (31%), Gaps = 37/142 (26%)

Query: 21  RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------- 73
           +    A+       G        L     +R ++ +K L+++G DV+ R           
Sbjct: 76  KPLVNAQCTDEFYQGH--SA---LHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQG 130

Query: 74  ------RTALHVAACQGFTEVVSLLLERG---ADVDPKDRWGSTPL-------------- 110
                    L +AAC    +VV+ LLE     A ++  D  G+T L              
Sbjct: 131 TCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENS 190

Query: 111 --GDAIYYKNHEVIKLLEKHGA 130
                +Y    ++   L     
Sbjct: 191 ALVIHMYDGLLQMGARLCPTVQ 212

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 67.1 bits (164), Expect = 4e-13
 Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 15/91 (16%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-------------WGSTP 109
                       +ALH+A  +   + V LL+E GADV  +               +G  P
Sbjct: 80  NAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELP 139

Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
           L  A   K  +V+  L ++  +P  A +   
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQP--ASLEAT 168

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 65.6 bits (160), Expect = 1e-12
 Identities = 13/76 (17%), Positives = 26/76 (34%), Gaps = 1/76 (1%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
           +   +    +AL +    G  ++ + L       +  +  G TPL  A      E+ + +
Sbjct: 181 MIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHI 240

Query: 126 EKHGAKPLMAPMHVKH 141
            +       A  H  H
Sbjct: 241 LQREFSG-AAAHHHHH 255

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 58.3 bits (141), Expect = 4e-10
 Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 22/110 (20%)

Query: 43  RLMFLANERDVEGIKELLDS--------GIDVNFRDIDNRTALHVAAC---QGFTEVVSL 91
           RL  + +    E +  LL+                    +T L  A      G    +  
Sbjct: 5   RLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMP 64

Query: 92  LLERG-----------ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           LL+             A    +   G + L  AI  ++ + +KLL ++GA
Sbjct: 65  LLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGA 114

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 52.5 bits (126), Expect = 4e-08
 Identities = 9/48 (18%), Positives = 18/48 (37%)

Query: 53  VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
           ++    L  +       +    T L +AA +G  E+   +L+R     
Sbjct: 201 LQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGA 248

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 42.5 bits (100), Expect = 8e-05
 Identities = 13/71 (18%), Positives = 20/71 (28%), Gaps = 11/71 (15%)

Query: 73  NRTALHVAACQGFTEVVSLLLE--------RGADVDPKDRWGSTPLGDAIY--YKNH-EV 121
           +R  L     +G  E ++ LLE               +   G T L  A+          
Sbjct: 2   DRDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNAC 61

Query: 122 IKLLEKHGAKP 132
           I  L +     
Sbjct: 62  IMPLLQIDKDS 72

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.4 bits (173), Expect = 5e-14
 Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 29/142 (20%)

Query: 175 GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----- 226
             +VA+KK     I   D      A R E+ +++++ H N+V+    +  S   +     
Sbjct: 36  DKRVAIKK-----IVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89

Query: 227 ---------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
                    IV EY+   DL   L  +G L    A  F   + RG+ Y+H      ++HR
Sbjct: 90  SLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHR 144

Query: 278 DLEPSNILRDDSG-NLKVADFG 298
           DL+P+N+  +     LK+ DFG
Sbjct: 145 DLKPANLFINTEDLVLKIGDFG 166

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 69.4 bits (170), Expect = 6e-14
 Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 26/114 (22%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN--------------RTALHVAACQGFTEVV 89
           L      R    ++ L++ G DV+ +                     L +AAC     +V
Sbjct: 97  LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156

Query: 90  SLLLERG---ADVDPKDRWGSTPLGDAIYYKNH---------EVIKLLEKHGAK 131
             L E G   AD+  +D  G+T L   +   ++         ++  LL    AK
Sbjct: 157 HYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAK 210

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 62.9 bits (153), Expect = 1e-11
 Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 25/113 (22%)

Query: 45  MFLANERDVEGIKELLDSG---------IDVNFRDIDNR--TALHVAACQGFTEVVSLLL 93
           +   +    + I  LLD           I+  FRD+  R  TALH+A  +     V LL+
Sbjct: 54  LLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLV 113

Query: 94  ERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           E+GADV  + R              +G  PL  A       ++  L ++G K 
Sbjct: 114 EKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQ 166

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 61.3 bits (149), Expect = 4e-11
 Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 22/105 (20%)

Query: 48  ANERDVEGIKE----LLDSGIDVNFRDIDN----RTALHVAA---CQGFTEVVSLLLERG 96
            +    +G++     LL     +   +       +T L  A      G  + + +LL+  
Sbjct: 13  VSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTIPILLDIA 72

Query: 97  ADVDP-----------KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                               G T L  AI  +    ++LL + GA
Sbjct: 73  EKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGA 117

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 19/107 (17%), Positives = 34/107 (31%), Gaps = 19/107 (17%)

Query: 44  LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
           L   A       +  L ++G    D+  +D    T LH                T++  L
Sbjct: 144 LSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203

Query: 92  LLERGADVDPK-------DRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
           LL + A + P        +  G +PL  A       + + + +    
Sbjct: 204 LLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIA 250

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 14/70 (20%), Positives = 23/70 (32%), Gaps = 11/70 (15%)

Query: 73  NRTALHVAA----CQGFTEVVSLLLERGADVDPKDRW----GSTPLGDA---IYYKNHEV 121
           NR  L          G   ++S LL     +  ++      G T L  A   +    ++ 
Sbjct: 5   NRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDT 64

Query: 122 IKLLEKHGAK 131
           I +L     K
Sbjct: 65  IPILLDIAEK 74

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 44.4 bits (105), Expect = 2e-05
 Identities = 8/59 (13%), Positives = 17/59 (28%), Gaps = 7/59 (11%)

Query: 49  NERDVEGIKELLDSGIDVN-------FRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
            +   +    LL     +          + D  + L +AA  G   +   ++ R     
Sbjct: 194 TKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADA 252

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 33/181 (18%), Positives = 66/181 (36%), Gaps = 56/181 (30%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-------- 226
           G + A+KK     +  D R    R EL +++ + H N+++ +     +            
Sbjct: 32  GKRFALKK-----VLQDPR-YKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84

Query: 227 ------------------------------IVTEYLPKGDL----RAFLKRKGALKPSTA 252
                                         ++ EY+P   L    ++F++   ++  +  
Sbjct: 85  DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLI 143

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPL 311
             +   + R + ++H      I HRD++P N+L +     LK+ DFG +K L      P 
Sbjct: 144 SIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI--PSEPS 198

Query: 312 T 312
            
Sbjct: 199 V 199

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 20/93 (21%), Positives = 40/93 (43%)

Query: 48  ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
            +   +  +  L+ +  +++ +     TALH        E + LLL   A ++  +  G 
Sbjct: 180 VDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGE 239

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
           TPL  A   K+    +LL +  +    + +HV+
Sbjct: 240 TPLDIAKRLKHEHCEELLTQALSGRFNSHVHVE 272

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 9/93 (9%)

Query: 49  NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQG---FTEVVSLLLERGADV 99
             RD+ G+ +    G+D+            + TALH+A          +V  L++   ++
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198

Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           D +   GST L       N E +KLL +  A  
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASI 231

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 20/160 (12%), Positives = 46/160 (28%), Gaps = 36/160 (22%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------------------HPNV 212
           G    V           + ++  ++E+  L+ +R                       P  
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162

Query: 213 VQFLGAVTQSSPMMIVTEYLPK-----------GDLRAFLKRKGALKPSTAVRFALDIAR 261
            + +        M +++ +                L +      +L     ++  L + R
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            +  LH      ++H  L P +I+ D  G + +  F    
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 35/110 (31%), Positives = 49/110 (44%), Gaps = 16/110 (14%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
           ++E     L       + +G F   I A   GI        VAVK L E   +     RA
Sbjct: 16  KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 71

Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQSS-PMMIVTEYLPKGDLRAFLKRK 244
              EL +L  I  H NVV  LGA T+   P+M++ E+   G+L  +L+ K
Sbjct: 72  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.9 bits (145), Expect = 2e-10
 Identities = 19/59 (32%), Positives = 31/59 (52%), Gaps = 3/59 (5%)

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            K  L     + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ DFG+++
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 241

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.7 bits (166), Expect = 6e-13
 Identities = 32/125 (25%), Positives = 60/125 (48%), Gaps = 5/125 (4%)

Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           A+K L    ++         R E  +L+ IR  P +V    A    + + ++ +Y+  G+
Sbjct: 86  AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L   L ++          +  +I   + +LH+     II+RD++  NIL D +G++ + D
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 202

Query: 297 FGVSK 301
           FG+SK
Sbjct: 203 FGLSK 207

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 67.3 bits (164), Expect = 8e-13
 Identities = 19/160 (11%), Positives = 43/160 (26%), Gaps = 36/160 (22%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-------------------------H 209
           G    V           + ++  ++E+  L+ +R                          
Sbjct: 98  GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157

Query: 210 PNVVQFLGAVTQSSPMMIVTEYL--------PKGDLRAFLKRKGALKPSTAVRFALDIAR 261
             +++          +     Y             L +      +L     ++  L + R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
            +  LH      ++H  L P +I+ D  G + +  F    
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.4 bits (165), Expect = 9e-13
 Identities = 41/129 (31%), Positives = 66/129 (51%), Gaps = 13/129 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM----IVT 229
           G  VAVKK+ +   +  D  R FR E+ +L ++  H N+V  L  +   +       +V 
Sbjct: 34  GEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLR--ADNDRDVYLVF 90

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +Y+   DL A + R   L+P         + + + YLH      ++HRD++PSNIL +  
Sbjct: 91  DYMET-DLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE 145

Query: 290 GNLKVADFG 298
            ++KVADFG
Sbjct: 146 CHVKVADFG 154

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 26/99 (26%), Positives = 38/99 (38%), Gaps = 9/99 (9%)

Query: 43  RLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVA---ACQGFTEVVSLLL 93
           RL      RD+  + E   +G D                 LH+A   A Q    +V  ++
Sbjct: 135 RLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFII 194

Query: 94  ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + G  +D K   G+T L  A  Y   + +KLL K  A  
Sbjct: 195 QNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALV 233

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368

 Score = 60.2 bits (145), Expect = 2e-10
 Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 3/101 (2%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N ++   +   P   L+       +   + LL +G +VN  D   R  LH A   G 
Sbjct: 224 ADVNWVNGGQDNATP---LIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGH 280

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
           T +  L L+RGAD+  +D  G  PL  A+   N +++ LL 
Sbjct: 281 TGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLR 321

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368

 Score = 59.0 bits (142), Expect = 4e-10
 Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 2/87 (2%)

Query: 48  ANERDVEGIKELLDSGIDVNFR--DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105
            +   +  + + L  G DVN+     DN T L  A           LL+ GA+V+  D  
Sbjct: 208 GHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSA 267

Query: 106 GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           G  PL  A    +  +  L  K GA  
Sbjct: 268 GRGPLHHATILGHTGLACLFLKRGADL 294

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 27/151 (17%)

Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH------PNV 212
           KG+F   + A+       VA+K     ++ ++ R  R   +E+ +L+ +R        NV
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP--STAVR-FALDIARGMNYLHEN 269
           +  L   T  + + +  E L   +L   +K K   +      VR FA  I + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHSILQCLDALHKN 219

Query: 270 KPVPIIHRDLEPSNIL--RDDSGNLKVADFG 298
           +   IIH DL+P NIL  +     +KV DFG
Sbjct: 220 R---IIHCDLKPENILLKQQGRSGIKVIDFG 247

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 38/165 (23%), Positives = 65/165 (39%), Gaps = 37/165 (22%)

Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIR---------- 208
            G F    LA        VA+K     ++  D     A  DE+ LLQ++           
Sbjct: 29  WGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 209 -HPNVVQFLGAVTQSSPMM----IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIAR 261
              ++++ L       P      +V E L   +L A +K+      P   V+  +  +  
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVS 300
           G++Y+H      IIH D++P N+L +          +K+AD G +
Sbjct: 143 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 31/138 (22%), Positives = 52/138 (37%), Gaps = 18/138 (13%)

Query: 174 RGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMM 226
               VA+K     +I +        + E+ LL+ +          +V         + + 
Sbjct: 78  EQEWVAIK-----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132

Query: 227 IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           +V E L   +L   L+            R FA  +   + +L   + + IIH DL+P NI
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENI 190

Query: 285 L--RDDSGNLKVADFGVS 300
           L        +K+ DFG S
Sbjct: 191 LLCNPKRSAIKIVDFGSS 208

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 37/172 (21%), Positives = 65/172 (37%), Gaps = 47/172 (27%)

Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRH-----PNVV 213
            GTF   +L          AVK     V+ +  +   + + E  +L+KI++      N+V
Sbjct: 45  DGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKP 271
           ++ G       M ++ E L    L   + R          ++ + ++I + +NYL +   
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS- 157

Query: 272 VPIIHRDLEPSNIL-------------------------RDDSGNLKVADFG 298
             + H DL+P NIL                         R  S  +K+ DFG
Sbjct: 158 --LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 42/149 (28%), Positives = 58/149 (38%), Gaps = 37/149 (24%)

Query: 178 VAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVTE 230
           VAVK     ++ + DR   A R E+ +L+ +           VQ L        + IV E
Sbjct: 43  VAVK-----IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97

Query: 231 YLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            L       F+K  G L      +R  A  I + +N+LH NK   + H DL+P NIL   
Sbjct: 98  LLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQ 153

Query: 289 SGN-------------------LKVADFG 298
           S                     +KV DFG
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFG 182

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 41/150 (27%), Positives = 60/150 (40%), Gaps = 37/150 (24%)

Query: 177 QVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVT 229
           QVA+K     +I +  + R A R E+ +L+KI+          V           M I  
Sbjct: 47  QVALK-----IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101

Query: 230 EYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
           E L K +   FLK       P   VR  A  +   + +LHEN+   + H DL+P NIL  
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFV 157

Query: 286 -----------------RDDSGNLKVADFG 298
                               + +++VADFG
Sbjct: 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.1 bits (109), Expect = 8e-06
 Identities = 36/138 (26%), Positives = 54/138 (39%), Gaps = 23/138 (16%)

Query: 164 TKGTFILA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPN---VV 213
              T  L+        VA+K     V S +       DE+ LL+ +R      PN   VV
Sbjct: 49  HFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 214 QFLGAVTQSSP----MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLH 267
           Q L     S      + +V E L    L  ++ +     L      +    + +G++YLH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163

Query: 268 ENKPVPIIHRDLEPSNIL 285
                 IIH D++P NIL
Sbjct: 164 TK--CRIIHTDIKPENIL 179

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 27/133 (20%), Positives = 54/133 (40%), Gaps = 16/133 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
             +VA+K    E  +   +      E  + + ++    +        +    ++V + L 
Sbjct: 32  NEEVAIKL---E--NVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG 86

Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
               DL  F  RK +LK  T +  A  +   + ++H       +HRD++P N L      
Sbjct: 87  PSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRR 141

Query: 289 SGNLKVADFGVSK 301
           +  + + DFG++K
Sbjct: 142 ANQVYIIDFGLAK 154

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 44.1 bits (103), Expect = 3e-05
 Identities = 29/202 (14%), Positives = 52/202 (25%), Gaps = 52/202 (25%)

Query: 152 PHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDD-----RVRAFRDELAL 203
                     +I +G F            VA+K +  E     +            E+ +
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 204 LQKI---------RHPNVVQFLGA--VTQSSP---------------------------- 224
            +++         R    +       V  S P                            
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 225 MMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           + IV E+   G DL     +      +TA      +   +     +  +   HRDL   N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGN 192

Query: 284 ILRDDSGNLKVADFGVSKLLTV 305
           +L   +   K+      K  T+
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI 214

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 21/77 (27%), Positives = 41/77 (53%), Gaps = 6/77 (7%)

Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
           +V E L   DL+    + G  K ST ++  + +   + Y+HEN+    +H D++ +N+L 
Sbjct: 129 MVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184

Query: 286 -RDDSGNLKVADFGVSK 301
              +   + +AD+G+S 
Sbjct: 185 GYKNPDQVYLADYGLSY 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 30/135 (22%), Positives = 50/135 (37%), Gaps = 18/135 (13%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
              VA+K     +     R      E    +++     + Q            +V E L 
Sbjct: 34  NEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLG 88

Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
               DL     R  +LK  T +  A+ +   M Y+H      +I+RD++P N L  R  +
Sbjct: 89  PSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGN 143

Query: 290 GNLKVA---DFGVSK 301
              +V    DF ++K
Sbjct: 144 KTQQVIHIIDFALAK 158

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 3e-05
 Identities = 32/249 (12%), Positives = 70/249 (28%), Gaps = 72/249 (28%)

Query: 29  NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
           + +  D   +  +     L  ++  E    +    +++    ++N  ALH          
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK-VKLENEYALH---------- 446

Query: 89  VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEY 148
              +++        D     P     Y+ +H        H         H+K+       
Sbjct: 447 -RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG------H---------HLKNIEHPERM 490

Query: 149 EIDPHE-LDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
            +     LDF              F          L +++  D     A    L  LQ++
Sbjct: 491 TLFRMVFLDF-------------RF----------LEQKIRHDSTAWNASGSILNTLQQL 527

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL----KPSTAVRFALDIARGM 263
           +      +   +  + P       +    +  FL +        K +  +R AL      
Sbjct: 528 K-----FYKPYICDNDPKY--ERLV--NAILDFLPKIEENLICSKYTDLLRIAL------ 572

Query: 264 NYLHENKPV 272
             + E++ +
Sbjct: 573 --MAEDEAI 579

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.6 bits (94), Expect = 6e-04
 Identities = 35/323 (10%), Positives = 89/323 (27%), Gaps = 112/323 (34%)

Query: 19  PDRER---KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT 75
            D  +    + E++ +    + +    RL +    +  E +++ ++  + +N+       
Sbjct: 39  QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY------- 91

Query: 76  ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
                    F      L+      + +     T +    Y +  + +     +    + A
Sbjct: 92  --------KF------LMSPIKT-EQRQPSMMTRM----YIEQRDRL-----YNDNQVFA 127

Query: 136 PMHVKHAREVPE-----YEIDPHELDFTNSVEIT----KGTFILAFWRGIQVAVKKLGEE 186
             +V   +   +      E+ P +        +      G+       G       +  +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKN-------VLIDGVLGS-------GKTW----VALD 169

Query: 187 VISDDDRVRAF---------------RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           V                            L +LQK+ +     +      SS + +    
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH- 228

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DS 289
                ++A L+R                      L ++KP       L    +L +  ++
Sbjct: 229 ----SIQAELRR----------------------LLKSKPYE---NCLL---VLLNVQNA 256

Query: 290 GNLKVADFGVSKLLTVKEDRPLT 312
                 +     LLT +  + +T
Sbjct: 257 KAWNAFNLSCKILLTTR-FKQVT 278

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 8/69 (11%)

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNL 292
           DL  F  RK +LK  T +  A  +   + Y+H       IHRD++P N L         +
Sbjct: 93  DLFNFCSRKFSLK--TVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147

Query: 293 KVADFGVSK 301
            + DFG++K
Sbjct: 148 YIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 12/82 (14%)

Query: 227 IVTEYLPK--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           +V + L     DL     RK ++K  T    A  +   +  +HE     +++RD++P N 
Sbjct: 83  LVIDLLGPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIHEKS---LVYRDIKPDNF 137

Query: 285 L-----RDDSGNLKVADFGVSK 301
           L       ++  + V DFG+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVK 159

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 6/68 (8%)

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
                  +   L   + ++ A  +   + +LHEN+    +H ++   NI    +D   + 
Sbjct: 146 SALDVSPKH-VLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVT 201

Query: 294 VADFGVSK 301
           +A +G + 
Sbjct: 202 LAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 14/68 (20%), Positives = 35/68 (51%), Gaps = 7/68 (10%)

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
            +     ++ + K  T ++ +L I   + Y+HE++    +H D++ SN+L    +   + 
Sbjct: 140 KIYEANAKRFSRK--TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY 194

Query: 294 VADFGVSK 301
           + D+G++ 
Sbjct: 195 LVDYGLAY 202

>3agd_A Salt-tolerant glutaminase; glutaminase super family, hydrolase; 2.20A {Micrococcus luteus} PDB: 3age_A* 3if5_A 3ih8_A 3ih9_A 3iha_A* 3ihb_A 2dfw_A Length = 456

 Score = 40.5 bits (94), Expect = 5e-04
 Identities = 6/85 (7%), Positives = 17/85 (20%), Gaps = 2/85 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           + F   E  ++ + +L                     A      + +             
Sbjct: 335 IRFGGAEAVLDALTDLRTGAEKPGTGWDAAVYPRWQEAAADRAALSAATGGGAVHEAAAA 394

Query: 104 RWGSTPLGD--AIYYKNHEVIKLLE 126
                  G    +      V ++ +
Sbjct: 395 AARDENDGPIRTVVLNLARVDRIDD 419

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	319
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.95
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.95
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.95
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.95
3niz_A	311	Rhodanese family protein; structural genomics, str	99.95
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.94
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.94
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.94
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.94
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.94
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.94
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.94
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.94
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.94
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.94
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.94
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.94
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.94
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.94
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.94
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.94
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.94
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.94
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.94
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.94
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.94
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.94
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.94
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.94
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.94
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.94
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.94
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.94
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.94
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.94
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.94
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.94
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.93
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.93
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.93
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.93
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.93
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.93
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.93
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.93
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.93
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.93
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.93
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.93
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.93
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.93
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.93
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.93
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.93
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.93
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.93
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.93
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.93
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.93
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.93
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.93
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.93
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.93
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.93
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.93
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.93
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.93
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.93
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.93
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.93
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.93
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.93
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.93
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.93
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.93
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.93
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.93
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.93
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.93
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.93
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.93
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.93
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.93
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.93
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.93
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.92
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.92
3uqc_A	286	Probable conserved transmembrane protein; structur	99.92
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.92
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.92
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.92
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.92
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.92
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.92
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.92
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.92
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.92
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.92
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.92
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.92
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.92
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.92
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.92
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.92
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.92
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.92
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.92
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.92
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.92
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.92
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.92
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.92
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.92
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.92
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.92
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.92
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.92
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.92
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.92
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.92
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.92
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.92
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.92
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.92
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.91
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.91
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.91
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.91
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.91
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.91
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.91
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.91
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.91
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.91
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.91
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.91
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.91
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.91
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.91
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.91
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.91
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.91
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.91
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.91
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.91
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.91
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.91
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.91
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.91
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.91
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.91
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.91
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.91
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.91
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.9
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.9
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.9
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.9
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.9
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.9
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.9
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.9
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.9
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.9
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.9
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.9
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.9
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.89
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.89
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.89
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.89
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.89
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.89
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.89
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.89
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.89
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.89
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.89
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.89
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.89
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.89
2pnn_A	273	Transient receptor potential cation channel subfa	99.89
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.89
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.89
2rfa_A	232	Transient receptor potential cation channel subfa	99.88
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.88
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.88
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.88
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.88
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.88
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.88
2etb_A	256	Transient receptor potential cation channel subfam	99.88
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.88
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.88
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.88
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.88
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.88
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.88
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.88
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.88
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.87
2rfa_A	232	Transient receptor potential cation channel subfa	99.87
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.87
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.87
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.87
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.87
2etb_A	256	Transient receptor potential cation channel subfam	99.87
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.87
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.87
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.87
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.87
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.87
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.86
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.86
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.86
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.86
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.86
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.86
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.86
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.86
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.86
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.86
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.86
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.85
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.85
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.85
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.85
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.85
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.84
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.84
2pnn_A	273	Transient receptor potential cation channel subfa	99.84
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.84
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.84
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.84
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.84
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.84
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.84
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.84
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.84
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.83
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.83
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.83
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.83
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.82
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.82
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.82
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.81
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.8
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.78
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.74
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.74
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.74
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.71
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.69
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.67
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.03
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.02
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.73
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.58
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.42
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.21
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.05
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.94
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.77
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.63
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.49
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.43
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.88
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.83
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.76
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.14
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.12
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.3
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	92.04
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.98
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	89.89
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.05
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.13
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	88.04
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	86.49

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-38  Score=279.39  Aligned_cols=162  Identities=23%  Similarity=0.441  Sum_probs=145.3

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|...+.||+|+||.||.     +|+.||||++.+.........+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3688999999999999985     57899999998654433344577899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC--C
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK--E  307 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~--~  307 (319)
                      |||+||+|.+++.+.+.+++..+..|+.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.+...  .
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999999999999889999999999999999999999999   999999999999999999999999999988644  3


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                      ....+.+|||+|
T Consensus       189 ~~~~~~~GTp~Y  200 (311)
T 4aw0_A          189 ARANSFVGTAQY  200 (311)
T ss_dssp             CCBCCCCSCGGG
T ss_pred             ccccCcccCccc
Confidence            345678999965

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-37  Score=276.89  Aligned_cols=160  Identities=24%  Similarity=0.475  Sum_probs=138.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||||++.+... .....+.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            688899999999999985     478999999987654 34556789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      ||+||+|.+++..++  .+++..+..|+.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+|+.+.....
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            999999999997653  4789999999999999999999999   99999999999999999999999999998877655


Q ss_pred             CceeeccCCCC
Q 020981          309 RPLTCQDTSCR  319 (319)
Q Consensus       309 ~~~~~~~~~~~  319 (319)
                      ...+++|||.|
T Consensus       181 ~~~~~~GT~~Y  191 (350)
T 4b9d_A          181 LARACIGTPYY  191 (350)
T ss_dssp             HHHHHHSCCTT
T ss_pred             cccccCCCccc
Confidence            66678899965

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.1e-37  Score=274.11  Aligned_cols=157  Identities=22%  Similarity=0.373  Sum_probs=142.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|....+||+|+||.||.     +|+.||||++.......   .+.+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            578888999999999985     47899999997654332   3567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ||+||+|.+++.+ +.+++..+..|+.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+|+.+.......
T Consensus       152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  227 (346)
T 4fih_A          152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  227 (346)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence            9999999999876 56999999999999999999999999   9999999999999999999999999999998877777


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      .+.+|||+|
T Consensus       228 ~~~~GTp~Y  236 (346)
T 4fih_A          228 KSLVGTPYW  236 (346)
T ss_dssp             CCCCSCGGG
T ss_pred             cccccCcCc
Confidence            889999965

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.5e-37  Score=264.47  Aligned_cols=159  Identities=26%  Similarity=0.490  Sum_probs=127.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            688889999999999985     488999999987665555556779999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |+ +|+|.+++.+++++++..+..+++|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+...... ..
T Consensus        94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~  168 (275)
T 3hyh_A           94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FL  168 (275)
T ss_dssp             CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC-cc
Confidence            99 6899999999889999999999999999999999999   9999999999999999999999999998876543 34


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      .+.+|||.|
T Consensus       169 ~~~~GT~~Y  177 (275)
T 3hyh_A          169 KTSCGSPNY  177 (275)
T ss_dssp             ------CTT
T ss_pred             CCeeECccc
Confidence            567899865

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=275.81  Aligned_cols=157  Identities=22%  Similarity=0.373  Sum_probs=142.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|....+||+|+||.||.     +|+.||||++.......   .+.+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            588889999999999985     47899999997543322   3567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ||+||+|.++++. +.+++..+..|++||+.||+|||+++   |+||||||+||||+.+|.+||+|||+|+.+.......
T Consensus       229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  304 (423)
T 4fie_A          229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  304 (423)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred             CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence            9999999999875 46999999999999999999999999   9999999999999999999999999999998887778


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      .+.+|||+|
T Consensus       305 ~~~~GTp~Y  313 (423)
T 4fie_A          305 KSLVGTPYW  313 (423)
T ss_dssp             CCCEECTTT
T ss_pred             cccccCcCc
Confidence            889999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.9e-37  Score=271.42  Aligned_cols=160  Identities=25%  Similarity=0.351  Sum_probs=135.0

Q ss_pred             cccceeeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|...+.||+|+||.||.        +++.||+|++.+...... ....+.+|+.++++++|||||++++++.+++.+|+
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            688999999999999984        357899999976543221 12357789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |||||+||+|.+++.+.+.+++..+..|++|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999999999999889999999999999999999999999   9999999999999999999999999999887777


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                      ....+.+|||.|
T Consensus       181 ~~~~~~~GT~~Y  192 (304)
T 3ubd_A          181 KKAYSFCGTVEY  192 (304)
T ss_dssp             CCCCSCCCCGGG
T ss_pred             ccccccccCccc
Confidence            777788999964

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-35  Score=258.48  Aligned_cols=158  Identities=28%  Similarity=0.517  Sum_probs=136.8

Q ss_pred             cceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe----CCceEEE
Q 020981          158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMIV  228 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv  228 (319)
                      ....+||+|+||.||.     ++..||+|.+..... .....+.|.+|+.++++++|||||+++++|.+    +..+|+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            4456799999999985     478999999976543 44556789999999999999999999999865    3468999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCcccccccCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||||+||+|.+++.+.+.+++..+..|+.||+.||+|||++++ +|+||||||+|||++ .+|.+||+|||+|+....  
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  184 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence            9999999999999998899999999999999999999999874 499999999999998 579999999999986433  


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                      ....+.+|||.|
T Consensus       185 ~~~~~~~GTp~Y  196 (290)
T 3fpq_A          185 SFAKAVIGTPEF  196 (290)
T ss_dssp             TSBEESCSSCCC
T ss_pred             CccCCcccCccc
Confidence            345678899965

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.4e-36  Score=264.81  Aligned_cols=154  Identities=27%  Similarity=0.393  Sum_probs=132.9

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ..|...++||+|+||.||.     +|+.||||+++.+...        .+|+.+++.++|||||++++++.++..+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3567778899999999985     4789999999865432        35999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DFgla~~~~~~~~  308 (319)
                      |||+||+|.+++++.+.+++..+..|+.|++.||+|||+++   |+||||||+||||+.+| .+||+|||+|+.+.....
T Consensus       130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999999999889999999999999999999999999   99999999999999988 599999999998865432


Q ss_pred             C-----ceeeccCCCC
Q 020981          309 R-----PLTCQDTSCR  319 (319)
Q Consensus       309 ~-----~~~~~~~~~~  319 (319)
                      .     ....+|||.|
T Consensus       207 ~~~~~~~~~~~GT~~Y  222 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETH  222 (336)
T ss_dssp             -------CCCCCCGGG
T ss_pred             ccceecCCccccCccc
Confidence            2     2335789854

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-35  Score=257.69  Aligned_cols=167  Identities=29%  Similarity=0.422  Sum_probs=136.5

Q ss_pred             CccccCCCcccccceeeeecceEEEEEEe--ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  223 (319)
                      ..|+++..+  +...++||+|+||.||..  ...||||+++... .+....+.|.+|+.++++++|||||++++++. ++
T Consensus        29 ~~Wei~~~~--l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~  104 (307)
T 3omv_A           29 YYWEIEASE--VMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD  104 (307)
T ss_dssp             CCCBCCTTS--CCEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             cCcEEcHHH--eEEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence            357777664  556778999999999852  3579999987543 34566788999999999999999999999765 46


Q ss_pred             ceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      .+|+|||||++|+|.+++... .++++..+..|+.|++.||+|||+++   ||||||||+|||+++++.+||+|||+|+.
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            789999999999999999764 56999999999999999999999998   99999999999999999999999999998


Q ss_pred             cccCC--CCceeeccCCCC
Q 020981          303 LTVKE--DRPLTCQDTSCR  319 (319)
Q Consensus       303 ~~~~~--~~~~~~~~~~~~  319 (319)
                      .....  ......+|||.|
T Consensus       182 ~~~~~~~~~~~~~~GT~~y  200 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLW  200 (307)
T ss_dssp             ------------CCCCTTS
T ss_pred             cccCCcceeecccccCCCc
Confidence            75432  233456888864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-35  Score=258.77  Aligned_cols=157  Identities=31%  Similarity=0.491  Sum_probs=133.5

Q ss_pred             cccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|...+.||+|+||.||.          ++..||||++...   +....+.|.+|+.+|++++|||||++++++.+++.+
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            567778999999999985          2678999999743   455667899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCE
Q 020981          226 MIVTEYLPKGDLRAFLKRK-------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~  292 (319)
                      |+|||||++|+|.+++.+.             ..+++..+..|+.|++.||+|||+++   |+||||||+|||+++++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence            9999999999999999764             35899999999999999999999999   9999999999999999999


Q ss_pred             EEEecCcccccccCCCCc--eeeccCCC
Q 020981          293 KVADFGVSKLLTVKEDRP--LTCQDTSC  318 (319)
Q Consensus       293 kl~DFgla~~~~~~~~~~--~~~~~~~~  318 (319)
                      ||+|||+|+.........  ....||+.
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~  195 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIR  195 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGG
T ss_pred             EECCcccceecCCCCceeecCceecChh
Confidence            999999999775543322  22456663

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.4e-35  Score=254.82  Aligned_cols=159  Identities=24%  Similarity=0.383  Sum_probs=125.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-------
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-------  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-------  223 (319)
                      +|...+.||+|+||.||.     +|+.||||++....  .+...+.+.+|+.+++.++|||||+++++|...+       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            577888999999999985     47899999987542  4555678899999999999999999999987654       


Q ss_pred             -----ceEEEEeecCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          224 -----PMMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       224 -----~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                           .+|+|||||++|+|.+++..+..   .++..+..|+.|++.||+|||+++   |+||||||+|||++.+|.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                 37999999999999999987654   345668899999999999999999   9999999999999999999999


Q ss_pred             ecCcccccccCCCC------------ceeeccCCCC
Q 020981          296 DFGVSKLLTVKEDR------------PLTCQDTSCR  319 (319)
Q Consensus       296 DFgla~~~~~~~~~------------~~~~~~~~~~  319 (319)
                      |||+|+.+......            ..+.+|||.|
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y  196 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY  196 (299)
T ss_dssp             CCCCC--------------------------CCCTT
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccc
Confidence            99999988654322            2346799865

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.7e-35  Score=257.81  Aligned_cols=157  Identities=31%  Similarity=0.474  Sum_probs=128.4

Q ss_pred             cccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      ++...++||+|+||.||.          ++..||||++...   +....+.|.+|+.+|++++|||||++++++.+...+
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            566778999999999985          2678999999743   455667899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC
Q 020981          226 MIVTEYLPKGDLRAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~  290 (319)
                      |+|||||++|+|.+++++.               .++++.++..|+.|++.||.|||+++   ||||||||+|||+++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence            9999999999999999753               35899999999999999999999999   99999999999999999


Q ss_pred             CEEEEecCcccccccCCC--CceeeccCCC
Q 020981          291 NLKVADFGVSKLLTVKED--RPLTCQDTSC  318 (319)
Q Consensus       291 ~~kl~DFgla~~~~~~~~--~~~~~~~~~~  318 (319)
                      .+||+|||+|+.......  ......|||.
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~  225 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIR  225 (329)
T ss_dssp             EEEECCCC----------------CCCCGG
T ss_pred             cEEEcccccceeccCCCcceecCccccccc
Confidence            999999999997754432  2234567764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-34  Score=254.06  Aligned_cols=157  Identities=29%  Similarity=0.460  Sum_probs=132.3

Q ss_pred             ccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          157 FTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      +...++||+|+||.||.          +++.||||.+....  .....+.|.+|+.++++++|||||+++|++..+..++
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            44567899999999984          34789999997543  2334577999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC
Q 020981          227 IVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~  290 (319)
                      +|||||++|+|.+++..+                ..+++..+..|+.|++.||+|||+++   ||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            999999999999999653                34889999999999999999999999   99999999999999999


Q ss_pred             CEEEEecCcccccccCCC--CceeeccCCC
Q 020981          291 NLKVADFGVSKLLTVKED--RPLTCQDTSC  318 (319)
Q Consensus       291 ~~kl~DFgla~~~~~~~~--~~~~~~~~~~  318 (319)
                      .+||+|||+|+.......  ......||+.
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~  212 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIR  212 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGG
T ss_pred             CEEECCcccceeccCCCceeEecccccCCc
Confidence            999999999997754432  2234566663

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.7e-34  Score=269.21  Aligned_cols=163  Identities=24%  Similarity=0.338  Sum_probs=139.8

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCC---HHHHHHHHHHHHHHHhcCCCcccccceeEEeCC
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  223 (319)
                      ....+|...+.||+|+||.||.     +|+.||||++.+.....   .........++.+++.++|||||+++++|.+.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            3345799999999999999985     58899999997653321   222223344567777889999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .+|+|||||+||+|.+++.+.+.+++..+..|++||+.||+|||+++   ||||||||+||||+.+|++||+|||+|+.+
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999999999899999999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCceeeccCCCC
Q 020981          304 TVKEDRPLTCQDTSCR  319 (319)
Q Consensus       304 ~~~~~~~~~~~~~~~~  319 (319)
                      ...  ...+.+|||.|
T Consensus       343 ~~~--~~~t~~GTp~Y  356 (689)
T 3v5w_A          343 SKK--KPHASVGTHGY  356 (689)
T ss_dssp             SSC--CCCSCCSCGGG
T ss_pred             CCC--CCCCccCCcCc
Confidence            654  45567899964

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-33  Score=253.58  Aligned_cols=159  Identities=24%  Similarity=0.411  Sum_probs=137.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe------CCc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~  224 (319)
                      +|...+.||+|+||.||.     +|+.||||++.... ......+.+.+|+.+|+.++|||||++++++..      ...
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            588899999999999985     58899999997653 334555778899999999999999999998754      357


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +|+|||||+ |+|.+++.+++.+++..+..|++||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            899999995 789999998889999999999999999999999999   9999999999999999999999999999875


Q ss_pred             cC----CCCceeeccCCCC
Q 020981          305 VK----EDRPLTCQDTSCR  319 (319)
Q Consensus       305 ~~----~~~~~~~~~~~~~  319 (319)
                      ..    .....+.+|||+|
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y  228 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWY  228 (398)
T ss_dssp             ------CCCCCSSCCCCTT
T ss_pred             cCccccccccccceeChHh
Confidence            43    3344567899865

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.3e-33  Score=245.89  Aligned_cols=159  Identities=28%  Similarity=0.425  Sum_probs=126.7

Q ss_pred             cccceeeeecceEEEEE---EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC----ceEEE
Q 020981          156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~lv  228 (319)
                      ++...+.||+|+||.||   ++|+.||||++....    .....+..|+..+..++|||||++++++..++    .+|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            46677899999999887   578999999986432    22223345666677889999999999997654    57999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ||||++|+|.++++.. .+++..+.+++.|++.||.|||++.     ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus        80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999999864 5899999999999999999999871     113999999999999999999999999999987


Q ss_pred             ccCCCC----ceeeccCCCC
Q 020981          304 TVKEDR----PLTCQDTSCR  319 (319)
Q Consensus       304 ~~~~~~----~~~~~~~~~~  319 (319)
                      ......    ....+|||.|
T Consensus       159 ~~~~~~~~~~~~~~~GT~~y  178 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRY  178 (303)
T ss_dssp             ETTTTEESCC-----CCGGG
T ss_pred             cCCCCceeeecccccccccc
Confidence            655432    2345788743

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.8e-33  Score=249.61  Aligned_cols=164  Identities=30%  Similarity=0.470  Sum_probs=137.1

Q ss_pred             ccccCCCcccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCC-Cccccc
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF  215 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l  215 (319)
                      .|+++.+  +|...+.||+|+||.||..          ++.||||.+....  .....+.|.+|+.+|++++| ||||++
T Consensus        58 ~wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           58 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4677654  5777889999999999852          3679999997543  34556789999999999975 899999


Q ss_pred             ceeEEeC-CceEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcC
Q 020981          216 LGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD  278 (319)
Q Consensus       216 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~D  278 (319)
                      +++|... ..+|+|||||++|+|.++++..                ..+++..+..|+.||+.||+|||+++   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9998664 5789999999999999999753                23789999999999999999999999   99999


Q ss_pred             CCCCCEEecCCCCEEEEecCcccccccCCCCc--eeeccCC
Q 020981          279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTS  317 (319)
Q Consensus       279 lk~~Nill~~~~~~kl~DFgla~~~~~~~~~~--~~~~~~~  317 (319)
                      |||+|||+++++.+||+|||+|+.+.......  .+..||+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~  251 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  251 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence            99999999999999999999999876554322  3456666

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=2.2e-31  Score=239.42  Aligned_cols=139  Identities=22%  Similarity=0.333  Sum_probs=123.6

Q ss_pred             cccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceE
Q 020981          156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~  226 (319)
                      .|...+.||+|+||.||..        ++.||+|.+.+..  .   ...+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            5888999999999999852        5789999986532  1   24567899999998 5999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC-CCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DFgla~~~~~  305 (319)
                      +|||||++|+|.++++   .+++.++..+++|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+....
T Consensus        97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            9999999999999884   4899999999999999999999999   9999999999999876 8999999999986643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=4.5e-31  Score=250.99  Aligned_cols=157  Identities=24%  Similarity=0.411  Sum_probs=138.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||+|.+....   ....+.+.+|+.+|+.++||||++++++|.+...+|+|||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            688889999999999985     58899999987542   3445778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC--CCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DFgla~~~~~~~  307 (319)
                      ||+||+|.+++.. .+.+++..+..|++||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+|+.+... 
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            9999999999864 457999999999999999999999999   9999999999999854  89999999999988765 


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                      ....+.+|||.|
T Consensus       311 ~~~~~~~GT~~y  322 (573)
T 3uto_A          311 QSVKVTTGTAEF  322 (573)
T ss_dssp             SEEEEECSSGGG
T ss_pred             CceeeeEECccc
Confidence            344567888854

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=4.9e-30  Score=233.51  Aligned_cols=162  Identities=27%  Similarity=0.418  Sum_probs=142.9

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ..+|.....||+|+||.||.     +++.||+|++.+...........+.+|..++.++ +||||+++++++......|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            34688899999999999985     4789999999877665555566788899999887 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||||+++|+|..++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+......
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            9999999999999998888999999999999999999999999   9999999999999999999999999999866666


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                      ....+.+|||.
T Consensus       208 ~~~~~~~gt~~  218 (396)
T 4dc2_A          208 DTTSTFCGTPN  218 (396)
T ss_dssp             CCBCCCCBCGG
T ss_pred             CccccccCCcc
Confidence            66677788874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.97  E-value=1.2e-29  Score=227.38  Aligned_cols=161  Identities=28%  Similarity=0.428  Sum_probs=145.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .+|.....||+|+||.||.     +++.||+|++.+...........+.+|..+++.+ +||||+++++++......|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            3688889999999999985     4789999999887666677778889999999988 799999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||+++|+|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.......
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            999999999999998888999999999999999999999999   99999999999999999999999999997665555


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      .....+||+.
T Consensus       166 ~~~~~~gt~~  175 (345)
T 3a8x_A          166 TTSTFCGTPN  175 (345)
T ss_dssp             CBCCCCSCGG
T ss_pred             cccccCCCcc
Confidence            5666778874

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=3.9e-30  Score=231.21  Aligned_cols=161  Identities=29%  Similarity=0.382  Sum_probs=136.8

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .+|.....||+|+||.||.     +++.||+|++.+...........+.+|..+++.+ +||||+++++++......|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            3688889999999999985     4789999999865433334456778899999998 699999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.......
T Consensus       103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence            999999999999998888999999999999999999999999   99999999999999999999999999998766666


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      ...+.+|||.
T Consensus       180 ~~~~~~gt~~  189 (353)
T 3txo_A          180 TTATFCGTPD  189 (353)
T ss_dssp             ------CCGG
T ss_pred             cccccCCCcC
Confidence            6667788874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=4.1e-30  Score=229.62  Aligned_cols=161  Identities=29%  Similarity=0.375  Sum_probs=141.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     +|+.||+|++.+...........+.+|..+++.++||||+++++++......|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            3688889999999999985     47899999997653222233466888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+........
T Consensus        85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            99999999999998888999999999999999999999999   999999999999999999999999999986655555


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                      ..+.+|||.
T Consensus       162 ~~~~~gt~~  170 (337)
T 1o6l_A          162 MKTFCGTPE  170 (337)
T ss_dssp             BCCCEECGG
T ss_pred             ccccccChh
Confidence            566677773

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=2.9e-29  Score=223.34  Aligned_cols=159  Identities=25%  Similarity=0.435  Sum_probs=141.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      -+|.....+|+|+||.||.     +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++......|+||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            3688899999999999984     578999999976543 4455677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  169 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-  169 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999988765533 


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                      ....+|||.
T Consensus       170 ~~~~~gt~~  178 (328)
T 3fe3_A          170 LDAFCGAPP  178 (328)
T ss_dssp             GGTTSSSGG
T ss_pred             cccccCCcc
Confidence            334566663

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=8.6e-30  Score=228.18  Aligned_cols=164  Identities=29%  Similarity=0.398  Sum_probs=141.3

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCce
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  225 (319)
                      ....+|.....||+|+||.||.     +++.||+|++.+...........+..|..+++.+ +||||+++++++.+....
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            3445788899999999999985     4789999999764322222345677899999887 899999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+||||+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+....
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            999999999999999998888999999999999999999999999   99999999999999999999999999998766


Q ss_pred             CCCCceeeccCCC
Q 020981          306 KEDRPLTCQDTSC  318 (319)
Q Consensus       306 ~~~~~~~~~~~~~  318 (319)
                      ........+|||.
T Consensus       171 ~~~~~~~~~gt~~  183 (345)
T 1xjd_A          171 GDAKTNTFCGTPD  183 (345)
T ss_dssp             TTCCBCCCCSCGG
T ss_pred             CCCcccCCCCCcc
Confidence            5556666778874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=2.2e-29  Score=226.25  Aligned_cols=161  Identities=30%  Similarity=0.387  Sum_probs=141.1

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .+|.....||+|+||.||.     +++.||+|++.+.........+.+..|..++..+ +||+|+++++++......|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            4688889999999999985     4788999999765332223346678899999988 699999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||++||+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.......
T Consensus       100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence            999999999999998888999999999999999999999999   99999999999999999999999999998665555


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      .....+|||.
T Consensus       177 ~~~~~~gt~~  186 (353)
T 2i0e_A          177 TTKTFCGTPD  186 (353)
T ss_dssp             CBCCCCSCGG
T ss_pred             ccccccCCcc
Confidence            5666778874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=3.6e-29  Score=226.44  Aligned_cols=163  Identities=28%  Similarity=0.393  Sum_probs=134.4

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHH-HHhcCCCcccccceeEEeCCceEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ..+|.....||+|+||.||.     ++..||+|++.+...........+..|..+ ++.++||||+++++++......|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            34788899999999999985     467899999987665555555566677776 567899999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||||+++|+|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+++......
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            9999999999999998888999999999999999999999999   9999999999999999999999999999866665


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                      ......+||+.|
T Consensus       194 ~~~~~~~gt~~y  205 (373)
T 2r5t_A          194 STTSTFCGTPEY  205 (373)
T ss_dssp             CCCCSBSCCCCC
T ss_pred             CccccccCCccc
Confidence            666667888743

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=1.8e-28  Score=215.31  Aligned_cols=158  Identities=22%  Similarity=0.429  Sum_probs=140.6

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ..+|.....||+|+||.||.     +++.||+|.+.......   .+.+.+|+.+++.++||||+++++++......|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            34688889999999999985     47899999987554333   35678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||+++++|.+++... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999999875 5899999999999999999999999   99999999999999999999999999998887776


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      ......||+.
T Consensus       172 ~~~~~~gt~~  181 (297)
T 3fxz_A          172 KRSTMVGTPY  181 (297)
T ss_dssp             CBCCCCSCGG
T ss_pred             ccCCccCCcC
Confidence            6666777774

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=1.1e-28  Score=216.37  Aligned_cols=160  Identities=24%  Similarity=0.416  Sum_probs=136.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     .+..||+|.+...........+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   91 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME   91 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence            688889999999999985     478999999876655566777889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC-
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-  309 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~-  309 (319)
                      |+++++|.+++...+++++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+...... 
T Consensus        92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            9999999999998888999999999999999999999999   999999999999999999999999999887654322 


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                      .....||+.
T Consensus       169 ~~~~~gt~~  177 (294)
T 4eqm_A          169 TNHVLGTVQ  177 (294)
T ss_dssp             ------CCS
T ss_pred             cCccccCcc
Confidence            233456663

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.96  E-value=1.9e-29  Score=232.53  Aligned_cols=164  Identities=23%  Similarity=0.310  Sum_probs=138.9

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      ....+|.....||+|+||.||.     +++.||+|++.+...........+.+|..++..++||||+++++++.+....|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            3345788899999999999985     46899999987532211122234788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +||||+++|+|.+++.+ .+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            99999999999999987 467999999999999999999999999   99999999999999999999999999987765


Q ss_pred             CCCC-ceeeccCCC
Q 020981          306 KEDR-PLTCQDTSC  318 (319)
Q Consensus       306 ~~~~-~~~~~~~~~  318 (319)
                      .... ....+|||.
T Consensus       228 ~~~~~~~~~~GT~~  241 (437)
T 4aw2_A          228 DGTVQSSVAVGTPD  241 (437)
T ss_dssp             TSCEECCSCCSCGG
T ss_pred             CCCcccccccCCcC
Confidence            5433 234578874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=3.7e-29  Score=221.71  Aligned_cols=158  Identities=27%  Similarity=0.479  Sum_probs=138.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     +|+.||+|++.+.........+.+.+|..+++.++||||+++++++.+....|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            3688889999999999985     47899999997643222233466788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+++.....   
T Consensus        86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            99999999999998888999999999999999999999999   999999999999999999999999999876432   


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                      ..+.+|||.
T Consensus       160 ~~~~~gt~~  168 (318)
T 1fot_A          160 TYTLCGTPD  168 (318)
T ss_dssp             BCCCCSCTT
T ss_pred             cccccCCcc
Confidence            334567764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=230.45  Aligned_cols=163  Identities=26%  Similarity=0.349  Sum_probs=139.5

Q ss_pred             CcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ...+|.....||+|+||.||.     +++.||+|++.+...........+.+|..++..++||||+++++++.+....|+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            345788899999999999884     478999999975432222233457889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            999999999999998754 7999999999999999999999999   999999999999999999999999999987665


Q ss_pred             CCC-ceeeccCCC
Q 020981          307 EDR-PLTCQDTSC  318 (319)
Q Consensus       307 ~~~-~~~~~~~~~  318 (319)
                      ... ....+||+.
T Consensus       216 ~~~~~~~~~Gt~~  228 (412)
T 2vd5_A          216 GTVRSLVAVGTPD  228 (412)
T ss_dssp             SCEECSSCCSCGG
T ss_pred             CccccceeccccC
Confidence            432 234577774

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=2.3e-29  Score=228.34  Aligned_cols=160  Identities=28%  Similarity=0.443  Sum_probs=139.8

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     +++.||+|++.+...........+.+|+.+++.++||||+++++++......|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            3688889999999998885     46889999987644323334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+.+|+|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||+|+.+.... .
T Consensus        95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~  170 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-Q  170 (384)
T ss_dssp             CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-C
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC-c
Confidence            99999999999998888999999999999999999999999   9999999999999999999999999999876543 3


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                      ....+||+.
T Consensus       171 ~~~~~gt~~  179 (384)
T 4fr4_A          171 ITTMAGTKP  179 (384)
T ss_dssp             BCCCCSCGG
T ss_pred             eeccCCCcc
Confidence            344667763

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=1.1e-28  Score=219.48  Aligned_cols=161  Identities=27%  Similarity=0.403  Sum_probs=127.8

Q ss_pred             ccccceeeeecceEEEEEE--------eceEeEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      .+|.....||+|+||.||.        +++.+|+|++.+.... .......+.+|+.+++.++||||+++++++......
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            3688889999999999983        5789999999865432 223445678899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+||||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            999999999999999998888999999999999999999999999   99999999999999999999999999987655


Q ss_pred             CCCCceeeccCCC
Q 020981          306 KEDRPLTCQDTSC  318 (319)
Q Consensus       306 ~~~~~~~~~~~~~  318 (319)
                      .........||+.
T Consensus       174 ~~~~~~~~~gt~~  186 (327)
T 3a62_A          174 DGTVTHTFCGTIE  186 (327)
T ss_dssp             -----CTTSSCCT
T ss_pred             CCccccccCCCcC
Confidence            5444445567764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=2.8e-28  Score=225.33  Aligned_cols=159  Identities=18%  Similarity=0.311  Sum_probs=140.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +|+.+|+|.+..... .....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            578888999999999985     578999999876543 33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec---CCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++|+|.+.+...+.+++..+..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||+|+.+....
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~  167 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ  167 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence            9999999999999888999999999999999999999999   99999999999998   46789999999999887776


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                      .......|||.
T Consensus       168 ~~~~~~~gt~~  178 (444)
T 3soa_A          168 QAWFGFAGTPG  178 (444)
T ss_dssp             CBCCCSCSCGG
T ss_pred             ceeecccCCcc
Confidence            66666778874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=6.7e-29  Score=222.95  Aligned_cols=158  Identities=27%  Similarity=0.412  Sum_probs=137.8

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     +|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            3688889999999999885     47899999987643322233467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++|+|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+++.....   
T Consensus       121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC---
Confidence            99999999999998888999999999999999999999999   999999999999999999999999999876543   


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                      ....+|||.
T Consensus       195 ~~~~~gt~~  203 (350)
T 1rdq_E          195 TWTLCGTPE  203 (350)
T ss_dssp             BCCCEECGG
T ss_pred             cccccCCcc
Confidence            234456663

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=2.9e-29  Score=229.52  Aligned_cols=163  Identities=26%  Similarity=0.332  Sum_probs=137.4

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      ....+|.....||+|+||.||.     +++.||+|++.+...........+.+|..+++.++||||+++++++.+....|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3344788899999999999985     47899999987532211112234778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +||||++||+|.+++.. ..+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            99999999999999876 46899999999999999999999999   999999999999999999999999999887654


Q ss_pred             CC-CceeeccCCC
Q 020981          307 ED-RPLTCQDTSC  318 (319)
Q Consensus       307 ~~-~~~~~~~~~~  318 (319)
                      .. ...+.+|||.
T Consensus       222 ~~~~~~~~~gt~~  234 (410)
T 3v8s_A          222 GMVRCDTAVGTPD  234 (410)
T ss_dssp             SEEECCSCCSCGG
T ss_pred             CcccccCCcCCcc
Confidence            32 2335677774

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=4.9e-29  Score=236.89  Aligned_cols=141  Identities=16%  Similarity=0.201  Sum_probs=121.4

Q ss_pred             EEeceEeEEEEecccccC-------CHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEeecCCCCHHHHHHH
Q 020981          172 FWRGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR  243 (319)
Q Consensus       172 ~~~~~~vAvK~l~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  243 (319)
                      ++.|..+++|++.+....       .....+.|.+|+++|+++ .|+||+++++++.++...||||||++|++|.+++.+
T Consensus       256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~  335 (569)
T 4azs_A          256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA  335 (569)
T ss_dssp             EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred             ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence            467899999999765322       123346799999999999 599999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCceeeccCCC
Q 020981          244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       244 ~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~  318 (319)
                      .+++++.   .|++||+.||+|+|++|   ||||||||+|||++.+|.+||+|||+|+....+.....+.+|||.
T Consensus       336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~  404 (569)
T 4azs_A          336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFF  404 (569)
T ss_dssp             TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHH
T ss_pred             CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechh
Confidence            8888765   58899999999999999   999999999999999999999999999998877776777777764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=4.2e-29  Score=231.46  Aligned_cols=161  Identities=28%  Similarity=0.370  Sum_probs=130.8

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     +++.||+|++.............+.+|+.+++.++||||+++++++......|+||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            3688889999999999984     47899999998765445555667888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||+ ++   |+||||||+|||++.++.+||+|||+|+.......
T Consensus       228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            999999999999988889999999999999999999998 88   99999999999999999999999999998766655


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      .....+||+.
T Consensus       305 ~~~~~~gt~~  314 (446)
T 4ejn_A          305 TMKTFCGTPE  314 (446)
T ss_dssp             --CCSSSCGG
T ss_pred             ccccccCCcc
Confidence            5566777774

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.96  E-value=1.1e-27  Score=209.62  Aligned_cols=171  Identities=25%  Similarity=0.399  Sum_probs=148.1

Q ss_pred             CCCccccCC-CcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccce
Q 020981          144 EVPEYEIDP-HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG  217 (319)
Q Consensus       144 ~~~~~~~~~-~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~  217 (319)
                      ++|++.+++ ...+|.....||+|+||.||.     +++.+|+|.+...........+.+.+|+.+++.++||||+++++
T Consensus         3 ~~p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   82 (294)
T 2rku_A            3 EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG   82 (294)
T ss_dssp             CCCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cCcceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence            344444433 334788899999999999985     36789999998766666677788999999999999999999999


Q ss_pred             eEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      ++......++||||+++++|.+++...+.+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             eeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEec
Confidence            99999999999999999999999988888999999999999999999999999   999999999999999999999999


Q ss_pred             CcccccccCCCCceeeccCC
Q 020981          298 GVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       298 gla~~~~~~~~~~~~~~~~~  317 (319)
                      |+++.............||+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~  179 (294)
T 2rku_A          160 GLATKVEYDGERKKVLCGTP  179 (294)
T ss_dssp             TTCEECCSTTCCBCCCCSCC
T ss_pred             cCceecccCccccccccCCC
Confidence            99998765554445556665

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.95  E-value=9.1e-29  Score=220.74  Aligned_cols=158  Identities=27%  Similarity=0.474  Sum_probs=136.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +++.||+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            688889999999999984     578999999875432222223568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |+ +|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....+... 
T Consensus        90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~-  164 (336)
T 3h4j_B           90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL-  164 (336)
T ss_dssp             CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT-
T ss_pred             CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCccc-
Confidence            99 7899999988888999999999999999999999999   999999999999999999999999999987665433 


Q ss_pred             eeeccCCC
Q 020981          311 LTCQDTSC  318 (319)
Q Consensus       311 ~~~~~~~~  318 (319)
                      ...+|||.
T Consensus       165 ~~~~gt~~  172 (336)
T 3h4j_B          165 KTSCGSPN  172 (336)
T ss_dssp             CCCTTSTT
T ss_pred             ccccCCcC
Confidence            33567764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.95  E-value=4.9e-28  Score=213.71  Aligned_cols=162  Identities=40%  Similarity=0.649  Sum_probs=129.5

Q ss_pred             ccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      .+|.....+|+|+||.||.   .+..||+|++..... .....+.+.+|+.++++++||||+++++++......++||||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY  115 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred             hHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence            4688889999999998874   688999999876543 455567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          232 LPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      +++++|.+++.....   +++..+..++.|++.||.|||++++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~  194 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL  194 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence            999999999986543   8999999999999999999999873 499999999999999999999999999987666554


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      ......||+.
T Consensus       195 ~~~~~~gt~~  204 (309)
T 3p86_A          195 SSKSAAGTPE  204 (309)
T ss_dssp             -------CCT
T ss_pred             ccccCCCCcc
Confidence            4555667663

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.95  E-value=1e-27  Score=211.51  Aligned_cols=145  Identities=36%  Similarity=0.588  Sum_probs=131.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     ++..+|+|.+...   .....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            677888999999999985     3788999988542   45666789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++.. ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999999987 456999999999999999999999999   999999999999999999999999999877544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.95  E-value=3.8e-28  Score=218.85  Aligned_cols=160  Identities=25%  Similarity=0.398  Sum_probs=138.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCH---HHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      ..|.....||+|+||.||.     +|..||+|.+.+......   ...+.+.+|+.+++.++||||+++++++......|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            3588889999999999985     478999999976543211   12467889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC----CEEEEecCcccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL  302 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DFgla~~  302 (319)
                      +||||+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++    .+||+|||+++.
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            99999999999999988888999999999999999999999999   99999999999999877    799999999998


Q ss_pred             cccCCCCceeeccCCC
Q 020981          303 LTVKEDRPLTCQDTSC  318 (319)
Q Consensus       303 ~~~~~~~~~~~~~~~~  318 (319)
                      +..... .....|||.
T Consensus       169 ~~~~~~-~~~~~gt~~  183 (361)
T 2yab_A          169 IEDGVE-FKNIFGTPE  183 (361)
T ss_dssp             CCTTCC-CCCCCSCGG
T ss_pred             cCCCCc-cccCCCCcc
Confidence            766533 334567764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=1.8e-27  Score=212.36  Aligned_cols=162  Identities=23%  Similarity=0.358  Sum_probs=144.9

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ..+|.....||+|+||.||.     +++.+|+|++...........+.+.+|+.+++.++||||+++++++......|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            34788899999999999985     3678999999876666667778899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            999999999999998888999999999999999999999999   99999999999999999999999999998765555


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      ......||+.
T Consensus       197 ~~~~~~gt~~  206 (335)
T 2owb_A          197 RKKVLCGTPN  206 (335)
T ss_dssp             CBCCCCSCCS
T ss_pred             cccccCCCcc
Confidence            5555666663

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=2.5e-28  Score=230.04  Aligned_cols=162  Identities=24%  Similarity=0.353  Sum_probs=141.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     +|+.||+|++.+...........+.+|..+++.++||||+++++++.....+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            4688888999999999985     47899999997654322233467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||++||+|.+++...    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999764    35999999999999999999999999   99999999999999999999999999998877


Q ss_pred             CCCCceeeccCCCC
Q 020981          306 KEDRPLTCQDTSCR  319 (319)
Q Consensus       306 ~~~~~~~~~~~~~~  319 (319)
                      ........+|||.|
T Consensus       342 ~~~~~~~~~GT~~Y  355 (543)
T 3c4z_A          342 GQTKTKGYAGTPGF  355 (543)
T ss_dssp             TCCCBCCCCSCTTT
T ss_pred             CCcccccccCCccc
Confidence            66655666888854

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.95  E-value=1.2e-28  Score=198.43  Aligned_cols=133  Identities=35%  Similarity=0.416  Sum_probs=96.4

Q ss_pred             ccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHH
Q 020981           10 TLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV   89 (319)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v   89 (319)
                      +|..|++.|+....+.+.-+|+|+|.+|.+|+||||+|+..++.++++.|++.|+|+|.+|.+|+||||+|+..|+.++|
T Consensus         7 ~L~~Aa~~G~~~~v~~Ll~~Gadvn~~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v   86 (169)
T 4gpm_A            7 RLIEAAENGNKDRVKDLIENGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVV   86 (169)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHH
T ss_pred             HHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHH
Confidence            46667777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             HHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        90 ~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      ++|+++|+++|.+|..|+||||+|+..|+.+++++|++.|+++...+....+|
T Consensus        87 ~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~Tp  139 (169)
T 4gpm_A           87 KLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSDGRTP  139 (169)
T ss_dssp             HHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             HHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCH
Confidence            77777777777777777777777777777777777777777665555444433

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=6e-28  Score=211.24  Aligned_cols=157  Identities=24%  Similarity=0.464  Sum_probs=134.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     +++.||+|++..... .......+.+|+.+++.++||||+++++++......++|||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            577888999999999885     478899999976543 33444677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      |+++ ++.+.+.. .+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..+...
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9965 66666554 567999999999999999999999999   999999999999999999999999999988766555


Q ss_pred             ceeeccCC
Q 020981          310 PLTCQDTS  317 (319)
Q Consensus       310 ~~~~~~~~  317 (319)
                      .....||+
T Consensus       158 ~~~~~~t~  165 (292)
T 3o0g_A          158 YSAEVVTL  165 (292)
T ss_dssp             CCSCCSCG
T ss_pred             ccCCcccc
Confidence            55556665

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=1.3e-27  Score=215.67  Aligned_cols=159  Identities=23%  Similarity=0.378  Sum_probs=138.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     ++..||+|++..... .....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            588889999999999985     478999999976543 34556778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC---CCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DFgla~~~~~~~  307 (319)
                      |+++|+|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.+   +.+||+|||+++......
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            9999999999988888999999999999999999999999   9999999999999865   459999999998876543


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                      . .....|||.|
T Consensus       186 ~-~~~~~gt~~y  196 (362)
T 2bdw_A          186 A-WHGFAGTPGY  196 (362)
T ss_dssp             S-CCCSCSCTTT
T ss_pred             c-cccCCCCccc
Confidence            3 3345677743

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=2e-28  Score=227.87  Aligned_cols=160  Identities=30%  Similarity=0.480  Sum_probs=139.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +|+.||||++.............+.+|+.+++.++||||+++++++......|+|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            678888999999998884     478999999975432222234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |+++|+|.+++.+++.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~-~  172 (476)
T 2y94_A           97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-L  172 (476)
T ss_dssp             CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-B
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc-c
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999998766533 3


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      .+.+|||.|
T Consensus       173 ~~~~gt~~y  181 (476)
T 2y94_A          173 RTSCGSPNY  181 (476)
T ss_dssp             CCCCSCSTT
T ss_pred             cccCCCcCe
Confidence            345677743

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=4e-28  Score=214.36  Aligned_cols=148  Identities=27%  Similarity=0.445  Sum_probs=130.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc----eE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----MM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~~  226 (319)
                      +|.....||+|+||.||.     +++.||+|++.............+.+|+.+++.++||||+++++++.....    .|
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            688889999999999984     578999999987766666777889999999999999999999999876554    49


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            99999999999999998888999999999999999999999999   999999999999999999999999999877554

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=4.4e-28  Score=229.19  Aligned_cols=161  Identities=26%  Similarity=0.354  Sum_probs=138.6

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ..+|.....||+|+||.||.     +|+.||+|++.+...........+.+|+.+++.++||||+++++++.+....|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            34688889999999999985     5789999999764332223345678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |||++||+|.+++...+.  +++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999987543  999999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCceeeccCCC
Q 020981          307 EDRPLTCQDTSC  318 (319)
Q Consensus       307 ~~~~~~~~~~~~  318 (319)
                      .. ....+|||.
T Consensus       340 ~~-~~~~~GT~~  350 (576)
T 2acx_A          340 QT-IKGRVGTVG  350 (576)
T ss_dssp             CC-EECCCSCGG
T ss_pred             cc-ccccCCCcc
Confidence            33 334577774

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=3.6e-28  Score=235.49  Aligned_cols=162  Identities=30%  Similarity=0.381  Sum_probs=142.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .+|.....||+|+||.||.     +++.||||++.+.........+.+..|..++..+ +||+|+++++++.+...+|+|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            3688889999999999985     4678999999865332233346677899999988 599999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |||+++|+|.+++...+.+++..+..|+.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.......
T Consensus       421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            999999999999998888999999999999999999999999   99999999999999999999999999998766666


Q ss_pred             CceeeccCCCC
Q 020981          309 RPLTCQDTSCR  319 (319)
Q Consensus       309 ~~~~~~~~~~~  319 (319)
                      ...+.+|||.|
T Consensus       498 ~~~~~~GT~~Y  508 (674)
T 3pfq_A          498 TTKTFCGTPDY  508 (674)
T ss_dssp             CBCCCCSCSSS
T ss_pred             ccccccCCCcc
Confidence            66777888854

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.7e-27  Score=211.79  Aligned_cols=159  Identities=26%  Similarity=0.428  Sum_probs=137.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCH---HHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      .|.....||+|+||.||.     ++..||+|.+........   ...+.+.+|+.+++.++||||+++++++......++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            577888999999999985     478999999876533211   124678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC----CEEEEecCccccc
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLL  303 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DFgla~~~  303 (319)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++    .+||+|||+++.+
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            9999999999999988888999999999999999999999999   99999999999999887    7999999999987


Q ss_pred             ccCCCCceeeccCCC
Q 020981          304 TVKEDRPLTCQDTSC  318 (319)
Q Consensus       304 ~~~~~~~~~~~~~~~  318 (319)
                      ..... .....||+.
T Consensus       169 ~~~~~-~~~~~gt~~  182 (326)
T 2y0a_A          169 DFGNE-FKNIFGTPE  182 (326)
T ss_dssp             CTTSC-CCCCCSCTT
T ss_pred             CCCCc-cccccCCcC
Confidence            65433 233556664

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.5e-27  Score=210.28  Aligned_cols=155  Identities=16%  Similarity=0.313  Sum_probs=135.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     ++..+|+|.+...    ......+.+|+.+++.++||||+++++++......++|||
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            678888999999999985     4789999998643    2344668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC--CCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++++|.+++.... .+++..+..++.|++.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+....
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            999999999997653 6999999999999999999999999   999999999999997  7899999999999876543


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                       ......|||.
T Consensus       159 -~~~~~~gt~~  168 (321)
T 1tki_A          159 -NFRLLFTAPE  168 (321)
T ss_dssp             -EEEEEESCGG
T ss_pred             -ccccccCChh
Confidence             3344567763

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=6.7e-28  Score=216.61  Aligned_cols=160  Identities=23%  Similarity=0.340  Sum_probs=134.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .|.....||+|+||.||.     +++.||+|++......  .....+.+.+|+.+++.++||||+++++++......|+|
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            578888999999999985     4789999998643211  111246788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC---EEEEecCccc
Q 020981          229 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSK  301 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DFgla~  301 (319)
                      |||+++++|.+++...    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||+++
T Consensus       105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999998887643    24899999999999999999999999   999999999999986654   9999999999


Q ss_pred             ccccCCCCceeeccCCC
Q 020981          302 LLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       302 ~~~~~~~~~~~~~~~~~  318 (319)
                      .+...........||+.
T Consensus       182 ~~~~~~~~~~~~~gt~~  198 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPH  198 (351)
T ss_dssp             ECCTTSCBCCCCCSCGG
T ss_pred             EecCCCeeecCCcCCcC
Confidence            88766554555667764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=2.3e-27  Score=214.12  Aligned_cols=163  Identities=17%  Similarity=0.197  Sum_probs=135.6

Q ss_pred             cccCCCcccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC---CCcccc
Q 020981          148 YEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQ  214 (319)
Q Consensus       148 ~~~~~~~~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~  214 (319)
                      .++.....+|.....||+|+||.||..          ++.||+|++....      ...+..|..+++.++   |+||++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            344445567888999999999999854          6789999987532      245667888888886   899999


Q ss_pred             cceeEEeCCceEEEEeecCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-
Q 020981          215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-  288 (319)
Q Consensus       215 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-  288 (319)
                      +++++...+..|+||||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++. 
T Consensus       132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNG  208 (365)
T ss_dssp             EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGG
T ss_pred             hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccc
Confidence            99999999999999999999999999974     356999999999999999999999999   999999999999998 


Q ss_pred             ----------CCCEEEEecCcccccccC--CCCceeeccCCCC
Q 020981          289 ----------SGNLKVADFGVSKLLTVK--EDRPLTCQDTSCR  319 (319)
Q Consensus       289 ----------~~~~kl~DFgla~~~~~~--~~~~~~~~~~~~~  319 (319)
                                ++.+||+|||+|+.+...  .......+||+.|
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y  251 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGF  251 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSC
T ss_pred             ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCC
Confidence                      899999999999866432  2233445677643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=1.2e-27  Score=222.43  Aligned_cols=146  Identities=24%  Similarity=0.389  Sum_probs=121.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-----Cce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~  225 (319)
                      +|.....||+|+||.||.     +++.||||++... .......+.+.+|+.+++.++||||+++++++...     ..+
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            688889999999999884     5789999998754 33455667889999999999999999999998443     568


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+||||+ +++|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            9999998 6799999998888999999999999999999999999   99999999999999999999999999998754


Q ss_pred             C
Q 020981          306 K  306 (319)
Q Consensus       306 ~  306 (319)
                      +
T Consensus       209 ~  209 (458)
T 3rp9_A          209 P  209 (458)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.95  E-value=2.6e-27  Score=210.39  Aligned_cols=147  Identities=24%  Similarity=0.433  Sum_probs=125.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-------
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-------  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-------  223 (319)
                      +|.....||+|+||.||.     +++.||||++....  .....+.+.+|+.+++.++||||+++++++....       
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            577888999999999984     47899999987543  2334577899999999999999999999886543       


Q ss_pred             --------------------------------------------------ceEEEEeecCCCCHHHHHHHcCC---CCHH
Q 020981          224 --------------------------------------------------PMMIVTEYLPKGDLRAFLKRKGA---LKPS  250 (319)
Q Consensus       224 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~---~~~~  250 (319)
                                                                        ..++||||+++++|.+++.....   .++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              38999999999999999987643   4556


Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       251 ~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      .+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+....
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  218 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE  218 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC-
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccch
Confidence            78899999999999999999   9999999999999999999999999999886653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.95  E-value=2e-27  Score=209.99  Aligned_cols=160  Identities=25%  Similarity=0.454  Sum_probs=133.1

Q ss_pred             cccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ..+|.....+|+|+||.||.    .++.||+|++..... .......+.+|+.+++.++||||+++++++......++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            34788899999999999885    478899999875432 2233467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      ||++ ++|.+++.... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..+..
T Consensus        99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            9996 58888887654 4899999999999999999999999   99999999999999999999999999998876655


Q ss_pred             CceeeccCCC
Q 020981          309 RPLTCQDTSC  318 (319)
Q Consensus       309 ~~~~~~~~~~  318 (319)
                      ......||+.
T Consensus       175 ~~~~~~~t~~  184 (311)
T 3niz_A          175 SYTHEVVTLW  184 (311)
T ss_dssp             ---CCCCCCT
T ss_pred             cccCCcccCC
Confidence            5555566664

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.95  E-value=5.4e-27  Score=220.60  Aligned_cols=161  Identities=22%  Similarity=0.415  Sum_probs=135.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCH----------HHHHHHHHHHHHHHhcCCCcccccceeE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD----------DRVRAFRDELALLQKIRHPNVVQFLGAV  219 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~l~~~~  219 (319)
                      .+|.....||+|+||.||.     ++..+|+|++........          ...+.+.+|+.+++.++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3688899999999999985     468999999876543211          2246788999999999999999999999


Q ss_pred             EeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC---CEEEEe
Q 020981          220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVAD  296 (319)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~D  296 (319)
                      ......|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++   .+||+|
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEE
Confidence            999999999999999999999988888999999999999999999999999   99999999999999776   699999


Q ss_pred             cCcccccccCCCCceeeccCCCC
Q 020981          297 FGVSKLLTVKEDRPLTCQDTSCR  319 (319)
Q Consensus       297 Fgla~~~~~~~~~~~~~~~~~~~  319 (319)
                      ||+|+.+..... .....|||+|
T Consensus       193 fg~a~~~~~~~~-~~~~~gt~~y  214 (504)
T 3q5i_A          193 FGLSSFFSKDYK-LRDRLGTAYY  214 (504)
T ss_dssp             CTTCEECCTTSC-BCCCCSCTTT
T ss_pred             CCCCEEcCCCCc-cccccCCcCC
Confidence            999998766533 3345677754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=3.3e-27  Score=217.88  Aligned_cols=146  Identities=23%  Similarity=0.434  Sum_probs=129.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-----Cce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~  225 (319)
                      +|.....||+|+||.||.     +++.||||++... .......+.+.+|+.+++.++||||+++++++...     ...
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            688899999999999985     4789999999754 34455667889999999999999999999998766     579


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+||||++ ++|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            99999995 699999998888999999999999999999999999   99999999999999999999999999998765


Q ss_pred             C
Q 020981          306 K  306 (319)
Q Consensus       306 ~  306 (319)
                      .
T Consensus       182 ~  182 (432)
T 3n9x_A          182 E  182 (432)
T ss_dssp             -
T ss_pred             c
Confidence            4

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.95  E-value=3.9e-27  Score=209.03  Aligned_cols=155  Identities=23%  Similarity=0.372  Sum_probs=135.5

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      |.....||+|+||.||.     +|+.||||++......   ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            55566899999999984     4789999998754322   245688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCce
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~  311 (319)
                      +++++|.+++.. ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+........
T Consensus       124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  199 (321)
T 2c30_A          124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  199 (321)
T ss_dssp             CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence            999999998865 46899999999999999999999999   99999999999999999999999999998876655555


Q ss_pred             eeccCCC
Q 020981          312 TCQDTSC  318 (319)
Q Consensus       312 ~~~~~~~  318 (319)
                      ...||+.
T Consensus       200 ~~~gt~~  206 (321)
T 2c30_A          200 SLVGTPY  206 (321)
T ss_dssp             CCCSCGG
T ss_pred             cccCCcc
Confidence            6677764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=2.4e-27  Score=213.75  Aligned_cols=159  Identities=28%  Similarity=0.406  Sum_probs=128.8

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      ....+|.....||+|+||.||.     +++.||+|++.......    +.+.+|+.+++.++||||+++++++......|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            3345788999999999998874     57899999997643322    45778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC--EEEEecCcccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGVSKLLT  304 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DFgla~~~~  304 (319)
                      +||||+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.  +||+|||+|+...
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            99999999999999988888999999999999999999999999   999999999999987765  9999999998654


Q ss_pred             cCCCCceeeccCCC
Q 020981          305 VKEDRPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~~~~~~~~  318 (319)
                      ... ......||+.
T Consensus       170 ~~~-~~~~~~gt~~  182 (361)
T 3uc3_A          170 LHS-QPKSTVGTPA  182 (361)
T ss_dssp             ------------CT
T ss_pred             ccC-CCCCCcCCCC
Confidence            432 2334556664

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=2.5e-27  Score=209.89  Aligned_cols=157  Identities=24%  Similarity=0.498  Sum_probs=122.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +++.||+|.+.....  ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            678888999999999985     478999999875432  1223567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          231 YLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       231 ~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |++ ++|.+++...      ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 6999998754      34889999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCceeeccCCC
Q 020981          305 VKEDRPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~~~~~~~~  318 (319)
                      .+........||+.
T Consensus       160 ~~~~~~~~~~~t~~  173 (317)
T 2pmi_A          160 IPVNTFSSEVVTLW  173 (317)
T ss_dssp             SCCCCCCCCCSCCT
T ss_pred             CCcccCCCCccccc
Confidence            65555555566663

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.95  E-value=7e-28  Score=214.02  Aligned_cols=157  Identities=25%  Similarity=0.377  Sum_probs=133.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +++.||+|++.....  ....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            688889999999999985     478999999865432  2233568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC--C
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--D  308 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~--~  308 (319)
                      |+++++|.+++.....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+....  .
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            9999999999988778999999999999999999999999   9999999999999999999999999998765332  2


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                      ......||+
T Consensus       163 ~~~~~~gt~  171 (323)
T 3tki_A          163 LLNKMCGTL  171 (323)
T ss_dssp             CBCSCCSCG
T ss_pred             ccCCCccCc
Confidence            223445665

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=4.4e-27  Score=207.43  Aligned_cols=158  Identities=25%  Similarity=0.389  Sum_probs=132.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     +++.||+|++.... ......+.+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            577888999999999985     37899999987543 344556778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+..+....
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence            9999999999888888999999999999999999999999   9999999999999999999999999999877555444


Q ss_pred             eeeccCC
Q 020981          311 LTCQDTS  317 (319)
Q Consensus       311 ~~~~~~~  317 (319)
                      ....||+
T Consensus       160 ~~~~~~~  166 (311)
T 4agu_A          160 DDEVATR  166 (311)
T ss_dssp             ------G
T ss_pred             CCCcCCc
Confidence            4455554

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=1.7e-27  Score=206.66  Aligned_cols=160  Identities=28%  Similarity=0.495  Sum_probs=130.8

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|+|+||.||.     +++.||+|.+...........+.+.+|+.+++.++||||+++++++......++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            4688889999999999884     47899999987543222222467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....+..
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999875 56899999999999999999999999   99999999999999999999999999998765554


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                      ......||+
T Consensus       168 ~~~~~~~~~  176 (278)
T 3cok_A          168 KHYTLCGTP  176 (278)
T ss_dssp             ---------
T ss_pred             cceeccCCC
Confidence            444455555

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.95  E-value=5.2e-27  Score=212.28  Aligned_cols=147  Identities=31%  Similarity=0.572  Sum_probs=130.5

Q ss_pred             ccccceeeeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEe
Q 020981          155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ  221 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~  221 (319)
                      .+|...+.||+|+||.||..            +..||+|.+...  ......+.+.+|+.+++.+ +||||+++++++..
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            46788889999999999842            357999999754  2455667899999999999 79999999999999


Q ss_pred             CCceEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEE
Q 020981          222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL  285 (319)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nil  285 (319)
                      ....|+||||+++|+|.+++....                .+++..+..++.|++.||+|||+++   |+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            999999999999999999998753                3788999999999999999999999   999999999999


Q ss_pred             ecCCCCEEEEecCcccccccC
Q 020981          286 RDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       286 l~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++.++.+||+|||+++.+...
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~  256 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNI  256 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCC
T ss_pred             ECCCCCEEEccccCCcccCcc
Confidence            999999999999999876543

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.95  E-value=1.1e-27  Score=192.64  Aligned_cols=125  Identities=38%  Similarity=0.432  Sum_probs=118.6

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.++..++....+...-.|.|+|.++.+|.||||+||..|+.+++++|+++|+|+|.+|.+|+||||+||..|+.+
T Consensus        38 ~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~  117 (169)
T 4gpm_A           38 RTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKE  117 (169)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHH
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      +|++|+++|++++.+|..|+|||++|+..|+.+++++|++.|++.
T Consensus       118 ~v~~Ll~~gad~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GA~i  162 (169)
T 4gpm_A          118 VVKLLISKGADVNTSDSDGRTPLDLAREHGNEEVVKLLEKQGGWL  162 (169)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTC----
T ss_pred             HHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCc
Confidence            999999999999999999999999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.5e-27  Score=209.32  Aligned_cols=158  Identities=29%  Similarity=0.471  Sum_probs=129.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCC-----------------------HHHHHHHHHHHHHHHhc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------------------DDRVRAFRDELALLQKI  207 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~-----------------------~~~~~~~~~E~~~l~~l  207 (319)
                      +|.....||+|+||.||.     +++.||+|++.......                       ....+.+.+|+.+++.+
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            688889999999999985     47899999987643211                       12235688999999999


Q ss_pred             CCCcccccceeEEe--CCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEE
Q 020981          208 RHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL  285 (319)
Q Consensus       208 ~h~~iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nil  285 (319)
                      +||||+++++++..  ....|+||||+++++|.+++. ...+++..+..++.|++.||.|||+++   |+||||||+|||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil  169 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL  169 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence            99999999999886  567999999999999987654 356999999999999999999999999   999999999999


Q ss_pred             ecCCCCEEEEecCcccccccCCCCceeeccCC
Q 020981          286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       286 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~  317 (319)
                      ++.++.+||+|||+++.+...........||+
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  201 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTP  201 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCG
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCc
Confidence            99999999999999998776554444456665

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=7.2e-27  Score=209.09  Aligned_cols=154  Identities=25%  Similarity=0.416  Sum_probs=133.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....||+|+||.||.     +++.||+|.+.+....       ..+|+.++.++ +||||+++++++.+....|+||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            577888999999999885     4789999999765422       23578888887 6999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC----CCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DFgla~~~~~  305 (319)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||+...    +.+||+|||+++.+..
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            99999999999998888999999999999999999999999   9999999999998543    3599999999998877


Q ss_pred             CCCCceeeccCCCC
Q 020981          306 KEDRPLTCQDTSCR  319 (319)
Q Consensus       306 ~~~~~~~~~~~~~~  319 (319)
                      ......+.+||+.|
T Consensus       173 ~~~~~~~~~gt~~y  186 (342)
T 2qr7_A          173 ENGLLMTPCYTANF  186 (342)
T ss_dssp             TTCCBCCSSCCSSC
T ss_pred             CCCceeccCCCccc
Confidence            66666667777754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.94  E-value=1.2e-28  Score=219.98  Aligned_cols=156  Identities=16%  Similarity=0.181  Sum_probs=125.0

Q ss_pred             ccccceeeeecceEEEEEE---eceEeEEEEecccccC-----CHHHHHHHHHHHHHHHhcC------------------
Q 020981          155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIR------------------  208 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~------------------  208 (319)
                      .+|.....||+|+||.||.   +|+.||||++......     .....+.+.+|+.+++.++                  
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~   99 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS   99 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred             ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence            4688889999999998874   6899999999865321     2223366788999998886                  


Q ss_pred             --------CCcccccceeEEe-------------CCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh
Q 020981          209 --------HPNVVQFLGAVTQ-------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH  267 (319)
Q Consensus       209 --------h~~iv~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH  267 (319)
                              ||||+++++++..             ....|+||||+++|++.+.+.+ +.+++..+..++.|++.||+|||
T Consensus       100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH  178 (336)
T 2vuw_A          100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAE  178 (336)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence                    5555555555544             6789999999999976655543 56899999999999999999999


Q ss_pred             -hCCCCCeEEcCCCCCCEEecCCC--------------------CEEEEecCcccccccCCCCceeeccCCCC
Q 020981          268 -ENKPVPIIHRDLEPSNILRDDSG--------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCR  319 (319)
Q Consensus       268 -~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~DFgla~~~~~~~~~~~~~~~~~~~  319 (319)
                       +++   |+||||||+|||++.++                    .+||+|||+|+.+...     ..+||+.|
T Consensus       179 ~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y  243 (336)
T 2vuw_A          179 ASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVS  243 (336)
T ss_dssp             HHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCT
T ss_pred             HhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecc
Confidence             899   99999999999999887                    8999999999977543     35677643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.94  E-value=3.4e-27  Score=209.48  Aligned_cols=157  Identities=25%  Similarity=0.370  Sum_probs=131.5

Q ss_pred             CcccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc----e
Q 020981          153 HELDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----M  225 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~  225 (319)
                      ...+|.....+|+|+||.||.   .++.||||++....    ........|+.+++.++||||+++++++.....    +
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             chhhchhhheecccCceEEEEEEECCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            334788899999999998874   58899999986432    233455669999999999999999999987543    6


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN----------KPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~----------~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      ++||||+++|+|.+++... .+++..+..++.|++.||.|||+.          +   |+||||||+|||++.++.+||+
T Consensus        98 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999999774 589999999999999999999998          8   9999999999999999999999


Q ss_pred             ecCcccccccCCCC--ceeeccCC
Q 020981          296 DFGVSKLLTVKEDR--PLTCQDTS  317 (319)
Q Consensus       296 DFgla~~~~~~~~~--~~~~~~~~  317 (319)
                      |||+|+.+......  .....||+
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~  197 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTR  197 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCG
T ss_pred             cCCcccccccccCccccccCccCc
Confidence            99999877654332  22245665

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.94  E-value=4e-27  Score=209.35  Aligned_cols=148  Identities=24%  Similarity=0.364  Sum_probs=122.4

Q ss_pred             eeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEeecCC
Q 020981          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       161 ~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      +.||+|+||.||.     +++.||+|++....      ...+.+|+.+++.+. ||||+++++++......|+||||+++
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            5799999999985     47899999986432      245678999999997 99999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC---CEEEEecCcccccccCCCCce
Q 020981          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRPL  311 (319)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DFgla~~~~~~~~~~~  311 (319)
                      |+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++   .+||+|||+++..........
T Consensus        91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  167 (325)
T 3kn6_A           91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK  167 (325)
T ss_dssp             CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence            999999999888999999999999999999999999   99999999999998766   799999999998766555555


Q ss_pred             eeccCC
Q 020981          312 TCQDTS  317 (319)
Q Consensus       312 ~~~~~~  317 (319)
                      ...||+
T Consensus       168 ~~~~t~  173 (325)
T 3kn6_A          168 TPCFTL  173 (325)
T ss_dssp             ------
T ss_pred             ccCCCc
Confidence            555665

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.94  E-value=1.2e-26  Score=211.13  Aligned_cols=150  Identities=17%  Similarity=0.340  Sum_probs=134.4

Q ss_pred             CCcccccceeeeecc--eEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          152 PHELDFTNSVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G--~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      ....+|.....||+|  +||.||.     +++.||||++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            344578899999999  9998884     478999999986543 45566788999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      .|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999999876  56999999999999999999999999   99999999999999999999999999876


Q ss_pred             ccc
Q 020981          303 LTV  305 (319)
Q Consensus       303 ~~~  305 (319)
                      ...
T Consensus       178 ~~~  180 (389)
T 3gni_B          178 MIS  180 (389)
T ss_dssp             CEE
T ss_pred             ecc
Confidence            543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.94  E-value=9.1e-27  Score=207.02  Aligned_cols=150  Identities=31%  Similarity=0.498  Sum_probs=131.0

Q ss_pred             cccccceeeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      ..+|.....||+|+||.||.        .+..||||.+....  .....+.+.+|+.+++.++||||+++++++......
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            34688889999999999984        23459999997542  455567899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999765 56999999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCC
Q 020981          305 VKED  308 (319)
Q Consensus       305 ~~~~  308 (319)
                      ....
T Consensus       203 ~~~~  206 (325)
T 3kul_A          203 DDPD  206 (325)
T ss_dssp             ----
T ss_pred             cCcc
Confidence            6543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=1.8e-26  Score=203.39  Aligned_cols=161  Identities=24%  Similarity=0.473  Sum_probs=127.3

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|...+.+|+|+||.||.     ++..||+|.+.............+.+|+.+++.++||||+++++++......++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            3688889999999999985     47899999998655556667788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+..
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999874    355899999999999999999999999   99999999999999999999999999988766


Q ss_pred             CCCCceeeccCCC
Q 020981          306 KEDRPLTCQDTSC  318 (319)
Q Consensus       306 ~~~~~~~~~~~~~  318 (319)
                      .........|++.
T Consensus       189 ~~~~~~~~~~~~~  201 (310)
T 2wqm_A          189 KTTAAHSLVGTPY  201 (310)
T ss_dssp             ----------CCS
T ss_pred             CCccccccCCCee
Confidence            5444444455553

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.94  E-value=2.2e-26  Score=199.65  Aligned_cols=156  Identities=25%  Similarity=0.406  Sum_probs=136.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....+|+|+||.||.     ++..+|+|.+.......   .+.+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            577888999999999985     35689999987654333   3568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe---cCCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++++|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+||++   +.++.+||+|||++..+....
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            9999999999998888999999999999999999999999   9999999999999   788999999999998876554


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                      .. ....||+.
T Consensus       164 ~~-~~~~~t~~  173 (277)
T 3f3z_A          164 MM-RTKVGTPY  173 (277)
T ss_dssp             CB-CCCCSCTT
T ss_pred             ch-hccCCCCC
Confidence            33 33456653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=2.2e-27  Score=222.12  Aligned_cols=159  Identities=24%  Similarity=0.438  Sum_probs=139.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....||+|+||.||.     +++.||||++.............+.+|+.+++.++||||+++++++......|+|||
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  106 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE  106 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            578888999999999984     578999999976554434445778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe---cCCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |+.+++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+|+.+....
T Consensus       107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            9999999999998888999999999999999999999999   9999999999999   467899999999998876553


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                      . .....|||+
T Consensus       184 ~-~~~~~gt~~  193 (484)
T 3nyv_A          184 K-MKDKIGTAY  193 (484)
T ss_dssp             S-HHHHTTGGG
T ss_pred             c-cccCCCCcc
Confidence            3 334556664

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.94  E-value=1e-26  Score=205.97  Aligned_cols=157  Identities=27%  Similarity=0.401  Sum_probs=132.5

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC--ceEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMI  227 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~l  227 (319)
                      ..|.....||+|+||.||.     +++.||+|++.......  ..+.+.+|+.+++.++||||+++++++....  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            3688889999999999985     37899999987543322  2456778999999999999999999987655  7899


Q ss_pred             EEeecCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe----cCCCCEEEEecCcc
Q 020981          228 VTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGVS  300 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DFgla  300 (319)
                      ||||+++++|.+++.....   +++..+..++.|++.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999986533   899999999999999999999999   9999999999999    77788999999999


Q ss_pred             cccccCCCCceeeccCC
Q 020981          301 KLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       301 ~~~~~~~~~~~~~~~~~  317 (319)
                      +.+...... ....||+
T Consensus       164 ~~~~~~~~~-~~~~gt~  179 (319)
T 4euu_A          164 RELEDDEQF-VSLYGTE  179 (319)
T ss_dssp             EECCTTCCB-CCCCSCG
T ss_pred             eecCCCCce-eecccCC
Confidence            987665433 2344555

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.94  E-value=2.8e-27  Score=206.64  Aligned_cols=158  Identities=27%  Similarity=0.482  Sum_probs=129.7

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|.....||+|+||.||.    .++.+|+|++...... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            577888999999999985    3789999998754321 22235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ++ ++|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..+....
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            96 5999998764 56899999999999999999999999   9999999999999999999999999998876554444


Q ss_pred             eeeccCCC
Q 020981          311 LTCQDTSC  318 (319)
Q Consensus       311 ~~~~~~~~  318 (319)
                      ....||+.
T Consensus       158 ~~~~~t~~  165 (288)
T 1ob3_A          158 THEIVTLW  165 (288)
T ss_dssp             ----CCCT
T ss_pred             cccccccc
Confidence            45556653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=9.8e-27  Score=218.29  Aligned_cols=159  Identities=21%  Similarity=0.382  Sum_probs=132.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....||+|+||.||.     ++..+|+|++.+..... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            588889999999999984     47799999987654322 224668889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++|+|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+|+.+....
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            9999999999988888999999999999999999999999   999999999999976   4559999999999876553


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                      . .....|||+|
T Consensus       194 ~-~~~~~gt~~y  204 (494)
T 3lij_A          194 K-MKERLGTAYY  204 (494)
T ss_dssp             C-BCCCCSCTTT
T ss_pred             c-ccccCCCcCe
Confidence            3 3445677754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.94  E-value=1.1e-26  Score=210.45  Aligned_cols=150  Identities=32%  Similarity=0.526  Sum_probs=126.2

Q ss_pred             CcccccceeeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      ...+|.....||+|+||.||.        .+..||||.+....  .....+.+.+|+.++++++||||+++++++.....
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            344788889999999999985        25679999987542  45556789999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .++||||+++++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999999998754 5999999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCC
Q 020981          304 TVKE  307 (319)
Q Consensus       304 ~~~~  307 (319)
                      ....
T Consensus       198 ~~~~  201 (373)
T 2qol_A          198 EDDP  201 (373)
T ss_dssp             ----
T ss_pred             ccCC
Confidence            6543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=1.2e-26  Score=208.23  Aligned_cols=147  Identities=29%  Similarity=0.510  Sum_probs=130.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....||+|+||.||.     +++.||||++...........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            477888999999999984     478999999976544455566788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+. |+|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            996 688888754 457999999999999999999999999   999999999999999999999999999877543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.94  E-value=6.5e-27  Score=203.25  Aligned_cols=149  Identities=26%  Similarity=0.488  Sum_probs=130.5

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|.|+||.||.     ++..+|+|++.............+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            4688889999999999985     35689999986543322223466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999999998888999999999999999999999999   999999999999999999999999998665443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.94  E-value=1.7e-26  Score=204.01  Aligned_cols=156  Identities=21%  Similarity=0.260  Sum_probs=126.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....||+|+||.||.     +++.||||++....... ........|+..+..+ +||||+++++++......|+||
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            688888999999999985     47899999987654333 3334444455555555 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      ||+ +++|.+++...+ .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999 679998887654 5999999999999999999999999   99999999999999999999999999987755432


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                       .....||+
T Consensus       213 -~~~~~gt~  220 (311)
T 3p1a_A          213 -GEVQEGDP  220 (311)
T ss_dssp             ---CCCCCG
T ss_pred             -CcccCCCc
Confidence             23344555

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.94  E-value=1.1e-26  Score=204.84  Aligned_cols=149  Identities=23%  Similarity=0.305  Sum_probs=131.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|+|+||.||.     +++.||+|++...........+.+.+|+.+++.++||||+++++++......|++|
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            3688889999999998885     47899999998765556666788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999998888999999999999999999999999   999999999999999999999999999876544

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.94  E-value=2.1e-26  Score=202.14  Aligned_cols=147  Identities=27%  Similarity=0.577  Sum_probs=127.1

Q ss_pred             cccceeeeecceEEEEEE---------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--Cc
Q 020981          156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~  224 (319)
                      .|...+.+|+|+||.||.         .++.||+|.+....  .....+.+.+|+.+++.++||||+++++++...  ..
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            578888999999999873         57899999987543  223346788999999999999999999999876  67


Q ss_pred             eEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence            89999999999999999554 56999999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCC
Q 020981          304 TVKE  307 (319)
Q Consensus       304 ~~~~  307 (319)
                      ....
T Consensus       177 ~~~~  180 (302)
T 4e5w_A          177 ETDK  180 (302)
T ss_dssp             CTTC
T ss_pred             cCCC
Confidence            6654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.94  E-value=1.1e-26  Score=208.83  Aligned_cols=148  Identities=32%  Similarity=0.516  Sum_probs=129.4

Q ss_pred             cccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeC
Q 020981          154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~  222 (319)
                      ..+|.....||+|+||.||..          ++.||||.+....  .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            346888899999999999853          3789999997542  345567789999999999 699999999998875


Q ss_pred             C-ceEEEEeecCCCCHHHHHHHcCC-------------------------------------------------------
Q 020981          223 S-PMMIVTEYLPKGDLRAFLKRKGA-------------------------------------------------------  246 (319)
Q Consensus       223 ~-~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  246 (319)
                      . ..++||||+++|+|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            5 48999999999999999986532                                                       


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          247 -----------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       247 -----------~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                                 +++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                       888999999999999999999999   999999999999999999999999999877544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.94  E-value=4e-26  Score=207.31  Aligned_cols=147  Identities=31%  Similarity=0.560  Sum_probs=131.4

Q ss_pred             ccccceeeeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEe
Q 020981          155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ  221 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~  221 (319)
                      .+|...+.||+|+||.||..            +..||+|++...  ........+.+|+.+++.+ +||||+++++++..
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            36888899999999999853            257999998754  3455667889999999999 89999999999999


Q ss_pred             CCceEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEE
Q 020981          222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL  285 (319)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nil  285 (319)
                      ....++||||+++|+|.+++....                .+++..+..++.|++.||.|||+++   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            999999999999999999998754                4899999999999999999999999   999999999999


Q ss_pred             ecCCCCEEEEecCcccccccC
Q 020981          286 RDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       286 l~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++.++.+||+|||+|+.....
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~  244 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHI  244 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCC
T ss_pred             EcCCCcEEEcccCcccccccc
Confidence            999999999999999877543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.94  E-value=3e-26  Score=204.27  Aligned_cols=156  Identities=31%  Similarity=0.577  Sum_probs=133.9

Q ss_pred             CCCccccCCCcccccceeeeecceEEEEEE------------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCC
Q 020981          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHP  210 (319)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~ig~G~f~~v~~------------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~  210 (319)
                      +.+.|++..  .+|...+.+|+|+||.||.            .+..||+|.+....  .......+.+|+.+++.+ +||
T Consensus        26 ~~~~~~~~~--~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp  101 (334)
T 2pvf_A           26 EDPKWEFPR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHK  101 (334)
T ss_dssp             CCTTTBCCG--GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCT
T ss_pred             CCccccCCH--hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCC
Confidence            344554443  3688889999999999884            24679999987542  445567889999999999 899


Q ss_pred             cccccceeEEeCCceEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 020981          211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPI  274 (319)
Q Consensus       211 ~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~i  274 (319)
                      ||+++++++......|+||||+++++|.+++....                .+++..+..++.|++.||.|||+++   |
T Consensus       102 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i  178 (334)
T 2pvf_A          102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---C  178 (334)
T ss_dssp             TBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             CEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            99999999999999999999999999999998653                3889999999999999999999999   9


Q ss_pred             EEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       275 vH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +||||||+||+++.++.+||+|||+++.....
T Consensus       179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  210 (334)
T 2pvf_A          179 IHRDLAARNVLVTENNVMKIADFGLARDINNI  210 (334)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECTTT
T ss_pred             eCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            99999999999999999999999999877554

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=2.9e-27  Score=211.08  Aligned_cols=159  Identities=25%  Similarity=0.373  Sum_probs=136.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCH-----HHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....||+|+||.||.     ++..||+|.+........     .....+.+|+.+++.++||||+++++++......
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  104 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF  104 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence            688889999999998885     478999999876532211     1234567799999999999999999999999999


Q ss_pred             EEEEeecCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++||||+.+| +|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            9999999766 99999998888999999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCceeeccCCC
Q 020981          305 VKEDRPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~~~~~~~~  318 (319)
                      .... .....||+.
T Consensus       182 ~~~~-~~~~~gt~~  194 (335)
T 3dls_A          182 RGKL-FYTFCGTIE  194 (335)
T ss_dssp             TTCC-BCEECSCGG
T ss_pred             CCCc-eeccCCCcc
Confidence            6543 334566663

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=1.4e-26  Score=205.42  Aligned_cols=159  Identities=25%  Similarity=0.394  Sum_probs=136.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCH---HHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      ..|...+.+|+|+||.||.     ++..||+|.+........   ...+.+.+|+.+++.++||||+++++++......+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            3578889999999999985     478999999876433221   12467889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC----CEEEEecCcccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL  302 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DFgla~~  302 (319)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+||+++.++    .+||+|||+++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            99999999999999998888999999999999999999999999   99999999999999888    799999999988


Q ss_pred             cccCCCCceeeccCC
Q 020981          303 LTVKEDRPLTCQDTS  317 (319)
Q Consensus       303 ~~~~~~~~~~~~~~~  317 (319)
                      ....... ....||+
T Consensus       169 ~~~~~~~-~~~~gt~  182 (321)
T 2a2a_A          169 IEDGVEF-KNIFGTP  182 (321)
T ss_dssp             CCTTCCC-CCCCSCG
T ss_pred             cCccccc-cccCCCC
Confidence            7654332 2344555

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.94  E-value=1.8e-26  Score=209.69  Aligned_cols=156  Identities=19%  Similarity=0.390  Sum_probs=134.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|...+.||+|+||.||.     +++.+|+|.+....   ......+.+|+.+++.++||||+++++++......++|||
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            688889999999999985     47899999987542   3445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC--CCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||+++   |+||||||+|||++.  .+.+||+|||+++.+....
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999987653 6899999999999999999999999   999999999999984  4779999999999876553


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                      . .....||+.
T Consensus       206 ~-~~~~~gt~~  215 (387)
T 1kob_A          206 I-VKVTTATAE  215 (387)
T ss_dssp             C-EEEECSSGG
T ss_pred             c-eeeeccCCC
Confidence            3 334566663

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=5.1e-27  Score=208.94  Aligned_cols=159  Identities=20%  Similarity=0.394  Sum_probs=126.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     +++.||+|++..... .......+.+|+.+++.++||||+++++++......++||
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            3688899999999999885     478999999975532 2333456778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-----CCCCEEEEecCcccccc
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-----DSGNLKVADFGVSKLLT  304 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-----~~~~~kl~DFgla~~~~  304 (319)
                      ||++ ++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++     ..+.+||+|||+++.+.
T Consensus       113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9996 599999998888999999999999999999999999   99999999999995     44569999999999876


Q ss_pred             cCCCCceeeccCCC
Q 020981          305 VKEDRPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~~~~~~~~  318 (319)
                      .+........||+.
T Consensus       189 ~~~~~~~~~~~t~~  202 (329)
T 3gbz_A          189 IPIRQFTHEIITLW  202 (329)
T ss_dssp             -----------CCT
T ss_pred             CcccccCCCcCCcc
Confidence            65555555556653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=3.8e-26  Score=202.31  Aligned_cols=146  Identities=29%  Similarity=0.551  Sum_probs=130.0

Q ss_pred             cccceeeeecceEEEEEE---------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--Cc
Q 020981          156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~  224 (319)
                      .|.....||+|+||.||.         +++.||+|++...  ......+.+.+|+.+++.++||||+++++++...  ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            458888999999999952         5789999999754  2455667899999999999999999999999874  67


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .++||||+++++|.+++... .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            89999999999999999765 4899999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCC
Q 020981          305 VKE  307 (319)
Q Consensus       305 ~~~  307 (319)
                      ...
T Consensus       186 ~~~  188 (318)
T 3lxp_A          186 EGH  188 (318)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            553

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.94  E-value=6.3e-27  Score=207.85  Aligned_cols=168  Identities=30%  Similarity=0.469  Sum_probs=138.8

Q ss_pred             CCccccCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEE
Q 020981          145 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (319)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~  220 (319)
                      ++..++.....+|.....+|+|+||.||.    ++..||+|.+......  .....+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            34445555566889999999999999985    4788999998754321  12235788999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhC---CCCCeEEcCCCCCCEEecCCCCEE
Q 020981          221 QSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHEN---KPVPIIHRDLEPSNILRDDSGNLK  293 (319)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~~~~ivH~Dlk~~Nill~~~~~~k  293 (319)
                      .....++||||+++|+|.+++....    .+++..+..++.|++.||.|||++   +   |+||||||+|||++.++.+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEE
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999998643    389999999999999999999999   8   99999999999999999999


Q ss_pred             EEecCcccccccCCCCc-eeeccCC
Q 020981          294 VADFGVSKLLTVKEDRP-LTCQDTS  317 (319)
Q Consensus       294 l~DFgla~~~~~~~~~~-~~~~~~~  317 (319)
                      |+|||+++.+....... ....||+
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~  199 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTI  199 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCG
T ss_pred             eccCccccccCcccccccccccCCc
Confidence            99999999876543332 3334665

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.94  E-value=2.2e-26  Score=206.06  Aligned_cols=162  Identities=22%  Similarity=0.345  Sum_probs=134.2

Q ss_pred             CCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCC--CcccccceeEEeCCce
Q 020981          152 PHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPM  225 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~  225 (319)
                      .....|.....||+|+||.||.    +++.||+|++.... ......+.+.+|+.+++.++|  |||+++++++......
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            3445688899999999999985    47889999987654 345556788999999999986  9999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+|||+ .+++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            999995 58899999999888999999999999999999999999   99999999999997 58899999999998765


Q ss_pred             CCCC--ceeeccCCCC
Q 020981          306 KEDR--PLTCQDTSCR  319 (319)
Q Consensus       306 ~~~~--~~~~~~~~~~  319 (319)
                      ....  .....||+.|
T Consensus       160 ~~~~~~~~~~~gt~~y  175 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNY  175 (343)
T ss_dssp             ----------CCCCSS
T ss_pred             ccccccCCCCcCCcCc
Confidence            4332  2355677743

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.94  E-value=4.3e-26  Score=198.42  Aligned_cols=158  Identities=23%  Similarity=0.390  Sum_probs=136.9

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....+|+|+||.||.     ++..||+|++..... .....+.+.+|+.+++.++||||+++++++......+++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3688889999999999985     378999999976543 4455677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC---EEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DFgla~~~~~~  306 (319)
                      ||+++++|.+.+.....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.   +||+|||++......
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            99999999999988888999999999999999999999999   999999999999986655   999999999877654


Q ss_pred             CCCceeeccCC
Q 020981          307 EDRPLTCQDTS  317 (319)
Q Consensus       307 ~~~~~~~~~~~  317 (319)
                      ... ....||+
T Consensus       162 ~~~-~~~~~~~  171 (284)
T 3kk8_A          162 EAW-HGFAGTP  171 (284)
T ss_dssp             CBC-CCSCSCG
T ss_pred             ccc-cCCCCCc
Confidence            332 2244554

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.94  E-value=1.3e-26  Score=203.00  Aligned_cols=147  Identities=31%  Similarity=0.594  Sum_probs=126.9

Q ss_pred             cccccceeeeecceEEEEEE---------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--C
Q 020981          154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--S  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~  222 (319)
                      ..+|.....||+|+||.||.         +++.||+|++...   .....+.+.+|+.+++.++||||+++++++..  .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            34688889999999999874         4789999998743   45556788999999999999999999998854  3


Q ss_pred             CceEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      ...++||||+++++|.+++.... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            56899999999999999998754 4899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccC
Q 020981          302 LLTVK  306 (319)
Q Consensus       302 ~~~~~  306 (319)
                      .+...
T Consensus       163 ~~~~~  167 (295)
T 3ugc_A          163 VLPQD  167 (295)
T ss_dssp             -----
T ss_pred             cccCC
Confidence            87554

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.94  E-value=2.8e-26  Score=202.34  Aligned_cols=148  Identities=32%  Similarity=0.570  Sum_probs=131.7

Q ss_pred             cccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC
Q 020981          154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  223 (319)
                      ..+|...+.+|+|+||.||..          +..||+|.+....  .....+.+.+|+.+++.++||||+++++++....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            346888899999999998852          3789999987542  4566678999999999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCC
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGA------------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDL  279 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~------------------------~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dl  279 (319)
                      ..++||||+++++|.+++.....                        +++..+..++.|++.||.|||+++   |+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence            99999999999999999987543                        788999999999999999999999   999999


Q ss_pred             CCCCEEecCCCCEEEEecCcccccccC
Q 020981          280 EPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       280 k~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+||+++.++.+||+|||+++.....
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~  203 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEE  203 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTT
T ss_pred             chheEEEcCCCCEEEcccccccccccc
Confidence            999999999999999999999877544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.94  E-value=1.1e-26  Score=210.57  Aligned_cols=152  Identities=34%  Similarity=0.522  Sum_probs=132.9

Q ss_pred             CccccCCCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEE
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~  220 (319)
                      ..|.+..  .+|.....||+|+||.||.     ++..||||.+...  ........+.+|+.+++.++||||+++++++.
T Consensus       107 ~~~~~~~--~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  182 (377)
T 3cbl_A          107 DKWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCT  182 (377)
T ss_dssp             CTTBCCG--GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccEEch--HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            3444443  3677888999999999984     4789999998754  23455567889999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          221 QSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       221 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                      .....|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCC
Confidence            9999999999999999999998654 5899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccc
Q 020981          300 SKLLT  304 (319)
Q Consensus       300 a~~~~  304 (319)
                      ++...
T Consensus       260 s~~~~  264 (377)
T 3cbl_A          260 SREEA  264 (377)
T ss_dssp             CEECT
T ss_pred             ceecC
Confidence            98654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.94  E-value=1.7e-26  Score=206.35  Aligned_cols=148  Identities=34%  Similarity=0.521  Sum_probs=131.6

Q ss_pred             CcccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC
Q 020981          153 HELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  222 (319)
                      ...+|.....||+|+||.||..          +..||+|.+....  .....+.+.+|+.+++.++||||+++++++...
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            3447888899999999998842          2789999997543  345567899999999999999999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcC
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD  278 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~D  278 (319)
                      ...|+||||+++++|.+++...                        ..+++..+..++.|++.||.|||+++   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            9999999999999999999864                        46899999999999999999999999   99999


Q ss_pred             CCCCCEEecCCCCEEEEecCccccccc
Q 020981          279 LEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       279 lk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |||+|||++.++.+||+|||+++.+..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~  226 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYS  226 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             CCcceEEECCCCeEEEeecCCCccccc
Confidence            999999999999999999999987644

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=1.1e-26  Score=206.79  Aligned_cols=160  Identities=26%  Similarity=0.386  Sum_probs=132.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     +++.||+|.+.... ......+.+.+|+.+++.++||||+++++++......++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3688889999999998874     37899999986543 34455667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+..+...
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999999888877778999999999999999999999999   999999999999999999999999999887766555


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                      .....||+.
T Consensus       181 ~~~~~~t~~  189 (331)
T 4aaa_A          181 YDDEVATRW  189 (331)
T ss_dssp             ---CCCCCT
T ss_pred             cCCCcCCcc
Confidence            555566653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=1e-26  Score=201.56  Aligned_cols=148  Identities=29%  Similarity=0.511  Sum_probs=131.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     +++.||+|.+.............+.+|+.+++.++||||+++++++......++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            678889999999999885     478999999875432222234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++......
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999998888999999999999999999999999   999999999999999999999999999887654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.8e-27  Score=212.86  Aligned_cols=161  Identities=24%  Similarity=0.355  Sum_probs=136.0

Q ss_pred             ccccceeeeecceEEEEEE--------eceEeEEEEecccccC-CHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCc
Q 020981          155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  224 (319)
                      .+|.....||+|+||.||.        +++.||||++...... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4788899999999999983        5789999998754321 111224466799999999 69999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .++||||+++++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            9999999999999999998888999999999999999999999999   9999999999999999999999999998775


Q ss_pred             cCCC-CceeeccCCC
Q 020981          305 VKED-RPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~-~~~~~~~~~~  318 (319)
                      .... ......||+.
T Consensus       211 ~~~~~~~~~~~gt~~  225 (355)
T 1vzo_A          211 ADETERAYDFCGTIE  225 (355)
T ss_dssp             GGGGGGGCGGGSCCT
T ss_pred             cCCCCcccCcccCcC
Confidence            4332 2334566664

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.94  E-value=4.4e-26  Score=196.72  Aligned_cols=146  Identities=33%  Similarity=0.555  Sum_probs=129.9

Q ss_pred             cccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ..+|.....+|+|+||.||.    .+..||+|.+......    .+.+.+|+.+++.++||||+++++++......++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            34688889999999999884    3568999999765432    246788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+++++|.+++...+ .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999999998754 4999999999999999999999999   999999999999999999999999999876554

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.94  E-value=9e-27  Score=206.53  Aligned_cols=156  Identities=29%  Similarity=0.518  Sum_probs=134.9

Q ss_pred             CCCccccCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeE
Q 020981          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (319)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~  219 (319)
                      ..+..++.....+|.....+|+|+||.||.    ++..||+|.+....   ....+.+.+|+.+++.++||||+++++++
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFC  104 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            344455555666899999999999999985    47899999887542   23456788999999999999999999999


Q ss_pred             EeCCceEEEEeecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          220 TQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      ......++||||+++|+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEEC
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEe
Confidence            99999999999999999999986543    4889999999999999999999999   9999999999999999999999


Q ss_pred             ecCccccccc
Q 020981          296 DFGVSKLLTV  305 (319)
Q Consensus       296 DFgla~~~~~  305 (319)
                      |||+++....
T Consensus       182 Dfg~~~~~~~  191 (321)
T 2qkw_B          182 DFGISKKGTE  191 (321)
T ss_dssp             CCTTCEECSS
T ss_pred             eccccccccc
Confidence            9999987654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.94  E-value=1.4e-26  Score=201.68  Aligned_cols=147  Identities=28%  Similarity=0.525  Sum_probs=130.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     ++..||+|.+.............+.+|+.+++.++||||+++++++......++|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            688889999999999985     367899999865432222224568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999998888999999999999999999999999   99999999999999999999999999976644

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.94  E-value=3e-26  Score=206.85  Aligned_cols=159  Identities=28%  Similarity=0.422  Sum_probs=136.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccC-C----HHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-D----DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~-~----~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  224 (319)
                      +|.....||.|+||.||.     +|+.||||++...... .    ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            577788999999999985     4789999998754321 1    22346688999999999 79999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .|+||||+++++|.+++.....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+.
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            9999999999999999998888999999999999999999999999   9999999999999999999999999998876


Q ss_pred             cCCCCceeeccCCC
Q 020981          305 VKEDRPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~~~~~~~~  318 (319)
                      .... .....||+.
T Consensus       252 ~~~~-~~~~~gt~~  264 (365)
T 2y7j_A          252 PGEK-LRELCGTPG  264 (365)
T ss_dssp             TTCC-BCCCCSCGG
T ss_pred             CCcc-cccCCCCCC
Confidence            5533 334556653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.94  E-value=1e-26  Score=217.69  Aligned_cols=158  Identities=25%  Similarity=0.436  Sum_probs=134.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +++.||+|++.+..... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            688889999999999985     47899999986543222 224678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec---CCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++++|.+.+...+.+++..+..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||+|+.+....
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            9999999999988888999999999999999999999999   99999999999995   45679999999998876553


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                      . .....|||+
T Consensus       179 ~-~~~~~gt~~  188 (486)
T 3mwu_A          179 K-MKDRIGTAY  188 (486)
T ss_dssp             ----CCTTGGG
T ss_pred             c-cCCCcCCCC
Confidence            3 233556664

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.94  E-value=4.5e-26  Score=211.34  Aligned_cols=143  Identities=35%  Similarity=0.610  Sum_probs=126.6

Q ss_pred             ccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-ceEEEEe
Q 020981          155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-PMMIVTE  230 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~lv~e  230 (319)
                      .+|.....||+|+||.||.   .+..||||.+....     ..+.+.+|+.++++++||||+++++++.... ..|+|||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3677788999999998874   68899999997543     2357889999999999999999999987665 7999999


Q ss_pred             ecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++|+|.+++...+.  +++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999987654  789999999999999999999999   99999999999999999999999999986543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=2.8e-26  Score=208.70  Aligned_cols=144  Identities=27%  Similarity=0.505  Sum_probs=118.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCC--ceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS--PMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~--~~~l  227 (319)
                      +|.....||+|+||.||.     +++.||+|++.... ........+.+|+.+++.+. ||||+++++++...+  .+|+
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            678888999999999885     47899999987543 34555677888999999997 999999999997544  6899


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||||++ ++|..++.. +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence            999996 699999876 46899999999999999999999999   99999999999999999999999999987643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.94  E-value=2.8e-26  Score=207.67  Aligned_cols=154  Identities=23%  Similarity=0.390  Sum_probs=126.8

Q ss_pred             cceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      ...+.||+|+||.||.     +|..||+|++....   ....+.+.+|+.+++.++||||+++++++......++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3356799999999985     47899999987542   345577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe--cCCCCEEEEecCcccccccCCCC
Q 020981          233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--DDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       233 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||+  +.++.+||+|||+++.+......
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            999999988754 45899999999999999999999999   9999999999999  56788999999999987655433


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                       ....||+.
T Consensus       246 -~~~~gt~~  253 (373)
T 2x4f_A          246 -KVNFGTPE  253 (373)
T ss_dssp             -CCCCSSCT
T ss_pred             -ccccCCCc
Confidence             33456664

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.94  E-value=2.1e-26  Score=205.02  Aligned_cols=155  Identities=20%  Similarity=0.233  Sum_probs=132.5

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .+|.....||+|+||.||.     +++.||||.+......     +.+.+|+.+++.+ +||||+++++++......++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            3688889999999998874     5789999998754321     3577899999999 899999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC-----EEEEecCcccc
Q 020981          229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSKL  302 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DFgla~~  302 (319)
                      |||+ +++|.+++... +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.     +||+|||+|+.
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999 89999999874 57999999999999999999999999   999999999999998887     99999999998


Q ss_pred             cccCCCC-------ceeeccCCC
Q 020981          303 LTVKEDR-------PLTCQDTSC  318 (319)
Q Consensus       303 ~~~~~~~-------~~~~~~~~~  318 (319)
                      +..+...       .....||+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~  182 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTAR  182 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTT
T ss_pred             eecCCCCccccccccCCcCCCcc
Confidence            7655432       235567764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.94  E-value=1.3e-26  Score=207.94  Aligned_cols=153  Identities=29%  Similarity=0.445  Sum_probs=118.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....||+|+||.||.     +++.||+|++....     ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            578888999999999985     46789999987532     23567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgla~~~~~~~  307 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+++......
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            9999999999988888999999999999999999999999   999999999999975   8899999999998765442


Q ss_pred             CCceeeccCC
Q 020981          308 DRPLTCQDTS  317 (319)
Q Consensus       308 ~~~~~~~~~~  317 (319)
                      . .....||+
T Consensus       206 ~-~~~~~gt~  214 (349)
T 2w4o_A          206 L-MKTVCGTP  214 (349)
T ss_dssp             --------CG
T ss_pred             c-cccccCCC
Confidence            2 23345555

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=3.4e-26  Score=204.65  Aligned_cols=148  Identities=32%  Similarity=0.508  Sum_probs=127.6

Q ss_pred             ccccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCC
Q 020981          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~  223 (319)
                      .+|.....||+|+||.||.          .+..||+|.+....  .....+.+.+|+.+++.+ +||||+++++++....
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4678889999999999874          24579999997542  233456788999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE  280 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk  280 (319)
                      ..++||||+++|+|.+++....                       .+++..+..++.|++.||.|||+++   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            9999999999999999998653                       2788999999999999999999999   9999999


Q ss_pred             CCCEEecCCCCEEEEecCcccccccCC
Q 020981          281 PSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       281 ~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |+|||++.++.+||+|||+++.+....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~  226 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDS  226 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCc
Confidence            999999999999999999998776543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.94  E-value=3.7e-26  Score=208.07  Aligned_cols=159  Identities=21%  Similarity=0.345  Sum_probs=133.6

Q ss_pred             cccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCcccccceeEEeCCceEE
Q 020981          154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~~l  227 (319)
                      ...|.....||+|+||.||.    .++.||||++..... .....+.+.+|+.+++.++  ||||+++++++.....+|+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            34588899999999999985    378899999876543 4556678999999999996  5999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||| +.+++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+....
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999 558899999998888999999999999999999999999   99999999999996 5899999999999876543


Q ss_pred             CC--ceeeccCCC
Q 020981          308 DR--PLTCQDTSC  318 (319)
Q Consensus       308 ~~--~~~~~~~~~  318 (319)
                      ..  ....+||+.
T Consensus       209 ~~~~~~~~~gt~~  221 (390)
T 2zmd_A          209 TSVVKDSQVGAVN  221 (390)
T ss_dssp             -----CCSCCCGG
T ss_pred             ccccCCCCCcCCC
Confidence            22  234567774

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.94  E-value=5.7e-26  Score=198.54  Aligned_cols=150  Identities=28%  Similarity=0.414  Sum_probs=129.7

Q ss_pred             Cccccccee-eeecceEEEEEEe-------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          153 HELDFTNSV-EITKGTFILAFWR-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       153 ~~~~~~~~~-~ig~G~f~~v~~~-------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      ...+|.... .||+|+||.||..       +..||+|.+..... .....+.+.+|+.+++.++||||+++++++ ....
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            344677766 8999999999853       67899999876532 334457789999999999999999999998 5677


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            8999999999999999998888999999999999999999999999   9999999999999999999999999998876


Q ss_pred             cCC
Q 020981          305 VKE  307 (319)
Q Consensus       305 ~~~  307 (319)
                      ...
T Consensus       169 ~~~  171 (291)
T 1xbb_A          169 ADE  171 (291)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.94  E-value=2.7e-26  Score=213.43  Aligned_cols=157  Identities=24%  Similarity=0.340  Sum_probs=126.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC------
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------  223 (319)
                      .+|.....||+|+||.||.     +++.||||++.... ......+.+.+|+.+++.++||||+++++++....      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            3688889999999999985     47899999997653 34556677889999999999999999999986553      


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ..|+||||+++ +|.+.+..  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            57999999965 67666643  4899999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCceeeccCCCC
Q 020981          304 TVKEDRPLTCQDTSCR  319 (319)
Q Consensus       304 ~~~~~~~~~~~~~~~~  319 (319)
                      .... .....+||+.|
T Consensus       215 ~~~~-~~~~~~gt~~y  229 (464)
T 3ttj_A          215 GTSF-MMTPYVVTRYY  229 (464)
T ss_dssp             --CC-CC----CCCTT
T ss_pred             CCCc-ccCCCcccccc
Confidence            6543 33446777743

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=5e-26  Score=199.24  Aligned_cols=156  Identities=31%  Similarity=0.509  Sum_probs=133.9

Q ss_pred             CCccccCCCcccccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccc
Q 020981          145 VPEYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL  216 (319)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~  216 (319)
                      ...+.++.....|...+.||+|+||.||..        +..+|+|.+...  ......+.+.+|+.+++.++||||++++
T Consensus        11 ~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~   88 (298)
T 3pls_A           11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALI   88 (298)
T ss_dssp             TGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             hhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            345556666667778889999999999842        237999998743  3456667889999999999999999999


Q ss_pred             eeEEeCCce-EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEE
Q 020981          217 GAVTQSSPM-MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV  294 (319)
Q Consensus       217 ~~~~~~~~~-~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl  294 (319)
                      +++...+.. +++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl  165 (298)
T 3pls_A           89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKV  165 (298)
T ss_dssp             EEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEe
Confidence            999876655 9999999999999999863 45889999999999999999999999   999999999999999999999


Q ss_pred             EecCccccccc
Q 020981          295 ADFGVSKLLTV  305 (319)
Q Consensus       295 ~DFgla~~~~~  305 (319)
                      +|||+++.+..
T Consensus       166 ~Dfg~~~~~~~  176 (298)
T 3pls_A          166 ADFGLARDILD  176 (298)
T ss_dssp             CCTTSSCTTTT
T ss_pred             CcCCCcccccC
Confidence            99999986644

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.5e-26  Score=207.32  Aligned_cols=161  Identities=30%  Similarity=0.478  Sum_probs=131.1

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCC--HHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      ..+|.....+|+|+||.||.     +|+.||+|.+.......  ....+.+.+|+.+++.++||||+++++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            44788899999999999985     47899999987543221  112246778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +||||+++ +|.+++.... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            99999965 8988887653 5889999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCceeeccCCC
Q 020981          306 KEDRPLTCQDTSC  318 (319)
Q Consensus       306 ~~~~~~~~~~~~~  318 (319)
                      .........||+.
T Consensus       165 ~~~~~~~~~~t~~  177 (346)
T 1ua2_A          165 PNRAYTHQVVTRW  177 (346)
T ss_dssp             CCCCCCCSCCCCT
T ss_pred             CcccCCccccccc
Confidence            6555555667764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.94  E-value=8.8e-27  Score=211.26  Aligned_cols=146  Identities=14%  Similarity=0.188  Sum_probs=121.5

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHH---HHHhcCCCcccccc-------ee
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA---LLQKIRHPNVVQFL-------GA  218 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~---~l~~l~h~~iv~l~-------~~  218 (319)
                      ..+|.....||+|+||.||.     +|+.||||++...........+.+.+|+.   .++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            34688889999999999984     47899999998654445556678899994   55555799999998       55


Q ss_pred             EEeCC-----------------ceEEEEeecCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHhhCCCCCe
Q 020981          219 VTQSS-----------------PMMIVTEYLPKGDLRAFLKRKGALKP-------STAVRFALDIARGMNYLHENKPVPI  274 (319)
Q Consensus       219 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~qi~~al~~lH~~~~~~i  274 (319)
                      +...+                 ..|++|||+ +|+|.+++...+.+++       ..+..++.|++.||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 389999999 6899999987655555       777789999999999999999   9


Q ss_pred             EEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          275 IHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       275 vH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      +||||||+|||++.++.+||+|||+|+..
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~  256 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRD  256 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheec
Confidence            99999999999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.94  E-value=3.3e-26  Score=197.81  Aligned_cols=160  Identities=32%  Similarity=0.497  Sum_probs=121.9

Q ss_pred             ccccceeeeecceEEEEEE---eceEeEEEEecccccCC-HHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISD-DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .+|.....+|+|+||.||.   .+..+|+|++....... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            4688888999999998874   58899999987543222 2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC--------CCCEEEEecCcccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--------SGNLKVADFGVSKL  302 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~--------~~~~kl~DFgla~~  302 (319)
                      |+++++|.+++.. +.+++..+..++.|++.||.|||+++..+|+||||||+||+++.        ++.+||+|||+++.
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           87 FARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             CCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             cCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            9999999998864 56999999999999999999999998555889999999999986        67899999999987


Q ss_pred             cccCCCCceeeccCC
Q 020981          303 LTVKEDRPLTCQDTS  317 (319)
Q Consensus       303 ~~~~~~~~~~~~~~~  317 (319)
                      +......  ...||+
T Consensus       166 ~~~~~~~--~~~~~~  178 (271)
T 3dtc_A          166 WHRTTKM--SAAGAY  178 (271)
T ss_dssp             ------------CCG
T ss_pred             ccccccc--CCCCcc
Confidence            6554322  334554

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.94  E-value=5.3e-26  Score=197.78  Aligned_cols=151  Identities=30%  Similarity=0.552  Sum_probs=128.9

Q ss_pred             CccccCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~  221 (319)
                      ..|++.  ..+|...+.||+|+||.||.    .+..||+|++......    .+.+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           17 GSWEID--PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             CTTBCC--GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCccCC--HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            344443  34688889999999999985    3568999999865432    2467889999999999999999999999


Q ss_pred             CCceEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcc
Q 020981          222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (319)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla  300 (319)
                      ....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccc
Confidence            9999999999999999999986 456999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccc
Q 020981          301 KLLTV  305 (319)
Q Consensus       301 ~~~~~  305 (319)
                      +....
T Consensus       168 ~~~~~  172 (283)
T 3gen_A          168 RYVLD  172 (283)
T ss_dssp             GGBCC
T ss_pred             ccccc
Confidence            86643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=1.1e-25  Score=195.76  Aligned_cols=148  Identities=23%  Similarity=0.398  Sum_probs=128.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....+|+|+||.||.     +++.||+|.+....... .....+.+|+..+..+ +||||+++++++......++||
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            577888999999999985     48899999988654433 3446677899999999 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC----------------
Q 020981          230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----------------  289 (319)
Q Consensus       230 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~----------------  289 (319)
                      ||+++++|.+++...    +.+++..+..++.|++.||.|||+++   |+||||||+|||++.+                
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999765    56899999999999999999999999   9999999999999844                


Q ss_pred             ---CCEEEEecCcccccccCC
Q 020981          290 ---GNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       290 ---~~~kl~DFgla~~~~~~~  307 (319)
                         ..+||+|||++.......
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~  188 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ  188 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC
T ss_pred             CCceEEEEcccccccccCCcc
Confidence               479999999998876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=5.1e-26  Score=197.83  Aligned_cols=148  Identities=27%  Similarity=0.499  Sum_probs=130.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCH---HHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|.....+|+|+||.||.     +++.+|+|.+........   ...+.+.+|+.+++.++||||+++++++......++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            577888999999999985     478999999876543211   124678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC----CEEEEecCccccc
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLL  303 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DFgla~~~  303 (319)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+++   ++||||||+||+++.++    .+||+|||++...
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999999999988888999999999999999999999999   99999999999999877    8999999999877


Q ss_pred             ccC
Q 020981          304 TVK  306 (319)
Q Consensus       304 ~~~  306 (319)
                      ...
T Consensus       163 ~~~  165 (283)
T 3bhy_A          163 EAG  165 (283)
T ss_dssp             C--
T ss_pred             cCC
Confidence            554

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=4.8e-26  Score=198.52  Aligned_cols=156  Identities=22%  Similarity=0.414  Sum_probs=128.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....||+|+||.||.     ++..+|+|.+......  ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            688889999999999984     4789999998765422  224678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe---cCCCCEEEEecCccccc
Q 020981          231 YLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLL  303 (319)
Q Consensus       231 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DFgla~~~  303 (319)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||+++   |+||||||+||++   +.++.+||+|||+++.+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543    56999999999999999999999999   9999999999999   45678999999999877


Q ss_pred             ccCCCCceeeccCC
Q 020981          304 TVKEDRPLTCQDTS  317 (319)
Q Consensus       304 ~~~~~~~~~~~~~~  317 (319)
                      ...... ....||+
T Consensus       178 ~~~~~~-~~~~~t~  190 (285)
T 3is5_A          178 KSDEHS-TNAAGTA  190 (285)
T ss_dssp             ----------CTTG
T ss_pred             CCcccC-cCccccc
Confidence            654332 3344554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.93  E-value=8.8e-26  Score=197.78  Aligned_cols=150  Identities=27%  Similarity=0.373  Sum_probs=132.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccC------CHHHHHHHHHHHHHHHhcC-CCcccccceeEEeC
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS------DDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS  222 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~------~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~  222 (319)
                      .+|.....+|.|+||.||.     +++.||+|.+......      .....+.+.+|+.+++++. ||||+++++++...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            3688889999999999985     5789999998754311      1233466889999999996 99999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      ...++||||+++++|.+++.....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence            999999999999999999998888999999999999999999999999   99999999999999999999999999988


Q ss_pred             cccCC
Q 020981          303 LTVKE  307 (319)
Q Consensus       303 ~~~~~  307 (319)
                      +....
T Consensus       174 ~~~~~  178 (298)
T 1phk_A          174 LDPGE  178 (298)
T ss_dssp             CCTTC
T ss_pred             cCCCc
Confidence            76543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.93  E-value=1.3e-26  Score=209.53  Aligned_cols=145  Identities=33%  Similarity=0.481  Sum_probs=126.7

Q ss_pred             ccccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      .+|.....||+|+||.||.          .+..||||.+...  ........+.+|+.+++.++||||+++++++.....
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            3678888999999998874          2457999998643  234555678889999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC---CEEE
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV  294 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~---~~kl  294 (319)
                      .++||||+++|+|.+++...+       .+++..+..++.|++.||.|||+++   |+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999998653       4889999999999999999999999   99999999999999555   5999


Q ss_pred             EecCcccccc
Q 020981          295 ADFGVSKLLT  304 (319)
Q Consensus       295 ~DFgla~~~~  304 (319)
                      +|||+|+.+.
T Consensus       226 ~DFG~a~~~~  235 (367)
T 3l9p_A          226 GDFGMARDIY  235 (367)
T ss_dssp             CCCHHHHHHH
T ss_pred             CCCccccccc
Confidence            9999998653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.93  E-value=9.3e-26  Score=198.91  Aligned_cols=148  Identities=32%  Similarity=0.487  Sum_probs=131.9

Q ss_pred             ccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCC
Q 020981          155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~  223 (319)
                      .+|.....+|+|+||.||..          +..||+|.+....  .....+.+.+|+.+++++ +||||+++++++....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            46888899999999998742          4789999997542  345567899999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEE
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL  285 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nil  285 (319)
                      ..++||||+++|+|.+++....                  .+++..+..++.|++.||.|||+++   |+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            9999999999999999998654                  3899999999999999999999999   999999999999


Q ss_pred             ecCCCCEEEEecCcccccccCC
Q 020981          286 RDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       286 l~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ++.++.+||+|||+++......
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~  199 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDS  199 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCT
T ss_pred             EcCCCCEEEccccccccccccc
Confidence            9999999999999998876554

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.93  E-value=5.4e-26  Score=199.34  Aligned_cols=144  Identities=28%  Similarity=0.463  Sum_probs=122.2

Q ss_pred             ccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHh--cCCCcccccceeEEeC----Cce
Q 020981          155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQS----SPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~----~~~  225 (319)
                      .+|.....+|+|+||.||.   +++.||||++....      ...+..|.+++..  ++||||+++++++...    ...
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            3688889999999998874   68899999986432      2345556777766  7899999999986543    458


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH--------~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      ++||||+++|+|.++++. ..+++..+..++.|++.||.|||        +++   |+||||||+|||++.++.+||+||
T Consensus        82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeC
Confidence            999999999999999964 46899999999999999999999        888   999999999999999999999999


Q ss_pred             CcccccccCCC
Q 020981          298 GVSKLLTVKED  308 (319)
Q Consensus       298 gla~~~~~~~~  308 (319)
                      |+|+.......
T Consensus       158 g~a~~~~~~~~  168 (301)
T 3q4u_A          158 GLAVMHSQSTN  168 (301)
T ss_dssp             TTCEEEETTTT
T ss_pred             CCeeecccccc
Confidence            99987765543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=5.2e-26  Score=196.47  Aligned_cols=144  Identities=32%  Similarity=0.569  Sum_probs=128.6

Q ss_pred             ccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .+|.....+|+|+||.||.    .+..||+|++......    .+.+.+|+.++++++||||+++++++......++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            3678888999999999885    5678999999865432    2468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++....
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence            99999999999764 45899999999999999999999999   99999999999999999999999999986643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.93  E-value=2.3e-26  Score=207.11  Aligned_cols=146  Identities=32%  Similarity=0.502  Sum_probs=132.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||.|+||.||.     ++..||+|++....  .....+.+.+|+.+++.++||||+++++++......++||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            3688889999999999985     47899999987642  4555678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999999888899999999999999999999996 8   99999999999999999999999999976643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.93  E-value=8.3e-26  Score=200.21  Aligned_cols=148  Identities=28%  Similarity=0.510  Sum_probs=130.1

Q ss_pred             cccccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC
Q 020981          154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  223 (319)
                      ..+|.....||+|+||.||.          .+..||+|.+....  .......+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            34688889999999998884          36789999987542  3455567889999999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEE
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK  293 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~k  293 (319)
                      ..++||||+++++|.+++...          ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence            999999999999999999753          34688999999999999999999999   99999999999999999999


Q ss_pred             EEecCcccccccC
Q 020981          294 VADFGVSKLLTVK  306 (319)
Q Consensus       294 l~DFgla~~~~~~  306 (319)
                      |+|||+++.....
T Consensus       179 l~Dfg~~~~~~~~  191 (322)
T 1p4o_A          179 IGDFGMTRDIYET  191 (322)
T ss_dssp             ECCTTCCCGGGGG
T ss_pred             ECcCccccccccc
Confidence            9999999876543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=5.9e-26  Score=205.11  Aligned_cols=145  Identities=26%  Similarity=0.454  Sum_probs=122.1

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC------
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------  223 (319)
                      ..|.....+|+|+||.||.     +|+.||||++.... ......+.+.+|+.+++.++||||+++++++....      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            3688889999999999885     47899999987543 34555677889999999999999999999987653      


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            469999999 8899999886 56899999999999999999999999   999999999999999999999999999876


Q ss_pred             cc
Q 020981          304 TV  305 (319)
Q Consensus       304 ~~  305 (319)
                      ..
T Consensus       179 ~~  180 (367)
T 1cm8_A          179 DS  180 (367)
T ss_dssp             CS
T ss_pred             cc
Confidence            54

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.93  E-value=1.5e-26  Score=212.67  Aligned_cols=158  Identities=26%  Similarity=0.383  Sum_probs=125.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccC-----CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|...+.||+|+||.||.     +++.||+|++.+....     .......+.+|+.+++.++||||+++++++. ....
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~  214 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY  214 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence            578888999999999985     4689999998765332     1222335788999999999999999999875 4568


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC---CEEEEecCcccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKL  302 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DFgla~~  302 (319)
                      |+||||+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++   .+||+|||+|+.
T Consensus       215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            999999999999999988888999999999999999999999999   99999999999997544   599999999998


Q ss_pred             cccCCCCceeeccCCC
Q 020981          303 LTVKEDRPLTCQDTSC  318 (319)
Q Consensus       303 ~~~~~~~~~~~~~~~~  318 (319)
                      +.... ......||+.
T Consensus       292 ~~~~~-~~~~~~gt~~  306 (419)
T 3i6u_A          292 LGETS-LMRTLCGTPT  306 (419)
T ss_dssp             CC------------CT
T ss_pred             cCCCc-cccccCCCCC
Confidence            76543 2234556653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.93  E-value=6.3e-26  Score=201.13  Aligned_cols=148  Identities=34%  Similarity=0.525  Sum_probs=117.7

Q ss_pred             ccccceeeeecceEEEEEEe-----c---eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce-
Q 020981          155 LDFTNSVEITKGTFILAFWR-----G---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~-----~---~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~-  225 (319)
                      .+|.....+|+|+||.||..     +   ..||+|.+....... ...+.+.+|+.+++.++||||+++++++...... 
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            46888899999999999842     2   279999987654333 4467789999999999999999999999876655 


Q ss_pred             -----EEEEeecCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEE
Q 020981          226 -----MIVTEYLPKGDLRAFLKRKG------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV  294 (319)
Q Consensus       226 -----~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl  294 (319)
                           +++|||+++++|.+++....      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999996542      5899999999999999999999999   999999999999999999999


Q ss_pred             EecCcccccccC
Q 020981          295 ADFGVSKLLTVK  306 (319)
Q Consensus       295 ~DFgla~~~~~~  306 (319)
                      +|||+++.+...
T Consensus       179 ~Dfg~a~~~~~~  190 (323)
T 3qup_A          179 ADFGLSRKIYSG  190 (323)
T ss_dssp             CCCCC-------
T ss_pred             eecccccccccc
Confidence            999999877554

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.93  E-value=5.3e-26  Score=213.24  Aligned_cols=145  Identities=34%  Similarity=0.577  Sum_probs=129.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|.....||+|+||.||.     .+..||||.+.....    ..+.+.+|+.+++.++||||+++++++......|+||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            3577788999999998874     278999999875432    2467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            999999999999864  34899999999999999999999999   999999999999999999999999999987543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.93  E-value=3.5e-26  Score=208.67  Aligned_cols=158  Identities=27%  Similarity=0.391  Sum_probs=132.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC--ceEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMI  227 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~l  227 (319)
                      ..|.....+|+|+||.||.     +++.||+|++......  ...+.+.+|+.+++.++||||+++++++....  ..++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            3688889999999999985     3789999999754332  22456778999999999999999999988655  7899


Q ss_pred             EEeecCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe----cCCCCEEEEecCcc
Q 020981          228 VTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGVS  300 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DFgla  300 (319)
                      ||||+++|+|.+++.....   +++..+..++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999976432   899999999999999999999999   9999999999999    77778999999999


Q ss_pred             cccccCCCCceeeccCCC
Q 020981          301 KLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~  318 (319)
                      +.+..... .....||+.
T Consensus       164 ~~~~~~~~-~~~~~gt~~  180 (396)
T 4eut_A          164 RELEDDEQ-FVSLYGTEE  180 (396)
T ss_dssp             EECCCGGG-SSCSSSCCT
T ss_pred             eEccCCCc-cccccCCcc
Confidence            88765533 233556663

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.93  E-value=2.8e-25  Score=193.97  Aligned_cols=163  Identities=27%  Similarity=0.495  Sum_probs=135.9

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe----C
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S  222 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~  222 (319)
                      .....|.....||+|+||.||.     ++..||+|.+..... .....+.+.+|+.+++.++||||+++++++..    .
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            3344577778899999999985     467899999876543 45566788999999999999999999998865    3


Q ss_pred             CceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCccc
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSK  301 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgla~  301 (319)
                      ...++||||+++++|.+++...+.+++..+..++.|++.||.|||++++ +|+||||||+||+++ .++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            5689999999999999999988889999999999999999999999863 499999999999998 78999999999997


Q ss_pred             ccccCCCCceeeccCCC
Q 020981          302 LLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       302 ~~~~~~~~~~~~~~~~~  318 (319)
                      .....  ......||+.
T Consensus       181 ~~~~~--~~~~~~~t~~  195 (290)
T 1t4h_A          181 LKRAS--FAKAVIGTPE  195 (290)
T ss_dssp             GCCTT--SBEESCSSCC
T ss_pred             ccccc--ccccccCCcC
Confidence            65433  2334456653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.93  E-value=1.3e-25  Score=196.79  Aligned_cols=156  Identities=31%  Similarity=0.517  Sum_probs=133.5

Q ss_pred             CccccCCCcccccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccce
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG  217 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~  217 (319)
                      ..+.+.+....|...+.||+|+||.||..        ...+|+|.+...  ......+.+.+|+.++++++||||+++++
T Consensus        16 ~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   93 (298)
T 3f66_A           16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG   93 (298)
T ss_dssp             GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             hheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence            34556666778889999999999999842        235899988753  34566678999999999999999999999


Q ss_pred             eE-EeCCceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          218 AV-TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       218 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      ++ ..+...+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+
T Consensus        94 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~  170 (298)
T 3f66_A           94 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVA  170 (298)
T ss_dssp             EECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEEC
Confidence            85 4556789999999999999999764 45889999999999999999999999   9999999999999999999999


Q ss_pred             ecCcccccccC
Q 020981          296 DFGVSKLLTVK  306 (319)
Q Consensus       296 DFgla~~~~~~  306 (319)
                      |||+++.+...
T Consensus       171 Dfg~a~~~~~~  181 (298)
T 3f66_A          171 DFGLARDMYDK  181 (298)
T ss_dssp             SCGGGCCCSCG
T ss_pred             ccccccccccc
Confidence            99999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.93  E-value=1.4e-26  Score=205.74  Aligned_cols=156  Identities=26%  Similarity=0.467  Sum_probs=123.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +++.||+|++.....  ......+.+|+.+++.++||||+++++++......++|||
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            577888999999999985     478899999864321  1112234579999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      |++ ++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....+...
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            996 69999887754 5899999999999999999999999   999999999999999999999999999877655544


Q ss_pred             ceeeccCC
Q 020981          310 PLTCQDTS  317 (319)
Q Consensus       310 ~~~~~~~~  317 (319)
                      .....||+
T Consensus       157 ~~~~~~t~  164 (324)
T 3mtl_A          157 YDNEVVTL  164 (324)
T ss_dssp             ------CG
T ss_pred             cccccCcc
Confidence            44445555

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.93  E-value=1.9e-25  Score=196.59  Aligned_cols=145  Identities=31%  Similarity=0.509  Sum_probs=127.9

Q ss_pred             ceeeeecceEEEEEE---eceEeEEEEecccc-cCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          159 NSVEITKGTFILAFW---RGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       159 ~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      ....||+|+||.||.   .+..+|+|.+.... .......+.+.+|+.+++.++||||+++++++......+++|||+++
T Consensus        35 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  114 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN  114 (307)
T ss_dssp             TCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             cCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence            347899999999885   67899999987543 22334567789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          235 GDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       235 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++|.+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.....
T Consensus       115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence            999999974   245899999999999999999999999   999999999999999999999999999876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.93  E-value=1.2e-25  Score=198.75  Aligned_cols=144  Identities=20%  Similarity=0.331  Sum_probs=124.0

Q ss_pred             cccc-eeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEE
Q 020981          156 DFTN-SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       156 ~~~~-~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      .|.. ...+|+|+||.||.     +++.||||++.....   .....+.+|+.++.++ +||||+++++++...+..|+|
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            3444 35689999999985     578999999875432   2235678899999985 699999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC---EEEEecCccccccc
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV  305 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DFgla~~~~~  305 (319)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||+++.+..
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999999998888999999999999999999999999   999999999999998776   99999999987643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.93  E-value=9e-26  Score=197.13  Aligned_cols=145  Identities=30%  Similarity=0.506  Sum_probs=121.4

Q ss_pred             cccceeeeecceEEEEEE--eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecC
Q 020981          156 DFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~--~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      +|.....||+|+||.||.  ....+|+|++.... ......+.+.+|+.+++.++||||++++++ ......++||||++
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~lv~e~~~  102 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCE  102 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSSSCEEEEECCC
T ss_pred             ceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCCccEEEEEecC
Confidence            688889999999999985  35579999987553 345666789999999999999999999995 45667899999999


Q ss_pred             CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          234 KGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       234 ~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A          103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999643 45899999999999999999999999   99999999999999999999999999987653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.93  E-value=1.5e-25  Score=199.12  Aligned_cols=148  Identities=34%  Similarity=0.586  Sum_probs=130.5

Q ss_pred             cccccceeeeecceEEEEEE---------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEE--eC
Q 020981          154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QS  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~  222 (319)
                      ..+|.....+|+|+||.||.         .+..||+|.+...   .....+.+.+|+.+++.++||||+++++++.  ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            34788899999999999873         4688999998753   3455677899999999999999999999886  45


Q ss_pred             CceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      ...++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence            6689999999999999999874 45999999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCC
Q 020981          302 LLTVKE  307 (319)
Q Consensus       302 ~~~~~~  307 (319)
                      .+....
T Consensus       176 ~~~~~~  181 (327)
T 3lxl_A          176 LLPLDK  181 (327)
T ss_dssp             ECCTTC
T ss_pred             ecccCC
Confidence            875543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.93  E-value=6.4e-26  Score=207.15  Aligned_cols=151  Identities=26%  Similarity=0.355  Sum_probs=119.2

Q ss_pred             cccce-eeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHh-cCCCcccccceeEEe----CCc
Q 020981          156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ----SSP  224 (319)
Q Consensus       156 ~~~~~-~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~----~~~  224 (319)
                      +|... ..||.|+||.||.     ++..||||++...        ..+.+|+.++.+ .+||||+++++++..    ...
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            45554 5799999999985     4788999998632        345678888744 579999999998875    567


Q ss_pred             eEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV  299 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgl  299 (319)
                      +|+||||+++|+|.+++....  .+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            899999999999999998653  5999999999999999999999999   999999999999997   78999999999


Q ss_pred             ccccccCCCCceeeccCCC
Q 020981          300 SKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       300 a~~~~~~~~~~~~~~~~~~  318 (319)
                      ++....... ....+||+.
T Consensus       211 a~~~~~~~~-~~~~~gt~~  228 (400)
T 1nxk_A          211 AKETTSHNS-LTTPCYTPY  228 (400)
T ss_dssp             CEECC------------CT
T ss_pred             ccccCCCCc-cccCCCCCC
Confidence            997664432 334566664

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.93  E-value=1e-25  Score=195.98  Aligned_cols=146  Identities=24%  Similarity=0.472  Sum_probs=120.2

Q ss_pred             ccccceeeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      .+|.....+|+|+||.||.        .+..+|+|.+...  ......+.+.+|+.+++.++||||+++++++ ..+..|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~   91 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW   91 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence            4688889999999999884        2356999988653  3455667899999999999999999999987 456789


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +||||+++++|.+++.... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            9999999999999998654 5899999999999999999999999   99999999999999999999999999988755


Q ss_pred             C
Q 020981          306 K  306 (319)
Q Consensus       306 ~  306 (319)
                      .
T Consensus       169 ~  169 (281)
T 1mp8_A          169 S  169 (281)
T ss_dssp             -
T ss_pred             c
Confidence            4

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.93  E-value=1.7e-25  Score=196.59  Aligned_cols=156  Identities=31%  Similarity=0.499  Sum_probs=136.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....+|+|+||.||.     +++.||+|.+......  ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            578888999999999885     3789999998754322  335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |+++++|.+++.. +.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..+.......
T Consensus       101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A          101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            9999999999865 56899999999999999999999999   9999999999999999999999999998876655444


Q ss_pred             eeeccCC
Q 020981          311 LTCQDTS  317 (319)
Q Consensus       311 ~~~~~~~  317 (319)
                      ....||+
T Consensus       177 ~~~~~~~  183 (303)
T 3a7i_A          177 NTFVGTP  183 (303)
T ss_dssp             CCCCSCG
T ss_pred             CccCCCc
Confidence            4455655

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.93  E-value=1.2e-25  Score=208.70  Aligned_cols=149  Identities=30%  Similarity=0.517  Sum_probs=128.6

Q ss_pred             ccccCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  222 (319)
                      .|++..  .+|...+.||+|+||.||.    .+..||||.+.....    ..+.+.+|+.+++.++||||+++++++. .
T Consensus       182 ~~~i~~--~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          182 AWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             CSBCCG--GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             ceeech--HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            344443  3677788999999999985    367899999976432    2467889999999999999999999876 6


Q ss_pred             CceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcc
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla  300 (319)
                      ...|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            6799999999999999999754  35889999999999999999999999   999999999999999999999999999


Q ss_pred             ccccc
Q 020981          301 KLLTV  305 (319)
Q Consensus       301 ~~~~~  305 (319)
                      +.+..
T Consensus       332 ~~~~~  336 (454)
T 1qcf_A          332 RVIED  336 (454)
T ss_dssp             GGBCC
T ss_pred             eEcCC
Confidence            87643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=5.7e-26  Score=205.58  Aligned_cols=156  Identities=31%  Similarity=0.509  Sum_probs=125.7

Q ss_pred             CccccCCCcccccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccce
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG  217 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~  217 (319)
                      ..+.+......|...+.||+|+||.||..        +..+|+|.+...  ......+.+.+|+.+++.++||||+++++
T Consensus        80 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~  157 (373)
T 3c1x_A           80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG  157 (373)
T ss_dssp             TTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCE
T ss_pred             cccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            34455556667788889999999999841        246899988643  34456678999999999999999999999


Q ss_pred             eEE-eCCceEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEE
Q 020981          218 AVT-QSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (319)
Q Consensus       218 ~~~-~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  295 (319)
                      ++. .....++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+
T Consensus       158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~  234 (373)
T 3c1x_A          158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVA  234 (373)
T ss_dssp             EECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEe
Confidence            865 4567899999999999999998653 4888999999999999999999999   9999999999999999999999


Q ss_pred             ecCcccccccC
Q 020981          296 DFGVSKLLTVK  306 (319)
Q Consensus       296 DFgla~~~~~~  306 (319)
                      |||+++.+...
T Consensus       235 DFG~a~~~~~~  245 (373)
T 3c1x_A          235 DFGLARDMYDK  245 (373)
T ss_dssp             CC---------
T ss_pred             ecccccccccc
Confidence            99999876443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.93  E-value=1.3e-25  Score=195.75  Aligned_cols=144  Identities=24%  Similarity=0.375  Sum_probs=127.2

Q ss_pred             ccccceeeeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC
Q 020981          155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  222 (319)
                      .+|.....+|+|+||.||..            +..||+|.+....   ....+.+.+|+.+++.++||||+++++++...
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            46888889999999998842            2579999986543   23346788999999999999999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC--------EE
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LK  293 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~--------~k  293 (319)
                      ...++||||+++++|.+++..... +++..+..++.|++.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999987654 899999999999999999999999   999999999999998887        99


Q ss_pred             EEecCcccccc
Q 020981          294 VADFGVSKLLT  304 (319)
Q Consensus       294 l~DFgla~~~~  304 (319)
                      |+|||+++...
T Consensus       162 l~Dfg~~~~~~  172 (289)
T 4fvq_A          162 LSDPGISITVL  172 (289)
T ss_dssp             ECCCCSCTTTS
T ss_pred             eccCccccccc
Confidence            99999997654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.93  E-value=4.5e-26  Score=198.67  Aligned_cols=147  Identities=34%  Similarity=0.563  Sum_probs=130.8

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ..+|.....+|+|+||.||.     ++..||+|.+....    ...+.+.+|+.+++.++||||+++++++......++|
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            34688889999999998885     37889999987532    3356788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          229 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999999874  34899999999999999999999999   999999999999999999999999999887654


Q ss_pred             C
Q 020981          307 E  307 (319)
Q Consensus       307 ~  307 (319)
                      .
T Consensus       165 ~  165 (288)
T 3kfa_A          165 T  165 (288)
T ss_dssp             S
T ss_pred             c
Confidence            3

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.93  E-value=2.4e-25  Score=196.51  Aligned_cols=155  Identities=26%  Similarity=0.433  Sum_probs=130.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ..|.....+|.|+||.||.     +|+.||+|.+....     ..+.+.+|+.+++.++||||+++++++......|+||
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3688888999999999885     37899999987542     1256788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++..+.....
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            99999999999974 457999999999999999999999999   99999999999999999999999999988766544


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                      ......||+
T Consensus       181 ~~~~~~~~~  189 (314)
T 3com_A          181 KRNTVIGTP  189 (314)
T ss_dssp             CBCCCCSCG
T ss_pred             ccCccCCCC
Confidence            444455555

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.93  E-value=5.2e-26  Score=196.98  Aligned_cols=145  Identities=27%  Similarity=0.428  Sum_probs=130.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     +++.||+|.+.....  ....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            577888999999999885     478999999875432  2344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++.....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..+..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999999987777999999999999999999999999   99999999999999999999999999987643

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.93  E-value=3e-26  Score=177.53  Aligned_cols=124  Identities=29%  Similarity=0.385  Sum_probs=119.0

Q ss_pred             ccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Q 020981            6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      ...||+++|+..++....+...-+|.|+|..|..|.||||+||..|+.++++.|+++|+++|.+|.+|+||||+|+..|+
T Consensus        13 ~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~   92 (136)
T 2jab_A           13 DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGH   92 (136)
T ss_dssp             HHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTC
T ss_pred             cccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCC
Confidence            35689999999999999999989999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhC
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g  129 (319)
                      .+++++|+++|++++.+|..|+||+|+|+..++.+++++|++.|
T Consensus        93 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~Ll~~G  136 (136)
T 2jab_A           93 LEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKLN  136 (136)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHC-
T ss_pred             HHHHHHHHHcCCCCcCcCCCCCCHHHHHHHCCCHHHHHHHHHcC
Confidence            99999999999999999999999999999999999999999865

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.93  E-value=6.5e-26  Score=201.07  Aligned_cols=146  Identities=27%  Similarity=0.436  Sum_probs=123.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccC-----CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|.....||+|+||.||.     +++.||||.+......     .......+.+|+.+++.++||||+++++++.... .
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~   89 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y   89 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence            577888999999999985     4689999998754321     1222345788999999999999999999887654 8


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC---EEEEecCcccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKL  302 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DFgla~~  302 (319)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||+++.
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            999999999999999988888999999999999999999999999   999999999999987664   99999999987


Q ss_pred             ccc
Q 020981          303 LTV  305 (319)
Q Consensus       303 ~~~  305 (319)
                      ...
T Consensus       167 ~~~  169 (322)
T 2ycf_A          167 LGE  169 (322)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=2.4e-26  Score=205.61  Aligned_cols=147  Identities=23%  Similarity=0.362  Sum_probs=125.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      +|.....||+|+||.||.     ++..+|+|++......  .....+.+.+|+.+++.++||||+++++++......++|
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  106 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV  106 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence            688889999999999885     4678999998754321  234457789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhh
Q 020981          229 TEYLPKGDLRAFLKRK----------------------------------------GALKPSTAVRFALDIARGMNYLHE  268 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~----------------------------------------~~~~~~~~~~~~~qi~~al~~lH~  268 (319)
                      |||+++|+|.+++...                                        ..+++..+..++.|++.||.|||+
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  186 (345)
T 3hko_A          107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN  186 (345)
T ss_dssp             EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999988420                                        113567788899999999999999


Q ss_pred             CCCCCeEEcCCCCCCEEecCCC--CEEEEecCccccccc
Q 020981          269 NKPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTV  305 (319)
Q Consensus       269 ~~~~~ivH~Dlk~~Nill~~~~--~~kl~DFgla~~~~~  305 (319)
                      ++   |+||||||+|||++.++  .+||+|||+++.+..
T Consensus       187 ~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          187 QG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             TT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             CC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence            99   99999999999998776  899999999987654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.93  E-value=1.5e-25  Score=197.03  Aligned_cols=144  Identities=27%  Similarity=0.463  Sum_probs=127.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     +|+.||+|.+....   ....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            577888999999999984     47899999987543   2233568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe---cCCCCEEEEecCccccccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DFgla~~~~~  305 (319)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||++   +.++.+||+|||+++....
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999999988888999999999999999999999999   9999999999999   7788999999999976543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.93  E-value=1.5e-25  Score=197.50  Aligned_cols=159  Identities=29%  Similarity=0.446  Sum_probs=127.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCC--HHHHHHHHHHHHHHHhc---CCCcccccceeEEeCC-
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSS-  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~-  223 (319)
                      .+|.....||+|+||.||.     +++.||+|++.......  ......+.+|+.+++.+   +||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            3688899999999998884     47899999987533211  11113445677766666   4999999999998765 


Q ss_pred             ----ceEEEEeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          224 ----PMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       224 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                          ..+++|||+. ++|.+++.....  +++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSC
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeC
Confidence                5899999996 699999987654  899999999999999999999999   999999999999999999999999


Q ss_pred             CcccccccCCCCceeeccCCC
Q 020981          298 GVSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       298 gla~~~~~~~~~~~~~~~~~~  318 (319)
                      |+|+.+...... ....||+.
T Consensus       165 g~a~~~~~~~~~-~~~~gt~~  184 (308)
T 3g33_A          165 GLARIYSYQMAL-TPVVVTLW  184 (308)
T ss_dssp             SCTTTSTTCCCS-GGGGCCCS
T ss_pred             ccccccCCCccc-CCcccccc
Confidence            999887654333 33556653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.1e-25  Score=197.78  Aligned_cols=148  Identities=32%  Similarity=0.503  Sum_probs=125.9

Q ss_pred             cccccceeeeecceEEEEEEe---------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          154 ELDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~~---------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      ..+|...+.||+|+||.||..         +..||+|.+....  .......+.+|+.+++.++||||+++++++.....
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            346777889999999998852         2359999987542  34556678899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999865 56999999999999999999999999   999999999999999999999999999887


Q ss_pred             ccC
Q 020981          304 TVK  306 (319)
Q Consensus       304 ~~~  306 (319)
                      ...
T Consensus       198 ~~~  200 (333)
T 1mqb_A          198 EDD  200 (333)
T ss_dssp             ---
T ss_pred             ccc
Confidence            654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.93  E-value=5.7e-26  Score=204.94  Aligned_cols=150  Identities=16%  Similarity=0.263  Sum_probs=122.6

Q ss_pred             CcccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHH--------HHHHHHHHHHHhcCCCcccc
Q 020981          153 HELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQ  214 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~iv~  214 (319)
                      ...+|.....||+|+||.||..          ++.||+|++.........+.        ..+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            3347888999999999999853          47899999875431111111        12344666777888999999


Q ss_pred             cceeEEeC----CceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec--
Q 020981          215 FLGAVTQS----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--  287 (319)
Q Consensus       215 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~--  287 (319)
                      +++++...    ...|+||||+ +++|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence            99998765    4589999999 99999999876 57999999999999999999999999   99999999999999  


Q ss_pred             CCCCEEEEecCcccccccC
Q 020981          288 DSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       288 ~~~~~kl~DFgla~~~~~~  306 (319)
                      .++.+||+|||+|+.+...
T Consensus       189 ~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             CTTCEEECCCTTCEESSGG
T ss_pred             CCCeEEEEECCcceecccC
Confidence            8899999999999887543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.93  E-value=2.3e-25  Score=196.60  Aligned_cols=149  Identities=29%  Similarity=0.454  Sum_probs=120.8

Q ss_pred             cccccceeeeecceEEEEEE--------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC--
Q 020981          154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--  223 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--  223 (319)
                      ..+|.....+|+|+||.||.        ++..||+|.+..... .....+.+.+|+.+++.++||||+++++++....  
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            34688888999999998873        345899999875532 4455677899999999999999999999987654  


Q ss_pred             ---ceEEEEeecCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEE
Q 020981          224 ---PMMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV  294 (319)
Q Consensus       224 ---~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl  294 (319)
                         ..+++|||+++++|.+++..      ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence               45999999999999999853      245899999999999999999999999   999999999999999999999


Q ss_pred             EecCcccccccC
Q 020981          295 ADFGVSKLLTVK  306 (319)
Q Consensus       295 ~DFgla~~~~~~  306 (319)
                      +|||+++.+...
T Consensus       189 ~Dfg~~~~~~~~  200 (313)
T 3brb_A          189 ADFGLSKKIYSG  200 (313)
T ss_dssp             CSCSCC------
T ss_pred             eecCcceecccc
Confidence            999999877544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.93  E-value=5.8e-25  Score=197.88  Aligned_cols=143  Identities=27%  Similarity=0.400  Sum_probs=127.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-----CCcccccceeEEeCCc
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPNVVQFLGAVTQSSP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~l~~~~~~~~~  224 (319)
                      .+|.....||+|+||.||.     +++.||||++..    .......+..|+.+++.+.     ||||+++++++.....
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            3788899999999999985     578999999863    2344566778999999996     9999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC--------------
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--------------  288 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~--------------  288 (319)
                      .++||||+ +++|.+++....  .+++..+..++.|++.||+|||+++   |+||||||+|||++.              
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence            99999999 899999998764  4899999999999999999999999   999999999999975              


Q ss_pred             -----------CCCEEEEecCccccccc
Q 020981          289 -----------SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       289 -----------~~~~kl~DFgla~~~~~  305 (319)
                                 ++.+||+|||+|+....
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~  214 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSD  214 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred             ccccccccccCCCCEEEEeccCceecCC
Confidence                       78999999999987554

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.93  E-value=2.6e-25  Score=197.35  Aligned_cols=159  Identities=26%  Similarity=0.400  Sum_probs=127.6

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEe----
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----  221 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~----  221 (319)
                      .....|.....+|.|+||.||.     +++.||+|++.....    ....+.+|+.+++.+ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            3444788899999999999885     578999999875432    225678899999999 79999999999976    


Q ss_pred             --CCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          222 --SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       222 --~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                        ....++||||+++++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence              46799999999999999999864  46899999999999999999999999   999999999999999999999999


Q ss_pred             CcccccccCCCCceeeccCC
Q 020981          298 GVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       298 gla~~~~~~~~~~~~~~~~~  317 (319)
                      |++..+...........||+
T Consensus       174 g~~~~~~~~~~~~~~~~~~~  193 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTP  193 (326)
T ss_dssp             TTTC-------------CCG
T ss_pred             cCceecCcCccccccccCCc
Confidence            99988765544444455655

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=2.1e-25  Score=198.61  Aligned_cols=143  Identities=27%  Similarity=0.452  Sum_probs=120.9

Q ss_pred             ccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc--CCCcccccceeEEeC----Cce
Q 020981          155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQS----SPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~----~~~  225 (319)
                      .+|.....+|+|+||.||.   .+..||||++....      ...+..|.+++...  +||||+++++++...    ...
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3688899999999998874   68899999986431      12334455555554  899999999999877    689


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC--------CCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN--------KPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~--------~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      |+||||+++|+|.++++.. .+++..+..++.|++.||.|||++        +   |+||||||+|||++.++.+||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeC
Confidence            9999999999999999764 689999999999999999999998        7   999999999999999999999999


Q ss_pred             CcccccccCC
Q 020981          298 GVSKLLTVKE  307 (319)
Q Consensus       298 gla~~~~~~~  307 (319)
                      |+++.+....
T Consensus       187 g~a~~~~~~~  196 (337)
T 3mdy_A          187 GLAVKFISDT  196 (337)
T ss_dssp             TTCEECC---
T ss_pred             CCceeecccc
Confidence            9998775543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.93  E-value=2.7e-25  Score=194.35  Aligned_cols=156  Identities=31%  Similarity=0.518  Sum_probs=128.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      ++.....||+|+||.||.     ++..||+|.+....   ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            455556899999998885     46799999987542   2344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-CCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++. ++.+||+|||+++.+...
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            999999999998652   3668888999999999999999999   999999999999997 899999999999887654


Q ss_pred             CCCceeeccCC
Q 020981          307 EDRPLTCQDTS  317 (319)
Q Consensus       307 ~~~~~~~~~~~  317 (319)
                      ........||+
T Consensus       177 ~~~~~~~~~~~  187 (295)
T 2clq_A          177 NPCTETFTGTL  187 (295)
T ss_dssp             ----CCCCCCG
T ss_pred             CCcccccCCCc
Confidence            43333445554

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.93  E-value=2.4e-25  Score=195.05  Aligned_cols=143  Identities=29%  Similarity=0.489  Sum_probs=126.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe---------
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ---------  221 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---------  221 (319)
                      +|.....+|+|+||.||.     +++.||+|.+..    .....+.+.+|+.+++.++||||+++++++..         
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            577888999999999885     478999999864    23456778899999999999999999998754         


Q ss_pred             ----CCceEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEe
Q 020981          222 ----SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (319)
Q Consensus       222 ----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  296 (319)
                          ....|+||||+++++|.+++.... .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence                456899999999999999998654 4788899999999999999999999   99999999999999999999999


Q ss_pred             cCccccccc
Q 020981          297 FGVSKLLTV  305 (319)
Q Consensus       297 Fgla~~~~~  305 (319)
                      ||+++....
T Consensus       160 fg~~~~~~~  168 (303)
T 1zy4_A          160 FGLAKNVHR  168 (303)
T ss_dssp             CCCCSCTTC
T ss_pred             Ccchhhccc
Confidence            999987653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.93  E-value=2.5e-25  Score=194.05  Aligned_cols=158  Identities=25%  Similarity=0.408  Sum_probs=120.0

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ..+|.....+|+|+||.||.     +++.||+|.+.... ........+.++...++.++||||+++++++......++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            34688899999999999985     57899999987543 2233444556666668888999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |||++ |+|.+++..    ...+++..+..++.|++.||.|||++ +   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99996 588777754    45799999999999999999999998 8   999999999999999999999999999877


Q ss_pred             ccCCCCceeeccCC
Q 020981          304 TVKEDRPLTCQDTS  317 (319)
Q Consensus       304 ~~~~~~~~~~~~~~  317 (319)
                      ....... ...||+
T Consensus       161 ~~~~~~~-~~~~t~  173 (290)
T 3fme_A          161 VDDVAKD-IDAGCK  173 (290)
T ss_dssp             ----------CCCC
T ss_pred             ccccccc-ccCCCc
Confidence            6543332 234555

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.93  E-value=2.2e-25  Score=198.48  Aligned_cols=148  Identities=30%  Similarity=0.534  Sum_probs=130.1

Q ss_pred             cccccceeeeecceEEEEEEe-----c-----eEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeC
Q 020981          154 ELDFTNSVEITKGTFILAFWR-----G-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~~-----~-----~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~  222 (319)
                      ..+|.....+|.|+||.||..     +     ..||+|.+....  .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            346888899999999999852     1     379999987542  345567889999999999 899999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD  288 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~  288 (319)
                      ...++||||+++|+|.+++...              ..+++..+..++.|++.||.|||+++   |+||||||+|||++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence            9999999999999999999753              35789999999999999999999999   999999999999999


Q ss_pred             CCCEEEEecCcccccccC
Q 020981          289 SGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       289 ~~~~kl~DFgla~~~~~~  306 (319)
                      ++.+||+|||+++.....
T Consensus       200 ~~~~kl~Dfg~~~~~~~~  217 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMND  217 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGC
T ss_pred             CCeEEECccccccccccc
Confidence            999999999999877554

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.93  E-value=1.4e-26  Score=179.45  Aligned_cols=124  Identities=19%  Similarity=0.209  Sum_probs=118.9

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCC-CCCHHHHHHHcCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQGF   85 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~-g~tpLh~A~~~~~   85 (319)
                      -.|||+.|+..++....+...-.|.|+|..+..|.||||+||. |+.+++++|+++|+++|.+|.. |+||||+|+..|+
T Consensus        12 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~   90 (136)
T 1d9s_A           12 SDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGF   90 (136)
T ss_dssp             CSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTC
T ss_pred             CccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCC
Confidence            4689999999999988888888999999999999999999999 9999999999999999999999 9999999999999


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCC
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~  131 (319)
                      .+++++|+++|++++.+|..|+||+|+|+..++.+++++|++.|++
T Consensus        91 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~Gad  136 (136)
T 1d9s_A           91 LDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGHRDIARYLHAATGD  136 (136)
T ss_dssp             HHHHHHHHHTCCCCCCCSSSSSCHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence            9999999999999999999999999999999999999999998874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=6.3e-26  Score=196.84  Aligned_cols=163  Identities=23%  Similarity=0.422  Sum_probs=131.8

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--CCceE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMM  226 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~  226 (319)
                      ..+|.....+|+|+||.||.     +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++..  ....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            34688889999999998885     478999999976543 34556789999999999999999999998754  56899


Q ss_pred             EEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCC--CCeEEcCCCCCCEEecCCCCEEEEecCcc
Q 020981          227 IVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~--~~ivH~Dlk~~Nill~~~~~~kl~DFgla  300 (319)
                      +||||+++++|.+++...    ..+++..+..++.|++.||.|||++++  .+++||||||+||+++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999999999753    348999999999999999999999761  23999999999999999999999999999


Q ss_pred             cccccCCCCceeeccCC
Q 020981          301 KLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       301 ~~~~~~~~~~~~~~~~~  317 (319)
                      +.............||+
T Consensus       164 ~~~~~~~~~~~~~~~~~  180 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTP  180 (279)
T ss_dssp             HHC---CHHHHHHHSCC
T ss_pred             eeeccccccccccCCCc
Confidence            87765433333334444

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.93  E-value=1.2e-25  Score=196.93  Aligned_cols=157  Identities=25%  Similarity=0.492  Sum_probs=130.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|.|+||.||.     +++.||+|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCcc-chhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            577888999999998885     478999999875432 12223567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       231 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |++ ++|.+++...  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++....+..
T Consensus        83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  158 (299)
T 2r3i_A           83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  158 (299)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccCCcc
Confidence            996 6999999875  45889999999999999999999999   99999999999999999999999999987765443


Q ss_pred             CceeeccCC
Q 020981          309 RPLTCQDTS  317 (319)
Q Consensus       309 ~~~~~~~~~  317 (319)
                      ......||+
T Consensus       159 ~~~~~~~~~  167 (299)
T 2r3i_A          159 TYTHEVVTL  167 (299)
T ss_dssp             CTTSCBCCC
T ss_pred             ccCcccccc
Confidence            333444554

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.93  E-value=2.6e-25  Score=214.08  Aligned_cols=142  Identities=29%  Similarity=0.438  Sum_probs=125.1

Q ss_pred             eeeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecC
Q 020981          161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       161 ~~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      ..||+|+||.||.       .+..||||++..... .....+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999984       357899999976533 33445778999999999999999999998864 56899999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       234 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      +|+|.+++...+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+....
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            9999999998888999999999999999999999999   9999999999999999999999999999876543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=2.7e-25  Score=201.93  Aligned_cols=153  Identities=22%  Similarity=0.388  Sum_probs=124.4

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-------
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------  221 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-------  221 (319)
                      ..+|.....||+|+||.||.     +|+.||+|++......       ..+|+.+++.++||||+++++++..       
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34788899999999999985     4789999998654321       2369999999999999999999844       


Q ss_pred             -------------------------------CCceEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Q 020981          222 -------------------------------SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYL  266 (319)
Q Consensus       222 -------------------------------~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~l  266 (319)
                                                     ....++||||++ ++|.+.+..    ...+++..+..++.|++.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999997 587776653    46799999999999999999999


Q ss_pred             hhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCcccccccCCCCceeeccCCC
Q 020981          267 HENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       267 H~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~  318 (319)
                      |+++   |+||||||+|||++ .++.+||+|||+|+.+...... ....||++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~t~~  206 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYICSRF  206 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC-CCCCCCSS
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC-cCcccCCC
Confidence            9999   99999999999998 6889999999999987655433 33455553

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.93  E-value=8.1e-25  Score=197.39  Aligned_cols=156  Identities=26%  Similarity=0.460  Sum_probs=132.3

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-----Cc
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~  224 (319)
                      .+|.....||+|+||.||.     ++..||+|++...  ......+.+.+|+.+++.++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            4688999999999999985     4788999998743  3455567788999999999999999999998655     36


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .|+||||++ ++|.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            899999996 699999876 46899999999999999999999999   9999999999999999999999999998776


Q ss_pred             cCCCC---ceeeccCC
Q 020981          305 VKEDR---PLTCQDTS  317 (319)
Q Consensus       305 ~~~~~---~~~~~~~~  317 (319)
                      .....   .....||+
T Consensus       180 ~~~~~~~~~~~~~gt~  195 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATR  195 (364)
T ss_dssp             GGGCBCCTTCCCCSCG
T ss_pred             CCCCcccccccccccc
Confidence            44322   23345665

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.93  E-value=4.2e-25  Score=199.77  Aligned_cols=156  Identities=25%  Similarity=0.342  Sum_probs=123.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC------
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------  223 (319)
                      .+|.....||+|+||.||.     +++.||||++.... ........+.+|+.+++.++||||+++++++....      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            3688889999999999985     47899999987543 34556677889999999999999999999987654      


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ..|+||||++ ++|.+++.  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             ceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            6899999996 58888886  35899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCceeeccCCC
Q 020981          304 TVKEDRPLTCQDTSC  318 (319)
Q Consensus       304 ~~~~~~~~~~~~~~~  318 (319)
                      .... ......||+.
T Consensus       178 ~~~~-~~~~~~gt~~  191 (371)
T 2xrw_A          178 GTSF-MMTPYVVTRY  191 (371)
T ss_dssp             -------------CT
T ss_pred             cccc-ccCCceecCC
Confidence            5442 2233455553

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.93  E-value=2e-25  Score=193.97  Aligned_cols=151  Identities=28%  Similarity=0.466  Sum_probs=128.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe---------
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ---------  221 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---------  221 (319)
                      +|...+.+|+|+||.||.     +++.||+|.+....       ..+.+|+.+++.++||||+++++++..         
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            577888999999998874     47899999987542       245679999999999999999998754         


Q ss_pred             -------CCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCE
Q 020981          222 -------SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (319)
Q Consensus       222 -------~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~  292 (319)
                             ....++||||+++++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                   44589999999999999999764  56899999999999999999999999   9999999999999999999


Q ss_pred             EEEecCcccccccCCCCceeeccCC
Q 020981          293 KVADFGVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       293 kl~DFgla~~~~~~~~~~~~~~~~~  317 (319)
                      ||+|||+++.+..... .....||+
T Consensus       162 kl~Dfg~~~~~~~~~~-~~~~~~~~  185 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK-RTRSKGTL  185 (284)
T ss_dssp             EECCCTTCEESSCCSC-CCCCCSCC
T ss_pred             EECcchhheecccccc-ccccCCcc
Confidence            9999999988765432 22344555

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.93  E-value=7.9e-25  Score=191.61  Aligned_cols=143  Identities=21%  Similarity=0.277  Sum_probs=126.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....+|+|+||.||.     +++.||+|++......     +.+.+|+.+++.+ +|++++++++++......++||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            688889999999998884     5789999998654321     3467899999999 6999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC-----EEEEecCccccc
Q 020981          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSKLL  303 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DFgla~~~  303 (319)
                      ||+ +++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.     +||+|||+++.+
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999 999999998754 5999999999999999999999999   999999999999987776     999999999987


Q ss_pred             ccCC
Q 020981          304 TVKE  307 (319)
Q Consensus       304 ~~~~  307 (319)
                      ....
T Consensus       162 ~~~~  165 (298)
T 1csn_A          162 RDPV  165 (298)
T ss_dssp             BCTT
T ss_pred             cccc
Confidence            6553

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.93  E-value=7.4e-26  Score=198.54  Aligned_cols=148  Identities=27%  Similarity=0.480  Sum_probs=115.4

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ..+|.....||.|+||.||.     ++..||+|.+.....  ....+.+.+|+.+++.++||||+++++++......++|
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34788889999999998874     578999999865432  23456788899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcc
Q 020981          229 TEYLPKGDLRAFLKR--------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla  300 (319)
                      |||+++++|.+++..        ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999974        345899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccC
Q 020981          301 KLLTVK  306 (319)
Q Consensus       301 ~~~~~~  306 (319)
                      +.+...
T Consensus       169 ~~~~~~  174 (303)
T 2vwi_A          169 AFLATG  174 (303)
T ss_dssp             HHCC--
T ss_pred             heeccC
Confidence            876543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.93  E-value=2.5e-25  Score=196.44  Aligned_cols=149  Identities=32%  Similarity=0.512  Sum_probs=129.8

Q ss_pred             cccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeC
Q 020981          154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~  222 (319)
                      ..+|.....+|+|+||.||..          ++.||+|.+....  .......+.+|+.+++.+ +||||+++++++...
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            447888899999999999852          4789999997543  345567789999999999 699999999998765


Q ss_pred             C-ceEEEEeecCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEE
Q 020981          223 S-PMMIVTEYLPKGDLRAFLKRKGA----------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL  285 (319)
Q Consensus       223 ~-~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nil  285 (319)
                      . ..+++|||+++++|.+++.....                +++..+..++.|++.||.|||+++   |+||||||+||+
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil  180 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  180 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence            4 59999999999999999987543                789999999999999999999999   999999999999


Q ss_pred             ecCCCCEEEEecCcccccccCC
Q 020981          286 RDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       286 l~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ++.++.+||+|||+++.+....
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~  202 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDP  202 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCT
T ss_pred             ECCCCCEEECCCccccccccCc
Confidence            9999999999999998775543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.93  E-value=1.9e-25  Score=201.80  Aligned_cols=154  Identities=29%  Similarity=0.448  Sum_probs=114.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------Cc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~  224 (319)
                      +|.....||+|+||.||.     +|+.||||++.... ......+.+.+|+.+++.++||||+++++++...      ..
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            688889999999999885     47899999987543 3455567788999999999999999999998654      56


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .|+++|++ +++|.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            89999999 7899998876 56999999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCCCceeeccCCC
Q 020981          305 VKEDRPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~~~~~~~~  318 (319)
                      ..   .....||+.
T Consensus       184 ~~---~~~~~~t~~  194 (367)
T 2fst_X          184 DE---MTGYVATRW  194 (367)
T ss_dssp             ----------CCCT
T ss_pred             cc---CCCcCcCcC
Confidence            33   233455553

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.92  E-value=7.4e-26  Score=198.63  Aligned_cols=143  Identities=27%  Similarity=0.467  Sum_probs=124.7

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      ..|.....+|.|+||.||.     ++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++......++||
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3688888999999998885     37889999987543   223467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       230 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999876 456999999999999999999999999   999999999999999999999999998654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=4.2e-25  Score=190.34  Aligned_cols=142  Identities=33%  Similarity=0.600  Sum_probs=128.0

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|.....+|+|+||.||.    .+..||+|.+......    .+.+.+|+.+++.++||||+++++++......+++|||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            677888999999999885    4678999999865432    25688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +++++|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence            9999999999875 45899999999999999999999999   9999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.92  E-value=1.8e-25  Score=198.84  Aligned_cols=149  Identities=28%  Similarity=0.554  Sum_probs=123.6

Q ss_pred             cccccceeeeecceEEEEEE-----ece----EeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      ..+|.....||+|+||.||.     ++.    .||+|.+....  .....+.+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            34688889999999999985     233    35777775432  2334567889999999999999999999988754 


Q ss_pred             eEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .++++||+.+|+|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            78999999999999999874 56999999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCC
Q 020981          304 TVKED  308 (319)
Q Consensus       304 ~~~~~  308 (319)
                      .....
T Consensus       168 ~~~~~  172 (327)
T 3poz_A          168 GAEEK  172 (327)
T ss_dssp             TTTCC
T ss_pred             cCCcc
Confidence            65543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.92  E-value=4.4e-25  Score=192.61  Aligned_cols=141  Identities=17%  Similarity=0.171  Sum_probs=126.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....+|+|+||.||.     +++.||+|++...........+.+.+|+..++.++||||+++++++...+..|+|||
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  111 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE  111 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence            588889999999998884     378999999987766666777889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      |++|++|.++++..  ..+.++..++.|++.||+|||+++   |+||||||+|||++.+|.+||+++|...
T Consensus       112 ~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          112 WIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             CCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             ecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence            99999999998543  466678999999999999999999   9999999999999999999999887654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.92  E-value=1.1e-25  Score=201.92  Aligned_cols=145  Identities=29%  Similarity=0.453  Sum_probs=123.8

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--------
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------  221 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--------  221 (319)
                      .+|.....||+|+||.||.     +++.||+|++....... .....+.+|+.+++.++||||+++++++..        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4688889999999998874     47899999986554322 223456789999999999999999999876        


Q ss_pred             CCceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcc
Q 020981          222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (319)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla  300 (319)
                      ....|+||||++ ++|.+.+... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            346899999996 5787777654 56999999999999999999999999   999999999999999999999999999


Q ss_pred             cccc
Q 020981          301 KLLT  304 (319)
Q Consensus       301 ~~~~  304 (319)
                      +.+.
T Consensus       172 ~~~~  175 (351)
T 3mi9_A          172 RAFS  175 (351)
T ss_dssp             EECC
T ss_pred             cccc
Confidence            8775

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.92  E-value=8.6e-25  Score=193.23  Aligned_cols=143  Identities=21%  Similarity=0.355  Sum_probs=125.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEE----eCCce
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT----QSSPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----~~~~~  225 (319)
                      .+|.....||+|+||.||.     +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++.    .....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            4688899999999999874     5789999988643   4556678899999999999999999999986    33478


Q ss_pred             EEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          226 MIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            999999999999999976    356999999999999999999999999   9999999999999999999999999887


Q ss_pred             cc
Q 020981          302 LL  303 (319)
Q Consensus       302 ~~  303 (319)
                      ..
T Consensus       183 ~~  184 (317)
T 2buj_A          183 QA  184 (317)
T ss_dssp             ES
T ss_pred             hc
Confidence            64

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=7.6e-25  Score=191.01  Aligned_cols=145  Identities=28%  Similarity=0.466  Sum_probs=126.9

Q ss_pred             ccccee-eeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~-~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|.... .||+|+||.||.       .+..||+|.+...  ......+.+.+|+.+++.++||||+++++++ .....++
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            455554 899999999874       4678999999754  2455667899999999999999999999998 5567999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+...
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999654 45999999999999999999999999   999999999999999999999999999887544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.92  E-value=3.9e-25  Score=205.16  Aligned_cols=143  Identities=36%  Similarity=0.566  Sum_probs=122.8

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|.....||+|+||.||.    .+..||||.+......    .+.+.+|+.+++.++||||+++++++.. ...++||||
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            577788999999999885    2467999999764322    3568899999999999999999998765 678999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       232 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +++|+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999743  46899999999999999999999999   999999999999999999999999999877543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.92  E-value=4.6e-25  Score=196.01  Aligned_cols=145  Identities=37%  Similarity=0.624  Sum_probs=124.6

Q ss_pred             cccceeeeecceEEEEEE-----ece--EeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~--~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|.....+|+|+||.||.     ++.  .+|+|.+....  .....+.+.+|+.+++++ +||||+++++++......|+
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            688889999999998884     344  45999886432  334456788999999999 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC
Q 020981          228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      ||||+++++|.+++....                .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999998654                6899999999999999999999999   999999999999999999


Q ss_pred             EEEEecCccccccc
Q 020981          292 LKVADFGVSKLLTV  305 (319)
Q Consensus       292 ~kl~DFgla~~~~~  305 (319)
                      +||+|||+++....
T Consensus       181 ~kL~Dfg~~~~~~~  194 (327)
T 1fvr_A          181 AKIADFGLSRGQEV  194 (327)
T ss_dssp             EEECCTTCEESSCE
T ss_pred             EEEcccCcCccccc
Confidence            99999999985443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.92  E-value=6.8e-25  Score=190.39  Aligned_cols=144  Identities=33%  Similarity=0.537  Sum_probs=126.1

Q ss_pred             ccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .+|.....+|+|+||.||.    .+..||+|.+......    .+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence            3688889999999999985    3568999998754321    356889999999999999999999876 456899999


Q ss_pred             ecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            999999999987543  6899999999999999999999999   999999999999999999999999999877544

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.92  E-value=2.6e-25  Score=198.13  Aligned_cols=142  Identities=27%  Similarity=0.428  Sum_probs=117.7

Q ss_pred             cccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHH--HHhcCCCcccccceeEEe-----CC
Q 020981          154 ELDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELAL--LQKIRHPNVVQFLGAVTQ-----SS  223 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~l~~~~~~-----~~  223 (319)
                      ..+|.....||+|+||.||.   +++.||||++....      ...+..|.++  +..++||||+++++.+..     ..
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            34688889999999999884   68899999986432      1233334444  445889999999975542     23


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeEEcCCCCCCEEecCCCCEEE
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN---------KPVPIIHRDLEPSNILRDDSGNLKV  294 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---------~~~~ivH~Dlk~~Nill~~~~~~kl  294 (319)
                      .+++||||+++|+|.+++.... .++..+..++.|++.||.|||++         +   |+||||||+|||++.++.+||
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence            5789999999999999997654 58899999999999999999999         8   999999999999999999999


Q ss_pred             EecCccccccc
Q 020981          295 ADFGVSKLLTV  305 (319)
Q Consensus       295 ~DFgla~~~~~  305 (319)
                      +|||+|+.+..
T Consensus       162 ~DFG~a~~~~~  172 (336)
T 3g2f_A          162 SDFGLSMRLTG  172 (336)
T ss_dssp             CCCTTCEECSS
T ss_pred             eeccceeeccc
Confidence            99999987754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.92  E-value=4.4e-25  Score=190.43  Aligned_cols=149  Identities=26%  Similarity=0.390  Sum_probs=130.3

Q ss_pred             ccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC--CceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~  229 (319)
                      .+|.....+|+|+||.||.   .+..+|+|++..... .....+.+.+|+.+++.++||||+++++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            3678888999999998874   588999999986533 345567799999999999999999999999876  7889999


Q ss_pred             eecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+++|+|.+++....  .+++..+..++.|++.||.|||++++ +++||||||+||+++.++.++|+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999998765  48999999999999999999999874 499999999999999999999999998766443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.92  E-value=7.8e-25  Score=190.26  Aligned_cols=147  Identities=29%  Similarity=0.507  Sum_probs=126.5

Q ss_pred             cccccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          154 ELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      ..+|.....+|+|+||.||..        +..||+|.+....  .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            346888899999999988852        2459999987542  34556789999999999999999999998764 467


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      |+||||+++++|.+++...+ .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999997654 5899999999999999999999999   9999999999999999999999999998775


Q ss_pred             cC
Q 020981          305 VK  306 (319)
Q Consensus       305 ~~  306 (319)
                      ..
T Consensus       165 ~~  166 (281)
T 3cc6_A          165 DE  166 (281)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.92  E-value=9.7e-26  Score=200.29  Aligned_cols=148  Identities=30%  Similarity=0.552  Sum_probs=124.3

Q ss_pred             cccccceeeeecceEEEEEEe-----ce----EeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          154 ELDFTNSVEITKGTFILAFWR-----GI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~~-----~~----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      ..+|.....||+|+||.||..     +.    .+|+|.+.....  ......+.+|+.+++.++||||+++++++. ...
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            346888899999999999852     33    377777653321  122245667999999999999999999876 567


Q ss_pred             eEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .++||||+.+|+|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            89999999999999999864 46899999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCC
Q 020981          304 TVKE  307 (319)
Q Consensus       304 ~~~~  307 (319)
                      ....
T Consensus       166 ~~~~  169 (325)
T 3kex_A          166 PPDD  169 (325)
T ss_dssp             CCCT
T ss_pred             Cccc
Confidence            6543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.92  E-value=1.7e-25  Score=202.32  Aligned_cols=147  Identities=12%  Similarity=0.137  Sum_probs=110.9

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc--CCCcccccc-------eeEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFL-------GAVT  220 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~-------~~~~  220 (319)
                      ..|.....||+|+||.||.     +++.||+|++...........+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            3588889999999999985     4789999999876554556667788886555555  699988755       4443


Q ss_pred             eC-----------------CceEEEEeecCCCCHHHHHHHcC-CCCHHHH------HHHHHHHHHHHHHHhhCCCCCeEE
Q 020981          221 QS-----------------SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTA------VRFALDIARGMNYLHENKPVPIIH  276 (319)
Q Consensus       221 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~------~~~~~qi~~al~~lH~~~~~~ivH  276 (319)
                      ..                 ...|+||||++ |+|.+++...+ .+++...      ..++.|++.||+|||+++   |+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence            33                 33899999997 89999998642 3444444      567799999999999999   999


Q ss_pred             cCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          277 RDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       277 ~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      |||||+|||++.++.+||+|||+|+....
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~  246 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT  246 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCC
Confidence            99999999999999999999999987643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.92  E-value=3.9e-25  Score=192.89  Aligned_cols=150  Identities=31%  Similarity=0.517  Sum_probs=121.6

Q ss_pred             cccccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          154 ELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      ..+|.....||+|+||.||..        +..||+|.+...........+.+.+|+.+++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            447888899999999988742        2368999988665545566788999999999999999999999987654 8


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence            9999999999999999764 56899999999999999999999999   9999999999999999999999999998876


Q ss_pred             cCC
Q 020981          305 VKE  307 (319)
Q Consensus       305 ~~~  307 (319)
                      ...
T Consensus       173 ~~~  175 (291)
T 1u46_A          173 QND  175 (291)
T ss_dssp             C-C
T ss_pred             ccc
Confidence            543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.92  E-value=1.4e-24  Score=194.65  Aligned_cols=144  Identities=25%  Similarity=0.421  Sum_probs=126.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-----Cc
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~  224 (319)
                      .+|.....+|+|+||.||.     +|+.||||.+...  ........+.+|+.+++.++||||+++++++...     ..
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4788899999999999985     3789999998643  3455567788999999999999999999987654     67


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .|++|||+. ++|.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            899999996 699999876 46899999999999999999999999   9999999999999999999999999998775


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       164 ~  164 (353)
T 2b9h_A          164 E  164 (353)
T ss_dssp             -
T ss_pred             c
Confidence            4

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.92  E-value=7e-25  Score=195.75  Aligned_cols=142  Identities=30%  Similarity=0.475  Sum_probs=125.4

Q ss_pred             cccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHh--cCCCcccccceeEEeCC----ceE
Q 020981          156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQSS----PMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~~----~~~  226 (319)
                      +|.....+|+|+||.||.   +++.||+|.+....      ...+.+|.+++..  ++||||+++++++....    ..+
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             cEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            688889999999998874   68999999986431      2456778888888  68999999999998776    799


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEcCCCCCCEEecCCCCEEEEecC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH--------~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFg  298 (319)
                      +||||+++|+|.+++.+. .+++..+..++.|++.||.|||        +++   |+||||||+|||++.++.+||+|||
T Consensus       117 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECC
Confidence            999999999999999764 6899999999999999999999        778   9999999999999999999999999


Q ss_pred             cccccccCC
Q 020981          299 VSKLLTVKE  307 (319)
Q Consensus       299 la~~~~~~~  307 (319)
                      +++......
T Consensus       193 ~~~~~~~~~  201 (342)
T 1b6c_B          193 LAVRHDSAT  201 (342)
T ss_dssp             TCEEEETTT
T ss_pred             Cceeccccc
Confidence            998776554

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.92  E-value=7.4e-25  Score=190.92  Aligned_cols=149  Identities=33%  Similarity=0.526  Sum_probs=125.2

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHH----HHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRV----RAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      ..+|.....+|+|+||.||.     +++.||+|.+...........    +.+.+|+.+++.++||||+++++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            34688889999999998884     478999999876443332222    67889999999999999999999886554 


Q ss_pred             eEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC-----EEEEecC
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFG  298 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DFg  298 (319)
                       ++||||+++++|.+++... ..+++..+..++.|++.||.|||++++ +|+||||||+|||++.++.     +||+|||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence             7999999999999888754 469999999999999999999999873 4999999999999998776     9999999


Q ss_pred             ccccccc
Q 020981          299 VSKLLTV  305 (319)
Q Consensus       299 la~~~~~  305 (319)
                      +++....
T Consensus       175 ~~~~~~~  181 (287)
T 4f0f_A          175 LSQQSVH  181 (287)
T ss_dssp             TCBCCSS
T ss_pred             ccccccc
Confidence            9985543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.92  E-value=1.2e-24  Score=193.40  Aligned_cols=148  Identities=31%  Similarity=0.598  Sum_probs=129.3

Q ss_pred             cccccceeeeecceEEEEEE---------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC-
Q 020981          154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-  223 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-  223 (319)
                      ..+|.....+|+|+||.||.         +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++.... 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            34678889999999999874         4789999998753   3455678899999999999999999999886543 


Q ss_pred             -ceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          224 -PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       224 -~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                       ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence             789999999999999999876 45899999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCC
Q 020981          302 LLTVKE  307 (319)
Q Consensus       302 ~~~~~~  307 (319)
                      ......
T Consensus       194 ~~~~~~  199 (326)
T 2w1i_A          194 VLPQDK  199 (326)
T ss_dssp             ECCSSC
T ss_pred             hccccc
Confidence            876543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.92  E-value=4.7e-26  Score=203.98  Aligned_cols=148  Identities=24%  Similarity=0.457  Sum_probs=129.4

Q ss_pred             cccceeeeecceEEEEEE---eceEeEEEEecccccCCHH--------------HHHHHHHHHHHHHhcCCCccccccee
Q 020981          156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDD--------------RVRAFRDELALLQKIRHPNVVQFLGA  218 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~~iv~l~~~  218 (319)
                      +|.....+|.|+||.||.   +++.||+|.+.........              ..+.+.+|+.+++.++||||++++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  111 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI  111 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred             ceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            688889999999988774   6899999998754322211              12678899999999999999999999


Q ss_pred             EEeCCceEEEEeecCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCC
Q 020981          219 VTQSSPMMIVTEYLPKGDLRAF------LKR--KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDS  289 (319)
Q Consensus       219 ~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~  289 (319)
                      +......++||||+++++|.++      +..  ...+++..+..++.|++.||.|||+ ++   ++||||||+||+++.+
T Consensus       112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTT
T ss_pred             EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCC
Confidence            9999999999999999999998      655  4669999999999999999999999 88   9999999999999999


Q ss_pred             CCEEEEecCcccccccC
Q 020981          290 GNLKVADFGVSKLLTVK  306 (319)
Q Consensus       290 ~~~kl~DFgla~~~~~~  306 (319)
                      +.+||+|||++......
T Consensus       189 ~~~kl~dfg~~~~~~~~  205 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK  205 (348)
T ss_dssp             SCEEECCCTTCEECBTT
T ss_pred             CcEEEeccccccccccc
Confidence            99999999999876443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.92  E-value=4.3e-25  Score=211.99  Aligned_cols=140  Identities=27%  Similarity=0.474  Sum_probs=121.6

Q ss_pred             eeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecCC
Q 020981          162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       162 ~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      .||+|+||.||.       .+..||||++....  .....+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            799999999884       35679999997643  22345678899999999999999999999876 569999999999


Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       235 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |+|.+++... ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+....
T Consensus       420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            9999999754 45999999999999999999999999   9999999999999999999999999999875543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=3.1e-25  Score=199.19  Aligned_cols=142  Identities=16%  Similarity=0.233  Sum_probs=123.2

Q ss_pred             CcccccceeeeecceEEEEEEe-------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccc-----
Q 020981          153 HELDFTNSVEITKGTFILAFWR-------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ-----  214 (319)
Q Consensus       153 ~~~~~~~~~~ig~G~f~~v~~~-------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-----  214 (319)
                      ...+|.....||+|+||.||..             ++.||+|.+...        +.+.+|+.+++.++||||++     
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhh
Confidence            3457899999999999999842             689999998743        35678999999999999998     


Q ss_pred             ----------cceeEEe-CCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCC
Q 020981          215 ----------FLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP  281 (319)
Q Consensus       215 ----------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~  281 (319)
                                +++++.. ....|+||||+ +++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp  187 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTA  187 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCG
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCH
Confidence                      4566655 67899999999 99999999876  67999999999999999999999999   99999999


Q ss_pred             CCEEecCCC--CEEEEecCcccccccC
Q 020981          282 SNILRDDSG--NLKVADFGVSKLLTVK  306 (319)
Q Consensus       282 ~Nill~~~~--~~kl~DFgla~~~~~~  306 (319)
                      +|||++.++  .+||+|||+++.+...
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGG
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCC
Confidence            999999998  8999999999887654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.92  E-value=4.6e-25  Score=194.40  Aligned_cols=140  Identities=32%  Similarity=0.574  Sum_probs=118.0

Q ss_pred             cccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      +|.....||+|+||.||.   .++.||+|.+...     ...+.+.+|+.++++++||||+++++++.  +..++||||+
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            577788999999998874   6789999998632     34567889999999999999999999876  4589999999


Q ss_pred             CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhh---CCCCCeEEcCCCCCCEEecCCCC-EEEEecCccccccc
Q 020981          233 PKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHE---NKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTV  305 (319)
Q Consensus       233 ~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~---~~~~~ivH~Dlk~~Nill~~~~~-~kl~DFgla~~~~~  305 (319)
                      ++++|.+++.....   +++..+..++.|++.||.|||+   ++   |+||||||+|||++.++. +||+|||+++....
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999986543   7888999999999999999999   66   999999999999998887 79999999986643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.92  E-value=4.1e-25  Score=191.76  Aligned_cols=145  Identities=34%  Similarity=0.598  Sum_probs=121.1

Q ss_pred             cccccceeeeecceEEEEEE---eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-CceEEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVT  229 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-~~~~lv~  229 (319)
                      ..+|.....+|+|+||.||.   .+..||+|.+....     ..+.+.+|+.+++.++||||+++++++... ...++||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            34688889999999998874   68899999987432     346788999999999999999999987544 4789999


Q ss_pred             eecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          230 EYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||+++++|.+++.....  +++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.....
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999999986543  889999999999999999999999   999999999999999999999999999866543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.92  E-value=4.9e-25  Score=193.66  Aligned_cols=146  Identities=25%  Similarity=0.432  Sum_probs=123.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCcccccceeEE--eCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~~l  227 (319)
                      +|.....+|+|+||.||.     ++..+|+|++...... .......+.+|+.+++.++||||+++++++.  .....++
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            578888999999999985     4679999998754321 1234567889999999999999999999984  4568999


Q ss_pred             EEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      ||||++++ |.+++..  ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999765 8777765  346899999999999999999999999   99999999999999999999999999987754

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.92  E-value=2.4e-25  Score=160.80  Aligned_cols=93  Identities=46%  Similarity=0.578  Sum_probs=89.1

Q ss_pred             CcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCccccccccc
Q 020981           39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN  118 (319)
Q Consensus        39 ~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~  118 (319)
                      +|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||+|+|+..++
T Consensus         1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~   80 (93)
T 1n0q_A            1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH   80 (93)
T ss_dssp             --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhCCC
Q 020981          119 HEVIKLLEKHGAK  131 (319)
Q Consensus       119 ~~i~~~L~~~g~~  131 (319)
                      .+++++|++.|++
T Consensus        81 ~~~~~~Ll~~ga~   93 (93)
T 1n0q_A           81 LEVVKLLLEAGAY   93 (93)
T ss_dssp             HHHHHHHHHTTCC
T ss_pred             HHHHHHHHHcCCC
Confidence            9999999998864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.92  E-value=1.2e-24  Score=193.40  Aligned_cols=150  Identities=21%  Similarity=0.397  Sum_probs=128.1

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEe--CCceE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMM  226 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~--~~~~~  226 (319)
                      .+|.....||+|+||.||.     +++.||+|++....      .+.+.+|+.+++.++ ||||+++++++..  ....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            3688889999999999985     47899999987432      256788999999997 9999999999987  66789


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DFgla~~~~~  305 (319)
                      +||||+++++|.+++..   +++..+..++.|++.||.|||+++   |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus       110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999998753   889999999999999999999999   99999999999999777 899999999987765


Q ss_pred             CCCCceeeccCC
Q 020981          306 KEDRPLTCQDTS  317 (319)
Q Consensus       306 ~~~~~~~~~~~~  317 (319)
                      ..... ...||+
T Consensus       184 ~~~~~-~~~~~~  194 (330)
T 3nsz_A          184 GQEYN-VRVASR  194 (330)
T ss_dssp             TCCCC-SCCSCG
T ss_pred             CCccc-cccccc
Confidence            54332 234444

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.92  E-value=4.4e-25  Score=197.67  Aligned_cols=149  Identities=21%  Similarity=0.270  Sum_probs=120.7

Q ss_pred             cccccceeeeecceEEEEEE--------eceEeEEEEecccccCCHHH--------HHHHHHHHHHHHhcCCCcccccce
Q 020981          154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDR--------VRAFRDELALLQKIRHPNVVQFLG  217 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~l~~  217 (319)
                      ..+|.....||+|+||.||.        .+..+|+|.+.........+        ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            34788899999999998884        45789999987542111111        123567889999999999999999


Q ss_pred             eEEe----CCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC--C
Q 020981          218 AVTQ----SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--N  291 (319)
Q Consensus       218 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~--~  291 (319)
                      ++..    ....|+||||+ +++|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++  .
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence            9987    67899999999 9999999988778999999999999999999999999   99999999999999887  9


Q ss_pred             EEEEecCcccccccC
Q 020981          292 LKVADFGVSKLLTVK  306 (319)
Q Consensus       292 ~kl~DFgla~~~~~~  306 (319)
                      +||+|||+|+.+...
T Consensus       192 ~kL~Dfg~a~~~~~~  206 (345)
T 2v62_A          192 VYLADYGLSYRYCPN  206 (345)
T ss_dssp             EEECCCTTCEESSGG
T ss_pred             EEEEeCCCceecccc
Confidence            999999999887543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.92  E-value=8e-25  Score=190.84  Aligned_cols=147  Identities=27%  Similarity=0.479  Sum_probs=130.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|.....||+|+||.||.     +++.||+|++...... ......+.+|+.++++++||||+++++++......+++||
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            688889999999999885     4789999998765432 2234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC---CCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DFgla~~~~~~  306 (319)
                      |+++++|.+++.....+++..+..++.|++.||.|||+++   ++||||||+||+++.+   +.+||+|||+++.....
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            9999999999988888999999999999999999999999   9999999999999754   47999999999877554

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.92  E-value=5.9e-25  Score=207.97  Aligned_cols=149  Identities=36%  Similarity=0.557  Sum_probs=127.9

Q ss_pred             ccccCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  222 (319)
                      .|++..  .+|.....||+|+||.||.    .+..||||++......    .+.|.+|+.+|+.++||||+++++++.. 
T Consensus       261 ~~~i~~--~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          261 AWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             CSBCCG--GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ceecch--hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            344433  3577788999999999985    2467999999764322    3568899999999999999999998765 


Q ss_pred             CceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcc
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla  300 (319)
                      ...|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence            6799999999999999999743  45899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccc
Q 020981          301 KLLTV  305 (319)
Q Consensus       301 ~~~~~  305 (319)
                      +.+..
T Consensus       411 ~~~~~  415 (535)
T 2h8h_A          411 RLIED  415 (535)
T ss_dssp             TTCCC
T ss_pred             eecCC
Confidence            87653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.92  E-value=6.7e-25  Score=197.60  Aligned_cols=148  Identities=28%  Similarity=0.455  Sum_probs=122.4

Q ss_pred             ccccceeeeecceEEEEEE----eceEeEEEEeccccc--------CCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-
Q 020981          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVI--------SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-  221 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-  221 (319)
                      .+|.....||+|+||.||.    .+..||||.+.....        ......+.+.+|+.+++.++||||+++++++.. 
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            4688899999999999985    478999999865322        233445788999999999999999999999854 


Q ss_pred             ----CCceEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEe
Q 020981          222 ----SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (319)
Q Consensus       222 ----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  296 (319)
                          ....|+||||++ |+|.+++.... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEe
Confidence                336899999996 68888887543 6899999999999999999999999   99999999999999999999999


Q ss_pred             cCcccccccC
Q 020981          297 FGVSKLLTVK  306 (319)
Q Consensus       297 Fgla~~~~~~  306 (319)
                      ||+++.....
T Consensus       178 fg~~~~~~~~  187 (362)
T 3pg1_A          178 FNLAREDTAD  187 (362)
T ss_dssp             TTC-------
T ss_pred             cCcccccccc
Confidence            9999865544

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.92  E-value=1e-24  Score=184.18  Aligned_cols=178  Identities=15%  Similarity=0.021  Sum_probs=145.5

Q ss_pred             ccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Q 020981            6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      -..|+|+.|+..++....+...-.|.|+|..+.+|.||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+
T Consensus        20 ~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~   99 (229)
T 2vge_A           20 NPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCND   99 (229)
T ss_dssp             CHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTC
T ss_pred             chhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCC
Confidence            35678999999999999888888999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCcccCCC-CCCCCCcccc--cccccHHHHHHHHhhCCCCCCccccccccCC------CCccccCC-Ccc
Q 020981           86 TEVVSLLLERGADVDPKD-RWGSTPLGDA--IYYKNHEVIKLLEKHGAKPLMAPMHVKHARE------VPEYEIDP-HEL  155 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~-~~g~tpl~~a--~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~------~~~~~~~~-~~~  155 (319)
                      .+++++|+++|++++.++ ..|+||+|+|  +..++.+++++|++.|++....+.....+..      .....+.. ...
T Consensus       100 ~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~l~~~~~~~~~~~ll~~ga~~  179 (229)
T 2vge_A          100 TVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDYSAEFGDELSFREGESV  179 (229)
T ss_dssp             HHHHHHHHTTTCCTTCCCSSTTCCTGGGCCTTSTTHHHHHHHHHHHHHHTTTSGGGEEEESSCBCCSSTTBCCBCTTCEE
T ss_pred             HHHHHHHHHcCCCcccccCCCCCCHHHHHHHHhcChHHHHHHHHHcCCCcccccCCchHHHHHHhhccccccCccccccc
Confidence            999999999999999997 5999999999  9999999999999999887655433222211      11111111 001


Q ss_pred             cccceeeeecceEEEEEEeceEeEEEEe
Q 020981          156 DFTNSVEITKGTFILAFWRGIQVAVKKL  183 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~~~~vAvK~l  183 (319)
                      +......-|......+...|..-.||..
T Consensus       180 ~~~~~d~~G~TpL~~A~~~g~~~~v~~~  207 (229)
T 2vge_A          180 TVLRRDGPEETDWWWAALHGQEGYVPRN  207 (229)
T ss_dssp             EEEESSCTTCSSEEEEEETTEEEEEEGG
T ss_pred             cccccCCCcccHHHHHHHcCCcceeehh
Confidence            1222334477788888888888888864

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.92  E-value=5.3e-26  Score=180.37  Aligned_cols=136  Identities=20%  Similarity=0.213  Sum_probs=118.9

Q ss_pred             ccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCC-HHHHHHHcC
Q 020981            6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT-ALHVAACQG   84 (319)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~t-pLh~A~~~~   84 (319)
                      +-.|||+.|+..++....+...-+|.|+|..+..|.||||+|+ .|+.+++++|+++|+++|.+|..|+| |||+|+..|
T Consensus        11 ~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~   89 (156)
T 1bi7_B           11 PSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREG   89 (156)
T ss_dssp             CSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHT
T ss_pred             cchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCC
Confidence            4578999999999999999999999999999999999999985 99999999999999999999999999 999999999


Q ss_pred             CHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      +.+++++|+++|++++.+|..|+||+|+|+..++.+++++|++.|+++........++
T Consensus        90 ~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~  147 (156)
T 1bi7_B           90 FLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDA  147 (156)
T ss_dssp             CHHHHHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSSCC-------------
T ss_pred             CHHHHHHHHHcCCCCcccCCCCCCHHHHHHHhCHHHHHHHHHHcCCCCCccCcCcCcc
Confidence            9999999999999999999999999999999999999999999999886665444443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.92  E-value=3.8e-25  Score=196.63  Aligned_cols=156  Identities=25%  Similarity=0.432  Sum_probs=127.1

Q ss_pred             ccce-eeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEE
Q 020981          157 FTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       157 ~~~~-~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      |... +.||+|+||.||.     +++.||+|++...... ......+.+|+.+++.+. ||||+++++++......++||
T Consensus        30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            4444 6899999999985     4789999998765432 223456888999999995 799999999999999999999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCcccccc
Q 020981          230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLT  304 (319)
Q Consensus       230 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgla~~~~  304 (319)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.   ++.+||+|||+++.+.
T Consensus       109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999998543  56999999999999999999999999   999999999999997   7899999999999876


Q ss_pred             cCCCCceeeccCC
Q 020981          305 VKEDRPLTCQDTS  317 (319)
Q Consensus       305 ~~~~~~~~~~~~~  317 (319)
                      ..... ....||+
T Consensus       186 ~~~~~-~~~~gt~  197 (327)
T 3lm5_A          186 HACEL-REIMGTP  197 (327)
T ss_dssp             ---------CCCG
T ss_pred             Ccccc-ccccCCc
Confidence            54332 2345555

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.92  E-value=4.9e-25  Score=177.12  Aligned_cols=132  Identities=32%  Similarity=0.371  Sum_probs=125.2

Q ss_pred             ccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Q 020981            6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      +..|++++|++.++....+...-+|.|+|..+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus        13 ~~~~~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~   92 (169)
T 2y1l_E           13 DLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGH   92 (169)
T ss_dssp             CHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             cccchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence            45688999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      .+++++|+++|++++.+|..|.||||+|+..++.+++++|++.|++....+.
T Consensus        93 ~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  144 (169)
T 2y1l_E           93 LEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDK  144 (169)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence            9999999999999999999999999999999999999999999988755443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.92  E-value=7.4e-25  Score=213.07  Aligned_cols=151  Identities=24%  Similarity=0.347  Sum_probs=127.4

Q ss_pred             cccceeeeecceEEEEEE------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc-----
Q 020981          156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-----  224 (319)
                      +|.....||+|+||.||.      +++.||||.+...  ........+.+|+.+++.++||||+++++++.....     
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            688889999999999984      3688999988643  244556778899999999999999999999987665     


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .|+||||+++++|.+++..  .+++..+..++.|++.||.|||+++   |+||||||+|||++.+ .+||+|||+++...
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            7999999999999988765  6899999999999999999999999   9999999999999985 89999999998775


Q ss_pred             cCCCCceeeccCCC
Q 020981          305 VKEDRPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~~~~~~~~  318 (319)
                      ..    ....||+.
T Consensus       233 ~~----~~~~gt~~  242 (681)
T 2pzi_A          233 SF----GYLYGTPG  242 (681)
T ss_dssp             CC----SCCCCCTT
T ss_pred             cC----CccCCCcc
Confidence            44    33456664

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.92  E-value=1.8e-24  Score=198.73  Aligned_cols=153  Identities=27%  Similarity=0.415  Sum_probs=123.1

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------  222 (319)
                      ...|.....||+|+||.||.     +++.||||++.....       ...+|+.+++.++||||+++++++...      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            34688889999999999985     478999999865321       223699999999999999999988542      


Q ss_pred             CceEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC-CCEEEEec
Q 020981          223 SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADF  297 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DF  297 (319)
                      ..+++||||+++ ++.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.+ +.+||+||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccc
Confidence            237799999965 67666543    456999999999999999999999999   9999999999999965 56899999


Q ss_pred             CcccccccCCCCceeeccCCC
Q 020981          298 GVSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       298 gla~~~~~~~~~~~~~~~~~~  318 (319)
                      |+|+.+..... .....||++
T Consensus       202 G~a~~~~~~~~-~~~~~~t~~  221 (420)
T 1j1b_A          202 GSAKQLVRGEP-NVSYICSRY  221 (420)
T ss_dssp             TTCEECCTTCC-CCSCCSCTT
T ss_pred             hhhhhcccCCC-ceeeeeCCC
Confidence            99998765433 233566664

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.92  E-value=7.3e-25  Score=194.71  Aligned_cols=146  Identities=32%  Similarity=0.457  Sum_probs=124.8

Q ss_pred             ccccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      .+|.....+|+|+||.||.          ++..||+|.+...  ........+.+|+.+++.++||||+++++++.....
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            4788889999999998874          2457999998643  234556678899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC---CCEEE
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKV  294 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~---~~~kl  294 (319)
                      .|+||||+++++|.+++....       .+++..+..++.|++.||.|||+++   |+||||||+|||++.+   ..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999998753       3889999999999999999999999   9999999999999944   46999


Q ss_pred             EecCccccccc
Q 020981          295 ADFGVSKLLTV  305 (319)
Q Consensus       295 ~DFgla~~~~~  305 (319)
                      +|||+++....
T Consensus       185 ~Dfg~~~~~~~  195 (327)
T 2yfx_A          185 GDFGMARDIYR  195 (327)
T ss_dssp             CCCHHHHHHHC
T ss_pred             Ccccccccccc
Confidence            99999986543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.92  E-value=1.1e-24  Score=199.39  Aligned_cols=150  Identities=27%  Similarity=0.422  Sum_probs=111.2

Q ss_pred             eeeeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--CCceEEEEe
Q 020981          160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE  230 (319)
Q Consensus       160 ~~~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e  230 (319)
                      ...||+|+||.||.       .+..||+|.+......     ..+.+|+.+++.++||||+++++++..  ....|+|||
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e  100 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD  100 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence            34699999999984       2568999998754322     356789999999999999999999954  678999999


Q ss_pred             ecCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe----cCCCCEEEEec
Q 020981          231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF  297 (319)
Q Consensus       231 ~~~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DF  297 (319)
                      |++ ++|.+++...         ..+++..+..++.|++.||.|||+++   |+||||||+|||+    +.++.+||+||
T Consensus       101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A          101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            995 6888887632         14899999999999999999999999   9999999999999    67789999999


Q ss_pred             CcccccccCC---CCceeeccCCC
Q 020981          298 GVSKLLTVKE---DRPLTCQDTSC  318 (319)
Q Consensus       298 gla~~~~~~~---~~~~~~~~~~~  318 (319)
                      |+|+.+....   .......||+.
T Consensus       177 g~a~~~~~~~~~~~~~~~~~gt~~  200 (405)
T 3rgf_A          177 GFARLFNSPLKPLADLDPVVVTFW  200 (405)
T ss_dssp             TCCC----------------CCCT
T ss_pred             CCceecCCCCcccccCCCceecCc
Confidence            9999876432   22234566664

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.92  E-value=1.9e-24  Score=192.35  Aligned_cols=152  Identities=31%  Similarity=0.594  Sum_probs=128.7

Q ss_pred             cCCCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEE---
Q 020981          150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVT---  220 (319)
Q Consensus       150 ~~~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~---  220 (319)
                      +.....+|.....||+|+||.||.     +++.||+|.+...   .....+.+.+|+.+++.+. ||||+++++++.   
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            334445788999999999999984     5789999988543   3455677889999999996 999999999984   


Q ss_pred             -----eCCceEEEEeecCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCE
Q 020981          221 -----QSSPMMIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (319)
Q Consensus       221 -----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~  292 (319)
                           ....++++|||+. |+|.+++..   .+.+++..+..++.|++.||.|||++++ +|+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCE
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCE
Confidence                 3345899999995 799998865   4569999999999999999999999863 49999999999999999999


Q ss_pred             EEEecCcccccccC
Q 020981          293 KVADFGVSKLLTVK  306 (319)
Q Consensus       293 kl~DFgla~~~~~~  306 (319)
                      ||+|||+++.+...
T Consensus       178 kl~Dfg~~~~~~~~  191 (337)
T 3ll6_A          178 KLCDFGSATTISHY  191 (337)
T ss_dssp             EBCCCTTCBCCSSC
T ss_pred             EEecCccceecccc
Confidence            99999999887654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.91  E-value=2.7e-24  Score=194.54  Aligned_cols=143  Identities=24%  Similarity=0.475  Sum_probs=122.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce-----
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~-----  225 (319)
                      +|.....+|+|+||.||.     +|+.||+|++.... ........+.+|+.+++.++||||+++++++......     
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            688888999999999985     47899999997653 3455567788999999999999999999999877654     


Q ss_pred             -EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 -MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                       |+||||+. ++|.+++.  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence             99999996 68888774  34899999999999999999999999   9999999999999999999999999998664


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       196 ~  196 (371)
T 4exu_A          196 A  196 (371)
T ss_dssp             -
T ss_pred             c
Confidence            4

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.91  E-value=2.6e-24  Score=188.80  Aligned_cols=139  Identities=27%  Similarity=0.394  Sum_probs=120.4

Q ss_pred             cccce-eeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHH-HhcCCCcccccceeEEe----CCc
Q 020981          156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQ----SSP  224 (319)
Q Consensus       156 ~~~~~-~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~----~~~  224 (319)
                      +|... ..+|.|+||.||.     +++.||+|.+...        ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            45555 6699999999984     4789999998632        3456788887 55689999999999876    678


Q ss_pred             eEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV  299 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgl  299 (319)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||+++   |+||||||+||+++.   ++.+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            999999999999999998764  5999999999999999999999999   999999999999998   78999999999


Q ss_pred             cccccc
Q 020981          300 SKLLTV  305 (319)
Q Consensus       300 a~~~~~  305 (319)
                      ++....
T Consensus       167 a~~~~~  172 (299)
T 3m2w_A          167 AKETTG  172 (299)
T ss_dssp             CEECTT
T ss_pred             cccccc
Confidence            987654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.91  E-value=6.6e-25  Score=195.15  Aligned_cols=148  Identities=28%  Similarity=0.561  Sum_probs=120.5

Q ss_pred             cccccceeeeecceEEEEEE-----eceE----eEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~----vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      ..+|.....||+|+||.||.     ++..    +|+|.+....  .....+.+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            34788899999999999985     2343    5777665432  2233467889999999999999999999988754 


Q ss_pred             eEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .+++++|+.+|+|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            88999999999999999874 56999999999999999999999999   999999999999999999999999999887


Q ss_pred             ccCC
Q 020981          304 TVKE  307 (319)
Q Consensus       304 ~~~~  307 (319)
                      ....
T Consensus       168 ~~~~  171 (327)
T 3lzb_A          168 GAEE  171 (327)
T ss_dssp             ----
T ss_pred             cCcc
Confidence            5543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.91  E-value=1.7e-24  Score=197.38  Aligned_cols=151  Identities=28%  Similarity=0.460  Sum_probs=121.3

Q ss_pred             ccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc------
Q 020981          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP------  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~------  224 (319)
                      .+|.....||+|+||.||.    .+..+|+|++......       ..+|+.+++.++||||+++++++.....      
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            3688899999999999985    3456999987643221       2269999999999999999999865443      


Q ss_pred             eEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCc
Q 020981          225 MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGV  299 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgl  299 (319)
                      .++||||+++ ++...+.    ..+.+++..+..++.|++.||.|||+++   |+||||||+|||++ .++.+||+|||+
T Consensus       113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            8899999976 4444333    2457999999999999999999999999   99999999999999 799999999999


Q ss_pred             ccccccCCCCceeeccCC
Q 020981          300 SKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       300 a~~~~~~~~~~~~~~~~~  317 (319)
                      |+.+...... ....||+
T Consensus       189 a~~~~~~~~~-~~~~~t~  205 (394)
T 4e7w_A          189 AKILIAGEPN-VSYICSR  205 (394)
T ss_dssp             CEECCTTCCC-CSSCSCG
T ss_pred             cccccCCCCC-cccccCc
Confidence            9987655433 2345555

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.91  E-value=5.2e-24  Score=196.23  Aligned_cols=151  Identities=28%  Similarity=0.383  Sum_probs=128.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc------CCCcccccceeEEeCCc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI------RHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~l~~~~~~~~~  224 (319)
                      +|.....||+|+||.||.     +++.||||++...    ......+.+|+.+++.+      +|+||+++++.+.....
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            688899999999999985     3789999998743    34445677788888887      57799999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC--EEEEecCcc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGVS  300 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DFgla  300 (319)
                      .++||||+. ++|.+++....  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.  +||+|||+|
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999995 69999998764  4899999999999999999999999   999999999999999987  999999999


Q ss_pred             cccccCCCCceeeccCC
Q 020981          301 KLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       301 ~~~~~~~~~~~~~~~~~  317 (319)
                      +.....   ..+..||+
T Consensus       250 ~~~~~~---~~~~~gt~  263 (429)
T 3kvw_A          250 CYEHQR---VYTYIQSR  263 (429)
T ss_dssp             EETTCC---CCSSCSCG
T ss_pred             eecCCc---ccccCCCC
Confidence            765433   22345565

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.91  E-value=7.2e-25  Score=166.67  Aligned_cols=124  Identities=40%  Similarity=0.439  Sum_probs=119.4

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-++.+++..+..|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.+
T Consensus         3 ~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~   82 (126)
T 1n0r_A            3 RTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLE   82 (126)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             ccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHH
Confidence            58899999999988888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~  131 (319)
                      ++++|+++|++++.+|..|.||+++|+..++.+++++|++.|++
T Consensus        83 ~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~Gad  126 (126)
T 1n0r_A           83 VVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY  126 (126)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCC
T ss_pred             HHHHHHHcCCCCcccCCCCCCHHHHHHHcCcHHHHHHHHHcCCC
Confidence            99999999999999999999999999999999999999999875

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.91  E-value=7.9e-25  Score=175.34  Aligned_cols=130  Identities=22%  Similarity=0.263  Sum_probs=123.1

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-.+.++|..+.+|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+
T Consensus         4 ~t~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~   83 (167)
T 3v31_A            4 SLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTD   83 (167)
T ss_dssp             CCCHHHHHHTTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHH
T ss_pred             cchHHHHHHCCCHHHHHHHHHcCCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHH
Confidence            58999999999988888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      ++++|+++|++++.+|..|.||+|+|+..++.+++++|++.|+++...+.
T Consensus        84 ~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  133 (167)
T 3v31_A           84 IVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETD  133 (167)
T ss_dssp             HHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence            99999999999999999999999999999999999999999988755443

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.91  E-value=7.2e-25  Score=189.57  Aligned_cols=138  Identities=24%  Similarity=0.283  Sum_probs=108.6

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|||+.|+..++....+-..-.+.|++..+.+|.||||+|+..++.++++.|++.|+|+|.+|..|+||||+||..|+.+
T Consensus        87 ~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~~~g~~~  166 (269)
T 4b93_B           87 SSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHE  166 (269)
T ss_dssp             CCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCGG
T ss_pred             CCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHH
Confidence            36666666666666666666666677777777777777777777777777777778888888888999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccCCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV  145 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~~  145 (319)
                      +|++|+++|+++|.+|..|+||||+|+..|+.+++++|++.|+++...+....++..+
T Consensus       167 ~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~  224 (269)
T 4b93_B          167 LVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTAVDC  224 (269)
T ss_dssp             GHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCSGGG
T ss_pred             HHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHH
Confidence            9999999999999999999999999999999999999999888887666555555443

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.91  E-value=7.6e-25  Score=193.22  Aligned_cols=158  Identities=28%  Similarity=0.385  Sum_probs=126.9

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCH---HHHHHHHHHHHHHHhc----CCCcccccceeEEeC
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKI----RHPNVVQFLGAVTQS  222 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~iv~l~~~~~~~  222 (319)
                      .+|.....+|+|+||.||.     +++.||+|.+........   .....+.+|+.+++.+    +||||+++++++...
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            4688899999999999985     477999999976543221   1223456799999998    899999999999999


Q ss_pred             CceEEEEee-cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCcc
Q 020981          223 SPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVS  300 (319)
Q Consensus       223 ~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgla  300 (319)
                      ...++++|+ +.+++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++ .++.+||+|||++
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            999999999 789999999998888999999999999999999999999   99999999999999 8899999999999


Q ss_pred             cccccCCCCceeeccCC
Q 020981          301 KLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       301 ~~~~~~~~~~~~~~~~~  317 (319)
                      +.+....  .....||+
T Consensus       188 ~~~~~~~--~~~~~~~~  202 (312)
T 2iwi_A          188 ALLHDEP--YTDFDGTR  202 (312)
T ss_dssp             EECCSSC--BCCCCSCT
T ss_pred             hhcccCc--ccccCCcc
Confidence            8876542  22344555

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.91  E-value=2.1e-24  Score=175.01  Aligned_cols=135  Identities=20%  Similarity=0.209  Sum_probs=83.5

Q ss_pred             ccccccccccCchhhhhhhhhc-CCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .++++.|+..++....+...-+ +.++|..+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.
T Consensus         6 ~~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~   85 (179)
T 3f6q_A            6 MDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHR   85 (179)
T ss_dssp             -CCHHHHHHHTCHHHHHHHHHCTTSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCH
T ss_pred             HHHHHHHHHcCCHHHHHHHHhcCcccccccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCH
Confidence            4556666666665555544443 555666666666666666666666666666666666666666666666666666666


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      +++++|+++|++++.+|..|.||||+|+..++.+++++|++.|++....+....++
T Consensus        86 ~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp  141 (179)
T 3f6q_A           86 DIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMP  141 (179)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCG
T ss_pred             HHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCCc
Confidence            66666666666666666666666666666666666666666666655444443333

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.91  E-value=3.8e-24  Score=190.05  Aligned_cols=149  Identities=32%  Similarity=0.478  Sum_probs=122.7

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHH-HHHhcCCCcccccceeEEeCCce
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      ....+|.....||+|+||.||.     +++.||+|.+....  .......+..|+. +++.++||||+++++++......
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            3445788888999999999984     47899999997542  2333444555555 77778999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          226 MIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                      ++||||++ ++|.+++..     ...+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||+
T Consensus        97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence            99999996 588888763     45689999999999999999999998 8   99999999999999999999999999


Q ss_pred             ccccccC
Q 020981          300 SKLLTVK  306 (319)
Q Consensus       300 a~~~~~~  306 (319)
                      ++.+...
T Consensus       173 ~~~~~~~  179 (327)
T 3aln_A          173 SGQLVDS  179 (327)
T ss_dssp             SCC----
T ss_pred             ceecccc
Confidence            9877544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.91  E-value=3e-24  Score=189.49  Aligned_cols=151  Identities=23%  Similarity=0.397  Sum_probs=129.8

Q ss_pred             cCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCcccccceeEEeCC
Q 020981          150 IDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSS  223 (319)
Q Consensus       150 ~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~  223 (319)
                      +.....+|.....||+|+||.||.    +++.||+|.+..... .......+.+|+.+++.++  ||||+++++++....
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            334445788899999999999985    378899999875432 4556678899999999997  599999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ..+++|| +.+++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||+++ +.+||+|||+++.+
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            9999999 458899999998888999999999999999999999999   999999999999975 89999999999887


Q ss_pred             ccC
Q 020981          304 TVK  306 (319)
Q Consensus       304 ~~~  306 (319)
                      ...
T Consensus       177 ~~~  179 (313)
T 3cek_A          177 QPD  179 (313)
T ss_dssp             ---
T ss_pred             cCc
Confidence            554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.91  E-value=4e-24  Score=188.79  Aligned_cols=142  Identities=27%  Similarity=0.519  Sum_probs=118.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEE----------
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT----------  220 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----------  220 (319)
                      +|.....+|+|+||.||.     +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++.          
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            688889999999999885     3789999998643   4556678899999999999999999998873          


Q ss_pred             ----eCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEE
Q 020981          221 ----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVA  295 (319)
Q Consensus       221 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~  295 (319)
                          .....|+||||++ |+|.+++.. +.+++..+..++.|++.||+|||+++   |+||||||+||+++ .++.+||+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence                3467899999996 699998865 56899999999999999999999999   99999999999997 56799999


Q ss_pred             ecCccccccc
Q 020981          296 DFGVSKLLTV  305 (319)
Q Consensus       296 DFgla~~~~~  305 (319)
                      |||+++....
T Consensus       164 Dfg~~~~~~~  173 (320)
T 2i6l_A          164 DFGLARIMDP  173 (320)
T ss_dssp             CCTTCBCC--
T ss_pred             cCccccccCC
Confidence            9999987653

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.91  E-value=2.3e-24  Score=172.33  Aligned_cols=138  Identities=28%  Similarity=0.326  Sum_probs=115.9

Q ss_pred             ccccccccccCchhhhhhhhh-cCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAEL-NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .|+++.|++.++....+.... .+.+.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus         9 ~~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~   88 (165)
T 3twr_A            9 DRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHY   88 (165)
T ss_dssp             HHHHHHHHHHTCHHHHHHHCCTTTTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred             hHHHHHHHHhCCHHHHHHHHHcCCCCccccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcH
Confidence            577888888888666655544 6777888888888999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccCCC
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV  145 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~~  145 (319)
                      +++++|+++|++++.+|..|+||+|+|+..++.+++++|++.|+++...+....++...
T Consensus        89 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~  147 (165)
T 3twr_A           89 EVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDL  147 (165)
T ss_dssp             HHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTGGG
T ss_pred             HHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCChhHh
Confidence            99999999999999999999999999999999999999999988877666555555443

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.91  E-value=1.3e-24  Score=173.01  Aligned_cols=126  Identities=24%  Similarity=0.238  Sum_probs=107.0

Q ss_pred             ccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Q 020981            6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      +-.||++.|+..++....+...-++.++|..+..|.||||+|+. |+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus         4 ~~~~~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~   82 (162)
T 1ihb_A            4 PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGF   82 (162)
T ss_dssp             -CHHHHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTC
T ss_pred             hHhhHHHHHHHcCCHHHHHHHHhCCCCccccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCC
Confidence            34578888888888888887777888888888888888888888 88888888888888888888888888888888888


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      .+++++|+++|++++.+|..|+||||+|+..++.+++++|++.|++.
T Consensus        83 ~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~  129 (162)
T 1ihb_A           83 LDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASN  129 (162)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCC
T ss_pred             HHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCC
Confidence            88888888888888888888888888888888888888888888764

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.91  E-value=1.8e-24  Score=175.38  Aligned_cols=129  Identities=19%  Similarity=0.140  Sum_probs=123.8

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-.|.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        40 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~  119 (179)
T 3f6q_A           40 FSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQ  119 (179)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHH
Confidence            58999999999998888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      ++++|+++|++++.+|..|.||+++|+..++.+++++|++.|++....+
T Consensus       120 ~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~g~~~~~~~  168 (179)
T 3f6q_A          120 VAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIP  168 (179)
T ss_dssp             HHHHHHHTTCCSSBCCTTSCCGGGGSCHHHHHHHHHHHHHTTCCCSCBC
T ss_pred             HHHHHHHCCCCcchhccCCCCcHHHHHHHHHHHHHHHHHHhhcCcccCC
Confidence            9999999999999999999999999999999999999999999876544

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.91  E-value=5.3e-25  Score=177.22  Aligned_cols=131  Identities=23%  Similarity=0.280  Sum_probs=96.1

Q ss_pred             ccccccccccCchhhhhhhhhcCCC-CCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLD-DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .||++.|+..++....+.....+.+ +|..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus         3 ~~~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~   82 (172)
T 3v30_A            3 SLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYT   82 (172)
T ss_dssp             -CCHHHHHHTTCHHHHHHHHTTCSGGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCH
T ss_pred             hhhHHHHHHcCCHHHHHHHHHcCcccccCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCH
Confidence            4667777777776666666666555 677777777777777777777777777777777777777777777777777777


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH  138 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~  138 (319)
                      +++++|+++|++++.+|..|+||||+|+..++.+++++|++.|++....+..
T Consensus        83 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  134 (172)
T 3v30_A           83 DIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADS  134 (172)
T ss_dssp             HHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCC
Confidence            7777777777777777777777777777777777777777777766554433

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.91  E-value=2.7e-24  Score=193.06  Aligned_cols=143  Identities=24%  Similarity=0.475  Sum_probs=123.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc------
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP------  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~------  224 (319)
                      +|.....+|.|+||.||.     +|+.||||.+.... ........+.+|+.+++.++||||+++++++.....      
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            688889999999999985     47899999997643 345556778899999999999999999999877654      


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .|++|||++ ++|.+++..  .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++...
T Consensus       104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            499999996 688877643  4899999999999999999999999   9999999999999999999999999998754


Q ss_pred             c
Q 020981          305 V  305 (319)
Q Consensus       305 ~  305 (319)
                      .
T Consensus       178 ~  178 (353)
T 3coi_A          178 A  178 (353)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.91  E-value=6.5e-25  Score=194.56  Aligned_cols=161  Identities=26%  Similarity=0.393  Sum_probs=134.2

Q ss_pred             CCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCH---HHHHHHHHHHHHHHhcC--CCcccccceeEEe
Q 020981          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIR--HPNVVQFLGAVTQ  221 (319)
Q Consensus       152 ~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~  221 (319)
                      .-..+|.....||+|+||.||.     +++.||+|.+........   .....+.+|+.+++.++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3345788899999999999985     478999999876543221   11234567999999996  5999999999999


Q ss_pred             CCceEEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCc
Q 020981          222 SSPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGV  299 (319)
Q Consensus       222 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgl  299 (319)
                      ....+++||++.+ ++|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++ .++.+||+|||+
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            9999999999976 899999998888999999999999999999999999   99999999999999 789999999999


Q ss_pred             ccccccCCCCceeeccCC
Q 020981          300 SKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       300 a~~~~~~~~~~~~~~~~~  317 (319)
                      ++.+....  .....||+
T Consensus       197 ~~~~~~~~--~~~~~gt~  212 (320)
T 3a99_A          197 GALLKDTV--YTDFDGTR  212 (320)
T ss_dssp             CEECCSSC--BCCCCSCG
T ss_pred             cccccccc--ccCCCCCc
Confidence            98776432  22334554

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.91  E-value=1.1e-24  Score=171.99  Aligned_cols=130  Identities=29%  Similarity=0.318  Sum_probs=119.7

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|+++.|++.++....+...-+|.+.+ .+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+
T Consensus         3 ~~~L~~A~~~g~~~~v~~Ll~~g~~~~-~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~   81 (153)
T 1awc_B            3 GKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHAN   81 (153)
T ss_dssp             HHHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHH
T ss_pred             cHHHHHHHHcCCHHHHHHHHHcCCCCC-cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHH
Confidence            467889999999888888888888887 5889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH  138 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~  138 (319)
                      ++++|+++|++++.+|..|+||+|+|+..++.+++++|++.|++....+..
T Consensus        82 ~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  132 (153)
T 1awc_B           82 IVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKF  132 (153)
T ss_dssp             HHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCC
Confidence            999999999999999999999999999999999999999999887655433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.91  E-value=1.3e-23  Score=183.61  Aligned_cols=143  Identities=19%  Similarity=0.273  Sum_probs=122.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeE-EeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~~~~~~lv~  229 (319)
                      +|.....+|+|+||.||.     +++.||+|++......     +.+.+|+.+++.++|++++..+..+ ......++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            688889999999999985     4789999998754322     3577899999999988866655554 5667889999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe---cCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+ +++|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 8999999974 456999999999999999999999999   9999999999999   4888999999999998766


Q ss_pred             CC
Q 020981          306 KE  307 (319)
Q Consensus       306 ~~  307 (319)
                      ..
T Consensus       161 ~~  162 (296)
T 3uzp_A          161 AR  162 (296)
T ss_dssp             TT
T ss_pred             cc
Confidence            54

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.91  E-value=5.9e-24  Score=205.41  Aligned_cols=146  Identities=25%  Similarity=0.477  Sum_probs=126.9

Q ss_pred             ccccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      .+|.....||+|+||.||..        +..+|+|.+...  ......+.+.+|+.+++.++||||+++++++. .+..|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            35777889999999998842        357999988643  34555678999999999999999999999874 56789


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +||||+++|+|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            9999999999999998654 5899999999999999999999999   99999999999999999999999999998755


Q ss_pred             C
Q 020981          306 K  306 (319)
Q Consensus       306 ~  306 (319)
                      .
T Consensus       544 ~  544 (656)
T 2j0j_A          544 S  544 (656)
T ss_dssp             -
T ss_pred             C
Confidence            4

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.91  E-value=9.9e-25  Score=178.89  Aligned_cols=133  Identities=26%  Similarity=0.311  Sum_probs=124.4

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      -.||++.|+..++....+...-.+.|++..+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.
T Consensus        35 g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~  114 (192)
T 2rfm_A           35 NRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYS  114 (192)
T ss_dssp             CCCHHHHHHHHTCGGGHHHHHHHHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHhccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCH
Confidence            36899999999998888888888999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~  139 (319)
                      +++++|+++|++++.+|..|.||+|+|+..++.+++++|++.|+++...+...
T Consensus       115 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g  167 (192)
T 2rfm_A          115 EMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTG  167 (192)
T ss_dssp             HHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTS
T ss_pred             HHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCC
Confidence            99999999999999999999999999999999999999999998876554333

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.91  E-value=7.1e-24  Score=188.62  Aligned_cols=142  Identities=29%  Similarity=0.418  Sum_probs=124.6

Q ss_pred             cccceeeeecceEEEEEE------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCC------cccccceeEEeCC
Q 020981          156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP------NVVQFLGAVTQSS  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~l~~~~~~~~  223 (319)
                      +|.....||+|+||.||.      .++.||+|++...    ....+.+.+|+.+++.++|+      +++++++++....
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            688899999999999884      3688999998642    34456788899999998765      4999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-------------
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-------------  288 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-------------  288 (319)
                      ..++||||+ +++|.+++...+  .+++..+..++.|++.||+|||+++   |+||||||+|||++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999 889999998765  5889999999999999999999999   999999999999987             


Q ss_pred             ------CCCEEEEecCccccccc
Q 020981          289 ------SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       289 ------~~~~kl~DFgla~~~~~  305 (319)
                            ++.+||+|||+++....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~  189 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE  189 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS
T ss_pred             ccccccCCCceEeeCcccccCcc
Confidence                  66899999999987544

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.91  E-value=7.4e-25  Score=169.80  Aligned_cols=121  Identities=24%  Similarity=0.185  Sum_probs=83.8

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-.|.|+|..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        11 ~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~   90 (137)
T 3c5r_A           11 ETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVD   90 (137)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHcCCHH
Confidence            46677777777666666666667777777777777777777777777777777777777777777777777777777777


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhh
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      ++++|+++|++++.+|..|.||+++|...+..+++.++.+.
T Consensus        91 ~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~l~~l~~~  131 (137)
T 3c5r_A           91 IVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKN  131 (137)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCGGGGCCCHHHHHHHSCC---
T ss_pred             HHHHHHHcCCCCCCCCCCCCCHHHHHhhccHHHHHhhcccc
Confidence            77777777777777777777777777766666666555543

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.91  E-value=8.8e-25  Score=166.19  Aligned_cols=115  Identities=23%  Similarity=0.174  Sum_probs=100.2

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      -.||++.|+..++....+...-.+.|+|..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus         7 ~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~   86 (123)
T 3aaa_C            7 CDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHV   86 (123)
T ss_dssp             CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred             cchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCH
Confidence            35788889988888888888888899999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHH
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV  121 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i  121 (319)
                      +++++|+++|++++.+|..|.||+++|...+..++
T Consensus        87 ~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~l  121 (123)
T 3aaa_C           87 SCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKAL  121 (123)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHCCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCcCCCCCCHHHHhCCHHHHHH
Confidence            99999999999999999999999999865554443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.91  E-value=4.3e-24  Score=194.31  Aligned_cols=128  Identities=24%  Similarity=0.375  Sum_probs=109.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC--------CCcccccceeEE-
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--------HPNVVQFLGAVT-  220 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~l~~~~~-  220 (319)
                      .+|.....||+|+||.||.     +++.||+|++...    ....+.+.+|+.+++.++        |+||+++++.+. 
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            3688889999999999986     3789999998743    344567888999999985        788999999987 


Q ss_pred             ---eCCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCC
Q 020981          221 ---QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSG  290 (319)
Q Consensus       221 ---~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~  290 (319)
                         .....|+||||+ ++++.+.+...  +.+++..+..++.|++.||.|||++ +   |+||||||+|||++.++
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~  184 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence               556899999999 66777776554  4599999999999999999999998 8   99999999999999775

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.91  E-value=1.7e-24  Score=174.26  Aligned_cols=130  Identities=23%  Similarity=0.218  Sum_probs=122.7

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|||+.|+..++....+...-.|.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        37 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  116 (172)
T 3v30_A           37 FTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVK  116 (172)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHH
Confidence            58999999999998888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      ++++|+++|++++.+|..|.||+++|+..++.+++++|++.+++....+.
T Consensus       117 ~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~  166 (172)
T 3v30_A          117 CVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKLFQSNL  166 (172)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHHSCC--
T ss_pred             HHHHHHHcCCCccccCCCCCCHHHHHHHhCcHHHHHHHHHHHHHHhcccC
Confidence            99999999999999999999999999999999999999999887654443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.91  E-value=5.6e-24  Score=185.90  Aligned_cols=143  Identities=19%  Similarity=0.269  Sum_probs=120.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeE-EeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~~~~~~lv~  229 (319)
                      +|.....+|+|+||.||.     +++.||+|++.....     ...+.+|+.+++.++|++++..+..+ ......+++|
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            688889999999999884     478999998764322     23477899999999988877666555 6677889999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe---cCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+ +++|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 8999999985 456999999999999999999999999   9999999999999   7889999999999998765


Q ss_pred             CC
Q 020981          306 KE  307 (319)
Q Consensus       306 ~~  307 (319)
                      ..
T Consensus       161 ~~  162 (296)
T 4hgt_A          161 AR  162 (296)
T ss_dssp             TT
T ss_pred             cc
Confidence            43

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.91  E-value=2.3e-24  Score=172.26  Aligned_cols=122  Identities=27%  Similarity=0.237  Sum_probs=115.9

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-.|.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        43 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  122 (165)
T 3twr_A           43 STPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYE  122 (165)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHH
Confidence            48999999999988888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA  130 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~  130 (319)
                      ++++|+++|++++.+|..|.||+++|.. ++.+++++|.+.|+
T Consensus       123 ~v~~Ll~~ga~~~~~~~~g~t~l~~a~~-~~~~i~~~L~~~gA  164 (165)
T 3twr_A          123 ICKLLLQHGADPTKKNRDGNTPLDLVKD-GDTDIQDLLRGDAA  164 (165)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCTGGGSCT-TCHHHHHHHHTC--
T ss_pred             HHHHHHHcCCCCcccCCCCCChhHhHhc-CChHHHHHHhhccc
Confidence            9999999999999999999999999877 88999999998764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.91  E-value=4.6e-24  Score=189.17  Aligned_cols=148  Identities=28%  Similarity=0.545  Sum_probs=122.6

Q ss_pred             cccccceeeeecceEEEEEE------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc---CCCcccccceeEE----
Q 020981          154 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT----  220 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~----  220 (319)
                      ..+|.....||+|+||.||.      .++.||+|.+....... .....+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            34788899999999999884      36789999987543221 1112345677777666   8999999999987    


Q ss_pred             -eCCceEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          221 -QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       221 -~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                       .....++||||++ |+|.+++....  .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence             5567999999996 69999998753  3899999999999999999999999   999999999999999999999999


Q ss_pred             CcccccccC
Q 020981          298 GVSKLLTVK  306 (319)
Q Consensus       298 gla~~~~~~  306 (319)
                      |+++.....
T Consensus       165 g~~~~~~~~  173 (326)
T 1blx_A          165 GLARIYSFQ  173 (326)
T ss_dssp             CSCCCCCGG
T ss_pred             cccccccCC
Confidence            999877543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.91  E-value=1.3e-24  Score=200.31  Aligned_cols=155  Identities=26%  Similarity=0.366  Sum_probs=121.6

Q ss_pred             cccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ..+|.....||+|+||.|+.    +++.||||++......      .+.+|+.+++.+ +||||+++++++......|+|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            34688889999999987543    5789999998754322      245799999999 799999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC-----CCEEEEecCcccc
Q 020981          229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-----GNLKVADFGVSKL  302 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~DFgla~~  302 (319)
                      |||+. |+|.+++.... ..++..+..++.|++.||.|||+++   |+||||||+|||++.+     ..+||+|||+|+.
T Consensus        97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            99995 69999998654 3555667889999999999999999   9999999999999532     3588999999998


Q ss_pred             cccCC---CCceeeccCCC
Q 020981          303 LTVKE---DRPLTCQDTSC  318 (319)
Q Consensus       303 ~~~~~---~~~~~~~~~~~  318 (319)
                      +....   .......||+.
T Consensus       173 ~~~~~~~~~~~~~~~gt~~  191 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEG  191 (432)
T ss_dssp             C------------CCSCTT
T ss_pred             ccCCCcceeeccccCCCcC
Confidence            76543   22334556664

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=1e-24  Score=206.03  Aligned_cols=147  Identities=21%  Similarity=0.231  Sum_probs=115.5

Q ss_pred             eeeeecceEEEEEE---eceEeEEEEecccccCCH-----HHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          160 SVEITKGTFILAFW---RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       160 ~~~ig~G~f~~v~~---~~~~vAvK~l~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      .+.||+|+||.||.   .+..+++|..........     ...+.+.+|+.++++++||||+++..++......|+||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~  420 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY  420 (540)
T ss_dssp             -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred             CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence            45799999999984   678899998765433322     2245689999999999999999766666677888999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc-
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-  310 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~-  310 (319)
                      +++++|.+++..        +..++.|++.||+|||+++   |+||||||+|||++.  .+||+|||+|+.+...+... 
T Consensus       421 ~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          421 INGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             CCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             CCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            999999999875        5589999999999999999   999999999999999  99999999999887654322 


Q ss_pred             ------eeeccCCCC
Q 020981          311 ------LTCQDTSCR  319 (319)
Q Consensus       311 ------~~~~~~~~~  319 (319)
                            .+..|||+|
T Consensus       488 ~~~~~~~~~~GT~~y  502 (540)
T 3en9_A          488 DLIVFKKAVLSTHHE  502 (540)
T ss_dssp             HHHHHHHHHHHHCGG
T ss_pred             chhhhhhhhcCCCCc
Confidence                  355677653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.91  E-value=1.3e-23  Score=195.88  Aligned_cols=154  Identities=17%  Similarity=0.243  Sum_probs=127.6

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCC-CcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|.....||.|+||.||.     ++..||||++......     ..+..|+.+++.++| ++++.+..++......++||
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            678888999999999985     3789999987654322     246789999999986 55666666667788899999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe---cCCCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DFgla~~~~~  305 (319)
                      ||+ +++|.+++.. .+.+++..+..|+.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999 8999999985 456999999999999999999999999   9999999999999   5889999999999998766


Q ss_pred             CCCC-------ceeeccCCC
Q 020981          306 KEDR-------PLTCQDTSC  318 (319)
Q Consensus       306 ~~~~-------~~~~~~~~~  318 (319)
                      ....       .....||+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~  178 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTAR  178 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTT
T ss_pred             CccccccccccccccCCCcc
Confidence            5432       224566664

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.90  E-value=5e-24  Score=191.61  Aligned_cols=154  Identities=27%  Similarity=0.402  Sum_probs=113.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc-----
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-----  224 (319)
                      .+|.....||+|+||.||.     ++..||||++.......    ..+.+|+..++.++||||+++++++.....     
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            3688888999999999884     47899999886543222    244567888889999999999999876443     


Q ss_pred             --eEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEEcCCCCCCEEecC-CCCEEEE
Q 020981          225 --MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDD-SGNLKVA  295 (319)
Q Consensus       225 --~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~~ivH~Dlk~~Nill~~-~~~~kl~  295 (319)
                        .++||||+++ +|...+.    ....+++..+..++.|++.||.|||  +++   |+||||||+|||++. ++.+||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred             eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence              8899999975 6555443    3456889999999999999999999  888   999999999999996 8999999


Q ss_pred             ecCcccccccCCCCceeeccCC
Q 020981          296 DFGVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       296 DFgla~~~~~~~~~~~~~~~~~  317 (319)
                      |||+++.+...... ....||+
T Consensus       175 Dfg~a~~~~~~~~~-~~~~gt~  195 (360)
T 3e3p_A          175 DFGSAKKLSPSEPN-VAYICSR  195 (360)
T ss_dssp             CCTTCBCCCTTSCC-CSTTSCG
T ss_pred             eCCCceecCCCCCc-ccccCCc
Confidence            99999987655332 2334554

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.90  E-value=1.1e-23  Score=187.84  Aligned_cols=141  Identities=26%  Similarity=0.375  Sum_probs=114.5

Q ss_pred             ccccee-eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe----CCce
Q 020981          156 DFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM  225 (319)
Q Consensus       156 ~~~~~~-~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~  225 (319)
                      +|.... .||.|+||.||.     +++.||+|++...    ...   ..+....++.++||||+++++++..    ....
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            577744 599999999985     4789999998642    211   2223334666789999999999876    4558


Q ss_pred             EEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCcc
Q 020981          226 MIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVS  300 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgla  300 (319)
                      ++||||+++|+|.+++....  .+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998764  5999999999999999999999999   999999999999986   456999999999


Q ss_pred             cccccC
Q 020981          301 KLLTVK  306 (319)
Q Consensus       301 ~~~~~~  306 (319)
                      +.....
T Consensus       179 ~~~~~~  184 (336)
T 3fhr_A          179 KETTQN  184 (336)
T ss_dssp             EEC---
T ss_pred             eecccc
Confidence            876543

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.90  E-value=2.3e-24  Score=170.26  Aligned_cols=119  Identities=26%  Similarity=0.298  Sum_probs=114.8

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      -.||++.|+..++....+...-.|.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus        34 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~  113 (153)
T 1awc_B           34 GTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQ  113 (153)
T ss_dssp             CCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCH
Confidence            36899999999998888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHH
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL  125 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L  125 (319)
                      +++++|+++|++++.+|..|.||+++|+..|+.+++++|
T Consensus       114 ~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~i~~~L  152 (153)
T 1awc_B          114 EVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL  152 (153)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHh
Confidence            999999999999999999999999999999999999886

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.90  E-value=1.9e-24  Score=172.07  Aligned_cols=124  Identities=26%  Similarity=0.294  Sum_probs=116.7

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      -.||++.|+. ++....+...-.|.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.
T Consensus        38 g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~  116 (162)
T 1ihb_A           38 GRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHL  116 (162)
T ss_dssp             SCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred             CccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCH
Confidence            3688999998 888888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCc-ccCCCCCCCCCcccccccccHHHHHHHHhhCCC
Q 020981           87 EVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (319)
Q Consensus        87 ~~v~~Ll~~g~~-~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~  131 (319)
                      +++++|+++|++ ++.+|..|.||+|+|+..++.+++++|++.|++
T Consensus       117 ~~v~~Ll~~g~~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~GAd  162 (162)
T 1ihb_A          117 RVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGAG  162 (162)
T ss_dssp             HHHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred             HHHHHHHHccCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence            999999999998 699999999999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.90  E-value=2.6e-24  Score=198.58  Aligned_cols=152  Identities=28%  Similarity=0.357  Sum_probs=116.0

Q ss_pred             ccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEEEEee
Q 020981          157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +.....||+|+||.|+.    +|+.||||.+....      .+.+.+|+.+++.+ +||||+++++++......|+||||
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            44467899999998763    57899999986432      24567899999876 799999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC-------------CC
Q 020981          232 LPKGDLRAFLKRKGAL-------KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-------------GN  291 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~-------~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~-------------~~  291 (319)
                      +. |+|.+++......       ++..+..++.|++.||+|||+++   |+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 6999999865432       22235679999999999999999   9999999999999754             47


Q ss_pred             EEEEecCcccccccCCCC----ceeeccCCC
Q 020981          292 LKVADFGVSKLLTVKEDR----PLTCQDTSC  318 (319)
Q Consensus       292 ~kl~DFgla~~~~~~~~~----~~~~~~~~~  318 (319)
                      +||+|||+|+.+......    .....||+.
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~  197 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSG  197 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCT
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCC
Confidence            999999999987665332    223466664

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.90  E-value=4.3e-24  Score=171.59  Aligned_cols=122  Identities=30%  Similarity=0.342  Sum_probs=117.3

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-+|.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+
T Consensus        48 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  127 (169)
T 2y1l_E           48 WTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLE  127 (169)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHH
Confidence            68899999999988888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g  129 (319)
                      ++++|+++|++++.+|..|.||+++|+..++.+++++|++.|
T Consensus       128 ~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~G  169 (169)
T 2y1l_E          128 IVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKLN  169 (169)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTC-
T ss_pred             HHHHHHHcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcC
Confidence            999999999999999999999999999999999999999865

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.90  E-value=1.8e-23  Score=184.68  Aligned_cols=148  Identities=28%  Similarity=0.438  Sum_probs=114.6

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEE
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv  228 (319)
                      ..+|.....+|.|+||.||.     +++.||+|.+..... .....+.+.++..+++.++||||+++++++......++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            34678888999999998885     478999999875432 233334455566678888999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |||+ ++.+..+... ...+++..+..++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||+++.+...
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 6677666654 45799999999999999999999995 8   999999999999999999999999999876554

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.90  E-value=2.6e-24  Score=186.08  Aligned_cols=111  Identities=21%  Similarity=0.161  Sum_probs=106.1

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.++..++....+...-.|.|+|.+|.+|.||||+||..|+.++|++|+++|+|+|.+|..|+||||+||..|+.+
T Consensus       120 ~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~  199 (269)
T 4b93_B          120 AVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVF  199 (269)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHH
T ss_pred             CCccccccccChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHH
Confidence            57888899999988888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCccccccccc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKN  118 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~  118 (319)
                      +|++|+++|||++.+|..|+||||+|+.++.
T Consensus       200 ~v~~Ll~~Gad~~~~d~~G~TpL~~A~~~~~  230 (269)
T 4b93_B          200 VVELLLLHGASVQVLNKRQRTAVDCAEQNSK  230 (269)
T ss_dssp             HHHHHHHTTCCSCCCCTTSCCSGGGSCTTCH
T ss_pred             HHHHHHHCCCCCCCcCCCCCCHHHHHHhCCc
Confidence            9999999999999999999999999998775

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.90  E-value=7.4e-25  Score=193.74  Aligned_cols=152  Identities=28%  Similarity=0.475  Sum_probs=125.0

Q ss_pred             CccccCCCcccccceeeeecceEEEEEE--eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~~--~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  223 (319)
                      ..|++..  .+|.....+|+|+||.||.  .+..+|+|.+...... ....+.+.+|+.+++.++||||+++++++....
T Consensus        26 ~~~~i~~--~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           26 QEWDIPF--EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGSSSCC--SCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccCCH--HHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            3444443  3678888999999998884  3457999998754322 222345677999999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      ..+++|||+++++|.+++...+ .+++..+..++.|++.||.|||+++   ++||||||+||+++ ++.+||+|||+++.
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            9999999999999999998754 6899999999999999999999999   99999999999998 68999999999876


Q ss_pred             cc
Q 020981          303 LT  304 (319)
Q Consensus       303 ~~  304 (319)
                      ..
T Consensus       179 ~~  180 (319)
T 2y4i_B          179 SG  180 (319)
T ss_dssp             --
T ss_pred             cc
Confidence            53

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.90  E-value=8.7e-24  Score=163.73  Aligned_cols=115  Identities=28%  Similarity=0.326  Sum_probs=104.3

Q ss_pred             CCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCC
Q 020981           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (319)
Q Consensus        30 ~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tp  109 (319)
                      |+|+ .++.+|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||
T Consensus         1 G~d~-~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~   79 (137)
T 3c5r_A            1 GIDP-FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSP   79 (137)
T ss_dssp             ---C-CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCH
T ss_pred             CCCC-CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCH
Confidence            5677 788999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccHHHHHHHHhhCCCCCCccccccccCCC
Q 020981          110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV  145 (319)
Q Consensus       110 l~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~~  145 (319)
                      ||+|+..++.+++++|++.|++....+....++...
T Consensus        80 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~  115 (137)
T 3c5r_A           80 LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDY  115 (137)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCGGGG
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence            999999999999999999999887666555555443

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.90  E-value=5.1e-24  Score=174.60  Aligned_cols=123  Identities=27%  Similarity=0.254  Sum_probs=118.6

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      -.||++.|+..++....+...-.|.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus        68 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~  147 (192)
T 2rfm_A           68 GSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRS  147 (192)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCH
T ss_pred             CccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCH
Confidence            46899999999998888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhC
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g  129 (319)
                      +++++|+++|++++.+|..|.||+++|+..++.+++++|++.+
T Consensus       148 ~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~~  190 (192)
T 2rfm_A          148 EIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVR  190 (192)
T ss_dssp             HHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCcHHHHHHHHhcc
Confidence            9999999999999999999999999999999999999999865

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.90  E-value=9.5e-24  Score=167.01  Aligned_cols=129  Identities=21%  Similarity=0.204  Sum_probs=99.9

Q ss_pred             ccccccccccCchhhhhhhhhc-CCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .|+++.|+..++....+...-. +.++|..+..|.||||+ |..|+.++++.|+++|+++|.+|..|+||||+|+..|+.
T Consensus         3 ~~~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~   81 (156)
T 1bd8_A            3 GDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFL   81 (156)
T ss_dssp             HHHHHHHHHHTCHHHHHHHHHTTCCCTTCCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred             chHHHHHHHhCCHHHHHHHHHhhCcCccccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcH
Confidence            3667777777776666665554 44788888888888888 778888888888888888888888888888888888888


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH  138 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~  138 (319)
                      +++++|+++|++++.+|..|+||+|+|+..|+.+++++|++. ++....+..
T Consensus        82 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~  132 (156)
T 1bd8_A           82 DTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDAR  132 (156)
T ss_dssp             HHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCCCTT
T ss_pred             HHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCcCCC
Confidence            888888888888888888888888888888888888888877 555444433

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.90  E-value=2.9e-24  Score=180.24  Aligned_cols=129  Identities=19%  Similarity=0.204  Sum_probs=112.0

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHc-CCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~-ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .|||+.|+..++....+...-.|.|+|..+..|.||||+||..|+.+++++|++. |+++|.+|.+|+||||+|+..|+.
T Consensus        74 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~  153 (222)
T 3ehr_A           74 DNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYA  153 (222)
T ss_dssp             SCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCH
T ss_pred             ccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCH
Confidence            5899999999998888888889999999999999999999999999999999998 999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      +++++|+++|++++.+|..|.||+++|+..+..++++.+...++.....+
T Consensus       154 ~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~l~~l~~~~~~~~~~~  203 (222)
T 3ehr_A          154 DIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSN  203 (222)
T ss_dssp             HHHHHHHHHTCCSCCCCTTSCCHHHHCCSHHHHHHHC-------------
T ss_pred             HHHHHHHHcCCCCccccCCCCCHHHHhcchhHHHHHHHHhccchhhhccc
Confidence            99999999999999999999999999999999999999999887765443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.89  E-value=6.7e-24  Score=202.91  Aligned_cols=156  Identities=30%  Similarity=0.428  Sum_probs=131.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe------CCc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~  224 (319)
                      +|.....||.|+||.||.     +|..||+|++...  ......+.+.+|+.+++.++||||+++++++..      ...
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            688888999999999874     5789999998754  245566788999999999999999999988654      677


Q ss_pred             eEEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC---EEEEecC
Q 020981          225 MMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFG  298 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DFg  298 (319)
                      .|+||||+++|+|.+++....   .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998654   5889999999999999999999999   999999999999997765   9999999


Q ss_pred             cccccccCCCCceeeccCC
Q 020981          299 VSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       299 la~~~~~~~~~~~~~~~~~  317 (319)
                      +++........ ....||+
T Consensus       170 ~a~~~~~~~~~-~~~~gt~  187 (676)
T 3qa8_A          170 YAKELDQGELC-TEFVGTL  187 (676)
T ss_dssp             CCCBTTSCCCC-CCCCSCC
T ss_pred             ccccccccccc-ccccCCc
Confidence            99987654322 3345554

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.89  E-value=6e-23  Score=183.86  Aligned_cols=143  Identities=28%  Similarity=0.372  Sum_probs=122.6

Q ss_pred             ccccceeeeecceEEEEEE-----ec-eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCc------ccccceeEEeC
Q 020981          155 LDFTNSVEITKGTFILAFW-----RG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN------VVQFLGAVTQS  222 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~-~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~l~~~~~~~  222 (319)
                      .+|.....||+|+||.||.     ++ ..||+|++...    ....+.+.+|+.+++.++|++      ++.+++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            3688899999999999984     23 78999998642    344567888999999997655      88899999999


Q ss_pred             CceEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe--------------
Q 020981          223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--------------  286 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill--------------  286 (319)
                      ...++||||+ ++++.+++....  .+++..+..++.|++.||.|||+++   |+||||||+|||+              
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            9999999999 678877777653  6999999999999999999999999   9999999999999              


Q ss_pred             -----cCCCCEEEEecCccccccc
Q 020981          287 -----DDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       287 -----~~~~~~kl~DFgla~~~~~  305 (319)
                           +.++.+||+|||+++....
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~  194 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHE  194 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTS
T ss_pred             ccccccCCCcEEEeecCccccccc
Confidence                 5678999999999987543

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.89  E-value=6.3e-24  Score=180.38  Aligned_cols=128  Identities=21%  Similarity=0.068  Sum_probs=106.8

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|+++.|+..++....+...-.|.|+|..|..|.||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+
T Consensus        38 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~  117 (239)
T 1ycs_B           38 LALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQ  117 (239)
T ss_dssp             HHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             hHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHH
Confidence            57788888888887777777788888888888888888888888888888888888888888888888888888888888


Q ss_pred             HHHHhhhCCCcccCCCCCCC-CCcccc--cccccHHHHHHHHhhCCCCCCc
Q 020981           88 VVSLLLERGADVDPKDRWGS-TPLGDA--IYYKNHEVIKLLEKHGAKPLMA  135 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~-tpl~~a--~~~~~~~i~~~L~~~g~~~~~~  135 (319)
                      ++++|+++|++++.+|..|. ||+|+|  +..|+.+++++|++.+++....
T Consensus       118 ~v~~Ll~~ga~~~~~~~~~~~t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~  168 (239)
T 1ycs_B          118 VCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGIM  168 (239)
T ss_dssp             HHHHHHHTTCCTTCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHHHHTTTT
T ss_pred             HHHHHHHcCCCcceecCCCCcchHHHHHHhhhccHHHHHHHHHhhhccccc
Confidence            88888888888888887776 888888  6678888888888887766543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.89  E-value=8.4e-23  Score=185.39  Aligned_cols=143  Identities=24%  Similarity=0.309  Sum_probs=122.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CC-----cccccceeEEeCC
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQSS  223 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~l~~~~~~~~  223 (319)
                      .+|.....||+|+||.||.     +++.||||++...    ......+..|+.+++.++ |+     +++++++.+....
T Consensus        54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3688889999999999985     3789999998742    344566778999988885 55     4899999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh--CCCCCeEEcCCCCCCEEec--CCCCEEEEec
Q 020981          224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHE--NKPVPIIHRDLEPSNILRD--DSGNLKVADF  297 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~~~~ivH~Dlk~~Nill~--~~~~~kl~DF  297 (319)
                      ..|+||||++ ++|.+++...  +.+++..+..++.|++.||.|||+  .+   |+||||||+|||++  .++.+||+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999995 6999999875  358999999999999999999995  56   99999999999995  4778999999


Q ss_pred             Cccccccc
Q 020981          298 GVSKLLTV  305 (319)
Q Consensus       298 gla~~~~~  305 (319)
                      |+|+....
T Consensus       206 G~a~~~~~  213 (382)
T 2vx3_A          206 GSSCQLGQ  213 (382)
T ss_dssp             TTCEETTC
T ss_pred             cCceeccc
Confidence            99987754

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.89  E-value=1.1e-23  Score=168.54  Aligned_cols=125  Identities=26%  Similarity=0.203  Sum_probs=119.7

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-.|.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        37 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  116 (167)
T 3v31_A           37 FTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVK  116 (167)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHH
Confidence            58999999999988888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      ++++|+++|++++.+|..|.||+++|+..|+.+++++|++++.+.
T Consensus       117 ~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~  161 (167)
T 3v31_A          117 CVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKL  161 (167)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999999999987543

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.89  E-value=2e-23  Score=180.82  Aligned_cols=117  Identities=29%  Similarity=0.326  Sum_probs=101.6

Q ss_pred             CCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCC-CCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCC
Q 020981           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (319)
Q Consensus        31 ~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~-g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tp  109 (319)
                      .++|..+..|.||||+||..|+.+++++|+++|+++|.++.. |+||||+|+..|+.++|++|+++|++++.+|..|+||
T Consensus       149 ~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tp  228 (282)
T 1oy3_D          149 LQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTP  228 (282)
T ss_dssp             GGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             hcCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCCH
Confidence            458889999999999999999999999999999999999865 9999999999999999999999999999999999999


Q ss_pred             cccccccccHHHHHHHHhhCCCCCCccccccccCCCCc
Q 020981          110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPE  147 (319)
Q Consensus       110 l~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~~~~  147 (319)
                      ||+|+..++.+++++|+++|+++........++.....
T Consensus       229 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~a~  266 (282)
T 1oy3_D          229 LGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSG  266 (282)
T ss_dssp             HHHHHTSSCHHHHHHHHHTTCCCCCCC-----------
T ss_pred             HHHHHHcCCcHHHHHHHHcCCCcCcCCCcccccccccC
Confidence            99999999999999999999998877766666655443

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.89  E-value=1.1e-23  Score=166.66  Aligned_cols=120  Identities=24%  Similarity=0.297  Sum_probs=114.4

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      -.||++. +..++....+...-.|.|+|..+..|.||||+||..|+.++++.|+++|+++|.+|.+|+||||+|+..|+.
T Consensus        36 g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~  114 (156)
T 1bd8_A           36 GKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHT  114 (156)
T ss_dssp             SCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCH
T ss_pred             CCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChH
Confidence            4688999 888888888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhh
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      +++++|+++ ++++.+|..|.||+++|+..|+.+++++|+++
T Consensus       115 ~~v~~Ll~~-~~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~  155 (156)
T 1bd8_A          115 AVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLVDILQGH  155 (156)
T ss_dssp             HHHHHHHTT-SCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred             HHHHHHHhc-cCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhh
Confidence            999999999 99999999999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.89  E-value=4.4e-23  Score=186.23  Aligned_cols=144  Identities=22%  Similarity=0.386  Sum_probs=123.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-----------CCccccccee
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLGA  218 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~l~~~  218 (319)
                      .+|.....||+|+||.||.     +++.||+|++...    ......+.+|+.+++.++           ||||++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            4788899999999999985     4789999998743    344567788999999886           7899999999


Q ss_pred             EEeCC----ceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEec----
Q 020981          219 VTQSS----PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRD----  287 (319)
Q Consensus       219 ~~~~~----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~----  287 (319)
                      +....    ..+++|||+ +++|.+++...  ..+++..+..++.|++.||.|||++ +   |+||||||+|||++    
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            87654    789999999 89999999874  4589999999999999999999998 8   99999999999995    


Q ss_pred             --CCCCEEEEecCcccccccC
Q 020981          288 --DSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       288 --~~~~~kl~DFgla~~~~~~  306 (319)
                        ..+.+||+|||+++.....
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~  191 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH  191 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC
T ss_pred             CcCcceEEEcccccccccCCC
Confidence              3447999999999877543

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.89  E-value=3.1e-24  Score=175.29  Aligned_cols=132  Identities=18%  Similarity=0.140  Sum_probs=82.4

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCC-CCcchHHHHHHHcCCH----HHHHHHHHcCCCCcccCCCCCCHHHHHHHc
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQ   83 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~L~~a~~~~~~----~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~   83 (319)
                      +++..|++.++....+...-.  ++|..+ ..|.||||+|+..|+.    +++++||++|||||.+|.+|+||||+|+..
T Consensus         8 ~~l~~Aa~~g~~~~~~~l~~~--~~~~~~~~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~   85 (186)
T 3t8k_A            8 RTVSAAAMLGTYEDFLELFEK--GYEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQG   85 (186)
T ss_dssp             SSHHHHHHHSCHHHHHHHHHH--SSSCHHHHHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHH
T ss_pred             cHHHHHHHcCCHHHHHHHHhc--CcccccccCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHc
Confidence            455666666665444433322  234444 5677777777776654    367777777777777777777777777776


Q ss_pred             CC------HHHHHHhhhCCCcccCCCCCCC-CCccccccc-----ccHHHHHHHHh-hCCCCCCcccccccc
Q 020981           84 GF------TEVVSLLLERGADVDPKDRWGS-TPLGDAIYY-----KNHEVIKLLEK-HGAKPLMAPMHVKHA  142 (319)
Q Consensus        84 ~~------~~~v~~Ll~~g~~~~~~~~~g~-tpl~~a~~~-----~~~~i~~~L~~-~g~~~~~~~~~~~~~  142 (319)
                      |+      .+++++|+++||++|.+|..|+ ||||+|+..     +..+++++|++ .|+++...+....++
T Consensus        86 ~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~Tp  157 (186)
T 3t8k_A           86 GGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTA  157 (186)
T ss_dssp             CTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCH
T ss_pred             CCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCH
Confidence            65      4567777777777777777777 777777663     33456667776 666666555444443

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.89  E-value=2.1e-23  Score=181.23  Aligned_cols=125  Identities=19%  Similarity=0.160  Sum_probs=113.4

Q ss_pred             cccccccccCchhhhhhhhhcCCC------CCCCCCCcchHHHHHHHc---CCHHHHHHHHHcCCCCcccCCCCCCHHHH
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLD------DDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHV   79 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~t~L~~a~~~---~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~   79 (319)
                      ++++.|+..+.......+...|.|      ++..+..|.||||+||..   |+.+++++|+++|+|+|.+|.+|+||||+
T Consensus       132 ~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~  211 (278)
T 1dcq_A          132 HSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHY  211 (278)
T ss_dssp             HHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHH
T ss_pred             hhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHH
Confidence            456777777777666667777888      445588999999999999   89999999999999999999999999999


Q ss_pred             HHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCC
Q 020981           80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (319)
Q Consensus        80 A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~  133 (319)
                      |+..|+.++|++|+++|++++.+|..|.||||+|+..|+.+++++|++.|++..
T Consensus       212 A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~  265 (278)
T 1dcq_A          212 CCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALSGRF  265 (278)
T ss_dssp             HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTTCC
T ss_pred             HHHcCCHHHHHHHHHcCCCCCCccCCCCCHHHHHHHcCCHHHHHHHHHcCCCCC
Confidence            999999999999999999999999999999999999999999999999998653

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.89  E-value=4.3e-23  Score=174.59  Aligned_cols=124  Identities=21%  Similarity=0.133  Sum_probs=68.8

Q ss_pred             cccccccccCchhhhhhhhhcCCC------CCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCC-CCCCHHHHHH
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLD------DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAA   81 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~-~g~tpLh~A~   81 (319)
                      ||++.|+..++....+...-.+.+      .+..+..|.||||+|+..|+.+++++|+++|+++|.+|. .|+||||+|+
T Consensus        80 t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~  159 (236)
T 1ikn_D           80 TPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAV  159 (236)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHH
T ss_pred             CHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Confidence            445555554444444444333333      344444555555555555555555555555556655554 5566666666


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      ..|+.+++++|+++|++++.+|..|+||+++|+..++.+++++|++.|++.
T Consensus       160 ~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~Ll~~ga~~  210 (236)
T 1ikn_D          160 DLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLEN  210 (236)
T ss_dssp             HTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTTSSCHHHHHHHHTTSCGG
T ss_pred             HcCCHHHHHHHHHcCCCCCcccCCCCCHHHHHHccCchHHHHHHHHcchhh
Confidence            666666666666666666666666666666666656666666666555543

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.89  E-value=3.8e-23  Score=173.67  Aligned_cols=137  Identities=23%  Similarity=0.162  Sum_probs=116.8

Q ss_pred             ccccccccccCchhhhhhhhhcC--CCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Q 020981            8 RTTLLKQSSLAPDRERKEAELNG--LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      .||++.|+..++....+...-.+  .|++..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus        73 ~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~  152 (228)
T 2dzn_A           73 WTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGS  152 (228)
T ss_dssp             CCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTC
T ss_pred             CCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCC
Confidence            57888888888877777777777  8888888899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCC-CcccCCCCCCCCCcccccccccHHHHHHHH-hhCCCCCCccccccccCC
Q 020981           86 TEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLLE-KHGAKPLMAPMHVKHARE  144 (319)
Q Consensus        86 ~~~v~~Ll~~g-~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~-~~g~~~~~~~~~~~~~~~  144 (319)
                      .+++++|++.| ++++.+|..|+||+|+|+..++.+++++|+ +.|+++...+....++..
T Consensus       153 ~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~l~  213 (228)
T 2dzn_A          153 LKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAED  213 (228)
T ss_dssp             HHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBGGG
T ss_pred             HHHHHHHHhcCcccccCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcHHH
Confidence            99999999988 889999999999999999999999999988 888887766655555433

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.89  E-value=1.6e-23  Score=157.18  Aligned_cols=102  Identities=37%  Similarity=0.473  Sum_probs=97.0

Q ss_pred             CCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCccccc
Q 020981           35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI  114 (319)
Q Consensus        35 ~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~  114 (319)
                      -+|.+|.||||+||..|+.++++.|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+
T Consensus         4 ~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~   83 (115)
T 2l6b_A            4 WGSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAK   83 (115)
T ss_dssp             CCSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHH
T ss_pred             ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Confidence            35778999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccHHHHHHHHhhCCCCCCcc
Q 020981          115 YYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus       115 ~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      ..++.+++++|++.|+++....
T Consensus        84 ~~~~~~~~~~Ll~~ga~~n~~~  105 (115)
T 2l6b_A           84 KNGHHEIVKLLDAKGADVNARS  105 (115)
T ss_dssp             TTTCHHHHHHHHTTSSSHHHHS
T ss_pred             HCCCHHHHHHHHHcCCCCCcCC
Confidence            9999999999999998875444

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.89  E-value=1.1e-23  Score=182.33  Aligned_cols=130  Identities=22%  Similarity=0.131  Sum_probs=118.6

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCC--------------CcchHHHHHHHcCCHHHHHHHHH---cCCCCccc
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEI--------------KPEFRLMFLANERDVEGIKELLD---SGIDVNFR   69 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~t~L~~a~~~~~~~~~~~Ll~---~ga~vn~~   69 (319)
                      -.|||+.|+..++....+.+.-.|.|+|..+.              .|.||||+||..|+.+++++|++   +|+|+|.+
T Consensus       101 g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~  180 (273)
T 2pnn_A          101 GQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISAR  180 (273)
T ss_dssp             TCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCC
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCceee
Confidence            46999999999999999988889999999997              89999999999999999999999   99999999


Q ss_pred             CCCCCCHHHHHHHcCC---------HHHHHHhhhCCCccc-------CCCCCCCCCcccccccccHHHHHHHHhhCC-CC
Q 020981           70 DIDNRTALHVAACQGF---------TEVVSLLLERGADVD-------PKDRWGSTPLGDAIYYKNHEVIKLLEKHGA-KP  132 (319)
Q Consensus        70 d~~g~tpLh~A~~~~~---------~~~v~~Ll~~g~~~~-------~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~-~~  132 (319)
                      |.+|+||||+|+..|+         .+++++|+++|++++       .+|..|+||||+|+..|+.+++++|++.|+ ++
T Consensus       181 d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~dp  260 (273)
T 2pnn_A          181 DSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEP  260 (273)
T ss_dssp             CTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTC--
T ss_pred             CCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcccccccccccCCCCCCHHHHHHHhChHHHHHHHHHCCCCCc
Confidence            9999999999999998         899999999999997       589999999999999999999999999998 55


Q ss_pred             CCcc
Q 020981          133 LMAP  136 (319)
Q Consensus       133 ~~~~  136 (319)
                      ...+
T Consensus       261 ~~~~  264 (273)
T 2pnn_A          261 ECRH  264 (273)
T ss_dssp             ----
T ss_pred             hhhh
Confidence            4433

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.89  E-value=1.1e-23  Score=163.10  Aligned_cols=108  Identities=23%  Similarity=0.219  Sum_probs=102.3

Q ss_pred             CCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCC-CCC
Q 020981           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-GST  108 (319)
Q Consensus        30 ~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~-g~t  108 (319)
                      +.|+|..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+. |+.+++++|+++|++++.+|.. |+|
T Consensus         2 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t   80 (136)
T 1d9s_A            2 SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTR   80 (136)
T ss_dssp             CCCCSCCCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBC
T ss_pred             CCCccCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCC
Confidence            56889999999999999999999999999999999999999999999999999 9999999999999999999999 999


Q ss_pred             CcccccccccHHHHHHHHhhCCCCCCcccc
Q 020981          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMH  138 (319)
Q Consensus       109 pl~~a~~~~~~~i~~~L~~~g~~~~~~~~~  138 (319)
                      |||+|+..++.+++++|++.|+++...+..
T Consensus        81 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~  110 (136)
T 1d9s_A           81 PVHDAAREGFLDTLVVLHRAGARLDVCDAW  110 (136)
T ss_dssp             HHHHHHHHTCHHHHHHHHHTCCCCCCCSSS
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCCCccCCC
Confidence            999999999999999999999887655443

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.89  E-value=1.5e-23  Score=178.09  Aligned_cols=129  Identities=25%  Similarity=0.266  Sum_probs=93.9

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      -.|||+.|++.+.....+...-.|.|++.. ..|.||||+||..|+.++++.|++.|+|+|.+|..|+||||+||..|+.
T Consensus         5 g~t~L~~a~~~~~~~~~~~ll~~g~~~~~~-~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~   83 (239)
T 1ycs_B            5 GQVSLPPGKRTNLRKTGSERIAHGMRVKFN-PLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHT   83 (239)
T ss_dssp             ---------------------------------CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCH
T ss_pred             ccccCchhhhhhhHHHHHHHhccCCCcccC-chhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCH
Confidence            368999999999988888888899999864 7899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      +++++|+++|++++.+|..|+||||+|+..|+.+++++|++.|++.....
T Consensus        84 ~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~  133 (239)
T 1ycs_B           84 EIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMT  133 (239)
T ss_dssp             HHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceec
Confidence            99999999999999999999999999999999999999999999876544

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.88  E-value=3e-23  Score=174.88  Aligned_cols=130  Identities=23%  Similarity=0.262  Sum_probs=119.2

Q ss_pred             cccccccccccCchhhhhhhhhc-CCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCC-----cccCCCCCCHHHHH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVA   80 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~v-----n~~d~~g~tpLh~A   80 (319)
                      -.|||+.|++.++....+...-. +.|+|..+.+|+||||+||..|+.+++++|++.|+++     +.+|..|+||||+|
T Consensus         3 g~t~L~~A~~~g~~~~v~~Ll~~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A   82 (232)
T 2rfa_A            3 WESPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIA   82 (232)
T ss_dssp             TTCHHHHHHHTTCHHHHHHHHTTTCSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHH
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHH
Confidence            36899999999998887777766 9999999999999999999999999999999999987     77888999999999


Q ss_pred             HHcCCHHHHHHhhhCCCcccCCCC-------------CCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           81 ACQGFTEVVSLLLERGADVDPKDR-------------WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        81 ~~~~~~~~v~~Ll~~g~~~~~~~~-------------~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      +..|+.+++++|+++|++++..+.             .|.||||+|+..|+.+++++|++.|+++...+
T Consensus        83 ~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d  151 (232)
T 2rfa_A           83 VINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQD  151 (232)
T ss_dssp             HHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Confidence            999999999999999999999876             79999999999999999999999998865444

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.88  E-value=1.8e-23  Score=183.66  Aligned_cols=129  Identities=24%  Similarity=0.194  Sum_probs=119.9

Q ss_pred             ccccccccccccCchhhhhhhhhcCCCCCC------CCCCcchHHHHHHHc---CCHHHHHHHHHcCCCCcccCCCCCCH
Q 020981            6 PVRTTLLKQSSLAPDRERKEAELNGLDDDG------EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTA   76 (319)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~t~L~~a~~~---~~~~~~~~Ll~~ga~vn~~d~~g~tp   76 (319)
                      |..+++++|+..++....+.....|.|+|.      .+..|.||||+||..   |+.+++++|++.|+|+|.+|.+|+||
T Consensus       150 ~~~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~Tp  229 (301)
T 2b0o_E          150 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA  229 (301)
T ss_dssp             -CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCH
T ss_pred             chHHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCH
Confidence            344668999999998888888889999998      699999999999997   89999999999999999999999999


Q ss_pred             HHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCC
Q 020981           77 LHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (319)
Q Consensus        77 Lh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~  134 (319)
                      ||+|+..|+.++|++|+++|++++.+|..|.|||++|+..++.+++++|++.+++...
T Consensus       230 Lh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~~g~  287 (301)
T 2b0o_E          230 LHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQAQAGTFA  287 (301)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHTTS
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCC
Confidence            9999999999999999999999999999999999999999999999999999877433

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.88  E-value=8.8e-24  Score=181.38  Aligned_cols=127  Identities=17%  Similarity=0.084  Sum_probs=119.7

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCC--------------CCcchHHHHHHHcCCHHHHHHHHH---cCCCCccc
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEE--------------IKPEFRLMFLANERDVEGIKELLD---SGIDVNFR   69 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~t~L~~a~~~~~~~~~~~Ll~---~ga~vn~~   69 (319)
                      -.|||+.|+..++....+.+.-.|.|+|..+              ..|.||||+||..|+.+++++|++   +|+|+|.+
T Consensus        93 g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~  172 (260)
T 3jxi_A           93 GQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQ  172 (260)
T ss_dssp             SBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCC
T ss_pred             CCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCccc
Confidence            3689999999999999998888999999999              689999999999999999999999   99999999


Q ss_pred             CCCCCCHHHHHHHcCC---------HHHHHHhhhCCCcc-------cCCCCCCCCCcccccccccHHHHHHHHhhCCCCC
Q 020981           70 DIDNRTALHVAACQGF---------TEVVSLLLERGADV-------DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (319)
Q Consensus        70 d~~g~tpLh~A~~~~~---------~~~v~~Ll~~g~~~-------~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~  133 (319)
                      |.+|+||||+|+..|+         .+++++|+++|+++       +.+|..|+||||+|+..|+.+++++|++.|....
T Consensus       173 d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~  252 (260)
T 3jxi_A          173 DSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADA  252 (260)
T ss_dssp             CTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHHH
T ss_pred             CCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccccccchhhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCcc
Confidence            9999999999999888         79999999999999       7899999999999999999999999999987643

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.88  E-value=2.5e-23  Score=178.10  Aligned_cols=130  Identities=21%  Similarity=0.147  Sum_probs=92.2

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCC-CCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga-~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .|||+.|+..++....+...-.|.|+|..+..|.||||+|+..|+.+++++|++.|+ +++.+|..|+||||+|+..|+.
T Consensus        58 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~  137 (253)
T 1yyh_A           58 ETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVE  137 (253)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTTSCTTCCCTTCCCHHHHHHHHTCS
T ss_pred             CcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCCCcHHHHHHHcChH
Confidence            567777777777666666666777777777777777777777777777777777765 6777777777777777777777


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      +++++|++.|++++.+|..|+||||+|+..|+.+++++|++.|++....+.
T Consensus       138 ~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~  188 (253)
T 1yyh_A          138 GMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNN  188 (253)
T ss_dssp             SHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence            777777777777777777777777777777777777777777666554443

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.88  E-value=2.5e-23  Score=169.35  Aligned_cols=109  Identities=28%  Similarity=0.279  Sum_probs=99.9

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d-~~g~tpLh~A~~~~~~   86 (319)
                      .||++.|+..++....+...- +.|+|..|.+|.||||+||..|+.+++++|+++|+++|.+| .+|+||||+|+..|+.
T Consensus        45 ~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~  123 (183)
T 3deo_A           45 ETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRP  123 (183)
T ss_dssp             HHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCH
T ss_pred             CCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcH
Confidence            588999999998777666665 99999999999999999999999999999999999999998 8899999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYK  117 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~  117 (319)
                      +++++|+++|++++.+|..|+||+|+|+..+
T Consensus       124 ~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~  154 (183)
T 3deo_A          124 EVVEALVELGADIEVEDERGLTALELAREIL  154 (183)
T ss_dssp             HHHHHHHHHTCCTTCCCTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCcCCCCCCCCHHHHHHHhc
Confidence            9999999999999999999999999988764

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.88  E-value=6.2e-23  Score=172.77  Aligned_cols=130  Identities=25%  Similarity=0.207  Sum_probs=99.6

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-.|.|+|..+..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+
T Consensus        41 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  120 (231)
T 3aji_A           41 RTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHE  120 (231)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHH
Confidence            57777777777777777766677777777777777888777777777777777777777777777777777777777777


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      ++++|+++|++++.+|..|.||+|+|+..|+.+++++|++.|++....+.
T Consensus       121 ~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  170 (231)
T 3aji_A          121 IAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDT  170 (231)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCT
T ss_pred             HHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccCC
Confidence            77777777777777777777777777777777777777777776654443

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.88  E-value=4.6e-23  Score=175.67  Aligned_cols=122  Identities=29%  Similarity=0.284  Sum_probs=112.2

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d-~~g~tpLh~A~~~~~~   86 (319)
                      .|||+.|++.++....+...- +.|+|..+.+|.||||+||..|+.+++++|+++|+|+|.+| ..|+||||+|+..|+.
T Consensus        46 ~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~  124 (244)
T 3ui2_A           46 ETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRP  124 (244)
T ss_dssp             HHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCH
T ss_pred             CCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCH
Confidence            589999999999877776666 99999999999999999999999999999999999999999 8899999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCccccc----------------ccccHHHHHHHHhhCC
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAI----------------YYKNHEVIKLLEKHGA  130 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~----------------~~~~~~i~~~L~~~g~  130 (319)
                      ++|++|+++|++++.+|..|+||+|+|+                ..|+.+++++|.+.+.
T Consensus       125 ~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~  184 (244)
T 3ui2_A          125 EVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVF  184 (244)
T ss_dssp             HHHHHHHHTTCCTTCCCTTCCCHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHE
T ss_pred             HHHHHHHHCCCCCCCCCCCCCcHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhcc
Confidence            9999999999999999999999999887                5577888888887654

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.88  E-value=2.8e-23  Score=177.94  Aligned_cols=126  Identities=20%  Similarity=0.125  Sum_probs=119.8

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCC-------------cchHHHHHHHcCCHHHHHHHHH---cCCCCcccC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIK-------------PEFRLMFLANERDVEGIKELLD---SGIDVNFRD   70 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~t~L~~a~~~~~~~~~~~Ll~---~ga~vn~~d   70 (319)
                      -.|||+.|+..++....+...-.|.|+|..+..             |.||||+||..|+.+++++|++   +|+|+|.+|
T Consensus        90 g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d  169 (256)
T 2etb_A           90 GHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATD  169 (256)
T ss_dssp             TCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCC
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccC
Confidence            469999999999998888888899999999886             9999999999999999999999   999999999


Q ss_pred             CCCCCHHHHHHH--cCCHH-------HHHHhhhCCCcc-------cCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           71 IDNRTALHVAAC--QGFTE-------VVSLLLERGADV-------DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        71 ~~g~tpLh~A~~--~~~~~-------~v~~Ll~~g~~~-------~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      .+|+||||+|+.  .++.+       ++++|+++|+++       +.+|..|+||+|+|+..|+.+++++|+++|.+.
T Consensus       170 ~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~  247 (256)
T 2etb_A          170 SLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSG  247 (256)
T ss_dssp             TTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHSTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCcccccccccccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCC
Confidence            999999999999  88988       999999999999       999999999999999999999999999988654

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.88  E-value=2.8e-23  Score=169.63  Aligned_cols=123  Identities=16%  Similarity=0.096  Sum_probs=111.1

Q ss_pred             ccccccccccCchh----hhhhhhhcCCCCCCCCCCcchHHHHHHHcCC------HHHHHHHHHcCCCCcccCCCCC-CH
Q 020981            8 RTTLLKQSSLAPDR----ERKEAELNGLDDDGEEIKPEFRLMFLANERD------VEGIKELLDSGIDVNFRDIDNR-TA   76 (319)
Q Consensus         8 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~------~~~~~~Ll~~ga~vn~~d~~g~-tp   76 (319)
                      .|||+.|+..++..    ..+-+.-.|+|+|.++.+|.||||+|+..++      .+++++|+++|||||.+|..|+ ||
T Consensus        39 ~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttp  118 (186)
T 3t8k_A           39 SNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVV  118 (186)
T ss_dssp             TTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCT
T ss_pred             CCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchH
Confidence            68999999988643    4566666899999999999999999999987      6899999999999999999999 99


Q ss_pred             HHHHHHcC-----CHHHHHHhhh-CCCcccCCCCCCCCCcccccccccHHHHHHHHhhCC
Q 020981           77 LHVAACQG-----FTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA  130 (319)
Q Consensus        77 Lh~A~~~~-----~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~  130 (319)
                      ||+|+..+     +.+++++|++ +|++++.+|..|+||||+|+..++.+++++|.....
T Consensus       119 Lh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~  178 (186)
T 3t8k_A          119 FKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIK  178 (186)
T ss_dssp             TGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHH
Confidence            99999944     4679999999 999999999999999999999999999999997653

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.88  E-value=7.3e-23  Score=171.41  Aligned_cols=133  Identities=26%  Similarity=0.161  Sum_probs=107.7

Q ss_pred             ccccccccccCchhhhhhhhhcCC-CCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGL-DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .||++.|+..++....+...-.+. +++..+..|.||||+|+..|+.++++.|++.|+++|.+|..|+||||+|+..|+.
T Consensus        59 ~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~  138 (223)
T 2f8y_A           59 RTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNV  138 (223)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCH
Confidence            578888888887776666666655 7888888888888888888888888888888888888888888888888888888


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK  140 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~  140 (319)
                      +++++|+++|++++.+|..|.||+|+|+..++.+++++|++.|+++...+....
T Consensus       139 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~  192 (223)
T 2f8y_A          139 DAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDR  192 (223)
T ss_dssp             HHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred             HHHHHHHHcCCCCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCccccccCC
Confidence            888888888888888888888888888888888888888888887765544333

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.88  E-value=9.4e-23  Score=154.89  Aligned_cols=106  Identities=29%  Similarity=0.366  Sum_probs=96.3

Q ss_pred             CCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCccccccc
Q 020981           37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY  116 (319)
Q Consensus        37 ~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~  116 (319)
                      +..|.||||+|+..|+.++++.|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..
T Consensus         4 ~~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~   83 (123)
T 3aaa_C            4 GSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE   83 (123)
T ss_dssp             ---CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHH
T ss_pred             ccccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence            45788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccHHHHHHHHhhCCCCCCcccccccc
Q 020981          117 KNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       117 ~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      ++.+++++|++.|+++...+....++
T Consensus        84 ~~~~~v~~Ll~~ga~~~~~~~~g~t~  109 (123)
T 3aaa_C           84 GHVSCVKLLLSKGADKTVKGPDGLTA  109 (123)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             CCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence            99999999999998876555444333

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.88  E-value=1.4e-22  Score=177.32  Aligned_cols=135  Identities=26%  Similarity=0.195  Sum_probs=78.4

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCC----------------
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI----------------   71 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~----------------   71 (319)
                      .|||+.|+..++....+-..-.|.|+|..+..|.||||+|+..|+.+++++|+++|++++.+|.                
T Consensus        74 ~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~  153 (299)
T 1s70_B           74 LTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEE  153 (299)
T ss_dssp             CBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHhcchHH
Confidence            3555566665555555555555666666666666666666666666666666666665554432                


Q ss_pred             --------------------------------------------CCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCC
Q 020981           72 --------------------------------------------DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (319)
Q Consensus        72 --------------------------------------------~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~  107 (319)
                                                                  .|+||||+|+..|+.+++++|+++|++++.+|..|+
T Consensus       154 ~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g~  233 (299)
T 1s70_B          154 LLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGW  233 (299)
T ss_dssp             HHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCC
T ss_pred             HHHHHHhhcCCCchhhhhhhhhHHHHHHHHHHhccCcchhhhcCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCCC
Confidence                                                        244555555666666666666666666666666666


Q ss_pred             CCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       108 tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      ||||+|+..|+.+++++|++.|+++...+....++
T Consensus       234 tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t~  268 (299)
T 1s70_B          234 TPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTA  268 (299)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred             cHHHHHHhcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence            66666666666666666666665555444444444

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.88  E-value=9.3e-23  Score=172.51  Aligned_cols=134  Identities=22%  Similarity=0.253  Sum_probs=105.2

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCC------CcccCCCCCCHHHHHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHVAA   81 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~------vn~~d~~g~tpLh~A~   81 (319)
                      .|||+.|+..++....+...-.|.|+|..+..|.||||+||..|+.+++++|++.|++      ++.+|..|+||||+|+
T Consensus        46 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~  125 (236)
T 1ikn_D           46 QTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLAS  125 (236)
T ss_dssp             CCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHH
Confidence            4778888888877777777777888888888888888888888888888888888765      4667777888888888


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCC-CCCCCcccccccccHHHHHHHHhhCCCCCCccccccc
Q 020981           82 CQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH  141 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~-~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~  141 (319)
                      ..|+.+++++|+++|++++.+|. .|+||||+|+..|+.+++++|++.|+++...+....+
T Consensus       126 ~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t  186 (236)
T 1ikn_D          126 IHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYS  186 (236)
T ss_dssp             HTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCC
T ss_pred             HcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCC
Confidence            88888888888888888888886 8888888888888888888888888776555433333

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.88  E-value=1.9e-22  Score=166.12  Aligned_cols=129  Identities=22%  Similarity=0.291  Sum_probs=118.6

Q ss_pred             cccccccccccCchhhhhhhhhcCC-CCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGL-DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      -.||++.|+..++....+.....+. |+|..+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus         5 ~~~~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~   84 (201)
T 3hra_A            5 EVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGR   84 (201)
T ss_dssp             CTTHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             cccHHHHHHHhccHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCC
Confidence            4688999999999888777777665 999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhh-hCCCcccCCCCCCCCCcccccccccHHHHHHHHhhC-CCCCCc
Q 020981           86 TEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG-AKPLMA  135 (319)
Q Consensus        86 ~~~v~~Ll-~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g-~~~~~~  135 (319)
                      .+++++|+ ..+++++..|..|.||+|+|+..++.+++++|++.+ .+....
T Consensus        85 ~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  136 (201)
T 3hra_A           85 TEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQ  136 (201)
T ss_dssp             HHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCC
T ss_pred             HHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCC
Confidence            99999999 568899999999999999999999999999999998 554433

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.88  E-value=1.3e-22  Score=169.84  Aligned_cols=136  Identities=20%  Similarity=0.132  Sum_probs=123.8

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCC-CCcccCCCCCCHHHHHHHcCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga-~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      -.||++.|+..++....+...-.|.|++..+..|.||||+|+..|+.+++++|++.|+ +++.+|..|+||||+|+..|+
T Consensus        25 g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~  104 (223)
T 2f8y_A           25 GETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAV  104 (223)
T ss_dssp             CCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTC
T ss_pred             CCchHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCc
Confidence            4689999999999888888888899999999999999999999999999999999987 899999999999999999999


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      .+++++|+++|++++.+|..|+||||+|+..++.+++++|++.|++....+....++
T Consensus       105 ~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~  161 (223)
T 2f8y_A          105 EGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETP  161 (223)
T ss_dssp             HHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred             HHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCH
Confidence            999999999999999999999999999999999999999999998876655444333

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.87  E-value=8.8e-23  Score=177.13  Aligned_cols=126  Identities=26%  Similarity=0.182  Sum_probs=61.3

Q ss_pred             ccccccccccCchhhhhhhhhcCC-CCCCCCCCcchHHHHHH-----HcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGL-DDDGEEIKPEFRLMFLA-----NERDVEGIKELLDSGIDVNFRDIDNRTALHVAA   81 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~t~L~~a~-----~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~   81 (319)
                      .|||+.|+..++....+...-.|. ++|..+..|.||||+|+     ..++.++++.|++.|++++.+|..|+||||+|+
T Consensus       112 ~T~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpLh~A~  191 (276)
T 4hbd_A          112 NTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTALMLAV  191 (276)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCCHHHHHH
T ss_pred             CCHHHHHHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCCHHHHHH
Confidence            455666666665555555555554 55555555444444444     334444444444444444444444444444444


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHh-hCCCCC
Q 020981           82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK-HGAKPL  133 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~-~g~~~~  133 (319)
                      ..|+.++|++|+++|++++.+|..|+||||+|+..|+.+++++|++ .|++..
T Consensus       192 ~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~  244 (276)
T 4hbd_A          192 SHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDIS  244 (276)
T ss_dssp             HTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTT
T ss_pred             HcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCc
Confidence            4444444444444444444444444444444444444444444444 344433

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.87  E-value=1e-22  Score=171.60  Aligned_cols=127  Identities=24%  Similarity=0.235  Sum_probs=116.5

Q ss_pred             cccccccccccCchhhhhhhhhcCCCC-----CCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCC----------
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDD-----DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI----------   71 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~----------   71 (319)
                      -.|||+.|+..++....+...-.+.++     +..+..|.||||+||..|+.+++++|+++|++++.++.          
T Consensus        37 g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~  116 (232)
T 2rfa_A           37 GETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHN  116 (232)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTC
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeecccc
Confidence            368999999999988777777677765     78888999999999999999999999999999999876          


Q ss_pred             ---CCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHH----HHHHhhCCCCC
Q 020981           72 ---DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI----KLLEKHGAKPL  133 (319)
Q Consensus        72 ---~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~----~~L~~~g~~~~  133 (319)
                         .|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..++.+++    ++|++.|++..
T Consensus       117 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~  185 (232)
T 2rfa_A          117 LIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH  185 (232)
T ss_dssp             SCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCS
T ss_pred             cccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchh
Confidence               799999999999999999999999999999999999999999999999887    99999998763

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.87  E-value=1.5e-22  Score=170.47  Aligned_cols=131  Identities=27%  Similarity=0.292  Sum_probs=108.9

Q ss_pred             cccccccccccCchhhhhhhhhc-CCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      -.|+++.|+..++....+..... ..+.+..+.+|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+
T Consensus         6 ~~~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~   85 (231)
T 3aji_A            6 SNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGX   85 (231)
T ss_dssp             SSSHHHHHHHHTCHHHHHHHHHHCGGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTC
T ss_pred             ccchHHHHHHhCCHHHHHHHHHhchhhhhcCCCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCH
Confidence            35678888888886666555544 34467778888999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      .+++++|+++|++++.+|..|.||+|+|+..++.+++++|++.|+++.....
T Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~  137 (231)
T 3aji_A           86 DEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDH  137 (231)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence            9999999999999999999999999999999999999999988887655443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=3.2e-22  Score=173.99  Aligned_cols=135  Identities=17%  Similarity=0.111  Sum_probs=107.3

Q ss_pred             ccceeeeecceEEEEEE----eceEeEEEEecccccCCH---------------HHHHHHHHHHHHHHhcCCCcccccce
Q 020981          157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD---------------DRVRAFRDELALLQKIRHPNVVQFLG  217 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv~l~~  217 (319)
                      |.....||.|+||.||.    +|+.||+|.++.......               .....+.+|+.+++.++  | +++.+
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            44568999999999885    478999999865321111               23567889999999999  5 67766


Q ss_pred             eEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      ++.. +..|+||||++|++|.+ +.      ......++.|++.||.|||+++   |+||||||+|||++ ++.+||+||
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCC
T ss_pred             EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEEC
Confidence            5544 56799999999999987 42      1234579999999999999999   99999999999999 999999999


Q ss_pred             CcccccccC
Q 020981          298 GVSKLLTVK  306 (319)
Q Consensus       298 gla~~~~~~  306 (319)
                      |+|+....+
T Consensus       237 G~a~~~~~~  245 (282)
T 1zar_A          237 PQSVEVGEE  245 (282)
T ss_dssp             TTCEETTST
T ss_pred             CCCeECCCC
Confidence            999876544

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.87  E-value=1.1e-22  Score=174.04  Aligned_cols=126  Identities=26%  Similarity=0.165  Sum_probs=70.7

Q ss_pred             cccccccccCchhhhhhhhhcCC-CCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            9 TTLLKQSSLAPDRERKEAELNGL-DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      |||+.|+..++....+...-.+. +++..+..|.||||+|+..|+.++++.|++.|+++|.+|..|+||||+|+..|+.+
T Consensus        92 t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~  171 (253)
T 1yyh_A           92 TPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVD  171 (253)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHSTTSCTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHH
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCCCccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHH
Confidence            55555555555444444444443 55555555555555555555555555555555555555555555555555555555


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~  134 (319)
                      ++++|+++|++++.+|..|.||+|+|+..|+.+++++|++.|+++..
T Consensus       172 ~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~  218 (253)
T 1yyh_A          172 AAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDI  218 (253)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTC
T ss_pred             HHHHHHHcCCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccc
Confidence            55555555555555555555555555555555555555555555443

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.87  E-value=2.6e-22  Score=169.89  Aligned_cols=135  Identities=21%  Similarity=0.183  Sum_probs=89.8

Q ss_pred             ccccccccccCchhhhhhhhhcCC----CCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCCHHHHHHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGL----DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAAC   82 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d-~~g~tpLh~A~~   82 (319)
                      .||++.|+..++....+...-.+.    +++..+..|.||||+|+..|+.+++++|++.|++++.++ ..|+||||+|+.
T Consensus        80 ~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~  159 (241)
T 1k1a_A           80 QTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVE  159 (241)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCccccccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHH
Confidence            456666666666555555544444    666666667777777777777777777777777777666 567777777777


Q ss_pred             cCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        83 ~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      .|+.+++++|+++|++++.+|..|+||+|+|+..++.+++++|++.|+++...+....++
T Consensus       160 ~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp  219 (241)
T 1k1a_A          160 NNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTP  219 (241)
T ss_dssp             TTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred             cCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCH
Confidence            777777777777777777777777777777777777777777777776665544444443

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.87  E-value=1.8e-22  Score=170.83  Aligned_cols=123  Identities=21%  Similarity=0.195  Sum_probs=113.6

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCC-CCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      -.||++.|+..++....+...-.|.|++..+ ..|.||||+|+..|+.+++++|+++|+|+|.+|..|+||||+|+..|+
T Consensus       116 g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~  195 (241)
T 1k1a_A          116 GLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGL  195 (241)
T ss_dssp             SCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTC
T ss_pred             CCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCC
Confidence            3588999999999888888888999999999 899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhC
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g  129 (319)
                      .+++++|+++|++++.+|..|.||+++|+..++.++++.|...+
T Consensus       196 ~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~i~~~l~~~~  239 (241)
T 1k1a_A          196 LPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILRGKATRP  239 (241)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCTTTTCSSHHHHHHHTC-----
T ss_pred             HHHHHHHHhcCCCCCCcCCCCCCHHHHHHhcCcHHHHhhhccCC
Confidence            99999999999999999999999999999999999999888754

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.87  E-value=1.8e-22  Score=181.60  Aligned_cols=124  Identities=26%  Similarity=0.311  Sum_probs=117.6

Q ss_pred             cccccccccc-CchhhhhhhhhcCCCCCCCC--CCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcC
Q 020981            8 RTTLLKQSSL-APDRERKEAELNGLDDDGEE--IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG   84 (319)
Q Consensus         8 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~   84 (319)
                      .|+|+.|+.. ++....+.+.-.|.|+|..+  ..|.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|
T Consensus       200 ~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g  279 (368)
T 3jue_A          200 GALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILG  279 (368)
T ss_dssp             HHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred             CcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC
Confidence            4688899998 88888888888999999998  89999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCC
Q 020981           85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (319)
Q Consensus        85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~  131 (319)
                      +.+++++|+++|++++.+|..|.||||+|+..++.+++++|+..+..
T Consensus       280 ~~~~v~~LL~~Gad~~~~d~~G~TpL~~A~~~g~~~iv~lLl~~~~~  326 (368)
T 3jue_A          280 HTGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLRLAKMR  326 (368)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHC-
T ss_pred             cHHHHHHHHHCcCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence            99999999999999999999999999999999999999999987743

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.87  E-value=5.9e-23  Score=175.87  Aligned_cols=126  Identities=25%  Similarity=0.275  Sum_probs=112.7

Q ss_pred             ccccccccccc---CchhhhhhhhhcCCCCCC-----------CCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCC
Q 020981            7 VRTTLLKQSSL---APDRERKEAELNGLDDDG-----------EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID   72 (319)
Q Consensus         7 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-----------~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~   72 (319)
                      -.|||+.|+..   ++....+...-.|.+++.           .+..|.||||+||..|+.+++++|+++|+|+|.+|..
T Consensus        43 g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~  122 (256)
T 2etb_A           43 GKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACG  122 (256)
T ss_dssp             TBCHHHHHHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCS
T ss_pred             CCCHHHHHHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCccccc
Confidence            36899999988   887666666666666553           3478999999999999999999999999999999986


Q ss_pred             -------------CCCHHHHHHHcCCHHHHHHhhh---CCCcccCCCCCCCCCcccccc--cccHH-------HHHHHHh
Q 020981           73 -------------NRTALHVAACQGFTEVVSLLLE---RGADVDPKDRWGSTPLGDAIY--YKNHE-------VIKLLEK  127 (319)
Q Consensus        73 -------------g~tpLh~A~~~~~~~~v~~Ll~---~g~~~~~~~~~g~tpl~~a~~--~~~~~-------i~~~L~~  127 (319)
                                   |+||||+|+..|+.+++++|++   +|++++.+|..|+||||+|+.  .++.+       ++++|++
T Consensus       123 ~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~  202 (256)
T 2etb_A          123 RFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQ  202 (256)
T ss_dssp             GGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHH
Confidence                         9999999999999999999999   999999999999999999998  77887       9999999


Q ss_pred             hCCCC
Q 020981          128 HGAKP  132 (319)
Q Consensus       128 ~g~~~  132 (319)
                      .|++.
T Consensus       203 ~ga~~  207 (256)
T 2etb_A          203 MGARL  207 (256)
T ss_dssp             HHHHH
T ss_pred             cCCCc
Confidence            98876

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.87  E-value=1.2e-22  Score=182.91  Aligned_cols=125  Identities=19%  Similarity=0.131  Sum_probs=120.2

Q ss_pred             ccccccccccC--chhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCC-----CcccCCCCCCHHHHH
Q 020981            8 RTTLLKQSSLA--PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID-----VNFRDIDNRTALHVA   80 (319)
Q Consensus         8 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~-----vn~~d~~g~tpLh~A   80 (319)
                      .|||+.|+..+  +....+.+.-.|.|+|..+..|.||||+||..|+.+++++|+++|++     +|.+|..|+||||+|
T Consensus       139 ~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A  218 (364)
T 3ljn_A          139 QTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWA  218 (364)
T ss_dssp             CCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHH
T ss_pred             CCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHH
Confidence            68999999999  88888888888999999999999999999999999999999999999     999999999999999


Q ss_pred             HHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           81 ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        81 ~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      +..|+.++|++|+++|++++.+|..|+||||+|+..|+.+++++|++.+++.
T Consensus       219 ~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~  270 (364)
T 3ljn_A          219 ILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVF  270 (364)
T ss_dssp             HTTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTCCHHHHHHHHHHSCHH
T ss_pred             HHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhChHHHHHHHHHcCCch
Confidence            9999999999999999999999999999999999999999999999998765

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.87  E-value=3.4e-22  Score=168.90  Aligned_cols=128  Identities=22%  Similarity=0.203  Sum_probs=77.7

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcC-CCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~g-a~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .||++.|+..++....+-..-.|.+++..+..|.||||+|+..|+.+++++|++.| ++++.+|..|+||||+|+..|+.
T Consensus        45 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~  124 (237)
T 3b7b_A           45 RTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHV  124 (237)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred             CCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCCCCHHHHHHHcCCH
Confidence            35566666666655555555556666666666666666666666666666666665 56666666666666666666666


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~  135 (319)
                      +++++|+++|++++.+|..|.||+|+|+..|+.+++++|++.|++....
T Consensus       125 ~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~  173 (237)
T 3b7b_A          125 DLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAV  173 (237)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCC
T ss_pred             HHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCc
Confidence            6666666666666666666666666666666666666666665555433

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.87  E-value=2.8e-22  Score=165.08  Aligned_cols=132  Identities=23%  Similarity=0.242  Sum_probs=122.4

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHH-HcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll-~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .|||+.|+..++....+...-.|.|+|..+..|.||||+|+..|+.+++++|+ ..+++++.+|..|+||||+|+..|+.
T Consensus        40 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~  119 (201)
T 3hra_A           40 NTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHI  119 (201)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCH
Confidence            68999999999998888888899999999999999999999999999999999 56789999999999999999999999


Q ss_pred             HHHHHhhhCC-CcccCCCCCCCCCccccccccc-----HHHHHHHHhhCCCCCCccccc
Q 020981           87 EVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKN-----HEVIKLLEKHGAKPLMAPMHV  139 (319)
Q Consensus        87 ~~v~~Ll~~g-~~~~~~~~~g~tpl~~a~~~~~-----~~i~~~L~~~g~~~~~~~~~~  139 (319)
                      +++++|+++| ++++.+|..|+||+|+|+..++     .+++++|++.|+++...+...
T Consensus       120 ~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~g  178 (201)
T 3hra_A          120 DNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNSG  178 (201)
T ss_dssp             HHHHHHHHHCCCCTTCCCTTSCCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCCTTS
T ss_pred             HHHHHHHHcCCCCcCCCCCCCCCHHHHHHHhccchhhHHHHHHHHHHCCCCCCccCCCC
Confidence            9999999998 9999999999999999998887     899999999998876555433

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.87  E-value=2.8e-22  Score=178.76  Aligned_cols=132  Identities=29%  Similarity=0.353  Sum_probs=121.5

Q ss_pred             ccccccccccCchhhhhhhhh-cCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAEL-NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .|+++.|++.++....+.... .+.++|..|..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus        25 ~~~L~~A~~~g~~~~v~~ll~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~  104 (351)
T 3utm_A           25 KDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHY  104 (351)
T ss_dssp             HHHHHHHHHHTCHHHHHHHCCTTTTTCCCSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCH
T ss_pred             chhHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCH
Confidence            478999999999776665555 4899999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~  139 (319)
                      +++++|+++|++++..|..|.||||+|+..|+.+++++|++.|+++.......
T Consensus       105 ~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g  157 (351)
T 3utm_A          105 EVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHG  157 (351)
T ss_dssp             HHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             HHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCC
Confidence            99999999999999999999999999999999999999999998876555433

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.87  E-value=1.6e-22  Score=175.16  Aligned_cols=90  Identities=17%  Similarity=0.032  Sum_probs=53.6

Q ss_pred             ccccccccccCchhhhhhhhhcCCC---CCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcC
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLD---DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG   84 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~   84 (319)
                      .|||+.|++.++....+...-.+.+   +|..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus        10 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~~   89 (282)
T 1oy3_D           10 DTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVR   89 (282)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHHHTTTT
T ss_pred             CcHHHHHHHcCCHHHHHHHHhcCCCcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC
Confidence            3556666666665555555555555   5555566666666666666666666666666666666666666666666666


Q ss_pred             CHHHHHHhhhCCC
Q 020981           85 FTEVVSLLLERGA   97 (319)
Q Consensus        85 ~~~~v~~Ll~~g~   97 (319)
                      +.+++++|+++|+
T Consensus        90 ~~~~v~~Ll~~~~  102 (282)
T 1oy3_D           90 AHTCACVLLQPRP  102 (282)
T ss_dssp             CHHHHHHHSSSCC
T ss_pred             CcchhHhhhccCC
Confidence            6666666665543

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.86  E-value=2.8e-22  Score=149.38  Aligned_cols=94  Identities=32%  Similarity=0.449  Sum_probs=86.3

Q ss_pred             CCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcc
Q 020981           32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG  111 (319)
Q Consensus        32 ~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~  111 (319)
                      ..+..+.+|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||+|
T Consensus        16 ~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~   95 (110)
T 2zgd_A           16 RGSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFD   95 (110)
T ss_dssp             ------CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred             cccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHH
Confidence            34567889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccHHHHHHH
Q 020981          112 DAIYYKNHEVIKLL  125 (319)
Q Consensus       112 ~a~~~~~~~i~~~L  125 (319)
                      +|+..++.+++++|
T Consensus        96 ~A~~~~~~~~~~~L  109 (110)
T 2zgd_A           96 ISIDNGNEDLAEIL  109 (110)
T ss_dssp             HHHHHTCHHHHHHH
T ss_pred             HHHHcCCHHHHHHh
Confidence            99999999999876

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.86  E-value=4.2e-22  Score=173.57  Aligned_cols=128  Identities=20%  Similarity=0.137  Sum_probs=110.5

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|||+.|+..++....+...-.|.|+|..+.+|.||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+
T Consensus        60 ~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~  139 (285)
T 3d9h_A           60 WSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWD  139 (285)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHH
Confidence            58888888888888888888888899988999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      ++++|+++|++++..+ .|.||||+|+..|+.+++++|++.|++....+
T Consensus       140 ~v~~Ll~~g~~~~~~~-~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d  187 (285)
T 3d9h_A          140 CVNLLLQHGASVQPES-DLASPIHEAARRGHVECVNSLIAYGGNIDHKI  187 (285)
T ss_dssp             HHHHHHHTTCCSSCSC-TTSCHHHHHHHHTCHHHHHHHHHTTCCTTCCB
T ss_pred             HHHHHHHCCCCCCCCC-CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcC
Confidence            9999999988887654 48899999999999999999998887765444

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.86  E-value=4e-22  Score=174.36  Aligned_cols=121  Identities=22%  Similarity=0.241  Sum_probs=112.6

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      ..|+++.|+..++....+...-.|.|+|..+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus        40 ~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~  119 (299)
T 1s70_B           40 DGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYL  119 (299)
T ss_dssp             HHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred             CccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCH
Confidence            35789999999999998888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHh
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK  127 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~  127 (319)
                      +++++|+++|++++..|..|.||+|+|+..++.++++.++.
T Consensus       120 ~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~ll~  160 (299)
T 1s70_B          120 DIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVN  160 (299)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCcCCCCCCHHHHHHhcchHHHHHHHHh
Confidence            99999999999999999999999888888887777765554

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.86  E-value=2.1e-22  Score=174.77  Aligned_cols=122  Identities=25%  Similarity=0.241  Sum_probs=110.7

Q ss_pred             cccccccc-----ccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Q 020981            8 RTTLLKQS-----SLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC   82 (319)
Q Consensus         8 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~   82 (319)
                      .||++.|+     ..++....+...-.|.+.+..+..|.||||+||..|+.++++.|+++|+|+|.+|.+|+||||+|+.
T Consensus       146 ~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~  225 (276)
T 4hbd_A          146 YSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACE  225 (276)
T ss_dssp             CCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHH
Confidence            46777777     5566666666777889999999999999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHhhh-CCCcccCCCCCCCCCcccccccccHHHHHHHHhhC
Q 020981           83 QGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        83 ~~~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g  129 (319)
                      .|+.+++++|++ .|++++.+|..|+||+|+|+..|+.+++++|++..
T Consensus       226 ~g~~~iv~~Ll~~~gad~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~~  273 (276)
T 4hbd_A          226 HGHKEIAGLLLAVPSCDISLTDRDGSTALMVALDAGQSEIASMLYSRM  273 (276)
T ss_dssp             HTCHHHHHHHHTSTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHC
T ss_pred             CCCHHHHHHHHhcCCCCCcCcCCCCCCHHHHHHHcCCHHHHHHHHhcc
Confidence            999999999999 89999999999999999999999999999999865

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.86  E-value=5.4e-22  Score=153.43  Aligned_cols=102  Identities=31%  Similarity=0.392  Sum_probs=95.1

Q ss_pred             CCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccc
Q 020981           36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY  115 (319)
Q Consensus        36 ~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~  115 (319)
                      ....+.||||+||..|+.++++.|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus        10 ~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~   89 (136)
T 2jab_A           10 HGSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAF   89 (136)
T ss_dssp             --CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred             ccccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence            34578899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccHHHHHHHHhhCCCCCCccc
Q 020981          116 YKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus       116 ~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      .++.+++++|++.|++....+.
T Consensus        90 ~~~~~~v~~Ll~~g~~~~~~~~  111 (136)
T 2jab_A           90 IGHLEIAEVLLKHGADVNAQDK  111 (136)
T ss_dssp             HTCHHHHHHHHHTTCCTTCCCT
T ss_pred             cCCHHHHHHHHHcCCCCcCcCC
Confidence            9999999999999988755443

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.86  E-value=1.4e-22  Score=176.59  Aligned_cols=123  Identities=20%  Similarity=0.096  Sum_probs=95.1

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|||+.|+..++....+...-.|.|+|..  +|.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+
T Consensus        32 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~--~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~  109 (285)
T 3kea_A           32 HSASYYAIADNNVRLVCTLLNAGALKNLL--ENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQ  109 (285)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTGGGSCC--TTCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHhCCCCCCCC--CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHH
Confidence            57777777777777777777777777777  3778888888888888888888888888877777888888888888888


Q ss_pred             HHHHhhhCCCcccCCCCCC-CCCcccccccccHHHHHHHHhhCCCC
Q 020981           88 VVSLLLERGADVDPKDRWG-STPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g-~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      ++++|+++|++++.+|..| .||||+|+..|+.+++++|++.|++.
T Consensus       110 ~v~~Ll~~ga~~~~~~~~g~~t~L~~A~~~~~~~~v~~Ll~~g~~~  155 (285)
T 3kea_A          110 TVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST  155 (285)
T ss_dssp             HHHHHHHHCGGGGGCSSSGGGSHHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred             HHHHHHhcCCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCcc
Confidence            8888887788888777777 68888887777777887777776554

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.86  E-value=4.8e-22  Score=183.29  Aligned_cols=129  Identities=25%  Similarity=0.250  Sum_probs=83.7

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+-..-++.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus       246 ~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~  325 (437)
T 1n11_A          246 VTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIK  325 (437)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSH
T ss_pred             CCHHHHHHHCCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcHH
Confidence            45566666666655555555566666666666666666666666666666666666666666666666666666666666


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      +|++|+++|++++.+|..|+||||+|+..|+.+++++|++.|+++...+
T Consensus       326 ~v~~Ll~~gad~n~~~~~g~t~L~~A~~~g~~~iv~~Ll~~ga~~~~~~  374 (437)
T 1n11_A          326 LVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS  374 (437)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCC
T ss_pred             HHHHHHhcCCCCCCCCCCCCCHHHHHHHCChHHHHHHHHHCcCCCCCCC
Confidence            6666666666666666666666666666666666666666666654443

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.86  E-value=5.7e-22  Score=166.42  Aligned_cols=122  Identities=25%  Similarity=0.233  Sum_probs=63.7

Q ss_pred             ccccccccccCchhhhhhhhhcC--CCCCC-CCCCcchHHHHHHHcCCHHHHHHHHHcC--CCCcccCCCCCCHHHHHHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNG--LDDDG-EEIKPEFRLMFLANERDVEGIKELLDSG--IDVNFRDIDNRTALHVAAC   82 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~t~L~~a~~~~~~~~~~~Ll~~g--a~vn~~d~~g~tpLh~A~~   82 (319)
                      .||++.|+..++....+...-.+  .+++. .+..|.||||+|+..|+.++++.|+++|  ++++.+|..|+||||+|+.
T Consensus        37 ~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~  116 (228)
T 2dzn_A           37 RIPLHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVG  116 (228)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTCTTCCGGGCCCTTSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHhccccccccccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHH
Confidence            34555555555544444444444  33333 4445555555555555555555555554  4555555555555555555


Q ss_pred             cCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhC
Q 020981           83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        83 ~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g  129 (319)
                      .|+.+++++|+++|++++.+|..|+||+|+|+..|+.+++++|++.|
T Consensus       117 ~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g  163 (228)
T 2dzn_A          117 KKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLG  163 (228)
T ss_dssp             TTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTT
T ss_pred             cCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcC
Confidence            55555555555555555555555555555555555555555555544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.86  E-value=3.8e-22  Score=182.91  Aligned_cols=148  Identities=14%  Similarity=0.159  Sum_probs=110.4

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCC-Ccccccc------------
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFL------------  216 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~------------  216 (319)
                      ..+.....||+|+||.||.     +|+.||||++...........+.+.+|+.+++.++| ++.....            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3467778999999999985     378999999875433333445778999999999976 3221111            


Q ss_pred             ---------eeEEe-----CCceEEEEeecCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 020981          217 ---------GAVTQ-----SSPMMIVTEYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARGMNYLHENKPVPII  275 (319)
Q Consensus       217 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~lH~~~~~~iv  275 (319)
                               ..+..     ....+++|+++ +++|.+++..       ...+++..+..++.|++.||+|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                     11111     23467778866 7899999852       123677788889999999999999999   99


Q ss_pred             EcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       276 H~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||||||+|||++.++.+||+|||+++.....
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~  264 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS  264 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc
Confidence            9999999999999999999999999875543

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.86  E-value=2.3e-22  Score=172.52  Aligned_cols=126  Identities=21%  Similarity=0.163  Sum_probs=110.4

Q ss_pred             ccccccccc---ccCchhhhhhhhhcC-----------CCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccC--
Q 020981            7 VRTTLLKQS---SLAPDRERKEAELNG-----------LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--   70 (319)
Q Consensus         7 ~~~~~~~~~---~~~~~~~~~~~~~~~-----------~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d--   70 (319)
                      -.|||+.|+   +.++....+...-.|           .+.+..+..|.||||+||..|+.++|++|+++|+|+|.+|  
T Consensus        46 g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~  125 (260)
T 3jxi_A           46 GKTCLPKALLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARG  125 (260)
T ss_dssp             CCCHHHHHHTSCBTTBCTHHHHHHHHHHHTTCHHHHHTCCBCCSSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEE
T ss_pred             CCcHHHHHHHHhhcCCHHHHHHHHHhcccccchHhhhcccccccccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccc
Confidence            468899777   667766655555544           4456666799999999999999999999999999999999  


Q ss_pred             ------------CCCCCHHHHHHHcCCHHHHHHhhh---CCCcccCCCCCCCCCccccccccc---------HHHHHHHH
Q 020981           71 ------------IDNRTALHVAACQGFTEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKN---------HEVIKLLE  126 (319)
Q Consensus        71 ------------~~g~tpLh~A~~~~~~~~v~~Ll~---~g~~~~~~~~~g~tpl~~a~~~~~---------~~i~~~L~  126 (319)
                                  ..|+||||+|+..|+.++|++|++   +|++++.+|..|+||||+|+..++         .+++++|+
T Consensus       126 ~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll  205 (260)
T 3jxi_A          126 RFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLL  205 (260)
T ss_dssp             CCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHH
T ss_pred             cccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHH
Confidence                        689999999999999999999999   999999999999999999998776         68999999


Q ss_pred             hhCCCC
Q 020981          127 KHGAKP  132 (319)
Q Consensus       127 ~~g~~~  132 (319)
                      +.|++.
T Consensus       206 ~~ga~~  211 (260)
T 3jxi_A          206 IKCAKL  211 (260)
T ss_dssp             HHHHHH
T ss_pred             HhCccc
Confidence            998876

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.85  E-value=1.3e-21  Score=165.37  Aligned_cols=130  Identities=29%  Similarity=0.317  Sum_probs=122.8

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      -.||++.|+..++....+...-+|.|+|..+.+|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.
T Consensus        11 g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~   90 (237)
T 3b7b_A           11 KRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHY   90 (237)
T ss_dssp             SCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCH
T ss_pred             CCCHHHHHHHcCcHHHHHHHHHcCCCcCccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCH
Confidence            46899999999999888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCC-CcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           87 EVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        87 ~~v~~Ll~~g-~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      +++++|++.| ++++..|..|.||+|+|+..++.+++++|++.|++.....
T Consensus        91 ~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~  141 (237)
T 3b7b_A           91 EVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRD  141 (237)
T ss_dssp             HHHHHHHTTTCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHHHHhCCCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccC
Confidence            9999999998 8999999999999999999999999999999998765443

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.85  E-value=1.9e-21  Score=168.18  Aligned_cols=129  Identities=26%  Similarity=0.202  Sum_probs=121.0

Q ss_pred             ccccccccccCchhhhhhhhhc-CCCCCCCCCCcchHHHHHHHcCC----HHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAAC   82 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~L~~a~~~~~----~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~   82 (319)
                      .||++.|+..++....+...-. +.++|..+..|.||||+|+..++    .+++++|+++|+|+|.+|..|+||||+|+.
T Consensus       149 ~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~~  228 (285)
T 1wdy_A          149 ATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVE  228 (285)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHH
T ss_pred             CcHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHHH
Confidence            4899999999987777777666 99999999999999999999999    999999999999999999999999999999


Q ss_pred             cCCHHHHHHhhh-CCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           83 QGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        83 ~~~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      .|+.+++++|++ .|++++.+|..|.||+|+|+..++.+++++|++.|+++...+
T Consensus       229 ~~~~~~v~~Ll~~~g~~~~~~~~~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~d  283 (285)
T 1wdy_A          229 KKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD  283 (285)
T ss_dssp             TTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred             cCCHHHHHHHHhccCCCccccCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCCccc
Confidence            999999999999 899999999999999999999999999999999999876543

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.85  E-value=2.9e-22  Score=178.08  Aligned_cols=134  Identities=22%  Similarity=0.129  Sum_probs=76.8

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCC---HHHHHHHHHcC-CCCcccCCCCCCHHHHHHH--
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERD---VEGIKELLDSG-IDVNFRDIDNRTALHVAAC--   82 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~---~~~~~~Ll~~g-a~vn~~d~~g~tpLh~A~~--   82 (319)
                      |||+.|+..++....+.+.-.|+|+|.++.+|.||||+||..|+   .++++.|++.+ +++|.+|..|+||||+|+.  
T Consensus       133 TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~~~d~~g~tpLh~A~~~~  212 (327)
T 1sw6_A          133 TPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHIIITS  212 (327)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHHHHHHHH
T ss_pred             cHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccccCCCCCCCCHHHHHHHHc
Confidence            44555555555444444444455555555555555555555444   34444444443 4455555555555555554  


Q ss_pred             --cCCHHHHHHhhhCCC---------------------------------------------cccCCCCCCCCCcccccc
Q 020981           83 --QGFTEVVSLLLERGA---------------------------------------------DVDPKDRWGSTPLGDAIY  115 (319)
Q Consensus        83 --~~~~~~v~~Ll~~g~---------------------------------------------~~~~~~~~g~tpl~~a~~  115 (319)
                        .|+.+++++|++.++                                             +++.+|..|+||||+|+.
T Consensus       213 ~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~~n~~d~~G~TpLh~A~~  292 (327)
T 1sw6_A          213 GMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR  292 (327)
T ss_dssp             TSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHHHHHHH
T ss_pred             cccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Confidence              555566666665432                                             466777777777777777


Q ss_pred             cccHHHHHHHHhhCCCCCCcccccccc
Q 020981          116 YKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       116 ~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      .|+.+++++|++.|+++...+....++
T Consensus       293 ~g~~~~v~~Ll~~Gad~~~~d~~G~Tp  319 (327)
T 1sw6_A          293 LGNISIVDALLDYGADPFIANKSGLRP  319 (327)
T ss_dssp             HCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred             cCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence            777778888887777776555444444

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.85  E-value=7.3e-22  Score=177.81  Aligned_cols=132  Identities=17%  Similarity=0.095  Sum_probs=114.2

Q ss_pred             ccccccccccCchhhhhhhhhc----CCCCCC-----------------CCCCcchHHHHHHHcC--CHHHHHHHHHcCC
Q 020981            8 RTTLLKQSSLAPDRERKEAELN----GLDDDG-----------------EEIKPEFRLMFLANER--DVEGIKELLDSGI   64 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-----------------~~~~~~t~L~~a~~~~--~~~~~~~Ll~~ga   64 (319)
                      .||++.|+..++....+...-.    +.+++.                 .+..|.||||+||..|  +.+++++|+++|+
T Consensus        85 ~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~~~v~~Ll~~ga  164 (364)
T 3ljn_A           85 QKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGA  164 (364)
T ss_dssp             BCHHHHHHHTTCHHHHHHHHHHHHHHTCCHHHHHTCCCCCCEEEETTEEEEESCCCHHHHHHHSCGGGHHHHHHHHHHTC
T ss_pred             CCHHHHHHHcCCHHHHHHHHHhccccCCCHHHHHhhcchHhhhhhccccCCCCCCCHHHHHHHcCCchHHHHHHHHHcCC
Confidence            4566666666665555544444    555554                 8889999999999999  9999999999999


Q ss_pred             CCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCc-----ccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccc
Q 020981           65 DVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-----VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (319)
Q Consensus        65 ~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~-----~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~  139 (319)
                      |+|.+|..|+||||+|+..|+.++|++|+++|++     ++..|..|+||||+|+..|+.+++++|++.|+++...+...
T Consensus       165 ~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d~~g  244 (364)
T 3ljn_A          165 SPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMEDNEH  244 (364)
T ss_dssp             CTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCCTTS
T ss_pred             CCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCC
Confidence            9999999999999999999999999999999999     99999999999999999999999999999999876555433

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.85  E-value=1.5e-21  Score=180.01  Aligned_cols=126  Identities=29%  Similarity=0.238  Sum_probs=112.8

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|||+.|+..++....+...-.|.|+|..+..|.||||+||..|+.+++++|++.|+++|.+|.+|+||||+|+..|+.+
T Consensus        15 ~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~   94 (437)
T 1n11_A           15 LTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTN   94 (437)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHH
T ss_pred             CCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHH
Confidence            58899999999988888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~  133 (319)
                      +|++|+++|++++..|..|.||+|+|+..|+.++++.|++.+++..
T Consensus        95 ~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~  140 (437)
T 1n11_A           95 MVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQA  140 (437)
T ss_dssp             HHHHHHHHTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSC
T ss_pred             HHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCc
Confidence            9999999999999999999999999999999999988888877654

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.84  E-value=2.1e-21  Score=169.14  Aligned_cols=125  Identities=22%  Similarity=0.156  Sum_probs=104.6

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|||+.|+..++....+...-.|.|+|..+.+|.||||+|+..|+.+++++|++.|++++..+ +|+||||+|+..|+.+
T Consensus        93 ~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~-~g~t~L~~A~~~g~~~  171 (285)
T 3d9h_A           93 VSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DLASPIHEAARRGHVE  171 (285)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCSC-TTSCHHHHHHHHTCHH
T ss_pred             CCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHHHHHHHHHCCCCCCCCC-CCCCHHHHHHHcCCHH
Confidence            578888888888877777777888888888888888888888888888888888888887544 4888888888888888


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~  133 (319)
                      ++++|+++|++++.+|..|+||||+|+..++.+++++|++.|++..
T Consensus       172 ~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~  217 (285)
T 3d9h_A          172 CVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN  217 (285)
T ss_dssp             HHHHHHHTTCCTTCCBTTTBCHHHHHHHTTCHHHHHHHHHTTCCTT
T ss_pred             HHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHCCCCCC
Confidence            8888888888888888888888888888888888888888887765

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.84  E-value=6.9e-22  Score=172.25  Aligned_cols=131  Identities=15%  Similarity=0.084  Sum_probs=118.8

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCC-CCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g-~tpLh~A~~~~~~   86 (319)
                      .|||+.|+..++....+...-.|.|+|..+..|.||||+||..|+.+++++|+++|+++|.+|..| .||||+|+..|+.
T Consensus        63 ~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~~t~L~~A~~~~~~  142 (285)
T 3kea_A           63 EFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDV  142 (285)
T ss_dssp             CCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCSSSGGGSHHHHHHHTTCH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCccCCCCCCCHHHHHHHcCCH
Confidence            689999999999988888888999999999999999999999999999999999999999999999 7999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~  139 (319)
                      +++++|+++|+++... ..|.||||+|+..|+.+++++|++.|+++...+...
T Consensus       143 ~~v~~Ll~~g~~~~~~-~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~~~g  194 (285)
T 3kea_A          143 SIVSYFLSEIPSTFDL-AILLSCIHITIKNGHVDMMILLLDYMTSTNTNNSLL  194 (285)
T ss_dssp             HHHHHHHTTSCTTCCC-STHHHHHHHHHHTTCHHHHHHHHHHHHHTCTTCCCB
T ss_pred             HHHHHHHhCCCccccc-cCCccHHHHHHHcChHHHHHHHHHcCCCCCcccCCC
Confidence            9999999999887333 289999999999999999999999988876554433

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.84  E-value=5.2e-22  Score=171.66  Aligned_cols=127  Identities=21%  Similarity=0.190  Sum_probs=110.0

Q ss_pred             ccccccccccc---CchhhhhhhhhcCCC-----------CCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCC-
Q 020981            7 VRTTLLKQSSL---APDRERKEAELNGLD-----------DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-   71 (319)
Q Consensus         7 ~~~~~~~~~~~---~~~~~~~~~~~~~~~-----------~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~-   71 (319)
                      -.|||+.|+..   ++....+-+.-.|.+           .+..+..|.||||+||..|+.+++++|+++|+|+|.+|. 
T Consensus        54 g~tpL~~A~~~~~~g~~~~v~~Ll~~ga~~~~~~~~i~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~  133 (273)
T 2pnn_A           54 GKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANG  133 (273)
T ss_dssp             CCCHHHHHHHSCBTTBCHHHHHHHHHHHHTTCHHHHHTCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCS
T ss_pred             CCCHHHHHHHHHhcCChHHHHHHHHhhccccchhHHhhcccccccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccccc
Confidence            46899999965   665555544444433           233567899999999999999999999999999999997 


Q ss_pred             -------------CCCCHHHHHHHcCCHHHHHHhhh---CCCcccCCCCCCCCCccccccccc---------HHHHHHHH
Q 020981           72 -------------DNRTALHVAACQGFTEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKN---------HEVIKLLE  126 (319)
Q Consensus        72 -------------~g~tpLh~A~~~~~~~~v~~Ll~---~g~~~~~~~~~g~tpl~~a~~~~~---------~~i~~~L~  126 (319)
                                   .|+||||+|+..|+.+++++|++   +|++++.+|..|+||||+|+..++         .+++++|+
T Consensus       134 ~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll  213 (273)
T 2pnn_A          134 DFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEIL  213 (273)
T ss_dssp             GGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHH
Confidence                         79999999999999999999999   999999999999999999999887         78999999


Q ss_pred             hhCCCCC
Q 020981          127 KHGAKPL  133 (319)
Q Consensus       127 ~~g~~~~  133 (319)
                      +.|++..
T Consensus       214 ~~ga~~n  220 (273)
T 2pnn_A          214 ILGAKLH  220 (273)
T ss_dssp             HHHHHHC
T ss_pred             Hhhhhcc
Confidence            9987764

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.84  E-value=3.4e-21  Score=171.71  Aligned_cols=87  Identities=28%  Similarity=0.158  Sum_probs=49.7

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|||+.|+..++....+-..-.|.|+|..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        59 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  138 (351)
T 3utm_A           59 STPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVE  138 (351)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHH
Confidence            45555566555555555555555555555555666666666666666666666555555555555555555555555554


Q ss_pred             HHHHhhh
Q 020981           88 VVSLLLE   94 (319)
Q Consensus        88 ~v~~Ll~   94 (319)
                      ++++|++
T Consensus       139 ~v~~Ll~  145 (351)
T 3utm_A          139 VCSLLLS  145 (351)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            4444444

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.84  E-value=3.6e-21  Score=166.49  Aligned_cols=129  Identities=23%  Similarity=0.225  Sum_probs=122.0

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCC-CCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~   85 (319)
                      -.|+++.|++.++....+...-.|.++|.. +..|.||||+||..|+.+++++|+++|++++.+|.+|+||||+|+..|+
T Consensus         5 g~~~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~   84 (285)
T 1wdy_A            5 DNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGS   84 (285)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTC
T ss_pred             cchHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC
Confidence            357899999999988888888899999988 8899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCc
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~  135 (319)
                      .+++++|+++|++++..|..|.||+|+|+..++.+++++|++.|++....
T Consensus        85 ~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~  134 (285)
T 1wdy_A           85 VKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLR  134 (285)
T ss_dssp             HHHHHHHHHTTCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             HHHHHHHHHcCCCCCccCcccCCHHHHHHHhCCHHHHHHHHHhCCCcccc
Confidence            99999999999999999999999999999999999999999999876543

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.84  E-value=4.2e-21  Score=145.68  Aligned_cols=99  Identities=43%  Similarity=0.525  Sum_probs=94.2

Q ss_pred             CcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCccccccccc
Q 020981           39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN  118 (319)
Q Consensus        39 ~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~  118 (319)
                      +|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||+|+|+..++
T Consensus         1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~   80 (126)
T 1n0r_A            1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH   80 (126)
T ss_dssp             CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhCCCCCCccc
Q 020981          119 HEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus       119 ~~i~~~L~~~g~~~~~~~~  137 (319)
                      .+++++|++.|++....+.
T Consensus        81 ~~~~~~Ll~~g~~~~~~~~   99 (126)
T 1n0r_A           81 LEVVKLLLEAGADVNAKDK   99 (126)
T ss_dssp             HHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHHHHcCCCCcccCC
Confidence            9999999999887655443

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.84  E-value=1.1e-21  Score=159.69  Aligned_cols=105  Identities=33%  Similarity=0.316  Sum_probs=97.0

Q ss_pred             CCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCC-CCCCCCcccccc
Q 020981           37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIY  115 (319)
Q Consensus        37 ~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~-~~g~tpl~~a~~  115 (319)
                      +.+|.||||+||..|+.++++.|++ |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+| ..|+||||+|+.
T Consensus        41 ~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~  119 (183)
T 3deo_A           41 VSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG  119 (183)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHh
Confidence            4688999999999999999999999 99999999999999999999999999999999999999999 899999999999


Q ss_pred             cccHHHHHHHHhhCCCCCCcccccccc
Q 020981          116 YKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       116 ~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      .|+.+++++|++.|+++...+....++
T Consensus       120 ~~~~~~v~~Ll~~ga~~~~~d~~g~tp  146 (183)
T 3deo_A          120 YVRPEVVEALVELGADIEVEDERGLTA  146 (183)
T ss_dssp             TTCHHHHHHHHHHTCCTTCCCTTSCCH
T ss_pred             cCcHHHHHHHHHcCCCCcCCCCCCCCH
Confidence            999999999999998876555444433

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.84  E-value=2.1e-21  Score=175.58  Aligned_cols=124  Identities=23%  Similarity=0.240  Sum_probs=111.4

Q ss_pred             ccccccccccC---chhhhhhhhhcCCCCCC--------CCCCcchHHHHHHHcCCHHHHHHHHHcC-CCCcccCCCCCC
Q 020981            8 RTTLLKQSSLA---PDRERKEAELNGLDDDG--------EEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRT   75 (319)
Q Consensus         8 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~--------~~~~~~t~L~~a~~~~~~~~~~~Ll~~g-a~vn~~d~~g~t   75 (319)
                      .||++.|+..+   +....+...-.|.|+|.        .+..|.||||+||..|+.++|++|++.| +++|.+|.+|+|
T Consensus       236 ~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~T  315 (373)
T 2fo1_E          236 MTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKT  315 (373)
T ss_dssp             CCHHHHHHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCC
T ss_pred             CCHHHHHHHhCCcchHHHHHHHHHCCCCcccccccccCcccccCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCC
Confidence            57888888776   56666666667888876        6779999999999999999999999875 999999999999


Q ss_pred             HHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCC
Q 020981           76 ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (319)
Q Consensus        76 pLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~  131 (319)
                      |||+|+..|+.++|++|+++|++++.+|..|.||+++|+..|+.+++++|++.+++
T Consensus       316 pL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~t~l~~A~~~g~~~iv~~Ll~~~a~  371 (373)
T 2fo1_E          316 PIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPE  371 (373)
T ss_dssp             HHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHHHHTTCHHHHHHHHTTC--
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCccCCCCCCCCHHHHHHHcCCHHHHHHHHhcCcc
Confidence            99999999999999999999999999999999999999999999999999998765

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.84  E-value=1.6e-21  Score=154.36  Aligned_cols=108  Identities=23%  Similarity=0.226  Sum_probs=95.8

Q ss_pred             CCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCC-Ccc
Q 020981           33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST-PLG  111 (319)
Q Consensus        33 ~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t-pl~  111 (319)
                      .+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+ .|+.+++++|+++|++++.+|..|+| |||
T Consensus         5 ~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~   83 (156)
T 1bi7_B            5 AGSSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVH   83 (156)
T ss_dssp             -----CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHH
T ss_pred             ccCCCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHH
Confidence            3456778899999999999999999999999999999999999999986 99999999999999999999999999 999


Q ss_pred             cccccccHHHHHHHHhhCCCCCCccccccc
Q 020981          112 DAIYYKNHEVIKLLEKHGAKPLMAPMHVKH  141 (319)
Q Consensus       112 ~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~  141 (319)
                      +|+..|+.+++++|++.|++....+....+
T Consensus        84 ~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t  113 (156)
T 1bi7_B           84 DAAREGFLDTLVVLHRAGARLDVRDAWGRL  113 (156)
T ss_dssp             HHHHHTCHHHHHHHHHHTCCSSCCCTTCCC
T ss_pred             HHHHCCCHHHHHHHHHcCCCCcccCCCCCC
Confidence            999999999999999999887655544333

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.84  E-value=6e-21  Score=137.53  Aligned_cols=91  Identities=36%  Similarity=0.386  Sum_probs=87.7

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..++....+...-+|.|+|.+|..|.||||+|+..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+
T Consensus         3 ~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~   82 (93)
T 1n0q_A            3 RTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLE   82 (93)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHH
Confidence            58999999999988888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCc
Q 020981           88 VVSLLLERGAD   98 (319)
Q Consensus        88 ~v~~Ll~~g~~   98 (319)
                      ++++|+++||+
T Consensus        83 ~~~~Ll~~ga~   93 (93)
T 1n0q_A           83 VVKLLLEAGAY   93 (93)
T ss_dssp             HHHHHHHTTCC
T ss_pred             HHHHHHHcCCC
Confidence            99999999985

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.84  E-value=6.6e-21  Score=160.73  Aligned_cols=102  Identities=25%  Similarity=0.320  Sum_probs=96.7

Q ss_pred             CCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCccccc
Q 020981           35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI  114 (319)
Q Consensus        35 ~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~  114 (319)
                      ..+.+|.||||+||..|+.++++.|++.|+|+|.+|..|+||||+||..|+.+++++|+++|++++.+|..|+||||+|+
T Consensus        16 ~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~   95 (229)
T 2vge_A           16 RARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAA   95 (229)
T ss_dssp             CTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred             ccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence            45667889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccHHHHHHHHhhCCCCCCcc
Q 020981          115 YYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus       115 ~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      ..|+.+++++|++.|++.....
T Consensus        96 ~~g~~~~v~~Ll~~ga~~~~~~  117 (229)
T 2vge_A           96 SCNDTVICMALVQHGAAIFATT  117 (229)
T ss_dssp             HTTCHHHHHHHHTTTCCTTCCC
T ss_pred             HcCCHHHHHHHHHcCCCccccc
Confidence            9999999999999998876553

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.83  E-value=4.2e-21  Score=160.91  Aligned_cols=107  Identities=23%  Similarity=0.320  Sum_probs=98.7

Q ss_pred             CCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhC-CCcccCCCCCCCCCccccc
Q 020981           36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAI  114 (319)
Q Consensus        36 ~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~-g~~~~~~~~~g~tpl~~a~  114 (319)
                      .+..|.||||+||..|+.++++.|++.|+++|.+|..|+||||+||..|+.++|++|+++ |++++.+|..|+||||+|+
T Consensus        69 ~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~  148 (222)
T 3ehr_A           69 QAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAA  148 (222)
T ss_dssp             HEEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHH
T ss_pred             cccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHH
Confidence            355788999999999999999999999999999999999999999999999999999998 9999999999999999999


Q ss_pred             ccccHHHHHHHHhhCCCCCCcccccccc
Q 020981          115 YYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       115 ~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      ..|+.+++++|++.|++....+....++
T Consensus       149 ~~~~~~~v~~Ll~~ga~~~~~~~~g~t~  176 (222)
T 3ehr_A          149 WKGYADIVQLLLAKGARTDLRNIEKKLA  176 (222)
T ss_dssp             HHTCHHHHHHHHHHTCCSCCCCTTSCCH
T ss_pred             HcCCHHHHHHHHHcCCCCccccCCCCCH
Confidence            9999999999999999876655444443

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.83  E-value=5.1e-21  Score=173.09  Aligned_cols=128  Identities=24%  Similarity=0.227  Sum_probs=118.2

Q ss_pred             cccccccccccCchhhhhhhh--------hcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHH
Q 020981            7 VRTTLLKQSSLAPDRERKEAE--------LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALH   78 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh   78 (319)
                      -.|||+.|+..++....+...        -.|.|+|..|.+|.||||+||..|+.++|++|+++|+|+|.+|..|+||||
T Consensus       125 g~t~Lh~Aa~~g~~~~v~~Ll~~~~~~ll~~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~L~  204 (373)
T 2fo1_E          125 NRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALH  204 (373)
T ss_dssp             CCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHH
T ss_pred             CCCHHHHHHHCCCHHHHHHHHHHHHHHHHhcCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcccCCCCCCHHH
Confidence            358999999998876555543        579999999999999999999999999999999999999999999999999


Q ss_pred             HHHHcCCHHHHHHhhhCC---CcccCCCCCCCCCcccccccc---cHHHHHHHHhhCCCCCC
Q 020981           79 VAACQGFTEVVSLLLERG---ADVDPKDRWGSTPLGDAIYYK---NHEVIKLLEKHGAKPLM  134 (319)
Q Consensus        79 ~A~~~~~~~~v~~Ll~~g---~~~~~~~~~g~tpl~~a~~~~---~~~i~~~L~~~g~~~~~  134 (319)
                      +|+..|+.+++++|+++|   ++++..|..|.||||+|+..+   +.+++++|++.|++...
T Consensus       205 ~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~~g~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~  266 (373)
T 2fo1_E          205 QAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDY  266 (373)
T ss_dssp             HHHHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSC
T ss_pred             HHHHCCCHHHHHHHHhcCccccChhhcCCCCCCHHHHHHHhCCcchHHHHHHHHHCCCCccc
Confidence            999999999999999998   899999999999999999987   89999999999988754

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.83  E-value=2.7e-21  Score=144.91  Aligned_cols=105  Identities=30%  Similarity=0.297  Sum_probs=97.6

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      -.|+++.|+..++....+...-++.|+|..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus         9 g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~~~~   88 (115)
T 2l6b_A            9 GNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHH   88 (115)
T ss_dssp             SCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTTTCH
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHCCCH
Confidence            46899999999998888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhCCCcccCCCCCCCCCcc
Q 020981           87 EVVSLLLERGADVDPKDRWGSTPLG  111 (319)
Q Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~tpl~  111 (319)
                      +++++|+++|+++|.++..|.||-.
T Consensus        89 ~~~~~Ll~~ga~~n~~~~~~~~~~~  113 (115)
T 2l6b_A           89 EIVKLLDAKGADVNARSWGSSHHHH  113 (115)
T ss_dssp             HHHHHHHTTSSSHHHHSCCCC----
T ss_pred             HHHHHHHHcCCCCCcCCcccccccc
Confidence            9999999999999999999999853

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.83  E-value=1.2e-21  Score=166.96  Aligned_cols=104  Identities=34%  Similarity=0.326  Sum_probs=96.7

Q ss_pred             CCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCC-CCCCCCccccccc
Q 020981           38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYY  116 (319)
Q Consensus        38 ~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~-~~g~tpl~~a~~~  116 (319)
                      .+|.||||+||..|+.++++.|++ |+++|.+|..|+||||+||..|+.++|++|+++|++++.+| ..|+||||+|+..
T Consensus        43 ~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~  121 (244)
T 3ui2_A           43 SEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGY  121 (244)
T ss_dssp             HHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHT
T ss_pred             cCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHc
Confidence            578999999999999999999999 99999999999999999999999999999999999999999 8899999999999


Q ss_pred             ccHHHHHHHHhhCCCCCCcccccccc
Q 020981          117 KNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       117 ~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      |+.+++++|++.|+++...+....++
T Consensus       122 g~~~~v~~Ll~~ga~~~~~d~~g~t~  147 (244)
T 3ui2_A          122 VRPEVVEALVELGADIEVEDERGLTA  147 (244)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCCcH
Confidence            99999999999999887655444443

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.82  E-value=2.1e-20  Score=157.61  Aligned_cols=130  Identities=21%  Similarity=0.170  Sum_probs=121.1

Q ss_pred             cccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCC-CCCCHHHHHHHcCC
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGF   85 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~-~g~tpLh~A~~~~~   85 (319)
                      ..|+++.|++.++....+...-.|.|++..+.+|.||||+|+..|+.+++++|++.|++++..+. .|+||||+|+..|+
T Consensus         9 ~~~~l~~A~~~g~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~   88 (240)
T 3eu9_A            9 STWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGH   88 (240)
T ss_dssp             GGCCHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTC
T ss_pred             cchHHHHHHHcCChHHHHHHHHcCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCC
Confidence            35789999999998888888889999999999999999999999999999999999999986654 59999999999999


Q ss_pred             HHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      .+++++|++.|++++.+|..|.||+|+|+..++.+++++|++.+++.....
T Consensus        89 ~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~  139 (240)
T 3eu9_A           89 LSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMD  139 (240)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCccccC
Confidence            999999999999999999999999999999999999999999988765444

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.82  E-value=1.1e-20  Score=168.27  Aligned_cols=128  Identities=26%  Similarity=0.200  Sum_probs=88.2

Q ss_pred             ccccccccccCchhhhhhhhh-cCCCCCCCCCCcchHHHHHHHcCC----HHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Q 020981            8 RTTLLKQSSLAPDRERKEAEL-NGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAAC   82 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~L~~a~~~~~----~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~   82 (319)
                      .|||+.|+..++....+.+.- .|.|+|..+..|.|+||.++..+.    ..++++|+++|+|+|.+|.+|+||||+|+.
T Consensus       169 ~T~L~~A~~~g~~~~v~~LL~~~gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~  248 (337)
T 4g8k_A          169 ATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVE  248 (337)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHH
T ss_pred             CcHHHHHHHCCCHHHHHHHHhccCCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHH
Confidence            567777777777655555442 467777777777777776665433    346667777777777777777777777777


Q ss_pred             cCCHHHHHHhhhC-CCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCc
Q 020981           83 QGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (319)
Q Consensus        83 ~~~~~~v~~Ll~~-g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~  135 (319)
                      .|+.+++++|++. |++++.+|..|+||||+|+..|+.+++++|++.|+++...
T Consensus       249 ~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~  302 (337)
T 4g8k_A          249 KKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG  302 (337)
T ss_dssp             TTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC
T ss_pred             hhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence            7777777777763 6777777777777777777777777777777777665433

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.82  E-value=1.3e-20  Score=167.71  Aligned_cols=110  Identities=25%  Similarity=0.282  Sum_probs=99.4

Q ss_pred             hhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHc-CCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcc
Q 020981           21 RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV   99 (319)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~-ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~   99 (319)
                      ...+-+.-.|+|+|.++.+|.||||+||..|+.++++.|++. |+++|.+|.+|+||||+|+..|+.++|++|+++||++
T Consensus       220 ~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~  299 (337)
T 4g8k_A          220 AITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST  299 (337)
T ss_dssp             HHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSS
T ss_pred             HHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCC
Confidence            344555668999999999999999999999999999999985 8999999999999999999999999999999999998


Q ss_pred             cCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCc
Q 020981          100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (319)
Q Consensus       100 ~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~  135 (319)
                      |.+     +||++|+..++.+++++|+++|+++...
T Consensus       300 n~~-----~~L~~A~~~~~~~iv~~Ll~~GA~~d~~  330 (337)
T 4g8k_A          300 DCG-----DLVMTARRNYDHSLVKVLLSHGAKEDFH  330 (337)
T ss_dssp             TTC-----CHHHHHHHTTCHHHHHHHHHTTCCC---
T ss_pred             CCC-----CHHHHHHHcCCHHHHHHHHHCcCCCCCC
Confidence            765     5999999999999999999999987654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=5.5e-20  Score=157.88  Aligned_cols=138  Identities=20%  Similarity=0.204  Sum_probs=103.8

Q ss_pred             ccceeeeecceEEEEEE-----eceE--eEEEEecccccCC---------------------HHHHHHHHHHHHHHHhcC
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISD---------------------DDRVRAFRDELALLQKIR  208 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~--vAvK~l~~~~~~~---------------------~~~~~~~~~E~~~l~~l~  208 (319)
                      +.....||.|+||.||.     +|..  ||||+++......                     ......+.+|+.+++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            44567899999998873     5778  9999875432110                     112246788999999998


Q ss_pred             CCcc--cccceeEEeCCceEEEEeecCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEEcCCC
Q 020981          209 HPNV--VQFLGAVTQSSPMMIVTEYLPK-G----DLRAFLKRKGALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLE  280 (319)
Q Consensus       209 h~~i--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~~ivH~Dlk  280 (319)
                      |+++  +..++.    ...++||||+.+ |    +|.++...   .++..+..++.|++.||.||| +.+   |+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence            8764  333332    357899999942 3    67665432   234567889999999999999 898   9999999


Q ss_pred             CCCEEecCCCCEEEEecCcccccccC
Q 020981          281 PSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       281 ~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |+|||++.  .++|+|||+|.....+
T Consensus       199 p~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEETTST
T ss_pred             HHHEEEcC--cEEEEECcccccCCCc
Confidence            99999998  9999999999877554

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.81  E-value=4.2e-20  Score=155.78  Aligned_cols=124  Identities=24%  Similarity=0.208  Sum_probs=60.8

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCCCC-cchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIK-PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      ||++.|+..++....+...-++.+++..+.. |.||||+|+..|+.++++.|++.|++++.+|..|+||||+|+..|+.+
T Consensus        44 t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~  123 (240)
T 3eu9_A           44 TLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTS  123 (240)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCHHH
Confidence            4455555555544444444444444433322 455555555555555555555555555555555555555555555555


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCccccccccc-HHHHHHHHhhCCCC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKN-HEVIKLLEKHGAKP  132 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~-~~i~~~L~~~g~~~  132 (319)
                      ++++|+++|++++.+|..|.||+|+|+..+. .+++++|...+++.
T Consensus       124 ~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~  169 (240)
T 3eu9_A          124 IVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSV  169 (240)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCT
T ss_pred             HHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCc
Confidence            5555555555555555555555554443332 34444444444443

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.80  E-value=1.8e-20  Score=166.49  Aligned_cols=113  Identities=15%  Similarity=0.022  Sum_probs=101.8

Q ss_pred             CchhhhhhhhhcCCCCCC-CCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCC---HHHHHHhh
Q 020981           18 APDRERKEAELNGLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLL   93 (319)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~-~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~---~~~v~~Ll   93 (319)
                      ......+...-.|.|+|. .+.+|.||||+||..|+.++|++||++|||+|.+|.+|+||||+|+..|+   .++++.|+
T Consensus       108 ~~~~~~~~l~~~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll  187 (327)
T 1sw6_A          108 LLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL  187 (327)
T ss_dssp             HHHHHHHHCTTSCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHH
T ss_pred             hHHHHHHHHHhcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHH
Confidence            334444555557899999 89999999999999999999999999999999999999999999999999   78899999


Q ss_pred             hCC-CcccCCCCCCCCCcccccc----cccHHHHHHHHhhCC
Q 020981           94 ERG-ADVDPKDRWGSTPLGDAIY----YKNHEVIKLLEKHGA  130 (319)
Q Consensus        94 ~~g-~~~~~~~~~g~tpl~~a~~----~~~~~i~~~L~~~g~  130 (319)
                      +.+ ++++.+|..|+||||+|+.    .|+.+++++|++.+.
T Consensus       188 ~~~~~~~~~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~  229 (327)
T 1sw6_A          188 DYLYPCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILM  229 (327)
T ss_dssp             HHHGGGGGEECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHH
T ss_pred             HhhhccccCCCCCCCCHHHHHHHHccccccHHHHHHHHHHHH
Confidence            875 8899999999999999998    889999999998754

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.78  E-value=1.2e-19  Score=159.24  Aligned_cols=108  Identities=20%  Similarity=0.063  Sum_probs=93.0

Q ss_pred             cccccccccccc---CchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Q 020981            6 PVRTTLLKQSSL---APDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC   82 (319)
Q Consensus         6 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~   82 (319)
                      .-.|||+.|+..   ++....+-+.-+|.|+|..|.+|+||||+||..|+.+++++|+++|||+|.+|.+|+||||+|+.
T Consensus       189 ~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~  268 (301)
T 2b0o_E          189 PEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARK  268 (301)
T ss_dssp             CEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHHHHH
T ss_pred             CCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHH
Confidence            346899999986   66777777777899999999999999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccH
Q 020981           83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH  119 (319)
Q Consensus        83 ~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~  119 (319)
                      .|+.+++++|+++|++      .|.||||+|+.+|+.
T Consensus       269 ~~~~~iv~~Ll~~ga~------~g~tpLh~A~~~g~~  299 (301)
T 2b0o_E          269 KHHKECEELLEQAQAG------TFAFPLHVDYSWVIS  299 (301)
T ss_dssp             HTCHHHHHHHHHHHHH------TTSSCCC--------
T ss_pred             cCCHHHHHHHHHhcCC------CCCChhHHHHhcCCc
Confidence            9999999999999987      589999999988753

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.74  E-value=2e-18  Score=155.10  Aligned_cols=109  Identities=25%  Similarity=0.287  Sum_probs=97.1

Q ss_pred             CCCCCCcchHHHHHHHc-CCHHHHHHHHHcCCCCcccC--CCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCc
Q 020981           34 DGEEIKPEFRLMFLANE-RDVEGIKELLDSGIDVNFRD--IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL  110 (319)
Q Consensus        34 ~~~~~~~~t~L~~a~~~-~~~~~~~~Ll~~ga~vn~~d--~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl  110 (319)
                      +.....+.|+||+|+.. |+.++++.|+++|+|+|.+|  ..|+||||+|+..|+.++|++|+++|+++|.+|..|+|||
T Consensus       193 ~l~~~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpL  272 (368)
T 3jue_A          193 DLGSLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPL  272 (368)
T ss_dssp             ----CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred             ccccCCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence            34455678999999999 99999999999999999998  8999999999999999999999999999999999999999


Q ss_pred             ccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981          111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       111 ~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      |+|+..|+.+++++|++.|++....+....++
T Consensus       273 h~A~~~g~~~~v~~LL~~Gad~~~~d~~G~Tp  304 (368)
T 3jue_A          273 HHATILGHTGLACLFLKRGADLGARDSEGRDP  304 (368)
T ss_dssp             HHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             HHHHHcCcHHHHHHHHHCcCCCCCcCCCCCCH
Confidence            99999999999999999999876655444333

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.74  E-value=2.5e-18  Score=149.13  Aligned_cols=103  Identities=17%  Similarity=0.060  Sum_probs=93.6

Q ss_pred             cccccccccccc---CchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Q 020981            6 PVRTTLLKQSSL---APDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC   82 (319)
Q Consensus         6 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~   82 (319)
                      .-.|||+.|+..   ++....+-..-+|.|+|.+|.+|+||||+||..|+.+++++|+++|||+|.+|.+|+||||+|+.
T Consensus       168 ~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~  247 (278)
T 1dcq_A          168 PDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKR  247 (278)
T ss_dssp             TTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred             CCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCHHHHHHH
Confidence            457999999998   77778888888999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHhhhCCCcccCCCCCCCCCccccccc
Q 020981           83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY  116 (319)
Q Consensus        83 ~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~  116 (319)
                      .|+.+++++|+++|++        .+++|.+..+
T Consensus       248 ~~~~~~v~~Ll~~ga~--------~~~~~~~v~~  273 (278)
T 1dcq_A          248 LKHEHCEELLTQALSG--------RFNSHVHVEY  273 (278)
T ss_dssp             TTCHHHHHHHHHHHTT--------CCCSSCCCCC
T ss_pred             cCCHHHHHHHHHcCCC--------CCCcceeeec
Confidence            9999999999999984        4666666543

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.74  E-value=4.3e-20  Score=166.59  Aligned_cols=123  Identities=13%  Similarity=0.006  Sum_probs=104.4

Q ss_pred             cccccccccccCchhhhhhhhhcCCCC---CCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCC---cccCCCCCCHHHHH
Q 020981            7 VRTTLLKQSSLAPDRERKEAELNGLDD---DGEEIKPEFRLMFLANERDVEGIKELLDSGIDV---NFRDIDNRTALHVA   80 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~v---n~~d~~g~tpLh~A   80 (319)
                      ..|||+.|++.++....+...-+|.+.   +..+..|.||||+||..|+.++|++|+++|+|+   +..+.+ +||||+|
T Consensus        92 ~~T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~A  170 (376)
T 2aja_A           92 SEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLA  170 (376)
T ss_dssp             HHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHH
T ss_pred             cCCHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHH
Confidence            469999999999998888888777732   344567899999999999999999999999862   333333 9999999


Q ss_pred             HHcCCHHHHHHhhhCCCcccC--CCCCCCCCccccc-ccccHHHHHHHHhhCC
Q 020981           81 ACQGFTEVVSLLLERGADVDP--KDRWGSTPLGDAI-YYKNHEVIKLLEKHGA  130 (319)
Q Consensus        81 ~~~~~~~~v~~Ll~~g~~~~~--~~~~g~tpl~~a~-~~~~~~i~~~L~~~g~  130 (319)
                      |..|+.++|++|+++|++++.  .|..|.||||+|+ ..|+.+++++|++.|+
T Consensus       171 a~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~Aa~~~G~~eiv~~Ll~~ga  223 (376)
T 2aja_A          171 AENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPV  223 (376)
T ss_dssp             HHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHH
T ss_pred             HHCCCHHHHHHHHHcCCccchhccCCCCCCHHHHHHHHCCCHHHHHHHHhCCC
Confidence            999999999999999999988  8899999999999 9999999999998664

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E*

Probab=99.71  E-value=1.6e-17  Score=155.74  Aligned_cols=103  Identities=25%  Similarity=0.264  Sum_probs=94.4

Q ss_pred             cchHHHHHHHcCCHHHHHHHHHcCCCCccc------CCCCCCHHHHHHH---cCCHHHHHHhhhCCCcccCCCCCCCCCc
Q 020981           40 PEFRLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAAC---QGFTEVVSLLLERGADVDPKDRWGSTPL  110 (319)
Q Consensus        40 ~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~------d~~g~tpLh~A~~---~~~~~~v~~Ll~~g~~~~~~~~~g~tpl  110 (319)
                      ..+.||.|+..|+.+.++.||+.|+|+|.+      |..|+||||+||.   .|+.++|++|+++|+++|.+|..|+|||
T Consensus       132 ~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpL  211 (497)
T 3lvq_E          132 EPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTAL  211 (497)
T ss_dssp             CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHH
T ss_pred             cHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHH
Confidence            347899999999999999999999999988      8899999999976   9999999999999999999999999999


Q ss_pred             ccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981          111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       111 ~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      |+|+..|+.+++++|++.|+++...+....++
T Consensus       212 h~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp  243 (497)
T 3lvq_E          212 HYAALYNQPDCLKLLLKGRALVGTVNEAGETA  243 (497)
T ss_dssp             HHHTTTTCHHHHHHHHHTCCCCSCCCTTCCCH
T ss_pred             HHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence            99999999999999999999987665444433

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.69  E-value=2.8e-17  Score=122.07  Aligned_cols=85  Identities=25%  Similarity=0.316  Sum_probs=81.5

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|+++.|+..++....+...-.|.|+|..|..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        25 ~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~  104 (110)
T 2zgd_A           25 GKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISIDNGNED  104 (110)
T ss_dssp             HHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHH
T ss_pred             chHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHHHHHcCCHH
Confidence            57899999999988888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHh
Q 020981           88 VVSLL   92 (319)
Q Consensus        88 ~v~~L   92 (319)
                      ++++|
T Consensus       105 ~~~~L  109 (110)
T 2zgd_A          105 LAEIL  109 (110)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            99987

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.67  E-value=5.8e-19  Score=159.18  Aligned_cols=117  Identities=11%  Similarity=0.007  Sum_probs=104.8

Q ss_pred             ccccccccccCchhhhhhhhhcCCCC---CCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcc--cCCCCCCHHHHHH-
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDD---DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF--RDIDNRTALHVAA-   81 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~--~d~~g~tpLh~A~-   81 (319)
                      .|||+.|+..++....+-..-.|.|+   +..+.+ .||||+||..|+.++|++|+++|++++.  +|..|+||||+|| 
T Consensus       129 ~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~Aa~  207 (376)
T 2aja_A          129 YQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAV  207 (376)
T ss_dssp             HHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCHHHHHHH
Confidence            57999999999999999888888652   333333 8999999999999999999999999998  9999999999999 


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      ..|+.++|++|++.|++       |.||++.|+..|+.+++++|++.|++.
T Consensus       208 ~~G~~eiv~~Ll~~ga~-------~~taL~~Aa~~g~~evv~lL~~~ga~~  251 (376)
T 2aja_A          208 GRGHHNVINFLLDCPVM-------LAYAEIHEFEYGEKYVNPFIARHVNRL  251 (376)
T ss_dssp             TTCCHHHHHHHTTSHHH-------HHHHHHCTTTTTTTTHHHHHHHHHHHH
T ss_pred             HCCCHHHHHHHHhCCCc-------cchHHHHHHHCCCHHHHHHHHhcCccc
Confidence            99999999999998864       889999999999999999999988754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=5.3e-17  Score=145.47  Aligned_cols=138  Identities=17%  Similarity=0.104  Sum_probs=96.3

Q ss_pred             ccceeeeecceEEEEEE----eceEeEEEEecccccC--------------CH-H----HHHHHHHHHHHHHhcCCCccc
Q 020981          157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS--------------DD-D----RVRAFRDELALLQKIRHPNVV  213 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~--------------~~-~----~~~~~~~E~~~l~~l~h~~iv  213 (319)
                      |.....||.|+++.||.    .|+.||||+++.....              .. .    ..-....|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            66778999999999996    4789999987643211              00 0    011123466777776544432


Q ss_pred             ccceeEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC---
Q 020981          214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---  290 (319)
Q Consensus       214 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~---  290 (319)
                      ...-+..  ...++||||++|++|..+.      .......++.|++.+|.+||+++   ||||||||.|||++++|   
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSS
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcc
Confidence            2211111  2347999999988876542      22335678899999999999999   99999999999999877   


Q ss_pred             -------CEEEEecCccccccc
Q 020981          291 -------NLKVADFGVSKLLTV  305 (319)
Q Consensus       291 -------~~kl~DFgla~~~~~  305 (319)
                             .+.|+||+.+-....
T Consensus       246 d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEETTS
T ss_pred             cccccccceEEEEeCCcccCCC
Confidence                   389999998765443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=1.5e-11  Score=105.16  Aligned_cols=138  Identities=12%  Similarity=0.024  Sum_probs=99.4

Q ss_pred             ccceeeeecceEEEEE---EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEeec
Q 020981          157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      |......+.|+...+|   ..+..+++|.........   ...+.+|+.+++.+. +..++++++++......|+|||++
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            3333334444444444   346899999987532111   135778999999985 677889999888888999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------------
Q 020981          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------------------------------------------  270 (319)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~------------------------------------------  270 (319)
                      +|.+|.+.+.     +......++.+++.+|..||+..                                          
T Consensus        93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            9999876521     12233467889999999999811                                          


Q ss_pred             --------------CCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          271 --------------PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       271 --------------~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                                    +..++|+|++|.|||++..+.+.|+||+.+..
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                          12389999999999998765667999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.03  E-value=5.2e-10  Score=100.11  Aligned_cols=138  Identities=14%  Similarity=0.204  Sum_probs=95.8

Q ss_pred             eeeecceEEEEE---EeceEeEEEEec--ccccCCHHHHHHHHHHHHHHHhcC--CCcccccceeEEeC---CceEEEEe
Q 020981          161 VEITKGTFILAF---WRGIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQS---SPMMIVTE  230 (319)
Q Consensus       161 ~~ig~G~f~~v~---~~~~~vAvK~l~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~---~~~~lv~e  230 (319)
                      ..++.|.+..+|   ..+..+++|...  ....  ......+.+|..+++.+.  +..+++++..+.+.   ...|+|||
T Consensus        44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEcCCcccceEEEEEECCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            345555554444   346788888765  3211  112246778999999997  44578888877665   34899999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK----------------------------------------  270 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~----------------------------------------  270 (319)
                      |++|..+.+..  ...+++.....++.+++..|..||+..                                        
T Consensus       122 ~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (359)
T 3dxp_A          122 FVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS  199 (359)
T ss_dssp             CCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred             ecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence            99987774311  123677888889999999999999731                                        


Q ss_pred             ---------------CCCeEEcCCCCCCEEecCCCC--EEEEecCcccc
Q 020981          271 ---------------PVPIIHRDLEPSNILRDDSGN--LKVADFGVSKL  302 (319)
Q Consensus       271 ---------------~~~ivH~Dlk~~Nill~~~~~--~kl~DFgla~~  302 (319)
                                     +..++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                           234999999999999997753  68999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.02  E-value=2e-10  Score=97.78  Aligned_cols=115  Identities=20%  Similarity=0.162  Sum_probs=84.3

Q ss_pred             ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCc--ccccceeEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHH
Q 020981          175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA  252 (319)
Q Consensus       175 ~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  252 (319)
                      |..+++|......      ...+..|..+++.+.+.+  ++++++.....+..++||||++|.++.  ..   ..+   .
T Consensus        44 g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~---~  109 (264)
T 1nd4_A           44 RPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLA---P  109 (264)
T ss_dssp             SCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCC---H
T ss_pred             CCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCC---H
Confidence            4679999876431      134677999999886434  566888888777899999999998874  11   122   2


Q ss_pred             HHHHHHHHHHHHHHhhCC-------------------------------------------------------CCCeEEc
Q 020981          253 VRFALDIARGMNYLHENK-------------------------------------------------------PVPIIHR  277 (319)
Q Consensus       253 ~~~~~qi~~al~~lH~~~-------------------------------------------------------~~~ivH~  277 (319)
                      ..++.+++..|..||+..                                                       +..++|+
T Consensus       110 ~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Hg  189 (264)
T 1nd4_A          110 AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHG  189 (264)
T ss_dssp             HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECS
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECC
Confidence            256677778888888643                                                       1129999


Q ss_pred             CCCCCCEEecCCCCEEEEecCccccc
Q 020981          278 DLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       278 Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |++|.||+++.++.+.|+|||.+...
T Consensus       190 Dl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          190 DACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             SCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             CCCCCcEEEECCcEEEEEcchhcccC
Confidence            99999999987766779999998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.73  E-value=6.3e-08  Score=84.45  Aligned_cols=136  Identities=18%  Similarity=0.152  Sum_probs=98.3

Q ss_pred             eeeecceEEEEEEeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCc--ccccceeEEeCC---ceEEEEeecCC
Q 020981          161 VEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPN--VVQFLGAVTQSS---PMMIVTEYLPK  234 (319)
Q Consensus       161 ~~ig~G~f~~v~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~l~~~~~~~~---~~~lv~e~~~~  234 (319)
                      ..++.|....+|.-+..+++|....     ......+.+|..+++.+. +..  +++.+.......   ..|+||++++|
T Consensus        26 ~~~~~G~~n~v~~v~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEINRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEESTTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEECCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            3477888888887778899998642     234567889999999884 333  344444433332   35889999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------------
Q 020981          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK--------------------------------------------  270 (319)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--------------------------------------------  270 (319)
                      .++......  .++..+...++.|++..+..||+..                                            
T Consensus       101 ~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  178 (304)
T 3sg8_A          101 VPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR  178 (304)
T ss_dssp             EECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred             eECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence            888654332  3677777888888888888888621                                            


Q ss_pred             -----------CCCeEEcCCCCCCEEecC--CCCEEEEecCccccc
Q 020981          271 -----------PVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLL  303 (319)
Q Consensus       271 -----------~~~ivH~Dlk~~Nill~~--~~~~kl~DFgla~~~  303 (319)
                                 +..++|+|++|.||+++.  .+.+.|+||+.+...
T Consensus       179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                       123899999999999998  456789999988654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.58  E-value=7.1e-07  Score=77.87  Aligned_cols=137  Identities=19%  Similarity=0.154  Sum_probs=92.2

Q ss_pred             eeeeecceEEEEEEeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCC---cccccceeEE-eCCceEEEEeecCCC
Q 020981          160 SVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP---NVVQFLGAVT-QSSPMMIVTEYLPKG  235 (319)
Q Consensus       160 ~~~ig~G~f~~v~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~l~~~~~-~~~~~~lv~e~~~~g  235 (319)
                      ...++.|....+|.-+..+++|+-.     .......+.+|..+++.+.+.   .+++.+.+.. ..+..|++||+++|.
T Consensus        24 v~~l~~G~~n~v~~vg~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILVNGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEETTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEECCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            3446677766777768889999843     233456788999999999742   3556666653 345678999999988


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------------------
Q 020981          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN----------------------------------------------  269 (319)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~----------------------------------------------  269 (319)
                      .+....-  ..++......++.++...|..||+.                                              
T Consensus        99 ~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  176 (306)
T 3tdw_A           99 ILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF  176 (306)
T ss_dssp             ECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred             ECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence            7765321  1234444445555555555555532                                              


Q ss_pred             -----------CCCCeEEcCCCCCCEEecC---CCCE-EEEecCccccc
Q 020981          270 -----------KPVPIIHRDLEPSNILRDD---SGNL-KVADFGVSKLL  303 (319)
Q Consensus       270 -----------~~~~ivH~Dlk~~Nill~~---~~~~-kl~DFgla~~~  303 (319)
                                 .+..++|+|++|.||+++.   ++.+ .|+||+.+..-
T Consensus       177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                       1223799999999999997   4554 89999988654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.42  E-value=1.8e-06  Score=73.69  Aligned_cols=118  Identities=14%  Similarity=0.161  Sum_probs=87.7

Q ss_pred             ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHH
Q 020981          175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV  253 (319)
Q Consensus       175 ~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  253 (319)
                      +..+.+|.-..      .....+.+|...|+.+. +--+++++.++...+..|+|||+++|.++.+.....    .....
T Consensus        50 ~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~  119 (272)
T 4gkh_A           50 APELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGE  119 (272)
T ss_dssp             CCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHH
T ss_pred             CeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHH
Confidence            45788887542      23456788999999885 434778888888888999999999998887765432    22334


Q ss_pred             HHHHHHHHHHHHHhhCC-------------------------------------------------------CCCeEEcC
Q 020981          254 RFALDIARGMNYLHENK-------------------------------------------------------PVPIIHRD  278 (319)
Q Consensus       254 ~~~~qi~~al~~lH~~~-------------------------------------------------------~~~ivH~D  278 (319)
                      .+..++...|.-||+..                                                       +..++|+|
T Consensus       120 ~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGD  199 (272)
T 4gkh_A          120 NIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD  199 (272)
T ss_dssp             HHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSC
T ss_pred             HHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCC
Confidence            56677777777777532                                                       11289999


Q ss_pred             CCCCCEEecCCCCEEEEecCcccc
Q 020981          279 LEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       279 lk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      +.+.|||++..+.+-|+||+.+..
T Consensus       200 l~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          200 FSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCeEEEECCeEEEEEECccccc
Confidence            999999999877777999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.94  E-value=1.4e-05  Score=70.94  Aligned_cols=60  Identities=5%  Similarity=0.017  Sum_probs=38.7

Q ss_pred             ceEeEEEEecccc---cCCHHHHHHHHHHHHHHHhcC-C--CcccccceeEEeC---CceEEEEeecCCCCH
Q 020981          175 GIQVAVKKLGEEV---ISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQS---SPMMIVTEYLPKGDL  237 (319)
Q Consensus       175 ~~~vAvK~l~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~~iv~l~~~~~~~---~~~~lv~e~~~~g~L  237 (319)
                      +..+++|......   ...   ...+.+|..+++.+. +  -.+++++......   ...|++||+++|..+
T Consensus        52 ~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A           52 QQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             EEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred             CceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence            6678898765432   101   124567888888875 3  3467777776554   346899999987554

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.77  E-value=0.00062  Score=59.62  Aligned_cols=31  Identities=19%  Similarity=0.317  Sum_probs=27.4

Q ss_pred             CCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       272 ~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            3499999999999998888999999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.63  E-value=0.00012  Score=65.96  Aligned_cols=72  Identities=18%  Similarity=0.157  Sum_probs=41.9

Q ss_pred             eeeecceEEEEEE-----eceEeEEEEeccccc-CCH---HHHHHHHHHHHHHHhcCC--C-cccccceeEEeCCceEEE
Q 020981          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVI-SDD---DRVRAFRDELALLQKIRH--P-NVVQFLGAVTQSSPMMIV  228 (319)
Q Consensus       161 ~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-~iv~l~~~~~~~~~~~lv  228 (319)
                      ..+|.|..+.+|.     .++.+++|....... ..+   .....+..|..+++.+..  | .+++++.+  +....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            3567777766653     346899998653211 000   012345678888888742  3 34455543  34557899


Q ss_pred             EeecCC
Q 020981          229 TEYLPK  234 (319)
Q Consensus       229 ~e~~~~  234 (319)
                      ||++++
T Consensus       114 mE~l~g  119 (397)
T 2olc_A          114 MEDLSH  119 (397)
T ss_dssp             ECCCTT
T ss_pred             EEeCCC
Confidence            999976

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.49  E-value=0.00047  Score=60.04  Aligned_cols=72  Identities=19%  Similarity=0.105  Sum_probs=51.1

Q ss_pred             eeeeecceEEEEE---EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC---CCcccccceeEEeCCceEEEEeecC
Q 020981          160 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       160 ~~~ig~G~f~~v~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      ...++.|....+|   ..+..+.+|.....      ....+..|...|+.+.   ...+++.+.........++|||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3455666554444   24678889986532      1356788999998884   3567888888877788999999998


Q ss_pred             CCCH
Q 020981          234 KGDL  237 (319)
Q Consensus       234 ~g~L  237 (319)
                      +..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.43  E-value=0.00071  Score=61.43  Aligned_cols=30  Identities=23%  Similarity=0.288  Sum_probs=26.3

Q ss_pred             CeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       273 ~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      .++|+|++|.|||++.++ ++++||+.+..-
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            399999999999999876 999999887643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.88  E-value=0.013  Score=49.98  Aligned_cols=72  Identities=18%  Similarity=0.125  Sum_probs=45.7

Q ss_pred             cceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCC---cccccceeEEeCCceEEEEe
Q 020981          158 TNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP---NVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       158 ~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .....+|.|..+.+|.    +|+.+.+|+-.......   ...+..|...|+.+.-.   .+++.+...    .-+++||
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            3455677777666663    47899999865432221   23577899999988521   344555432    3478999


Q ss_pred             ecCCCC
Q 020981          231 YLPKGD  236 (319)
Q Consensus       231 ~~~~g~  236 (319)
                      |++++.
T Consensus        91 ~l~~~~   96 (288)
T 3f7w_A           91 WVDERP   96 (288)
T ss_dssp             CCCCCC
T ss_pred             eecccC
Confidence            987654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.83  E-value=0.0046  Score=53.24  Aligned_cols=29  Identities=24%  Similarity=0.290  Sum_probs=25.0

Q ss_pred             CeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       273 ~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      .++|+|+.|.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 6667889999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.76  E-value=0.0043  Score=54.23  Aligned_cols=32  Identities=31%  Similarity=0.444  Sum_probs=27.2

Q ss_pred             CCeEEcCCCCCCEEecCC----CCEEEEecCccccc
Q 020981          272 VPIIHRDLEPSNILRDDS----GNLKVADFGVSKLL  303 (319)
Q Consensus       272 ~~ivH~Dlk~~Nill~~~----~~~kl~DFgla~~~  303 (319)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            349999999999999874    67999999988643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.12  E-value=0.022  Score=50.80  Aligned_cols=119  Identities=21%  Similarity=0.289  Sum_probs=69.9

Q ss_pred             eEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEeecCCCCHH--------------HH
Q 020981          176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLR--------------AF  240 (319)
Q Consensus       176 ~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~--------------~~  240 (319)
                      ..+.+|+.... ..   ....+.+|..+++.+. +.-.+++++.+..    .+||||++|..|.              +.
T Consensus        83 ~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~  154 (379)
T 3feg_A           83 REVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATK  154 (379)
T ss_dssp             SEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHH
T ss_pred             CeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHH
Confidence            57888875321 11   1234557999988885 3333566665543    3899999875432              11


Q ss_pred             H---HHc-----CCCC--HHHHHHHHHHHHH-------------------HHHHHh----hC-CCCCeEEcCCCCCCEEe
Q 020981          241 L---KRK-----GALK--PSTAVRFALDIAR-------------------GMNYLH----EN-KPVPIIHRDLEPSNILR  286 (319)
Q Consensus       241 l---~~~-----~~~~--~~~~~~~~~qi~~-------------------al~~lH----~~-~~~~ivH~Dlk~~Nill  286 (319)
                      +   +.-     +...  +.++.+|..++-.                   .+++|.    .. .+..++|+|+.+.|||+
T Consensus       155 La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~  234 (379)
T 3feg_A          155 MAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILL  234 (379)
T ss_dssp             HHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEE
T ss_pred             HHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEE
Confidence            1   111     0111  3455555554422                   233332    21 23359999999999999


Q ss_pred             cCC----CCEEEEecCcccc
Q 020981          287 DDS----GNLKVADFGVSKL  302 (319)
Q Consensus       287 ~~~----~~~kl~DFgla~~  302 (319)
                      +.+    +.+.++||..|..
T Consensus       235 ~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          235 LSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             ESCC---CCEEECCCTTCEE
T ss_pred             cCCCCccCcEEEEecccCCc
Confidence            876    7899999998753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.30  E-value=0.033  Score=48.12  Aligned_cols=44  Identities=25%  Similarity=0.301  Sum_probs=31.5

Q ss_pred             HHHHHHHHhhC----CCCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          259 IARGMNYLHEN----KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       259 i~~al~~lH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      +...++++...    .+..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            33445555532    123499999999999999876668999987753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=92.04  E-value=0.14  Score=44.12  Aligned_cols=28  Identities=21%  Similarity=0.233  Sum_probs=24.5

Q ss_pred             CeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       273 ~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      .++|+|+++.|||++ + .+.|+||+.+..
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            489999999999999 4 899999987754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.98  E-value=0.59  Score=37.95  Aligned_cols=89  Identities=11%  Similarity=0.085  Sum_probs=62.8

Q ss_pred             CCCcccccceeEEeCCceEEEEeecCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEEcCCCCCCEE
Q 020981          208 RHPNVVQFLGAVTQSSPMMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMN-YLHENKPVPIIHRDLEPSNIL  285 (319)
Q Consensus       208 ~h~~iv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~qi~~al~-~lH~~~~~~ivH~Dlk~~Nil  285 (319)
                      .||++  --.+-..++.+.+.++.-+++ ++. .++   .++.....+++.+++.... +++.     -+|--+.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~---~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR---KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH---TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH---hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence            47777  233335666677666654333 333 333   3678888888888888776 5544     478899999999


Q ss_pred             ecCCCCEEEEecCcccccccCC
Q 020981          286 RDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       286 l~~~~~~kl~DFgla~~~~~~~  307 (319)
                      ++.++.++|.-.|+-..+.+-+
T Consensus       117 f~~~~~p~i~hRGi~~~lpP~e  138 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESLPPDE  138 (219)
T ss_dssp             ECTTCCEEESCCEETTTBSSCS
T ss_pred             EeCCCcEEEEEcCCcccCCCCC
Confidence            9999999999999877665443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=89.89  E-value=0.22  Score=43.44  Aligned_cols=30  Identities=20%  Similarity=0.427  Sum_probs=26.8

Q ss_pred             CeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       273 ~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            499999999999999888899999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.05  E-value=0.17  Score=44.68  Aligned_cols=28  Identities=32%  Similarity=0.536  Sum_probs=23.7

Q ss_pred             CeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          273 PIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       273 ~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      .++|+|+.+.|||++.++ +.|+||..|.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            489999999999998655 8999998765

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.13  E-value=0.42  Score=38.65  Aligned_cols=89  Identities=11%  Similarity=0.133  Sum_probs=62.8

Q ss_pred             CCCcccccceeEEeCCceEEEEeecCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe
Q 020981          208 RHPNVVQFLGAVTQSSPMMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR  286 (319)
Q Consensus       208 ~h~~iv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill  286 (319)
                      .||+++.. .+-...+.+.+.++.-+.+ ++.. ++   .++.....+++.+|+...+++++     -+|--+.|+||++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence            47888765 4455566666666643211 2222 22   36778888999999888866554     3788999999999


Q ss_pred             cCCCCEEEEecCcccccccC
Q 020981          287 DDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       287 ~~~~~~kl~DFgla~~~~~~  306 (319)
                      +.++.+++.-.|+-..+.+-
T Consensus       113 ~~~~~p~i~~RGik~~l~P~  132 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVDPL  132 (215)
T ss_dssp             CTTSCEEESCCEETTTBSCC
T ss_pred             cCCCCEEEEEccCccCCCCC
Confidence            99999999999987666544

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=88.04  E-value=0.54  Score=42.89  Aligned_cols=52  Identities=10%  Similarity=0.025  Sum_probs=31.5

Q ss_pred             eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcc-cccceeEEeCCceEEEEeecCCC
Q 020981          176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVTEYLPKG  235 (319)
Q Consensus       176 ~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~e~~~~g  235 (319)
                      ..+.+|+.......-    -...+|..+++.+...++ +++++.+.  +  .+|+||++|.
T Consensus       134 ~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          134 AKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             ceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            678888764321100    011468888888874444 56777653  2  3599999863

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=86.49  E-value=0.22  Score=45.11  Aligned_cols=51  Identities=12%  Similarity=0.161  Sum_probs=31.2

Q ss_pred             ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCc-ccccceeEEeCCceEEEEeecCC
Q 020981          175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSSPMMIVTEYLPK  234 (319)
Q Consensus       175 ~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~e~~~~  234 (319)
                      +..+.+|+....  ..   ...+..|..+++.+...+ .+++++.+..    .+|+||++|
T Consensus       105 ~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G  156 (429)
T 1nw1_A          105 PNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPS  156 (429)
T ss_dssp             CSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCE
T ss_pred             CceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCC
Confidence            367888887432  11   123446888888885333 3566665432    388999976

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	319
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-38
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-36
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-35
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-34
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-33
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-33
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-32
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-32
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-32
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-32
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-32
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-31
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-30
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-30
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-30
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-29
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-29
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-29
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-28
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-27
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-27
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-26
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-25
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-25
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-25
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-25
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-25
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-24
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-24
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-23
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	6e-23
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	1e-16
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	6e-15
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	5e-14
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	7e-13
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-12
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	9e-12
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-22
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-22
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-21
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-20
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	2e-20
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	3e-14
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	1e-09
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	2e-08
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	1e-07
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-20
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-19
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-18
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	3e-17
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	1e-11
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	8e-10
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	2e-06
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	0.002
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-17
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-16
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	1e-14
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	5e-11
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	5e-10
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	3e-07
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-14
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	2e-11
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-09
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	3e-06
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	2e-05
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	2e-13
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	6e-12
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	3e-10
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	3e-08
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	3e-13
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	2e-07
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	4e-07
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	8e-07
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	6e-13
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	1e-10
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	4e-08
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	6e-08
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	2e-04
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	1e-12
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-12
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-11
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	5e-08
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	7e-04
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	3e-12
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	3e-09
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	1e-05
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	0.001
d1dcqa1	154	d.211.1.1 (A:369-522) Pyk2-associated protein beta	5e-12
d1dcqa1	154	d.211.1.1 (A:369-522) Pyk2-associated protein beta	8e-06
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	8e-11
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	5e-09
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	1e-08
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	6e-10
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-09
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-08
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	1e-06
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-06
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-09
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-08
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	3e-08
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	9e-07
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	7e-05
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	9e-08
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	2e-05
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	5e-05
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	2e-07
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	9e-05
d1ycsb1	130	d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens)	6e-05
d1ycsb1	130	d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens)	0.004
d1bi7b_	125	d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma	3e-04
d1bi7b_	125	d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma	0.002

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (339), Expect = 6e-38
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 9/162 (5%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
           ++ DP +L F++  EI  G+F     A        VA+KK+       +++ +    E+ 
Sbjct: 9   FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
            LQK+RHPN +Q+ G   +     +V EY            K  L+            +G
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           + YLH +    +IHRD++  NIL  + G +K+ DFG + ++ 
Sbjct: 128 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 1e-36
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 12/170 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           ++EI   ++       I  G+F       W G  VAVK L     +     +AF++E+ +
Sbjct: 2   DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL-QAFKNEVGV 57

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
           L+K RH N++ F+G  T    + IVT++     L   L   +   +    +  A   A+G
Sbjct: 58  LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           M+YLH      IIHRDL+ +NI   +   +K+ DFG++ + +        
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 3e-36
 Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 16/167 (9%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
           + ++  EL       I KG F   +L  +RG +VAVK      I +D   +AF  E +++
Sbjct: 2   WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVM 54

Query: 205 QKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIAR 261
            ++RH N+VQ LG + +    + IVTEY+ KG L  +L+ +G   L     ++F+LD+  
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
            M YL  N     +HRDL   N+L  +    KV+DFG++K  +  +D
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-35
 Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 9/154 (5%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF    E+  G          +  G+ +A K +  E             EL +L +   P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +V F GA      + I  E++  G L   LK+ G +      + ++ + +G+ YL E  
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
              I+HRD++PSNIL +  G +K+ DFGVS  L 
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 3e-35
 Identities = 40/163 (24%), Positives = 76/163 (46%), Gaps = 12/163 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDEL 201
           ++ ++    DF     + KG F    LA  +     +A+K L +  +         R E+
Sbjct: 2   QWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
            +   +RHPN+++  G    ++ + ++ EY P G +   L++           +  ++A 
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
            ++Y H  +   +IHRD++P N+L   +G LK+ADFG S    
Sbjct: 118 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 157

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-34
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 13/167 (7%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +++P +  +    E+  G F     A  +   +  A K +  +    ++ +  +  E+ +
Sbjct: 7   DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDI 62

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
           L    HPN+V+ L A    + + I+ E+   G + A + + +  L  S            
Sbjct: 63  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
           +NYLH+NK   IIHRDL+  NIL    G++K+ADFGVS   T    R
Sbjct: 123 LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-34
 Identities = 53/174 (30%), Positives = 85/174 (48%), Gaps = 16/174 (9%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDEL 201
            E+E+    L       +  G F    + ++    +VAVK L +  +S D     F  E 
Sbjct: 6   DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS--TAVRFALDI 259
            L+++++H  +V+    VTQ  P+ I+TEY+  G L  FLK    +K +    +  A  I
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           A GM ++ E      IHRDL  +NIL  D+ + K+ADFG+++L+   E      
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-33
 Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 12/152 (7%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           EI +G+F            ++VA  +L +  ++  +R R F++E  +L+ ++HPN+V+F 
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVRFY 74

Query: 217 GA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
            +    V     +++VTE +  G L+ +LKR   +K      +   I +G+ +LH   P 
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133

Query: 273 PIIHRDLEPSNIL-RDDSGNLKVADFGVSKLL 303
           PIIHRDL+  NI     +G++K+ D G++ L 
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 6e-33
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 10/166 (6%)

Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P   D+     + +G +    LA  R     VAVK +  +     D     + E+ + + 
Sbjct: 2   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKM 59

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + H NVV+F G   + +   +  EY   G+L   ++    +    A RF   +  G+ YL
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           H      I HRD++P N+L D+  NLK++DFG++ +        L 
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-32
 Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 41/202 (20%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-------IQVAVKKLGEEVISDDDRVR 195
            ++E     L+F     +  G F   + A   G       IQVAVK L E+  +D     
Sbjct: 30  LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 85

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
           A   EL ++ ++  H N+V  LGA T S P+ ++ EY   GDL  +L+ K          
Sbjct: 86  ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145

Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
                          L     + FA  +A+GM +L        +HRDL   N+L      
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 202

Query: 292 LKVADFGVSKLLTVKEDRPLTC 313
           +K+ DFG+++ +    +  +  
Sbjct: 203 VKICDFGLARDIMSDSNYVVRG 224

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-32
 Identities = 37/174 (21%), Positives = 79/174 (45%), Gaps = 14/174 (8%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           D+     I  G++        +  G  +  K+L    +++ ++ +    E+ LL++++HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63

Query: 211 NVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMN 264
           N+V++   +    ++ + IV EY   GDL + + +    +  L     +R    +   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 265 YLHENKPV--PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             H        ++HRDL+P+N+  D   N+K+ DFG++++L            T
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 177

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-32
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 14/175 (8%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP +L F    E+  G F       WR    VA+K + E  +S+D+    F +E  ++ 
Sbjct: 1   IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
            + H  +VQ  G  T+  P+ I+TEY+  G L  +L + +   +    +    D+   M 
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           YL        +HRDL   N L +D G +KV+DFG+S+ +   E           R
Sbjct: 115 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 4e-32
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 15/170 (8%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRD 199
           +  +    L   + +E+  G F       +R     I VA+K L +   ++         
Sbjct: 2   KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 58

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E  ++ ++ +P +V+ +G V Q+  +M+V E    G L  FL  ++  +  S        
Sbjct: 59  EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
           ++ GM YL E      +HRDL   N+L  +    K++DFG+SK L   + 
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 5e-32
 Identities = 52/196 (26%), Positives = 78/196 (39%), Gaps = 36/196 (18%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEVISDDDRVR 195
            ++E   + L F     +  G F   + A           + VAVK L     +      
Sbjct: 16  HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK          
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
                    AL     + F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188

Query: 297 FGVSKLLTVKEDRPLT 312
           FG+++ +    +  + 
Sbjct: 189 FGLARDIKNDSNYVVK 204

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (295), Expect = 9e-32
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 16/177 (9%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
              ++E++  ++   +  ++  G +       W+   + VAVK L E    D   V  F 
Sbjct: 8   NYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFL 61

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFA 256
            E A++++I+HPN+VQ LG  T+  P  I+TE++  G+L  +L    +  +     +  A
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
             I+  M YL +      IHRDL   N L  ++  +KVADFG+S+L+T         
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 9e-32
 Identities = 38/162 (23%), Positives = 76/162 (46%), Gaps = 8/162 (4%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + +G+F   +LA       + A+K L +  I  +++V     E  ++ ++ HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
             V+          +     Y   G+L  ++++ G+   +    +  +I   + YLH   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK- 127

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
              IIHRDL+P NIL ++  ++++ DFG +K+L+ +  +   
Sbjct: 128 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-31
 Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 17/169 (10%)

Query: 162 EITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
            I KG F       WRG +VAVK       S ++R      E+     +RH N++ F+ A
Sbjct: 10  SIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV-- 272
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH       
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 273 ---PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
               I HRDL+  NIL   +G   +AD G++       D      +   
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 5e-31
 Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 14/175 (8%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F    L +W    +VA+K + E  +S++D    F +E  ++ 
Sbjct: 2   IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ +  L    T +   LD+  GM 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +   +    T      +
Sbjct: 116 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-30
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 5/146 (3%)

Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +G +     + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + P
Sbjct: 26  RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPP 84

Query: 225 MMIVTEYLPKGDLRAF-LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           M +VTE  P G L     K +G     T  R+A+ +A GM YL        IHRDL   N
Sbjct: 85  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARN 141

Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDR 309
           +L      +K+ DFG+ + L   +D 
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDH 167

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 3e-30
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 13/162 (8%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELA 202
           +D   L   +  E+  G F      +++       VAVK L  E  +D         E  
Sbjct: 3   LDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEAN 60

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K    +     ++ G
Sbjct: 61  VMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           M YL E+     +HRDL   N+L       K++DFG+SK L 
Sbjct: 120 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  114 bits (285), Expect = 4e-30
 Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 16/180 (8%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDE 200
           EID   +       I  G F        +      I VA+K L       + + R F  E
Sbjct: 22  EIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSE 77

Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDI 259
            +++ +  HPNV+   G VT+S+P+MI+TE++  G L +FL++  G       V     I
Sbjct: 78  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           A GM YL +      +HRDL   NIL + +   KV+DFG+S+ L      P        +
Sbjct: 138 AAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  114 bits (286), Expect = 6e-30
 Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 23/187 (12%)

Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISD 190
           P+ +KH   +  Y+I           E+  G F        R  G   A K +     SD
Sbjct: 16  PVEIKHDHVLDHYDIHE---------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66

Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKP 249
            +     R E+  +  +RHP +V    A    + M+++ E++  G+L   +      +  
Sbjct: 67  KET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
             AV +   + +G+ ++HEN     +H DL+P NI+     S  LK+ DFG++  L  K+
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180

Query: 308 DRPLTCQ 314
              +T  
Sbjct: 181 SVKVTTG 187

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  114 bits (286), Expect = 7e-30
 Identities = 31/160 (19%), Positives = 70/160 (43%), Gaps = 14/160 (8%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           E+  G F        +  G     K +      D       ++E++++ ++ HP ++   
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLH 92

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
            A      M+++ E+L  G+L   +  +   +  +  + +      G+ ++HE+    I+
Sbjct: 93  DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 149

Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           H D++P NI+     + ++K+ DFG++  L   E   +T 
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 189

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-29
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 9/169 (5%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRH 209
           DF     + KG+F    LA ++      A+K L ++V+  DD V     E  +L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           P +            +  V EYL  GDL   ++       S A  +A +I  G+ +LH  
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
               I++RDL+  NIL D  G++K+ADFG+ K   + + +  T   T  
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD 168

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-29
 Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 16/179 (8%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELA 202
            +EI    L      ++ +G F    +  W    +VA+K L    +S +     F  E  
Sbjct: 11  AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 64

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIA 260
           +++K+RH  +VQ    V++  P+ IVTEY+ KG L  FLK +    L+    V  A  IA
Sbjct: 65  VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            GM Y+        +HRDL  +NIL  ++   KVADFG+++L+   E           +
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 179

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-29
 Identities = 40/182 (21%), Positives = 83/182 (45%), Gaps = 17/182 (9%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFR 198
           +YEI    ++      I +G F       +       + VA+K    +  + D     F 
Sbjct: 1   DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFL 56

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF-LKRKGALKPSTAVRFAL 257
            E   +++  HP++V+ +G +T+ +P+ I+ E    G+LR+F   RK +L  ++ + +A 
Sbjct: 57  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
            ++  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +     
Sbjct: 116 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172

Query: 318 CR 319
            +
Sbjct: 173 IK 174

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-29
 Identities = 35/160 (21%), Positives = 73/160 (45%), Gaps = 12/160 (7%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I +G       A     G +VA++++    +    +     +E+ ++++ ++PN+V +L
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            +      + +V EYL  G L   +                +  + + +LH N+   +IH
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIH 139

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
           RD++  NIL    G++K+ DFG    +T ++ +  T   T
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  112 bits (282), Expect = 3e-29
 Identities = 36/157 (22%), Positives = 70/157 (44%), Gaps = 11/157 (7%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
           DF+    I +G F           G   A+K L ++ I          +E   L+L+   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
             P +V    A      +  + + +  GDL   L + G    +    +A +I  G+ ++H
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
                 +++RDL+P+NIL D+ G+++++D G++   +
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (275), Expect = 1e-28
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 13/160 (8%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G F   ILA  +     VA+K + ++ +  + +  +  +E+A+L KI+HPN+V   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALD 73

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                   + ++ + +  G+L   +  KG      A R    +   + YLH+     I+H
Sbjct: 74  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVH 130

Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           RDL+P N+L    D+   + ++DFG+SK+          C
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 170

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  109 bits (272), Expect = 2e-28
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 15/155 (9%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-H 209
            + +G          +    + AVK +              +   A   E+ +L+K+  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           PN++Q       ++   +V + + KG+L  +L  K  L      +    +   +  LH+ 
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
               I+HRDL+P NIL DD  N+K+ DFG S  L 
Sbjct: 130 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 8e-28
 Identities = 28/160 (17%), Positives = 63/160 (39%), Gaps = 15/160 (9%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           ++ +G F                 K +    +   D+V   + E+++L   RH N++   
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVL-VKKEISILNIARHRNILHLH 67

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
            +      ++++ E++   D+   +      L     V +   +   + +LH +    I 
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124

Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           H D+ P NI+     S  +K+ +FG ++ L   ++  L  
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (268), Expect = 1e-27
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 41/206 (19%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF----------ILAFWRGIQVAVKKLGEEVISDDDR 193
           ++   E   + +++    +I +G F          +L +     VAVK L EE  +  D 
Sbjct: 4   KLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADM 59

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------- 245
              F+ E AL+ +  +PN+V+ LG      PM ++ EY+  GDL  FL+           
Sbjct: 60  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
                            L  +  +  A  +A GM YL E K    +HRDL   N L  ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQD 315
             +K+ADFG+S+ +   +       D
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGND 202

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (265), Expect = 3e-27
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 8/148 (5%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G+F    L   R  G   A+K L +E++    +V    DE  +L  + HP +++  
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
           G    +  + ++ +Y+  G+L + L++        A  +A ++   + YLH      II+
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIY 127

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLT 304
           RDL+P NIL D +G++K+ DFG +K + 
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYVP 155

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 7e-27
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 31/189 (16%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRDEL 201
            +D +++ F +   I +G F   + A  +     +  A+K++  +  +  D  R F  EL
Sbjct: 6   VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 61

Query: 202 ALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------------- 244
            +L K+  HPN++  LGA      + +  EY P G+L  FL++                 
Sbjct: 62  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121

Query: 245 GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
             L     + FA D+ARGM+YL +      IHRDL   NIL  ++   K+ADFG+S+   
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE 178

Query: 305 VKEDRPLTC 313
           V   + +  
Sbjct: 179 VYVKKTMGR 187

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 2e-26
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 17/174 (9%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
           EI P  +       I  G F        +       + VA+K L       + +   F  
Sbjct: 3   EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLG 58

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD-LRAFLKRKGALKPSTAVRFALD 258
           E  ++ +  H N+++  G +++  PMMI+TEY+  G   +   ++ G       V     
Sbjct: 59  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           IA GM YL        +HRDL   NIL + +   KV+DFG+S++L    +   T
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 4e-26
 Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 15/186 (8%)

Query: 143 REVPEYEIDPHELDFTNSVEITKGTF---ILAFW-----RGIQVAVKKLGEEVISDDDRV 194
           + V    I P  L    +  I +G F             + I  AVK L    I+D   V
Sbjct: 15  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEV 72

Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLK-RKGALKPSTA 252
             F  E  +++   HPNV+  LG   +S    ++V  Y+  GDLR F++           
Sbjct: 73  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           + F L +A+GM +L   K    +HRDL   N + D+   +KVADFG+++ +  KE   + 
Sbjct: 133 IGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189

Query: 313 CQDTSC 318
            +  + 
Sbjct: 190 NKTGAK 195

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 5e-26
 Identities = 42/188 (22%), Positives = 89/188 (47%), Gaps = 27/188 (14%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  +   E+ +G+F        +G+       +VA+K + E   +       
Sbjct: 14  EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIE 69

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------A 246
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+              
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
              S  ++ A +IA GM YL+ N     +HRDL   N +  +   +K+ DFG+++ +   
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 307 EDRPLTCQ 314
           +      +
Sbjct: 187 DYYRKGGK 194

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-25
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 17/170 (10%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I +GTF     A  R  G +VA+KK+  E   +   + A R E+ +LQ ++H NVV  +
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 75

Query: 217 GAVTQSSP--------MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
                 +         + +V ++                  S   R    +  G+ Y+H 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135

Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           NK   I+HRD++ +N+L    G LK+ADFG+++  ++ ++          
Sbjct: 136 NK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-25
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 10/149 (6%)

Query: 163 ITKGTF---ILAFWR--GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215
           + +G F     A  +     VA+KK+  G    + D   R    E+ LLQ++ HPN++  
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
           L A    S + +V +++              L PS    + L   +G+ YLH++    I+
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WIL 122

Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           HRDL+P+N+L D++G LK+ADFG++K   
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFG 151

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-25
 Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 14/167 (8%)

Query: 156 DFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           +F     +  G F       W        I VA+K+L E   +     +   DE  ++  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 67

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + +P+V + LG    S+  +I         L    + K  +     + + + IA+GMNYL
Sbjct: 68  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
            + +   ++HRDL   N+L     ++K+ DFG++KLL  +E      
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  100 bits (250), Expect = 2e-25
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 12/157 (7%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G      LA        VAVK L  ++  D      FR E      + HP +V   
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 217 GAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
                 +P      IV EY+    LR  +  +G + P  A+    D  + +N+ H+N   
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG-- 131

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
            IIHRD++P+NI+   +  +KV DFG+++ +    + 
Sbjct: 132 -IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 3e-25
 Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 33/198 (16%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDR 193
           +  ++E     L       + +G F   I A   GI        VAVK L E     + R
Sbjct: 4   DASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRKG------- 245
                +   L+    H NVV  LGA T+   P+M++ E+   G+L  +L+ K        
Sbjct: 62  -ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120

Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
                     L     + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICD 177

Query: 297 FGVSKLLTVKEDRPLTCQ 314
           FG+++ +    D      
Sbjct: 178 FGLARDIYKDPDYVRKGD 195

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 3e-25
 Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 36/198 (18%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR---------GIQVAVKKLGEEVISDDDR 193
           P +E+    L       + +G F   +LA              +VAVK L  +    D  
Sbjct: 6   PRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 61

Query: 194 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------- 245
           +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  KG+LR +L+ +        
Sbjct: 62  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
                     L     V  A  +ARGM YL        IHRDL   N+L  +   +K+AD
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIAD 178

Query: 297 FGVSKLLTVKEDRPLTCQ 314
           FG+++ +   +    T  
Sbjct: 179 FGLARDIHHIDYYKKTTN 196

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 4e-25
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 8/159 (5%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
              +++RD++  N++ D  G++K+ DFG+ K        
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  100 bits (250), Expect = 7e-25
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 8/145 (5%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G+F   +L   +  G   A+K L ++ +    ++    +E  +LQ +  P +V+  
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            +   +S + +V EY+  G++ + L+R G      A  +A  I     YLH      +I+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164

Query: 277 RDLEPSNILRDDSGNLKVADFGVSK 301
           RDL+P N+L D  G ++V DFG +K
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK 189

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 2e-24
 Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 25/180 (13%)

Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F     A     G  VA+KK+           R    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRK 69

Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+      R + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+ L  D+  LK+ DFG +K L   E         
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 97.6 bits (242), Expect = 3e-24
 Identities = 41/156 (26%), Positives = 80/156 (51%), Gaps = 8/156 (5%)

Query: 162 EITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
           +I +GT+     A    G   A+KK+  E   +       R E+++L++++H N+V+   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYD 67

Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
            +     +++V E+L +   +     +G L+  TA  F L +  G+ Y H+ +   ++HR
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124

Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           DL+P N+L +  G LK+ADFG+++   +   +    
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 3e-24
 Identities = 41/175 (23%), Positives = 78/175 (44%), Gaps = 18/175 (10%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
           +++ P    +TN   I +G +     A+     ++VA+KK+           +    E+ 
Sbjct: 4   FDVGPR---YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58

Query: 203 LLQKIRHPNVVQFLGAV----TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           +L + RH N++     +     +    + +  +L   DL   LK +  L       F   
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
           I RG+ Y+H      ++HRDL+PSN+L + + +LK+ DFG++++     D     
Sbjct: 118 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.1 bits (241), Expect = 6e-24
 Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 15/164 (9%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDR---VRAFRDELALLQKIRHPNVV 213
           E+  G F        +  G+Q A K + +       R         E+++L++I+HPNV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
                    + ++++ E +  G+L  FL  K +L    A  F   I  G+ YLH      
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---Q 133

Query: 274 IIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTC 313
           I H DL+P NI+  D       +K+ DFG++  +    +     
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.9 bits (238), Expect = 1e-23
 Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 15/155 (9%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIR--HPN 211
            +  G F            + VA+K + ++ ISD   +        E+ LL+K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 212 VVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
           V++ L    +    +++ E   P  DL  F+  +GAL+   A  F   +   + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130

Query: 271 PVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLT 304
              ++HRD++  NIL D + G LK+ DFG   LL 
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFGSGALLK 162

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.8 bits (237), Expect = 6e-23
 Identities = 36/145 (24%), Positives = 57/145 (39%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   +    +  +K LL  G   N  ++   T LH+AA  G TEV   LL+  A V+ K 
Sbjct: 4   LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEI 163
           +   TPL  A    +  ++KLL ++ A P +A         +   E     +      E 
Sbjct: 64  KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEA 123

Query: 164 TKGTFILAFWRGIQVAVKKLGEEVI 188
           ++       +  + VA K     V 
Sbjct: 124 SQACMTKKGFTPLHVAAKYGKVRVA 148

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.7 bits (190), Expect = 1e-16
 Identities = 33/119 (27%), Positives = 53/119 (44%)

Query: 29  NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
           +G+  D         L   ++  +++ +K LL    DVN +     + LH AA QG T++
Sbjct: 286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDI 345

Query: 89  VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPE 147
           V+LLL+ GA  +     G+TPL  A       V  +L+    +     +  KH    PE
Sbjct: 346 VTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPE 404

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.3 bits (176), Expect = 6e-15
 Identities = 35/152 (23%), Positives = 56/152 (36%), Gaps = 12/152 (7%)

Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK--- 131
           T LHVA+  G   +V  LL+RGA  +  +    TPL  A    + EV K L ++ AK   
Sbjct: 2   TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNA 61

Query: 132 -------PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
                  PL     + H   + +  ++ +  +   +         +A   G    V  L 
Sbjct: 62  KAKDDQTPLHCAARIGH-TNMVKLLLE-NNANPNLATTAGHTPLHIAAREGHVETVLALL 119

Query: 185 EEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           E+  S     +     L +  K     V + L
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELL 151

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.0 bits (170), Expect = 5e-14
 Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 17/217 (7%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           +    +    +G        L   A +  VE  + LL  G   N   +   T LH+AA +
Sbjct: 187 RGGSPHSPAWNGY-----TPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQE 241

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PL 133
           G  E+V+LLL + A+ +  ++ G TPL       +  V  +L KHG            PL
Sbjct: 242 GHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPL 301

Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 193
               H  + + V        +++    +  +      A  +G    V  L +   S ++ 
Sbjct: 302 HVASHYGNIKLVKFLLQHQADVNAKTKLGYS--PLHQAAQQGHTDIVTLLLKNGASPNEV 359

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
                  LA+ +++ + +V   L  VT  +  ++V++
Sbjct: 360 SSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 396

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.2 bits (160), Expect = 7e-13
 Identities = 41/182 (22%), Positives = 55/182 (30%), Gaps = 12/182 (6%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    V   + LL+     N    +  T LHVA      ++V LLL RG       
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195

Query: 104 RWGSTPLGDAIYYKNHEVIKLL----------EKHGAKPLMAPMHVKHAREVPEYEIDPH 153
             G TPL  A      EV + L             G  PL       HA  V        
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQA 255

Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
             +  N   +T     L    G       L +  +  D   R     L +     +  +V
Sbjct: 256 NGNLGNKSGLT--PLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLV 313

Query: 214 QF 215
           +F
Sbjct: 314 KF 315

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.4 bits (158), Expect = 2e-12
 Identities = 36/143 (25%), Positives = 47/143 (32%), Gaps = 38/143 (26%)

Query: 23  RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
           ++ A  N  +   E       L   A     E  K LL +   VN +  D++T LH AA 
Sbjct: 21  QRGASPNVSNVKVETP-----LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAAR 75

Query: 83  QGFTEVVSLLLER---------------------------------GADVDPKDRWGSTP 109
            G T +V LLLE                                   A      + G TP
Sbjct: 76  IGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP 135

Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
           L  A  Y    V +LL +  A P
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHP 158

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.1 bits (152), Expect = 9e-12
 Identities = 40/164 (24%), Positives = 63/164 (38%), Gaps = 8/164 (4%)

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           +             T LHVAA  G   V  LLLER A  +   + G TPL  A+++ N +
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLD 179

Query: 121 VIKLLEKHGAKPL------MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGT--FILAF 172
           ++KLL   G  P         P+H+   +   E      +   + + E  +G     LA 
Sbjct: 180 IVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAA 239

Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
             G    V  L  +  + +   ++    L L+ +  H  V   L
Sbjct: 240 QEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 283

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 3e-22
 Identities = 38/153 (24%), Positives = 75/153 (49%), Gaps = 9/153 (5%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I +GT+     A  R     VA+K++  +   +     A R E+ LL++++H N+V+  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLH 67

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +     + +V E+  +   + F    G L P     F   + +G+ + H      ++H
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
           RDL+P N+L + +G LK+A+FG+++   +    
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 3e-22
 Identities = 38/166 (22%), Positives = 65/166 (39%), Gaps = 24/166 (14%)

Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
           +  G     +  F +    + A+K L        D  +A R+     +  + P++V+ + 
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72

Query: 218 A----VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKP 271
                      ++IV E L  G+L + ++ +G  A     A      I   + YLH    
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 131

Query: 272 VPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKEDRPLTCQ 314
             I HRD++P N+L      +  LK+ DFG +K  T        C 
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 1e-21
 Identities = 39/164 (23%), Positives = 80/164 (48%), Gaps = 10/164 (6%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+     A  +  G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN 269
           N+V+ L  +   + + +V E+L +   +         +       +   + +G+ + H +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
               ++HRDL+P N+L +  G +K+ADFG+++   V        
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.9 bits (222), Expect = 4e-21
 Identities = 36/157 (22%), Positives = 65/157 (41%), Gaps = 5/157 (3%)

Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH-PNVVQFLGAVTQS 222
               I     G   A+K L +  I    +     R E  +L+ IR  P +V    A    
Sbjct: 42  LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101

Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + + ++ +Y+  G+L   L ++          +  +I   + +LH+     II+RD++  
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 158

Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           NIL D +G++ + DFG+SK     E         +  
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 88.4 bits (218), Expect = 8e-21
 Identities = 28/152 (18%), Positives = 53/152 (34%), Gaps = 17/152 (11%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I  G+F    L      G +VA+K     +     +      E  + + ++    +  +
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 217 GAV-TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
                +    ++V E L       F          T +  A  +   + Y+H       I
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 125

Query: 276 HRDLEPSNILRDDSG---NLKVADFGVSKLLT 304
           HRD++P N L         + + DFG++K   
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.0 bits (217), Expect = 2e-20
 Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 21/169 (12%)

Query: 148 YEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
            E+     +        +    G +     A     G +VA+KKL     S+    RA+R
Sbjct: 7   QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEYLPKGDLRAFLKRKGALKPSTA 252
            EL LL+ +RH NV+  L   T    +       +V  ++  G     L +   L     
Sbjct: 67  -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
                 + +G+ Y+H       IHRDL+P N+  ++   LK+ DFG+++
Sbjct: 124 QFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR 169

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.9 bits (214), Expect = 2e-20
 Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 2/112 (1%)

Query: 22  ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
           +   A++N  D+ G         +   +         LLD G DVN R    +T L +A 
Sbjct: 169 DEMGADVNACDNMGRNALIHAL-LSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227

Query: 82  CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +    +V  LLE+   +++  D  G T L  A+  K  ++ +LL K GA  
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.2 bits (168), Expect = 3e-14
 Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 6/79 (7%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
           A++N   + G+       L+    ++ +  ++ LL+   I++N  D D +TAL +A    
Sbjct: 210 ADVNVRGERGKTP-----LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264

Query: 85  FTEVVSLLLERGADVDPKD 103
             ++  LL +RGA  D  D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (134), Expect = 1e-09
 Identities = 20/72 (27%), Positives = 39/72 (54%), Gaps = 1/72 (1%)

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHG 129
           +++   L  A      ++V  LLE GA+V+ ++   G TPL +A+     ++++LL +HG
Sbjct: 3   VEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHG 62

Query: 130 AKPLMAPMHVKH 141
           A P++   +   
Sbjct: 63  ADPVLRKKNGAT 74

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (125), Expect = 2e-08
 Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 1/96 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
           L+      DV+ +++LL+ G +VNF++ +   T LH A      ++V LLL  GAD   +
Sbjct: 9   LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
            + G+TP   A    + +++KL    GA       +
Sbjct: 69  KKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFY 104

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (117), Expect = 1e-07
 Identities = 24/72 (33%), Positives = 31/72 (43%), Gaps = 5/72 (6%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----E 120
                    TAL  AA +G  EV+ +LL E GADV+  D  G   L  A+   +      
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200

Query: 121 VIKLLEKHGAKP 132
           +  LL  HGA  
Sbjct: 201 ITHLLLDHGADV 212

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 4e-20
 Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 17/166 (10%)

Query: 162 EITKGTF---ILAFWR---GIQVAVKKLGEEVISDDDRVRAFR--DELALLQKIRHPNVV 213
           EI +G +     A      G  VA+K++  +   +   +   R    L  L+   HPNVV
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 214 QFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLH 267
           +     T S       + +V E++ +       K     +   T       + RG+++LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
            ++   ++HRDL+P NIL   SG +K+ADFG++++ + +       
Sbjct: 134 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 176

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 84.5 bits (208), Expect = 3e-19
 Identities = 34/192 (17%), Positives = 79/192 (41%), Gaps = 27/192 (14%)

Query: 137 MHVKHAREVPEYEIDPHELDFTNS------VEITKGTF---ILAFWR--GIQVAVKKLGE 185
             V   R    ++ + H +++ N        ++ +G +     A       +V VK L  
Sbjct: 11  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-- 68

Query: 186 EVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLK 242
                  + +  + E+ +L+ +R  PN++     V    S    +V E++   D +   +
Sbjct: 69  ----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSK 301
               L       +  +I + ++Y H      I+HRD++P N++ D +   L++ D+G+++
Sbjct: 125 T---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178

Query: 302 LLTVKEDRPLTC 313
                ++  +  
Sbjct: 179 FYHPGQEYNVRV 190

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 79.9 bits (196), Expect = 9e-18
 Identities = 30/166 (18%), Positives = 53/166 (31%), Gaps = 17/166 (10%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            I +G+F             QVA+K       SD  ++R       LL        V + 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
           G   +    ++V + L                  T    A  +   +  +HE     +++
Sbjct: 70  G--QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 124

Query: 277 RDLEPSNIL-----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           RD++P N L       ++  + V DFG+ K       +        
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 78.2 bits (191), Expect = 3e-17
 Identities = 18/65 (27%), Positives = 35/65 (53%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G + + +D D +T + +AA +G  EVV  L+++GA V+  D    T    A    +H ++
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270

Query: 123 KLLEK 127
            + ++
Sbjct: 271 DIFDR 275

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 62.1 bits (149), Expect = 1e-11
 Identities = 28/110 (25%), Positives = 39/110 (35%), Gaps = 10/110 (9%)

Query: 41  EFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLL------ 93
           E  +           I E +     VN  D   NRT LH  A     E    L+      
Sbjct: 1   ESPIKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKE 59

Query: 94  --ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
               GADV+  D   +TPL  A+  +   ++  L K GA P +     + 
Sbjct: 60  CIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERS 109

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 56.3 bits (134), Expect = 8e-10
 Identities = 12/51 (23%), Positives = 20/51 (39%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
           +M  A E  +E +  L+  G  V   D  + TA  +A       +V +   
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDR 275

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 45.9 bits (107), Expect = 2e-06
 Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 1/71 (1%)

Query: 63  GIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
               +      RTALH AA       V  L+ E+G++ D +D  G TP+  A      EV
Sbjct: 177 AARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEV 236

Query: 122 IKLLEKHGAKP 132
           +  L + GA  
Sbjct: 237 VMYLIQQGASV 247

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 37.4 bits (85), Expect = 0.002
 Identities = 18/88 (20%), Positives = 35/88 (39%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
              KE + +G DVN  D D  T L +A       +V+ L++ GAD    ++   + L  A
Sbjct: 55  HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 114

Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
              ++  ++  +              ++
Sbjct: 115 AANRDFGMMVYMLNSTKLKGDIEELDRN 142

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.4 bits (192), Expect = 4e-17
 Identities = 43/148 (29%), Positives = 66/148 (44%), Gaps = 13/148 (8%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G +     AF    G++VAVKKL     S     R +R EL LL+ ++H NV+  L
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83

Query: 217 GAVTQSSPMMIVTEYL----PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
              T +  +    +        G     + +   L           I RG+ Y+H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVS 300
            IIHRDL+PSN+  ++   LK+ DFG++
Sbjct: 142 -IIHRDLKPSNLAVNEDCELKILDFGLA 168

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.8 bits (185), Expect = 4e-16
 Identities = 38/152 (25%), Positives = 60/152 (39%), Gaps = 18/152 (11%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            I  G       A+       VA+KKL     +     RA+R EL L++ + H N++  L
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLL 82

Query: 217 GAVTQSSPMM------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
              T    +       +V E +     +                    +  G+ +LH   
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSA- 138

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
              IIHRDL+PSNI+      LK+ DFG+++ 
Sbjct: 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLART 168

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 70.9 bits (172), Expect = 1e-14
 Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 4/88 (4%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A +   E +K L+ +  DVN +D D  T LH AA  G  E   +L+E   D++  +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
           + G T         + +++  LE+   K
Sbjct: 263 KVGQTAF----DVADEDILGYLEELQKK 286

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 60.1 bits (144), Expect = 5e-11
 Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 9/115 (7%)

Query: 48  ANERDVEGIKELLDSGIDVNFR---------DIDNRTALHVAACQGFTEVVSLLLERGAD 98
           A ++  E +K  + S  D+              D+      A   G TE V  LLERGAD
Sbjct: 6   AKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD 65

Query: 99  VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPH 153
           ++  +  G T L  A    N +++K L ++GA                       
Sbjct: 66  INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD 120

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 57.0 bits (136), Expect = 5e-10
 Identities = 26/74 (35%), Positives = 39/74 (52%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
           L    I+         TALHVAA +G+TEV+ LL++   DV+ KD  G TPL  A ++  
Sbjct: 185 LNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGK 244

Query: 119 HEVIKLLEKHGAKP 132
            E  ++L ++    
Sbjct: 245 EEACRILVENLCDM 258

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 48.9 bits (115), Expect = 3e-07
 Identities = 34/175 (19%), Positives = 65/175 (37%), Gaps = 2/175 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
            +   +  D E +  LL+ G D+N+ ++D  TALH A      ++V  L+E GA+++  D
Sbjct: 44  FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHAREVPEYEIDPHELDFTNSV 161
             G  PL  A      ++ + L   GA                  E   +  + +     
Sbjct: 104 NEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQG 163

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
              +          ++ A + L    I+D    ++    L +     +  V++ L
Sbjct: 164 VDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLL 218

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 71.1 bits (173), Expect = 1e-14
 Identities = 15/82 (18%), Positives = 25/82 (30%), Gaps = 2/82 (2%)

Query: 53  VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR--WGSTPL 110
           ++ +  LL S   V     +N  A  +AA  G   V++ L E                  
Sbjct: 106 LDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAF 165

Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
             A    +  V+  L +     
Sbjct: 166 RLAAENGHLHVLNRLCELAPTE 187

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 61.4 bits (148), Expect = 2e-11
 Identities = 13/83 (15%), Positives = 22/83 (26%), Gaps = 3/83 (3%)

Query: 51  RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVDPKDRWGS 107
                 +       D + + I +     VAA  G     + + LLL     V        
Sbjct: 68  YYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENY 127

Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
                A    +  V+  L +   
Sbjct: 128 QAFRLAAENGHLHVLNRLCELAP 150

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 56.1 bits (134), Expect = 1e-09
 Identities = 27/166 (16%), Positives = 48/166 (28%), Gaps = 13/166 (7%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID--NRTALHVAA 81
            +  +  +  +  +          A    +  +  L +         I   N  A  +AA
Sbjct: 115 SDEIVKVIQAENYQA-----FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAA 169

Query: 82  CQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
             G   V++ L E          +          A+   +H VI  L         A + 
Sbjct: 170 ENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEI- 228

Query: 139 VKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
             H  E  E  ++P      N ++     F L+   G+   V K  
Sbjct: 229 --HEFEYGEKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSE 272

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 46.0 bits (108), Expect = 3e-06
 Identities = 10/77 (12%), Positives = 20/77 (25%), Gaps = 7/77 (9%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-----GST 108
           +G+ +L+        +       L     +   + +  LL                  + 
Sbjct: 262 DGVFDLVTK--SECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319

Query: 109 PLGDAIYYKNHEVIKLL 125
            L  A+   N     LL
Sbjct: 320 LLRLALRLGNQGACALL 336

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 43.3 bits (101), Expect = 2e-05
 Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 5/56 (8%)

Query: 44  LMFLANERDVEGIKELLDSG-----IDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
           L+   +E  ++ I+ LL                D    L +A   G     +LLL 
Sbjct: 283 LIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLS 338

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 67.0 bits (162), Expect = 2e-13
 Identities = 24/65 (36%), Positives = 31/65 (47%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
                  RT LH+A       V+ LLL+ GAD   +   G TPLG A+   N  + +LL 
Sbjct: 186 KPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLR 245

Query: 127 KHGAK 131
            HGA 
Sbjct: 246 AHGAP 250

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 62.4 bits (150), Expect = 6e-12
 Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 1/59 (1%)

Query: 45  MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
                 +    ++ LL +G D   R    RT L  A  +    +  LL   GA  +P+D
Sbjct: 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 57.8 bits (138), Expect = 3e-10
 Identities = 19/78 (24%), Positives = 28/78 (35%), Gaps = 3/78 (3%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGAD---VDPKDRWGSTPLGDAIYYKNHEVIK 123
            +   D  TALH+A        +  LL   A    +D ++  G T L  A        ++
Sbjct: 3   GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE 62

Query: 124 LLEKHGAKPLMAPMHVKH 141
            L   GA  L+A      
Sbjct: 63  KLYAAGAGVLVAERGGHT 80

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 51.6 bits (122), Expect = 3e-08
 Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)

Query: 28  LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
              + +DG+       L      +    +  LL        ++ ++   +TALH+AA  G
Sbjct: 2   FGYVTEDGDTA-----LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               V  L   GA V   +R G T L  A   + H    +L +     
Sbjct: 57  EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 65.6 bits (158), Expect = 3e-13
 Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 5/104 (4%)

Query: 23  RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
             +A++N  D+ G+       L + A   + E +  LL    + + +D  + T L +AA 
Sbjct: 111 TADADINAADNSGKTA-----LHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAR 165

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
           +G  E    LL+  A+ +  D     P   A    +H++++LL+
Sbjct: 166 EGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLLD 209

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 48.6 bits (114), Expect = 2e-07
 Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 1/56 (1%)

Query: 87  EVVSLLLERGADVDPK-DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
           +V+S LL +GA+++   D+ G T L  A  +   +  K L   GA         + 
Sbjct: 3   QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRT 58

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.9 bits (112), Expect = 4e-07
 Identities = 26/76 (34%), Positives = 39/76 (51%)

Query: 57  KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
           ++L+ +  D+N  D   +TALH AA    TE V++LL   A+ D +D    TPL  A   
Sbjct: 107 EDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAARE 166

Query: 117 KNHEVIKLLEKHGAKP 132
            ++E  K L  + A  
Sbjct: 167 GSYEASKALLDNFANR 182

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.7 bits (109), Expect = 8e-07
 Identities = 12/40 (30%), Positives = 19/40 (47%), Gaps = 1/40 (2%)

Query: 54 EGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLL 92
          + I +LL  G ++N   D    T+LH+AA     +    L
Sbjct: 3  QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 65.8 bits (159), Expect = 6e-13
 Identities = 16/58 (27%), Positives = 28/58 (48%)

Query: 53  VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           +E +         +N +D +  T L++AA  G   +V  LL+ GAD    ++ G  P+
Sbjct: 239 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 59.3 bits (142), Expect = 1e-10
 Identities = 19/129 (14%), Positives = 45/129 (34%), Gaps = 2/129 (1%)

Query: 2   ETKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD 61
           E K+ +   L +               +  + + E      +   ++ +  ++ + +   
Sbjct: 34  EQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFP 93

Query: 62  -SGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
            + +++N   D    T LH        E+V  L++ G++    D  G + L  A+   N+
Sbjct: 94  NTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNN 153

Query: 120 EVIKLLEKH 128
                 E  
Sbjct: 154 YDSGTFEAL 162

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 51.6 bits (122), Expect = 4e-08
 Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 3/77 (3%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER---GADVDPKDRWGSTPLGDAIY 115
           +      +     +  +  +    +    ++  L  +      ++ +D  G T L  A  
Sbjct: 209 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 268

Query: 116 YKNHEVIKLLEKHGAKP 132
             N  ++  L  +GA P
Sbjct: 269 LGNISIVDALLDYGADP 285

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 50.8 bits (120), Expect = 6e-08
 Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 5/132 (3%)

Query: 6   PVRTT---LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
           P+ T    L      +P +  K      ++D+ +++K E  L  L      E    L + 
Sbjct: 2   PIITFTHDLTSDFLSSPLKIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNND 61

Query: 63  GIDVNFRDIDNRTALHVAACQGFT-EVVSLLLERGADVD-PKDRWGSTPLGDAIYYKNHE 120
             + N     +       +      EV         +++ P D  G+TPL       N E
Sbjct: 62  SSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLE 121

Query: 121 VIKLLEKHGAKP 132
           ++K L KHG+  
Sbjct: 122 LVKHLVKHGSNR 133

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 40.0 bits (92), Expect = 2e-04
 Identities = 12/57 (21%), Positives = 19/57 (33%), Gaps = 5/57 (8%)

Query: 25  EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
              LN  D +G+       L   A   ++  +  LLD G D    +      +   A
Sbjct: 249 ANMLNAQDSNGDTC-----LNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.2 bits (155), Expect = 1e-12
 Identities = 32/123 (26%), Positives = 46/123 (37%), Gaps = 34/123 (27%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG------------------ 84
           +  LA    +E +KE + +        D D+RTALH A   G                  
Sbjct: 7   VCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 66

Query: 85  ---------------FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
                            E+V  LL +GA V+  ++ G TPL  A     HE+  +L + G
Sbjct: 67  DDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGG 126

Query: 130 AKP 132
           A P
Sbjct: 127 ANP 129

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.4 bits (153), Expect = 2e-12
 Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N ++ +G        L + A++   E    LL+ G + + +D    TA+H AA +G 
Sbjct: 94  AQVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +++ +LL   A  + +D  G+TPL  A   +  E  KLL   GA  
Sbjct: 149 LKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASI 195

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.0 bits (144), Expect = 3e-11
 Identities = 24/70 (34%), Positives = 37/70 (52%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
           LL  G  VN  + +  T LH AA +   E+  +LLE GA+ D KD + +T +  A    N
Sbjct: 89  LLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148

Query: 119 HEVIKLLEKH 128
            ++I +L  +
Sbjct: 149 LKMIHILLYY 158

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (119), Expect = 5e-08
 Identities = 13/52 (25%), Positives = 23/52 (44%), Gaps = 1/52 (1%)

Query: 43  RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
            L    +E  VE  K L+  G  +   + + +T L VA   G   ++  ++E
Sbjct: 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 7e-04
 Identities = 8/48 (16%), Positives = 15/48 (31%), Gaps = 1/48 (2%)

Query: 73  NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           +   +   A  G   E+   +L   +     D+   T L  A    + 
Sbjct: 3   SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHT 50

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (151), Expect = 3e-12
 Identities = 21/82 (25%), Positives = 38/82 (46%)

Query: 42  FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP 101
             L+       +  ++ LL  G +VN +     +ALH A+ +G   +V  L+  GAD   
Sbjct: 146 SPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSL 205

Query: 102 KDRWGSTPLGDAIYYKNHEVIK 123
           K+    TPL  A   +  ++++
Sbjct: 206 KNCHNDTPLMVARSRRVIDILR 227

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.1 bits (128), Expect = 3e-09
 Identities = 15/52 (28%), Positives = 22/52 (42%), Gaps = 4/52 (7%)

Query: 72  DNRTALHVAACQGFTEVVSLLL----ERGADVDPKDRWGSTPLGDAIYYKNH 119
           D  T LH+A  QG    V  L+    + G ++D  +    TPL  A+     
Sbjct: 2   DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLP 53

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (100), Expect = 1e-05
 Identities = 20/102 (19%), Positives = 40/102 (39%), Gaps = 4/102 (3%)

Query: 44  LMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
           L     + ++  +  L++     G +++  +   +T LH+A       VV LL+  GA  
Sbjct: 7   LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 66

Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
              DR G T    A  +++   ++ L    A   +      +
Sbjct: 67  MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNY 108

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.001
 Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 1/90 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           L    N    E ++ LL+ G D++  DI   R+ L  A       +V LLL+ GA+V+ +
Sbjct: 114 LHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQ 173

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
              GS+ L  A       +++ L + GA  
Sbjct: 174 MYSGSSALHSASGRGLLPLVRTLVRSGADS 203

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 60.8 bits (146), Expect = 5e-12
 Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 42/140 (30%)

Query: 43  RLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAA---CQGFTEVVSLLL 93
            L      RD+ G+ +    G+D+  +         + TALH+A     +    +V  L+
Sbjct: 9   SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLV 68

Query: 94  ERGADVDPK---------------------------------DRWGSTPLGDAIYYKNHE 120
           +   ++D +                                 +  G TPL  A   K+  
Sbjct: 69  QNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEH 128

Query: 121 VIKLLEKHGAKPLMAPMHVK 140
             +LL +  +    + +HV+
Sbjct: 129 CEELLTQALSGRFNSHVHVE 148

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 43.0 bits (100), Expect = 8e-06
 Identities = 15/129 (11%), Positives = 30/129 (23%), Gaps = 12/129 (9%)

Query: 72  DNRTALHV---AACQGFTEVVSLLLERGADVDPK------DRWGSTPLGDAIYYKNH--- 119
           D    LH    A        +      G D+  K           T L  A+   +    
Sbjct: 2   DTAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSL 61

Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
            ++  L ++             A        +   L      + +      +    + +A
Sbjct: 62  HIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 121

Query: 180 VKKLGEEVI 188
            +   E   
Sbjct: 122 KRLKHEHCE 130

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.8 bits (140), Expect = 8e-11
 Identities = 19/67 (28%), Positives = 31/67 (46%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
                + RTALH+A      ++VSLLL+ GADV+     G +P        +  + + L 
Sbjct: 139 AQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLG 198

Query: 127 KHGAKPL 133
           +   + L
Sbjct: 199 QLTLENL 205

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.4 bits (126), Expect = 5e-09
 Identities = 9/55 (16%), Positives = 20/55 (36%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
           L    + ++ + +  LL  G DVN       +   +   +  T +   L +   +
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.2 bits (123), Expect = 1e-08
 Identities = 11/52 (21%), Positives = 20/52 (38%), Gaps = 4/52 (7%)

Query: 72  DNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           D  + LH+A          EV+  +    A ++ ++    TPL  A+     
Sbjct: 1   DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQP 52

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 56.4 bits (134), Expect = 6e-10
 Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 4/66 (6%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKL 124
           VN++D    T L  A  +G  +   LL+E+ GA+ D  D  G+     A+   N +V K 
Sbjct: 165 VNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKF 221

Query: 125 LEKHGA 130
              +  
Sbjct: 222 FLNNVV 227

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.8 bits (130), Expect = 2e-09
 Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 1/68 (1%)

Query: 75  TALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
             LH A  +     V  LL  + + +  KD+ G  PL  ++ ++ HE+   L        
Sbjct: 2   YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61

Query: 134 MAPMHVKH 141
           +       
Sbjct: 62  LDDYPDDS 69

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 51.4 bits (121), Expect = 3e-08
 Identities = 10/55 (18%), Positives = 17/55 (30%), Gaps = 4/55 (7%)

Query: 45  MFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
                E   +    L++  G + +  D     A  VA  +   +V    L    D
Sbjct: 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNNVVD 228

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 46.4 bits (108), Expect = 1e-06
 Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 2/90 (2%)

Query: 45  MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-VDPKD 103
                ++  E  + L+++G  V  +D  N+  LH AA  G  +++ LL   G   V+ +D
Sbjct: 110 HLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQD 169

Query: 104 RWGSTPLGDAIYYKNHEVIK-LLEKHGAKP 132
           + G TPL  A+   + +    L+EK+GA+ 
Sbjct: 170 KQGWTPLFHALAEGHGDAAVLLVEKYGAEY 199

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 46.0 bits (107), Expect = 2e-06
 Identities = 19/99 (19%), Positives = 39/99 (39%), Gaps = 1/99 (1%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           L     E +   ++ELL S    +  +D D R  LH +      E+ S LL +  +V+  
Sbjct: 4   LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 63

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
           D    +         +   +++++    +PL   ++   
Sbjct: 64  DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKIT 102

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 54.4 bits (130), Expect = 2e-09
 Identities = 25/160 (15%), Positives = 49/160 (30%), Gaps = 30/160 (18%)

Query: 174 RGIQVAVKKLGEEVISDDD---------------RVRAFRDELALLQKIRHPNVVQFLGA 218
           +  +  VK       S                   +R+ R+E   LQK++   V +    
Sbjct: 23  KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
                   ++ E +   +L          +          I   +   +      I+H D
Sbjct: 83  ----EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHR---GIVHGD 128

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           L   N+L  + G + + DF  S  +  +  R +  +D   
Sbjct: 129 LSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN 167

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 53.1 bits (126), Expect = 1e-08
 Identities = 35/167 (20%), Positives = 62/167 (37%), Gaps = 33/167 (19%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ-- 214
           ++  G F    LA        VA+K +      D     A  DE+ LLQ++   +  +  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 215 -------------FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIA 260
                        F         +++V E L +  L    K +    P     + +  + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSG------NLKVADFGVSK 301
            G++Y+H      IIH D++P N+L +          +K+AD G + 
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.9 bits (117), Expect = 3e-08
 Identities = 9/32 (28%), Positives = 18/32 (56%)

Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
             L  AA +G  E ++ LL+   +V+ ++ +G
Sbjct: 3   NELASAAARGDLEQLTSLLQNNVNVNAQNGFG 34

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (106), Expect = 9e-07
 Identities = 12/31 (38%), Positives = 15/31 (48%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERG 96
           V  R+    TA  +A   G  EVVSL+   G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 7e-05
 Identities = 9/31 (29%), Positives = 16/31 (51%)

Query: 99  VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
           V  ++  G T    A  Y  +EV+ L++ +G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 48.7 bits (114), Expect = 9e-08
 Identities = 23/64 (35%), Positives = 36/64 (56%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G DVN +D+   TALH A      EVV LL++ GADV  + ++  T    +I   N ++ 
Sbjct: 90  GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149

Query: 123 KLLE 126
           ++L+
Sbjct: 150 EILQ 153

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 42.2 bits (97), Expect = 2e-05
 Identities = 12/64 (18%), Positives = 29/64 (45%)

Query: 29  NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
           +G D + +++     L +       E ++ L+  G DV+ +    +TA  ++   G  ++
Sbjct: 89  HGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDL 148

Query: 89  VSLL 92
             +L
Sbjct: 149 AEIL 152

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 40.6 bits (93), Expect = 5e-05
 Identities = 15/48 (31%), Positives = 21/48 (43%), Gaps = 1/48 (2%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           D    L  AA  G  + V +L+  GA     D  G++PL  A  Y + 
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHF 47

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (112), Expect = 2e-07
 Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 1/66 (1%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G DVN  D      +H+A  +G T VVS L    +D+  +D  G TPL  A+     +++
Sbjct: 91  GADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLV 149

Query: 123 KLLEKH 128
            +L+ H
Sbjct: 150 DILQGH 155

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (91), Expect = 9e-05
 Identities = 13/46 (28%), Positives = 19/46 (41%), Gaps = 1/46 (2%)

Query: 75  TALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNH 119
             L  AA +G  + V  LL R     D  +R+G T L   ++    
Sbjct: 4   DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTA 49

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (92), Expect = 6e-05
 Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)

Query: 56  IKELLDSGIDVNFRDI-DNRTA--LHVAACQGFTEVVSLLLERGADV 99
            K L++SG  V      D +TA        +G+T+    L      +
Sbjct: 83  CKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 129

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 34.6 bits (78), Expect = 0.004
 Identities = 18/124 (14%), Positives = 34/124 (27%), Gaps = 36/124 (29%)

Query: 44  LMFLANERDVEGIKELLDSGIDVN---------------------------------FRD 70
           L+  + E + + ++ ++    D +                                   D
Sbjct: 5   LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 64

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDR---WGSTPLGDAIYYKNHEVIKLLEK 127
            D  T LH AA     +V   L+E GA V          +    + +     +  + L  
Sbjct: 65  SDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYG 124

Query: 128 HGAK 131
              K
Sbjct: 125 VQEK 128

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 3e-04
 Identities = 20/114 (17%), Positives = 33/114 (28%)

Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
             L  AA +G  E V  LLE GA+ +  + +G  P+   +         LL         
Sbjct: 5   DWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCA 64

Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVI 188
            P  +         E     L   +                + +A +    +V 
Sbjct: 65  DPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVA 118

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.3 bits (79), Expect = 0.002
 Identities = 7/28 (25%), Positives = 11/28 (39%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLE 94
           + RD   R  + +A   G  +V   L  
Sbjct: 96  DVRDAWGRLPVDLAEELGHRDVARYLRA 123

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	319
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.98
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.98
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.98
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.98
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.98
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.98
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.98
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.96
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.96
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.95
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.95
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.94
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.94
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.94
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.93
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.91
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.91
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.91
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.9
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.88
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.87
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.86
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.85
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.85
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.85
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.84
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.84
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.83
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.82
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.82
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.82
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.82
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.81
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.81
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.81
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.81
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.81
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.8
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.8
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.8
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.79
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.79
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.78
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.77
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.77
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.77
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.76
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.75
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.74
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.72
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.69
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.69
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.66
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.7
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.53
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.97
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.12
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.36

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=262.92  Aligned_cols=161  Identities=29%  Similarity=0.377  Sum_probs=146.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            688889999999999984     588999999986543333345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ||+||+|.+++.+.+.+++..+..+++|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.........
T Consensus        86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            9999999999999999999999999999999999999999   9999999999999999999999999999888777777


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      ...+|||.|
T Consensus       163 ~~~~GT~~Y  171 (337)
T d1o6la_         163 KTFCGTPEY  171 (337)
T ss_dssp             CCCEECGGG
T ss_pred             ccceeCHHH
Confidence            788999854

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-35  Score=253.50  Aligned_cols=157  Identities=22%  Similarity=0.428  Sum_probs=141.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||||++.......   .+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            688889999999999985     48899999987654333   3568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ||++|+|.+++.+ +.+++..+..|++|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.+.......
T Consensus        98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  173 (293)
T d1yhwa1          98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (293)
T ss_dssp             CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence            9999999998776 46999999999999999999999999   9999999999999999999999999999988777777


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      ...+|||.|
T Consensus       174 ~~~~gt~~Y  182 (293)
T d1yhwa1         174 STMVGTPYW  182 (293)
T ss_dssp             CCCCSCGGG
T ss_pred             cccccCCCc
Confidence            778899854

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-36  Score=256.27  Aligned_cols=159  Identities=25%  Similarity=0.362  Sum_probs=137.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||||++.....  ....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            688889999999999985     478999999976432  2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC--C
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--D  308 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~--~  308 (319)
                      ||++|+|.+++.+++.+++..+..+++|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+....  .
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999999988788999999999999999999999999   9999999999999999999999999999876543  3


Q ss_pred             CceeeccCCCC
Q 020981          309 RPLTCQDTSCR  319 (319)
Q Consensus       309 ~~~~~~~~~~~  319 (319)
                      ...+.+|||.|
T Consensus       161 ~~~~~~GT~~Y  171 (271)
T d1nvra_         161 LLNKMCGTLPY  171 (271)
T ss_dssp             CBCCCCSCGGG
T ss_pred             cccceeeCcCc
Confidence            34567888854

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-35  Score=253.28  Aligned_cols=159  Identities=26%  Similarity=0.456  Sum_probs=140.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +++.||+|++.+...........+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            688889999999999985     478999999876443333335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ||++|+|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....  ..
T Consensus        87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~  161 (263)
T d2j4za1          87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RR  161 (263)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CC
T ss_pred             ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC--cc
Confidence            9999999999998888999999999999999999999999   999999999999999999999999999876544  34


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      ....|||.|
T Consensus       162 ~~~~Gt~~Y  170 (263)
T d2j4za1         162 TTLCGTLDY  170 (263)
T ss_dssp             EETTEEGGG
T ss_pred             cccCCCCcc
Confidence            556788743

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-35  Score=255.06  Aligned_cols=161  Identities=24%  Similarity=0.447  Sum_probs=138.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||||++.+.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            588889999999999984     478999999976543333345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC--C
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--D  308 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~--~  308 (319)
                      ||++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+....  .
T Consensus        89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999999889999999999999999999999999   9999999999999999999999999999886443  3


Q ss_pred             CceeeccCCCC
Q 020981          309 RPLTCQDTSCR  319 (319)
Q Consensus       309 ~~~~~~~~~~~  319 (319)
                      ...+.+|||.|
T Consensus       166 ~~~~~~GT~~Y  176 (288)
T d1uu3a_         166 RANSFVGTAQY  176 (288)
T ss_dssp             ----CCCCGGG
T ss_pred             ccccccCCccc
Confidence            34556788854

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-34  Score=253.32  Aligned_cols=157  Identities=26%  Similarity=0.435  Sum_probs=140.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|...+.||+|+||.||.     +++.||||++...........+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            478888999999999985     478999999987665556667789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ||++|+|..++..++++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+.....    
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  168 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence            9999999888888888999999999999999999999999   999999999999999999999999999876543    


Q ss_pred             eeeccCCCC
Q 020981          311 LTCQDTSCR  319 (319)
Q Consensus       311 ~~~~~~~~~  319 (319)
                      ....|||+|
T Consensus       169 ~~~~GT~~Y  177 (309)
T d1u5ra_         169 NSFVGTPYW  177 (309)
T ss_dssp             CCCCSCGGG
T ss_pred             CccccCccc
Confidence            345688753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-35  Score=257.67  Aligned_cols=158  Identities=30%  Similarity=0.455  Sum_probs=138.6

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|...+.||+|+||.||.     +|+.||+|++....  .+.....+.+|+.+++.++||||++++++|.+...+|+||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4688889999999999985     47899999997653  2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      ||+++|+|.+++.+.+.+++..+..++.|++.||.|||++ +   |+||||||+|||++.+|.+||+|||+|+.+...  
T Consensus        84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            9999999999999888899999999999999999999974 8   999999999999999999999999999987554  


Q ss_pred             CceeeccCCCC
Q 020981          309 RPLTCQDTSCR  319 (319)
Q Consensus       309 ~~~~~~~~~~~  319 (319)
                      ...+.+||++|
T Consensus       159 ~~~~~~GT~~Y  169 (322)
T d1s9ja_         159 MANSFVGTRSY  169 (322)
T ss_dssp             TC---CCSSCC
T ss_pred             ccccccCCccc
Confidence            33456888854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-35  Score=252.64  Aligned_cols=158  Identities=28%  Similarity=0.404  Sum_probs=138.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|.....||+|+||.||.     ++..||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            467788999999999985     47899999987542   2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       231 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||++|+|.+++.+. +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+........
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            99999999997654 56999999999999999999999999   999999999999999999999999999887665555


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      ..+..|||.|
T Consensus       167 ~~~~~Gt~~y  176 (288)
T d2jfla1         167 RDSFIGTPYW  176 (288)
T ss_dssp             HTCCCSCCTT
T ss_pred             cccccccccc
Confidence            5567788753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-33  Score=240.65  Aligned_cols=159  Identities=28%  Similarity=0.518  Sum_probs=135.6

Q ss_pred             ccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe----CCceEE
Q 020981          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI  227 (319)
Q Consensus       157 ~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~l  227 (319)
                      +....+||+|+||.||.     ++..||+|.+..... .....+.+.+|++++++++||||+++++++..    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            34456899999999985     477999999876543 44556789999999999999999999999865    345899


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec-CCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DFgla~~~~~~  306 (319)
                      ||||+++|+|.+++.+...+++..+..|+.|++.||+|||++++ +|+||||||+|||++ +++.+||+|||+|+.... 
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-  167 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  167 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence            99999999999999988889999999999999999999999873 499999999999997 578999999999986443 


Q ss_pred             CCCceeeccCCCC
Q 020981          307 EDRPLTCQDTSCR  319 (319)
Q Consensus       307 ~~~~~~~~~~~~~  319 (319)
                       ....+.+|||.|
T Consensus       168 -~~~~~~~GT~~Y  179 (270)
T d1t4ha_         168 -SFAKAVIGTPEF  179 (270)
T ss_dssp             -TSBEESCSSCCC
T ss_pred             -CccCCcccCccc
Confidence             344567889854

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-34  Score=248.25  Aligned_cols=154  Identities=33%  Similarity=0.575  Sum_probs=135.4

Q ss_pred             CCccccCCCcccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeE
Q 020981          145 VPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (319)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~  219 (319)
                      ...|+++..  +|...+.||+|+||.||.     +++.||||+++....    ..+.|.+|+.+++.++||||+++++++
T Consensus         9 ~~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_           9 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             CCTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            445777665  577778999999998885     478999999875432    235688999999999999999999999


Q ss_pred             EeCCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          220 TQSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      .+.+..|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccc
Confidence            9999999999999999999999764  45899999999999999999999999   999999999999999999999999


Q ss_pred             CcccccccCC
Q 020981          298 GVSKLLTVKE  307 (319)
Q Consensus       298 gla~~~~~~~  307 (319)
                      |+|+......
T Consensus       160 G~a~~~~~~~  169 (287)
T d1opja_         160 GLSRLMTGDT  169 (287)
T ss_dssp             CCTTTCCSSS
T ss_pred             cceeecCCCC
Confidence            9999876553

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-34  Score=244.16  Aligned_cols=163  Identities=23%  Similarity=0.427  Sum_probs=126.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--CCceEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv  228 (319)
                      +|...+.||+|+||.||.     +|+.||+|.+..... .+...+.+.+|+.++++++||||+++++++.+  ...+|+|
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            688889999999999985     478999999987644 45556789999999999999999999999864  4568999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCC--CCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~~--~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      ||||++|+|.+++.+    ++.+++..+..++.|++.||+|||++++  .+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864    3569999999999999999999998642  2399999999999999999999999999999


Q ss_pred             cccCCCCceeeccCCCC
Q 020981          303 LTVKEDRPLTCQDTSCR  319 (319)
Q Consensus       303 ~~~~~~~~~~~~~~~~~  319 (319)
                      +..+.......+|||.|
T Consensus       164 ~~~~~~~~~~~~gt~~Y  180 (269)
T d2java1         164 LNHDTSFAKAFVGTPYY  180 (269)
T ss_dssp             C-----------CCCSC
T ss_pred             cccCCCccccCCCCccc
Confidence            88777777778899854

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-34  Score=250.22  Aligned_cols=159  Identities=27%  Similarity=0.472  Sum_probs=141.0

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEE
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .+|...+.||+|+||.||.     +|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            3688889999999999985     47899999997654333334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      |||+||+|..++.....+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.....   
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            99999999999999888999999999999999999999999   999999999999999999999999999987543   


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      ..+.+|||.|
T Consensus       158 ~~~~~Gt~~Y  167 (316)
T d1fota_         158 TYTLCGTPDY  167 (316)
T ss_dssp             BCCCCSCTTT
T ss_pred             cccccCcccc
Confidence            3457788854

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.3e-33  Score=239.79  Aligned_cols=159  Identities=26%  Similarity=0.362  Sum_probs=139.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCC------HHHHHHHHHHHHHHHhcC-CCcccccceeEEeCC
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS  223 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~  223 (319)
                      +|...+.||+|+||.||.     +|+.||||++.+.....      ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            678889999999999985     57899999997654322      223456888999999997 999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      ..|+|||||++|+|.++++.++++++..+..|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEc
Confidence            99999999999999999999889999999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCceeeccCCC
Q 020981          304 TVKEDRPLTCQDTSC  318 (319)
Q Consensus       304 ~~~~~~~~~~~~~~~  318 (319)
                      .... .....+||+.
T Consensus       161 ~~~~-~~~~~~gt~~  174 (277)
T d1phka_         161 DPGE-KLREVCGTPS  174 (277)
T ss_dssp             CTTC-CBCCCCSCGG
T ss_pred             cCCC-ceeeeeccCC
Confidence            6643 3344567763

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-33  Score=242.63  Aligned_cols=165  Identities=28%  Similarity=0.424  Sum_probs=133.6

Q ss_pred             ccccCCCcccccceeeeecceEEEEEE--eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~--~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  224 (319)
                      +|+++..  +|...+.||+|+||.||.  ....||||+++..... ....+.|.+|+.++++++||||+++++++. ...
T Consensus         2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~   77 (276)
T d1uwha_           2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ   77 (276)
T ss_dssp             CCBCCTT--CCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             Ccccccc--cEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence            4666655  466677899999999985  3457999999765433 345678999999999999999999999764 567


Q ss_pred             eEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      +++|||||++|+|.+++... ..+++..+..|+.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence            89999999999999999765 56999999999999999999999999   999999999999999999999999999887


Q ss_pred             ccCCC--CceeeccCCC
Q 020981          304 TVKED--RPLTCQDTSC  318 (319)
Q Consensus       304 ~~~~~--~~~~~~~~~~  318 (319)
                      .....  ......|||.
T Consensus       155 ~~~~~~~~~~~~~gt~~  171 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSIL  171 (276)
T ss_dssp             -----------CCCCGG
T ss_pred             cccCCcccccccccCcc
Confidence            64332  3345567763

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.7e-33  Score=245.77  Aligned_cols=157  Identities=24%  Similarity=0.415  Sum_probs=138.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            688889999999999985     48899999997542   3455778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec--CCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||+||+|.+++.+ .+.+++..+..|+.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+|+.+... 
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            9999999999854 457999999999999999999999999   99999999999996  4578999999999987665 


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                      ....+..|||.|
T Consensus       180 ~~~~~~~gT~~Y  191 (350)
T d1koaa2         180 QSVKVTTGTAEF  191 (350)
T ss_dssp             SCEEEECSCTTT
T ss_pred             cccceecCcccc
Confidence            344567888854

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-33  Score=246.29  Aligned_cols=158  Identities=24%  Similarity=0.409  Sum_probs=121.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      .|...+.||+|+||.||.     +++.||||++.+....  .....+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            378888999999998885     4789999999865432  223567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec---CCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||+||+|.+++.+++.+++..+..++.|++.||+|||+++   |+||||||+|||+.   +++.+||+|||+|+......
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            9999999999998888999999999999999999999999   99999999999995   57899999999999776553


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                       ...+.+|||.|
T Consensus       165 -~~~~~~GT~~y  175 (307)
T d1a06a_         165 -VLSTACGTPGY  175 (307)
T ss_dssp             ---------CTT
T ss_pred             -eeeeeeeCccc
Confidence             34457788854

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-33  Score=240.11  Aligned_cols=159  Identities=26%  Similarity=0.427  Sum_probs=138.4

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCC---HHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      .|...+.||+|+||.||.     +|+.||||++.+.....   ....+.+.+|+.++++++||||+++++++.+...+|+
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            588889999999999985     47899999997654322   1235678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC----CEEEEecCccccc
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLL  303 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DFgla~~~  303 (319)
                      |||||++|+|.+++.+++.+++..+..++.|++.||+|||+++   |+||||||+|||++.++    .+||+|||+|+..
T Consensus        91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            9999999999999998888999999999999999999999999   99999999999999776    4999999999987


Q ss_pred             ccCCCCceeeccCCC
Q 020981          304 TVKEDRPLTCQDTSC  318 (319)
Q Consensus       304 ~~~~~~~~~~~~~~~  318 (319)
                      ..... ..+..|||.
T Consensus       168 ~~~~~-~~~~~~t~~  181 (293)
T d1jksa_         168 DFGNE-FKNIFGTPE  181 (293)
T ss_dssp             TTSCB-CSCCCCCGG
T ss_pred             CCCcc-ccccCCCCc
Confidence            65533 334566663

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8e-33  Score=245.84  Aligned_cols=156  Identities=19%  Similarity=0.392  Sum_probs=137.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||||++....   ......+.+|+.++++++||||+++++++.++..+|+|||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            588889999999999985     47899999987543   3445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEec--CCCCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DFgla~~~~~~~  307 (319)
                      ||+||+|.+++...+ ++++..+..|+.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+|+.+... 
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence            999999998876544 6999999999999999999999999   99999999999998  6789999999999988765 


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                      ....+..|||+
T Consensus       183 ~~~~~~~gt~~  193 (352)
T d1koba_         183 EIVKVTTATAE  193 (352)
T ss_dssp             SCEEEECSSGG
T ss_pred             CceeeccCccc
Confidence            34455777774

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-33  Score=248.70  Aligned_cols=157  Identities=27%  Similarity=0.423  Sum_probs=139.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||||++.+.........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            688899999999999985     488999999876543333345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      |+.+|+|..++.+.+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+|+.+...   .
T Consensus       122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~  195 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T  195 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred             cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc---c
Confidence            9999999999998889999999999999999999999999   999999999999999999999999999987643   3


Q ss_pred             eeeccCCC
Q 020981          311 LTCQDTSC  318 (319)
Q Consensus       311 ~~~~~~~~  318 (319)
                      .+..|||.
T Consensus       196 ~~~~Gt~~  203 (350)
T d1rdqe_         196 WTLCGTPE  203 (350)
T ss_dssp             CCCEECGG
T ss_pred             ccccCccc
Confidence            34667774

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=4.5e-33  Score=244.52  Aligned_cols=161  Identities=30%  Similarity=0.418  Sum_probs=140.9

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHH-hcCCCcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~~~~~~~lv~  229 (319)
                      +|...+.||+|+||.||.     +++.||||++++.........+.+..|..++. .++||||+++++++.+++..|+||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            577888999999999985     58999999997654322233455666777665 689999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC
Q 020981          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~  309 (319)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+........
T Consensus        83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            99999999999999889999999999999999999999999   999999999999999999999999999988877777


Q ss_pred             ceeeccCCCC
Q 020981          310 PLTCQDTSCR  319 (319)
Q Consensus       310 ~~~~~~~~~~  319 (319)
                      .....|||.|
T Consensus       160 ~~~~~gt~~y  169 (320)
T d1xjda_         160 TNTFCGTPDY  169 (320)
T ss_dssp             BCCCCSCGGG
T ss_pred             ccccCCCCCc
Confidence            7778888853

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.98  E-value=4e-33  Score=249.05  Aligned_cols=159  Identities=25%  Similarity=0.363  Sum_probs=135.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHH---HHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAF---RDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~---~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|...+.||+|+||.||.     +|+.||||++.+...........+   ..|+.+++.++||||+++++++...+.+|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            688889999999999984     478999999875433222122223   345677777889999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      |||||++|+|.+++.++..+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.+... 
T Consensus        85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            9999999999999999888999999999999999999999999   999999999999999999999999999987654 


Q ss_pred             CCceeeccCCCC
Q 020981          308 DRPLTCQDTSCR  319 (319)
Q Consensus       308 ~~~~~~~~~~~~  319 (319)
                       ......|||+|
T Consensus       161 -~~~~~~GT~~y  171 (364)
T d1omwa3         161 -KPHASVGTHGY  171 (364)
T ss_dssp             -CCCSCCSCGGG
T ss_pred             -ccccccccccc
Confidence             34456788853

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=8.5e-33  Score=237.62  Aligned_cols=164  Identities=31%  Similarity=0.466  Sum_probs=135.4

Q ss_pred             CCCccccCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeE
Q 020981          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (319)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~  219 (319)
                      ...+|+++..  +|...+.||+|+||.||.    ++..||||++......    .+.|.+|+.++++++||||+++++++
T Consensus         4 ~~~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~   77 (272)
T d1qpca_           4 WEDEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVV   77 (272)
T ss_dssp             TTCTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeee
Confidence            3456777654  577788999999999984    3578999999754322    35688999999999999999999976


Q ss_pred             EeCCceEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          220 TQSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      . ++..|+||||+++|+|.+++...  .++++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+||
T Consensus        78 ~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             c-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccc
Confidence            5 46789999999999999977533  35899999999999999999999999   999999999999999999999999


Q ss_pred             CcccccccCCCCc-eeeccCC
Q 020981          298 GVSKLLTVKEDRP-LTCQDTS  317 (319)
Q Consensus       298 gla~~~~~~~~~~-~~~~~~~  317 (319)
                      |+|+.+....... ....||+
T Consensus       154 Gla~~~~~~~~~~~~~~~gt~  174 (272)
T d1qpca_         154 GLARLIEDNEYTAREGAKFPI  174 (272)
T ss_dssp             TTCEECSSSCEECCTTCCCCT
T ss_pred             cceEEccCCccccccccCCcc
Confidence            9999876543222 2345555

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.5e-32  Score=236.54  Aligned_cols=152  Identities=27%  Similarity=0.386  Sum_probs=127.4

Q ss_pred             eeeecceEEEEEE-------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeecC
Q 020981          161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (319)
Q Consensus       161 ~~ig~G~f~~v~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  233 (319)
                      ++||+|+||.||.       .++.||||+++.... ++...+.|.+|+.++++++||||+++++++.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            4799999999985       246899999976543 34456789999999999999999999998865 56799999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc---
Q 020981          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP---  310 (319)
Q Consensus       234 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~---  310 (319)
                      +|+|.+++.+...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+.......   
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999999999888999999999999999999999999   9999999999999999999999999999876554332   


Q ss_pred             eeeccCC
Q 020981          311 LTCQDTS  317 (319)
Q Consensus       311 ~~~~~~~  317 (319)
                      ....||+
T Consensus       168 ~~~~gt~  174 (277)
T d1xbba_         168 THGKWPV  174 (277)
T ss_dssp             ---CCCG
T ss_pred             cccCCCc
Confidence            2335555

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=8.1e-33  Score=236.66  Aligned_cols=156  Identities=29%  Similarity=0.508  Sum_probs=124.5

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|...+.||+|+||.||.    ++..||||++......    .+.|.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            577788999999998885    4678999999764322    25688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCC-
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-  309 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~-  309 (319)
                      +++|+|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+|+.+...... 
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999998765 45889999999999999999999999   999999999999999999999999999987654332 


Q ss_pred             ceeeccCCC
Q 020981          310 PLTCQDTSC  318 (319)
Q Consensus       310 ~~~~~~~~~  318 (319)
                      .....||+.
T Consensus       159 ~~~~~gt~~  167 (263)
T d1sm2a_         159 STGTKFPVK  167 (263)
T ss_dssp             ------CTT
T ss_pred             ecceecCcc
Confidence            234556653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=4.2e-32  Score=238.51  Aligned_cols=155  Identities=16%  Similarity=0.305  Sum_probs=135.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +++.||+|++....    .....+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            477888999999999985     47899999997542    233568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCC--CCEEEEecCcccccccCC
Q 020981          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DFgla~~~~~~~  307 (319)
                      ||+||+|.+++.+.+ .+++.++..|+.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++..... 
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-  157 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence            999999999998765 6999999999999999999999999   9999999999999854  47999999999987654 


Q ss_pred             CCceeeccCCC
Q 020981          308 DRPLTCQDTSC  318 (319)
Q Consensus       308 ~~~~~~~~~~~  318 (319)
                      ....+..|||+
T Consensus       158 ~~~~~~~~t~~  168 (321)
T d1tkia_         158 DNFRLLFTAPE  168 (321)
T ss_dssp             CEEEEEESCGG
T ss_pred             Ccccccccccc
Confidence            33455667764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=5.9e-33  Score=242.05  Aligned_cols=157  Identities=29%  Similarity=0.402  Sum_probs=133.0

Q ss_pred             eeeeecceEEEEEE-----eceEeEEEEecccccCCH--HHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEeec
Q 020981          160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (319)
Q Consensus       160 ~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  232 (319)
                      .+.||+|+||.||.     +|+.||||++........  ...+.+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            46799999999985     578999999875433221  12346889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCcee
Q 020981          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT  312 (319)
Q Consensus       233 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~~  312 (319)
                      .++++..+...+..+++..+..+++|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+...........
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred             cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence            88777766666667999999999999999999999999   999999999999999999999999999998887777777


Q ss_pred             eccCCCC
Q 020981          313 CQDTSCR  319 (319)
Q Consensus       313 ~~~~~~~  319 (319)
                      .+||+.|
T Consensus       160 ~~gt~~y  166 (299)
T d1ua2a_         160 QVVTRWY  166 (299)
T ss_dssp             SCCCCTT
T ss_pred             eecChhh
Confidence            8888854

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=7.7e-32  Score=232.36  Aligned_cols=161  Identities=25%  Similarity=0.401  Sum_probs=135.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCc----eE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----MM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~~  226 (319)
                      +|...+.||+|+||.||.     +|+.||||++++....++.....+.+|+.+++.++||||+++++++.....    .|
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~   87 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   87 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence            478889999999999985     488999999988776677777889999999999999999999999876543    89


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      +||||++|++|.+++...+.+++.++..++.|++.||+|||+++   |+||||||+|||++.++..+|+|||.++.....
T Consensus        88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence            99999999999999998889999999999999999999999999   999999999999999999999999999876443


Q ss_pred             C---CCceeeccCCCC
Q 020981          307 E---DRPLTCQDTSCR  319 (319)
Q Consensus       307 ~---~~~~~~~~~~~~  319 (319)
                      .   ....+.+|||.|
T Consensus       165 ~~~~~~~~~~~Gt~~Y  180 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQY  180 (277)
T ss_dssp             --------------TT
T ss_pred             cccccccccccCcccc
Confidence            3   334456788754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.3e-32  Score=239.10  Aligned_cols=164  Identities=29%  Similarity=0.468  Sum_probs=134.1

Q ss_pred             ccccCCCcccccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCccccc
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF  215 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l  215 (319)
                      .|+++.+  +|...+.||+|+||.||..          ...||+|.+....  .......+.+|+.+++++ +|||||++
T Consensus        31 kwei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l  106 (325)
T d1rjba_          31 KWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNL  106 (325)
T ss_dssp             GGBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence            3555544  5777889999999999852          1369999887543  233446788999999998 79999999


Q ss_pred             ceeEEeCCceEEEEeecCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 020981          216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPV  272 (319)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~~~qi~~al~~lH~~~~~  272 (319)
                      ++++...+..|+|||||++|+|.+++.++.                       .+++..+..|+.|++.||+|||+++  
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--  184 (325)
T d1rjba_         107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--  184 (325)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            999999999999999999999999997642                       3788999999999999999999999  


Q ss_pred             CeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc--eeeccCC
Q 020981          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTS  317 (319)
Q Consensus       273 ~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~--~~~~~~~  317 (319)
                       |+||||||+|||++.++.+||+|||+|+.........  ....|||
T Consensus       185 -IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~  230 (325)
T d1rjba_         185 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV  230 (325)
T ss_dssp             -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECG
T ss_pred             -eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCC
Confidence             9999999999999999999999999999876654432  2445666

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=3.4e-32  Score=236.88  Aligned_cols=148  Identities=34%  Similarity=0.545  Sum_probs=122.0

Q ss_pred             cccceeeeecceEEEEEEe-----c---eEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFWR-----G---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~-----~---~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|...+.||+|+||.||..     +   ..||||.+....  .....+.|.+|+.++++++|||||++++++......|+
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            5667789999999999842     2   258889876432  45566789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      |||||++|+|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999988874 46899999999999999999999999   999999999999999999999999999987654


Q ss_pred             CC
Q 020981          307 ED  308 (319)
Q Consensus       307 ~~  308 (319)
                      ..
T Consensus       182 ~~  183 (299)
T d1jpaa_         182 TS  183 (299)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9e-32  Score=232.43  Aligned_cols=146  Identities=27%  Similarity=0.451  Sum_probs=126.4

Q ss_pred             ccccee-eeecceEEEEEEe-------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEE
Q 020981          156 DFTNSV-EITKGTFILAFWR-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~-~ig~G~f~~v~~~-------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l  227 (319)
                      ++...+ +||+|+||.||..       +..||||++...  ......+.|.+|+.++++++||||+++++++.. +.+|+
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            344444 5999999999852       457999999754  345566789999999999999999999998865 56899


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||||+++|+|.+++... +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence            99999999999998654 56999999999999999999999999   999999999999999999999999999987654


Q ss_pred             C
Q 020981          307 E  307 (319)
Q Consensus       307 ~  307 (319)
                      .
T Consensus       163 ~  163 (285)
T d1u59a_         163 D  163 (285)
T ss_dssp             S
T ss_pred             c
Confidence            3

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-31  Score=227.72  Aligned_cols=155  Identities=28%  Similarity=0.491  Sum_probs=133.8

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|...++||+|+||.||.    +++.||||++++....    .+.|.+|+.++++++||||+++++++.+++.+++||||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            567778899999999985    4679999999865432    25688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       232 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      +++|+|..++... ..+++..+.+++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+|+.+.......
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            9999999997654 56899999999999999999999999   9999999999999999999999999998876554433


Q ss_pred             e-eeccCC
Q 020981          311 L-TCQDTS  317 (319)
Q Consensus       311 ~-~~~~~~  317 (319)
                      . ...||+
T Consensus       158 ~~~~~~t~  165 (258)
T d1k2pa_         158 SVGSKFPV  165 (258)
T ss_dssp             CCCSCCCG
T ss_pred             ecccCCCC
Confidence            2 344554

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.4e-32  Score=235.26  Aligned_cols=159  Identities=25%  Similarity=0.481  Sum_probs=134.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +|+.||||++..... .+...+.+.+|+.++++++||||+++++++.++...|+|||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            678889999999999985     478999999975432 22334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCC
Q 020981          231 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (319)
Q Consensus       231 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~  308 (319)
                      |+.+ ++.+++..  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+....+..
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9965 55555543  345999999999999999999999999   99999999999999999999999999998877766


Q ss_pred             CceeeccCCCC
Q 020981          309 RPLTCQDTSCR  319 (319)
Q Consensus       309 ~~~~~~~~~~~  319 (319)
                      ......||+.|
T Consensus       158 ~~~~~~gt~~y  168 (298)
T d1gz8a_         158 TYTHEVVTLWY  168 (298)
T ss_dssp             CTTCCBCCCTT
T ss_pred             cceeeccccee
Confidence            67777888743

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-31  Score=230.82  Aligned_cols=162  Identities=33%  Similarity=0.494  Sum_probs=129.2

Q ss_pred             CccccCCCcccccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~  221 (319)
                      ..|+++..  +|...+.||+|+||.||.    .+..||||++..... .   .+.|.+|+.++++++|||||++++++. 
T Consensus        10 ~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~---~~~~~~E~~~l~~l~h~nIv~~~g~~~-   82 (285)
T d1fmka3          10 DAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVS-   82 (285)
T ss_dssp             TCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-C---HHHHHHHHHHHHhcccCCEeEEEEEEe-
Confidence            35677654  688888999999999985    346899999975432 2   256889999999999999999999885 


Q ss_pred             CCceEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          222 SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                      .+..++||||+++|+|..++..  .+.+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccch
Confidence            5668999999999999988854  356999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCC-ceeeccCC
Q 020981          300 SKLLTVKEDR-PLTCQDTS  317 (319)
Q Consensus       300 a~~~~~~~~~-~~~~~~~~  317 (319)
                      |+.+...... .....||+
T Consensus       160 a~~~~~~~~~~~~~~~gt~  178 (285)
T d1fmka3         160 ARLIEDNEYTARQGAKFPI  178 (285)
T ss_dssp             TC--------------CCG
T ss_pred             hhhccCCCceeeccccccc
Confidence            9987554332 23355665

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.9e-31  Score=228.48  Aligned_cols=147  Identities=32%  Similarity=0.511  Sum_probs=124.2

Q ss_pred             cccceeeeecceEEEEEEe---------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          156 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~---------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      .|...+.||+|+||.||..         ...||||.+....  .......|.+|+.++++++||||+++++++......+
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            4677788999999999842         1479999987543  3455567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +||||+.++++.+++... ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999988765 56999999999999999999999999   99999999999999999999999999998765


Q ss_pred             CC
Q 020981          306 KE  307 (319)
Q Consensus       306 ~~  307 (319)
                      ..
T Consensus       163 ~~  164 (283)
T d1mqba_         163 DP  164 (283)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4e-31  Score=227.35  Aligned_cols=163  Identities=24%  Similarity=0.438  Sum_probs=124.7

Q ss_pred             ccccCCCcccccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCccccccee
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~  218 (319)
                      +|+++.+  +|...+.||+|+||.||..        +..||||.+...  ......+.+.+|+.++++++||||++++++
T Consensus         1 ~~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~   76 (273)
T d1mp8a_           1 DYEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGV   76 (273)
T ss_dssp             CCBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CCCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3666654  5778889999999999842        346888888643  345666789999999999999999999998


Q ss_pred             EEeCCceEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEec
Q 020981          219 VTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (319)
Q Consensus       219 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DF  297 (319)
                      +. .+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+||
T Consensus        77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~Df  152 (273)
T d1mp8a_          77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF  152 (273)
T ss_dssp             EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred             Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccc
Confidence            85 56799999999999999987654 46899999999999999999999999   999999999999999999999999


Q ss_pred             CcccccccCCCCc-eeeccCC
Q 020981          298 GVSKLLTVKEDRP-LTCQDTS  317 (319)
Q Consensus       298 gla~~~~~~~~~~-~~~~~~~  317 (319)
                      |+|+.+....... ....||+
T Consensus       153 G~a~~~~~~~~~~~~~~~gt~  173 (273)
T d1mp8a_         153 GLSRYMEDSTYYKASKGKLPI  173 (273)
T ss_dssp             ------------------CCG
T ss_pred             hhheeccCCcceeccceecCc
Confidence            9999876554433 3445555

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.5e-31  Score=231.60  Aligned_cols=159  Identities=26%  Similarity=0.447  Sum_probs=132.5

Q ss_pred             cccceeeeecceEEEEEE----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEee
Q 020981          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  231 (319)
                      +|...+.||+|+||.||.    +|+.||||++..... .....+.+.+|+.+++.++||||+++++++..++..++++|+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578889999999999985    468999999976532 222346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCce
Q 020981          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (319)
Q Consensus       232 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~~  311 (319)
                      +.++.+..+....+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|.....+.....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            987766666666778999999999999999999999999   99999999999999999999999999998877666556


Q ss_pred             eeccCCC
Q 020981          312 TCQDTSC  318 (319)
Q Consensus       312 ~~~~~~~  318 (319)
                      ...|+|+
T Consensus       159 ~~~~~~~  165 (286)
T d1ob3a_         159 HEIVTLW  165 (286)
T ss_dssp             ---CCCT
T ss_pred             eecccch
Confidence            6667764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.6e-31  Score=229.96  Aligned_cols=166  Identities=30%  Similarity=0.479  Sum_probs=126.9

Q ss_pred             CccccCCCcccccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccc
Q 020981          146 PEYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQ  214 (319)
Q Consensus       146 ~~~~~~~~~~~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~  214 (319)
                      ..|+++.+  +|...+.||+|+||.||.          +++.||||++....  .....+.+.+|...+.++ +|+||+.
T Consensus         6 ~~wei~~~--~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~   81 (299)
T d1ywna1           6 SKWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVN   81 (299)
T ss_dssp             HHHBCCGG--GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccHH--HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence            45666654  577888999999999985          24689999987543  344556777788888777 5899999


Q ss_pred             cceeEEeC-CceEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEc
Q 020981          215 FLGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHR  277 (319)
Q Consensus       215 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~  277 (319)
                      +++++... ..+++|||||++|+|.+++...                ..+++..+..++.|++.||.|||+++   |+||
T Consensus        82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHr  158 (299)
T d1ywna1          82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  158 (299)
T ss_dssp             EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence            99987654 4689999999999999999753                23789999999999999999999999   9999


Q ss_pred             CCCCCCEEecCCCCEEEEecCcccccccCCC--CceeeccCCC
Q 020981          278 DLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSC  318 (319)
Q Consensus       278 Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~--~~~~~~~~~~  318 (319)
                      ||||+|||++.++.+||+|||+|+.......  ......||+.
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~  201 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  201 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGG
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCcc
Confidence            9999999999999999999999997755433  2334567763

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.4e-31  Score=231.38  Aligned_cols=152  Identities=25%  Similarity=0.335  Sum_probs=128.0

Q ss_pred             ccccee-eeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEe----CCc
Q 020981          156 DFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----SSP  224 (319)
Q Consensus       156 ~~~~~~-~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~----~~~  224 (319)
                      +|.... .||+|+||.||.     +++.||||++...        ..+.+|+.++.++ +||||++++++|.+    ...
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            566655 499999999985     4789999998642        3466799887654 79999999999875    467


Q ss_pred             eEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCc
Q 020981          225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV  299 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgl  299 (319)
                      +|+|||||+||+|.+++.++  ..+++..+..|+.|++.||+|||+++   |+||||||+|||++.   .+.+||+|||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            89999999999999999875  36999999999999999999999999   999999999999985   56799999999


Q ss_pred             ccccccCCCCceeeccCCCC
Q 020981          300 SKLLTVKEDRPLTCQDTSCR  319 (319)
Q Consensus       300 a~~~~~~~~~~~~~~~~~~~  319 (319)
                      |+....... .....|||+|
T Consensus       161 a~~~~~~~~-~~~~~gt~~y  179 (335)
T d2ozaa1         161 AKETTSHNS-LTTPCYTPYY  179 (335)
T ss_dssp             CEECCCCCC-CCCCSCCCSS
T ss_pred             eeeccCCCc-cccccCCccc
Confidence            998876543 3456788854

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.7e-30  Score=226.49  Aligned_cols=158  Identities=32%  Similarity=0.463  Sum_probs=134.3

Q ss_pred             cccceeeeecceEEEEEEe----------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~~----------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      +|...+.||+|+||.||..          +..||||++....  .....+.|.+|+.+++.++||||+++++++......
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            5888889999999999842          3689999987543  445567899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCC
Q 020981          226 MIVTEYLPKGDLRAFLKRKG------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP  281 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~------------------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~  281 (319)
                      +++|||+++|+|.+++....                        .+++..+..|+.|++.||+|||+++   ++||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence            99999999999999997532                        3788899999999999999999999   99999999


Q ss_pred             CCEEecCCCCEEEEecCcccccccCCCCc--eeeccCCC
Q 020981          282 SNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSC  318 (319)
Q Consensus       282 ~Nill~~~~~~kl~DFgla~~~~~~~~~~--~~~~~~~~  318 (319)
                      +|||++.++.+||+|||+|+.+.......  .+..||++
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~  207 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR  207 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGG
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcC
Confidence            99999999999999999998775543222  23445553

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.6e-31  Score=224.71  Aligned_cols=150  Identities=31%  Similarity=0.536  Sum_probs=121.6

Q ss_pred             ccccceeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceE
Q 020981          155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  226 (319)
                      .+|+..+.||+|+||.||..        ...||||++.+.........+.|.+|+.++++++||||+++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            46888889999999998842        24799999987665566667889999999999999999999999865 5689


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +||||+++|++.+++..+ +.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999887654 56999999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCC
Q 020981          306 KED  308 (319)
Q Consensus       306 ~~~  308 (319)
                      ...
T Consensus       164 ~~~  166 (273)
T d1u46a_         164 NDD  166 (273)
T ss_dssp             -CC
T ss_pred             CCC
Confidence            543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-30  Score=225.24  Aligned_cols=165  Identities=30%  Similarity=0.440  Sum_probs=138.9

Q ss_pred             ccccCCCcccccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCccccc
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF  215 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l  215 (319)
                      .|+++..  +|...+.||+|+||.||.          .+..||||++....  .......+.+|+.+++.+ +||||+++
T Consensus        17 ~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          17 KWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             GGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            4666665  566678999999999985          24689999997543  345567899999999999 59999999


Q ss_pred             ceeEEeCCceEEEEeecCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEc
Q 020981          216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR  277 (319)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~  277 (319)
                      ++++......+++||||++|+|.+++....                  .+++..+..|+.||+.||.|||+++   ++||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr  169 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR  169 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence            999999999999999999999999997643                  4889999999999999999999999   9999


Q ss_pred             CCCCCCEEecCCCCEEEEecCcccccccCCCCc--eeeccCCC
Q 020981          278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSC  318 (319)
Q Consensus       278 Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~--~~~~~~~~  318 (319)
                      ||||+||+++.++.+||+|||+++.........  ....|||+
T Consensus       170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~  212 (311)
T d1t46a_         170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK  212 (311)
T ss_dssp             CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGG
T ss_pred             ccccccccccccCcccccccchheeccCCCcceEeeecccChH
Confidence            999999999999999999999999876543322  23455653

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.4e-31  Score=226.45  Aligned_cols=159  Identities=25%  Similarity=0.367  Sum_probs=134.1

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHH---HHHHHHHHHHHHHhcC--CCcccccceeEEeCCce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD---RVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~---~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~  225 (319)
                      +|...+.||+|+||.||.     +|+.||||++.+.......   ....+.+|+.++++++  ||||+++++++.+++..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            688889999999999984     4789999998765433211   1133567999999986  89999999999999999


Q ss_pred             EEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-CCCEEEEecCccccc
Q 020981          226 MIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLL  303 (319)
Q Consensus       226 ~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DFgla~~~  303 (319)
                      |+||||+.+ +++.+++.++..+++..+..++.|++.||+|||+++   |+||||||+|||++. ++.+||+|||+|+..
T Consensus        85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceec
Confidence            999999975 688899988888999999999999999999999999   999999999999985 478999999999876


Q ss_pred             ccCCCCceeeccCCCC
Q 020981          304 TVKEDRPLTCQDTSCR  319 (319)
Q Consensus       304 ~~~~~~~~~~~~~~~~  319 (319)
                      ...  ...+..||+.|
T Consensus       162 ~~~--~~~~~~GT~~y  175 (273)
T d1xwsa_         162 KDT--VYTDFDGTRVY  175 (273)
T ss_dssp             CSS--CBCCCCSCGGG
T ss_pred             ccc--cccccccCCCc
Confidence            543  34456788743

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.9e-30  Score=224.16  Aligned_cols=153  Identities=29%  Similarity=0.528  Sum_probs=133.4

Q ss_pred             ccccCCCcccccceeeeecceEEEEEE----------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccc
Q 020981          147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL  216 (319)
Q Consensus       147 ~~~~~~~~~~~~~~~~ig~G~f~~v~~----------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~  216 (319)
                      .|+++++  +|...+.||+|+||.||.          .+..||||++....  .......|.+|+.++++++||||++++
T Consensus        14 ~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          14 EWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             TTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence            4777764  677788999999999973          24689999997542  445567789999999999999999999


Q ss_pred             eeEEeCCceEEEEeecCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEe
Q 020981          217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR  286 (319)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill  286 (319)
                      +++......++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++   |+||||||+|||+
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl  166 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  166 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence            9999999999999999999999998643          23688899999999999999999999   9999999999999


Q ss_pred             cCCCCEEEEecCcccccccC
Q 020981          287 DDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       287 ~~~~~~kl~DFgla~~~~~~  306 (319)
                      +.++.+||+|||+|+.+...
T Consensus       167 d~~~~~Kl~DFGla~~~~~~  186 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYET  186 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGG
T ss_pred             cCCceEEEeecccceeccCC
Confidence            99999999999999877554

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.3e-30  Score=222.36  Aligned_cols=158  Identities=23%  Similarity=0.413  Sum_probs=139.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCceEEEEe
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  230 (319)
                      +|...+.||+|+||.||.     +++.||||+++.... .......+.+|+.+++.++||||+++++++......+++++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            588889999999999985     478899999976543 34456788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccCCCCc
Q 020981          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~~~~  310 (319)
                      ++.++++..++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.|+....+....
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            9999999988888888999999999999999999999999   9999999999999999999999999999887665555


Q ss_pred             eeeccCC
Q 020981          311 LTCQDTS  317 (319)
Q Consensus       311 ~~~~~~~  317 (319)
                      ....+++
T Consensus       159 ~~~~~~~  165 (292)
T d1unla_         159 SAEVVTL  165 (292)
T ss_dssp             CSCCSCG
T ss_pred             eeecccc
Confidence            5445544

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-30  Score=221.48  Aligned_cols=149  Identities=34%  Similarity=0.619  Sum_probs=123.0

Q ss_pred             cccCCCcccccceeeeecceEEEEE---EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-CC
Q 020981          148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS  223 (319)
Q Consensus       148 ~~~~~~~~~~~~~~~ig~G~f~~v~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~  223 (319)
                      |+++..  +|...+.||+|+||.||   ++|..||||+++.+.     ..+.+.+|+.++++++||||+++++++.. .+
T Consensus         2 w~i~~~--~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           2 WALNMK--ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CBCCGG--GEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHH--HeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            566665  45567789999999887   578999999997532     23678899999999999999999998854 46


Q ss_pred             ceEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       224 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      .+|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccce
Confidence            7899999999999999997543  4899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccC
Q 020981          302 LLTVK  306 (319)
Q Consensus       302 ~~~~~  306 (319)
                      .....
T Consensus       152 ~~~~~  156 (262)
T d1byga_         152 EASST  156 (262)
T ss_dssp             -----
T ss_pred             ecCCC
Confidence            76543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1e-29  Score=221.26  Aligned_cols=157  Identities=31%  Similarity=0.575  Sum_probs=130.6

Q ss_pred             CCCccccCCCcccccceeeeecceEEEEEEe------------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCC
Q 020981          144 EVPEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHP  210 (319)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~ig~G~f~~v~~~------------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~  210 (319)
                      ..|.|+++.+  +|...+.||+|+||.||..            +..||||++.++.  .......+.+|...+.++ +||
T Consensus         4 ~~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hp   79 (299)
T d1fgka_           4 EDPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHK   79 (299)
T ss_dssp             CCTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCT
T ss_pred             cCCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCC
Confidence            3456777665  5777789999999999852            2479999997653  345567788899999888 799


Q ss_pred             cccccceeEEeCCceEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 020981          211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPI  274 (319)
Q Consensus       211 ~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~i  274 (319)
                      ||+++++++.++...++||||+++|+|.+++...                ..+++..+..++.|++.||+|||+++   |
T Consensus        80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---i  156 (299)
T d1fgka_          80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---C  156 (299)
T ss_dssp             TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---E
Confidence            9999999999999999999999999999999754                24899999999999999999999999   9


Q ss_pred             EEcCCCCCCEEecCCCCEEEEecCcccccccCC
Q 020981          275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (319)
Q Consensus       275 vH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~~  307 (319)
                      +||||||+|||++.++.+||+|||+++......
T Consensus       157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~  189 (299)
T d1fgka_         157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHID  189 (299)
T ss_dssp             CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCC
T ss_pred             EeeeecccceeecCCCCeEeccchhhccccccc
Confidence            999999999999999999999999999886543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.3e-30  Score=223.63  Aligned_cols=158  Identities=26%  Similarity=0.484  Sum_probs=127.2

Q ss_pred             ccccceeeeecceEEEEEE-----ece----EeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCCce
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  225 (319)
                      .+|...+.||+|+||.||.     +|+    .||+|.+....  .....+.+.+|+.++++++||||+++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            3688899999999999984     233    58888876432  223356789999999999999999999998764 57


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      ++++|++.+|+|.+++... ..+++..+..|+.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            7888999999999988765 46999999999999999999999999   9999999999999999999999999999886


Q ss_pred             cCCCCce--eeccCCC
Q 020981          305 VKEDRPL--TCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~--~~~~~~~  318 (319)
                      .......  ...||+.
T Consensus       163 ~~~~~~~~~~~~gt~~  178 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIK  178 (317)
T ss_dssp             TTCC--------CCTT
T ss_pred             cccccccccccccCcc
Confidence            6544433  2356664

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.1e-29  Score=220.22  Aligned_cols=142  Identities=32%  Similarity=0.549  Sum_probs=124.0

Q ss_pred             eeeeecceEEEEEEe--------ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe-CCceEEEEe
Q 020981          160 SVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTE  230 (319)
Q Consensus       160 ~~~ig~G~f~~v~~~--------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~e  230 (319)
                      .+.||+|+||.||..        ...||||.+...  ......+.|.+|+.++++++||||+++++++.. +...++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            567999999999841        236899998642  356667889999999999999999999999875 457899999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       231 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ||++|+|.+++.... .+++..+..++.|++.||.|+|+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            999999999988553 4778889999999999999999999   999999999999999999999999999987554

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.6e-30  Score=222.73  Aligned_cols=157  Identities=34%  Similarity=0.561  Sum_probs=128.0

Q ss_pred             cccceeeeecceEEEEEE-----ece--EeEEEEecccccCCHHHHHHHHHHHHHHHhc-CCCcccccceeEEeCCceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~--~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l  227 (319)
                      +|...+.||+|+||.||.     ++.  .||||.+....  .....+.+.+|+.+++++ +||||+++++++...+..|+
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            566678999999999984     222  57888875432  334456789999999999 69999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCC
Q 020981          228 VTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~  291 (319)
                      ||||+++|+|.+++..+                ..+++..+..++.|++.||.|+|+++   |+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence            99999999999999754                45899999999999999999999999   999999999999999999


Q ss_pred             EEEEecCcccccccCCCCceeeccCCC
Q 020981          292 LKVADFGVSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       292 ~kl~DFgla~~~~~~~~~~~~~~~~~~  318 (319)
                      +||+|||+|+......... ...||++
T Consensus       166 ~kl~DfG~a~~~~~~~~~~-~~~gt~~  191 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKKT-MGRLPVR  191 (309)
T ss_dssp             EEECCTTCEESSCEECCC-----CCTT
T ss_pred             eEEcccccccccccccccc-ceecCCc
Confidence            9999999998776554433 3455553

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-29  Score=221.29  Aligned_cols=158  Identities=28%  Similarity=0.430  Sum_probs=125.1

Q ss_pred             cccceeeeecceEEEEE---EeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC----ceEEE
Q 020981          156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV  228 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~lv  228 (319)
                      ++...+.||+|+||.||   ++|+.||||++..+.    ........|+..++.++||||+++++++....    .+|+|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            46677889999999887   478999999986432    22222334666667789999999999997654    58999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEcCCCCCCEEecCCCCEEEEecCccccc
Q 020981          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (319)
Q Consensus       229 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~  303 (319)
                      |||+++|+|.+++++. .+++.....++.|++.||.|+|+..     ..+|+||||||+||||+.++.+||+|||+++.+
T Consensus        80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            9999999999999875 5899999999999999999999731     012999999999999999999999999999988


Q ss_pred             ccCCC----CceeeccCCC
Q 020981          304 TVKED----RPLTCQDTSC  318 (319)
Q Consensus       304 ~~~~~----~~~~~~~~~~  318 (319)
                      .....    ......||+.
T Consensus       159 ~~~~~~~~~~~~~~~gt~~  177 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKR  177 (303)
T ss_dssp             ETTTTEECC----CCSCGG
T ss_pred             cCCCcceeccccceecccC
Confidence            65543    2234567764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-29  Score=224.17  Aligned_cols=154  Identities=27%  Similarity=0.397  Sum_probs=124.4

Q ss_pred             cccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC------
Q 020981          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------  222 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------  222 (319)
                      ..+|...+.||+|+||.||.     +|+.||||++.....       .+.+|+.+++.++||||+++++++...      
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            44788888999999999985     578999999976432       223699999999999999999998542      


Q ss_pred             CceEEEEeecCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEecC
Q 020981          223 SPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFG  298 (319)
Q Consensus       223 ~~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DFg  298 (319)
                      .++|+|||||+++.+..+.   .....+++..++.|++|++.||+|||+++   |+||||||+|||++.++ .+||+|||
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEeccc
Confidence            3579999999765333332   33456999999999999999999999999   99999999999999775 89999999


Q ss_pred             cccccccCCCCceeeccCCC
Q 020981          299 VSKLLTVKEDRPLTCQDTSC  318 (319)
Q Consensus       299 la~~~~~~~~~~~~~~~~~~  318 (319)
                      +|+.+....... +..||+.
T Consensus       169 ~a~~~~~~~~~~-~~~gt~~  187 (350)
T d1q5ka_         169 SAKQLVRGEPNV-SYICSRY  187 (350)
T ss_dssp             TCEECCTTSCCC-SCCSCTT
T ss_pred             chhhccCCcccc-ccccccc
Confidence            999886654443 3456653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.9e-29  Score=222.78  Aligned_cols=156  Identities=26%  Similarity=0.439  Sum_probs=127.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC----ceE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMM  226 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~  226 (319)
                      .|.....||+|+||.||.     +|+.||||++.+..  .....+.+.+|+.+|+.++||||+++++++....    ..+
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            488889999999999985     48899999997532  4555677889999999999999999999986543    234


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccccC
Q 020981          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (319)
Q Consensus       227 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~~  306 (319)
                      ++++++.+|+|.+++..+ .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            445556699999999764 6999999999999999999999999   999999999999999999999999999877554


Q ss_pred             CCC---ceeeccCC
Q 020981          307 EDR---PLTCQDTS  317 (319)
Q Consensus       307 ~~~---~~~~~~~~  317 (319)
                      ...   ....+||+
T Consensus       163 ~~~~~~~~~~~gt~  176 (345)
T d1pmea_         163 HDHTGFLTEYVATR  176 (345)
T ss_dssp             GCBCCTTCCCCSCG
T ss_pred             Cccceeeccccccc
Confidence            322   23455665

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.5e-30  Score=225.55  Aligned_cols=161  Identities=25%  Similarity=0.364  Sum_probs=138.0

Q ss_pred             ccccceeeeecceEEEEEE--------eceEeEEEEecccccC-CHHHHHHHHHHHHHHHhcCC-CcccccceeEEeCCc
Q 020981          155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSP  224 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~--------~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~  224 (319)
                      .+|...+.||+|+||.||.        +|+.||||.+.+.... .....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            3588899999999999985        3688999998764321 12223567789999999976 899999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      .+++|||+.+|+|.+++...+.+++..+..+++|++.||+|+|+++   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999999999999888999999999999999999999999   9999999999999999999999999999875


Q ss_pred             cCCC-CceeeccCCC
Q 020981          305 VKED-RPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~-~~~~~~~~~~  318 (319)
                      .... ...+..|++.
T Consensus       181 ~~~~~~~~~~~g~~~  195 (322)
T d1vzoa_         181 ADETERAYDFCGTIE  195 (322)
T ss_dssp             GGGGGGGCGGGSCCT
T ss_pred             ccccccccccccccc
Confidence            5433 3445566664

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.8e-29  Score=220.51  Aligned_cols=154  Identities=25%  Similarity=0.416  Sum_probs=126.3

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeCC------c
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~  224 (319)
                      .|.....||+|+||.||.     +|+.||||++++.. ..+...+.+.+|+.+|+.++||||++++++|....      .
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            688889999999999985     48899999998654 34556678889999999999999999999997654      5


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +|+||||+ +.+|..+++. +.+++..+..+++|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        98 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccC
Confidence            79999999 6788877654 57999999999999999999999999   9999999999999999999999999998775


Q ss_pred             cCCCCceeeccCCC
Q 020981          305 VKEDRPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~~~~~~~~  318 (319)
                      ...   ....||++
T Consensus       173 ~~~---~~~~~t~~  183 (346)
T d1cm8a_         173 SEM---TGYVVTRW  183 (346)
T ss_dssp             SSC---CSSCSCGG
T ss_pred             Ccc---cccccccc
Confidence            432   34556663

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.95  E-value=9.7e-29  Score=217.92  Aligned_cols=149  Identities=20%  Similarity=0.394  Sum_probs=126.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeC--CceEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMI  227 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~l  227 (319)
                      +|...+.||+|+||.||.     +|+.||||+++...      .+.+.+|+.+|+.++ ||||+++++++...  ..+++
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            688899999999999985     47899999987432      256788999999996 99999999998743  56999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCC-CEEEEecCcccccccC
Q 020981          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK  306 (319)
Q Consensus       228 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DFgla~~~~~~  306 (319)
                      ||||+++++|..+.   +.+++..+..+++||+.||+|||+++   |+||||||+|||++.++ .+||+|||+|+.....
T Consensus       110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999987653   46999999999999999999999999   99999999999999665 5899999999987665


Q ss_pred             CCCceeeccCC
Q 020981          307 EDRPLTCQDTS  317 (319)
Q Consensus       307 ~~~~~~~~~~~  317 (319)
                      .. .....||+
T Consensus       184 ~~-~~~~~~t~  193 (328)
T d3bqca1         184 QE-YNVRVASR  193 (328)
T ss_dssp             CC-CCSCCSCG
T ss_pred             Cc-ccccccCc
Confidence            43 33455665

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.9e-29  Score=217.94  Aligned_cols=160  Identities=26%  Similarity=0.362  Sum_probs=128.2

Q ss_pred             ccccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe--------
Q 020981          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------  221 (319)
Q Consensus       155 ~~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--------  221 (319)
                      -+|...+.||+|+||.||.     +|+.||||++...... +.....+.+|+.+|+.++|||++++++++..        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            4688889999999999985     4789999998765332 2334567889999999999999999998855        


Q ss_pred             CCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       222 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      ....|++|||++++.+.........+++..+..+++|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence            3468999999987666655555567999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCC----CCceeeccCCC
Q 020981          302 LLTVKE----DRPLTCQDTSC  318 (319)
Q Consensus       302 ~~~~~~----~~~~~~~~~~~  318 (319)
                      .+....    ....+.+||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~  186 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLW  186 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGG
T ss_pred             ecccccccccccccceecCHH
Confidence            775432    33344567764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.5e-28  Score=212.17  Aligned_cols=161  Identities=25%  Similarity=0.421  Sum_probs=126.4

Q ss_pred             cccccceeeeecceEEEEEE------eceEeEEEEecccccCCHHHHHHHHHHHHHHHhc---CCCcccccceeEEe---
Q 020981          154 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ---  221 (319)
Q Consensus       154 ~~~~~~~~~ig~G~f~~v~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~---  221 (319)
                      ..+|.....||+|+||.||.      .++.||||++........ ....+.+|+.+++.+   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            45788899999999999985      256799999876433221 122344577776655   79999999998853   


Q ss_pred             --CCceEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecC
Q 020981          222 --SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (319)
Q Consensus       222 --~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFg  298 (319)
                        ....+++|||+.++++...... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence              3468999999987666544433 345899999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCceeeccCCCC
Q 020981          299 VSKLLTVKEDRPLTCQDTSCR  319 (319)
Q Consensus       299 la~~~~~~~~~~~~~~~~~~~  319 (319)
                      +++...... ......|||.|
T Consensus       162 ~~~~~~~~~-~~~~~~gT~~Y  181 (305)
T d1blxa_         162 LARIYSFQM-ALTSVVVTLWY  181 (305)
T ss_dssp             SCCCCCGGG-GGCCCCCCCTT
T ss_pred             hhhhhcccc-cCCCcccChhh
Confidence            998765543 44557788754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.95  E-value=3.3e-27  Score=204.67  Aligned_cols=155  Identities=20%  Similarity=0.243  Sum_probs=130.8

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCC-CcccccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~  229 (319)
                      .|...+.||+|+||.||.     +|+.||||++......     ..+.+|++.++.++| +|++.+++++......++||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            578889999999999985     4789999988654321     346679999999974 89999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC-----CCCEEEEecCccccc
Q 020981          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSKLL  303 (319)
Q Consensus       230 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~DFgla~~~  303 (319)
                      ||+ +++|.+++...+ .+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999 789999987654 6999999999999999999999999   999999999999974     578999999999987


Q ss_pred             ccCC-------CCceeeccCCCC
Q 020981          304 TVKE-------DRPLTCQDTSCR  319 (319)
Q Consensus       304 ~~~~-------~~~~~~~~~~~~  319 (319)
                      ....       ....+.+|||.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y  179 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARY  179 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTT
T ss_pred             ccCccccceeecccCceEEchhh
Confidence            5432       234456788854

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.7e-27  Score=209.83  Aligned_cols=155  Identities=25%  Similarity=0.338  Sum_probs=120.0

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEe------CCc
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SSP  224 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~  224 (319)
                      +|.....||+|+||.||.     +|+.||||++..... .......+.+|+.+++.++||||++++++|..      ...
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            588889999999999985     489999999986543 45566778899999999999999999999864      367


Q ss_pred             eEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCcccccc
Q 020981          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (319)
Q Consensus       225 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~  304 (319)
                      +|+||||+.+ ++.+.+  ...+++..++.+++|++.||.|||++|   |+||||||+|||++.++.+|++|||+++...
T Consensus        97 ~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence            8999999965 555544  346899999999999999999999999   9999999999999999999999999998876


Q ss_pred             cCCCCceeeccCCC
Q 020981          305 VKEDRPLTCQDTSC  318 (319)
Q Consensus       305 ~~~~~~~~~~~~~~  318 (319)
                      ... ......||+.
T Consensus       171 ~~~-~~~~~~~t~~  183 (355)
T d2b1pa1         171 TSF-MMTPYVVTRY  183 (355)
T ss_dssp             -----------CCT
T ss_pred             ccc-cccccccccc
Confidence            653 3334556653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.6e-27  Score=210.36  Aligned_cols=145  Identities=29%  Similarity=0.443  Sum_probs=121.7

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCcccccceeEEeC-----Cce
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM  225 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~  225 (319)
                      +|...+.||+|+||.||.     +|+.||||++.+.. .+....+.+.+|+.+++.++|||++++++++...     ...
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            588889999999998885     48899999998654 3445556788999999999999999999998643     234


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCccccccc
Q 020981          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (319)
Q Consensus       226 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~~~~  305 (319)
                      +++++++.+|+|.+++.. +++++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||+|.....
T Consensus        98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence            666777889999998865 46999999999999999999999999   99999999999999999999999999976643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=1.3e-26  Score=201.52  Aligned_cols=155  Identities=18%  Similarity=0.225  Sum_probs=124.2

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCCCccc-ccceeEEeCCceEEEE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-QFLGAVTQSSPMMIVT  229 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~l~~~~~~~~~~~lv~  229 (319)
                      .|...+.||+|+||.||.     +|+.||||++......     ..+..|+++++.++|++++ .+.+++......++||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            488889999999999985     3789999998754322     3467899999999877655 4556667788899999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecC---CCCEEEEecCccccccc
Q 020981          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV  305 (319)
Q Consensus       230 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DFgla~~~~~  305 (319)
                      ||+ ++++...+.. .+.+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+|+.+..
T Consensus        83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            999 5677666654 457999999999999999999999999   999999999999864   45799999999998765


Q ss_pred             CCC-------CceeeccCCCC
Q 020981          306 KED-------RPLTCQDTSCR  319 (319)
Q Consensus       306 ~~~-------~~~~~~~~~~~  319 (319)
                      ...       ...+..|||.|
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y  179 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARY  179 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSS
T ss_pred             cccccceeccccCCcCCCccc
Confidence            432       23455788754

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=8.9e-27  Score=174.30  Aligned_cols=108  Identities=26%  Similarity=0.199  Sum_probs=101.4

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||+.+|++.++....+...-+|.|+|..+.+|+||||+||..|+.+++++|++.|+|+|.+|.+|+||||+|+..|+.+
T Consensus         3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~   82 (118)
T d1myoa_           3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS   82 (118)
T ss_dssp             HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred             ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence            47899999999988888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIY  115 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~  115 (319)
                      ++++|+++|+|++.+|..|.||+|+|..
T Consensus        83 ~v~~Ll~~Gad~~~~d~~G~t~l~~a~~  110 (118)
T d1myoa_          83 CVKLLLSKGADKTVKGPDGLTALEATDN  110 (118)
T ss_dssp             HHHHHHTTCCCSSSSSSSTCCCCCTCSS
T ss_pred             hhhhhhcccccceeeCCCCCCHHHHHhH
Confidence            9999999999999999999999999854

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.91  E-value=3.6e-25  Score=173.02  Aligned_cols=125  Identities=19%  Similarity=0.157  Sum_probs=109.1

Q ss_pred             cccccccCchhhhhhhhhcCCCCCCC------CCCcchHHHHHHHc---CCHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Q 020981           11 LLKQSSLAPDRERKEAELNGLDDDGE------EIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAA   81 (319)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~t~L~~a~~~---~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~   81 (319)
                      +.+|++.+..........+|.|.+..      +..|+||||+|+..   ++.+++++|+++|+|+|.+|.+|+||||+||
T Consensus        10 L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~   89 (154)
T d1dcqa1          10 LCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCC   89 (154)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHH
T ss_pred             HHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhcccccccc
Confidence            45566666655555555667776665      77899999999974   7789999999999999999999999999999


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCc
Q 020981           82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~  135 (319)
                      ..|+.+++++|+++|++++.+|..|+||+|+|+..|+.+++++|++.+......
T Consensus        90 ~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~~~~i~~~L~~~~~~~~~~  143 (154)
T d1dcqa1          90 LTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALSGRFNS  143 (154)
T ss_dssp             HTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTTCCCS
T ss_pred             ccccccccccccccCccccccCCCCCCHHHHHHHcCCHHHHHHHHHhCCCCCCc
Confidence            999999999999999999999999999999999999999999999987665443

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.2e-25  Score=168.68  Aligned_cols=122  Identities=21%  Similarity=0.070  Sum_probs=111.1

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      -+.|+.|+..++....+...-+|.|+|.+|.+|+||||+||..|+.+++++|++.|+|+|.+|.+|+||||+|+..|+.+
T Consensus         2 l~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~   81 (130)
T d1ycsb1           2 LALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQ   81 (130)
T ss_dssp             HHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             hHHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHH
Confidence            46688999999988888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCC-CCCCCcc--cccccccHHHHHHHHhhC
Q 020981           88 VVSLLLERGADVDPKDR-WGSTPLG--DAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~-~g~tpl~--~a~~~~~~~i~~~L~~~g  129 (319)
                      +|++|+++|++++.++. .|+||++  .+...|+.+++++|+..+
T Consensus        82 ~v~~Ll~~ga~v~~~~~~~~~~~~~~~~a~~~g~~eiv~~L~~~~  126 (130)
T d1ycsb1          82 VCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQ  126 (130)
T ss_dssp             HHHHHHHTTCCTTCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHH
T ss_pred             HHHHHHHcCCCcccccCCCCCCHHHHHHHHHcChHHHHHHHHhHH
Confidence            99999999999998875 5888754  556778899999998753

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=7.6e-26  Score=170.95  Aligned_cols=121  Identities=21%  Similarity=0.258  Sum_probs=113.9

Q ss_pred             ccccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCC-CHHHHHHHcC
Q 020981            6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQG   84 (319)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~-tpLh~A~~~~   84 (319)
                      |-.++|+.|++.++....+...-.|.|+|..+.+|.||||+|+ .|+.+++++|+++|+|+|.+|..|. ||||+|+..|
T Consensus         2 p~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g   80 (125)
T d1bi7b_           2 PSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREG   80 (125)
T ss_dssp             CSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHT
T ss_pred             CChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence            5567899999999999999998899999999999999999775 7999999999999999999998875 6999999999


Q ss_pred             CHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHh
Q 020981           85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK  127 (319)
Q Consensus        85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~  127 (319)
                      +.+++++|+++|++++.+|..|+||+|+|+..|+.+++++|++
T Consensus        81 ~~~~v~~Ll~~ga~~~~~d~~G~T~l~~A~~~g~~~~v~~Lls  123 (125)
T d1bi7b_          81 FLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRA  123 (125)
T ss_dssp             CHHHHHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSS
T ss_pred             cccccccccccccccccccCCCCCHHHHHHHcCCHHHHHHHHh
Confidence            9999999999999999999999999999999999999999875

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.90  E-value=1.2e-24  Score=162.61  Aligned_cols=106  Identities=30%  Similarity=0.393  Sum_probs=99.2

Q ss_pred             chHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHH
Q 020981           41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE  120 (319)
Q Consensus        41 ~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~  120 (319)
                      +|||++||..|+.++|+.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+
T Consensus         3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~   82 (118)
T d1myoa_           3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS   82 (118)
T ss_dssp             HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred             ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhCCCCCCccccccccCCCC
Q 020981          121 VIKLLEKHGAKPLMAPMHVKHAREVP  146 (319)
Q Consensus       121 i~~~L~~~g~~~~~~~~~~~~~~~~~  146 (319)
                      ++++|++.|+++...+....++....
T Consensus        83 ~v~~Ll~~Gad~~~~d~~G~t~l~~a  108 (118)
T d1myoa_          83 CVKLLLSKGADKTVKGPDGLTALEAT  108 (118)
T ss_dssp             HHHHHHTTCCCSSSSSSSTCCCCCTC
T ss_pred             hhhhhhcccccceeeCCCCCCHHHHH
Confidence            99999999999887776666665443

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=3.4e-23  Score=157.25  Aligned_cols=95  Identities=29%  Similarity=0.351  Sum_probs=91.1

Q ss_pred             chHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHH
Q 020981           41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE  120 (319)
Q Consensus        41 ~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~  120 (319)
                      .++||.||..|+.++|+.|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|++++.+|.+|+||||+|+.+|+.+
T Consensus         2 l~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~   81 (130)
T d1ycsb1           2 LALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQ   81 (130)
T ss_dssp             HHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             hHHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHH
Confidence            36899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhCCCCCCc
Q 020981          121 VIKLLEKHGAKPLMA  135 (319)
Q Consensus       121 i~~~L~~~g~~~~~~  135 (319)
                      ++++|++.|++....
T Consensus        82 ~v~~Ll~~ga~v~~~   96 (130)
T d1ycsb1          82 VCKFLVESGAAVFAM   96 (130)
T ss_dssp             HHHHHHHTTCCTTCC
T ss_pred             HHHHHHHcCCCcccc
Confidence            999999999887543

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.87  E-value=7.7e-23  Score=159.40  Aligned_cols=116  Identities=28%  Similarity=0.327  Sum_probs=100.3

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHH----------------------------
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL----------------------------   60 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll----------------------------   60 (319)
                      |||+.|++.|+....+...-+|.|.+ .+..|.||||+|+..++.++++.++                            
T Consensus         4 t~L~~Aa~~g~~~~v~~LL~~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (153)
T d1awcb_           4 KKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANI   82 (153)
T ss_dssp             HHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHH
T ss_pred             HHHHHHHHCCCHHHHHHHHHcCCCcc-cccCCCcccccccccccccccccccccccccccccccccccccccccccccee
Confidence            78999999999888888888888877 6889999999999988888777664                            


Q ss_pred             -----HcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHH
Q 020981           61 -----DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL  125 (319)
Q Consensus        61 -----~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L  125 (319)
                           +.|++++.+|.+|+||||+||..|+.++|++|++.|++++.+|.+|.||+|+|+..|+.+++++|
T Consensus        83 ~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~lL  152 (153)
T d1awcb_          83 VEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL  152 (153)
T ss_dssp             HHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred             eecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHHHcCCHHHHHhC
Confidence                 56777788888899999999999999999999999999998899999999999999998888876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=3.1e-22  Score=162.16  Aligned_cols=134  Identities=19%  Similarity=0.144  Sum_probs=103.3

Q ss_pred             ceeeeecceEEEEEE----eceEeEEEEecccccC---------------CHHHHHHHHHHHHHHHhcCCCcccccceeE
Q 020981          159 NSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (319)
Q Consensus       159 ~~~~ig~G~f~~v~~----~~~~vAvK~l~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~  219 (319)
                      ....||+|+||.||.    +|+.||||+++.....               ..........|...+.++.|++++..++..
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            457899999999985    5789999987542111               011223456788999999999999877652


Q ss_pred             EeCCceEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCEEecCCCCEEEEecCc
Q 020981          220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (319)
Q Consensus       220 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DFgl  299 (319)
                          ..+++|||+++..+..       ++...+..++.|++.+|.|||+++   |+||||||+|||+++++ ++|+|||+
T Consensus        84 ----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~  148 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQ  148 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTT
T ss_pred             ----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCC
Confidence                2479999998755432       455667789999999999999999   99999999999999755 89999999


Q ss_pred             ccccccCC
Q 020981          300 SKLLTVKE  307 (319)
Q Consensus       300 a~~~~~~~  307 (319)
                      |.....+.
T Consensus       149 a~~~~~~~  156 (191)
T d1zara2         149 SVEVGEEG  156 (191)
T ss_dssp             CEETTSTT
T ss_pred             cccCCCCC
Confidence            98776543

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=4.3e-22  Score=165.25  Aligned_cols=136  Identities=25%  Similarity=0.204  Sum_probs=121.3

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .+++..++..++....+...-.+.|+|..|.+|.||||+|+..|+.+++++|+++|+|+|.+|..|.||||+|+..++.+
T Consensus        71 ~~~~~~~~~~~~~~i~~~Ll~~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~  150 (223)
T d1uoha_          71 WSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLK  150 (223)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             cccccccccccccchhHHHhccCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcc
Confidence            45666777777777777777789999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccC
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR  143 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~  143 (319)
                      ++++|++.|++++.+|.+|+||||.|+..|+.+++++|++.|+++...+....+|.
T Consensus       151 ~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tpl  206 (223)
T d1uoha_         151 MIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPL  206 (223)
T ss_dssp             HHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHH
T ss_pred             hhhhhccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence            99999999999999999999999999999999999999999998877766555553

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=5.9e-22  Score=164.40  Aligned_cols=119  Identities=21%  Similarity=0.158  Sum_probs=75.0

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .|||+.|+..++....+...-.|.|+|..+.+|.||||+|+..++.++++.|++.|+++|.+|.+|+||||+|+..|+.+
T Consensus       104 ~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~  183 (223)
T d1uoha_         104 CTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVE  183 (223)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHH
T ss_pred             CchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCceeccccccCcHH
Confidence            35566666666555555555556666666666666666666666666666666666666666666666666666666666


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHh
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK  127 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~  127 (319)
                      +|++|+++||+++.+|..|+||+|+|. .|+.++++.|++
T Consensus       184 ~v~~LL~~Gad~~~~d~~g~tpl~~A~-~~~~~i~~~Ll~  222 (223)
T d1uoha_         184 EAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE  222 (223)
T ss_dssp             HHHHHHHTTCCSCCCCTTSCCHHHHCC-TTHHHHHHHHHC
T ss_pred             HHHHHHHCCCCCCCCCCCCCCHHHHHH-CCCHHHHhcccC
Confidence            666666666666666666666666653 455566665553

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=6.8e-22  Score=154.73  Aligned_cols=117  Identities=24%  Similarity=0.272  Sum_probs=63.0

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHH
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV   88 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~   88 (319)
                      ||++.|+. ++....+...-++.|+|..+..|.+||+.++..++.++++.++++|+++|.+|.+|+||||+||..|+.++
T Consensus        38 t~L~~A~~-~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i  116 (156)
T d1bd8a_          38 TALQVMMF-GSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAV  116 (156)
T ss_dssp             CHHHHSCT-TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHH
T ss_pred             cccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCeeeccccccccccc
Confidence            44444433 33333344444555555555555555555555555555555555555555555555555555555555555


Q ss_pred             HHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHh
Q 020981           89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK  127 (319)
Q Consensus        89 v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~  127 (319)
                      +++|+ .|++++.+|..|+||+|+|+..|+.+++++|++
T Consensus       117 ~~~L~-~~~~~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~  154 (156)
T d1bd8a_         117 VSFLA-AESDLHRRDARGLTPLELALQRGAQDLVDILQG  154 (156)
T ss_dssp             HHHHH-TTSCTTCCCTTSCCHHHHHHHSCCHHHHHHHHT
T ss_pred             ccccc-ccccccccCCCCCCHHHHHHHcCCHHHHHHHHh
Confidence            55554 455555555555555555555555555555554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.85  E-value=1.9e-21  Score=172.91  Aligned_cols=152  Identities=21%  Similarity=0.357  Sum_probs=116.5

Q ss_pred             cccceeeeecceEEEEEE-----eceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-----------CCcccccceeE
Q 020981          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLGAV  219 (319)
Q Consensus       156 ~~~~~~~ig~G~f~~v~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~l~~~~  219 (319)
                      +|.....||+|+||.||.     +|+.||||+++++.    ...+.+.+|+.+++.++           |+||+++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            488899999999999985     48999999997542    33456778888888775           57899999887


Q ss_pred             EeC--CceEEEEeecCCCC-HHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCEEecCCCC--
Q 020981          220 TQS--SPMMIVTEYLPKGD-LRAFLKR--KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN--  291 (319)
Q Consensus       220 ~~~--~~~~lv~e~~~~g~-L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~~~~ivH~Dlk~~Nill~~~~~--  291 (319)
                      ...  ...+++++++..+. .......  ...+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.  
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence            543  45666666665443 3333332  3468999999999999999999998 77   999999999999986654  


Q ss_pred             ----EEEEecCcccccccCCCCceeeccCC
Q 020981          292 ----LKVADFGVSKLLTVKEDRPLTCQDTS  317 (319)
Q Consensus       292 ----~kl~DFgla~~~~~~~~~~~~~~~~~  317 (319)
                          +|++|||.|.......   ...+||+
T Consensus       167 ~~~~~kl~dfg~s~~~~~~~---~~~~gt~  193 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEHY---TNSIQTR  193 (362)
T ss_dssp             TEEEEEECCCTTCEETTBCC---CSCCSCG
T ss_pred             ccceeeEeeccccccccccc---ccccccc
Confidence                9999999998765432   3345665

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.84  E-value=1.7e-21  Score=164.44  Aligned_cols=103  Identities=33%  Similarity=0.394  Sum_probs=97.7

Q ss_pred             cCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCccc-CCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCC
Q 020981           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (319)
Q Consensus        29 ~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~-d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~  107 (319)
                      .+.++|.++.+|.||||+||..|+.++++.|++.|++++.+ +..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus       147 ~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~  226 (255)
T d1oy3d_         147 WRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGR  226 (255)
T ss_dssp             GGGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             cCcccccccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCC
Confidence            36677889999999999999999999999999999998864 67899999999999999999999999999999999999


Q ss_pred             CCcccccccccHHHHHHHHhhCCC
Q 020981          108 TPLGDAIYYKNHEVIKLLEKHGAK  131 (319)
Q Consensus       108 tpl~~a~~~~~~~i~~~L~~~g~~  131 (319)
                      ||||+|+..++.+++++|+++|++
T Consensus       227 t~L~~A~~~~~~~i~~~Ll~~Ga~  250 (255)
T d1oy3d_         227 TPLGSALLRPNPILARLLRAHGAP  250 (255)
T ss_dssp             CHHHHHHTSSCHHHHHHHHHTTCC
T ss_pred             CHHHHHHHCCCHHHHHHHHHcCCC
Confidence            999999999999999999999986

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.84  E-value=1.8e-21  Score=165.93  Aligned_cols=136  Identities=25%  Similarity=0.250  Sum_probs=114.1

Q ss_pred             cccccccccccCchhhhhhh--------hhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHH
Q 020981            7 VRTTLLKQSSLAPDRERKEA--------ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALH   78 (319)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh   78 (319)
                      -.||||.|+..++....+..        .-+|+|+|.+|.+|+||||+||..|+.++|++|+++|||+|.+|.+|.||||
T Consensus        33 g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t~l~  112 (277)
T d2fo1e1          33 NRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALH  112 (277)
T ss_dssp             CCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHH
T ss_pred             CccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeecccccccccccccccccccccccccccccccccc
Confidence            46999999999987666543        4478999999999999999999999999999999999999999999999999


Q ss_pred             HHHHcCCHH-----------------------------------------------------------------------
Q 020981           79 VAACQGFTE-----------------------------------------------------------------------   87 (319)
Q Consensus        79 ~A~~~~~~~-----------------------------------------------------------------------   87 (319)
                      +|+..++.+                                                                       
T Consensus       113 ~a~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~  192 (277)
T d2fo1e1         113 QAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALH  192 (277)
T ss_dssp             HHHHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHH
T ss_pred             chhhhcchhhhhhhhhcccccccccccccccchhHHHHHhcccccccccccccccccccccccccccccccccCCCCccc
Confidence            988876543                                                                       


Q ss_pred             ---------HHHHhh-hCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           88 ---------VVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        88 ---------~v~~Ll-~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                               ++++++ ..+.+++.+|..|+||||+|+..|+.+++++|++.|+++...+....++
T Consensus       193 ~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~  257 (277)
T d2fo1e1         193 YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTA  257 (277)
T ss_dssp             HHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCH
T ss_pred             cccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCH
Confidence                     333333 4577888888999999999999999999999999999887666555444

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.83  E-value=7.9e-21  Score=163.34  Aligned_cols=139  Identities=27%  Similarity=0.275  Sum_probs=122.3

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcc-------------------
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF-------------------   68 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~-------------------   68 (319)
                      .|+|++|+..|+....+.+.-+|+|+|..|.+|.||||+|+..|+.++|++|+++|++++.                   
T Consensus        41 ~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~~~~  120 (291)
T d1s70b_          41 GAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD  120 (291)
T ss_dssp             HHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHH
T ss_pred             chHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeecccccccccccccccccccccccccccc
Confidence            5789999999999999999999999999999999999999999999999999998876433                   


Q ss_pred             --------------------------------------------------------------------------cCCCCC
Q 020981           69 --------------------------------------------------------------------------RDIDNR   74 (319)
Q Consensus        69 --------------------------------------------------------------------------~d~~g~   74 (319)
                                                                                                .+.+|.
T Consensus       121 ~~~~l~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~  200 (291)
T d1s70b_         121 IAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGG  200 (291)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTCC
T ss_pred             hhhcccccCcccccccccCccccccccccccchhccccccccccccccccccccccccccchhhhcccccccccccCCCC
Confidence                                                                                      234567


Q ss_pred             CHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccCCCC
Q 020981           75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVP  146 (319)
Q Consensus        75 tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~~~  146 (319)
                      ||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|+++...+....++..+.
T Consensus       201 t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~~A  272 (291)
T d1s70b_         201 TALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVA  272 (291)
T ss_dssp             CHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTSC
T ss_pred             ChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHH
Confidence            788888888899999999999999999999999999999999999999999999999877766666665554

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.82  E-value=1.4e-20  Score=156.10  Aligned_cols=121  Identities=22%  Similarity=0.142  Sum_probs=107.7

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcC-CCCcccCCCCCCHHHHHHHcCCH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFT   86 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~g-a~vn~~d~~g~tpLh~A~~~~~~   86 (319)
                      .|++..++..++........-.+.+.+.++.+|+||||+|+..|+.++++.|++.| .++|.+|.+|+||||+|+..|+.
T Consensus       106 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~  185 (229)
T d1ixva_         106 VTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHG  185 (229)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCH
T ss_pred             ccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccH
Confidence            35566666767666666667789999999999999999999999999999999987 68999999999999999999999


Q ss_pred             HHHHHhhh-CCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCC
Q 020981           87 EVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (319)
Q Consensus        87 ~~v~~Ll~-~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~  131 (319)
                      ++|++|++ .|++++.+|..|+||||+|+.   .+++++|++.|+|
T Consensus       186 ~~v~~Ll~~~gad~~~~d~~g~t~l~~A~~---~~~~~~Ll~~g~d  228 (229)
T d1ixva_         186 DAAVLLVEKYGAEYDLVDNKGAKAEDVALN---EQVKKFFLNNVVD  228 (229)
T ss_dssp             HHHHHHHHHHCCCSCCCCTTSCCTGGGCSC---HHHHHHHHHHCCC
T ss_pred             HHHHHHHHhcCCCCCCcCCCCCCHHHHHhh---HHHHHHHHHcCCC
Confidence            99999997 599999999999999999984   4789999999876

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=3.4e-21  Score=145.05  Aligned_cols=102  Identities=24%  Similarity=0.247  Sum_probs=91.8

Q ss_pred             cchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCC-CCccccccccc
Q 020981           40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKN  118 (319)
Q Consensus        40 ~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~-tpl~~a~~~~~  118 (319)
                      +.++||+||..|+.++|++|+++|+|+|.+|.+|+||||+|+ .|+.+++++|+++|++++.+|..|. ||+|+|+..|+
T Consensus         3 ~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~   81 (125)
T d1bi7b_           3 SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF   81 (125)
T ss_dssp             STTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred             ChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence            457899999999999999999999999999999999999765 7999999999999999999999877 69999999999


Q ss_pred             HHHHHHHHhhCCCCCCcccccccc
Q 020981          119 HEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus       119 ~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      .+++++|++.|++....+....++
T Consensus        82 ~~~v~~Ll~~ga~~~~~d~~G~T~  105 (125)
T d1bi7b_          82 LDTLVVLHRAGARLDVRDAWGRLP  105 (125)
T ss_dssp             HHHHHHHHHHTCCSSCCCTTCCCH
T ss_pred             ccccccccccccccccccCCCCCH
Confidence            999999999998876655444433

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=8.3e-21  Score=148.44  Aligned_cols=126  Identities=21%  Similarity=0.220  Sum_probs=113.6

Q ss_pred             ccccccccCchhhhhhhhh-cCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHH
Q 020981           10 TLLKQSSLAPDRERKEAEL-NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV   88 (319)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~   88 (319)
                      +|+.|++.|+....+.... .+.|+|..|..|+||||+|+ .|+.+++++|++.|+++|.++..|.+||++|+..++.++
T Consensus         5 ~L~~Aa~~g~~~~vk~lL~~~~~~~n~~d~~g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~   83 (156)
T d1bd8a_           5 RLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDT   83 (156)
T ss_dssp             HHHHHHHHTCHHHHHHHHHTTCCCTTCCCTTSCCHHHHSC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHH
T ss_pred             HHHHHHHcCCHHHHHHHHHhCCCCCCccCCCCCccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence            4888999999777777655 58999999999999999987 488999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccc
Q 020981           89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (319)
Q Consensus        89 v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~  137 (319)
                      +++++++|++++.+|..|+||+|+|+..|+.+++++|+ .+++....+.
T Consensus        84 ~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~  131 (156)
T d1bd8a_          84 LKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDA  131 (156)
T ss_dssp             HHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCCT
T ss_pred             cccccccccccccccCCCCeeecccccccccccccccc-ccccccccCC
Confidence            99999999999999999999999999999999999887 5666554443

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.2e-20  Score=169.46  Aligned_cols=121  Identities=26%  Similarity=0.189  Sum_probs=108.2

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.++..++....+-..-+|.|++..+..+.||||.|+..++.++++.+++.|+|+|.+|.+|+||||+|+..|+.+
T Consensus       265 ~~~l~~a~~~~~~~i~~~Ll~~g~~~~~~~~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~  344 (408)
T d1n11a_         265 LTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTD  344 (408)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CChhhhhhhcCcHHHHHHHHHCCCccccccccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHH
Confidence            35666777777766666666679999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhh
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      +|++|+++||+++.+|.+|+||||+|+..|+.+++++|..-
T Consensus       345 iv~~Ll~~GAd~n~~d~~G~t~L~~A~~~~~~~iv~~L~~~  385 (408)
T d1n11a_         345 IVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVV  385 (408)
T ss_dssp             HHHHHHHTTCCSCCCCSSSCCHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHH
Confidence            99999999999999999999999999999999999877543

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.81  E-value=1.3e-20  Score=156.33  Aligned_cols=136  Identities=22%  Similarity=0.121  Sum_probs=111.6

Q ss_pred             cccccccccCchhhhhhhhh-cCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcc-------------------
Q 020981            9 TTLLKQSSLAPDRERKEAEL-NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF-------------------   68 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~-------------------   68 (319)
                      ||||+|++.++....+.... .+.+++.+|.+|+||||+||..|+.+++++|+++|+++|.                   
T Consensus         2 ~pLh~A~~~g~~~~v~~Ll~~~~~~~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~~   81 (229)
T d1ixva_           2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACSVG   81 (229)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHHCGGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHTTCTTCCGGGCCCTTSCCHHHHHHHHT
T ss_pred             HhHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCCHHHHHHHcCCccccchhhhhhcccccccccccccccccccccccc
Confidence            79999999999666655544 5789999999999999999999999999999999987541                   


Q ss_pred             ----------------------------------------------------cCCCCCCHHHHHHHcCCHHHHHHhhhCC
Q 020981           69 ----------------------------------------------------RDIDNRTALHVAACQGFTEVVSLLLERG   96 (319)
Q Consensus        69 ----------------------------------------------------~d~~g~tpLh~A~~~~~~~~v~~Ll~~g   96 (319)
                                                                          +|.+|+||||+|+..|+.+++++|++.|
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~  161 (229)
T d1ixva_          82 NLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLG  161 (229)
T ss_dssp             CHHHHHHHHSSSSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTT
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccc
Confidence                                                                3566788888888888888999999875


Q ss_pred             -CcccCCCCCCCCCcccccccccHHHHHHHHh-hCCCCCCccccccccCC
Q 020981           97 -ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHARE  144 (319)
Q Consensus        97 -~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~-~g~~~~~~~~~~~~~~~  144 (319)
                       .+++.+|..|+||||+|+..++.+++++|++ .|+++...+....++..
T Consensus       162 ~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l~  211 (229)
T d1ixva_         162 KSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAED  211 (229)
T ss_dssp             CCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCTGG
T ss_pred             cccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCCCCHHH
Confidence             6788899999999999999999999998886 58877666554444433

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.81  E-value=1.3e-20  Score=154.04  Aligned_cols=106  Identities=21%  Similarity=0.215  Sum_probs=99.4

Q ss_pred             hhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcc
Q 020981           20 DRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV   99 (319)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~   99 (319)
                      ........-.+.+++..+..|.|||++|+..+..++++.|++.++++|.+|.+|+||||+||..|+.++|++|+++|||+
T Consensus       103 ~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~  182 (209)
T d1ot8a_         103 EGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANR  182 (209)
T ss_dssp             TTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCT
T ss_pred             hhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCC
Confidence            34444455678999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCcccccccccHHHHHHH
Q 020981          100 DPKDRWGSTPLGDAIYYKNHEVIKLL  125 (319)
Q Consensus       100 ~~~~~~g~tpl~~a~~~~~~~i~~~L  125 (319)
                      +.+|..|+||+|+|+..|+.+++++|
T Consensus       183 n~~d~~g~Tpl~~A~~~~~~~iv~lL  208 (209)
T d1ot8a_         183 EITDHMDRLPRDVASERLHHDIVRLL  208 (209)
T ss_dssp             TCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred             CCcCCCCCCHHHHHHHcCCHHHHhhc
Confidence            99999999999999999999999987

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=2.3e-20  Score=152.80  Aligned_cols=139  Identities=19%  Similarity=0.106  Sum_probs=114.7

Q ss_pred             ccccccccccCchhhhhhhh----hcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccC-------------
Q 020981            8 RTTLLKQSSLAPDRERKEAE----LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-------------   70 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d-------------   70 (319)
                      .|||+.|++.++....+...    -+|+|+|..|.+|+||||+||..|+.++++.|+++|+++|..+             
T Consensus         4 ~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a~~~   83 (228)
T d1k1aa_           4 DTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEH   83 (228)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             ccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhccccccccccccccccccccccccccccccccccc
Confidence            58999999999866555443    3799999999999999999999999999999999998765332             


Q ss_pred             ----------------------------------------------------------CCCCCHHHHHHHcCCHHHHHHh
Q 020981           71 ----------------------------------------------------------IDNRTALHVAACQGFTEVVSLL   92 (319)
Q Consensus        71 ----------------------------------------------------------~~g~tpLh~A~~~~~~~~v~~L   92 (319)
                                                                                ..|.+|||.|+..+...+++.+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~~  163 (228)
T d1k1aa_          84 RSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLL  163 (228)
T ss_dssp             TCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHH
T ss_pred             ccccchhhhhhccccccccccccccccccccccccccccchhhhhhhccccccccccccchhhHHHHHHHhhhhhhhhhh
Confidence                                                                      2456666666666777788888


Q ss_pred             hhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccCCCC
Q 020981           93 LERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVP  146 (319)
Q Consensus        93 l~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~~~  146 (319)
                      ++.|.+++.+|..|.||+|+|+..|+.+++++|++.|+++...+....++..+.
T Consensus       164 ~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A  217 (228)
T d1k1aa_         164 LQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVA  217 (228)
T ss_dssp             HHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTC
T ss_pred             hhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence            988999999999999999999999999999999999998877776666665543

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.81  E-value=2.2e-21  Score=165.41  Aligned_cols=118  Identities=17%  Similarity=0.196  Sum_probs=95.3

Q ss_pred             cccccccc-cCchhhhhhhhhcCCCCCCCC-CCcchHHHHHHHcCCHHHHHHH--------HHcCCCCcccCCCCCCHHH
Q 020981            9 TTLLKQSS-LAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKEL--------LDSGIDVNFRDIDNRTALH   78 (319)
Q Consensus         9 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~t~L~~a~~~~~~~~~~~L--------l~~ga~vn~~d~~g~tpLh   78 (319)
                      ||++-+++ .+.........-.+  +|..+ .+|+||||+||..|+.++|+.|        ++.|||||.+|.+|+||||
T Consensus         2 ~p~~~~~~~~~~~~~~~~l~~~~--~n~~~~~~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh   79 (277)
T d2fo1e1           2 SPIKLHTEAAGSYAITEPITRES--VNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLM   79 (277)
T ss_dssp             CCCHHHHHHHSSSCCCSCCSTTT--TTTCCCSSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHH
T ss_pred             ChHHHHHHhCCCHHHHHHHHhcC--CCcCCCCCCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeec
Confidence            45553222 33333333333333  33444 4699999999999999998877        5679999999999999999


Q ss_pred             HHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhh
Q 020981           79 VAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH  128 (319)
Q Consensus        79 ~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~  128 (319)
                      +|+..|+.++|++|+++|++++.+|..|.||++.|...++.++...+...
T Consensus        80 ~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t~l~~a~~~~~~~~~~~l~~~  129 (277)
T d2fo1e1          80 LAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNS  129 (277)
T ss_dssp             HHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccccchhhhcchhhhhhhhhc
Confidence            99999999999999999999999999999999999999999988877654

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=6.9e-20  Score=151.38  Aligned_cols=123  Identities=23%  Similarity=0.212  Sum_probs=72.1

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHH---------------------------
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL---------------------------   60 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll---------------------------   60 (319)
                      +|||+.|+..++....+-..-.|.|++..+.+|.||||+|+..++.++++.|+                           
T Consensus        40 ~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~t~l~~a~  119 (221)
T d1iknd_          40 QTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLAS  119 (221)
T ss_dssp             CCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHH
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccchhhhHHh
Confidence            45555555555555555555555555555555555555555555444444443                           


Q ss_pred             ------------HcCCCCcccC-CCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHh
Q 020981           61 ------------DSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK  127 (319)
Q Consensus        61 ------------~~ga~vn~~d-~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~  127 (319)
                                  ..|++++.++ .+|+||||+|++.|+.+++++|+++|+|++.+|..|+||+|+|+..++.+++++|.+
T Consensus       120 ~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~~~~~~~~~~~l~~  199 (221)
T d1iknd_         120 IHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQ  199 (221)
T ss_dssp             HTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTTSSCHHHHHHHHT
T ss_pred             hcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHHHHCCCHHHHHHHHH
Confidence                        3333343333 456666666666666666666666666666666666666666666666666666666


Q ss_pred             hCC
Q 020981          128 HGA  130 (319)
Q Consensus       128 ~g~  130 (319)
                      ...
T Consensus       200 ~~~  202 (221)
T d1iknd_         200 LTL  202 (221)
T ss_dssp             TSC
T ss_pred             cCC
Confidence            544

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=2.8e-20  Score=145.08  Aligned_cols=121  Identities=24%  Similarity=0.240  Sum_probs=113.7

Q ss_pred             cccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHH
Q 020981            9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV   88 (319)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~   88 (319)
                      +||+.||..++....+...-+|+|+|.+|.+|.||||+|+ .|+.+++++|+++|+|++.++.+|.|||+.++..++.+.
T Consensus         3 ~~Lh~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~   81 (156)
T d1ihba_           3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDT   81 (156)
T ss_dssp             HHHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHH
T ss_pred             HHHHHHHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccc
Confidence            5789999999999999998899999999999999999886 789999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCC
Q 020981           89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA  130 (319)
Q Consensus        89 v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~  130 (319)
                      +++|++.+.+++..|..|.+|+++|+..++.++++.|++.++
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~Ll~~~~  123 (156)
T d1ihba_          82 LQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTA  123 (156)
T ss_dssp             HHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999999999999999999999999998876

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.80  E-value=5.6e-20  Score=159.31  Aligned_cols=116  Identities=19%  Similarity=0.190  Sum_probs=97.4

Q ss_pred             cCCCCCCC-CCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH-------HHHHHhhh------
Q 020981           29 NGLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT-------EVVSLLLE------   94 (319)
Q Consensus        29 ~~~~~~~~-~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~-------~~v~~Ll~------   94 (319)
                      .++|+|.. |.+|+||||+||..|+.++|+.||++|||++.+|..|+||||+||..++.       +++++|..      
T Consensus        95 ~~~dvn~~~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d  174 (301)
T d1sw6a_          95 TQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILED  174 (301)
T ss_dssp             SCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEEC
T ss_pred             cCCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcc
Confidence            57788876 89999999999999999999999999999999999999999999986642       33333221      


Q ss_pred             ------------------------------------CCC-------------------------------------cccC
Q 020981           95 ------------------------------------RGA-------------------------------------DVDP  101 (319)
Q Consensus        95 ------------------------------------~g~-------------------------------------~~~~  101 (319)
                                                          .+.                                     .+|.
T Consensus       175 ~~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~  254 (301)
T d1sw6a_         175 SMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNA  254 (301)
T ss_dssp             TTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTC
T ss_pred             cccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccC
Confidence                                                111                                     1688


Q ss_pred             CCCCCCCCcccccccccHHHHHHHHhhCCCCCCccccccccCC
Q 020981          102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE  144 (319)
Q Consensus       102 ~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~~~  144 (319)
                      +|..|+||||+|+..|+.+++++|++.|+++...+....+|..
T Consensus       255 ~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~  297 (301)
T d1sw6a_         255 QDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVD  297 (301)
T ss_dssp             CCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGG
T ss_pred             CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHH
Confidence            8999999999999999999999999999999887766666543

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.80  E-value=2.1e-20  Score=157.51  Aligned_cols=95  Identities=23%  Similarity=0.171  Sum_probs=89.5

Q ss_pred             CCCCcchHHHHHHHcCCHHHHHHHHHcCCC---CcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCccc
Q 020981           36 EEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD  112 (319)
Q Consensus        36 ~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~---vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~  112 (319)
                      .+.+|+||||+||..|+.+++++||++|++   +|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|.||+|+
T Consensus         5 i~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~~   84 (255)
T d1oy3d_           5 VTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHL   84 (255)
T ss_dssp             CCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHH
T ss_pred             CCcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhhh
Confidence            467899999999999999999999999998   77888999999999999999999999999999999999999999999


Q ss_pred             ccccccHHHHHHHHhhCC
Q 020981          113 AIYYKNHEVIKLLEKHGA  130 (319)
Q Consensus       113 a~~~~~~~i~~~L~~~g~  130 (319)
                      |+..++.++++.|++...
T Consensus        85 A~~~~~~~~~~~Ll~~~~  102 (255)
T d1oy3d_          85 ACRVRAHTCACVLLQPRP  102 (255)
T ss_dssp             HTTTTCHHHHHHHSSSCC
T ss_pred             hhccCchHHHHHHHhhcc
Confidence            999999999999987654

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=3.9e-20  Score=152.87  Aligned_cols=136  Identities=23%  Similarity=0.188  Sum_probs=105.0

Q ss_pred             ccccccccccCchhh----hhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHc
Q 020981            8 RTTLLKQSSLAPDRE----RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ   83 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~   83 (319)
                      .||||.|+..+....    .+....++.++|.+|.+|+||||+||..|+.+++++|++.|+|++.+|.+|+||||+|+..
T Consensus         3 ~t~Lh~A~~~g~~~~~~~li~~~~~~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~   82 (221)
T d1iknd_           3 DSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQ   82 (221)
T ss_dssp             CCTTHHHHHTTCSSSSSCCCC-----CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHH
T ss_pred             ChHHHHHHHcCCHHHHHHHHHHHHhCCCCcccCCCCCCcccccccccccccccccccccccccccccccccccccccccc
Confidence            478888888776422    2334447899999999999999999999999999999999999999999999999999988


Q ss_pred             CCHHHHHHhhhC---------------------------------------CCcccCCC-CCCCCCcccccccccHHHHH
Q 020981           84 GFTEVVSLLLER---------------------------------------GADVDPKD-RWGSTPLGDAIYYKNHEVIK  123 (319)
Q Consensus        84 ~~~~~v~~Ll~~---------------------------------------g~~~~~~~-~~g~tpl~~a~~~~~~~i~~  123 (319)
                      |+.++++.|++.                                       |+.++..+ ..|.||+|+|+..|+.++++
T Consensus        83 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~  162 (221)
T d1iknd_          83 GCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVS  162 (221)
T ss_dssp             TCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHH
T ss_pred             ccccccchhhhhcccccccccccccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHH
Confidence            877777666543                                       44444444 46888888888888888888


Q ss_pred             HHHhhCCCCCCccccccccC
Q 020981          124 LLEKHGAKPLMAPMHVKHAR  143 (319)
Q Consensus       124 ~L~~~g~~~~~~~~~~~~~~  143 (319)
                      +|++.|+++...+....++.
T Consensus       163 ~Ll~~gad~~~~~~~G~tpl  182 (221)
T d1iknd_         163 LLLKCGADVNRVTYQGYSPY  182 (221)
T ss_dssp             HHHTTTCCSCCCCTTCCCGG
T ss_pred             HHHhcCCcccccCCCCCCHH
Confidence            88888887765555444443

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.79  E-value=6.7e-22  Score=174.93  Aligned_cols=125  Identities=12%  Similarity=-0.055  Sum_probs=105.1

Q ss_pred             ccccccccccCchhhh---hhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccC--CCCCCHHHHHHH
Q 020981            8 RTTLLKQSSLAPDRER---KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--IDNRTALHVAAC   82 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d--~~g~tpLh~A~~   82 (319)
                      .|+++.||..|+....   ......|.++|..+.+|+||||+||..|+.++|++|++.|+++|.+|  .+|+||||+||.
T Consensus        91 ~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~  170 (346)
T d2ajaa1          91 EVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAE  170 (346)
T ss_dssp             HHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHH
T ss_pred             CcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHH
Confidence            5788899999985443   33566899999999999999999999999999999999999999876  459999999999


Q ss_pred             cCCHHHHHHhhhCCCcc---cCCCCCCCCCcccccccccHHHHHHHHhhCCCC
Q 020981           83 QGFTEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus        83 ~~~~~~v~~Ll~~g~~~---~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      .|+.++|++|++.|++.   +..+..|.||++.|+..|+.+++++|++.|++.
T Consensus       171 ~g~~~iv~~Ll~~~~~~~~~~~~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~  223 (346)
T d2ajaa1         171 NGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVML  223 (346)
T ss_dssp             TTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHHH
T ss_pred             HhhHHHHHHHHHcCCcccccccccCCCcchhhHHhhcCHHHHHHHHHhCCCCc
Confidence            99999999999999765   344456778888999999999999999987654

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=2.4e-19  Score=153.22  Aligned_cols=129  Identities=25%  Similarity=0.177  Sum_probs=113.4

Q ss_pred             ccccccccccCchhhhhhhh-hcCCCCCCCCCCcchHHHHHHHc----CCHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Q 020981            8 RTTLLKQSSLAPDRERKEAE-LNGLDDDGEEIKPEFRLMFLANE----RDVEGIKELLDSGIDVNFRDIDNRTALHVAAC   82 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~t~L~~a~~~----~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~   82 (319)
                      .|||+.|++.+.....+... -.++|++..+..|.++++.+...    +..+++++|+++|+++|.+|.+|+||||+|+.
T Consensus       149 ~t~L~~A~~~~~~~~~~~Ll~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~  228 (285)
T d1wdya_         149 ATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVE  228 (285)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHH
T ss_pred             chHHHHHHHcCCHHHHHHHHhccCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhh
Confidence            57888888888755555443 35899999999999988876654    34579999999999999999999999999999


Q ss_pred             cCCHHHHHHhhh-CCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcc
Q 020981           83 QGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (319)
Q Consensus        83 ~~~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~  136 (319)
                      .|+.+++++|++ .|++++.+|.+|.||||+|+..|+.+++++|++.|+++...+
T Consensus       229 ~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d  283 (285)
T d1wdya_         229 KKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD  283 (285)
T ss_dssp             TTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred             cCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccc
Confidence            999999999998 599999999999999999999999999999999999987654

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.77  E-value=1.5e-19  Score=156.62  Aligned_cols=107  Identities=21%  Similarity=0.133  Sum_probs=92.2

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCH-------HHHHH----------------------
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDV-------EGIKE----------------------   58 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~-------~~~~~----------------------   58 (319)
                      .||||+||+.++....+.+.-.|+|++.+|..|+||||.||..++.       ++++.                      
T Consensus       108 ~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~~g~t~lh~~~~~  187 (301)
T d1sw6a_         108 NTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHIIIT  187 (301)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHHHHHHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcccccCCHHHHHHHH
Confidence            4899999999999999998899999999999999999999986541       22222                      


Q ss_pred             --------------------HHHcCC-------------------------------------CCcccCCCCCCHHHHHH
Q 020981           59 --------------------LLDSGI-------------------------------------DVNFRDIDNRTALHVAA   81 (319)
Q Consensus        59 --------------------Ll~~ga-------------------------------------~vn~~d~~g~tpLh~A~   81 (319)
                                          +++.+.                                     .+|.+|.+|+||||+||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~D~~G~TpLh~A~  267 (301)
T d1sw6a_         188 SGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAA  267 (301)
T ss_dssp             HTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHHHHHH
T ss_pred             hCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCCCCCCCCHHHHHH
Confidence                                222221                                     17889999999999999


Q ss_pred             HcCCHHHHHHhhhCCCcccCCCCCCCCCccccc
Q 020981           82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI  114 (319)
Q Consensus        82 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~  114 (319)
                      +.|+.++|++|+++||+++.+|..|+|||++|+
T Consensus       268 ~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~  300 (301)
T d1sw6a_         268 RLGNISIVDALLDYGADPFIANKSGLRPVDFGA  300 (301)
T ss_dssp             HHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred             HcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence            999999999999999999999999999999996

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.77  E-value=5e-19  Score=151.89  Aligned_cols=95  Identities=27%  Similarity=0.327  Sum_probs=86.7

Q ss_pred             cCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCC
Q 020981           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (319)
Q Consensus        29 ~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  108 (319)
                      ...+....+..|.||||.|+..|+.++++.|++.|+|+|.+|.+|+||||+|+..|+.++|++|+++|||++.+|..|+|
T Consensus       188 ~~~~~~~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~T  267 (291)
T d1s70b_         188 GHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQT  267 (291)
T ss_dssp             TCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             cccccccccCCCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence            45666778889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccccccccHHHHHHHHh
Q 020981          109 PLGDAIYYKNHEVIKLLEK  127 (319)
Q Consensus       109 pl~~a~~~~~~~i~~~L~~  127 (319)
                      |||+|+.    +++++|.+
T Consensus       268 aL~~A~e----~~~~~L~~  282 (291)
T d1s70b_         268 AFDVADE----DILGYLEE  282 (291)
T ss_dssp             TTTSCCS----GGGHHHHH
T ss_pred             HHHHHHH----HHHHHHHH
Confidence            9999976    34455544

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=5.9e-19  Score=137.41  Aligned_cols=121  Identities=26%  Similarity=0.328  Sum_probs=112.5

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+ .++..+.+...-.+.|++..+..|.|+|+.++..++.+.++.|++.+.+++..|..|.+|||+|+..++.+
T Consensus        35 ~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~a~~~~~~~  113 (156)
T d1ihba_          35 RTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLR  113 (156)
T ss_dssp             CCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             cccccccc-cccccccccccccccccccccccCccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            68888665 56766777777889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCC-cccCCCCCCCCCcccccccccHHHHHHHHhhC
Q 020981           88 VVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG  129 (319)
Q Consensus        88 ~v~~Ll~~g~-~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g  129 (319)
                      ++++|+++|+ +++.+|..|+||+|+|+..++.+++++|++.|
T Consensus       114 ~~~~Ll~~~~~~~~~~d~~g~TpL~~A~~~~~~~iv~~Ll~~G  156 (156)
T d1ihba_         114 VVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG  156 (156)
T ss_dssp             HHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC
T ss_pred             ccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHhcC
Confidence            9999999875 89999999999999999999999999999876

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.76  E-value=5.2e-19  Score=137.29  Aligned_cols=102  Identities=30%  Similarity=0.333  Sum_probs=90.9

Q ss_pred             cchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH--------------------------------
Q 020981           40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE--------------------------------   87 (319)
Q Consensus        40 ~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~--------------------------------   87 (319)
                      ..||||.||..|+.++|+.||++|++++ +|..|+||||+|+..++.+                                
T Consensus         2 ~~t~L~~Aa~~g~~~~v~~LL~~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (153)
T d1awcb_           2 LGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHA   80 (153)
T ss_dssp             HHHHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCH
T ss_pred             CCHHHHHHHHCCCHHHHHHHHHcCCCcc-cccCCCccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4699999999999999999999999988 7999999999999987775                                


Q ss_pred             -HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           88 -VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        88 -~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                       ++++|+.+|++++.+|..|+||||+|+..|+.+++++|++.|+++...+....++
T Consensus        81 ~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tp  136 (153)
T d1awcb_          81 NIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTA  136 (153)
T ss_dssp             HHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             eeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCH
Confidence             5778888888999999999999999999999999999999999887665544444

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.75  E-value=1.2e-18  Score=135.53  Aligned_cols=92  Identities=16%  Similarity=0.046  Sum_probs=81.0

Q ss_pred             cccccccccccC---chhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHc
Q 020981            7 VRTTLLKQSSLA---PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ   83 (319)
Q Consensus         7 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~   83 (319)
                      -.|||+.|++.+   .....+...-+|.|+|.+|.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..
T Consensus        45 g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~  124 (154)
T d1dcqa1          45 DETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRL  124 (154)
T ss_dssp             TCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHHHHHHc
Confidence            368899888643   33444555557999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhhhCCCc
Q 020981           84 GFTEVVSLLLERGAD   98 (319)
Q Consensus        84 ~~~~~v~~Ll~~g~~   98 (319)
                      |+.+++++|++.++.
T Consensus       125 ~~~~i~~~L~~~~~~  139 (154)
T d1dcqa1         125 KHEHCEELLTQALSG  139 (154)
T ss_dssp             TCHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHhCCC
Confidence            999999999997643

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=1.8e-18  Score=155.08  Aligned_cols=135  Identities=24%  Similarity=0.229  Sum_probs=123.3

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE   87 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~   87 (319)
                      .||++.|+..+.....+.....+.+.+..+..|.||||.|+..++.+++++|++.|++++..+.++.||||.|+..++.+
T Consensus       232 ~t~l~~a~~~~~~~~~~~~~~~~~~~~~~~~~g~~~l~~a~~~~~~~i~~~Ll~~g~~~~~~~~~~~t~L~~~~~~~~~~  311 (408)
T d1n11a_         232 VTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIK  311 (408)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSH
T ss_pred             CCHHHHHHHhCcHhHhhhhhccccccccccCCCCChhhhhhhcCcHHHHHHHHHCCCccccccccccccchhhcccCcce
Confidence            56777788888777777777789999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCCCcccccccc
Q 020981           88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (319)
Q Consensus        88 ~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~~~~~~~~~~  142 (319)
                      +++++++.|++++.+|.+|.||||+|+..|+.+++++|+++|+++...+..+.++
T Consensus       312 ~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t~  366 (408)
T d1n11a_         312 LVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTP  366 (408)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCCH
T ss_pred             eeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            9999999999999999999999999999999999999999999987665444443

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.72  E-value=7.6e-20  Score=161.53  Aligned_cols=99  Identities=19%  Similarity=0.071  Sum_probs=86.8

Q ss_pred             CCCCCCcchHHHHHHHcCCHHHHHH---HHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCC--CCCCC
Q 020981           34 DGEEIKPEFRLMFLANERDVEGIKE---LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGST  108 (319)
Q Consensus        34 ~~~~~~~~t~L~~a~~~~~~~~~~~---Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~--~~g~t  108 (319)
                      +.++.+|.||||+||..|+.++++.   |++.|+++|.+|.+|+||||+||..|+.++|++|++.|++++..+  ..|+|
T Consensus        84 ~~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t  163 (346)
T d2ajaa1          84 HKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYH  163 (346)
T ss_dssp             HHHTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHH
T ss_pred             HhccCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCC
Confidence            4567789999999999999877665   789999999999999999999999999999999999999998876  46999


Q ss_pred             CcccccccccHHHHHHHHhhCCCC
Q 020981          109 PLGDAIYYKNHEVIKLLEKHGAKP  132 (319)
Q Consensus       109 pl~~a~~~~~~~i~~~L~~~g~~~  132 (319)
                      |||+|+..|+.+++++|++.|+..
T Consensus       164 ~L~~Aa~~g~~~iv~~Ll~~~~~~  187 (346)
T d2ajaa1         164 AFRLAAENGHLHVLNRLCELAPTE  187 (346)
T ss_dssp             HHHHHHHTTCHHHHHHHHHSCGGG
T ss_pred             hhHHHHHHhhHHHHHHHHHcCCcc
Confidence            999999999999999999988654

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=1.9e-17  Score=135.06  Aligned_cols=92  Identities=22%  Similarity=0.285  Sum_probs=86.1

Q ss_pred             CcchHHHHHHHcCCHHHHHHHHH----cCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCccccc
Q 020981           39 KPEFRLMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI  114 (319)
Q Consensus        39 ~~~t~L~~a~~~~~~~~~~~Ll~----~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~  114 (319)
                      +|+||||+||..|+.++++.|++    .|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++..+..|.++++.|.
T Consensus         2 dG~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a~   81 (228)
T d1k1aa_           2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLAC   81 (228)
T ss_dssp             TTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred             CCccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhccccccccccccccccccccccccccccccccc
Confidence            69999999999999999999885    79999999999999999999999999999999999999999999999999999


Q ss_pred             ccccHHHHHHHHhhCC
Q 020981          115 YYKNHEVIKLLEKHGA  130 (319)
Q Consensus       115 ~~~~~~i~~~L~~~g~  130 (319)
                      ..++.++++.+.....
T Consensus        82 ~~~~~~~~~~~~~~~~   97 (228)
T d1k1aa_          82 EHRSPTCLRALLDSAA   97 (228)
T ss_dssp             HTTCHHHHHHHHHHSC
T ss_pred             ccccccchhhhhhccc
Confidence            9999988887776543

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=1.6e-17  Score=141.70  Aligned_cols=89  Identities=22%  Similarity=0.261  Sum_probs=80.6

Q ss_pred             ccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHHHHHHHHHc-CCCCcccCCCCCCHHHHHHHcCCHHHHHHhhh
Q 020981           16 SLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLE   94 (319)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~~~~~Ll~~-ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~   94 (319)
                      ........+...-.|+|+|.++.+|.||||+||..|+.+++++||+. |+|||.+|.+|+||||+|+..|+.++|++|++
T Consensus       195 ~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~  274 (285)
T d1wdya_         195 DSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCK  274 (285)
T ss_dssp             TTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHH
T ss_pred             chHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHH
Confidence            33334556666668999999999999999999999999999999985 99999999999999999999999999999999


Q ss_pred             CCCcccCCCC
Q 020981           95 RGADVDPKDR  104 (319)
Q Consensus        95 ~g~~~~~~~~  104 (319)
                      +|||+|.+|.
T Consensus       275 ~GAd~n~~d~  284 (285)
T d1wdya_         275 RGASTDCGDL  284 (285)
T ss_dssp             HSSCSCCSSC
T ss_pred             CCCCCCcccC
Confidence            9999999884

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.66  E-value=1.6e-16  Score=129.22  Aligned_cols=135  Identities=24%  Similarity=0.193  Sum_probs=108.6

Q ss_pred             ccccccccccCchhhhhhhhhcCCCCCCCCCCcchHHHHHHHcCCHH---------------------------------
Q 020981            8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVE---------------------------------   54 (319)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~a~~~~~~~---------------------------------   54 (319)
                      .|||++|++.++....+.+.-.|.++|.++..+.|+++.++..++..                                 
T Consensus        24 ~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  103 (209)
T d1ot8a_          24 ETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNARMHDGTTPLILAARLAIE  103 (209)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTCCCHHHHHHHTTCT
T ss_pred             CCHHHHHHHcCCHHHHHHHHhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence            46777777777777777777777777777777777766666544433                                 


Q ss_pred             -HHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHhhhCCCcccCCCCCCCCCcccccccccHHHHHHHHhhCCCCC
Q 020981           55 -GIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (319)
Q Consensus        55 -~~~~Ll~~ga~vn~~d~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~a~~~~~~~i~~~L~~~g~~~~  133 (319)
                       ..+.|++.|++++.+|..|+||||+|+..+..++++.|++.+++++..|..|.||||+|+..|+.++++.|++.|+++.
T Consensus       104 ~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n  183 (209)
T d1ot8a_         104 GMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANRE  183 (209)
T ss_dssp             THHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTT
T ss_pred             hhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCC
Confidence             3444556677778889999999999999999999999999999999999999999999999999999999999999877


Q ss_pred             Ccccccccc
Q 020981          134 MAPMHVKHA  142 (319)
Q Consensus       134 ~~~~~~~~~  142 (319)
                      ..+....+|
T Consensus       184 ~~d~~g~Tp  192 (209)
T d1ot8a_         184 ITDHMDRLP  192 (209)
T ss_dssp             CCCTTSCCH
T ss_pred             CcCCCCCCH
Confidence            655444443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.22  E-value=2.6e-06  Score=70.18  Aligned_cols=127  Identities=13%  Similarity=0.024  Sum_probs=85.6

Q ss_pred             EEEEEEeceEeEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCcccccceeEEeCCceEEEEeecCCCCHHHHHHHcCC
Q 020981          168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA  246 (319)
Q Consensus       168 f~~v~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~  246 (319)
                      ++.+...+..+.+|.........   ...+.+|...++.+. +--+++++......+..++||++++|..+.+.....  
T Consensus        30 v~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--  104 (263)
T d1j7la_          30 VYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--  104 (263)
T ss_dssp             EEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--
T ss_pred             EEEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--
Confidence            34455567788899876443211   123567888887774 434677788777888899999999988876543211  


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------------------------
Q 020981          247 LKPSTAVRFALDIARGMNYLHENK--------------------------------------------------------  270 (319)
Q Consensus       247 ~~~~~~~~~~~qi~~al~~lH~~~--------------------------------------------------------  270 (319)
                         .....+..++...+..||+..                                                        
T Consensus       105 ---~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  181 (263)
T d1j7la_         105 ---QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE  181 (263)
T ss_dssp             ---SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCC
T ss_pred             ---ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcC
Confidence               112334555666666666432                                                        


Q ss_pred             CCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       271 ~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      +..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       182 ~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CcEEEEeeccCcceeecCCceEEEeechhccc
Confidence            11279999999999999876677999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.70  E-value=1.9e-05  Score=64.50  Aligned_cols=114  Identities=22%  Similarity=0.214  Sum_probs=71.8

Q ss_pred             ceEeEEEEecccccCCHHHHHHHHHHHHHHHhcCC--CcccccceeEEeCCceEEEEeecCCCCHHHHHHHcCCCCHHHH
Q 020981          175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA  252 (319)
Q Consensus       175 ~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  252 (319)
                      +..+.+|.-.....      ..+..|...++.+..  -.+++++....+.+..+++|++++|.++.+.     ..+..  
T Consensus        35 ~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~-----~~~~~--  101 (255)
T d1nd4a_          35 RPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS-----HLAPA--  101 (255)
T ss_dssp             SCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS-----CCCHH--
T ss_pred             CCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc-----cccHH--
Confidence            44577887554321      235667887777742  2366778887888889999999987554221     01111  


Q ss_pred             HHHHHHHHHHHHHHhh---------------------------------------------------CCC----CCeEEc
Q 020981          253 VRFALDIARGMNYLHE---------------------------------------------------NKP----VPIIHR  277 (319)
Q Consensus       253 ~~~~~qi~~al~~lH~---------------------------------------------------~~~----~~ivH~  277 (319)
                       ....++...|.-||+                                                   ..+    ..++|+
T Consensus       102 -~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHg  180 (255)
T d1nd4a_         102 -EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHG  180 (255)
T ss_dssp             -HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECS
T ss_pred             -HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeC
Confidence             112233333333332                                                   111    127999


Q ss_pred             CCCCCCEEecCCCCEEEEecCcccc
Q 020981          278 DLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       278 Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      |+.|.|||++.++.+-|+||+.+..
T Consensus       181 D~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         181 DACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             SCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCCCcceEEeCCceEEEEEchhccc
Confidence            9999999999876678999998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.53  E-value=0.00017  Score=62.90  Aligned_cols=29  Identities=28%  Similarity=0.375  Sum_probs=25.2

Q ss_pred             CeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       273 ~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      .++|+|+.|.|||++.++ ++|+||..|..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            389999999999999764 89999988754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.97  E-value=0.02  Score=47.77  Aligned_cols=30  Identities=30%  Similarity=0.371  Sum_probs=24.0

Q ss_pred             CCCeEEcCCCCCCEEecCCCCEEEEecCcccc
Q 020981          271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (319)
Q Consensus       271 ~~~ivH~Dlk~~Nill~~~~~~kl~DFgla~~  302 (319)
                      +..++|+|+.+.|||++. + ..++||+-|..
T Consensus       191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            335899999999999974 3 45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.12  E-value=0.012  Score=50.54  Aligned_cols=36  Identities=14%  Similarity=0.223  Sum_probs=24.9

Q ss_pred             HHHHHHHHHhcC-CCcccccceeEEeCCceEEEEeecCCCC
Q 020981          197 FRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (319)
Q Consensus       197 ~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~g~  236 (319)
                      ..+|..+++.+. +.-.+++++++..    .+|+||++|..
T Consensus        91 r~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~  127 (395)
T d1nw1a_          91 LVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP  127 (395)
T ss_dssp             HHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred             HHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecccc
Confidence            446888888885 4334677776643    68999997643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.36  E-value=0.0091  Score=49.59  Aligned_cols=29  Identities=24%  Similarity=0.213  Sum_probs=26.3

Q ss_pred             CeEEcCCCCCCEEecCCCCEEEEecCccc
Q 020981          273 PIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (319)
Q Consensus       273 ~ivH~Dlk~~Nill~~~~~~kl~DFgla~  301 (319)
                      +++|+|+.++|++++.+...-|.||+.|.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            59999999999999988777899999875